
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-10801-11100*
  '(".1-TRCN0000011645" ".2369C_T" ".2582T_A" "19b-26a" "23b-26a" "70S6K1"
    "A&D" "A+4" "A+4G" "A-2518G" "A-2Q" "A-375-TS" "A-C" "A-D" "A-E" "A-GFP"
    "A-LH" "A-T" "A-Trio-E-cadherin" "A-allele" "A-independent" "A-mediated"
    "A-type" "A1" "A2" "A25E-PKCγ" "A3140G" "A32" "A391E" "A4" "A465V" "A49G"
    "A5" "A549cells" "A6" "AA+GA" "AALL0232" "AAV-GFP-injected" "AAV-GFPCre"
    "AAV-GFPCre-injectedKlf4" "AB0" "AB0-compatible" "AB0-incompatible" "AB0c"
    "AB0i" "ABD" "ABI3" "ABPT" "ABT-737-induced" "ABT-737-treated" "ACAP3"
    "ACAs" "ACE2-knockout" "ACHKMNQRSTV" "ACP02" "ACP03" "ACU" "AChR" "AD169"
    "AD8" "AD8AxxA" "AD8FSNef" "ADCP" "ADNI-1" "ADNI-2" "ADNI-GO" "ADSC" "AE6"
    "AEG-1-shRNA-B" "AFC" "AG538" "AGAC" "AGGF1" "AIDS-like" "AIR-1" "AITDs"
    "AKAP-149" "AKLC" "AKRS" "AKT-273" "AKT-308" "AKT-mediated" "AKT8"
    "AKT_S473" "AKT + " "AKT–ERK1" "ALGENN" "ALGdS" "ALK-ALCL" "ALK-amplified"
    "ALK + " "ALL" "ALLTO" "ALS-like" "ALTTO" "AM38c1" "AMPAR" "AMPK-autophagy"
    "AMPKα2" "AMP∶ATP" "ANGPTL" "ANGPTL-4" "ANRIL" "AOAs" "AOA "
    "AP-1mut-MIR155HG" "APMK" "APOL2" "APPB2" "AR-1-660" "AR-1–660"
    "AR-481-919" "AR-binding-domain" "AR-interacting" "AR-knockout"
    "AR-mediated" "AR339" "ARACNe" "ARE-like" "ARG1" "ARKO" "ARL6IP" "ARMS-not"
    "ARMS-not=6" "ART-naïve" "ARTD" "ARby" "ARdMV" "AS-let-7a"
    "AS-let-7a-expressing" "AS-miR-30-expressing" "ASEAN" "ASOs" "ATAAGAATGC"
    "ATII-cell-derived" "ATII-cell-specific" "ATM-mediated" "ATP-competitive"
    "ATP-independent" "ATR-interaction" "ATRA–ATO" "AUC=0.94" "AUG" "AUKRA"
    "AV-45" "AW" "AXLXXX" "AZD" "AZD1208" "Ab-1-exposed" "Ab-1-occluded"
    "Abbott" "Abnet" "Ac-H3" "AcH3" "AcH4" "Accn" "Acetylated" "Act-1"
    "Activation-loop" "Ac–Phe–Phe–pSer–Pro–Arg–pNA" "Ad-AC" "Ad-Delo3-RGD"
    "Ad-EGFP" "Ad-Empty" "Ad-GFP" "Ad-Math1" "Ad-Math1-IRES-EGFP" "Ad-PTEN-NLS"
    "Ad-Pax2" "Ad-Pax2-IRES-EGFP" "Ad-Pax2-IRES-Math1" "Ad-WT" "Ad-WT-PTEN"
    "Ad-empty" "Adams" "Addadi" "Addgene" "Additivewith" "Aesop" "AffiniPure"
    "AffinitiPure" "Affy" "Affymetrix" "Africa" "African" "African-American"
    "African-Americans" "Africans" "Ag" "Aggregatibacter" "Ago2" "Agostino"
    "Aims" "Akisik" "Akt-p53-miR-365" "Akt1-3" "AktX" "Akti-1" "Akti1" "AlFx"
    "Ala+Ala" "Alamos" "Aldeflour" "Alexa" "Alexa-488-conjugated" "Alignment"
    "Alk" "Alloantibody" "Almendro" "Alvarado" "Alvarado-Vasquez" "Alves"
    "Alzheimer" "Alzheimer's" "Alzheimer’s" "Amadi" "Amadi-Obi" "America"
    "American" "Americans" "Amerindian" "Amersham" "AmiGo" "Amico"
    "Amphiphysin" "Amplification" "Amsterdam" "Amsterdam-like" "Andersen"
    "Andrew" "Ann" "Antonio" "Arabia" "Arg-1" "Arg399Gln" "Armitage"
    "Armstrong" "ArrayExpress" "Artandi" "Asano" "Ashcroft" "Ashkenazi" "Atm"
    "Atm-defective" "Auranen" "Aurora-A-T288" "Australia" "Austrian" "Axiocam"
    "Axioskop" "Axiovert" "Axis-Shield" "AxxA" "Aβ" "A–C" "A–D" "A–E" "A–T"
    "B-Myb-MuvB" "B-catenin" "B-cell-like" "B-cell−like" "B-induced"
    "B-lineage" "B-lymphoid" "B-lymphoma" "B-mediated" "B-ring" "B1" "B1-D"
    "B16-Fl" "B16BL6" "B1–C1" "B2" "B2–D" "B3" "B4" "B7.2-positive"
    "BAD-mimetic" "BAECs" "BAKΔN83" "BALB" "BALFs" "BAR-domain-containing"
    "BAR-domain-mediated" "BAT25" "BAT26" "BAT40" "BATTLE-2" "BAX-RE"
    "BAX-dependence" "BAX-p53-RE" "BAX-p53RE" "BBB" "BC145649" "BEZ" "BEZ-NVP"
    "BFAF" "BG430" "BG430-fluorescence" "BH1-3" "BH1–3" "BH3-domain"
    "BH3-domain-dependent" "BH3-domain-exposed" "BH3-only" "BH3-peptide"
    "BH3-peptides" "BIAcore" "BJ" "BJ-5ta" "BK-viral" "BK-viremia" "BM1"
    "BMCyt" "BMDMs" "BMI" "BMKs" "BMMs" "BOTs" "BPTES" "BRAF+PTC" "BRAF+PTCs"
    "BRAF-mutants" "BRAFL505H" "BRAFT1799A" "BRAFV600E" "BRAF→MEK→ERK" "BRB"
    "BT-35" "BT-40" "BT40" "BT474HR" "BT747" "BTB09089" "BTBD10-like" "BUZ"
    "BXL" "Ba" "Ba-L" "Background" "Bad_AA" "Bad_AG" "Bad_R-2A" "Bak" "Balb"
    "Balbiani" "BamHI" "Banff" "Barcelona" "Barcelona-Spanish" "Barlev"
    "Bartel" "Bastos" "Batf" "Bauer" "Bax-248" "Bax-248GA" "Bax-NT" "Bayes"
    "Bcl" "Bcl-2" "Bcl-x" "Bcl-xL-antagonist" "Bcl-xL–1LXL" "Bcl-xl"
    "Bcl-xl+BH3" "Bcl-xl-BH3" "BclXL-ligand" "BeadChip" "BeadChips" "BeadLab"
    "Beasley" "Beaucoudrey" "Beckman" "Beckwith" "Beckwith-Wiedemann" "Bedogni"
    "Begg" "Begg's" "Begg’s" "Behçet" "Behçet's" "Behçet’s" "Belmont" "Belzile"
    "Benites" "Benjamini" "Benjamini-Hochberg" "Benjamini-Hochberg-adjusted"
    "Bensaad" "Bernert" "Bertucci" "BglI" "Bhatla" "Bi" "Bi-allelic" "Bialik"
    "Bibikova" "Bid" "Bid-Bcl-xl" "Billen" "Bim" "Bin" "Biochemicals"
    "Biopsy-proven" "Biorad" "Bioscan" "Biosoft" "Biosystems" "Biotech"
    "Birt-Hogg-Dubé" "Bl6" "Blackburn" "Blasiak" "Blc-2" "Blum" "Bmf_A+4G"
    "Bmf_A+G" "Bmf_AG" "Bmf_R-2A" "BnAbs" "Boasso" "Bock" "Boer" "Bolli"
    "Boltzmann" "Bonefeld" "Bonefeld-Jørgensen" "Bonferroni" "Bonn" "Bordone"
    "Borrmann" "Borrmann’s" "Bothp53" "Bourguignon" "Box-whisker" "Boxtel"
    "Boyden" "Brachyury" "Braithwaite" "Brazil" "Brazionis" "Breg" "Bregs"
    "Bristol-Myers" "British" "Brodie" "Browser" "BsC-1" "Budanov" "Bukau"
    "Burk" "Burkitt" "Burkitt’s" "Burnett" "Byles" "Böckelman" "B–CDK1" "C+"
    "C-1031T" "C-260T" "C-260T多型がCAVI値と正の関連を認めた" "C-260T多型のCC型で最も低い値を示し"
    "C-F1-filtered" "C-NHEJ" "C-SAM" "C-allele" "C-alleles" "C-infected"
    "C-lobe" "C-ring" "C-rings" "C-termial" "C-terminal-most" "C-terminally"
    "C-type" "C-β-catenin" "C-δ" "C1" "C1-GAP" "C1-GAPtail" "C11orf36" "C14A"
    "C14orf130" "C166A" "C180" "C2" "C2orf44-ALK" "C2–D" "C3" "C3H" "C3H10T1"
    "C42Luc" "C42Luc-shBIM1" "C42Luc-shBIM2" "C4d" "C5" "C57" "C57BL6" "C9"
    "C9-deficient" "C91" "C=O" "CAAT" "CAAX" "CADOR" "CAGF9" "CALGB"
    "CAP-Glycine" "CASP12" "CASPs" "CAV-like" "CB-153" "CCCis" "CCL-3"
    "CCR5-tropic" "CD147-CD44s-STAT3" "CD147-STAT3" "CD147-mediated"
    "CD147dependent" "CD34-immunoreactivity" "CD34-negative" "CD34-positive"
    "CD44s-pSTAT3" "CD44v" "CDC20b" "CDK-consensus" "CDK1Y15P" "CEFs" "CEM-C7"
    "CEMC7" "CEP6" "CEP7" "CEU" "CEs" "CFP-E78P" "CFP-SKL" "CFP-peptide"
    "CGAGATAAAGAGTTGTTTGCGAA" "CGC" "CGCs" "CGG" "CH11" "CHKNQRST" "CHORI"
    "CHR" "CID" "CJ" "CJH" "CK1δ" "CK1ε" "CK2βbinding" "CKD4" "CKO+STZ"
    "CKO+Sal" "CKO+Saline" "CKβBP2" "CLOCK" "CLOCK-mediated" "CM-Dil" "CMTM6"
    "CNKI" "CNND1" "CNTF-treatment" "CNVR7875.1" "CNVs" "COBRA" "COIN" "COLI"
    "COXPH" "CP681301" "CPMG" "CR+PCR" "CRIF1-1-222" "CRIF1-158-206"
    "CRIF1-158–206" "CRIF1-2–222" "CRIF1-7-157" "CRIF1-7-222" "CRIF1-7–222"
    "CRIF1-99-222" "CRIF1-99–222" "CRL-2073" "CRTS" "CSA" "CT14" "CT21" "CT22"
    "CT9" "CTB-594" "CTCs" "CTGG" "CUG" "CUL3–RING" "CV" "CVF" "CVT-313" "CW"
    "CWWG" "CXCL" "CXW" "CYP450" "Ca" "CaArray" "CaCl" "Cabigas" "Cajal-like"
    "Calcusyn" "Caliper" "Calvisi" "Cambridge" "Campisi" "Canada"
    "Capture-ELISA" "Care" "Carl" "Carlsbad" "Carr-Purcell-Meiboom-Gill"
    "Carthew" "Cartron" "Caspase-3" "Caspase-3-CytoMet" "Caspse-3"
    "Catumaxomab" "Caucasians" "Cav-1" "Cavin-3" "Cavin-4" "Cavins" "Cbl"
    "Cbl-N" "Cdc37-knocked-down" "Cdc42" "Cdc42G12V" "Cdc42GTP" "Cdk1" "Celia"
    "Celia-Terrasa" "Cell" "CellMiner" "CellSearch" "CellTiter" "Cenit"
    "Cfr10I" "CgDHFR" "ChIP" "ChIP-PCR" "ChIP-ed" "ChIP-grade" "ChIP-qPCR"
    "ChIP-reChIP" "ChIP–quantitative" "Chaar" "Chae" "Chalfont" "Chang"
    "CheckMate" "Chehab" "Chemicon" "Chester" "Chi-Square" "Chi-square"
    "Chicago" "Choi" "Chou" "Chou-Talalay" "Chowdhury" "Ciras-3" "Circos"
    "Cistrome" "Clamydia" "Clarke" "CldU" "Clin" "ClinicalTrials"
    "Clinico-pathological" "Clone1" "ClustalW" "Cntf" "Cochran"
    "Cochran-Armitage" "Cochrane" "Coffin-Lowry" "Cofilin" "Cohen" "Complete"
    "CompuSyn" "Conclusion" "Conclusions" "Cong" "Cont+STZ" "Cont+Sal"
    "Cont+Saline" "Coomassie" "Cori" "Corp" "Corti" "Costello" "Coulomb"
    "Cowden" "Cox-regression" "Cp53" "Cr" "Cre" "Cre-loxP" "Crick-Watson"
    "Crohn" "Crohn’s" "Crouzon" "Cruz" "Ctl" "Ctla" "CuPhe" "Cufflinks" "Cul1"
    "Cullin-RING" "Cy3Cy5" "CyP-D" "CyPA-HAb18G" "CycD1-to-p21"
    "Cyclin-mediated" "Czech" "Cα" "Cα-atoms" "Cγ" "C–E" "C→T" "D+5" "D-box"
    "D-boxes" "D-type" "D186A-Nef" "D1C2" "D2" "D2-D3" "D2-class" "D2O" "D3"
    "D4" "D5" "D60C5" "D72H" "D837A" "D837A-Myc" "D84C12" "D88" "D88A" "DART"
    "DASL" "DASL-array" "DAVID" "DBD-hinge-LBD" "DBDH" "DCIS-like" "DCla1"
    "DDD-intact" "DDINR" "DDLS8817" "DEAD-box" "DEK-CAN" "DEK-NUP214-induced"
    "DENV" "DENV-host" "DESeq" "DEV" "DEVD" "DEVD-AFC" "DEVD-G" "DEVD-T"
    "DEVD-X" "DEVD-aldehyde" "DEVD-amc" "DEVDG" "DEVDT" "DEVDTRPASFWETS" "DFn"
    "DHB" "DHB-Ven" "DHBVen" "DHFRs" "DIANA" "DJ-1was" "DJM" "DKAT" "DL-21"
    "DLX" "DMEM" "DMPK-A" "DMPK-short" "DMR2" "DMYD" "DMYD-K" "DNA-PKs"
    "DNA-RNA-DNA" "DNA-protein" "DNAD-AFC" "DNAD-CHO" "DNAD-DEVD-T"
    "DNAD-DEVD-TRPASFWETS" "DNADDE" "DNADDEVD" "DNADDEVD-AFC" "DNADDEVDG"
    "DNADDEVDT" "DNAJB5" "DNAP" "DNA–Smad3" "DNID" "DNase-I" "DNaseI" "DNasel"
    "DO-1" "DO-24" "DPC" "DPSC" "DPSCs" "DQC" "DS-55004" "DSB-HR" "DSBs"
    "DSLLAYDY" "DTM" "DVL1-3" "DY5" "DYT" "DZNep" "Dalay" "Danish" "Danoy"
    "Danville" "Dartford" "Dasgupta" "Datta" "Davidson" "Davies" "Dbl-family"
    "DditT3" "Del19" "Design" "Desmond" "Dex" "Dgka" "Dharmacon" "Dhillon"
    "Diabetes-induced" "Diablo" "Dicer" "Dicer-substrate" "Dictyostelium"
    "Difco" "Dil" "Dimeglio" "Dimethylamino" "Disease" "DnaK" "Donald" "Dong"
    "Donnan" "Donnell" "Dontu" "Dornan" "Dose-dependently" "Double-strand"
    "Down-modulation" "Dual-Glo" "Dulbecco" "Dulbecco’s" "Dunn" "Durant"
    "Dutch" "Dynabeads" "Dyrk" "Dyrk1b" "Dyrkla" "E-01" "E-05" "E-Box" "E-Cad"
    "E-box" "E-boxes" "E-cadherin-catenin-Rho" "E-cadherin-mediated" "E-type"
    "E1-E5" "E129-R576" "E12–E15" "E13–19" "E17KAKT1" "E1A-like" "E1A13S"
    "E1B19-deletion" "E2+AP20187" "E2+BMS345541" "E2+FGF10" "E2-Ub" "E216"
    "E2A-HLF" "E2A-PBX1" "E2F-1▵87-95" "E2F3b" "E3-ligase" "E3-ligases"
    "E3-ubiquitin" "E4" "E4-mediated" "E5" "E6–12" "E74-like" "E78P" "E8"
    "EBPδ" "EBV-specific" "EC50" "EC50s" "ECIS" "ECOG" "EDNA" "EDNADDEV"
    "EDNADDEVD" "EDS" "EDS-PH" "EE-UL8" "EFGR" "EGF-R" "EGF-like" "EGFR-and"
    "EGFR-dependant" "EGFRvIII" "EGFRvIII-15" "EGFRvIII-5"
    "EGFRvIII-HB-EGF-EGFRwt" "EGFRvIII-positive" "EGFRvIII3" "EGFRvIIIdNLS"
    "EGFRwt-EGFRvIII-HBEGF" "EGFRwt-HA" "EHop" "EHop-016" "EJp" "EJp21"
    "EJp53-shp21" "ELISAs" "ELISPOT" "ELM" "ELYGNNAAAE" "EMG" "EMRA" "EMT-like"
    "EPPS" "ER-mosaic" "ER-negativity" "ER-positive" "ER-positivity" "ERE-Luc"
    "ERK-mediated" "ERMS" "ERMS=20" "ERSR" "ERα-S167A" "ERα-Ser167"
    "ERα-Ser305" "ERα-coregulatory" "ERα-network" "ERα-signalling"
    "ERα–IGF-1Rβ" "ES=0.53" "ESC-like" "ESPR-1" "ESPR1" "ESR1YAP1" "ESRP"
    "ESRP1-2" "ESRP1-5" "ESRP1-expression-vector" "ESRP1-transfection" "ESTV"
    "ESVD" "EScSG" "ETGE" "ETS-like" "EUFA1341" "EVD" "EVER1" "EVER2" "EXI"
    "EZH2-association" "EZH2-null" "EZH2in" "Easterners" "Eberhart" "Ecfp"
    "EcoRII" "Egger" "Egger's" "Egger’s" "Egwuagu" "Ehemann" "EhlersDanlos"
    "Eichhorn" "Eight-week" "Eighty-eight" "Eighty-five" "Ellis" "Elmer"
    "Elsevier" "Eluate" "Emory" "Endothelial-specific" "English" "Entrez" "Eph"
    "EphA2-Tiam1" "EphA2-initiated" "EphA2-mediated" "EphB" "EphBs" "Ephs"
    "EpiTECT" "Epithelial-mesenchymal" "Erb2" "Erdheim" "Erdheim-Chester" "Erk"
    "Ernst" "Ertumaxomab" "Esophago" "Esophago-gastric" "Español" "Espinosa"
    "Etopside" "Europe" "European" "European-ancestry" "European-descent"
    "Europeans" "Ewald" "Ex19Del" "Ex20Ins" "Exiqon" "Exon2" "Extra-dosage"
    "E–NADPH" "E–THF" "F-actin" "F-fludeoxyglucose-positron" "F-st" "F-star"
    "F1" "F12" "F191A-Nef" "F3-edited-NOESY" "F516G" "F6" "F83L" "FAIRE"
    "FAK-577" "FAK-RhoA-actomyosin" "FAKSer732" "FASTA" "FBWX7" "FCN" "FCRL4"
    "FCt" "FDA-approval" "FDSLLAYDY" "FEI" "FERM" "FERM-SH2-pseudokinase"
    "FFPE" "FGF" "FGFR1b" "FGFR2IIIc" "FGFR2b" "FGFR3tm" "FIMYDP"
    "FITC-streptavidin" "FLAG" "FLAG-CKβBP2" "FLAG-H1.1" "FLAG-SMAD2"
    "FLAG-SMAD3-polyubiquitylation" "FLAG-tag" "FLAG–Hsp90α" "FLJ10156"
    "FLJ43663" "FLNaL" "FLNaT" "FLT3-ITD" "FLT3-ITD-STAT5"
    "FLT3-ITD-expressing" "FM1-43" "FM4-64" "FNI" "FNI8-9" "FNII" "FNIII" "FOL"
    "FOX" "FOX01" "FOX03a" "FOX04" "FOXJ3" "FOXM1C" "FOXP3-functions"
    "FPRP=0.003" "FPRP=0.008" "FPRP=0.024" "FPRP=0.056" "FPRP=0.058" "FQELL"
    "FQNLF" "FSC" "FTSEC" "FTSECs" "FVBN" "FVC" "FWH" "FXXLF" "Fabrizio" "Fabs"
    "Factor" "Fas-induced" "Fas-mediated" "Fas→Caspase-8→Caspase-3" "Favetta"
    "Fc-induced" "Fcab" "FcabCD3" "FcabCD3showed" "FcγR1" "FcγRI" "Fe"
    "Fenton–Weiss–Haber" "Ferguson" "Fermentas" "Ferrari" "Ficoll"
    "Ficoll-paque" "Fifty-eight" "Fifty-six" "Fifty-two" "Fiji" "Fine-control"
    "Finland" "Finnish" "Fitchburg" "Flag" "Flag-ATM-WT" "Flag-HA-PALB2-Y551X"
    "Flag-L5" "Flag-Lac" "Flag-M2" "Flag-N" "Flag-RPL5-containing"
    "Flag-TRAF4-DM-Ring" "Flag-TRAF4-Ring" "Flag-TRAF4-TRAFc" "Fletcher"
    "Fletcher2013a" "Flna-null" "Flow-cytometric" "FlowJo" "Fluoromount" "Fn"
    "Fn-chips" "Follow-up" "FopFlash" "Fort-four" "Forty-eight" "Forty-five"
    "Forty-one" "Forty-seven" "Forty-six" "Forty-three" "Forty-two" "Fourier"
    "FoxO-DNA" "FoxO1-3A" "FoxO1-3A-5KQ" "FoxO1-5KR" "FoxO3-4KR" "Framingham"
    "France" "Fraser" "Fraser’s" "Fraumeni" "Frt" "Fu" "FuGene6" "Fucci"
    "Fuchs" "Fugene" "Fugene6" "Fung" "Fura" "Fura-2" "Fura2" "FuraRed" "FxxMF"
    "Fyn-mediated" "Förster" "G+4" "G+4A" "G-16854G" "G-8790A" "G-CIMP"
    "G-LISA" "G-actin" "G-allele" "G-conjugated" "G-coupled-protein" "G-rich"
    "G-to-A" "G0" "G0-like" "G1" "G1-arrest" "G1-peak" "G12C" "G12C_34G" "G15A"
    "G2" "G2-M" "G2-phase-acting" "G2–M" "G6" "G719X" "GA+AA" "GA+GG" "GA0044"
    "GA0075" "GA0098" "GA0119" "GA0139" "GA0152" "GAC" "GACCACCCA-like"
    "GACCACTCTCCGACCTAAAGG" "GADD45y" "GADD45α" "GADD45γbinding"
    "GAL-AR-624-919" "GAPtail" "GAS5-siRNA" "GAS5-siRNA-treated"
    "GATA3-positivity" "GAWSs" "GBM-4" "GBM748" "GBM9" "GBSW" "GBSW-membrane"
    "GC+CC" "GC+GG" "GCGs" "GCS" "GEFD1" "GEFD2" "GEFOS" "GFAPV12Ras"
    "GFAPV12RasPTEN" "GFP-DBDH-LBD" "GFP-EZH2-WT" "GFP-FAK-transfected"
    "GFP-H1.1" "GFP-Lpd-positive" "GFP-lifeact" "GFP-only" "GFP-tag" "GFPCre"
    "GG+GA" "GG+GC" "GG+TG" "GG4-like" "GGAT" "GGGAAAACAC3" "GGTCAT" "GGT→AGT"
    "GGT→GAC" "GGT→GAT" "GGT→GCT" "GGT→GTT" "GGT→TGC" "GGT→TGT" "GI50" "GI50s"
    "GIANT" "GKS-3β" "GLGC" "GLI-mediated" "GLI2ΔN" "GLI3C" "GLY82" "GMB"
    "GO-term" "GP-T" "GPCR-like" "GPL570" "GPL96" "GRAF1" "GREB" "GREs" "GS"
    "GS-positivity" "GSE14315" "GSE15361" "GSE21228" "GSE25055" "GSE4115"
    "GSH-ROS-JNK-ERK-iNOS" "GSH-Sepharose" "GSM1208799" "GSM935276" "GSM935557"
    "GST-Cbl-N" "GST-Cbl-N-G306E" "GST-ERα-S167" "GST-ERα-S212" "GST-NLS"
    "GST-Nef" "GST-Rac1ΔC" "GST-RhoAΔC" "GST-S6" "GST-Tat" "GST-Tat1-101"
    "GST-Tat1-45" "GST-fusions" "GST-pull" "GST-pulldown" "GSV" "GT-host"
    "GTCT" "GTG" "GTPases" "GUG" "GWA" "GWASs" "Gabbiani" "Gaiano"
    "Gain-of-function" "Gaithersburg" "Gal-AR-624-919" "Galbraith" "Garcia"
    "Garcia-Lozano" "Garcia-Saez" "Garcia-saez" "Garica-Saez" "Gatan" "Gd"
    "GenBank" "Gene-array" "GeneAtlas" "GeneChip" "GeneGET" "GeneID" "GeneIDs"
    "Genebank" "Genentech" "Genomatix" "Genome-Wide" "Genome-scale"
    "Genome-wide" "Genset" "Georgia" "Germ-line" "German" "German-GWAS"
    "Germany" "Ghoreschi" "Gibco" "Gingistat" "Gladesville" "Glaxo-Smith-Kline"
    "Gleason" "Gln426X" "Glueck" "Gly129-Leu131" "Gly2-Thr39" "Gogna" "Gonen"
    "Gornemann" "Gottlieb" "Gr1-population" "Gram-negative" "GraphPad" "Grn"
    "Grover" "Gu" "Guarente" "Guatemalans" "Gy" "Gα" "Gαq" "Gβγ" "H&E" "H+L"
    "H-RasG12V" "H-RasG12V-induced" "H-bond" "H-bonds" "H-heparin"
    "H-thymidine" "H1" "H1-Cy3" "H1-Cy5" "H1963" "H1972" "H1975" "H1993"
    "H1Cy3" "H1Cy3Cy5" "H1Cy5" "H2" "H265" "H265A" "H2A.Z-deposition" "H2AF"
    "H2B-mCherry–expressing" "H2B-mTurq" "H2O" "H3" "H3K27" "H3K27me3-HDAC4"
    "H3K27me3in" "H3K36" "H3K79" "H3K9ac" "H4" "H4C4" "H4K20" "H5" "H555A" "H7"
    "H733A" "H8" "H9" "H9N2" "HA-Ab" "HA-Akt-E17K" "HA-ERAP" "HA-Maz" "HA-Ub"
    "HADC4" "HADDOCK" "HAMA" "HAPLOTYPE" "HAb18" "HAb18G" "HCG" "HCVpro" "HCW"
    "HDAC1-dependent" "HDAC6-cortactin" "HDAC6has" "HDFs" "HEK-T" "HER2-E"
    "HER2-positive" "HER2-positivity" "HER2_siR3" "HERAKLES" "HFF" "HFK" "HFKs"
    "HG+Cont" "HG-U219" "HGSOC" "HGSOCs" "HIF-1does" "HIF-1is" "HIF-1response"
    "HIF-1show" "HIF1and" "HIF1does" "HIF1in" "HIF1α-1385-M0" "HIV-1Ada"
    "HIV-1MN" "HIV-1Tat-induced" "HJ" "HKR" "HL-7702" "HLA-A2"
    "HLA-DR4-restricted" "HMHA-1" "HNSCCs" "HOPC" "HOSE" "HOTAIR-transfected"
    "HOTAIR1" "HOTAIR1-mediated" "HOTAIR2" "HOX-A" "HOX-gene" "HOXD"
    "HR-relevant" "HR=3.0" "HR=3.8" "HRG-HER3-mediated" "HRasG12V" "HS90B"
    "HSCORE" "HSP7C" "HSP90-FLT3-ITD" "HSQC" "HSV-1" "HT29-ATMsh-GFP" "HV2EH"
    "HYT" "HYY" "Hannon" "Hansemann" "Hansen" "Hanssen" "Hanssen-Bauer"
    "HapMap" "Haploreg" "Hardy-Weinberg" "Hardy–Weinberg" "Harrison"
    "Hashimoto" "Hashimoto’s" "Hayakawa" "HbA1C" "Hck" "HckN" "Heidelberg"
    "Heinz" "Hematología" "Hep1-6" "Hepa-16"
    "Hepatocyte-specific-serine-45-mutated" "Herhaus" "Hernandez" "HiPerfect"
    "Hickey" "Hif-2α" "High-MEG3" "High-Risk" "High-potency" "High-risk"
    "High-titer" "Higher-molecular" "Hippo-YAP" "Hippo-YAP1" "Hippo-mediated"
    "His-LCK" "His-MafG" "His-SIRT3" "His-Xpress-tagged" "His-YAP" "His-tag"
    "His127-Leu131" "His130-Asp186" "Hispanic" "Hispanics" "Hje" "Hochberg"
    "Hochest" "Hodgkin" "Hodgkin's" "Hodgkin’s" "Hoechst" "Hoescht" "Holliday"
    "Hollowell" "Hondo" "Hozumi" "Hp91" "Hrk_A-2Q" "Hrk_G+4A" "Hs00153408"
    "Hs00269247" "Hs99999901" "Hs99999903_m1" "Hs99999905" "Hsp70"
    "Hsp70-knocked-down" "Hsp90–client" "Hu" "Huang" "Human1.2M-Duo"
    "Huntington" "Huntington’s" "Hussain" "Hyblot" "Hydroxychavicol"
    "Hypergene" "Hz" "I-IV" "I-TASSER" "I-labeled" "I-squared" "I-squared "
    "I941R" "IBFBP2" "IC-261" "ICC-SM" "ICI" "ICLC" "ICP8" "IDDM" "IDN"
    "IDN-1965" "IEC-iK" "IECs" "IEG" "IFI6-16" "IFN-β1a" "IFN-γ-pre-treated"
    "IGF-1-induced" "IGF2BPs" "IGFPB2" "II-III" "II-IV" "IIA" "IID" "IID=1"
    "IID=8" "III-IV" "IIIA" "IIIa" "IIIb" "IIIc" "III–IV" "IIβbinding" "IJL"
    "IKK-γ" "IL-17α" "IL6-like" "ILM" "INFγ" "IOCs" "IP-WB" "IPASS" "IPF"
    "IPMCs" "IPSS-R" "IQ" "IQ-domain" "ISI" "ITC" "ITIM" "IVIS" "IVTT" "Ibanez"
    "Ig-like" "Iggo" "Igs" "IkBαS32" "Ikβα" "Il" "Ile143Val" "Ile401Thr"
    "Iliopoulos" "Illumina" "Illumina's" "Immmunoprecipitations"
    "ImmunoReseach" "ImmunoResearch" "Immunoassay" "Immunochemistry" "Immunocy"
    "Immunogold" "Impedance" "In-gel" "InParanoid" "Inc" "Independent-samples"
    "Indian-Asians" "Indians" "Infinium" "InnateDB" "Inoue" "Institute"
    "InterPro" "International" "Interprosurf" "Intra-S-phase" "Invitrogen"
    "Iran" "Iscove" "Israeli" "Italian" "Italians" "Ito" "Ivanov" "I–II" "J2"
    "JAK-STAT3" "JAK2-V617F-positive" "JAPH" "JFH-1" "JFH1" "JM109" "JMYK"
    "JNJ" "JNJ-26854165" "JNK-ERK1" "JPA's" "JPT" "JQ1" "JR" "JS-124" "JV" "JW"
    "JYY" "Jaaskelainen" "Jab1" "Jackson" "Jak1-negative" "Jak1-positive"
    "Jak2-negative" "Jak2-positive" "JakI" "Jakkula" "Jakubowska" "Janicki"
    "Japanese" "Jeghers" "Jenster" "Jervell" "Jewish" "Jews" "Jiang"
    "JmjC-domain" "JmjC-domain-containing" "Jo2" "Johnson" "Jolla" "Jonsson"
    "Joseph" "Joutel" "Juglone" "Jun2-luc" "Jun2-luciferase" "Junttila" "JunΔN"
    "Justenhoven" "Jäger" "Jørgensen" "K142fs" "K1967" "K562b" "K652" "K652A"
    "K843–D1" "K860fs" "K860fs*43" "KAGKR" "KBrO" "KDACs" "KDASL" "KEAP" "KEGG"
    "KELCH" "KEN-box" "KFSHRC" "KGF-pre-treated" "KIEs" "KKK" "KLF4-pSTAT3"
    "KLF4dN100" "KLF4dN300" "KLP-3C" "KO-84" "KPL-3C" "KRAS-mutated" "KRL"
    "KRSTAMVHNQ" "KSAKDR" "KUE" "KVKF" "KVNF" "KX" "KYARTPN" "Kaeser" "Kajiho"
    "Kajstura" "Kaliman" "Kanagawa" "Kapan" "Kapan-meier" "Kaplan"
    "Kaplan-Mayer" "Kaplan-Meier" "Kaplan-Merier" "Kaplan–Meier" "Kaposi"
    "Karnofsky" "Karolinska" "Katoh" "Kaufman" "Kcat" "Keap1-CBD" "Kefas"
    "Kelch-like" "Kelsey" "Kendall" "Keunen" "Kheirelseid" "Khramtsov" "Ki-67"
    "Ki-67-positive" "Kim" "Kimura" "Kirchhoff" "Kirchhoff’s" "Kirsten" "Kit-8"
    "Klinefelter" "Klinefelter’s" "Km" "Knock-in" "Knocking-down" "Knowles"
    "Ko" "Kogyo" "Kohan" "Kolls" "Kones" "Korea" "Korean" "Koreans" "Korn"
    "Kornelia" "Kota" "Krekk" "Kruppel-Like" "Kruse" "Kruskal-Wallis"
    "Kruskall" "Kruskall-Wallis" "Krüppel-like" "Kubbutat" "Kultti" "Kumar"
    "Kuschel" "Kuwait" "Kuznestova" "Kyoto" "L-2R" "L-GMPs" "L-Type" "L0" "L2"
    "L3" "L50-823" "L505H" "L7" "L704N" "L8" "L858R" "LALIGN" "LAP1A"
    "LAP1B-BM2" "LAP1B-BM3" "LAP2β" "LBD-4,4" "LBD-CB-153" "LBD-DDE" "LBD-DHT"
    "LBD-POPs" "LBW242" "LC3-I" "LCL" "LCLs" "LDL-cholesterol" "LDS" "LER"
    "LHX" "LHbeta" "LIGPLOT" "LISA" "LJR" "LKB-1K78I" "LKB-K78I-expressing"
    "LKB1-K78I-expressing" "LKB1-defecive" "LKB1-defective" "LKB1-function"
    "LKB1-levels" "LKB1-substrate" "LKB1-substrates" "LKB1-tumor" "LKH" "LLL12"
    "LN229vIII" "LNA-ISH" "LNCap-PAK6-5A" "LNCap-PAK6-5E" "LNCap-PAK6-WT" "LNM"
    "LNP-DsiRNA" "LNP-DsiRNA–treated" "LNP2072-DsiRNA" "LNPs" "LOC643714" "LOD"
    "LOOCV" "LR" "LRQR" "LRQR–177" "LRT" "LTM" "LTSF" "LV-miR-130b"
    "LV-miRNA-130b" "LVMP" "LX" "LX22" "LXXLL" "LXXX" "LXXXXD" "LYRT301"
    "LYRT302" "LabWorks" "Labtech" "Lac" "LacO-LacI" "Laflamme" "Lai" "Laisk"
    "Lamp1-GFP–labeled" "Landi" "Lange" "Lange-Nielsen" "Laoukili"
    "Lapatinib-naïve" "Large-scale" "Latin" "Lats1" "Lbc" "Leave-one-out"
    "Lebiedzinska" "Leder" "Legesse" "Legesse-Miller" "Lehmann" "Leica" "Leng"
    "Leu84Phe" "Levels" "Levine" "Lewy" "Ley37D" "Leydig" "Li" "Li's"
    "Li-Fraumeni" "Liang" "Lif" "Ligthart" "Limit-dilution" "Lineweaver"
    "Lineweaver–Burk" "Lipofectamine" "Litovchick" "Liu" "Live-Cell"
    "Lkb1-mosaic" "Lkb1-null" "LncRNA-MEG3" "Loewe" "Lopez" "Lopez-Knowles"
    "Losonczi" "Loss-of" "Loss-of-function" "Louis" "Low-MEG3" "Low-density"
    "Lowry" "Lozano" "Lpd-Ena" "Lpd-F" "Ltd" "Lu" "Lubezky" "Luc-reporter"
    "Lucas" "Lue84" "Lue84Phe" "LumiCycle" "Luminal-A" "Luo" "Luzi" "Lyme"
    "Lyon" "Lys661AsnfsX24" "LysM-Cre-loxP" "M-to-S" "M0" "M11" "M12" "M14"
    "M27" "M29" "M35" "MA+gp120" "MA-induced" "MA-mediated" "MAASVR" "MAB1935"
    "MALAT-1" "MAP205" "MAPK-pathway" "MAPK-pathways" "MAPPER" "MARK1–4"
    "MATIIa" "MBP-FOXP3-Full" "MCF10ANeuT" "MCF7-TamR" "MCH903.1" "MCL-1shRNA"
    "MCL1-1916-M14" "MCM2–7" "MCN" "MDA-MB-1386" "MDA-MBA-231" "MDA-MD231"
    "MDM-C" "MDM2-A" "MDM2-B" "MDM2-C" "MDM2-FL" "MDM2Tr" "MDS-L" "MDSCs"
    "MDSs" "MDX-H210" "MEFS" "MEK-Functional" "MEK-functional" "MEK→ERK"
    "MET-hours" "MGMTLeu84Phe" "MHC-II" "MHC1" "MHV" "MHV-68" "MHW" "MIA-PaCa2"
    "MIR155GH" "MIR155HG" "MIR581" "MK-8876" "MK2206-TUSC2" "MKN" "MKN-cells"
    "MLL-AF1p" "MLL-fusion" "MLW" "MMGBSW" "MODELLER" "MP-eggNOG" "MPIP" "MRD"
    "MRGPRE" "MRN" "MS-PCR" "MS2-GFP-MS2-CRΔ4" "MS2-GFP-flag-MS2-CRΔ4"
    "MS2-GFP–MS2-CRΔ4" "MSCV" "MSCV-IRES-GFP" "MSCV-TDAG8-IRES-GFP" "MSI-H"
    "MSI-L" "MSK-922" "MSK-96" "MSS-subpopulations" "MTCp25" "MUC5A" "MV4"
    "MacRae" "Machado" "Machado-Joseph" "Madamanchi" "Madan" "Majek" "Makowska"
    "Malays" "Malpica" "Mammostrat" "Mander" "Mandila" "Mant-NMN" "Marasa"
    "Marchesani" "Marzec" "Mas" "Mass" "MassARRAY" "Masutani" "Math1-null"
    "Matrigels" "Matritech" "Maxisorp" "Mayer" "Mayne" "Mayo" "Mazzanti" "Mbp"
    "McCarthy" "McCarty" "McCoy" "McCoy’s" "McEwan" "McFarland" "Mcl1-specific"
    "Mdm2" "Mdmx-dependent" "Med1" "Medaka" "MegaTOPFLASH" "Meier" "Melanesia"
    "Melbourne" "Mellert" "Menten" "Meran" "Merier" "Merkel" "Mesenchymal-type"
    "Met-RANTES" "Met-dependence" "Meta-regression" "Metabochip" "Metamorph"
    "Metellus" "Methodology" "Methods" "Methylated-PTPRO" "Meunch" "Mexican"
    "Mi-2" "Mi-2β" "Mi2-α" "MiR-103" "MiR-130b" "MiR-19b" "MiR-23b" "MiR-24"
    "MiR-26a" "MiR-449b" "MiR-92" "Michaelis" "Michaelis-Menten"
    "Michaelis–Menten" "Micro-dissection" "MicroRNA-155" "MicroRNA-7" "Midgley"
    "Mifsud" "Migliaccio" "Miguel" "Millipore" "Milner" "Mini-gene" "Miniprep"
    "Miossec" "Mn" "MoDCs" "Mob1a" "Mock-infected" "Moloney" "Molsoft"
    "Monochromosome" "Monocyte-Derived" "Monocyte-derived" "Montalvo"
    "Montalvo-Ortiz" "Monte" "Morgan" "Moshynska" "Motiani" "Mourtada-M"
    "Mouse" "Mst" "Mst1" "Mukohara" "Multi-domain" "Multiphoton-based"
    "Multiscan" "Murex" "Murry" "Muscle-invasive" "Mut-1" "Mut-4" "Mut-5"
    "MutationTaster" "MyHits" "MyPhoNE" "Myc-tag" "Myers" "Myosin-1a"
    "Myosin-1c" "Myosin1c" "Myr-Akt" "Myr-Akt1" "Myrk" "Mzf" "Mzf-2" "N-BAR"
    "N-TROSY" "N-acetyl" "N-domain" "N-formyl-kynurenine" "N-labeled"
    "N-labelled" "N-lobe" "N-methyl-N" "N-methylanthraniloyl" "N-positive"
    "N-ras" "N-trimethylammonium" "N-β-catenin" "N-β-catenin-positive" "N0–N1"
    "N0–NI" "N23PP" "N320" "N339fs" "N=20" "N=7" "NA7-Nef" "NAC-1" "NACRT"
    "NADPH" "NAFLD" "NANOG-poised" "NANOG-regulated" "NAPDH" "NCAP" "NCBI"
    "NCI" "NCI-60" "NCI-H128" "NCI-H1688" "NCI-H187" "NCI-N592" "NCI60"
    "NC_siR" "NC_siR-treated" "NEs" "NF-kB1" "NF-κB1" "NFX1-91" "NFkappB" "NH"
    "NICD1" "NICD3" "NIMA-1" "NIS-Luc" "NLS-PTEN" "NMNAT2+SIRT3" "NM_015602"
    "NNP" "NOS-RE" "NOS3-RE" "NOS3-p53-RE" "NOS3-p53RE" "NOTCHs" "NP-IS"
    "NPC62" "NPM-ALK" "NPM-ALK-induced" "NPM-ALK-positive" "NPM1c" "NQO1-ARE"
    "NQO1-ARE-dependent" "NSLCC" "NTKD" "NVP" "NVP-BGJ398" "NVP-LDE225"
    "NVP-RAD001" "NVPAE" "NWASP-mediated" "NZB" "Na" "Nadal" "NaeI" "Nakagawa"
    "Nakao" "Nalge" "Nalls" "Naperville" "Napoli" "Naxos" "Ncr" "Necroptosis"
    "Neg" "NetNES1.1" "Netherlands" "NeuT" "Neuro-Oncology" "Neve" "Nfibiz"
    "Nielsen" "Nikon" "Nixdorf" "Nkd1" "Nkx2-9" "Nod" "Noel" "Nonidet" "Norway"
    "Novartis" "Novocastra" "Nras" "Nrf" "Nrf2-ARE" "Nrf2-indepentdent"
    "NuPAGE" "NuRD" "Nuc" "Nunc" "Nurr" "Nurr-77" "O-linked" "O1" "O2" "O4"
    "OA" "OB-LCA" "OHdG" "OMIM" "ONYX" "ONYX-015" "OPLS" "OR-α" "OR=0.65"
    "OR=0.680" "OR=0.693" "OR=0.71" "OR=0.84" "OR=0.96" "OR=1.03" "OR=1.031"
    "OR=1.04" "OR=1.05" "OR=1.08" "OR=1.09" "OR=1.11" "OR=1.14" "OR=1.17"
    "OR=1.21" "OR=1.28" "OR=1.29" "OR=1.30" "OR=1.31" "OR=1.41" "OR=1.47"
    "OR=1.48" "OR=1.57" "OR=1.64" "OR=2.35" "OR=2.96" "OR=3.14" "OR=3.25"
    "OR=3.45" "OR=3.85" "ORK" "ORs" "OR = 1.28" "OR = 1.29" "OR = 1.30"
    "OR = 1.31" "OSM-treatment" "OT-1" "OTUB1–SMAD2" "OVCA" "OVID" "Obserivng"
    "Oceania" "Oct3" "Oerlemans" "Oguchi" "Okuma" "OmniExpress"
    "OmniExpress-12" "On-Chip" "On-Target" "Oncol" "One-hundred" "One-time"
    "Ongusaha" "Op18" "Open" "Orai-3" "Orangutan" "Orbitrap" "Orbitrap-Velos"
    "Ordinario" "Organization" "OriGene" "Orthomyxovirus" "Ortiz" "Os" "OsO"
    "Oslo" "Over-representation" "OxCy" "OxR" "OγH" "P-FAKSer732" "P-S376-MSK"
    "P-S380-RSK" "P-T389" "P-T389-S6K1" "P0" "P1" "P1-P1" "P190RhoGEF" "P202A"
    "P261A" "P286R" "P2X" "P2Y" "P4-P3-P2-P1-P1" "P400T" "P430fs" "P53-null"
    "P65" "P7" "P=0.000" "P=0.001" "P=0.0022" "P=0.003" "P=0.005" "P=0.006"
    "P=0.008" "P=0.009" "P=0.011" "P=0.012" "P=0.014" "P=0.018" "P=0.02"
    "P=0.026" "P=0.027" "P=0.035" "P=0.047" "P=0.048" "P=0.050" "P=0.053"
    "P=0.058" "P=0.13" "PACF" "PAH-DNA" "PAI-1was" "PALB2ΔC" "PAM50" "PANC-EV"
    "PANC-EV-derived" "PANC-EV2" "PANC-EV9" "PANDA" "PANTHER" "PARP-1-Myc-His"
    "PARP-his" "PAb421" "PBLs" "PBS-G" "PBS-T" "PBS-injections" "PBS2" "PBS3"
    "PBS4" "PBS5" "PBTC" "PBTC-029" "PC-3" "PC-9R" "PC-space" "PCNA-positivity"
    "PCR-RFLP" "PCR-SSCP" "PD980059" "PDA" "PDACs" "PDCD4-absent"
    "PDCD4-less-expressing" "PDGFRα" "PDGFRα-negative" "PDGFRα-positive"
    "PDL-1" "PDX-unique" "PEST-like" "PETACC-3" "PETHEMA" "PF-573" "PF562271"
    "PHH3" "PHHs" "PHM82" "PI+ve" "PI-107" "PI3K-AKT-dependent"
    "PI3K-Akt-independent" "PI3K-pathway" "PI3KC" "PI3KCA" "PI5K" "PICT"
    "PIKKs" "PI−ve" "PK-8" "PKCα" "PLCγ2cKO" "PLX4720-induced"
    "PLX4720-resistance" "PMID" "PMN" "PMN-MDSCs" "PMW" "PP1γ1" "PP1γ2"
    "PP1γ2end" "PP2A-A" "PP6R2" "PPC-1" "PPIs" "PRC2-indepednent" "PRC4"
    "PRMTs" "PROMO" "PRTM5" "PSIVER" "PSQDNIDGEGNT" "PTEN-A4" "PTEN-E4"
    "PTEN-NLS" "PTEN-intact" "PTEN-null" "PTF" "PTs" "PUC" "PWN" "PWPP" "PXZ"
    "PY-20" "Palomero" "Palyi" "Palyi-Krekk" "Pan-Asian" "PanIN" "PanIN-like"
    "PanINs" "Pandolfi" "Parker" "Parkinson" "Parkville" "Partek" "Patchdock"
    "Patholog" "Patsialou" "Pd-l1" "Pearson" "Pearson’s" "Peifer" "Per2-Luc"
    "Perkin" "Perou" "Petitjean" "Peutz" "Peutz-Jeghers" "Peyer" "Peyer’s"
    "PfDHFR" "PgR-expressing" "PgR-negative" "PgR-positive" "Pgrn" "Ph"
    "Ph-like" "Ph-likeness" "Pharma" "Pharmacia" "Phase-contrast" "PhiC31"
    "PhiKan" "Philadelphia" "Phox-I1" "Phyre" "Pifithrin-α" "Pin1"
    "Pin1-competent" "Pin1-proficient" "Pin1wt" "Pinton" "Piscataway"
    "Platinum-doublet" "Pml" "Poisson" "Poisson-Boltzmann" "Poland" "Polo-box"
    "Polyak" "Polycomb-repressive" "Polyethylenimine" "Polyphen" "Ponti"
    "Post-hoc" "Post-simulation" "Post-surgery" "Post-transcriptional"
    "Posthoc" "PpXX" "Prager" "Pramanik" "Pratt" "Prepore" "Principal" "Prives"
    "Pro-N" "Pro-proliferative" "Pro-survival" "Pro105-Ala107" "ProTEV"
    "Programa" "Promega" "PromoterSweep" "Prosite" "Protein" "Protein-A"
    "Protorp" "Pro–Xaa" "PsA" "PtIns" "PuertoRico" "Puliyappadamba" "Puma_A+4G"
    "Punnoose" "Purkinje" "Pvu" "PvuII" "PxxP" "PyVAN" "Pygo1" "Pygopus"
    "P = 0.02" "P = 0.03" "P = 0.011" "P = 0.036" "Q-2A" "Q-MSP" "Q-Q"
    "Q-Value" "Q-value" "Q-value " "Q8l120" "QC-autophagy" "QL" "QT"
    "QVGRQLAIIG" "Qiagen" "Quantile-quantile" "R-2" "R-2A" "R-CHOP" "R-bearing"
    "R-rich" "R1" "R109-ADMA" "R111" "R113" "R113-SDMA" "R113K" "R139-D583"
    "R2" "R273H" "R28-GBM" "R3" "R5" "R656A" "R656suggest" "R6AL9A"
    "RA-response" "RA-treatment" "RAC1b" "RAD51B-C-D-XRCC2" "RANO"
    "RAS-pathway" "RB-pathway" "RB-pathways" "RB-proficient" "RD-mock"
    "RD-shDMPK" "REACTOME" "REGγ-knockout" "RF10" "RFDSRLAFHH" "RFLP"
    "RGD-fiber" "RGYR" "RHIM" "RHS4533-NM_003608" "RIE" "RIE-iH" "RING–E3"
    "RIP-seq" "RISC-dependent" "RISC-mediated" "RKRPS" "RKTs" "RLU" "RMSDs"
    "RNA-EMSA" "RNA22" "RNAhybrid" "RNCs" "RNeasy" "ROIs" "RORγ" "RP-IS"
    "RP11-1150O2" "RP11–328L16" "RPASFWETS" "RPL17p33" "RPMAs" "RPMI1640"
    "RPPAs" "RPVHAN" "RP–PCR" "RRB" "RRL" "RRRCWWGYYY" "RT-QPCR" "RT-qPCR"
    "RVxF" "RWNC" "RXLXXXSD" "RXXL" "Rab-7–positive" "Rab11" "Rab4" "Rac-GTP"
    "Rac1" "Rac1G12V" "Rac1GTP" "Rac1WT" "Rad3" "Radioresistance" "Raichu"
    "Ras-like" "Rb-E2F" "Rb-dependent" "Rb-positive" "Rb1" "RbC-E2F1-DP1" "RbN"
    "RbN-pocket" "Rbconstruct" "Re-exposure" "Re-expression" "Re-sequencing"
    "RedeR" "Reed-Sternberg" "RefSeq" "RegRNA" "Reis" "Reis-Filho’s" "Rela"
    "Rembrandt" "Renner" "Results" "Retiga" "Reuther" "Rev-Erbα" "Reverse
transcriptase–PCR"
    "Revman" "Rex1-negative" "Reynold" "Reynolds" "Rho-GTP"
    "Rho-GTPase-mediated" "Rho-family" "Rho-like" "Rho123" "RhoA-GDP"
    "RhoA-GTP" "RhoAL63" "RhoAN19" "RhoAV14" "RhoA⋅GDP" "RhoBTB" "Ring-H2"
    "Ripa" "Rizzuto" "Roberts" "Robeva" "Roche" "Rodier" "Roeder" "Romanowicz"
    "Romanowicz-Makowska" "Rosa26" "Rosa26-LSL-rtTA" "Rosa26-rtTA" "Rotterdam"
    "Rowland" "Rpn10" "Rpn6" "Rs1550532" "Rs1570669" "Rs780094" "Rudin"
    "Russia" "Rutitzky" "Rvs" "Ryan" "Ryuvidine" "S+4" "S+4A" "S+4G"
    "S-E-cadherin" "S-S" "S-antigen" "S-labelled" "S-radiolabeled" "S1" "S1-S6"
    "S104" "S106" "S109A" "S10A" "S10D" "S127A" "S164A" "S1C" "S1D" "S1E"
    "S1P-mediated" "S235" "S236" "S240" "S244" "S289A" "S289D" "S2A" "S2B"
    "S2C" "S2D" "S2E" "S3" "S305A" "S33Y" "S345" "S367A" "S367D" "S381A" "S383"
    "S3C" "S3D" "S3F" "S3H" "S3L" "S3N" "S4" "S4A" "S4B" "S4C" "S4D" "S4E"
    "S4F" "S5A" "S5C" "S5D" "S5E" "S5F" "S5G" "S5a" "S5aUIM" "S5aΔUIM" "S6"
    "S6-pSer" "S608" "S612" "S61A" "S62A-HA-Bcl-xL" "S63" "S652A" "S6A" "S6C"
    "S6Ki" "S7" "S73" "S734A" "S780A" "S788" "S795" "S8" "S807" "S811" "S8A"
    "S8B" "S9" "SA-β-gal-positive" "SA62-Bcl-xL" "SBE-4" "SCARNA5" "SCARNA6"
    "SCt" "SD+PD" "SDF1α" "SDS-gel" "SDS-glycine" "SDS-polyacrylamide"
    "SDS-soluble" "SF-induced" "SFAs" "SH3-ligand" "SHN" "SHP-2-knockout"
    "SIFT" "SIINFEKL" "SIK1–3" "SILK" "SIN-J" "SIRT" "SIRT3-C1" "SIRT3N"
    "SIRTs" "SIVdrl" "SIVmac" "SIVmac-251" "SIVmac251" "SIVmnd" "SIVmnd-2"
    "SIVrcm" "SK-3" "SK-N-DZ" "SKCM" "SKI-II" "SLE-risk" "SLEC" "SLEDAI"
    "SMAD3-interaction" "SMAD3–OTUB1" "SMART-MSP" "SMMC-7721cells" "SMP14"
    "SND-1" "SNESVD" "SNESVD-Y" "SNF-2-related" "SNORA54" "SNP30" "SNP6"
    "SNP6.0" "SNPPCR" "SNPPCR-RFLP" "SNPStats" "SNPinfo" "SNPs" "SNU" "SNU-C1"
    "SNV" "SNVs" "SOGC" "SP-IS" "SP100125" "SPCA-1" "SPKK" "SPOP-mediated"
    "SPSS" "SRI-9662" "SRKGQERLEH" "SSCP" "SSEDNADDEVDT" "STAT5A_ΔE18" "STEMI"
    "STRO-1" "STSF" "STZ+TG" "STZ+WT" "SU-DHL10" "SU-DHL2" "SU-DHL4" "SU-DHL6"
    "SV5" "SV589" "SVD" "SW-1990" "SWOG" "SXS" "SY" "SYMD3" "SZ" "Sall"
    "Salmena" "Sampson" "Samuels" "Sanger" "Sanna" "Santz" "Saretzki" "Sato"
    "Sattler" "Saudi" "Saxena" "Scan" "Schmidt" "Schrader" "Schrödinger"
    "Schwann" "Scimedx" "Scl70" "Scorpion-ARMS" "Seckel" "Self-Renew"
    "Selicilib" "Sendai" "Sensys" "Sephacryl" "Sequenom" "Sequential-ChIP"
    "Sequest" "Ser1981" "Ser2448p-mTOR" "Ser305" "Ser326Cys" "Ser732→Ala"
    "Ser807" "SerS305" "Sertoli" "Sertoli-cell-only" "Sertoli-cells-only"
    "Seto" "Settleman" "Seventy-eight" "Seventy-one" "Sharma" "Shedden"
    "Shedden’s" "Shenvi" "Sherman" "Shh" "Shimizu" "Shiraha" "Short" "Shugars"
    "Significance" "Simpson" "Single-cell" "Single-gene" "Sinha" "Sinha-Datta"
    "Sirius" "Sirt1-function" "Sixty-four" "Sixty-six" "Sjogren" "Sjogren’s"
    "Skp1" "Skp1–CUL1–F-box" "Slimb" "Sliwinski" "Smack" "Smad-binding" "Smad2"
    "Smad3" "Smad4-null" "Smad–DNA" "Small-cell" "Smart-pool" "SmartAmp"
    "Soas2" "Socio-economic" "Soroka" "Sottile" "Soucek" "Soung"
    "South-Central" "Southest" "Sox2" "Sp1-NF-Y-DNA" "Spalt" "Spanish"
    "Spearman" "Spearman’s" "Sphere" "Squibb" "Src-416" "Src-family" "SrcI-1"
    "Staab" "Stahmin1" "Steadman" "Steady-state" "SteadyGlo" "Sternberg"
    "Steroid-induced" "Stim" "Stockholm" "Stockinger" "Stromal-epithelial"
    "Structure-based" "Stupp" "Sub-G1" "SuperKiller" "SuperScript"
    "SuperSeries" "Superdex" "Sweden" "SwissProt" "Sydney" "Sykes" "Syndrome-1"
    "S–ROC" "T-B" "T-Lymphoma" "T-Pro" "T-allele" "T-alleles" "T-cell"
    "T-independent" "T-lineage" "T-lymphomas" "T-non-regulatory" "T-regulatory"
    "T-to-G" "T-type" "T1" "T1+T2" "T115E" "T119A" "T119D" "T1799→A" "T1–T2"
    "T2-3N0M0" "T202" "T2D" "T2DM" "T2N0M0" "T3" "T3-T4" "T356" "T373" "T3N0M0"
    "T3–T4" "T4" "T4-lymphocytes" "T425E" "T529N" "T790M" "T821" "T826" "T91"
    "T91T93" "T91–93" "T91–T93" "T93" "T95" "T95-T93-T91" "T=4" "TA-cloning"
    "TA-p63+Smad3" "TA-p73+Smad3" "TAGCAG" "TAGT" "TAM-R" "TAP1-promoter" "TAR"
    "TASSER" "TATA" "TATA-less" "TAp73" "TBARS" "TBEs" "TBST" "TC+CC" "TC+TT"
    "TCCN" "TCG" "TCID" "TCID50" "TCT" "TCell" "TDAD8" "TDAG" "TDAG8-shRNA"
    "TEAD1-4" "TEFb" "TEV" "TF-centric" "TFBIND" "TFDP" "TFSEARCH" "TG+STZ"
    "TG+Saline" "TG-ND" "TGAb" "TGF-β
RII"
    "TGF-βRI" "TGF-βRII" "TGG" "TGGC" "TGGT" "TIRFM" "TK-deprivation"
    "TK-deprivation-induced" "TLE" "TMEM" "TNBT" "TNF-family" "TNF-like"
    "TNFα-sensitivity" "TNUL76" "TOAST" "TOM" "TOM-20" "TOPFLASH"
    "TOX3-LOC643714" "TPOAb" "TPR-Met" "TRAAP220" "TRAF4-Ring" "TRAF4-TRAFc"
    "TRAIL-induced" "TRAIL-mediated" "TRANSFAC" "TRIPZ" "TRIS" "TROAP" "TROSY"
    "TRPASFWETS" "TS-1" "TS516" "TT+CT" "TT+TC" "TTA" "TTAA" "TTAGGG" "TTC"
    "TTC31-shR-V5" "TTCN" "TTT" "TUJ1" "TURB" "TUSC2-MK2206" "TUSC2-defective"
    "TW-37" "Tabas" "Table1" "Taiwanese" "Takahashi" "Talalay" "Tanaka"
    "Tannerella" "Taq" "Taq-Man" "TaqMan" "TargetScan" "TargetScanHuman" "Tat"
    "Tat-deleted" "Tat-independent" "Tat-induced" "Tat-mediated" "Tat-mutants"
    "Tat-specific" "Tat-stimulated" "Tat-treated" "Tecnai" "Telocytes" "Teng"
    "Tenovin-6" "Terrasa" "Testoni" "Tet+E2" "Tet+E2+FGF10" "Tet-on"
    "Tet-on-LKB1" "Tet-on-inducible" "TetO-PAF-IRES-emGFP" "Tg" "Tgf-β"
    "Tgf-β1" "Th1-like" "Th17" "Th172" "Th2" "Th308" "Thep53" "Thermo"
    "Thermoscientific" "Thirty-five" "Thirty-four" "Thirty-six" "Thirty-three"
    "Thirty-two" "Thr241Met" "Thr308p-AKT" "Thr39-Leu49" "Thr40-Gly129"
    "Thy-Noc" "Thy-Thy" "Tiam-EphA2" "Tiam1" "Tian" "Tikhmyanova" "Time-lapse"
    "Tnon" "Tnon-reg" "Tnv" "Tnv-37" "Tnv-45" "Tnv-6" "To-date" "Toll-like"
    "Tomer" "Tramtrack" "Tratamientos" "Treponema" "Trinei" "TrioGEFD"
    "TrioGEFD1" "TrioGEFD2" "TrioPH" "TrioPH1" "TrioPH2" "Triple-negative"
    "Tris-Cl" "Tris-HCl" "TrisCl" "Trp53" "Tsai" "Tumor-node-metastasis"
    "Tumorscape" "Turks" "Turley" "Turnell" "Turvy" "TvOH" "Tween" "Tween-20"
    "Twenty-eight" "Twenty-five" "Twenty-four" "Twenty-nine" "Twenty-one"
    "Twenty-two" "Two-Hybrid" "Tyr-342-specific" "T→A" "T→E" "U-Test" "U133"
    "U133A" "U1387-MG" "U20S" "U251-vIII" "U251EGFRvIII" "U251vIII"
    "U251vIII-15" "U251vIII-18" "U251vIII-2" "U251vIII-5" "U251vIII-C"
    "U373-PTEN" "U373MG-Null" "U6" "U87-vIII" "U87MG-Null" "U87PTEN" "U87vIII"
    "UADT" "UAG" "UBE2E" "UBL-binding" "UBR7" "UCEC" "UCHs" "UCP1006" "UCP1015"
    "UCP1017" "UCP1019" "UCP1025" "UCP1040" "UCP1075" "UCP1076" "UCP1076-1077"
    "UCP1077" "UCSC" "UCU" "UEA" "UGG" "UK-GWAS" "UK-replication" "UKBS"
    "UL146" "UL24" "UL52" "UL76-HA" "UL77" "UM-SCC-10B" "UM-SCC-19" "UNC5H"
    "UO-31" "UOCB1" "UP-transit" "USA" "USP29" "USP2a" "USP40" "UTR-wt" "UTRs"
    "UV-irradiation" "UV-irritation" "UVB" "UVB-irradiated" "UVC" "UVP"
    "Ub-TP53" "Udorn" "Ulex" "Ulk" "Ulrich" "Under-expression" "Uppsala" "Utah"
    "Utrera" "Uğurluer" "V-EGF" "V-Ki-ras2" "V5" "V5-tag" "V5-tagged" "V600"
    "VACO432" "VAF" "VDTRPASFWETS" "VE1" "VEF" "VEGF_siR4" "VHL-competent"
    "VHL-status" "VMD" "VMF" "VP-AR-1-660" "VP-TIF2.1" "VSV-G" "VUWT" "VUWT30"
    "Val511Ala" "Valencia" "Value" "Vasiri" "Vasquez" "Vaupel" "Vec"
    "Veeramani" "Velasco" "Velasco-Miguel" "Veldhoen" "Velos" "Ven" "Ventura"
    "Venus" "ViewRNA" "Vijver" "Villin-Cre" "Vironostika" "Vis" "Vis-based"
    "Vm10" "Vmax" "Vodicka" "Volgelstein" "Vousden" "VprK27M" "VprQ65R" "Vsr"
    "W199A" "W258" "WBC" "WFU3" "WG" "WG-6" "WHIM" "WHIM11" "WHIM12" "WHIM13"
    "WHIM14" "WHIM16" "WHIM18" "WHIM20" "WHIM21" "WHIM23" "WHIM24" "WHIM25"
    "WHIM26" "WHIM4" "WHIM5" "WHIM6" "WHIM8" "WHIM9" "WHR" "WI" "WIF" "WP’s"
    "WST" "WST-1" "WST-8" "WT+STZ" "WT+Sal" "WT+Saline" "WT-75" "WT-BAD"
    "WT-CD83-GFP" "WT-GST-Nef" "WT-INPP4B" "WT-MIR155HG" "WT-MLFs" "WT-ND"
    "WT-Nef" "WT-PKCγ" "WT-PTEN" "WT-p53" "WT-β-catenin" "WTCCC2" "WTMLFs"
    "WWQ" "WZ" "WZC" "Waals" "Wald" "Wallis" "Warburg" "Watson" "Waukesha"
    "Wauters" "Webb" "Webber" "Webster" "Weill" "Weill-Marchesani" "Weinberg"
    "Weinberg's" "Weinrich" "Weinstein" "Weitzman" "Welch" "Well-studied"
    "Well-to-moderately" "Wellcome" "Werner" "Westermarck" "Western-blot"
    "WhetherYAP1" "Whitney" "Whole-cell" "Wieczorek" "Wiedemann" "Wierstra"
    "Wijesinghe" "Wilcoxon" "Wiley" "Williamson" "Wnt-ligand" "Wnt-ligands"
    "Wu" "Wuhan" "X-inactivation" "X-ray" "X-ray-crystallographic" "X-α-gal"
    "X4" "X63" "XC" "XE" "XF24" "XFZ" "XJX" "XLXXXGD" "XMEN" "XTT" "XWP" "XXZ"
    "XY" "XZ" "Xaa" "Xaa-NH" "XbaI" "Xeloda" "Xie" "Xpress" "Xu" "Xuanwei"
    "Y-box" "Y-shaped" "Y204" "Y2H" "Y397" "Y551X" "Y705" "YAP-1" "YAP-3A"
    "YAP-3D" "YAP-S127A" "YAP-S127A-driven" "YAP-S127A-mediated"
    "YAP1-expressing" "YC" "YFP-Kelch" "YFP-fluorescence" "YMB-1" "YPC" "YPP"
    "YPW" "YRI" "YZ" "Yamamoto" "Yamasaki" "Yang" "Yaoita" "Yes-associated"
    "Yes-associated-protein-1" "Yogaratnam" "Yokobori" "Yoo" "York" "Yorkie"
    "Yoshimaru" "Yu" "Yung" "Yunli" "Yunnan" "Z-score" "Z-stacks" "Z-value"
    "ZFL" "ZH" "ZL" "ZPZ" "ZT0" "ZT12" "ZT14" "ZT16-ZT20" "ZT20" "ZT22"
    "ZT4-ZT8" "ZT8" "ZT9" "ZX" "ZY" "ZZ" "Zealand" "Zeiss" "Zenyaku"
    "Zero-hour" "Zetterberg" "Zhai" "Zhang" "Zhao" "Zheng" "Zhi" "Zhong" "Zhou"
    "Zhu" "ZipTip" "Zn" "ZnF" "ZnF-UBP" "Zuber" "Zundel" "a-TLR-4" "aCDK4"
    "aCGH" "aERK" "aIGF1R" "aPDGFR" "aPKCs" "above-normal" "absorbance"
    "absoute" "acH3" "acetyl-FoxO1" "acetyllysine" "achondropalsia"
    "acid-insensitive" "acid-sensitive" "acid-treated" "acinar-to-ductal"
    "across-the-board" "actin-depolymerization" "actin-nucleation"
    "activationwere" "activaton" "activators" "active-site" "additivity-based"
    "adduct" "adducts" "adenine-uracil-rich" "adeno" "adenocarcinoma-males"
    "adenocarcinoma-never-smoker" "adenocarcinomas" "adenxa" "adenylyl"
    "adipose-derived" "adr-mock" "adr3" "adult-type" "adultKlf4"
    "advance-stage" "advanced-stage" "agar" "age-at-death" "age-at-onset"
    "age-of-onset" "aged-associated" "ages≤55" "aggresome-autophagy"
    "aggresome-like" "agonism" "akt" "alarmins" "albicans" "alelle" "algorithm"
    "algorithms" "alkyl" "all-atom" "allele-frequency" "alloantibodies"
    "allograft" "allografts" "alloimmune" "almost-identical" "amines"
    "amino-acid" "amino-terminal" "amino-terminus" "aminobenzamide" "ammonium"
    "amoeboid" "amoebozoans" "amplicon" "amplicons" "amplifications"
    "amplitude-enhancing" "amrubicin" "an-ovulation" "analogue-sensitive"
    "anaplasia" "ancestry-specific" "and-6" "and17q21" "andAtm" "andBmal1"
    "andE2F2" "andKlf4" "andMDA" "andMDA-MB-453" "andPer2" "andStat3" "andand"
    "andp53" "andr" "androgenism" "aneuploid" "aneuploidy" "angiopoietin-like"
    "annexV" "annexV−ve" "annexinV-FITC" "annulus" "anterior-posterior"
    "antero" "antero-posterior" "anterograde" "anthracis" "antiacetyllysine"
    "antibodies" "antifade" "antigen-4" "antihormone" "antrum" "apnea"
    "apocrine" "apoptose" "apoptosis-regulatory" "apoptotis" "app" "arginase-1"
    "arisen" "armamentarium" "aromatase-inhibitor-resistant"
    "arrest-independent" "arrest-specific" "arrestat" "arrest–specific"
    "arsenic-trioxide-induced" "arthroplasty" "as-of-yet" "as-yet"
    "as-yet-unidentified" "ase" "associationΔG" "at15" "ation" "atleast"
    "atomic-level" "attempters" "attenuators" "atypia" "aureus" "authors"
    "auto-ADP-ribosylation" "auto-PARylation" "auto-poly-ADP-ribosylation"
    "autoantigens" "autoinhibited-dimers" "autoinhibits"
    "autophagy-dysregulatory" "autophagy-flux" "autoradiography"
    "autosomal-dominant" "autosomal-dominantly" "autrocrine" "axial"
    "axis-duplications" "axon" "b-5p" "b-H" "b-series" "b2MG" "baDHFR"
    "backbone-RMSD" "bacterially-produced" "bafilomycin" "basal-like"
    "basaloid" "base-pair" "basigin-2" "bead-on-a-string" "begun" "below5%"
    "beta-coefficients" "betel-quid" "betle" "between-study" "betweenTSP1"
    "bi-allelic" "bi-directional" "bi-directionally" "bi-lineage"
    "bi-orientation" "biflorus" "bilayer" "bilayers" "binding-site-mutant"
    "bindingthe" "binucleate" "bio-bone" "bio-information" "bio-marker"
    "bio-pulp" "bio-teeth" "bioMerieux" "biochemists" "biogps" "biolayer"
    "biomolecules" "biopsies" "biopsy" "biosensor-expressing" "biotin-ARE"
    "biotin-TNFα" "biphenyl" "biphosphate" "bis-phosphate" "bisphosphate"
    "blastemal-predominant" "blastocyst" "blastocyst-stagte" "blastocysts"
    "bleed-through" "blockde" "blocker" "blockers" "blood-based" "blood-blood"
    "blood-brain-barrier" "blood-testis" "bodies" "body-specific" "bothAtm"
    "botulinum" "bound-Cdc42" "bp" "bradykinesia" "break-induced"
    "bright-field" "brighter" "broad-functioning" "broadeningcorrespond"
    "broader" "bromide-activated" "brush-border" "btbd" "btbd-10" "buffy"
    "build-up" "burgdorferi" "by-product" "by-products" "c-12" "c-Jun-A95-HA"
    "c-Jun-p91" "c-Jun-wt-Ha" "c-Jun2-luc" "c-JunA95" "c-JunA95-HA"
    "c-JunA95-Ha" "c-JunA95-mutated" "c-JunD95" "c-JunD95-mutated" "c-JunΔN"
    "c-MycT58A" "c-kit-negative" "c-kit-positive" "c-terminally" "cHC-CC"
    "cIAPs" "cPKCs" "cRNAs" "cSHP" "cSHP-2" "caDHFR" "cacodylate" "caecum"
    "calcium-phosphate" "calnexin-FLT3-ITD" "calorimetry" "cancer-specifically"
    "cancers" "capillaroscopy" "capsid" "capture-ELISA" "carbon-containing"
    "carbonyl" "carboxyl" "carboxyl-terminal" "carboxyl-terminus" "carcimona"
    "cardia" "cardio" "cardio-ankle" "cardiology" "cardizem" "cardura" "cargos"
    "carriers" "carryover" "case-only" "case-subgroups"
    "casein-zymograph-positive" "caspase-independently" "caspase-like"
    "caspase-uncleavable" "castration-recurrent" "castration-resistant"
    "cation-π" "caveoli" "cavin" "cavin-4" "ceDHFR" "ceRNA" "cecal"
    "cell-autonomous" "cell-density" "cell-intrinsic" "cell-of-origin"
    "cell-permeable" "cell-proliferative" "cell-repulsion" "cell-to-cell"
    "cell-type-specific" "cells" "cells–despite" "celluler" "centromere"
    "cerebella" "cerebellum" "cerebrum" "cetuximab-sensitivity"
    "charcoal-stripped" "charge-coupled-device" "chemical–genetic"
    "chemo-naïve" "chemo-radiotherapy" "chemo-reagents" "chemoattractant"
    "chemonaïve" "chemoradiotherapy" "chemoresistance" "chemoresistant"
    "chemotherapeutica" "chemotherapeutics-treated" "chemotype" "chi-square"
    "chimerism" "chlornaphrazine" "cholerae" "cholesterol-associated" "choroid"
    "chosen" "chr10" "chromatid" "chromatids" "chromatin-bound"
    "chromatin-interaction" "chromophobe" "chromosome-positive"
    "cigarette-smoke-induced" "cilexetil" "cip1" "circuitry" "cis-eQTL"
    "cis-element" "cis-elements" "cis-regulatory" "cisplatin-resistance"
    "cisterna" "cisternae" "cl" "classes" "clearer" "client-protein-modulating"
    "client-release" "clinical-grade" "clinical-laboratory"
    "clinical-pathological" "clinical_t_stage" "clinically-confined"
    "clinically-derived" "clinicians" "clinico" "clinico-pathologic"
    "clinico-pathological" "clone1" "closely-related" "coactivates"
    "coactivator-3" "coal-derived" "coal-only" "cobblestone-like" "cochaperone"
    "cochleae" "codominant" "codon" "codon12" "codons" "cofillin"
    "cohesiveness" "coiled-coil-containing" "cold-shock" "colectomy"
    "collecetd" "colloid" "colonies" "colonoscopy" "colony-enhancing"
    "colony-formation" "colony-forming" "colony-growth" "colorectum"
    "combination-treated" "commercially-available" "commonalities" "commonest"
    "comorbid" "compacta" "compartment-specific" "compatibilities"
    "complementing-3" "complementing-4" "compound-mutant" "condensate"
    "conditionalBraf" "conductance" "confluency-induced" "confounder"
    "congener" "congeners" "contact-inhibited" "contact-mediated" "continuum"
    "contributeto" "control-K" "control-mimic-treated" "control-siRNA"
    "control-siRNA-treated" "controllers" "controls+cases" "conﬁrm" "cooccupy"
    "copy-number" "core-containing" "core-domain" "coregulators"
    "corpse-containing" "corpse-derived" "corpse-specific" "cortactin-tagRFP"
    "cost-effective" "cost-effectiveness" "cost-efficient" "coud"
    "counter-intuitive" "covariate" "covariates" "coverslips" "coworkers"
    "cpd188" "cross-check" "cross-complementing" "cross-contamination"
    "cross-peaks" "cross-phosphorylates" "cross-phosphorylation" "cross-react"
    "cross-reactivity" "cross-referencing" "cross-regulation"
    "cross-resistance" "cross-sectional" "cross-species" "cross-tabulations"
    "cross-transmitted" "cross-validation" "crossedBraf" "crossingBraf"
    "cryopreserve" "curative-intent" "curvature-generating" "cut-off"
    "cut-offs" "cyanogen" "cyclin-mediated" "cyclohexamide" "cyctoplasm"
    "cystein" "cysteinyl" "cysteinyl-tRNA" "cystoscopy" "cyte" "cytochemistry"
    "cytochome" "cytology" "cytome" "cytometer" "cytopenia" "cytopenias"
    "cytosol-to-membrane" "cytosolic-only" "cytospins" "cytoxicities" "dGARP"
    "damage-associated" "damage-induced" "damage-specific" "damage–induced"
    "databank" "datademonstrate" "dataindicate" "dataset" "dataset-one"
    "datasets" "datasinib" "days" "dbSNP" "dbSNPs" "ddTHF" "de-acetylases"
    "de-differentiate" "de-differentiated" "de-immunized" "de-regulated"
    "de-regulation" "de-repress" "de-repressed" "de-repression" "de-stabilizes"
    "de2–7" "dealkylate" "death-1" "deaths" "decamer" "decamers" "decapeptide"
    "decondense" "deeper" "defective-mutants" "deficienct" "degranulate"
    "degron" "dehydrogenase-1" "delta40p53" "deltaNef" "demonstratetwo"
    "denaturants" "dendrite" "denticola" "dentine" "deoxyneucleotidyl"
    "deoxynucleotidyl" "deoxythymidine-5" "deoxyuridine" "deoxyuridine-5"
    "depressant" "depxycytidine" "der" "derivate" "desferrioxamine" "desmoid"
    "desmoplasia" "destabilizer" "deubiquitininates" "deubiquitylate"
    "developmeng" "df" "diabetes-induced" "diabetes-related"
    "diabetes-specific" "diabodies" "diad" "diamide" "diaminopyrimidine"
    "dibutyrate" "dichlorodihydrofluorescein"
    "dichlorodiphenyldichloroethylene" "dideazatetrahydrofolate" "diencepahlon"
    "diencephalon" "diet-induced" "diethyl" "different-grades" "difficile"
    "diffuse-type" "difluorofluorescein" "dimerization-competent"
    "dinucleotides" "dioleoyloxy" "diphenylfuropyrimidines" "diploid"
    "disambiguate" "disease-1" "disease-relevant"
    "dishevelled–Egl10–pleckstrin" "disomy" "dispase-released"
    "dithiodipyridine" "dl703" "dmpk" "dock-and-lock" "doi" "dolichos"
    "dominant-negative" "donor-chimerism" "donor-derived" "donovani" "dormancy"
    "dosage-compensation" "dose-and" "dose-dependence" "dose-dependently"
    "dose-independent" "dose-limiting" "dose-response" "dose-responses"
    "dose–response" "double-blind" "double-chimeric"
    "double-immunofluorescence" "double-knockdown" "double-knockout"
    "double-mutant" "double-site" "double-stand" "double-strand"
    "double-substitution" "double–strand" "down-modulated" "down-modulating"
    "down-regulators" "down-stream" "dox" "doxorubicin-first" "doxorubin"
    "doxurubicin" "doxy" "doxyrubicin" "drawn" "drinkers" "droplets"
    "drug-bevacizumab" "drug-drug" "drug-pair" "drug-resistance" "drugs" "ds"
    "dsDNA" "dual-affinity" "dual-pronged" "dualism" "ductal-like" "dvpr"
    "dyslipidemia" "dysplasia" "e-7" "eIF-3B" "eIF3a-eIF3m" "eIF3i-1" "eIF3i-2"
    "eIF3i-over-expression-induced" "eIFs" "eLife" "early-onset"
    "early-passage" "early-phase" "early-stage" "eath" "ecDHFR" "eccrine"
    "ecdysone" "ecstacy" "ectoderm" "edema" "effecter" "efforts–particularly"
    "eight-well" "el" "elF4F" "elec" "electro" "embryoid" "empirically-derived"
    "enantiomer" "encephalomyelitis" "end-replication" "end-stage" "end-to-end"
    "endocrine-drug-resistance" "endocrine-resistance-associated"
    "endocrine-response" "endocrine-therapy" "endocrine-therapy-resistant"
    "endocrine-therapy-response" "endocytic-recycling" "endoderm" "endometria"
    "endometrial-specific" "endometrium" "endonuclease-like"
    "endosome-to-Golgi" "endosomes" "endothelia" "endothelial-pericyte"
    "endothelial-specific" "endpoint" "endpoints" "energy-dependent"
    "energy-efficient" "energy-intensive" "energy-producing" "engrailed-1"
    "enhancer" "enrichment-based" "enteropathy" "entitites" "entropies"
    "envelope-based" "eosin" "ephexin" "ephrin-induced" "ephrinA"
    "epigenetic-specific" "epigenome" "epithelial-derived"
    "epithelial-mesenchymal" "epithelial-specific" "epithelial-to-mesenchymal"
    "epithelial-to-mesenchymal-transition" "epithelial-tomesenchymal"
    "epithelial–mesenchymal" "epithelioid" "erythema" "erythrocytes" "esiRNAs"
    "esophagectomy" "et" "ethyle" "eukemia" "europaeus" "ever-improving"
    "ever-increasing" "evert " "ex" "exclusiveness" "exent" "exocrine" "exome"
    "exon-3" "exon1A" "exon2" "exons" "exozyme" "expansile"
    "experimental-computational" "experimentally-induced" "explants" "explcit"
    "expressers" "expression-cut-off" "expression-quantitative"
    "expression-status" "expressors" "exsit" "extra-adrenal" "extra-copy"
    "extra-domain" "extra-embryonic" "extra-ovarian" "extra-ribosomal"
    "extra-uterine" "extracellular-signal-regulated" "extreme-sized" "exvitro"
    "exvivo" "factor-1" "factor-kB" "fail-safe" "falciparum" "false-discovery"
    "false-negatives" "farnesyl" "fascilitate" "fast-growing" "fast-migrating"
    "febuxostat-inhibitable" "feedback-promoted" "female-to-male"
    "females+males" "femtosecond" "fibillin-1" "fibrillin-2" "fibrillin-3"
    "fibrillinopathies" "fibroblast-like" "fibroblast-to-myofibroblast" "fide"
    "field-of-origin" "fifty-four" "filamin-α" "filapodia" "fine-mapped"
    "fine-mapping" "fine-tune" "fine-tuning" "first-degree" "first-order"
    "first-time" "five-year" "flag-L5" "flag-RPL5-HEK293" "flash-frozen"
    "flip-flop" "flips-in" "flow-cytometric" "flow-through" "floxEx3"
    "fluorescently-labeled" "fluorophore" "fluorophores" "folA" "fold-increase"
    "folic" "follicles" "follow-up" "followed-up" "followup" "footpads"
    "forebrain" "foreseen" "formalin-fixation" "formyl" "forp53" "forty-eight"
    "forty-four" "forty-six" "foveolar-type" "frame-deletions" "frame-shift"
    "frameshift" "frameshifts" "freeware" "freshly-prepared" "fromAtm"
    "fromBmal1" "fromParp1" "fromp53" "frozen" "fs" "fs0" "full-restoration"
    "full-size" "full-text" "full-thickness" "fulminant" "fundi" "fundus"
    "fura-2" "fusion-gene" "gH2AX" "gadolinium" "gain-of-function" "gallate"
    "gallbladder" "gamma-amino" "gamma-subfamilies" "gapdh" "gas-phase"
    "gastrectomy" "gastric-type" "gastro" "gastrulate" "gatekeeper" "gavage"
    "gc" "gel-filtration" "gender-specific" "gene-array" "gene-environment"
    "gene-environmental" "gene-gene" "gene-level" "gene-per-gene" "generateMx1"
    "genes" "genetic-interaction" "genetically-linked" "gene–environment"
    "gene–gene" "genitalia" "genome-scale" "genome-wide" "genomewide"
    "genotype" "genotype-phenotype" "genotypes" "genotype–phenotype" "gens"
    "germline" "gigantism" "gingiva" "gingivalis" "glabrata" "glass-bottom"
    "glia" "glia-like" "globulin" "globulines" "glomeruli" "glossier"
    "glucose-deprivation" "glucose-starvation" "glutamate-rich" "glutaminases"
    "glutamylcysteine" "glutathione-Sepharose" "glycerophosphate" "glycinamide"
    "goes" "gold-AffiniPure" "gonad" "gonads" "gondii" "gone" "gp120+MA"
    "gp120-induced" "gp120-mediated" "gp120-plasmid" "gp120IIIB" "gp120s"
    "grade-3" "grade-astrocytomas" "grade3" "graft-versus-host" "gray-value"
    "greater" "greatest" "griffonia" "ground-state" "group-2" "group-wise"
    "grow-or-go" "growth-repressive" "growth-suppressive" "guanine-adenine"
    "gut-associated" "hAFP–TERT" "hBT112" "hBT145" "hBT70" "hBT75" "hCD2"
    "hCyPA" "hDHFR" "hESC" "hESCs" "hFN" "hGBM" "hMAD2L2" "hMSC" "hMSCs"
    "hNQO1-ARE" "hNQO1-ARE-dependent" "hPBMC" "hSynI" "hTERT-immortalized"
    "hTERTp" "hade" "hairpin-level" "half-life" "half-maximal" "half-site"
    "half-sites" "half-time" "hand-curation" "hand-foot" "haplo"
    "haplo-insufficient" "haplotypes" "harbouringp16" "headgroup" "headgroups"
    "heartier" "heat-shock" "heatmap" "heavier" "helical-repeat" "helices"
    "helix-loop-helix" "hemangiosarcomas" "hemplexin-like" "hepatectomy"
    "hepato" "hepato-cyte" "hepatocellular-cholangiocarcinoma"
    "hepatocyte-specific" "heptad" "hetermodimer" "hetero" "hetero-association"
    "hetero-dimeric" "hetero-oligomerization" "hetero-trimeric" "heterotopia"
    "heterotrimer" "heterozygote" "hexanucleotide" "hexokinases" "hg19"
    "high-affinity" "high-confidence" "high-density" "high-dose"
    "high-expression" "high-fidelity" "high-flow" "high-grade" "high-incidence"
    "high-level" "high-mannose" "high-mobility" "high-molecular-weight"
    "high-potency" "high-powered" "high-quality" "high-resolution" "high-risk"
    "higher-molecular" "higher-order" "higher-risk" "highest-ranked"
    "highly-conserved" "highly-homologous" "highly-metastatic"
    "highly-penetrant" "highly-stable" "hindbrain" "hinge-open" "hirsutism"
    "his-PARP-1" "histidine-to-arginine" "histiocyte-lineage" "histochemistry"
    "histologies" "histology" "histolyticum" "histopathologies"
    "histopathology" "hit-and" "hit-and-run" "homeodomain" "homepage" "homlog"
    "homo-oligomerization" "homolog" "homolog-like" "homologies" "homologs"
    "homozygote" "homozygotes" "hormone-binding-domain" "host-pathogen"
    "host-virus" "hot-spot" "hotspot" "hotspots" "hours" "hr" "hr-HPV" "http"
    "huDHFR" "human-Unique" "humanEGFR" "hybrid-hybridoma" "hydroxy"
    "hydroxyethyl" "hydroxyglutarate" "hydroxyl" "hydroxylases" "hyper-IgE"
    "hyper-androgenic" "hyper-androgenism" "hyper-proliferative"
    "hyper-replication" "hyper-vascularization" "hyperammonemia"
    "hyperandrogenism" "hyperchromasia" "hypercoagulabilty" "hyperdiploid"
    "hyperfibrinogenemia" "hyperoxia" "hypo-fibrinolysis" "hypocalcemia"
    "hypogranularM3" "hypomorph" "hypopharynx" "iBMM" "iCCAAT" "iDCs" "iFoxO4"
    "iNAMPT" "iNampt" "iOTUB1" "iWBC" "ice-cold" "ider" "ie" "ii" "iii" "ileum"
    "ill-defined" "immediate-early" "immune-blots" "immune-cell"
    "immune-compromised" "immune-deficientRag2" "immune-related"
    "immune-specific" "immune-suppressive" "immunesurveillance"
    "immunhistochemistry" "immuno-EM" "immuno-cytochemistry"
    "immuno-histochemistry" "immuno-inflammation" "immuno-precipitation"
    "immuno-reactive" "immuno-reactivity" "immunocomplex" "immunocomplexes"
    "immunocytes" "immunocytochemistry" "immunodominant" "immunoglobulin"
    "immunoglobulin-like" "immunohistochemistry" "immunohistochemistry-quality"
    "immunohistochemisty" "immunopathology" "immunophenotype"
    "immunophenotypes" "immunoprecipitation-WB" "immunostainings"
    "immunotherapies" "immunotherapy" "impactful" "implcit" "improvedAtm"
    "in-between" "in-depth" "in-frame" "in-gel" "in-home" "in-house"
    "in-parallel" "in-situ" "in-turn" "in-vitro" "in-vivo" "inAtm" "inCntf"
    "inParp1" "inPdx" "inPdx1-Cre" "inase" "indels" "independent-samples"
    "indicatig" "indicatives" "individuals" "indolinone" "inducible-knockout"
    "inducible-rescue" "inefficacy" "inflammation-associated"
    "inflammation-induced" "inflammation-linked" "inhibitionof" "inhibiton"
    "injectedAtm" "inlcude" "inside-out" "insightful" "instability-high"
    "integrin-linked" "inter-dependence" "inter-domain" "inter-individual"
    "inter-monomeric" "inter-observer" "inter-regulatory" "inter-regulon"
    "inter-species" "interactome" "interactomes" "interconvert" "interdomain"
    "interferometry" "interferon-regulatory" "interleukin-17A"
    "interleukin-17F" "intermediate-cell" "intermediated-cell" "intermembrane"
    "interquartile" "interspecies" "interstitium" "interstrand" "interwoven"
    "intestinal-type" "intestine-specific" "intima" "intimal-infiltrating"
    "intoBmal1" "intop53" "intra-PDX" "intra-S-phase" "intra-abdominal"
    "intra-graft" "intra-helix" "intra-membrane" "intra-patient" "intra-strand"
    "intra-tumor" "intra-vasation" "intracellular-type" "intravasate"
    "introduction-induced" "intron-exon" "invariant" "inversely-correlated"
    "inwild" "iodoacetamide" "iodoacetyl" "ion-conductive" "ionic" "iper"
    "irbesartan" "irradiation-induced" "irradiation-specific"
    "irregular-shaped" "ischemia-reflow" "ischemia-reperfusion"
    "ischemic-reperfusion" "isofrom" "isogenic-matched" "isogenic-pairs"
    "isogenically-corrected" "isopeptide" "isotype" "isotypes" "isovolumetry"
    "isozymes" "isprotein" "itsAtm" "iv" "iv–ix" "iv–vi" "jirovecii" "jitter"
    "juxta" "juxta-position" "juxtacrine" "kJ" "kPa" "kV" "kappa-B" "karyotype"
    "karyotypes" "kbp" "kcal" "kd" "ketoamide" "key-components" "kg" "killker"
    "kinase-2" "kinase-defective" "kinase-wild" "kinase-β" "kinases"
    "knock-down" "knock-in" "knocked-down" "knocked-out" "knockin"
    "knocking-down" "knowm" "l-BH3" "labor-intensive" "laboratory-adapted"
    "laboratory-generated" "laevis" "lamina" "langerhans" "lanthanides"
    "lapatinib-naive" "lapatinib-naïve" "large-cell" "large-scale"
    "large-sized" "large-vessel" "larger22-fold" "late-forming" "late-onset"
    "late-passage" "late-stage" "latex-bead–containing" "lavage" "leadings"
    "leakiness" "leave-k-out" "left-anterior-descending" "left-colon"
    "left-hand" "left-handed" "left-sided" "leftmost" "lenti" "lenti-K626A"
    "lentiviral-mediated" "lesion-induced" "less-heavily" "let-7b" "let-7c"
    "let-7d" "let7a" "let7c" "let7d" "leucopenia" "leukoencephalopathy"
    "levels" "life-time" "lifeact" "lifespan" "ligand-binding-domain"
    "ligand-engagement" "light-green" "lighter-skin" "light–dark" "limma"
    "lincRNA-Mkln1" "lincRNA-p21" "lineage-specific" "lineages" "lipid-nucleic"
    "lipid-phosphatase-independent" "lipid-raft" "lipidome"
    "lipopolysaccharide" "lipopolysaccharides" "lipopolysacharide"
    "lipoproteins" "liposome" "lithium-mediate" "lithium-sensitive"
    "littermate" "littermates" "live-cell" "liver-only" "lncRNA-GAS5"
    "lncRNA-H19" "lo" "loc285194" "long-lasting" "long-lived" "long-range"
    "long-standing" "long-survival" "long-tailed" "long-time" "longer-term"
    "loosely-adherent" "loss-of-function" "loss–of-function" "low-affinity"
    "low-coverage" "low-density" "low-dose" "low-estrogen" "low-expression"
    "low-fidelity" "low-grade" "low-incidence" "low-level" "low-oxygen"
    "low-oxygen-induced" "low-passage" "low-penetrance" "low-penetrant"
    "low-quantity" "low-risk" "low-to-moderate" "lower-confidence"
    "lower-molecular-weight" "lower-powered" "lower-risk" "lowest-error" "loxP"
    "loxP-STOP-loxP" "lumens" "luminal-A" "luminal-B" "luminal-basal"
    "luminometer" "lymphadenopathy" "lymphatic-blood" "lymphoblastoid"
    "lymphoid-lineage" "lymphopenia" "lympocytes" "lysis" "lysl" "lyso"
    "lyso­somes" "mAb16-39" "mBRAF" "mCherryRac1Q61L" "mCitrine" "mESCs" "mGFP"
    "mGSTA" "mGSTA1-ARE" "mGSTA1-ARE-or" "mK4a" "mKRAS" "mL " "mP" "mPU" "mPUA"
    "mPUB" "mPUC" "mPUD" "mRFP-Clc" "mRFP-clathrin" "mRNA" "mSNPs" "mSin3A"
    "mTERT" "mTOR-pathway" "mTORi" "mTOR + " "mTurquoise" "mVenus"
    "machine-learning" "macro-metastases" "macrophage-like"
    "macrophage-lineage" "magnitute" "malep53" "mammography" "mammosphere"
    "mammospheres" "mangabeys" "marfanoid" "marked-box" "massively-parallel"
    "mastermind-like" "materials" "matrigel-invasion" "mcherry-ER-tTA" "mdm2-A"
    "mdm2-B" "mdm2-C" "mdm2-E" "mdm2-FL" "meARTD1" "means±S" "mean±SD" "mean±s"
    "mebrane" "mechainsim" "mediator-induced" "medulla" "megachannel" "melanin"
    "melanogaster" "mellitus" "mem" "membrane-inserted" "membrane-permeable"
    "meninges" "mesenchymal-derived" "mesenchymal-like" "mesenchymal-type"
    "mesenchyme" "mesoderm" "mesothelia" "mesothelium" "mesylate"
    "meta-analytical" "meta-regression" "metadataset" "metagene"
    "metaphase-to-anaphase" "metaphase–anaphase" "metastasis-suppression"
    "metastatectomy" "metastectomy" "methanesulphonate" "methicillin" "methoxy"
    "methoxy-phenyl" "methoxyestradiol" "methyl-arginine" "methyl-lysine"
    "methyl-modification" "methyl-transferring" "methylanthraniloyl"
    "methylated-PTPRO" "metrix" "mevalonate" "miR-101" "miR-103" "miR-106b~25"
    "miR-107" "miR-107-mediated" "miR-107-overexpressing" "miR-1245" "miR-1248"
    "miR-124a" "miR-126" "miR-1263" "miR-130" "miR-130b" "miR-132" "miR-138"
    "miR-141" "miR-142" "miR-142-3p" "miR-145" "miR-145-quided" "miR-146a"
    "miR-147b" "miR-155-3p" "miR-155-5p" "miR-17" "miR-17-92" "miR-181"
    "miR-181b-1" "miR-181d" "miR-182" "miR-184" "miR-184-mediated"
    "miR-184-regulated" "miR-184-targeted" "miR-187" "miR-19" "miR-190b"
    "miR-193b-365" "miR-19a" "miR-19b" "miR-19b-23b" "miR-19b-26a" "miR-20"
    "miR-200" "miR-203" "miR-203-ATM" "miR-203-mediated" "miR-203-resistant"
    "miR-203-responsive" "miR-206" "miR-206-AS" "miR-206-inhibiting"
    "miR-206-mediated" "miR-20a" "miR-21" "miR-214" "miR-22" "miR-221"
    "miR-221-overexpressing" "miR-221-transfected" "miR-222" "miR-230"
    "miR-23b" "miR-24" "miR-25b" "miR-26" "miR-26a" "miR-26a-mimic"
    "miR-26a-mimics" "miR-26b" "miR-30" "miR-302" "miR-302-367" "miR-30a"
    "miR-30c" "miR-30e" "miR-320b" "miR-34" "miR-34c" "miR-34c-dependent"
    "miR-365" "miR-365-binding" "miR-365-independent" "miR-365-mediated"
    "miR-365-mimic-injected" "miR-365-overexpressing" "miR-365-treated"
    "miR-372" "miR-374b" "miR-3965" "miR-421" "miR-423" "miR-449" "miR-449a"
    "miR-449b" "miR-449c" "miR-494" "miR-502" "miR-512-5p" "miR-518b" "miR-561"
    "miR-663" "miR-874" "miR-892a" "miR-9" "miR-92" "miR-96" "miR-NC" "miR-Neg"
    "miR-RT" "miR-ctrl" "miR103" "miR155-5p" "miR19b-23b" "miR203" "miR221"
    "miR26a-inhibitor" "miR302b" "miR31" "miR34" "miR34a" "miR373" "miRNA-130b"
    "miRNA-182" "miRNA-7" "miRNA-mRNA" "miRNA–mRNA" "miRanda" "miRs-221"
    "miRwalk" "mice" "micelle" "micelles" "micro-dissected" "micro-dissection"
    "micro-dissemination" "micro-metastases" "micro-metastasis" "micro-molar"
    "micro-second" "micro-vascular" "microRNA-142-3p" "microRNA-206"
    "microRNA-375" "microRNA-induced" "microRNA–mRNA" "microTv3.0"
    "microbalance" "microcell" "microdomains" "microfractures" "microglobulin"
    "micrograph" "micrographs" "micrometastases" "microsatellite" "microsecond"
    "microseconds" "microstates" "microtome" "microtubule-organizing"
    "microvessel" "microvessels" "mid-G2" "mid-gestation" "mid-gestational"
    "mid-portion" "midbrain" "middle-passage" "midpoint" "migrans" "mildy"
    "milli" "millisecond" "milliseconds" "mini-gene" "miniMac" "minichromosome"
    "minigene" "minus-end" "mir" "mir-302a" "mir-302c" "mir-302d" "mir-367"
    "mir-449b" "mir29a" "mis-functional" "miscategorizations" "missense"
    "mito-aggresome" "mito-aggresomes" "mitochondrial-membrane" "mitomycin"
    "mitoses" "mmpNOS" "mmpNOS3p-luc2" "mobility-shift" "mock-infected"
    "mock-transfected" "mock-treated" "moderate-intensity" "moderate-to-highly"
    "molecularly-targeted" "moleculars" "molecules" "moncytes"
    "mono-phosphorylated" "monoclonals" "monocyte-derived" "monocyte-dominant"
    "monocyte-lineage" "monocyte-predominant" "monoethyle" "monolayer"
    "mononucleosome" "monophosphate" "monophosphoryl" "monotherapies"
    "monotherapy" "month-old" "mood-stabilizing" "morbidities"
    "more-than-additive" "morphism" "morpholino" "mortality–incidence"
    "motif-based" "motif-containing" "motile" "motor-neuron-specific"
    "mouseAtm" "mt" "mtERAP" "muations" "mucosa" "mucosae" "multi-TKI"
    "multi-acinar" "multi-analytic" "multi-cellular" "multi-component"
    "multi-drug" "multi-fold" "multi-functional" "multi-gene" "multi-genetic"
    "multi-lineage" "multi-modality" "multi-module" "multi-subunit"
    "multi-vesicular" "multicenter" "multichaperone" "multidomain" "multigene"
    "multihour" "multilineage" "multiorgan" "multipass" "multiphoton"
    "multiple-binding" "multiple-layered" "multiprotein" "multisite"
    "multistage" "multisystem" "multitarget" "multivariate" "multiwell"
    "muristerone" "muscle-invasive" "muscle-specific" "muscularis" "mutaions"
    "mutants" "mutations" "mutationwas" "myocardium" "myocytes"
    "myofibroblasts" "myoid" "myometrium" "myosin-1a" "myosin-1c" "myosin-X"
    "myristate" "myxoid" "n-octyl" "n=1" "n=10" "n=12" "n=19" "n=20" "n=21"
    "n=29" "n=3" "n=4" "n=5" "n=6" "n=7" "nPKCs" "nameley" "nanodelivery"
    "nanosecond" "nanoseconds" "nanovesicle" "nanovesicles"
    "naturally-occurring" "ncomms3443" "ncomms3464" "ncomms3519" "ncomms3544"
    "ncomms3667" "near-complete" "near-confluent" "near-maximal" "near-normal"
    "near-perfect" "nearest" "necrosome" "negative-feedback" "neo-vessel"
    "neoadjuvant" "neocortex" "neoplasias" "neoplastic-like" "nephrectomy"
    "nephron" "nephropathy" "network-based" "network-derived" "neuro"
    "neuro-ectodermal" "neuro-protective" "neuroectoderm" "neuroendocrine"
    "neuroendocrine-cognitive" "neuromas" "neuronal-like" "neuropathology"
    "neurosphere" "neurosphere-like" "neurospheres" "neutralizer"
    "neutrophilia" "never-smoker" "never-smokers" "never-smoking" "newer"
    "next-generation" "next-steps" "nick-end" "nigricans" "ninety-four"
    "nitrites" "nitroaniline" "nitrocelulose" "nmr" "node-negative"
    "node-positive" "noncognate" "nonhistone" "nonmalignant" "nonparticipants"
    "nonsignificant" "nonsmall" "normal-like" "normalizer" "normo"
    "normoandrogenism" "normoxia+insulin" "northern-European" "norvegicus"
    "nt-PAF" "nuclear-only" "nucleases" "nucleate" "nucleo"
    "nucleosome-association" "null-mutants" "null-ness" "nullisomy" "n = 10"
    "n = 3" "n = 4" "n = 5" "n = 6" "n = 7" "n = 12" "n = 3" "n = 4" "n = 5"
    "n = 7" "obp" "octyl" "odonto" "oestrogen" "ofAtm" "ofE2F1" "ofKlf4"
    "ofRbC" "ofRela" "off-rate" "off-target" "off-targets" "offs" "ofp53"
    "often-used" "oligo" "oligodeoxynucleotide" "oligodeoxynucleotides"
    "oligometastases" "oligomycin" "oligos" "omain" "omentum" "omics"
    "on-going" "on-off" "on-target" "oncocytic-type" "oncogenes" "oncologists"
    "oncology" "oncomine" "oncomir" "oncomorph" "oncomorphisms" "oncomorphs"
    "oncovirus" "one-carbon" "one-half" "one-phase" "one-side" "one-third"
    "one-to-two" "one-way" "ones" "oocytes" "oophorectomy" "open-groove"
    "open-label" "operon" "ophthalmopathy" "orAtm" "orKlf4" "orRb" "orRela"
    "ordinate" "organelles" "organochlorine" "organoid" "organoids" "organs"
    "ornithine" "oropharynx" "orphenadrine" "ortho" "ortholog" "orthologue"
    "orthology" "osteoblast-like" "osteoblasts" "osteopenia" "otherAtm" "ought"
    "out-of-frame" "outs" "over-activate" "over-activation" "over-activity"
    "over-duplication" "over-fitting" "over-representation" "over-weight"
    "overfit" "overridden" "oxidases" "oxoglutarate" "oxygenase-1" "oxygenases"
    "oxygenated-infarct" "oxygenation-induced" "ozogomycin" "p21-null"
    "p21-transfected" "p21WAF1" "p21or" "p21waf1" "p25OE" "p38MAPK" "p46Shc"
    "p4EBP1" "p4EBP1_S65" "p52Shc" "p53-BAX-RE" "p53-DNA" "p53-MDM2–related"
    "p53-NOS3-RE" "p53-NOS3RE" "p53-R175H-expressing" "p53-RE" "p53-consensus"
    "p53-dependence" "p53-dependent" "p53-family" "p53-family-dependent"
    "p53-gene" "p53-initiated" "p53-knockout" "p53-motif" "p53-null"
    "p53-occupied" "p53-pathway" "p53-peak" "p53-proficient" "p53-prosurvival"
    "p53-response" "p53ER" "p53ERTAM" "p53FamTag" "p53RE-1" "p53RE-2" "p53RE-3"
    "p53REs" "p53–DNA" "p53–Smad–DNA" "p62KO" "p65-responsive" "p70S6K-pThr"
    "p70SK6" "p85α" "p=0.0003" "p=0.0004" "p=0.0005" "p=0.001" "p=0.002"
    "p=0.004" "p=0.007" "p=0.008" "p=0.009" "p=0.01" "p=0.011" "p=0.012"
    "p=0.017" "p=0.02" "p=0.024" "p=0.029" "p=0.03" "p=0.031" "p=0.036"
    "p=0.038" "p=0.06" "p=0.064" "p=0.08" "p=0.1" "p=0.13" "p=0.34" "p=0.39"
    "p=0.50" "p=0.7" "p=2.98×10" "p=3×10" "p=4×10" "p=5×10" "pACT+pBIND-NMNAT2"
    "pACT-SIRT3+pBIND" "pAD8-1" "pAD8AxxA" "pAD8FSNef" "pAMPKα" "pAcGP67"
    "pBAD" "pBDGAL-CAM-AR-481-919" "pBIND-Id" "pBIND-NMNAT2" "pCAGGs"
    "pCAGGsHckN" "pCL10A-1" "pCMV" "pCMV-AR-1-660" "pCMV-VSV-G" "pCMV-dR8.2"
    "pEGFP" "pEGFP-C1" "pEGFP-C1-SIRT3" "pEGFR" "pERα-Ser167" "pET-28c"
    "pET28c-Nek2A" "pFGFR" "pFGFR1" "pFLT3" "pGADGH" "pGADGH-CKβBP2"
    "pGIPZ-CD147" "pGL-1" "pGL-137" "pGL-2,392" "pGL-404" "pGL-5" "pGL3-CRΔ1"
    "pGL3-CRΔ2" "pGL3-CRΔ3" "pGL3-CRΔ4" "pGL3-Δ4" "pGSK3" "pGal" "pGal4-Luc"
    "pGsk3" "pH-dependence" "pHck" "pIRES" "pLKO" "pM" "pMEK" "pMIR"
    "pMIR-REPORT" "pMIR-REPORT-c-Myc" "pN" "pNDRG1" "pNL4-3" "pNL4.3Luc" "pNLA"
    "pNLA1" "pNLA1-AD8env" "pNLA1Nef" "pNOS" "pNOS3p-luc1" "pNOS3p-luc2" "pNPP"
    "pRL-CMV" "pRRL" "pS173" "pS187" "pS296" "pS345" "pS383" "pS70S5K"
    "pSGFLAG" "pSGFLAG-CKβBP2" "pSGTIF2" "pSHP" "pSHP-2" "pSPL3" "pSTAT1"
    "pSTAT5" "pSer-Pro" "pT" "pT146" "pT202" "pTEFb" "pTM" "pTRIPZ" "pThr-Pro"
    "pThr–Pro" "pTyr-342-FOXP3" "pTyr1234" "pUL38" "pY204" "pYAP" "pYAP1"
    "pYLacO" "pYLacO-hTERTp" "pYxxM" "pack-year" "pack-years" "paired-box"
    "paired-end" "pan-HDACI" "pan-reactive" "pan-tyrosine" "panPI3K"
    "pancreatitis" "pancreatobiliary-type" "paque" "para-nitrophenyl"
    "paracrine" "paralog" "paralogues" "parenchyma" "parkinsonism" "parotid"
    "particle-mesh" "partner-and-localizer" "patho" "patho-biology"
    "pathobiology" "pathogen-associated" "pathogen-specific"
    "pathologic_response" "pathologic_response_rcb_class" "pathomechanism"
    "pathomechanisms" "pathophysiology" "patient-samples" "patient`s"
    "pcDNA-GAS5" "pcDNA3" "pcDNA3.1" "pds1-128" "peaksthat" "penetrance"
    "penetrant" "peptidases" "peptide-fragments" "peptide-reactive"
    "peptidyl-prolyl" "perhaps" "peri-implantation" "periodontium"
    "periodontopathogen" "periodontopathogens" "peroxidases" "person-years"
    "perturbation-based" "perturbation-response" "pharmacotherapies"
    "phase-acting" "phase-contrast" "phenacetin" "phenyl"
    "phenylmethylsulfonyl" "phisms" "phosRbC" "phoshatidylinositol"
    "phoshatidylinositol-triphosphate" "phosphatase-6" "phosphatase-like"
    "phosphatases" "phosphate-binding" "phosphatidyliositol" "phospho-Akt"
    "phospho-Thr389-S6K1" "phospho-mutants" "phosphoS6" "phosphoSer"
    "phosphodegron" "phosphoepitope" "phosphoinositol"
    "phosphoinositol-3-kinase" "phosphopeptide" "phosphopeptides"
    "phosphopyruvate" "phosphor-ylate" "phosphoregulators" "phosphorothioate"
    "phosphorthioate" "phosphorylated-T389" "phosphorylatedRb"
    "phosphorylatedS788" "phosphorylation-compatible" "phosphorylation-mimic"
    "phosphorylation-mimics" "photo-entrainment" "photoproducts"
    "physiologically-relevant" "phytohaemagglutinin" "pifithrin-α"
    "pifithrin-μ" "pigmentosum" "piperazinyl" "piritrexim" "pixel" "pixels"
    "placebo-controlled" "plakaglobin" "plasmacytoid" "plasmalogen" "plasmon"
    "plekstrin-homology-domain" "ploidy" "plumper" "pluripotency-associated"
    "pmTor" "podomers" "podoms" "poker-straight" "poly-I" "poly-glutamine"
    "polyC9" "polycomb-repressive" "polyendocrinopathy" "polymerase-1"
    "polymor-phisms" "polymorphism" "polymorphisms" "polyomaviridae" "polyp-1"
    "polyp-2" "polyploid" "polyprotein" "polypyrimidine" "polytene"
    "poor-prognosis" "poorer" "poorest" "poorly-differentiated"
    "poorly-reproducible" "pore-forming" "port-wine" "positive-sense" "pospho"
    "pospho-Y" "post-MI" "post-Tat" "post-confluent" "post-contrast"
    "post-diagnostic" "post-essential" "post-genome" "post-hoc" "post-hydride"
    "post-implantation" "post-infection" "post-menopausal" "post-mitotic"
    "post-mortem" "post-natal" "post-operative" "post-polycythemia"
    "post-prandially" "post-relapse" "post-remission" "post-simulation"
    "post-surgery" "post-surgical" "post-transcriptional"
    "post-transcriptionally" "post-transfection" "post-translational"
    "post-translationally" "post-transmission" "post-treatment"
    "postoperative-month" "postoperative-week" "potential-sensitive" "pp90rsk"
    "pravachol" "preadipose" "precipitations" "premolars" "preneoplasma"
    "prepronderance" "prepuberty" "preterm" "primary-derived" "primer-probes"
    "priori" "pro-aggressive" "pro-and" "pro-angiogenic" "pro-apoptogenicity"
    "pro-death" "pro-differentiation" "pro-fibrotic" "pro-inflammatory"
    "pro-invasive" "pro-metastatic" "pro-neoplastic" "pro-proliferative"
    "pro-survival" "pro-translational" "proband" "probands" "procaspase-3"
    "processing-1" "profilings" "proform" "progenitor-like" "progeny"
    "progeria-like" "progressors" "prokaryotes" "promoter-less"
    "promoter-proximal" "proof-of-principle" "propargyl" "propeptide" "propria"
    "propyl" "prostaglandins" "proteasomal-mediated" "proteasome-non-cleavable"
    "protein-2" "protein-A" "protein-DNA" "protein-ligand" "protein-like"
    "protein-pathway" "protein-to-lipid" "protein–1O0L" "protein–DNA"
    "proteome" "proven" "pseudo-substrate" "pseudogene" "pseudosubstrate"
    "pseudosubstrate-like" "publically-available" "pull-down" "pulse-chase"
    "punctiform" "pyogenes" "pyridine" "pyridyl" "pyrimidyl" "pyro" "pyrograms"
    "p = 0.0004" "p = 0.001" "p = 0.002" "p = 0.009" "p " "p = 0.002"
    "p = 0.004" "q-value=0.13" "qRT" "qd" "quality-control" "quencher"
    "quiesce" "quiescence-proliferation" "quinazolin" "quinazolin-6-yl"
    "r=0.18" "rAu565" "rBT474" "rDHFR" "rFBN" "rFBN1" "rFBN1-C" "rFBN1-N"
    "rFBN2" "rFBN2-C" "rFBN2-N" "rFBN3" "rFBN3-C" "rRNA" "rSKBR3" "rVISTA"
    "rVista2.0" "radiation-induced" "radiculoneuropathy" "radio-chemotherapy"
    "radio-resistance" "radiocystitis" "radioiodine" "radioresistant"
    "random-effect" "random-effects" "rapalogs" "rarer" "rationalise" "re-ChIP"
    "re-accumulation" "re-analyzed" "re-appearance" "re-direction"
    "re-encountered" "re-engage" "re-enter" "re-entrained" "re-entry"
    "re-escalated" "re-establish" "re-establishing" "re-evaluate" "re-examined"
    "re-expressed" "re-expression" "re-forms" "re-fuse" "re-growth"
    "re-identified" "re-implanted" "re-isolated" "re-localized" "re-plating"
    "re-programming" "re-proposed" "re-sensitive" "re-sensitized"
    "re-targeting" "re-transplantation" "re-transplanted" "reaction-diffusion"
    "reaction-restriction" "read-out" "read-outs" "reader-writer"
    "readily-available" "readout" "readouts" "receiver-impaired"
    "receiver-impairing" "receptor-ligand" "receptor-α" "recipient-derived"
    "recognition-binding" "recombination-mediated" "red-to-green" "reductases"
    "reenter" "reestablish" "reflow-induced" "reg" "region-Y" "region-leucine"
    "regrew" "regrow" "regrowth" "regulon" "regulons" "relatedness" "remodeler"
    "remodeller" "renilla" "repeat-containing" "replication-deficient"
    "replicon" "repopulate" "reporter-gene" "repositions" "repressors"
    "reprogrammes" "rerio" "researchs" "resi" "resiudes" "resolvases"
    "responder" "responders" "resveretrol" "retarget" "retro" "retromer"
    "retrotranslocate" "retrovirus" "reverse-phase" "reverse-transcribed"
    "reverse-transcription" "revertant" "revertants" "rhTNF" "ribose"
    "right-hand" "right-side" "right-sided" "rigid-body" "ring-like" "risen"
    "risk-associated" "rmTNF" "rosette-like" "rotamers" "rs10491003"
    "rs10509168" "rs1053005" "rs1059394" "rs1059394T" "rs1061981C" "rs10787498"
    "rs10787498T" "rs10937405" "rs11178" "rs1127687AA" "rs1127687G"
    "rs114447350" "rs1219648" "rs12247479AA" "rs12247479G" "rs12416109"
    "rs12912233" "rs12917" "rs12922061" "rs13300553" "rs1432295" "rs1518111"
    "rs1550532" "rs1570669" "rs16430" "rs16906252" "rs170934" "rs17221259"
    "rs17593222" "rs17711722" "rs1799782" "rs1799889" "rs1800871" "rs1800872"
    "rs1800896" "rs1801689" "rs1801725" "rs2013208" "rs2019960" "rs20417"
    "rs20541" "rs2227309" "rs2227310" "rs2227631" "rs2234693" "rs2274223"
    "rs2274223-G" "rs2279744" "rs228729" "rs2291281" "rs2291282" "rs2293152"
    "rs2395185" "rs25487" "rs25489" "rs2585590" "rs2608053" "rs2736100"
    "rs2790" "rs2981578" "rs2981582" "rs3024493" "rs3024495" "rs3024505"
    "rs3098914" "rs3122605" "rs3122605-G" "rs3127075" "rs334543" "rs334558"
    "rs3781093" "rs3782181" "rs3803662" "rs3806624" "rs3814231" "rs3815188"
    "rs3817963" "rs3819025" "rs3824662" "rs3842662" "rs4353229" "rs4353229T"
    "rs4415084" "rs4474514" "rs4488809" "rs457581" "rs4590952" "rs4975596"
    "rs501764" "rs5273" "rs5275" "rs61731974" "rs61749020" "rs61815643"
    "rs6557161" "rs672888" "rs689466" "rs6903608" "rs7086803" "rs7336933"
    "rs744166" "rs7465364" "rs7481584" "rs763780" "rs7640978" "rs7736074"
    "rs7745098" "rs780094" "rs78501403" "rs927651" "rs9340799" "rs934099"
    "rs9387478" "rs9447004" "rs995030" "rtTA" "s-BOT" "s-BOTs"
    "s10434-013-3220-2" "sSEMA4D" "sZIP" "saDHFR" "sacaratinib" "saez"
    "saline-treated" "saline–treated" "salpingo" "salpingo-oophorectomy"
    "salt-bridge" "salt-bridges" "samep53" "sample-unique" "sarcomatoid"
    "scatter-plot" "scatterplot" "scatterplots" "score≥4" "scrERAP"
    "scramble-shRNA" "screenings" "scrofa" "sebaceus" "second-generation"
    "second-site" "seeand" "segregants" "self-assembly" "self-association"
    "self-defense" "self-perpetuation" "self-phosphorylation" "self-renew"
    "self-renewal" "self-renewing" "self-report" "self-tolerance" "selumatinib"
    "semi" "semi-dry" "semi-heterochromatic" "semi-quantitative"
    "semi-quantitatively" "seminograms" "senesce" "senescense" "sensitizers"
    "sequelae" "sequence-binding" "sequence-scrambled" "sequence-sequence"
    "sequence-specific" "ser326Cys" "serine-PKC" "serine45-mutant-β-catenin"
    "serines" "serostatus" "serotype" "serum-re-stimulated" "seven-field"
    "sex-determining" "sh-PAF-induced" "sh-PAF–induced" "sh1-CD83" "sh235"
    "shControl" "shLacZ" "shMock" "shPDCD4" "shRFP" "shRNA2" "shScramble"
    "shTRAF6" "shake-off" "shezh" "shezh1" "shezh2-GFP" "shgapdh" "short-chain"
    "short-hairpin" "short-interfering" "short-range" "short-survival"
    "short-term" "shot-gun" "si-ER-α" "si-NF-YA" "siAR" "siARTD1" "siControl"
    "siEGFR" "siEGFR–transfected" "siESRP" "siESRP1" "siESRP1-A" "siESRP1-B"
    "siFAK" "siFGFR" "siFGFR-2" "siFLNA" "siGLO" "siNeg" "siPTTG1" "siRNA#2"
    "siRNA-1" "siRNA-2" "siRNA1" "siRNA2" "siSET7" "siScrm" "siTrio"
    "side-chain" "side-chains" "sidechain" "sidechains" "siderophores"
    "sigmoid" "signal-like" "signal-to-noise" "signal-to-noise=0.51"
    "signature-genes" "signifi" "signifi-cant" "signiﬁcance" "signiﬁcant"
    "silencer-3" "silencing-shRNA" "silico" "sim" "simpler" "simplest"
    "simplex" "simplicifolia" "single-cell" "single-digit" "single-figure"
    "single-gene" "single-locus" "single-molecule" "single-mutant"
    "single-nucleotide" "single-span" "single-strand" "single-target" "sip53"
    "sirtuin" "situ" "sixty-nine" "slot-like" "slow-migrating" "small-X"
    "small-branched" "small-cell" "small-conductance" "small-interfering"
    "small-interferring" "small-molecule" "small-to-mid" "small-vessel"
    "smaller-molecular-weight" "smaller3" "small–cell" "smokers" "so-to-speak"
    "socio" "socio-economic" "solid-tumor" "solute" "solvent-accessible"
    "somes" "somites" "sought-after" "spDHFR" "spacer" "spatio"
    "spatio-temporal" "specifiers" "speciﬁc" "spectrofluorometry"
    "spectrometer" "sphere-forming" "spindle-like" "spine-like" "spirochete"
    "spirochetes" "squamous-cell" "ss" "ssDNA" "ssDNA-dsDNA" "stably-expressed"
    "stably-expressing" "stably-transfected" "stagte" "stainings" "stand-alone"
    "standard-risk" "start-site" "stathmin-1" "stathmin-shRNA" "stathmin1sh"
    "stathmin1shRN" "stathmin1shRNA" "stathmin–cyan" "statmin1" "steady-state"
    "steepest" "stellate" "stem-cell" "stem-like" "stemness" "stemness-like"
    "stent" "step-wise" "stepwise" "steroid-induced" "stilbene" "stilbene-2,2"
    "stimulators" "strain-based" "strain-dependent" "strain-induced"
    "stramenopiles" "stress-activated" "stress-induced" "stress-mediated"
    "stress-responsive" "stress-specific" "stressful" "stromal-related"
    "structural-dynamic" "structurally-unrelated" "structure-activity"
    "structure-based" "structure–activity" "study-to-study" "sub-G1"
    "sub-cellular" "sub-classifications" "sub-classify" "sub-clones"
    "sub-complex" "sub-datasets" "sub-domain" "sub-endothelial" "sub-genomic"
    "sub-group" "sub-groups" "sub-lethal" "sub-lethally"
    "sub-lethally-irradiated" "sub-lytic" "sub-micromolar" "sub-phenotypes"
    "sub-picomolar" "sub-population" "sub-populations" "sub-ribosomal"
    "sub-sample" "sub-states" "sub-stoichiometric" "sub-types" "subG1"
    "subclass" "subclasses" "subcohort" "subcomplex" "subcomplexes" "subdomain"
    "subfamilies" "subfragments" "sublethally-irradiated" "sublines"
    "submucosa" "subnetworks" "subpool" "subsamples" "subset" "subsets"
    "subsite" "substituents" "subtype" "suggestively-associated" "sulfhydryl"
    "sulfide" "sulfonamide" "sulfonate" "sulfydryl" "sulphoximine"
    "sunitinibtamoxifen" "super-dataset" "super-datasets" "super-infection"
    "super-repressor" "super-shift" "super-shifts" "supernatant" "supernatants"
    "superoxides" "suppressPIP3" "suppressor-activity" "suppressorprotein"
    "surgically-resected" "survivor-ship" "survivorship" "suspension-tolerant"
    "switch-like" "switching-off" "synapse" "synapses" "synergism" "t-value"
    "tacrolimus" "tagRFP" "tail-cleft" "tail-region" "tamoxifen-resistance"
    "targeted-therapy" "tegafur-uracil" "telopodes" "temperature-dependence"
    "temperature-sensitive" "temserolimus" "ten-week-old" "tenovin" "tenovin-6"
    "tension-induced" "test-139%" "test-145%" "test-198%" "test-234%"
    "test-281%" "test-31%" "test-82%" "tet-off" "tetracycline-analogue"
    "tetrad" "tetramethylindocarbocyanine" "tetraploid" "thalamus"
    "thapsigargin-inhibitable" "thatMDM2" "thatcontains" "theAKT" "theAKT1ME-R"
    "theAtm" "theBraf" "theKras" "theParp1" "thegene" "theirknown" "thep53"
    "therapy-induced" "therapy-refractory" "therapy-resistance"
    "therapy-resistant" "therapy-treated" "thermocycler" "third-generation"
    "thoracotomy" "three-color" "three-dimensional" "three-domain" "three-hour"
    "three-phosphopeptides" "three-site" "three-way" "three-year"
    "thrombocythemia" "thymidines" "thymidine–nocodazole" "thymocytes"
    "tick-borne" "time-course" "time-course-dependent" "time-dependence"
    "time-dependently" "time-lapse" "time-point" "time-points" "timepoint"
    "timepoints" "timsecale" "tion" "tissue-like" "tissue-of-origin" "tissues"
    "titer" "titers" "titre" "titres" "tm1Bal" "tmlAwb" "toKlf4" "toll-like"
    "tooth-supporting" "topoisomerases" "topologies" "topology" "torsinA"
    "trachomatis" "trans-NE" "trans-dominant" "trans-endocytosis"
    "trans-endothelial" "trans-isomer" "trans-membrane" "transactivators"
    "transcription-PCR" "transcription-dependent" "transcription-prohibitive"
    "transcription-suppressive" "transcriptional–translational"
    "transcription–PCR" "transcription–quantitative" "transcriptome"
    "transdifferentiate" "transducer" "transfections" "transferrin-bound"
    "transformants" "transformations" "transgenes" "translocation-like"
    "transmembrane-type" "transposon" "transtuzumab" "transversions"
    "transwell" "transwells" "trauma-induced" "treatedp53" "treatment-naive"
    "treatment-naïve" "treatments" "trend=0.01" "trend=0.026" "tri-functional"
    "trichoepitheliomas" "trichrome" "trim-and-fill" "trimerizes"
    "trimethylate" "triphosphate" "triple-negative" "trisomy" "trisphosphate"
    "trypsin-like" "tube-like" "tubular-specific" "tubule" "tubules"
    "tumor-like" "tumor-modulatory" "tumor-node-metastasis" "tumor-reactive"
    "tumor-suppressive" "tumor-to-normal" "tumor-unique" "tumor-wide"
    "tumour-prognosis" "tumour-suppressive" "turn-back" "turned-over"
    "twenty-four" "twenty-two" "twisted-amide" "twisting-hinge" "two-hybrid"
    "two-major" "two-residue" "two-sided" "two-site" "two-stage" "two-tailed"
    "two-thirds" "two-way" "type-1" "type-A" "type1diabetes"
    "tyrosine-kinase-family" "ubiquitin-loaded" "ubiquitin-proteasome-mediated"
    "ubiquitin-proteosome" "ubiquitination-like" "ultra-structural"
    "ultra-structure" "ultrastructure" "un" "under-nutrition" "under-represent"
    "undergoes" "undergone" "underpinnings" "undertaken" "uninjectedMx1"
    "unitless" "units" "univariate" "unliganded-LBD" "unmet"
    "unmethylated-PTPRO" "unresponsiveness" "untangle" "untreatedAtm"
    "up-shift" "up-shifted" "upto" "uranyl" "urea" "ureter" "urinary-type"
    "urine-based" "urothelia" "urothelium" "uteri" "utricles" "uveal"
    "v-Ki-ras2" "v-Mybmyeloblastosis" "v-akt" "v-erb-b2" "v-raf" "v3–10"
    "vCXCL1" "vacuolar-type" "vacuole" "vacuoles" "valganciclovir"
    "value=0.017" "value=0.045" "values" "value " "van-der-Waals"
    "variably-expressed" "variant-specific" "variants" "variate" "vasculopathy"
    "vcDHFR" "vdW" "vector-treated" "vehicle-treated" "vemurafenib-resistance"
    "verpolin" "vesrus" "vi" "vide" "vii" "vii–ix" "vinorebine" "viroporin"
    "virotherapy" "viruria" "virus-like-particles" "vitamine" "vitro" "vivo"
    "vs.TT" "waist-hip" "water-soluble" "waveform" "weakest" "webserver"
    "website" "week-old" "well-accepted" "well-appreciated"
    "well-characterised" "well-defined" "well-designed" "well-differentiated"
    "well-documented" "well-imputed" "well-matched" "well-organized"
    "well-powered" "well-recognized" "well-regulated" "well-studied"
    "well-suited" "well-to-moderately" "well-tolerated" "western-blotting"
    "whenp53" "whereZ" "whereasp53" "whole-body" "whole-cell" "whole-gene"
    "whole-liver" "whole-transcriptome" "wide-spread" "widefield"
    "widely-employed" "widely-used" "wildtype" "winged-helix" "withdrawn"
    "withthe" "wk" "workers" "workup" "world-wide" "wortmannin-induced" "www"
    "x-ray" "x10" "xL" "xPAF" "xanthoastrocytomas" "xenogafts" "xenograph"
    "xenographs" "xβ-catenin" "y-H" "y-axis" "year-old" "yeloid"
    "yet-to-be-identified" "yl" "ylate" "ymphadenopathy" "yr" "z-stack" "zDHFR"
    "zGARP" "zVAD" "zeitgeber" "zero-hour" "zeste" "zinc-bound" "zonules"
    "zymograph" "zymography" "ÄktaPurifier" "×10" "×2" "×2 " "×His-tag" "×NZW"
    "× 10" "× 10" "× 2" "Δ1" "Δ1-229" "Δ190" "Δ2" "Δ29–186" "Δ3" "Δ50-250"
    "Δ6–198" "Δ79–339" "ΔA185" "ΔC" "ΔC125G" "ΔCT" "ΔCt" "ΔE" "ΔE302" "ΔEGFR"
    "ΔEnv" "ΔFKH" "ΔG" "ΔH" "ΔH-T" "ΔHAT" "ΔN" "ΔN-p53" "ΔN83" "ΔPEST" "ΔSASA"
    "ΔT" "ΔUIM" "ΔVpr" "ΔΔCT" "ΔΔCT=200" "ΔΔCT=5.1" "ΔΨ" "Δψm" "Λ-OS2" "α-C–H"
    "α-Galactosidase" "α-KG" "α-LKB1" "α-PDGFB" "α-PFTs" "α-enolase"
    "α-helical" "α-helices" "α-helix" "α-ketoamide" "α-pore-forming"
    "α-subunit" "α1-α4" "α2-α5" "α2β1" "α3" "α4" "α5" "α6" "α6β4" "α7-α8" "α9"
    "αC" "αF" "αhelical" "αv" "β-carbons" "β-cat" "β-cat-253" "β-cat-253-M14"
    "β-cat-3393" "β-cat-3393-M14" "β-cat-900" "β-cat-900-M14"
    "β-catenin-253-M0" "β-catenin-253-M14" "β-catenin-3393" "β-catenin-3393-M0"
    "β-catenin-900-M0" "β-catenin-conditional" "β-catenin–null" "β-geo"
    "β-glycerophosphate" "β-herpesvirus" "β-integrin" "β-oxidation"
    "β-peptide-induced" "β-propeller" "β-sheets" "β-strands" "β-transducing"
    "β-zipper" "β1" "β1kd" "β3" "β3kd" "βC" "βI" "βII" "βTrCP" "γ-ATP" "γ-GCS"
    "γ-chain" "γ-enolase" "γ-irradiation" "γ-phosphate" "γ-radiation" "γ1" "γ2"
    "γH2A.X" "γc" "γН2А" "κB" "κB-site" "κB1A" "κBα" "λ-phosphatase"
    "λ-phosphatase-treated" "λ-value" "μL" "μg" "μg " "μl" "μmol" "π-π" "χ2"
    "χ2 " "Мrе11" "∆1-1904" "∆45-84" "∆FKH" "∆NL" "∆Nβ-catenin" "∆P" "∆PL"
    "≡101.325" "　expression" "、50–59" "、60–69歳" "、CAVI値との関連は認められなかった" "、CD14"
    "、ICAM-1" "、IL-10" "、IL-6" "、MCP-1" "、TNF-α" "、cardio-ankle"
    "、さらに大規模な追跡研究が必要である" "、一般線形モデルを用いて性・年齢群" "、主要危険要因で調整した重回帰分析では"
    "、年齢別の効果については不明である" "、明確な関連が認められなかった" "、横断的および5年間の縦断的研究を行った" "、男性ではCD14"
    "、男性若年群におけるCD14" "、高血圧も女性若年群以外の男女全年齢群でCAVI値と正の関連があった"
    "。5年間におけるCAVI値の変化との関連も同様に縦断的に検討した" "。5年間のCAVI値の変化に関しては"
    "。CAVI値と遺伝および主要危険要因との関連は" "。この結果を確認するためには" "。一方" "。他の6遺伝子多型に関しては"
    "。年齢別の動脈硬化" "。炎症に関わる遺伝子多型は" "。遺伝子多型ごとのCAVI値は" "【方法" "【結果" "【結論" "【背景"
    "から選ばれた" "ごとに見積もった" "を動脈硬度の代理指標として用い" "対象は34"
    "本研究では炎症に関わる遺伝子多型は動脈硬化と関連していないことが示唆された" "炎症に関わる遺伝子多型は動脈硬化リスクに関与している可能性があるが"
    "耐糖能異常は女性の全年齢群で高CAVI値と関連していた" "ﬁrst" "（34–49" "（arterial"
    "）における遺伝子多型の効果を検索するために" "～69歳の一般住民1,850名である"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-10801-11100*
  '("anti-H4" "22.21±2.79%" "43.83±4.70%" "possible anti-immunoparalysis"
    "anti-immunoparalysis" "immunocytes" "44.32±5.52%" "35.29±1.34%"
    "73.18±2.44%" "CSA" "Rho123" "chronic lymphocytic leukemia/lymphoma"
    "deaths/day" "cecal" "Xie" "Mandila" "Ulrich" "Zhai" "Dalay" "Akisik"
    "Justenhoven" "Landi" "polymorphisms/variants" "0bp/0bp" "6bp/0bp"
    "rs1059394T" "OR=1.47" "6bp/6bp" "andr" "SNPs/variants" "6bp" "0bp"
    "rs1059394" "0 bp" "rs2790" "at least 19 SNPs" "approximately 483 SNPs"
    "18p11.32" "dbSNPs" "Bastos" "Kheirelseid" "-monophosphate" "deoxyuridine"
    "non-Hispanic" "rs16430" "≤55" "=0.033" "=0.056" "=0.032" "=0.65"
    "P = 0.027" "~50%" "P =0.006" "95% CI = 1" "= 0.010" "two unique datasets"
    "fibroblast growth factor-1" "BSC" "multicenter" "=0.0263" "P= 0.048" "HFS"
    "2.04-3.58" "8-week" "Eight-week" "= 0.048" "P= 0.012" "1-6" "0-1"
    "P- value" "grade 3" "VEGF/" "=0.026" "P=0.012" "overexpression/activation"
    "Merier" "the available gene expression datasets" "pERα-Ser167/Ser305"
    "pERα-Ser167" "p-ERα-Ser167/Ser305" "p-ERα-Ser167" "ERα-S167A/S305A"
    "endpoint" "μm/L" "TamR" "showed frequent overexpression/activation"
    "Co-existence" "E-01" "~4.0" "ymphadenopathy" "XMEN" "p85α" "S240/S244"
    "mostly T EM /T EMRA" "/T" "EMRA" "MutationTaster" "LRT" "SIFT" "ABD"
    "isotypes" "MPEC" "SLEC" "bis" "pYxxM" "lymphadenopathy" "1000 Genomes"
    "IgG +" "Campisi" "Rodier" "Legesse" "Sampson" "Kumar" "nonsmall" "Hannon"
    "Czech" "MacRae" "Pratt" "Targetscan" "Bartel" "let-7b" "~6.4" "~2.3-"
    "pre-let7a" "~3.5-fold" "Marasa" "p38MAPK" "2BS" "~PDL" "pGL3-CRΔ1"
    "pGL3-CRΔ2" "pGL3-CRΔ3" "Δ3" "Δ2" "Δ1" "CRΔ4" "Δ4" "RNA22" "dex" "~50–70%"
    "Ventura" "Trinei" "Favetta" "UVC" "Lebiedzinska" "Veeramani"
    "longer lifespan" "Napoli" "p52Shc/p46Shc" "Luzi" "p46Shc" "p52Shc"
    "Rizzuto" "Pinton" "Migliaccio" "Parker" "Fabrizio" "Guarente" "Bordone"
    "HDFs" "P = 0.0003" "P = 0.01" "~2.5" "let-7a" "antifade" "MDM2Tr"
    "N320/C180" "overridden" "Et" "CldU" "ecdysone" "D2 and" "P  - value"
    "addressing 2ME2" "Zundel" "GFAPV12 Ras" "LN229 vIII" "Synergism"
    "2ME2/LY294002" "LN229vIII" "and 2ME2" "PtIns" "muristerone"
    "hypoxia-inducible factor-1" "to 2ME2" "2ME2" "methoxyestradiol" "= 0.028"
    "anti-GBM" "96h" "responder" "FCRL4" "Cyclin-Dependent Kinase inhibitor 1A"
    "immune/inflammatory responses" "T-independent" "Peyer’s" "gp120s" "BnAbs"
    "Peyer" "lo" "Igs" "apurinic/apyrimidinic" "0–1" "~5%" "~40%" "~16%"
    "Toll-Like" "α 4" "anti-retroviral" "shgapdh" "shezh1" "shezh2-" "shezh"
    "re-appearance" "bothAtm" "untreatedAtm" "dendrites" "tm1Bal" "tmlAwb"
    "-injectedAtm" "injectedAtm" "live adult mouse cerebellum" "improvedAtm"
    "shezh2" "dendrite" "or 2SD-EZH2" "theAtm" "fromAtm" "EZH2 in" "2SD"
    "otherAtm" "orAtm" "S/T" "neocortex" "mouseAtm" "inAtm" "itsAtm"
    "H3K27me3 in" "ofAtm" "andAtm" "cerebella" "PIKK"
    "most profound neuropathology" "neuropathology" "~2%" "non-mitotic" "Gd"
    "gadolinium" "radiotherapy/chemotherapy" "132G395A" "1p" "hydroxylases"
    "2OG" "oxygenases" "oxoglutarate" "Chowdhury" "2HG" "Metellus"
    "hydroxyglutarate" "Volgelstein" "CIMP" "dehydrogenase-1" "KPS" "Karnofsky"
    "oncologists" "AOA " "and 1p/19q" "1p/19q" "AOA" "AOAs" "co-deletion"
    "and 1p" "ozogomycin" "cytogenetic subset"
    "a new clinically relevant subset" "Hematología" "Tratamientos" "Español"
    "Programa" "PETHEMA" "uniparental disomy (UPD)" "disomy"
    "morphologic subset" "ider" "Trisomy" "WBC" "000/μL" "ACAs" "iWBC" "= 0.72"
    "17q" "p = 0.06" "= 0.30" "= 0.18" "= 0.54" "p = 0.08" "Five-year"
    "McFarland" "Tumorscape" "Rudin" "Peifer" "caspase 3/7" "thrombocythemia"
    "amrubicin" "p=0.001" "=0.39" "=0.18" "tube-like" "Matrigels"
    "anti-angiogenesis" "_siR" "VEGF_siR4" "HER2_siR3" "_siR4" "absorbance"
    "_siR3" "*  P  " "± standard" "/propidium" "5 × 10" "1 × 10" "6 h" "Sharma"
    "RWNC" "Fiji" "the classical non-canonical" "FM4-64" "Fluo4/FuraRed"
    "Mazzanti" "cisterna" "waveform" "100 ng/ml" "253J" "Wnt/β-catenin"
    "oncomir" "miRwalk" "RNAhybrid" "shPDCD4"
    "cell apoptosis signals-associated moleculars" "moleculars" "shScramble"
    "clone1" "5-8F" "BRB" "Southest" "10q24" "≥50" "sense/antisense" "P =0.008"
    "P =0.029" "=0.24" "10.1038/ncomms3667" "reprogrammes" "TGF-β
RII"
    "TGF-β RI" "SHN" "trypsin-like" "MDA-MB-1386" "sip53" "−969" "+130" "−738"
    "synergism/collaboration" "Smad3/4" "GTCT" "AGAC" "1.3-Kb" "2.5-Kb"
    "177/+130" "−2,470" "the REGγ translational
initiation codon"
    "coactivator-3" "0.5–1 " "HCT116p53+/+" "6 h" "Smad2/3" "co-repressors"
    "FoxO1/3a" "Xpress" "btbd" "non-nervous" "BTBD10-like" "CALGB"
    "a particularly fit subset" "primary/liver" "Biopsies" "metastectomy"
    "colectomy" "P  = 0.007" "= 0.030" "= 3" "= 1" "= 0.033" "= 0.42"
    "= 0.0083" "= 1.86" "P  = 0.0022" "= 5" "7/62" "× 10" "= 9" "= 7"
    "= 0.0017" "= 6" "suppressing tumorigenesis-associated DNA aneuploidy"
    "cytometer" "-d" "binucleate" "Polyploid" "-c" "-b" "mmol/L" "Hansemann"
    "polyploid" "KBrO" "aneuploid" "≥ 1" "= 1.0" "36 h" "Zeste" "arrestat"
    "parental A549 cells" "HSCORE" "n=20" "A549 cells" "A549/HOTAIR"
    "A549/control" "pcDNA/p21 or" "HOXD" "trimethylate" "SPC-A1/HOTAIR" "subG1"
    "siRNA/control" "A549/CDDP" "ﬁrst" "one histological subtype"
    "siRNA/HOTAIR1" "HOTAIR1" "p21 WAF1/CIP1" "A549/DDP" "p21WAF1" "P =0.003"
    "P = 0.018" "=21" "G 0 /G 1  " "p21 WAF1" "G 0 /G 1" "　expression"
    "phospho-Tyr-342-specific" "anti-pTyr" "PY-20" "ΔFKH" "∆FKH"
    "hypoxia/reoxygenation" "enteropathy" "polyendocrinopathy"
    "forkhead/winged" "_s1" "Hs99999901" "non-receptor" "T-regulatory" "Pvu"
    "Non-Progressive" "Weinstein" "`s" "Dimeglio" "PpXX (CTGG)" "TTAA" "ppxx"
    "CTGG" "PpXX" "rs2234693" "rs9340799" "Takahashi" "Inoue" "antero"
    "non-progressive" "PvuII" "XbaI" "= 67" "= 56" "healthy supernatants"
    "activation/nuclear" "regulation/expression" "Kruskall" "TCCN" "TTCN"
    "activation/regulation" "P = 0.011" "S3D" "non-consensus" "S3B" "10 ng/ml"
    "Calvisi" "leadings" "Majek" "Uğurluer" "Infinium" "Bibikova" "P=0.050"
    "=0.050" "buccal mucosa" "Indians" "Malays" "the Pearson's" "Illumina's"
    "Partek" "the Illumina's" "Dimethylamino"
    "adenomatous polyposis coli (APC)" "coli (APC)" "ASEAN" "GLOBOCAN" "=29"
    "Pten-/-" "uveal" "P=0.018" "p=0.011" "P=0.003" "67/114" "76/114" "=0.011"
    "immunostainings" "non-immune" "5 -year" "=0.006" "=0.018" "P=0.001"
    "=0.003" "a p53 temperature-sensitive cell line Vm10" "Vm10" "TRAFc"
    "shMock" "50 ng/ml" "1 μg" "16 h" "pCDNA3"
    "the newly completed massively-parallel sequence dataset" "pSTAT1" "K142fs"
    "K860fs*43" "P430fs" "2580delA" "*43" "K860fs" "Binary Alignment/MAP (BAM)"
    "GYN" "processing-1" "databank" "50 ng/ml" "/K" "Insertion/deletion"
    "Non-synonymous" "mature progeny" "progeny"
    "progressive bi-lineage cytopenia" "non-cell-autonomous" "crossingBraf"
    "theBRAF" "V600E -activated" "chimerism" "Mx1::Cre" "neutrophilia"
    "conditionalBraf" "theBraf" "V600E -induced" "CA/+" "crossedBraf"
    "V600E -related" "ECD/LCH" "MEK→ERK" "Chester" "Erdheim"
    "monocyte/histiocyte" "V600E -expressing" "B-lineage" "non-hematopoietic"
    "E –" "E -" "monocyte/macrophage" "difficile" "siGLO" "AIR-1" "∼2.5"
    "CDK1Y15P" "cyan" "∼4 h" "dvpr" "pCL10A-1" ".1-TRCN0000011645" "Addgene"
    "_003608" "-ATAAGAATGC" "ATAAGAATGC" "website" "OriGene" "_m1"
    "SuperScript" "Valencia" "QIAGEN" "RNeasy" "UVP" "LabWorks" "Piscataway"
    "LDS" "-morpholino" "morpholino" "piperazinyl" "Hydroxyethyl" "EPPS"
    "hydroxyethyl" "Gibco" "BTB09089" "TDAG" "Oncomine" "H1299/TDAG8"
    "MSCV-TDAG8-IRES-GFP" "U937/vector" "U937/TDAG8" "-IRES" "MSCV"
    "H1299/vector" "Wnt/B-catenin" "rs4975596/rs7736074" "15p5.33" "at 15p5.33"
    "Heterozygotes" "Rs7736074" "SKCM" "UCEC" "monotherapies" "rs7736074"
    "rs4975596" ":532–536" ":1254–1261" "Oncol" "Clin" "Patholog" "= 0.003"
    "= 1.0" "SNP 6.0" "ORK"
    "physiologically relevant concentrations 10 −7 and 10 −9  m 17β-oestradiol"
    "structures/cells" "tissues/cells"
    "putative mesenchymal stem-cell marker STRO-1" "STRO-1" "E2-treated DPSCs"
    "exogenous 17β-oestradiol" "premolars" "exogenous oestrogen" "dentine"
    "dental tissues/cells" "available DPSCs" "odonto/osteogenic"
    "17β-oestradiol" "Δ C" "4,5-dimethylthiazol-2-yl"
    "GI tract pathophysiology" "re-proposed" "the entire GI mucosa" "Grover"
    "ileum" "an almost continuous monolayer" "The intramuscular ones" "podoms"
    "podomers" "telopodes" "the superficial mucosa"
    "An almost continuous monolayer" "antrum" "immunophenotypes" "and 2–3"
    "ICLC" "GI" "Telocytes (TC)" "Telocytes" "= 16" "researchs"
    "autologous MSCT" "MSCT" "ɛ" "VNTR" "T/C" "Classical Li responders"
    "non-responsive" "McCarthy" "vs acute Li" "Li's" "Comorbid"
    "disorder/substance" "PSAs" "comorbid" "the homozygous T/T genotype"
    "rs334558" "Homozygotes" "∼36%" "attempters" "Rev-Erbα" "N =5" "36 h"
    "=0.09" "4 h" "Q-Value" "N =7" "=19" "10.1038/ncomms3544" "medulla"
    "-deficiency-induced" "the opposite dorsal submucosa"
    "the ventral submucosa" "rVista" "PHM82" "60-day-old" "simplicifolia"
    "griffonia" "biflorus" "dolichos" "UEA" "europaeus" "ulex" "submucosa"
    "represented severe dysplasia" "gastric dysplasia" "fl/fl" "flox/+" "χ  2"
    "1.0 × 10" "~80%" "Williamson" "metagene"
    "the unfavourable PAX3/7-FOXO1-postive histology" "7-FOXO1-postive" "=2.7"
    "=0.0017" "⩾200" "95% CI=1" "=2.0–7.3"
    "the specific quantitative ALK mRNA cutoff value ΔΔCT=200" "ΔΔCT=200"
    "=200" "=555" "IID" "PAX3/7-FOXO1-negative" "mAb16-39"
    "PAX3/7-FOXO1-positive" "20–25" "embryonal histology (ERMS)" "ERMS"
    "commonest" "7-FOXO1-negative" "7-FOXO1-positive" "=0.50" "n =10" "=20"
    "=0.79" "LCLs" "rs501764" "rs2019960" "rs2608053" "rs1432295" "x10"
    "Subtype" "localises" "bps" "OR= 1.21" "genomewide" "5.0x10" "rs7745098"
    "rs3806624" "gc" "296,129 autosomal SNPs" "UKBS" "British" "Wellcome"
    "BeadChips" "Utah" "Nixdorf" "Heinz"
    "The most significant single nucleotide polymorphisms" "2p16.1" "non-HLA"
    "Sternberg" "3p24.1" "6q23.3" "H3K9ac" "≥75%" "= 1.21" "10p14"
    "non-equilibrium" "heparin-treated Fn" "pixels" "pixel" "Labtech" "BAECs"
    "MAB1935" "QCMD" "microbalance" "denaturants" "Fn" "d" "#32"
    "-methylguanine–methyltrasferase (MGMT)" "paralogues" "GMB" "#25" "#31"
    "Anti-phosphorylated" "24 hrs" "-methylguanine–DNA methyltransferase"
    "myxoid" "WDLPS" "coomassie" "non-radioactive" "SMP14"
    "co-immunopreciptated" "5Bi" "SNP30" "4Cv" "2A9" "4B11" "WGE" "normalizer"
    "T/T" "expressors" "LC-MS/MS" "G/T" "= 0.932" "OR = 1.031" "Moshynska"
    "Saxena" "Hodgkin’s" "an essential gatekeeper" "SE = 1.57" "SE = 1.28"
    "=0.86" "SE = 1" "GG+GA" "Kuznestova" "America (USA)" "Russia" "Bax-248GA"
    "TCG" "at least 111 Bax SNPs" "Smack/Diablo" "around 10 million SNPs"
    "Wiley" "= 0.87" "= 1.57" "= 0.85" "= 1.28" "=0.43" "= 0.19" "P-value"
    "= 0.680" "= 75" "= 65" "= 0.008" "=75" "APMK" "nanovesicle" "nanovesicles"
    "DOTAP" "dioleoyloxy" "6 H" "only DCIS luminal-A subtypes"
    "almost all triple-negative IDC subtypes" "triple-negative IDC" "PR+" "IDC"
    "co-workers" "normal-like" "Basal-like" "D-type" "remodeller" "doxyrubicin"
    "mononucleosome" "3AB" "IEG" "Donnell" "Espinosa" "endothelia" "L50-823"
    "adenxa" "Merkel" "epithelioid" "myometrium" "HCG" "chromophobe"
    "non-mucinous" "eccrine" "basaloid" "trichoepitheliomas"
    "the laryngeal ones" "pulmonary ones" "non-trophoblast"
    "testicular seminiferous tubules"
    "respiratory and pulmonary alveolar epithelia" "gallbladder" "mucosae"
    "Omental peritoneal mesothelium" "mesothelium" "parotid"
    "Seminal vesicle epithelia" "distal tubules" "Urothelial epithelia"
    "ureter" "Lobular and ductal epithelia" "apocrine" "Choroid"
    "approximately 1/3" "periocular mesenchyme" "the caudal mesenchyme"
    "mesenchyme" "peritoneal mesothelia"
    "respiratory and gastrointestinal epithelia" "mesothelia" "distal nephron"
    "some salivary gland and sweat gland ductal epithelia" "Leica" "tumor-like"
    "non-epithelial" "cisternae" "two closely associated organelles" "CAAX"
    "Cyclin E1" "BsC-1" "RhoBTB" "Tramtrack" "72H" "-to-S phase" "∼10%"
    "chemonaïve" "HT29-ATMsh-GFP" "OxR" "Dox" "USP29" "deubiquitininates"
    "73-393aa" "Joseph" "Machado" "UCHs" "Δ Ct" "36 h" "4h" "36h" "6h"
    "GSE25055" "gastric carcimona" "carcimona" "metrix" "knowm" "desmoid"
    "a clinically identifiable subclass" "_pcr" "_stage" "Borrmann’s"
    "Borrmann" "pathologic_response_rcb_class" "_rcb" "_response" "BT474HR"
    "Lehmann" "Jiang" "the luminal A subtype" "Knowles" "Lopez" "Khramtsov"
    "T1+T2" "_t" "_class" "transtuzumab" "DKAT" "Affy" "NNP" "mRNA/protein"
    "Non-MMP7" "zymograph" "Georgia" "MSK-96" "Emory" "non-TN" "DASL" "HR+"
    "Reis" "begun" "Perou" "WP’s" "Jonsson" "Kornelia Polyak’s" "Polyak"
    "Kornelia" "sulfide" "WP" "Gonen" "Almendro" "Triple Negative subset"
    "non-stimulated" "p = 0.01" "p = 0.008" "pGSK3" "foreseen"
    "the active NICD3" "choroid" "forebrain" "Eberhart" "Gaiano" "CNND1"
    "Sh235" "sh235" "Rembrandt" "19p13.12" "NOTCHs" "mastermind-like"
    "high grade astrocytic lineages" "Zhu" "Israeli" "Jewish" "insightful"
    "12p13/" "rs17221259" "10q21/" "rs10509168" "8q24/" "rs672888" "RPL17p33"
    "8p21/" "rs7465364" "6q25/" "rs6557161" "5p12/" "rs4415084"
    "these suggestively-associated SNPs" "LOC643714" "2.79×10" "16q21.1"
    "3.97×10" "1.31×10" "rs12922061" "rs3803662" "rs2981578" "Hondo" "PCA"
    "550,026 autosomal SNPs" "OmniExpress" "mammography" "individuals/year"
    "16q12" "= 1.16–" "8q24" "8p" "0/1" "10q26" "= 1.16" "= 1" "seeand"
    "BR/gene" "ABI3" "non-Hodgkin" "APOL2" "gene/BR" "RefSeq" "oncovirus"
    "Hochberg" "Benjamini" "DESeq" "B-cell-like (ABC)"
    "germinal center B-cell-like (GCB)" "B-cell-like (GCB)"
    "at least two subtypes" "germinal center B-cell−like" "B-cell−like" "= 1"
    "= 0.46" "344 bp" "hg19" "Egger's" "0.46-1.09" "=0.71" "=0.85" "=0.96"
    "0.89-1.18" "OR=1.03" "=0.78" "0.82-1.51" "0.87-1.28" "OR=1.05" "OR=1.11"
    "Val511Ala" "rs20417" "rs689466" "rs5275" "rs5273" "511Ala" "0.96-1.21"
    "OR=1.08" "=0.74" "=0.81" "=0.27" "p =0.03" "=0.07" "=1" "=1.11"
    "a Pearson's" "erythrocytes" "Benites" "cytochome" "NTBI" "cytopenia"
    "peripheral cytopenias" "cytopenias" "MDSs" "non-IO" "IO" "esiRNAs"
    "ferric ammonium citrate + desferrioxamine" "desferrioxamine" "ammonium"
    "P  = 0.004" "1 × 10" "IHC score 3+" "non-response" "GA0044" "GA0139"
    "0–2+" "EGFR IHC 3+" "12/20" "GA0075" "GA0152" "non-responders" "ΔT"
    "Esophago" "Xeloda" "ORR" "human/mouse" "2/4" "Exon2" "P = 0.008"
    "The breast cancer-associated L939W and L1143P mutants/variants" "coud"
    "three different breast cancer-associated missense mutants/variants"
    "mutation/variant" "PALB2ΔC" "Y551X" "EUFA1341" "es" "paralogs" "paralog"
    "partner-and-localizer" "mutants/variants" "breast/ovarian" "anti-flag"
    "pMIR" "gapdh" "serum-re-stimulated" "co-resides" "prokaryotes"
    "co-resided" "Anti-Flag" "developed significant diabetic nephropathy"
    "proximal tubules" "N-methylanthraniloyl" "Mant" "methylanthraniloyl"
    "iNampt/NMN" "Cont+Sal" "CKO+Sal" "the NMN-producing enzyme iNampt"
    "iNampt" "adenylyl" "iNAMPT" "5/6Nx" "db/db" "CKO+ STZ" "CKO+STZ"
    "Cont+STZ" "CKO+Saline" "Cont+Saline" "micro-dissected glomeruli" "PECs"
    "WT+Sal" "PEC" "a statistically significant upregulation greater" "Welch"
    "TG+STZ" "WT+STZ" "PTs" "diabetic nephropathy" "the proximal tubules (PT)"
    "Early diabetic nephropathy" "Diabetic nephropathy"
    "maintaining NMN concentrations around glomeruli" "glomeruli"
    "proximal tubules (PT)" "4 h" "non-CpG" "non-diabetic" "=0.94" "A/G"
    "this important high-risk subtype" "Guatemalans" "MRD" "Ph" "=511" "=67"
    "YRI" "OR=3.25" "=1.05×10" "non-Ph-like" "AALL0232" "rs3781093" "=2.17×10"
    "hyperdiploid" "Ph+" "rs3824662" "non-ALL" "Ph-like" "Philadelphia" "N=5"
    "N=6" "=0.0008" "P =0.007" "=0.028" "P =0.0005" "P =0.0004" "P =0.004"
    "P =0.01" "OR=3.45" "utricles" "/FM1-43" "FM1-43"
    "neomycin-damaged cochlear explants" "non-damaged cochlear explants"
    "non-damaged" "Ad-Pax2-IRES-EGFP" "cochlear explants" "explants"
    "Ad-Pax2-IRES-Math1" "transdifferentiate" "LER" "cochleae" "non-mammalian"
    "Corti" "co-infection" "24 h" "X63/0" "MATIIa" "Katoh"
    "co-activator/co-repressor" "enhancer/promoter" "polytene"
    "factors/co-factors" "mP" "anti-His" "CBD" "Keap" "ation"
    "hNQO1-ARE-dependent" "hNQO1-ARE-" "mGSTA" "κB-" "16h" "Shenvi"
    "polymerase-1" "co-repressor" "non-template" "TS516" "Akti-1/2" "Akti-1"
    "Akti1/2" "miR-34c" "FoxO1-5KR" "FoxO1-3A" "circuitry" "*p" "+ 2" "KG"
    "omentum" "colorectal adenoma/cancer" "15/49" "8/15" "1/49" "4/15" "5/15"
    "so far p53 immunohistochemistry" "Malpica" "IOCs" "IOC" "pyro" "BOTs"
    "immunophenotype" "± standard" "= 12" "= 10%" "- 6" "Andersen" "workup"
    "pyrograms" "v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)"
    "homolog (KRAS)" "five-year" "Poland" "underwent oophorectomy" "SOGC"
    "person-years" "survivorship" "underwent bilateral oophorectomy"
    "0.31–1.91" "Ŧ" "signifi" "non-pregnant" "Approximately one-half"
    "salpingo" "oophorectomy" "15-year" "At 15" "= 0.91" "= 0.83" "yes/no"
    "95 % CI" "replicon" "and 2a" "PPIs" "simplex" "INFV" "serotype" "and 1b"
    "GTs 1a" "HCVpro" "viral interactomes" "lipidome" "omics" "GT 2a" "JFH1"
    "Y2H" "DENV" "viroporin" "polyprotein" "interactomes" "non-tumorous"
    "P-Value" "non-structural" "Alk" "15AA" "ESVD" "DNID" "multipass"
    "Fulminant" "dmpk" "shDMPK" "ELM—the" "ELM" "5-thio-glucose" "diamide"
    "oligomycin" "intermembrane" "TOM" "OMM" "Kaliman" "CUG" "Tris/HCl" "α B"
    "genetic/mRNA" "SNU" "pFGFR" "Bonn" "a strong pFGFR1" "a weak pFGFR1"
    "the cytoplasmatic pFGFR1" "strong pFGFR1" "weak pFGFR1" "subcohort"
    "available LNM" "LNM" "Nakao" "pFGFR1" "non-amplified" "5/6"
    "Amplification/Protein" "~ 5%" "Rb1/p53" "Rb1/Nras" "19p13.2" "CVT-313"
    "Ser807/811" "indolinone" "MTCp25" "NSE promoter-driven p25OE" "colloid"
    "tTA" "p25OE" "CP681301" "marfanoid" "neuromas" "Neuroendocrine" "WST-1"
    "24 hr" "– 25" "co-amplify" "cooperative blockde" "blockde"
    "LN-229:EGFR/EGFRvIIIdNLS" "LN-229:EGFRvIIIdNLS" "EGFRvIIIdNLS" "6 h"
    "D813N protein" "NIH3T3:EGFR/EGFRvIII" "DY5"
    "the bulky covalent ATP-analogue 4TB" "4TB" "yl" "quinazolin"
    "LN-229:EGFRvIII" "LN-229:EGFR" "LN-229:parent" "p=0.0003"
    "LN-229:EGFR/EGFRvIII" "200 μg" "co-amplification" "=0.0003" "WZ" "KX" "ZY"
    "CW" "rs1799889" "4G/5G" "7q21.3-q22" "SNPStats" "a smaller BMI" "Asano"
    "Swiss" "Ferrari" "4G/4G" "Glueck" "Hozumi" "arthroplasty" "non-traumatic"
    "Non-traumatic" "rs11178" "codominant" "rs2227631" "MassARRAY" "Sequenom"
    "steroid-induced ONFH" "ONFH" "P = 0.03" "= 0.28" "non- 2 " "× 2" "C/T"
    "n = 6" "= 9" "= 8" "n = 10" "P = 0.02" "Roberts" "Bernert" "Kultti"
    "Sherman" "Krekk" "Palyi" "Bourguignon" "Steadman" "Kohan" "Midgley"
    "Carthew" "Webster" "Kefas" "Webber" "Meran" "Simpson" "Shiraha" "Ashcroft"
    "Gabbiani" "extracellular signal-regulated kinase 1/2" "secreted/soluble"
    "normoxia+insulin" "mg/L" "=0.00" "GA+AA" "non-MI" "homozygotes (AA)"
    "heterozygotes" "first-time acute STEMI" "STEMI" "first-time" "p =0.08"
    "preneoplasma" "H4C4" "FLLL32/WP1066" "pTRIPZ" "pGIPZ" "pLKO" "oncomine"
    "HAb18" "neoplasias" "pancreatitis" "PanINs" "systemic chemo/radiotherapy"
    "HAb18G/CD147" "** P" "* P" "Co-Immunoprecipitation" "ΔCt" "n=10" "FuGene6"
    "CD44s" "~5-fold" "revertants" "selumatinib" "JPA's" "xenogafts" "PBTC"
    "regrow" "144h" "24hr" "144hr" "BT40/AZD" "AM38c1" "parental BT-40"
    "untreated parental BT-40" "BT40" "the parental BT-40" "ΔΔCT" "ΔCT" "Taq"
    "CV" "BT-40/REV" "AZD" "revertant" "A5/A2" "regrew" "JPA" "BT-35"
    "patient/mouse" "PPTP" "≥90%" "xanthoastrocytomas" "neuroendocrine"
    "diencepahlon" "diencephalon" "BT-40/AZD" "LLL12" "BT-40" "~75%" "~90%"
    "P= 0.077" "=0.51" "=0.045" "=0.53" "Phospho-ERK1/2" "PanIN/PDA" "theAKT"
    "PDA" "ITNP" "hemangiosarcomas" "CEFs" "SNPPCR" "retrovirus" "Lubezky"
    "IPMN/IPMCs" "IPMCs" "Samuels" "inPdx" "theKras" "MUC5AC+"
    "dysplasia/carcinoma" "IPMC" "MCN" "8/8" "4/14" "p = 0.012" "= 11"
    "= 0.027" "= 0.018" "χ 2" "= 70" "~20%" "= 0.014" "centromeres"
    "co-precipitates" "LX" "ZX" "ZH" "HJ" "T2/T3N0M0" "T2N0M0" "T3N0M0"
    "esophagectomy" "IIa" "T2-3N0M0" "These inconsistent conclusions drawn"
    "P = 0.007" "IHC stainings" "the IHC stainings" "the public datasets" "akt"
    "v" "Mammalian/mechanistic target of rapamycin" "stainings" "_S65"
    "recognises" "rapalogs" "_S2448" "_S473" "4EBP1 cytoplasm "
    "4EBP1cytoplasm " "strong cytoplasmic p4EBP1" "pmTOR" "Vijver" "Karolinska"
    "8p12" "p4EBP1" "mammalian/mechanistic target of rapamycin" "Stockholm"
    "= 0.17" "= 0.60" "= 0.99" "= 0.32" "= 0.43" "P  = 0.007" "= 0.30" "≥5"
    "11q13" "C/EBP β/δ" "pTEFb" "Alamos" "A/T" "Shugars" "non-B" "reg" "Tnon"
    "Wnt/" "FopFlash" "TopFlash" "octyl" "HV2EH" "FDSLLAYDY" "RFDSRLAFHH"
    "Jolla" "Molsoft" "D-x-x-x-x-" "DSLLVFDY" "DSLLAYDY" "360-16R" "ASFV"
    "SwissProt" "MyHits" "DYT" "KDASL" "RPVHAN" "ILM" "LVMP" "ESTV" "Prosite"
    "co-crystal" "/Armadillo" "wg" "co- precipitates"
    "glycogen synthase kinase-3 β" "moncytes" "161 pg/ml"
    "examined TAMs directly ex vivo"
    "the two final gene subsets based on their suggested roles in regulation"
    "co-culturing" "SSC" "FSC" "co-cultures" "p = 0.1" "p= 0.03" "=10" "P=0.02"
    "1 X 10" "n = 3" "#190" "#261-265" "FxxMF" "2PAKs" "micrographs" "#326"
    "#308" "#285-618" "#292-368" "pGal" "siScrm" "siAR" "filapodia"
    "non-AR-interacting" "inase" "≤ 0.05" "W/V" "V/V" "/ R"
    "The SLE-associated rs3122605 G-allele"
    "SLE-associated rs3024505/rs3122605"
    "four publically available cis -eQTL datasets" "non-EA" "BeadChip"
    "Americans/Hispanics" "1.19–1.43" "Breg" "Bregs" "leucopenia" "pS383"
    "the SLE-associated haplotype" "DNasel" "these four SLE-associated SNPs"
    "a SLE-associated risk haplotype" "non-risk" "oligodeoxynucleotide"
    "SLEDAI" "the SLE-associated SNPs" "rs61815643" "1.3×10"
    "The BD-associated SNP rs1518111" "rs1518111" "rs1800896" "rs1800872"
    "rs1800871" "= 1.0×10" "rs3024495" "rs3024493"
    "additional SLE-associated SNPs" "the largest EA dataset"
    "Amerindian/Hispanic" "Behçet's" "Turks" "both Crohn's" "GWA" "1q31-32"
    "SLE-associated SNP rs3122605" "rs3122605"
    "three additional SLE-associated SNPs" "rs3024505" "American (EA)"
    "non-Europeans" "= 0.1" "= 0.0048" "= 0.0002" "= 0.74" "P  = 0.038" "n = 7"
    "n = 12" "= 11" "IL-10 +" "P  = 0.047" "−6" "= 0.18" "T/G" "non-European"
    "= 1.0" "= 5.0" "= 1.30" "type 1 diabetes" "2.7×10" "strong lymphopenia"
    "lymphopenia" "Armstrong" "programmed cell death-1" "TLR7/9-" "ISGs" "ISG"
    "progressors" "non-infectious" "phosphorothioate" "phosphorthioate" "Ba"
    "TLR7/9" "SuperKiller" "Plasmacytoid" "IFNα/β" "Non-Targeting" "TCID 50"
    "simpler" "standard isothermal calorimetry" "16mer" "E78P/F83L"
    "spectrometer" "multiwell" "co-solvent" "FE" "ProTEV" "TEV" "fluorophore"
    "fluorophores" "ETGE" "PPI" "Förster" "5-nm" "= 0.04 µ" "≥ 1" "∼80%"
    "Kelch-like" "datasinib" "3.3:1" "Biosoft" "Calcusyn" "Talalay" "PF562271"
    "H1299/IGFBP2" "responders" "sacaratinib" "≥ 4" "2 x 10" "8-week-old"
    "AAV-GFPCre-injectedKlf4" "-deletion-induced" "axonal regrowth" "adultKlf4"
    "ofKlf4" "anterograde" "SBS" "f/f" "hSynI" "GFPCre" "Lif" "Cntf" "inCntf"
    "JAK-STAT3" "Schwann" "regrowth" "axons" "TUJ1" "C2orf44" "sarcomatoid"
    "amplifications/gain" "KFSHRC" "AJCC" "=0.0135" "normal colorectal mucosa"
    "amplification/gain" "the 300 normal colorectal mucosa" "an intense 3+"
    "non-representative" "IQR" "interquartile" "Clinico" "Arabia" "Saudi"
    "non-informative" "sebaceus (NS)" "sebaceus" "Costello" "year-old"
    "cardiology" "Naxos" "remodeler" "acH3" "AcH3" "-depxycytidine"
    "depxycytidine" "phosphoS6" "xenograph" "TIP48/49" "ITIM" "tumor/MDSCs"
    "yr" "PLCγ2cKO-" "floxEx3/floxEx3" "caliper" "loxP" "dibutyrate" "Ag"
    "nitrites" "flow cytometric analysis 72 h" "pM" "OT-1" "SIINFEKL"
    "PLCγ2cKO" "exogenous PLCγ2-deficient MDSCs" "wk" "PMN-" "PMN" "βII"
    "anti–human" "P = 0.004" "1 +" "granulocyte/macrophage"
    "lateral plate mesoderm" "neuroectoderm"
    "pluripotent cells form primitive ectoderm" "ectoderm"
    "extra-embryonic endoderm" "maternal uteri" "embryoid" "blastocysts"
    "endoderm" "Fucci" "karyotypes" "Frt" "Aneuploidy" "Pml"
    "the pluripotency-associated transcription factor Oct3/4" "Oct3/4"
    "mesoderm" "Ecfp" "anti-Trp53" "senescense" "stagte" "blastocyst" "+ 3"
    "co-immunostaining" "Terrasa" "Celia" "deeper" "Ponti" "Hoescht"
    "Aldeflour" "re-analyzed" "the public dataset GSE15361" "GSE15361" "Neve"
    "STSF" "–STSF-" "–NSF-" "–LTSF-" "cells/ml" "DMEM:F12" "LTSF" "Dontu"
    "Reynolds" "typical mammospheres" "serial non-adherent" "mammosphere"
    "mammospheres" "mesenchymal-like" "re-expressed" "+1G" "Italians" "sanger"
    "Tata" "Easterners" "Koreans" "#6" "#5" "#4" "GI50" "GI50s"
    "RAS/RAF/mitogen-activated protein kinase (MAPK)" "7~7.6%" "HNSCCs"
    "RAS/RAF" "ornithine" "nitrogenous biomolecules" "biomolecules" "BPTES"
    "andMDA" "MCF10ANeuT" "NEUT" "glutaminases (GLS)" "glutaminases" "NeuT"
    "–6" "Caspse-3" "DMYD" "SNESVD" "diad"
    "the ‘artificial’ Caspase-3 inhibitors biochemists" "biochemists"
    "apoptosis/anoikis" "the bound immunocomplex" "anti-Met" "DNADDEVDG" "EVD"
    "IDN-1965" "IDN" "DEVDG" "DEVDT" "PSQDNIDGEGNT" "SSEDNADDEVDT"
    "PSLLSSEDNADDEVDTRPASFWETS" "EDNADDEVD" "EDNADDEV" "DEVDTRPASFWETS"
    "spectrofluorometry" "the cell permeable DEVD"
    "agonistic anti-Fas antibody Jo2" "Jo2" "DEV" "-EDNA" "EDNA" "RPASFWETS"
    "DDEVDTRPASFWETS" "Fas agonistic antibody CH11" "CH11" "TRPASFWETS"
    "ZipTip" "VDTRPASFWETS" "DNADDE" "CytoMet" "DNAD" "AFC" "DNADDEVD"
    "DNADDEVDT" "cyte" "hepato" "DNAD-DEVD-T" "omain" "cystoscopy" "TURB"
    "urothelium" "56/76" "multitarget" "Cambridge" "Matritech" "immunoassay"
    "Danville" "Corp" "Scimedx" "Immunocy" "cytology" "Weinberg's" "followup"
    "expression/localization" "junctional plakaglobin (JUP)" "plakaglobin"
    "mammary epithelia" "P - values" "∼2-fold" "Intrinsic proteasomal S5a"
    "S5aUIM" "S5aΔUIM" "ΔUIM" "S5a" "0.5–1" "HCT116 p53 +/+" "Multidomain"
    "prepore" "largely amphipathic helices" "amphipathic helices" "Prepore"
    "BAKΔN83" "evert " "BH3-domain-exposed" "topologies" "bilayer" "sulfydryl"
    "IASD" "stilbene" "iodoacetyl" "topology" "ΔN83" "domain/groove" "CuPhe"
    "an inactive enantiomer" "ABT-737-induced" "α6" "BH3:groove" "Cohen" "α3"
    "α9" "and 2E" "ΔΨ" "α5/α6" "Coulomb" "A391E" "GSV" "GG4-like" "tetrad"
    "bilayers" "intercalates" "headgroup" "heptad" "FGFR3 TM" "OγH" "hydroxyl"
    "app" "Hz" "TROSY" "D/P" "FGFR3tm" "9/1" "nigricans" "Crouzon"
    "achondropalsia" "DPC/SDS" "Δ G" "heparin/heparan sulfate"
    "periventricular heterotopia" "heterotopia" "EhlersDanlos" "EDS" "Lbc"
    "FLNaL" "CaRL" "TrioGEFD2" "TrioPH2-" "TrioPH1-" "TrioPH" "TrioPH2"
    "TrioPH1" "FLNaT" "GEFD2" "cohesiveness" "G-conjugated" "plumper"
    "glossier" "siFLNA-" "A-Trio-E-cadherin" "siTrio" "siFLNA" "GEFD1"
    "TrioGEFD1" "TrioGEFD" "phosphatidyliositol" "E-cadherin-catenin"
    "E-cadherin-mediated" "Rho-like" "immunoglobulin-like" "melanin" "arisen"
    "testicular cancer GWASs" "Armitage" "only six SNPs" "Wallis" "G:A"
    "a melanoma-inducing 5.6 kJ/m2" "kJ/m2" "Haplotype" "Caucasian Europeans"
    "most statistically significant ORs" "G/A" "rs4590952" "PMW" "LCL" "spacer"
    "RRRCWWGYYY" "many cancer-associated SNPs"
    "the nonfunctional associated SNPs"
    "almost 900 single-nucleotide polymorphisms" "ROSA26" "= 0.003"
    "HCT116 p53+/+" "= 1.5" "= 0.033" "= 1.0" "6/11" "microvessel"
    "co-dependency" "Yamasaki" "fide" "Hayakawa" "co-localisation" "PTEN+/+"
    "VHL-/-" "=1.5" "covariate" "E-"
    "the most aggressive RCC histological subtype" "patho"
    "curative radical nephrectomy" "upto" "nephrectomy" "= 0.06" "P  = 0.002"
    "= 0.05" "= 2.96" "= 0.18" "= 29" "P  = 0.001" "P  = 0.001" "P  = 0.03"
    "Dyrkla" "HRasG12V" "co-stabilize" "co-dependence" "Etopside"
    "co-knockdown" "half-time" "mCitrine" "mTurq" "mTurquoise"
    "co-stabilization" "Litovchick" "Dyrk" "Dictyostelium" "repositions" "a 2D"
    "∼30%" "non-cycling" "∼75%" "Saretzki" "Fu" "Reuther" "Datta" "Sinha"
    "Weinrich" "lenti" "Dharmacon" "mTERT" "Tg" "Kaufman" "Tabas" "Cong"
    "Artandi" "Blackburn" "Ellis" "LI" "Mammostrat" "multigene" "=   0.04"
    "=   0.045" "=   0.0007" "P  =   0.03" "P  =   0.0004" "P  =   0.001"
    "=   0.037" "Soroka" "subpool" "an Aesop's" "Aesop" "non-phosphorylation-"
    "non-phosphorylation" "non-phospho-mutants" "/Thr 425" "A25E" "Cγ"
    "co-chaperone" "multichaperone" "co-chaperones" "/Thr 603" "Hsp90α" "S2E"
    "/ k" "Noel" "C=O" "NH" "Xaa" "H 2 O" "D2O" "H2O" "Vis" "D 2 O" "βC" "NA"
    "Ac–Phe–Phe–pSer–Pro–Arg–pNA" "ketoamide" "hCyPA" "KIEs" "NIMA-1" "EXSY"
    "=O" "KIE" "-nitroaniline" "nitroaniline" "αC" "×2" "= 11 µ" "3  +"
    "Belzile" "SIVrcm" "SIVdrl" "SIVmnd" "distinct lentiviral lineages"
    "virus-like-particles" "sZIP/ZIP" "sZIP/GFP" "Jäger" "Chr" "ZIP/sZIP" "Zn"
    "Mi-2/NuRD" "sooty mangabeys" "two distinct primate lentiviral lineages"
    "mangabeys" "NuRD" "sZIP" "Anti-FLAG" "2x10" "Fugene 6" "Mi-2"
    "GBSW-membrane" "GBSW" "mebrane" "fascilitate" "Losonczi"
    "a much longer timsecale" "milli-" "milli" "timsecale" "milliseconds"
    "microseconds" "nmr" "mem" "BXL" "Patchdock" "~ -45" "Billen" "micelle"
    "micelles" "headgroups" "explcit" "Bcl-xl+BH3" "implcit" "h2 and" "resi"
    "Saez" "explicit water/membrane" "entropies" "solute" "absoute" "magnitute"
    "10ns" "MMGBSW" "100 ns" "resiudes" "100ns" "RGYR" "nanoseconds" "saez"
    "Sattler" "1BXL" "DDINR" "QVGRQLAIIG" "microstates" "sidechain (SC)"
    "sidechain" "SRKGQERLEH" "ELYGNNAAAE" "around 100ns" "inlcude" "xl" "A/C"
    "specifiers" "neuronal-like" "non-neuronal cell" "non-neuronal" "_015602"
    "γ2" "γ1" "OA" "LAP2β" "NPC62" "co-localizing" "ROIs" "nitrocelulose"
    "co-IPs" "co-transformed" "co-transformations" "pET28c-Nek2A" "non-induced"
    "BM2 and" "Orangutan" "ClustalW" "BM2" "BM3" "KVKF" "KVNF" "TAGCAG"
    "GenBank" "co-transformation" "torsinA" "PP1γ2" "PP1γ1" "-X-" "F-X-X-"
    "MyPhoNE" "SILK" "-V-" "FIMYDP" "KRSTAMVHNQ" "KRL" "CHKNQRST" "ACHKMNQRSTV"
    "HKR" "RVxF" "binding/regulatory subunits" "REVRF" "polypeptide 1B"
    "lamina" "Co-localization" "Non-transfected" "non-denaturing"
    "Non-Essential" "transcription/ translation" "= 4.03–17.63" "Fraser’s"
    "methylation-associated SNPs" "mSNPs" "Fraser" "the Begg’s" "Cochran"
    "Ibanez" "confounder" "protein 1A" "= 4.03" "3 p21" "pTM"
    "miR26a-inhibitor" "SW-1990" "Immunochemistry" "≥3" "ABPT" "3 p" "= 0.024"
    "n =  12" "P  = 0.024" "P =  0.001" "P  = 0.029" "a 3-year" "non-DTCs"
    "anatomic subsite" "GAWSs" "AG/GG" "Abnet" "IQ-domain" "IQ" "1.01–1.46"
    "1.10–1.32" "1.06–1.60" "1.14–1.29" "GA/AA" "GG/GA" "Dutch" "Rs2274223"
    "especially gene polymorphisms" "subsite" "rs2274223" "= 0.009" "= 58"
    "= 1.34" "= 0.003" "= 0.016" "P  = 0.005" "OR = 1.28" "= 1.32" "OR = 1.29"
    "P  = 0.027" "= 1.02" "= 1.24" "OR = 1.31" "= 65" "= 35" "P  = 0.012"
    "OR = 1.30" "= 1.21" "postoperative-month" "lympocytes"
    "immunesurveillance" "IL-6/STAT3" "IL-6/" "conﬁrm" "/CD8 +" "Subsets"
    "hade" "phoshatidylinositol" "-6" "postoperative-week"
    "underwent gastrectomy" "gastrectomy" "Dasgupta" "Lyon" "XCI"
    "Hyperandrogenism" "Robeva" "Mifsud" "Laisk" "I-squared " "Q-value " "df"
    "priori" "Jaaskelainen" "Hickey" "X-inactivation" "random X-inactivation"
    "normoandrogenism" "hirsutism" "non-hirsute" "normo"
    "subsequent ovarian hyperandrogenism" "Barcelona" "androgenism"
    "hyperandrogenism" "Oligo-" "Oligo" "Rotterdam" "follicles" "P-value "
    "Non-random" "= 0.082" "= 0.707" "= 0.34" "= 0.08" "= 0.027" "= 0.31"
    "= 0.60" "= 0.13" "non-random" "= 5" "non-obese" "P = 0.036" "χ 2  "
    "WhetherYAP1" "likely representing p-YAP1"
    "blastemal-predominant histopathology" "continuum" "sequelae" "YAP-1"
    "p-YAP1:YAP1" "VUWT" "MFK" "favorable histology" "nuclear/cytosolic"
    "heartier" "quiesce" "pYAP" "ureteric bud epithelia" "nucleo"
    "bizarre multipolar mitoses" "mitoses" "hyperchromasia" "gigantism"
    "anaplasia" "COG" "p-YAP1" "unfavorable histology"
    "favorable and unfavorable histology" "n = 6" "n = 12" "= 20"
    "the ventral midbrain" "a valid pathomechanism" "pathomechanisms" "Jews"
    "Ashkenazi" "retromer" "re-entry" "a counter-intuitive pathomechanism"
    "parkinsonism" "TOPflash" "the only changes proven"
    "a familial Parkinson's" "Parkinson" "thalamus" "Wnt/calcium" "compacta"
    "Lewy" "mortem" "bradykinesia" "co-activate" "Wnt/Ca" "furthers"
    "activity/signaling" "Ncr" "pTyr1234/1235" "radioresistance"
    "Radioresistance" "intrinsically more radioresistant" "radioresistant"
    "and 1/29" "1/27" "Neurospheres" "mGFP" "non-MET" "Subset" "repopulate"
    "parenchyma" "potently abrogated stemness" "Nu/Nu" "conditions/diseases"
    "production/release" "BMMs" "BMM" "spirochetes" "HOPC"
    "myelin-producing cells perhaps" "DHOPC" "10-μM" "co-incubated" "glia"
    "IL-17α" "CXCL" "encephalomyelitis" "radiculoneuropathy" "PNS" "migrans"
    "erythema" "spirochete" "burgdorferi" "LNB" "Lyme" "co-incubation" "4 fold"
    "autrocrine" "non-endothelial cells" "vascular leakiness" "leakiness"
    "ANGPTL" "chemoattractants" "co-association" "SEMA4D/"
    "mesodermal lineages" "C3H/10T1/2" "ELISAs" "botulinum" "sSEMA4D"
    "Plexin-B1/" "angiopoietin-like" "C3 H" "≤ 0.01" "≤ 0.05" "Co-culture"
    "ΔSASA" "Kirchhoff’s" "Kirchhoff" "ΔH" "Bmf_AG" "Bmf_R-2A" "AXLXXXGD"
    "AXLXXX" "_AG" "_AA" "R-2A/S+4A" "R-2A/S+4G" "A+4" "S+4" "RXLXXXSD" "_R-2A"
    "Q-2A" "A+4G" "G+4" "hotspots" "D+5" "risen" "LXXXXD" "+4" "R/Q" "A/S"
    "LXXXGD" "XLXXXGD" "LXXX" "=d" "+7" "non-linear" "× 10µ" "sensitizers" "h"
    "H1993" "Shedden’s" "genetic gains/amplifications" "poorest" "Shedden"
    "= 0.0006" "p = 0.001" "p = 0.002" "= 0.01" "= 35" "= 0.0003" "nmol/L"
    "RPMI1640" "possible non-destructive" "56–69" "m/z" "CID" "phosphopeptides"
    "c-JunD95" "SP100125" "GCGs" "c-JunA95-HA" "TK-treated CGCs" "T91/93"
    "∼55%" "SP100125 (SP)" "trophic/potassium" "S63/S73" "CPB/p300"
    "T91/T93/T95" "T91T93" "switch-like" "CGCs" "T91/T93"
    "Penicillin/streptomycin" "–69" "MA/gp120" "supplements/drugs" "BBB"
    "ecstacy" "tissues/organs" "superoxides" "+3" "Fe" "trend=0.01"
    "orphenadrine" "≤0.01" "gp120 IIIB" "1.7±0.2-fold" "gp120+MA"
    "1.3±0.1-fold" "±0.3-fold" "1.7±0.2-" "isozymes" "organs/tissues"
    "quencher" "MA+gp120" "gp120IIIB" "-chloromethyl-2" "Alzheimer's" "FWH"
    "200  μ g" "non-essential" "=0.34" "=0.91" "PTF-" "PTF"
    "overcoming chemoresistance" "Palomero" "Bedogni" "doxurubicin"
    "Madamanchi" "TFSEARCH" "++" "μ g/well" "oxidases" "Δψm" "Δ ψ m" "pIRES"
    "vitamine" "proform" "5 ng/ml" "at 15 " "pathophysiology—" "AV-45"
    "subsamples" "_known1" "a strong enhancer" "Haploreg" "APPB2" "rs334543"
    "Posthoc" "ADNI-1" "rs457581" "rs3098914" "rs2585590" "Aβ" "rs334543—two"
    "the Alzheimer’s" "ADNI" "Alzheimer’s" "G/G" "= 0.27" "Choi" "Tian"
    "sulfonamide" "propyl" "BRAFL505H" "BRAFV600E/T529N" "BRAFV600E/F516G"
    "gatekeeper" "all measured synonymous codons" "all possible 64 codons"
    "BRAFV600E/L505H" "non-synonymous" "CJ" "QL" "mTOR"
    "the histological subtype"
    "the transformed BaF3/NPM-ALK cells re-sensitive" "re-sensitive"
    "re-sensitized" "Dex" "17 p-AKT-" "Ann" "χ2 " "p-mTOR + " "p-mTOR-" "×2 "
    "p-mTOR+" "p-AKT+" "ALK+" "p-AKT-" "p-AKT + " "Histology" "ALK + " "2p23"
    "non-Hodgkin’s" "nonmalignant" "17 p" "mg/mL " "pcDNA3" "ephexin"
    "these internal active Ephs" "EphBs" "or/and" "Kajiho" "*P" "inwild"
    "receptor/ligand" "Blum" "Turvy" "GST-Cbl-N-G306E" "TKB" "bafilomycin"
    "juxtacrine" "ephrinA5/EphA8" "Yoo" "EphB" "Ephs" "G15A" "units/mL" "∼25%"
    "CHR" "developmental lineages" "cell types/lines" "cell lines/types"
    "FLJ10156" "TROAP" "G1/S-" "∼53%" "∼44%" "∼48%" "GeneID" "FOXM1C" "ACAP3"
    "luminometer" "LumiCycle" "cooccupy" "reChIP" "Cistrome" "minichromosome"
    "Overview" "Fourier" "M/G1" "GeneIDs" "Entrez" "A/Cdk1" "Laoukili" "Alves"
    "Wierstra" "MuvB" "FuGENE 6" "–25" "Zero-hour" "∼20%" "U20S" "= 1.32"
    "A/Cdk2" "Werner" "γH2A.X" "perfect dsDNA" "ss" "~2-fold" "ds" "derivate"
    "E216/219A" "annulus" "ΔPEST" "PEST-like" "caspase-like" "~60%" "С"
    "mitomycin" "а" "DNA/RNA-binding" "~70%" "α5" "Y-box" "microfractures"
    "osteopenia" "less mature osteoblasts" "osteoblast-like"
    "osteogenic lineages" "mt" "Gingistat" "Osteoblasts"
    "untreated subconfluent DPSCs" "DPSC" "OC" "Sirtuins" "DPSCs" "2 and"
    "fibroblast-like" "± SEM" "1 × 10" "vesrus" "codon 12/13" "COIN"
    "hepatectomy" "FOLFOX" "metastatectomy" "oligometastases" "1.21–3.26"
    "GGT→GTT" "GGT→AGT" "GGT→TGT" "GGT→GCT" "GGT→GAC" "GGT→TGC" "GGT→GAT"
    "mBRAF" "mKRAS" "BFAF" "4/202" "CRLM" "3-year" "= 0.030" "12/13" "BJ"
    "hexokinases" "+/G13D" "phosphopyruvate" "MST1/2" "shLacZ" "collecetd"
    "haplo" "shRFP" "sick/lethal" "TTC31-" "TTC" "non-chromatin-bound"
    "subnetworks" "TFDP" "MPIP" "non-redundant" "a less stringent orthology"
    "eggNOG" "stringent orthology" "InParanoid" "orthology"
    "stringent negative dGARP" "dGARP" "zGARP" "diploid"
    "sickness/lethal (SSL)" "non-isogenic" "P =0.038" "NOD/SCID" "∼15%" "XZ"
    "mutationwas" "V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog"
    "Kirsten" "DHPLC" "n = 5" "contributeto" "theirknown" "inhibitionof" "orRb"
    "interdomain" "datademonstrate" "2and" "1-3" "Rbconstruct" "thatcontains"
    "∆ PL/S780A" "380-816/780A" "T356/T373" "RbN" "ofRbC" "Additivewith"
    "dataindicate" "H555A/H733A" "K652A/R656A" "phosRbC" "sidechains"
    "bindingthe" "broadeningcorrespond" "peaksthat" "isprotein" "N-labeled"
    "S608/S612" "∆PL/S780A" "∆P/S780A" "phosphorylatedRb" "S807/S811"
    "compatibilities" "S788/S795" "use isothermal titration calorimetry (ITC)"
    "calorimetry (ITC)" "ITC" "calorimetry" "demonstratetwo" "= 0.13"
    "xenographs" "NAC-1" "Nurr" "1–3" "AR-1–660" "FQNLF" "αhelical" "microtome"
    "2–3" "siRNA-1" "siRNA1" "siRNA2" "FQEAA" "FXXLF" "FQELL" "pCMV" "AR-1-660"
    "the constitutively active AR-1-660" "pSGTIF2" "VP-AR-1-660" "pSGFLAG"
    "FLAG-CKβBP2/CRIF1-1-222" "MAASVR" "pGADGH" "Gornemann"
    "The multifunctional CKβBP2/CRIF1" "CKβBP2/CRIF1" "PBS 3"
    "Transcription/Translation" "5 ng/ml" "2 × 10" "PAI-1 was"
    "hyperfibrinogenemia" "Brazionis" "0.31–1.00" "ng/dL"
    "slightly higher HbA 1c" "HbA 1c" "whose fundi" "fundi" "mellitus (DM)"
    "T2DM" "hypercoagulabilty" "mg/dL" "seven-field stereoscopic fundus"
    "fundus" "VADT" "Mst" "Selicilib" "YAP-3D" "phosphopeptide-"
    "phosphopeptide" "non-phosphorylatable" "Coomassie" "shift/phosphorylation"
    "phosphorylated/shifted"
    "mitosis often causes genome instability/aneuploidy"
    "instability/aneuploidy" "Lats1/2" "Mst1/2" "Yorkie" "YAP3D" "T202/Y204"
    "Anti-phospho" "Balbiani" "30-nm" "mono-phosphorylated" "vii" "vi" "h/3"
    "∼40%" "mcherry-ER-tTA" "SKL" "operon" "Janicki" "Belmont" "lac"
    "decondense" "H1Cy5" "H1Cy3Cy5" "Cy3Cy5" "1:0.005" "H1/Pin1" "pS187"
    "Pin1wt" "Ciras-3" "10T1/2" "magnetic Dynabeads" "Dynabeads" "isomer" "PXZ"
    "10,000 g" "T/S" "untangle" "replication/recombination"
    "defective replication/recombination" "AUKRA" "C-terminally" "oocytes"
    "D-boxes" "D-box" "D-box (RXXL)" "RXXL" "hMAD2L2" "pseudosubstrate"
    "degron" "chromatids" "anti–mouse" "S4 C" "S2 A" "signals/molecules"
    "McEwan" "Brodie" "NCBI" "Δ50-250" "∼50%" "-DBDH-LBD" "Jenster" "ARby"
    "DBDH" "∼92%" "XC" "SY" "27/36" "14/21" "4/79" "colonoscopy" "59/136"
    "32/88" "5 ng/ml" "0.5-1 " "non-cancer" "HYY" "WWQ" "XWP" "LKH"
    "developmeng" "Zhou" "Yunli" "NSLCC" "meninges" "200nt" "Hochest"
    "G2/S phase" "DMR2" "squamous carcinoma subtypes" "histological subtype"
    "ANRIL" "= 21" "2 × 10" "5 × 10" "RPMI 1640" "cell death/apoptosis"
    "SK-N-DZ" "cytoxicities" "Anti-tumor" "/95%" "S/G2" "nameley"
    "co-occurring" "GNNK" "prepronderance" "2.8:1" "muations"
    "joint/interaction" "Fraumeni" "P=0.000" "Chaar" "1.037–1.311"
    "1.106–1.404" "1.055–1.358" "GT+" "GG+" "= 0.000" "=0.000" "GG+TG"
    "P=0.005" "SSCP" "Finnish" "= 0.53" "OR=1.28" "= 0.077" "rs2279744"
    "Salmena" "ceRNA" "exsit" "hAFP"
    "adeno-associated virus (AAV)-mediated miR-26a" "AAV" "adeno" "Kota"
    "MiR-23b" "homolog-like" "anti-miR-26a" "siRNA#2" "22RV1" "co-regulation"
    "anti-miR19b-23b" "anti-miR-19b-26a" "miR-19b" "mPUD" "mPUC" "mPUB" "mPUA"
    "mPU" "PUD" "PUC" "miR-23b" "the online software TargetScanHuman"
    "TargetScanHuman" "miR-26a" "Iliopoulos" "profilings" "10q23" "co-regulate"
    "S2D" "RHIM" "SM" "10,000g" "NuPAGE" "TrisCl" "iodoacetamide"
    "glycerophosphate" "Cl" "Immmunoprecipitations" "μg/well" "pEGFP"
    "HiPerfect" "LBW242" "rhTNF" "the Smac mimetic LBW242" "rmTNF" "CHX"
    "lipofectamine" "McCoy’s" "McCoy" "units/ml"
    "the NP-40 insoluble necrosome" "zVAD" "necrosome" "3 x 10"
    "Conclusions/Significance" "Methodology/Principal" "=0.7" "=0.1" "Pandolfi"
    "doxorubin" "impactful" "Alfred Yung’s" "Yung" "S6Ki" "NetNES1.1" "AktX"
    "score/" "whose tumor AC immunohistochemistry (IHC)"
    "immunohistochemistry (IHC)" "patient-matched benign adjacent biopsy" "Liu"
    "signal-like" "EC50s" "nu/nu" "10X" "effecter" "presence/absence" "exozyme"
    "RhoAL63" "RhoAN19" "S10A" "S10D" "cytochemistry" "CD34 +" "leydig"
    "idiopathic oligo/azoospermia" "cryopreserve" "clinicians" "Klinefelter’s"
    "Klinefelter" "gonads" "non-obstructive" "the seminiferous tubules"
    "interstitium" "LHbeta" "seminiferous tubules" "C3H10T1/2" "sertoli" "ARKO"
    "myoid" "Leydig" "genitalia" "karyotype" "the seminiferous tubule" "gonad"
    "testicular biopsies" "prepuberty" "seminograms" "AIS" "SCOS" "Sertoli"
    "non-invasive" "1 x 10" "C3H" "phosphorylation/activity" "cilexetil"
    "/ERK 1,2" "1.5±0.1-fold" "0.4±0.1-fold" "and 1.9±0.3-fold" "1.4±0.2-fold"
    "PD980059" "0.5±0.2-fold" "irbesartan" "Mas" "peptidases"
    "and 1.4±0.2-fold" "a 2.1±0.5" "preadipose" "n = 4" "p = 0.004" "= 9"
    "non-phosphorylated" "non-immortalized" "Kg/m 2" "Böckelman" "pmTor" "b2MG"
    "microglobulin" "propria" "muscularis" "Teng" "DFS" "Westermarck"
    "Junttila" "oncolytic HSV-1" "Turnell" "Weitzman" "ss/dsDNA"
    "9-1-1 recruitment" "UV-" "brighter" "Δ6–198" "Δ79–339" "Δ29–186" "S4/S8"
    "HU" "subcomplex" "heterotrimer" "UL52" "UL8" "9-1-1" "ICP8" "dsDNA"
    "ssDNA" "HSV-1" "donovani" "RVFV" "trachomatis" "TSC1/2" "IRES" "pUL38"
    "siderophores" "neutralizer" "paclitaxel/navitoclax" "FBWX7" "Bcl-2/Bim"
    "Bcl-2/Bak" "Bcl-2/" "phosphoepitope" "pulldowns" "5 × 10" "plasmalogen"
    "Patent Application #20" "MIR581" "MIR" "CMTM6" "= 7×10" "= 9×10" "T2D"
    "WHR" "= 6×10" "Sanna" "CEBP/B" "FAIRE" "= 8×10" "2×10" "Ernst" "rs1801689"
    "1×10" "our associated SNPs" "Framingham" "GLGC" "Metabochip"
    "lipid-associated SNPs" "5×10" "N=7" "N = 7" "#20" "= 0.99" "= 0.019" "N=4"
    "N=3" "= 0.17" "= 0.07" "= 9" "P = 5×10" "P = 4×10" "H3K36" "P = 3×10"
    "−25" "P = 0.017" "P = 0.002" "= 0.0002" "Yogaratnam" "Kones" "Wijesinghe"
    "Beasley" "the ischemic myocardium" "Mellert" "Roeder" "Ito" "Barlev"
    "Seto" "KDACs" "Petitjean" "Sykes" "Ryan" "RNCs" "Zheng" "gens" "Wieczorek"
    "Chehab" "Clarke" "Liang" "Gu" "Kruse" "Lu" "Kubbutat" "Chou" "Iggo"
    "Kaeser" "Ripa" "mmpNOS3p-luc2" "a mutant minimal mmpNOS3p-luc2" "mmpNOS"
    "the minimal pNOS3p-luc2" "Kim" "pNOS3p-luc1" "pNOS" "genomatix"
    "days/week" "thoracotomy" "min/day" "Ongusaha" "Braithwaite" "Utrera"
    "Tanaka" "Monte" "Kimura" "Leng" "Fuchs" "Dornan" "Rowland" "Miguel"
    "Velasco" "Masutani" "Budanov" "Bensaad" "Donald" "Hussain" "myocardium"
    "Vousden" "Madan" "Gogna" "Levine" "Ko" "Vasquez" "Alvarado" "Bialik"
    "OxCy" "Cabigas" "reflow" "Murry" "Laflamme" "Bolli" "Gottlieb" "Oerlemans"
    "Yaoita" "Kajstura" "Anti-acetylated" "anti-acetylated" "anti-phospho" "+1"
    "epidermal growth factor-like" "AChR" "EJp21" "EJp" "EJp53" "HCT116 p53−/−"
    "growth/viability" "prostaglandins" "viability/proliferation"
    "casein kinase 1α" "aggressive tumor progression/growth"
    "progression/growth" "anti-skin" "gallate" "anti-carcinogenic" "BRAF+ TC"
    "pMEK" "BRAF +" "BRAF+ PTCs" "BRAF+ PTC" "BRAF+PTC" "BRAF+PTCs" "BRAF+"
    "Eichhorn" "retrotranslocate" "SA62" "xL" "phosphorylation/degradation"
    "∼70%" "and 2D" "cofillin" "Turley" "Harrison" "non-neural" "Ac-"
    "Obserivng" "re-growth" "iper" "PHH3" "siFAK" "Anti-P-FAKSer732" "ac-" "ac"
    "#28" "non-receptor tyrosine kinase" "methanol/" "72 h" "Tnv-6-"
    "anti-leukaemic" "p21 waf1" "rationalise" "⩾90%" "⩽0.01" "p21waf1"
    "intracytoplasmic double-membraned vacuoles" "=9" "int/high" "Tnv-6" "Tnv"
    "Tenovin" "n =6" "=0.01" "n =3" "17p" "non-genotoxic" "LJR" "FCN" "TvOH"
    "neutral/polymorphisms" "caecum" "co-segregate" "a premature stop codon"
    "co-segregates" "lod" "skipping/deletion" "premature stop codons" "117-34A"
    "exonic/intronic" "polypyrimidine" "at least 200 bp" "1662-2A"
    "at least two different algorithms" "Amsterdam" "3439-16C " "2459-18delT"
    "1662-2A " "1732-2A " "117-34A " "benign polymorphisms" "+ 1G " "Danish"
    "34A" "34A " "+ 1" "XFZ" "XXZ" "ZL" "YPC" "HYT" "pN" "pT" "P  = 0.029"
    "= 0.037" "= 0.028" "the human sequence-specific β-cat-253-M14/M35"
    "only 2 mg/kg" "non-2" "ViewRNA" "LNP2072" "qd" "DsiRNA/kg"
    "β-cat-253-M14/M35" "nanodelivery" "LNPs" "kg" "titers" "25/27mer" "21mers"
    "21mer" "pmol/l" "M14/M12" "M0/M12" "M14/M35" "M0/M35" "M0/M29"
    "active DsiRNA" "-O-methyl" "the 72 human-Unique DsiRNAs" "DsiRNA" "90+"
    "DsiRNAs" "n = 4" "exvitro" "minigene" "/+" "thymocytes" "exvivo"
    "co-injection" "approximately 3-fold greater" "littermates" "cSHP" "B16BL6"
    "pSHP" "TDLN" "footpads" "tumor-promoting MDSCs" "death-1" "C/S" "mg/kg"
    "pSTAT3" "arginase-1" "48 h" "co-culture" "2 +" "miR-107" "CellMiner"
    "NCI-60" "NCI" "Chemoresistance" "Neg" "interstrand" "#2" "siSET7"
    "photoproducts" "femtosecond" "pRRL" "CEs" "NEs" "aminobenzamide" "ARTD"
    "KYARTPN" "ploidy" "rapidly shrink vacuoles"
    "in fact hybrid late endosome/lysosome organelles" "shrinking vacuole"
    "somes" "lyso" "the much larger lysosomal vacuoles" "fusion/fission"
    "corpse-containing vacuoles" "both large and small entotic vacuoles"
    "entotic corpse-containing vacuoles" "continual fusion/fission" "Vacuoles"
    "blocker" "Ulk" "Vacuole" "vacuole" "Macroendocytic vacuoles"
    "entotic vacuoles" "vacuoles" "anti–phospho" "AW" "Ehemann" "Huntington’s"
    "Huntington" "Byles" "tenovin" "Vasiri" "Luo" "exocrine" "Pramanik" "34a"
    "Nalls" "–clinically undetectable- micrometastases" "micrometastases"
    "immunhistochemistry" "Zhao" "Wauters" "entitites" "Sirt" "Burnett"
    "surgically resectable PDACs" "= 0.058" "= 0.045" "KUE" "JV" "globulin"
    "valganciclovir" "mTORi" "at least 1000 copies/ml" "/R" "IgG+"
    "ClinicalTrials" "HERAKLES" "non-study" "hydroxy"
    "each patient underwent 2.8 PCR screenings" "screenings" "Banff" "AB0"
    "intravenous immune globulines" "globulines" "stent" "tacrolimus" "BPAR"
    "viruria" "polyomaviridae" "unmet" "~10%" "anti-polyoma"
    "cytomegaly virus (CMV) serostatus" "serostatus" "PyVAN" "nephropathy"
    "n = 4" "= 0.018" "= 0.014" "p = 0.002" "p = 0.009" "- 25" "= 0.84"
    "= 0.019" "= 0.34" "= 0.11" "n = 5" "n = 7" "= 11" "p = 0.001" "copies/ml"
    "non-phagocytic" "homologs" "Gα" "clearer" "hetero-" "PDGFβ" "agonism"
    "Sendai" "I:C" "De-repression" "mir-449b" "InnateDB" "relatedness"
    "pfu/cell" "c" "rRNA" "miR-449b" "Udorn" "Orthomyxovirus" "de-repression"
    "attenuators" "influenza-inducible miR-449b" "acetylation/deacetylation"
    "j" "STAT5A_ΔE18" "non-ubiquitinated" "_ΔE18" "ZnF" "an Alzheimer’s" "MEFS"
    "quantitatively estimated Mander’s" "Nikon" "Mander" "cortactin/F-actin"
    "ZZ" "p62KO" "HDAC6 has" "BUZ" "HDAC6has" "perinuclear co-localization"
    "non-treated" "= 29" "P-values" "e" "+124WT" "Mut-1" "iCCAAT" "-25" "-29"
    "-69" "-73" "-107" "-112" "ATTGG" "GGTCAT" "PromoterSweep" "+124"
    "the pure anti-estrogen ICI" "ICI" "coregulators" "Co-transfection"
    "Morgan" "anti-HER2/anti-CD3" "MDX-H210" "FcγRI" "520C9" "HAMA"
    "Ertumaxomab" "RLU" "Elmer" "Perkin" "Caliper" "IVIS"
    "Statistical signiﬁcance" "SPSS" "speciﬁc" "no obvious FcabCD3" "GraphPad"
    "killker (NK)" "killker" "FcabCD3 showed" "only 40% lysis" "SKBR3cell line"
    "E:T" "MFI" "Superdex" "F-star" "expressers" "Genentech" "trivalent Fabs"
    "DART" "Fabs" "diabodies" "EU" "Catumaxomab" "ADCP" "retarget" "FcabCD3"
    "Fcab" "Fc" "=0.99" "1 x10" "BALB/C" "1x10" "BALB/c" "peritoneal lavage"
    "sulfhydryl" "stem/progenitor" "the typical subtype" "≥4" "15/29" "12/29"
    "8/29" "15/20" "24/38" "20/36" "11/64" "= 7" "P  = 0.008" "P  = 0.007"
    "P  = 0.004" "= 0.033" "P  = 0.001" "Non-tumor" "P  = 0.017" "Leu84Phe"
    "Chae" "Ile143Val" "84Phe" "143Val" "Lue84" "LXXLL" "the Egger’s" "=1.57"
    "=0.048" "=1.62" "P=0.035" "1.07-1.61" "=1.31" "1.05-1.59" "OR =1.29"
    "=0.014" "=0.84" "=0.019" "=1.64" "=0.32" "=1.67" "=0.027" "1.12-1.50"
    "OR=1.29" "1.24-1.50" "=1.30" "1.11-1.47" "=1.28" "UADT" "BeadLab"
    "Illumina" "dealkylate" "=1.29" "=0.12" "P =0.009" "P =0.002" "P=0.004"
    "P =0.02" "=0.06" "=0.035" "P=0.009" "P =0.001"
    "-methylguanine-DNA methyltransferase" "HADC4"
    "hypoxia inducible factor 1α" "stressful" "DNAJB5" "cochaperone"
    "co-morbidities" "The biological underpinnings" "=0.54"
    "immunohistochemisty" "Sequest" "Velos" "Orbitrap" "Proteome" "TBARS"
    "Kuwait" "blot and immunohistochemistry in both PBMCs and adipose tissue"
    "anti-obesity" "non-histone" "P = 0.036" "P = 0.024" "= 0.001" "= 0.046"
    "= 0.05" "P = 0.03" "P -values" "RNA/Protein" "n=6" "~0.5" "kg/m 2"
    "GLI1/2" "cyctoplasm" "atleast" "amplicons" "−1226" "+438" "TTAGGG"
    "GLI2ΔN" "Non-malignant" "N-domain" "miniMac" "rarer" "RSQ" "Schmidt"
    "freeware" "morphism" "ischemic stroke subtypes" "=0.047" "rs61749020"
    "these ischemic stroke subtypes" "rs3815188" "=0.0022" "rs78501403" "apnea"
    "pravachol" "cardura" "cardizem" "proband" "75-year-old" "TOAST"
    "the 269 familial ischemic stroke probands" "the actual pathomechanism"
    "pathomechanism" "Joutel" "ISGS" "Mayo" "269 Caucasian probands" "SWISS"
    "probands" "leukoencephalopathy" "P=0.13" "=0.053" "=0.058" "P=0.008"
    "bacterial lipopolysaccharide (LPS)" "trimerizes" "an important dataset"
    "an essential receptor status related gene dataset" "sublines" "lysl"
    "Bertucci" "GPL96" "DAVID" "lipoproteins" "Pairwise" "non-TNBC"
    "subclasses" "TNBC" "pcDNA 3.1" "foci/cell" "UVB" "Ser1981" "CTKD" "NTKD"
    "Syndrome-1" "Seckel" "PIKKs" "AMPAR" "Purkinje" "Lowry" "Anti-Mouse"
    "Anti-Rabbit" "Co-immunoprecipitation" "langerhans" "progenitor/stem cell"
    "Cdc42GTP" "LISA" "Rac1GTP" "AlFx" "P-loop" "⋅AlFx" "1tx4" "⋅GDP" "Phyre"
    "GRAF1" "Cdc42G12V" "spine-like" "ΔC" "RhoAV14" "mCherryRac1Q61L"
    "impedance" "Impedance" "ECIS" "GAPtail" "autoinhibits" "subclass" "HMHA-1"
    "co-localizes" "TRIS/HCl" "Kendall" "leftmost" "L / L" "pAMPKα"
    "endometria" "standard indirect immunohistochemistry" "monoclonals"
    "frameshifts" "p = 0.002" "= 10" "RAS /" "fs0" "fs" "=32.0%" "adduct"
    "CNKI" "Elsevier" "ISI" "Ovid"
    "-methylguanine-DNA methyltransferase (MGMT)" "non-cancerous" "ZFL" "JYY"
    "SMMC-7721cells" "4259–4284 nt" "SMMC-7721 cells" "EFGR" "Pearson’s"
    "Pearson" "DIANA" "RegRNA" "mir" "siEGFR" "miR302b" "72 h" "Staab" "Nfibiz"
    "Batf" "Ghoreschi" "Durant" "Renner" "Milner" "Beaucoudrey" "Miossec"
    "Veldhoen" "Stockinger" "Kolls" "its homozygous CC genotype" "Sato" "BD"
    "Davidson" "Prager" "homozygotes" "Jakkula" "Finland" "Danoy" "Zhong"
    "rs 17593222"
    "ophthalmopathy (GO) also known as thyroid-associated ophthalmopathy"
    "non-ophthalmopathy" "Only two SNPs" "Genotype" "rs2291282" "rs2291281"
    "rs744166" "rs2293152" "Crohn’s" "Sjogren’s" "Cenit" "PsA" "Okuma"
    "Sjogren" "Fung" "Ferguson" "Crohn" "Yang" "Ivanov" "Rutitzky" "Amadi"
    "Th17" "Korn" "Egwuagu" "Dong" "Davies" "Tomer" "TGAb" "TPOAb" "Hollowell"
    "Hashimoto’s" "AITDs" "AITD" "ophthalmopathy" "rs17593222" "rs1053005"
    "Hashimoto" "p  = 0.031" "95 %CI" "95%CI " "Glaxo-Smith-Kline"
    "exclusiveness" "high/HDAC4" "5q31" "8p11" "low/HDAC4" "Bayes"
    "35 publicly available datasets" "the Mesenchymal subtype"
    "the Proneural subtype" "The luminal A subtype" "Subtypes" "metadataset"
    "other public tumor datasets" "Even proposed end readouts"
    "a larger dataset" "resveretrol" "the EZH2-depleting drug DZNep"
    "publically available datasets" "large public gene expression datasets"
    "nonhistone" "DZNep" "homlog" "zeste" "Enhancer"
    "biologically relevant subsets" "CaArray" "17q21" "= 0.04" "p = 0.0004"
    "transgenes" "GEMMs" "mutated EGFR tumor biopsy" "H1975" "Pgrn" "/CD4 +"
    "200μg" "deoxynucleotidyl" "Del 19" "BALFs" "mildy" "littermate"
    "humanEGFR" "deletion/T790M (TD)" "Grn" "Il" "Ctla" "Del19" "immunotherapy"
    "1/20" "& D" "p=0.0005" "CD8 +" "co-occupies" "DLX" "homeodomain" "browser"
    "Interspecies" "Circos" "Huang" "andand" "shControl" "co-occupancy"
    "both untreated and 2-day RA-treated hESCs" "and 2-day" "re-ChIP"
    "co-occupy" "si" "mesodermal marker Brachyury" "Brachyury" "hESC" "axial"
    "FOX" "LHX" "InterPro" "+Adr" "+RA" "treated hESCs" "DNaseI" "Prives"
    "siControl" "oligos" "pluripotent hESCs" "hESCs" "Non-Coding" "EGF-like"
    "400 bp" "P -value" "nonparticipants" "dyslipidemia" "PWV" "-1β"
    "lipopolysaccharides" "、さらに大規模な追跡研究が必要である" "、明確な関連が認められなかった"
    "C-260T多型がCAVI値と正の関連を認めた" "C-260T多型のCC型で最も低い値を示し"
    "。5年間におけるCAVI値の変化との関連も同様に縦断的に検討した" "、60–69歳"
    "炎症に関わる遺伝子多型は動脈硬化リスクに関与している可能性があるが、年齢別の効果については不明である。年齢別の動脈硬化（arterial stiffness）における遺伝子多型の効果を検索するために、cardio-ankle vascular index (CAVI)を動脈硬度の代理指標として用い、横断的および5年間の縦断的研究を行った"
    "、cardio-ankle" "、横断的および5年間の縦断的研究を行った" "CAVI" "cardio" "P = 0.009"
    "P = 0.001" "pack-years" "insertion/deletion" "= a" "toll-like" "= 0.005"
    "ESPR1" "withthe" "an intense desmoplasia" "desmoplasia" "PanIN" "EV9"
    "IIIb/IIIc" "14-3-3ε" "siFGFR" "siESRP1" "siESRP1-B" "siNeg" "siESRP"
    "ESRP" "EV2" "WST" "EV" "ESPR-1" "TS-1" "UICC" "well/mod" "ductal-like"
    "silencer-3"
    "the downstream exon IIIc binding intronic splicing enhancer/intronic"
    "enhancer/intronic" "PDACs" "IIIc" "±SEM" "week-old" "promoter/enhancer"
    "1+" "=0.04" "co-exist" "activation/tyrosine" "GBM 9" "activaton" "pEGFR"
    "Puliyappadamba" "GBM9" "GBM748" "vIII" "U251EGFRvIII" "U251vIII"
    "phosphorylation/activation" "the classical subtype" "EGFRwt" "72 h"
    "PcDNA 3.1" "CellTiter" "RAS/MEK/ERK" "RAS/MEK" "phospho-ERK1/2"
    "pseudogene" "Exiqon" "ISH" "situ" "Qiagen" "EpiTECT" "thymidines"
    "Browser" "UCSC" "Santz" "aCGH" "nullisomy" "CEP6" "Abbott" "CHORI" "6q21"
    "Eosin" "U133" "GeneChip" "FTSEC" "micro-dissected HGSOCs" "FTE"
    "epigenome" "proteome" "most lethal histological subtype" "HGSOC" "HGSOCs"
    "FTSECs" "penicillin/ streptomycin" "n=5" "=6" "=12" "=2.98"
    "the highly divergent hDHFR" "::hDHFR" "soluble hDHFR" "folA" "caDHFR"
    "Subdomain" "stramenopiles" "amoebozoans" "bacterial DHFRs" "ceDHFR"
    "zDHFR" "rerio" "rDHFR" "norvegicus" "scrofa" "vcDHFR" "cholerae" "spDHFR"
    "saDHFR" "baDHFR" "prokaryotic DHFRs" "PWN" "N23PP" "PWPP"
    "eukaryotic DHFRs" "αF" "subdomains" "microsecond" "CPMG" "millisecond"
    "hydride" "HSQC" "–ddTHF" "ddTHF" "dideazatetrahydrofolate" "–FOL" "FOL"
    "folic" "ecDHFR" "hDHFR" "DHFRs" "g/mL" "~30%" "at 15" "hGBM"
    "-tetramethylindocarbocyanine" "tetramethylindocarbocyanine" "hBT145"
    "hBT112" "DFn" "hBT70" "neurospheres" "Neurosphere" "neurosphere"
    "datasets" "48h" "p = 0.02" "ultrastructure"
    "an N-terminal amphipathic helix" "DKO" "TIRFM" "Clc" "tubules"
    "non-neuronal cells" "TIRF" "axon" "Ena/VASP" "transcription/translation"
    "pCDNA3.1" "non-specifically" "co-depletion" "interferometry" "biolayer"
    "R111/113" "CADOR" "R111/R113" "E2F-1▵87-95" "▵87-95" "juxta" "R-rich"
    "RRL" "A/cdk2" "co-depleted" "R111/113K" "KKK" "symmetrically acting PRMTs"
    "immunocomplex" "PRMTs" "apoptotis" "re-enter" "multihour" "at least 8 hr"
    "G0-Like" "reenter" "Zetterberg" "a midpoint approximately 3 hr" "midpoint"
    "heatmap" "withdrawn" "gH2AX" "jitter" "invariant" "0.9–1.1" "A/CDK2"
    "approximately 1 hr" "interconvert" "G0-like" "inc" "Cyt/Nuc"
    "roughly 8 hr" "a 2N" "ylate" "DHBVen" "retro" "CDK1/2" "Ven" "DHB"
    "mVenus" "ought" "re-engage" "= 0.42" "EC 50" "co-evolution" "Cartron"
    "as 1:25" "topoisomerases" "liposome" "an indirect readout" "IVTT" "BMKs"
    "the relevant genotypes" "EC50" "= 0.021" "BH1–3" "Mzf-2" "Lac" "AcH4"
    "hetermodimer" "co-purified" "pYlacO" "hTERTp" "293TT" "LacO" "pYLacO"
    "HFK" "Mzf" "CAAT" "TATA" "apoptose" "non-gene" "Maz" "HFKs" "+2"
    "anti-Flag" "#1" "non-biased" "E-boxes" "LKB−/−" "Greater" "LKB-1K78I"
    "2 DG" "2DG" "cell proliferation/viability" "Jeghers" "Peutz" "NUAK1/2"
    "the histologic subtype" "48 h" "Non-Target" "U/ml" "reestablish" "C/EBPδ"
    "Boer" "temserolimus" "anti-phospho-Akt" "48 h" "MSS/right" "MSS/left"
    "PETACC-3" "SAR" "18q" "Wald" "Bonferroni" "endpoints" "clinico" "= 0.08"
    "= 0.29" "= 0.0005" "= 3.00" "= 5" "95% CI " "≤ 0.05" "= 20" "AKLC" "MLW"
    "YPP" "JMYK" "YC" "Microcell" "TLE" "/3.22" "3/5" "BIO" "stem cell-like"
    "segregants" "MCH903.1" "Monochromosome" "de-differentiated" "microcell"
    "10x" "stem-like" "Stupp" "BAT26" "=0.558" "=1.21" "=2.17" "Germline"
    "BAT25" "BAT40" "Microsatellite" "histopathology" "P =0.017" "P =0.012"
    "≥ 30" "The Egger’s" "1.56–3.53" "=2.35" "QMSP" "3p21"
    "unnecessary biopsies" "=0.13" "=0.024" "= 10" "3p" "= 7" "viremia"
    "unresponsiveness" "SIVmac" "1MT" "-dithiodipyridine" "dithiodipyridine"
    "Boasso" "JakI" "treated and untreated MoDCs" "Tat-stimulated MoDCs"
    "non-Tat-treated" "Eluate" "anti-Tat" "immature MoDCs" "Lai"
    "expression/activity" "gastro" "non-controllers" "Clamydia" "cystein" "TAR"
    "immunopathology" "MoDCs" "PBS 5" "Anti-mouse" "Anti-human" "newer"
    "mesylate" "Squibb" "Myers" "Perhaps" "EHop" "Ortiz" "Montalvo" "inhibiton"
    "RAC1b" "α6β4" "microRNA-142-3p" "amoeboid" "Amico" "VAV2/3" "edema"
    "stimulators" "ARP2/3" "pathobiology" "co-regulatory" "polymorphic SNPs"
    "a traditional thermocycler" "thermocycler" "chemotherapeutica" "bi"
    "COBRA" "rs13300553" "a few heterogeneously methylated T-alleles"
    "a heterogeneously methylated C-allele" "T-alleles" "G-allele" "rs16906252"
    "non-Hodgkin's" "A-allele" "T-allele" "= 0.016" "= 0.12" "C-alleles"
    "10.1038/ncomms3519" "Herhaus" "CDK8/9" "D/H" "D88A/H265A" "C91S" "ΔN"
    "iFoxO4" "qRT" "iOTUB1" "*MS" "BMDMs" "SMAD2/3/4" "SMAD2/3" "TRAF3/6"
    "isopeptide" "A proteomic screen undertaken" "deubiquitylate" "SXS"
    "transducers" "48 h" "# 3" "3/4" "hyperammonemia" "WIF" "=0.064" "=0.029"
    "=0.017" "S33Y-" "S33Y" "72h" "M/C" "stellate" "tumor-wide GS" "C/N" "N/C"
    "TOPFlash" "Sirius" "GS" "=0.08" "p =0.007" "=0.031" "p =0.004" "KAGKR"
    "helices" "TASSER" "pospho" "Cowden" "Burk" "Lineweaver" "Menten"
    "Michaelis" "Vmax" "6,8-difluoro-4-methylumbel-liferyl" "bisphosphate"
    "KSAKDR" "6,8-difluoro-4-methylumbelliferyl" "pNPP" "nitrophenyl"
    "ANTI-FLAG" "Co-expression" "co-eluted" "co-eluting"
    "exogenous heparin/heparan sulfate" "just FNI8-9" "FNI8-9" "non-ionic"
    "immunogold" "smaller subfragments" "rFBN1" "subfragments"
    "collagen/gelatin" "rFBN3" "rFBN2" "Multiscan" "Bioscan" "Gatan" "kV"
    "Tecnai" "FEI" "Reynold" "uranyl" "OsO" "cacodylate" "18-nm" "1/100"
    "ImmunoResearch" "Immunogold" "autoradiography" "Hyblot" "CL"
    "4-chloro-1-naphthol" "1/800" "BioRad" "cyanogen" "ml/min" "ÄktaPurifier"
    "Sephacryl" "mg/ml" "phenylmethylsulfonyl" "histolyticum" "EXI" "Retiga"
    "Axiocam" "Axioskop"
    "secondary Cy3-conjugated AffiniPure goat anti-rabbit and Alexa-488-conjugated AffiniPure goat anti-mouse"
    "AffinitiPure" "Alexa-488-" "1/500" "anti-rFBN1-C" "Na" "cells/well"
    "pyogenes" "FUD" "1/1000" "rFBN1-C" "ionic" "non-fat" "w/v" "TBST" "Tween"
    "CaCl" "Naperville" "Nunc" "Nalge" "Maxisorp" "g/ml" "Waukesha" "Canada"
    "TBS" "pAcGP67" "-FNII" "overview" "rFBN" "ImmunoReseach" "Jackson" "H+L"
    "AffiniPure" "anti-mouse" "5C3" "Louis" "fibrillin-3" "Sottile" "FNIII"
    "FNII" "acromicric dysplasia" "autosomal dominant geleophysic dysplasia"
    "Marchesani" "Weill" "fibrillinopathies" "zonules" "spatio" "-FNI" "FNI"
    "Non-specific" "Anti-sense" "Watson" "S2C" "loc285194" "PANDA" "Kyoto"
    "S5C" "S5D" "anti-sense" "pulldown" "κB1A" "-β1" "Dgka" "mir29a/b"
    "non-targeting" "oligo" "ASOs" "S2B" "evolutionary conserved codons"
    "Codon" "respectively 100,000 and 120,000 bp" "S2A" "Cufflinks" "BC145649"
    "mESCs" "non-reconstituted" "p53RE-3" "p53RE-1" "Hodgkin" "orthologs"
    "ortholog ( PINT )" "ortholog" "S5A" "co-regulated" "= 4" "cargos"
    "co-precipitate" "∼4-fold" "strong caveolae co-localization" "Myosin-1a"
    "cyclohexamide" "hypomorph" "PC-3" "cavin/caveolin" "caveoli" "Hansen"
    "Cori" "endometrium" "3-days" "Donnan" "trichrome" "shorter lifespan"
    "increased fermentative glycolysis ex vivo" "only cavin-3 re-expression"
    "re-expression" "H/GFP" "H/Cavin-3" "heavier" "co-fractionated" "myosin-1c"
    "Myosin-1c" "15-day" "SV589" "trisphosphate" "Cavin" "cavins" "Cavins"
    "microdomains" "cavin" "Hernandez" "eLife" "DOI" "co-IP" "co-localize"
    "Anti-phospho-Akt" "Re-expression" "co-localization" "Keunen" "nucleate"
    "VCA" "verpolin" "protein 2/3" "Y-shaped" "invasion/motility" "ie"
    "HIF1does" "HIF1in" "HIF1and" "discovery/validation" "chemoattractant"
    "HIF-1response" "hetero" "Vaupel" "RANO" "Oncology" "Neuro" "U251" "/mL"
    "IGFPB2" "437ng/ml" "German" "≤160.9ng/ml" "≤160.9" "=0.038"
    "histopathologies" "use/smoking" "= 8" "=0.001" "= 6" "P =0.036" "=0.0002"
    "Rb" "GREs" "GRE" "Mourtada-M" "urothelia" "muscle invasive UC" "UC"
    "one-half" "previous exploratory transcriptome" "≤0.05"
    "the distal nephron" "the proximal tubule" "tubule" "nephron" "GEFOS"
    "rs1801725" "ase" "Nielsen" "Lange" "Jervell" "metaphyseal dysplasia"
    "cyclin-dependent kinase inhibitor 1C" "MRGPRE" "protein-like" "Wiedemann"
    "Beckwith" "cysteinyl" "11p15.5" "epithelia" "Mbp" "hypocalcemia" "nearest"
    "USP40" "OMIM" "Oguchi" "±250" "AmiGo" "Chicago" "CEU" "HapMap" "WTCCC2"
    "GIANT" "Hypergene" "CNVs" "*E-5" "rs7336933" "rs10491003" "rs1550532"
    "rs780094" "rs17711722" "rs1570669" "rs7481584" "OH" "≤21,679" "pg/mL"
    "= 0.028" "P  = 0.0005" "P  = 0.009" "P  = 0.002" "= 3" "= 6" "= 8" "= 4"
    "AD169" "TNUL76" "Supernatants" "transposon" "D/E" "HFF" "MHV-68" "MHV"
    "subfamilies" "UL77" "Hje" "resolvases" "Holliday" "Vsr" "NaeI" "BglI"
    "EcoRII" "UL24" "UL76" "co-transfection" "-hours/ week" "HRs" "hours/ week"
    "hours/week" "hours/" "York" "= 0.11" "= 0.03" "ER +" "= 0.59" "= 0.02"
    "≥30" "= 0.65" "= 0.66" "= 0.61" "microsatellite" "sporadic IPF" "hoc"
    "p=0.007" "p=0.03" "=0.012" "=0.0004" "=0.0005" "p=0.002" "p=0.004"
    "=0.009" "=0.036" "IPF" "BALF" "Wilms tumor-1" "=0.03" "=0.004" "XE" "KEAP"
    "Kelch" "phosphodegron" "non-proteolytic" "KELCH" "pcDNA3.1" "non-stressed"
    "Tsai" "gastric cancer biopsies" "Li" "non-pCR" "Biopsy"
    "chemoradiotherapy (NACRT)" "NACRT" "chemoradiotherapy" "Neoadjuvant"
    "I/II" "miscategorizations" "non-additive" "disambiguate" "overfit"
    "an iterative BP algorithm" "data-driven network inference algorithms"
    "AG538" "ryuvidine" "synergism" "unitless" "aERK" "whereZ" "loewe" "sim"
    "pairwise" "aPDGFR" "a statistical inference algorithm"
    "Explicitly searching all possible subsets" "outs" "NVPAE" "CompuSyn"
    "DDLS8817" "the recurrent CDK4 amplicon" "Ryuvidine" "offs" "sigmoid"
    "Loewe" "19q" "12q13-15" "amplicon" "WDLS" "DDLS" "non-significant" "11q"
    "interactome" "commonalities" "PhiKan" "the mutated codon" "destabilizer"
    "MRN" "mevalonate" "the oncomorphic p53 R273" "LTR" "R273H/C" "Agostino"
    "oncomorphs" "oncomorph" "32/306" "Missense" "LOF" "chemoresistant"
    "oncomorphisms" "Addadi" "Dil" "hMSC" "TCM" "hMSCs" "tumor/stromal"
    "co-injected" "μ l" "μ g/ml" "/ml" "Mukohara" "L858R/T790M (LTM)" "DTM"
    "Ex20 Ins" "anti-phosphotyrosine" "L858R/I941R" "L858R/L704N" "soft agar"
    "LTM" "L858R/T790M" "Ex20Ins" "subdomain" "Ex19Del" "anti-proliferative"
    "co-authors" "EMG" "co-precipitations" "ANKRD" "enhancers" "simplest"
    "FWHM" "dox" "TRIPZ" "urea" "co-precipitation" "Renilla" "α4" "PP6R2"
    "re-plating" "biogps" "GeneAtlas" "phosphoSer" "means ± S"
    "co-transfecting" "co-precipitated" "co-localized" "IJL" "YPW" "HCW" "α/β"
    "α2β1" "peptidyl" "propeptide" "+52" "expansile" "Nod/SCID" "FCt" "SCt"
    "p  " "co-isolated (LYRIC)" "hypopharynx" "oropharynx" "Eastern Europe"
    "Melanesia" "n = 3" "= 10" "= 6" "= 4" "= 0.005" "Dulbecco’s"
    "Polyethylenimine" "Lipopolysaccharide" "kbp" "NF-κB/low" "MHC1"
    "AP-1mut-MIR155HG" "pcDNA" "B-lymphoma" "p50/65" "`-UTRs" "MIR155HG"
    "ERK/MSK" "anti-phosphorylated-T389" "S235/S236" "anti-phospho-Thr389-S6K1"
    "uterine ERSR" "CASP12/" "any gestational timepoint" "Casp12"
    "the uterine myocytes" "later gestational timepoints" "uterine myocytes"
    "uterine CASP12" "active CASP12" "CASP12" "the pregnant uterine myocytes"
    "each gestational timepoint" "timepoint"
    "these earlier gestational timepoints" "timepoints" "uteri"
    "the uterine ERSR" "ERSR" "n = 3" "non-apoptotic" "cytospins" "Punnoose"
    "Ligthart" "McCarty" "inefficacy" "11/14" "3/14" "10/14"
    "the cut-off of at least 5 CTCs" "CellSearch" "Nadal" "Bock" "13/16"
    "Whitney" "p " "at least 400bp" "400bp" "11/16" "CTCs" "n = 5" "7/14"
    "non-overlapping" "anti-fibrotic" "C/H3" "COL1A2/CAT" "Ac" "DNAP"
    "commercially available HDAC1 siRNA" "ΔHAT" "mSin3A" "Tikhmyanova" "Jr"
    "Lucas" "human late-onset Alzheimer’s" "Alzheimer" "and 2C" "GUG" "AUG"
    "UAG" "UGG" "ACU" "UCU" "HNSCC" "radiocystitis" "FIGO" "Venus"
    "any active synthesis/accumulation" "widefield" "synthesis/accumulation"
    "prometaphase/metaphase" "isovolumetry" "BG430-" "BG430" "AATAAA"
    "hexanucleotide" "tetraploid" "APC/C" "Os" "Behçet’s" "Behçet"
    "pathogenic homologies" "homologies" "autoantigens" "coworkers"
    "capillaroscopy" "The Spearman’s" "the Spearman’s" "Spearman’s" "EScSG"
    "Anti-ERα" "30/71" "multiorgan" "multisystem" "= 0.004" "= 0.04" "= 0.001"
    "= 0.03" "P  = 0.02" "± standard" "bio" "Orai-3" "Stim" "Motiani"
    "lanthanides" "49.4±18.5%" "fura" "Mn" "41±9%" "Gd 3+" "Fura" "p  "
    "non-tumoral" "= 20" "= 40" "G1/S" "IGF2BPs" "excitatory synapses"
    "synapses" "oncology" "pathophysiology" "gingiva" "periodontopathogen"
    "protein/10" "periodontium" "cc" "periodontopathogens" "Aggregatibacter"
    "denticola" "Treponema" "Tannerella" "gingivalis" "μ L" "μ g" "μ g/mL"
    "non-canonic" "inactive subcomplexes" "subcomplexes" "cRNAs" "14-3-3σ"
    "vitro" "supplemental Fig. S4A" "adenomatous polyposis coli" "Vec" "RIE"
    "eIF" "protooncogenic eIFs" "eIFs" "co-transfections" "G0/G1" "H&E"
    "Multiphoton" "disassemble" "tagRFP" "multiphoton" "iBMM" "transwells"
    "monolayers" "TMEM" "intravasate" "colony-stimulating factor-1" "Patsialou"
    "Nrf2-" "Nrf" "mechainsim" "the acid-insensitive mRFP" "mRFP" "carboxyl"
    "organelles" "neuro" "activation/phosphorylation" "blockers" "CQ"
    "cardiac myocytes" "non-adipose tissues" "droplets" "NAFLD" "SFAs"
    "non-transformed" "smoky coal condensate" "condensate"
    "bronchoalveolar lavage" "lavage" "Yunnan" "carryover" "histologies" "_G"
    "_C" "_A" "_T" "G12C_34G" "histology" "exent" "FFPE" "transversions" "_34G"
    "G719X" "ADSC" "Xuanwei" "= 12" "n = 7" "germline" "stemness" "∆Nβ-catenin"
    "Pygopus" "eosin" "iPAF:Villin-Cre:Rosa26-LSL-rtTA" "organoids" "organoid"
    "IEC" "Rosa26" "rtTA" "IECs" "doxy" "H3K27" "co-occupied" "TBEs" "homolog"
    "TBE" "MegaTOPFLASH" "xPAF" "TOPFLASH" "somites" "hindbrain" "midbrain"
    "homepage" "adenomatous polyposis coli ( APC )" "coli ( APC )" "laevis"
    "&E" "hotspot" "gene/protein" "phosphoinositol" "pS" "fulminant" "WHIM11"
    "WHIM24" "WHIM20" "WHIM6" "Polyphen" "WHIM16" "WHIM9" "nonsilent SNVs"
    "WHIM18" "tumor/PDX" "WHIM8" "VAF"
    "harbored additional sample-unique noncoding SNVs"
    "no single sample-unique SNV" "indels" "WHIM5" "CNV" "SNVs" "SNV" "RPPAs"
    "PAM50" "interspecies" "centromere" "WHIM" "exome" "WGS" "basal-like"
    "Socio" "pack-year" "Kcal" "alelle" "socio" "kcal" "hrs" "Mellitus" "Latin"
    "an intronic single nucleotide polymorphism (SNP)" "Mexican" "rs2981582"
    "= 1.07" "= 3" "proteosome" "κBα" "Zuber" "coactivates" "co-dependent"
    "Nakagawa" "chemoresistance" "H3K79" "ESC-like" "hyper" "non- MLL" "orRela"
    "ofRela" "Rela" "E2A" "non-MLL" "p" "KEGG" "kinases/phosphatases" "PANTHER"
    "phosphoregulators" "TEFb" "strong transactivators" "transactivators"
    "JAPH" "ARdMV" "DJM" "ALGdS" "aneuploidy" "Bi" "indicatives" "Bauer"
    "Hanssen" "Ser326Cys" "phisms" "Vodicka" "non-homologous" "chromatid" "FVC"
    "VEF" "CVF" "Ile401Thr" "Thr241Met" "Arg399Gln" "326Cys" "401Thr" "241Met"
    "399Gln" "homozygous genotype" "BMI" "complementing-3"
    "8-hydrodeoxy-guanine" "OHdG" "polymorphisms/haplotypes" "BMCyt" "cytome"
    "methanesulphonate" "non-specific" "=0.005" "= 5" "=8" "ED" "Ex"
    "its immunostimulatory peptide Hp91" "Hp91"
    "its shorter immunoactive decapeptide" "MyD88-" "MyD" "alarmins"
    "immunodominant" "its immunoreactive decapeptide"
    "human monocyte-derived iDCs" "4+" "3+" "2+" "degranulate" "FlowJo" "Cr"
    "HLA-A2" "CD8+" "IL-10+" "mature DC supernatants" "iDCs"
    "lipopolysacharide (LPS)" "lipopolysacharide" "dualism" "monophosphoryl"
    "oligodeoxynucleotides" "co-stimulatory"
    "the proTα-derived immunoactive decapeptide" "decapeptide" "vivo" "ex"
    "Active cancer immunotherapies" "immunotherapies" "non-adherent"
    "Non-adherent" "μg/mL" "Anti-cancer" "Toll-like" "WZC" "YZ" "CXW" "XJX"
    "Boltzmann" "Poisson" "Dichlorodiphenyldichloroethylene" "-DDE" "LIGPLOT"
    "ps" "1I37" "ΔG" "vdW" "elec" "ΔE" "nanosecond" "PBS4" "PBS5" "helix"
    "PBS3" "kJ/mol" "Jørgensen" "Bonefeld" "Schrader"
    "the 209 possible congeners" "congeners" "organochlorine" "AR/LBD" "LBD"
    "congener" "dichlorodiphenyldichloroethylene" "biphenyls" "= 3" "= 2.2 "
    "co-activators" "CRTS" "RRB" "AKRS" "VMF" "DQC" "6/31" "missense"
    "dormancy" "Soucek" "el" "Yokobori" "immunoglobulins" "Burkitt’s" "Burkitt"
    "immunoglobulin" "Northern Brazil" "trisomy" "Leder" "Adams" "punctiform"
    "Brazil" "ACP03" "ACP02" "= 0.001" "= 0.007" "= 0.008" "= 0.015" "= 0.0002"
    "penicillin/streptomycin" "C-rings" "PfDHFR" "CgDHFR"
    "huDHFR/NADPH/SRI-9662" "huDHFR/NADPH/UCP1006" "Cα" "1DLR" "1KMV"
    "piritrexim" "rotamers" "RMSDs" "alkyl" "enantiomer" "huDHFR/NADPH/"
    "Phe 31/34" "the parent UCP1040" "UCP1076-1077" "ortho" "-methoxy"
    "UCP1040" "C-ring" "methoxy" "pyrimidyl" "Waals" "der" "pyridyl" "B-ring"
    "substituents" "carbonyl" "diaminopyrimidine" "UCP1006" "UCP1017" "UCP1015"
    "RMSD" "2C2S" "2W3A" "UCP1019" "UCP1025" "frozen" "pyridine" "Propargyl"
    "UCP1075" "chemotype" "biphenyl" "aureus (MRSA)" "albicans" "anthracis"
    "methicillin" "opportunistic infections Pneumocystis jirovecii"
    "falciparum" "gondii" "jirovecii" "monophosphate" "glabrata" "huDHFR"
    "aureus" "propargyl" "cpd188" "tumor-associated MDSCs" "splenic MDSCs"
    "tumor-associated Gr-1 + CD11b + MDSCs" "ARG1" "indicatig" "PBLs"
    "osteoblastic, chondrogenic, and adipocytic lineages"
    "the immunomodulatory armamentarium" "armamentarium" "plasmacytoid"
    "extramesodermal lineages" "lineages" "osteoblasts" "MDSC" "MDSCs"
    "multilineage" "n = 3" "C57BL/6" "anti-inflammatory" "non-thyroid" "annexV"
    "ed" "PHHs" "−2000" "+375" "ones" "Testoni" "Genomatix" "diethyl"
    "radioiodine" "member A5" "sodium/iodide" "PHH" "p53REs" "Wilcoxon"
    "recognise" "AE6" "Netherlands" "Boxtel" "bioMerieux" "Vironostika"
    "anti-human" "Sweden" "Uppsala" "Fitchburg" "SteadyGlo" "Meunch" "Wt"
    "Dartford" "Murex" "phytohaemagglutinin" "U/mL" "Pharma" "Mayne"
    "Biochemicals" "Sydney" "Iscove" "mg/mL" "cells/mL" "Carlsbad"
    "healthy donor buffy" "Norway" "Oslo" "paque" "Ficoll" "Melbourne" "buffy"
    "Gaithersburg" "ATCC" "American" "Chalfont" "Parkville" "pCAGGs"
    "pCAGGsHckN" "BamHI" "The Nef-deleted expression vector pNLA1Nef"
    "pNLA1Nef" "Rev-R-E-" "pNLA1-AD8env" "pNLA1" "pNLA" "pNL4-3" "Gladesville"
    "Beckman" "GTG" "TGG" "CGC" "Sanger" "France" "Genset" "TTA" "GAC"
    "pAD8AxxA" "pAD8FSNef" "pAD8-1" "HckN" "localise" "anti-HIV" "anti-Nef"
    "capsid" "pelleted viral supernatant" "pHck" "deltaNef" "titre" "titres"
    "TCID" "AD8" "AxxA" "non-palmitoylated" "AD8AxxA" "AD8FSNef"
    "diphenylfuropyrimidines" "PxxP" "μL" "ΔN-p53" "sulfonate (MMS)"
    "sulfonate" "peak expression around ZT8" "Per2 DNA" "Per 2DNA"
    "two characteristic decamers" "ZT9" "CT21" "CT9" "h ±" "h±" "n=3" "CT22"
    "± SEM" "CT14" "thep53" "Thep53" "ZT14" "Wildtype" "ofp53" "ZT4-ZT8"
    "BMAL1/CLOCK:-45bp" "CLOCK:-45bp" "protein/DNA" "andp53" "ZT20" "ZT8"
    "chosen" "ZT16-ZT20" "ZT" "zeitgeber" "biotin" "-Luc" "the distal decamer"
    "its proximal decamer" "decamer" "-RRXCXXGXYX-N" "decamers" "TFBIND"
    "Genebank" "wildtype" "Luc" "E-box" "n=4" "=3" "=7" "anti-FLAG" "G/C" "= C"
    "= A" "10.1038/ncomms3443" "Yoshimaru" "its intronic ERE" "an intronic ERE"
    "=5" "anti-tumour" "Anti-tumour" "at least 24 h" "KLP-3C" "IGF-1Rβ" "ERE-"
    "KPL-3C" "ERE" "co-activator" "enhancer" "EREs" "BIAcore" "plasmon" "Kd"
    "mtERAP" "scrERAP" "LRQR" "PSIVER" "E2/ERα" "non-genomic" "Oestrogen"
    "ERAP" "μg " "6-week-old" "anti-rabbit" "n =4" "senesce" "H-bonds" "silico"
    "motif-based algorithm" "Accn" "Germany" "Heidelberg" "Bukau"
    "a motif-based algorithm" "FASTA" "VMD" "H-bond" "Ewald" "kPa" "kcal/mol/"
    "steepest descent algorithm" "algorithm" "steepest" "Desmond" "Schrödinger"
    "OPLS" "Protorp" "Interprosurf" "HADDOCK" "webserver" "DnaK" "MODELLER"
    "Metamorph" "Sensys" "Axiovert" "Difco" "Fluoromount" "Alexa" "Hoechst"
    "v/v" "Pharmacia" "Amersham" "Biorad" "semi" "Millipore" "electro"
    "immunocomplexes" "μl" "°C" "anti-p21WAF1" "DO-1" "monoclonal anti-V5"
    "Chemicon" "Novocastra" "Biotech" "Cruz" "anti-V5" "μg/ml" "Nonidet" "μg"
    "Roche" "Fugene" "Dulbecco" "DMEM" "Invitrogen" "TTT" "CGG" "TCT" "iv"
    "iii" "lifespan" "multisite" "attractive anti-cancer" "conductance"
    "multiprotein" "megachannel" "MHW" "CJH" "IKKα/β" "A&D" "AMPKα2"
    "Transwell" "paracrine" "κB" "× 10" "24 h" "myofibroblasts" "myristate"
    "WTMLFs" "Affymetrix" "non-exposed" "RVSP" "-deficienct" "deficienct" "=35"
    "=0.046" "_APOPTOSIS" "REACTOME" "_TP53" "CCLE" "PICT1-" "PICT" "Ub" "agar"
    "neoadjuvant" "survival/apoptosis" "gavage" "cell survival/apoptosis"
    "nonsignificant" "RKTs" "sunitinibtamoxifen" "deoxyneucleotidyl" "P = 0.02"
    "= 0.04" "microvessels" "cIAPs" "pathology whereby EC-bound alloantibody"
    "alloantibodies" "intra" "arterial segments re-implanted" "re-implanted"
    "CAV-like" "gone" "re-transplantation" "polyC9" "re-transplanted"
    "co-stained" "ULEX" "Ulex" "cardiac allografts" "endomyocardial biopsies"
    "allografts" "human arterial intima" "intima"
    "allogeneic memory CD4 + T cells co-cultured" "isotype" "monolayer"
    "scatterplot" "scatterplots" "C4d" "VCAM" "co-cultured" "CIPRA-" "CIPRA"
    "non-PRA" "subtypes" "=4" "alloimmune" "alloantibody" "titer"
    "pharmacotherapies" "Alloantibody" "non-canonical" "Non-canonical" "MAC"
    "DSA" "Cardiac allograft vasculopathy (CAV)" "vasculopathy (CAV)"
    "vasculopathy" "allograft" "PS" "UN" "chemo-" "cerebrum" "ONYX-015" "ONYX"
    "x" "PDCD" "chemo" "cerebellum" "the oncolytic adenovirus Ad-Delo3-RGD"
    "MOI" "dl703" "E1A13S" "biopsies" "micrograph" "CNS" "1/2" "RAS/MAPK"
    "E1B19-deletion" "RGD" "E1A13S protein"
    "the oncolytic adenovirus (OAV) Ad-Delo3-RGD" "OAV" "Dunn" "RAS/"
    "YB-1 based virotherapy" "virotherapy" "lysis" "Ad-Delo3-RGD"
    "histochemistry" "=0.05" "anti-tumor" "JW" "XY" "WG" "SZ"
    "phosphatase-like" "dataset" "Antonio" "non-HER" "biopsy"
    "predictive or correlative biologic readouts" "readouts" "COXPH" "β1 (HRG)"
    "Settleman" "a reliable pharmacodynamic readout" "readout" "NVP" "BEZ"
    "rSKBR3" "rBT474" "PI3KCA" "HER2+" "naïve" "RPMAs" "ALTTO" "monotherapy"
    "HER2 +" "broader" "underpinnings" "10.1038/ncomms3464" "doi" "Fletcher"
    "SuperSeries" "the causative SNPs" "co-regulator" "RedeR" "GREB"
    "the relevant regulons" "co-operatively" "-seq" "seq" "Transfac"
    "whose regulons" "TCGA" "weakest" "LOD" "AVS" "eQTL" "VSE" "greatest"
    "limma" "oestrogen" "FGFR1b" "FGFR2b" "ER+" "regulons" "regulon" "ARACNe"
    "algorithms" "Europeans" "24 h" "co-ordinate" "drawn" "isofrom" "synapse"
    "stepwise" "SIRTs" "NMNAT2+SIRT3" "PACF" "antiacetyllysine" "Co-IP" "SIRT"
    "pEGFP-C1-SIRT3" "WB" "renilla" "pACT-SIRT3+pBIND" "pBIND" "Lipofectamine"
    "transformants" "sirtuins" "Warburg" "sirtuin" "≥2" "Non-small" "ZPZ"
    "statmin1" "non-silencing" "non-dividing" "nucleases" "mucosa" "shRNA2"
    "non-silencing- shRNA" "non-transfected" "motile" "Boyden"
    "stathmin1 shRNA2" "MKN-cells" "MKN" "the possible anti-proliferative"
    "Stathmin1 shRNA2" "Stathmin1 shRNA" "stathmin1 shRNA" "stathmin1 shRNAs"
    "non-silencing-shRNA" "viral supernatants" "supernatants"
    "immunocytochemistry (ICC)" "immunocytochemistry" "melanogaster" "Iran"
    "the viral supernatant" "supernatant" "× 10" "Kit-8" "Bhatla" "Auranen"
    "Dhillon" "Hu" "Kuschel" "Blasiak" "Sliwinski" "Makowska" "Romanowicz"
    "Chang" "Jakubowska" "colorectum" "proven" "polymorphism (SNP)"
    "The Egger's" "Begg's" "Both Begg's" "GC+CC" "= 1.11–21.83" "C-allele"
    "Webb" "BRCA1/2" "European" "tion" "15q15.1" "coli" "DSB" "DSBs"
    "pigmentosum" "penetrant" "un" "UV" "covariates" "= 0%" "95% CIs" "= 0.06"
    "= 1.11" "miR-1/" "adr 3" "hyperoxia" "noncognate" "de-regulation"
    "non-BPD" "nt" "preterm" "XTT" "bronchopulmonary dysplasia (BPD)"
    "dysplasia" "cardiac QT" "prolonged cardiac QT" "QT" "mg/once" "U373"
    "Johnson Pharmaceutical R&D" "&D" "Johnson" "JNJ-26854165" "JNJ"
    "non-functional" "β1-" "lifeact" "FERM" "Z-stacks" "Raichu" "and 3D"
    "zymography" "β3kd" "αv" "β1kd" "kd" "COLI" "coverslips" "gastrulate"
    "activationwere" "β3" "β1" "AZD1208" "inhibition/knockdown" "undergoes"
    "24-hour" "48-hour" "pBAD" "AR339" "RKRPS" "Moloney" "ITD" "= 0.05"
    "non-target" "subset" "glycogen synthase kinase-3β" "Novartis" "Kogyo"
    "Zenyaku" "Gleason" "WFU3" "MCL-1 shRNA" "shRNAs"
    "either Mcl1-specific shRNA" "the fluorogenic substrate DEVD-amc"
    "substrate DEVD-amc" "DEVD-amc" "DEVD" "frameshift" "Bcl" "Multi"
    "multidomain" "-biphosphate" "biphosphate" "-triphosphate" "triphosphate"
    "eukemia" "yeloid" "eath" "cl2-" "cl" "C42Luc" "×10" "co-transfected"
    "pathological subtype" "subtype" "Shimizu" "the included studies used IHC"
    "= 0%" "=0.02" "= 0.76" "=0%" "=2.96" "high/positive" "ECOG" "IIIA" "IHC"
    "Yu" "JR" "formyl" "glycinamide" "vinorebine" "Low/negative" "low/negative"
    "Revman" "Cochrane" "OVID" "=0.002" "LR" "multi" "Lozano" "Garcia"
    "non-significantly" "rs4353229T"
    "rs10787498 homozygous GG variant genotype" "Xu" "SNPinfo" "GWASs"
    "rs2227310" "only rs2227310 homozygous GG variant genotype" "Korean"
    "lipopolysaccharide" "Soung" "lymphoblastoid" "≤59" "haplotype"
    "all the possible haplotypes" "GGAT" "TGGT" "TAGT" "TGGC" "haplotypes"
    "HAPLOTYPE" "all possible genotypes" "≥1"
    "the rs4353229 homozygous TT variant genotype" "non-cardia" "non-drinkers"
    "rs4353229 T" "rs12247479 AA" "rs1127687 AA" "rs10787498"
    "their homozygous variant genotypes" "their variant homozygous genotypes"
    "rs4353229" "Weinberg" "NGCA" "mellitus (IDDM)" "IDDM" "mellitus" "CASPs"
    "IARC" "Oceania" "Africa" "Zealand" "Australia" "America" "Europe" "Korea"
    "the risk genotypes (adjusted odds ratio = 0.81, 95% CI = 0.68–0.96), compared with those carrying zero risk genotypes"
    "cardia" "Taqman" "= 0.66" "95% CI " "Ordinario" "celluler" "subsets"
    "atypia" "lumens" "non-malignant" "low-to-moderate penetrance"
    "neoplastic-like" "Genome" "shRNA" "penetrance" "non-tumor"
    "Immunohistochemistry" "transwell" "#3" "quantitative RT-PCR 24 h"
    "kcal/mol" "-UTRs" "UTRs" "NHBE" "aPKCs" "nPKCs" "cPKCs" "24 h"
    "non-coding" "www" "ArrayExpress" "HOSE" "p53 RE" "dinucleotides" "p53RE"
    "CC" "o" "CWWG" "CCCis" "Gy" "intestinal epithelium" "epithelium" "perhaps"
    "24h" "p53 ER/ER" "p53ERTAM" "exon 2" "Cp53" "PAb421" "+282" "344bp"
    "suppressorprotein" "thegene" "LALIGN" "rVISTA" "exon 1A" "p53FamTag"
    "MAPPER" "TRANSFAC" "PROMO" "ALGENN" "wt" "p53  ER" "OVCA" "Latest"
    "Medaka" "spalt" "orthologue" "Sall" "transcriptome" "et" "knockin" "Spalt"
    "invasion/metastasis" "undergone" "Spearman" "miRanda" "TargetScan"
    "miRNA-130b" "anti-miR-130b" "MiR-130b" "poorer" "meier" "Kapan"
    "Multivariate" "miR-130b" "b" "= 0.005" "5-year" "WAF1/cip1"
    "genetic polymorphisms/mutations" "mutaions" "Americans" "intron"
    "ARE-like" "Univariate" "Meier" "re-programming" "Taiwanese" "Caucasians"
    "IPASS" "non-smoker" "non-smoking" "6p21.32" "6q22.2" "10q25.2" "3q28"
    "6p21.3" "5p15.33" "GWAS" "genome" "Genotypes" "univariate" "Mayer"
    "Kaplan" "IIA" "*4" "*4/" "multivariate" "A/A" "C/A" "C/C" "WT/SNP" "–617C"
    "heterozygote" "Ltd" "Biosystems" "Thermo Fisher Scientific Inc" "GeneGET"
    "Inc" "Thermo" "Fermentas" "Miniprep" "®-T" "USA" "WI" "Promega"
    "CGAGATAAAGAGTTGTTTGCGAA" "GACCACTCTCCGACCTAAAGG" "bp" "Kanagawa"
    "non-adenocarcinomas" "–617A" "SmartAmp" "Marzec" "Yamamoto" "undertaken"
    "cellular adaptation/protection" "Japanese" "Non-smokers" "non-small"
    "non-smokers" "myocytes" "co-treatment" "Pre" "hydroxychavicol" "ii"
    "siRNAs" "pre" "hPBMC" "monoethyle" "anti-cancer" "anti-leukemic"
    "antihormone-" "antihormone" "GCS" "glutamylcysteine" "sulphoximine"
    "ethyle" "phenyl" "peroxidases" "reductases" "siRNA" "-difluorofluorescein"
    "difluorofluorescein" "-dichlorodihydrofluorescein"
    "dichlorodihydrofluorescein" "-ribose" "ribose" "non-leukemic" "betle"
    "Hydroxychavicol" "farnesyl" "codons" "immunohistochemistry" "factor-kB"
    "Kaposi" "anti-apoptotic" "latest" "Zeiss" "Carl" "hr" "TUNEL" "vide"
    "ELISPOT" "pg/ml" "Immunoassay" "ELISA" "multistage" "immuno" "transducer"
    "interwoven" "genotypes" "Asian" "goes" "bulky adducts" "adducts" "=0.008"
    "=2.094" "OR=0.680" "OR=0.693" "homozygote" "Egger’s" "Begg’s" "Egger"
    "Begg" "Zhang" "Andrew" "Kelsey" "signiﬁcance" "Zhi" "Wu" "Galbraith"
    "signiﬁcant" "greater" "AA+GA" "= 0.002" "TT+CT" "=0.007" "=0.680" "=0.015"
    "=0.693" "GA+GG" "HWE" "genotype" "TaqMan" "RFLP" "Africans" "African"
    "Spanish" "English" "Polymorphisms" "codon" "exons" "dbSNP" "SNPs" "19q13"
    "chlornaphrazine" "phenacetin" "amines" "Asians" "95% CI" "95%CI" "GG"
    "polymorphism" "ORs" "CBM" "polymorphisms"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-10801-11100*
  '(("neutrophils, macrophages or DCs" . SPARSER::COLLECTION)
    ("the pathogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("platelets" . SPARSER::PROTEIN)
    ("the dominant stimulant" . SPARSER::DRUG) ("stimulant" . SPARSER::DRUG)
    ("H4 neutralization antibody (0, 10, 25 µg/ml) and control IgG (25 µg/ml)"
     . SPARSER::COLLECTION)
    ("p38, ERK and JNK" . SPARSER::COLLECTION) ("Histones" . SPARSER::PROTEIN)
    ("a major antimicrobial component" . SPARSER::COMPONENT)
    ("p38, and mitochondrial" . SPARSER::COLLECTION) ("CLP" . SPARSER::PROTEIN)
    ("Rhodamine" . SPARSER::PROTEIN)
    ("alcohol and folate" . SPARSER::COLLECTION)
    ("a major etiological factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("reproductive age" . SPARSER::PROTEIN) ("secondary mRNA" . SPARSER::RNA)
    ("variant and breast" . SPARSER::COLLECTION)
    ("allele and breast" . SPARSER::COLLECTION)
    ("types, and miRNAs" . SPARSER::COLLECTION)
    ("5-FU and its derivatives [ xref , xref ]" . SPARSER::COLLECTION)
    ("fluoropyrimidines" . SPARSER::DRUG)
    ("fluoropyrimidine-based chemotherapeutic drugs" . SPARSER::DRUG)
    ("fluoropyrimidine" . SPARSER::DRUG) ("dUMP" . SPARSER::DUMP)
    ("genetic, environmental, hormonal and reproductive factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SET8" . SPARSER::PROTEIN) ("messenger RNAs" . SPARSER::RNA)
    ("OR 1" . SPARSER::PROTEIN) ("Thymidylate synthase" . SPARSER::PROTEIN)
    ("erlotinib (68%) or bevacizumab (41%)" . SPARSER::COLLECTION)
    ("selumetinib, and sorafenib" . SPARSER::COLLECTION)
    ("VEGFR and PDGFR" . SPARSER::COLLECTION)
    ("IGFBP-7, and gastrin-releasing peptide" . SPARSER::COLLECTION)
    ("genes or groups" . SPARSER::COLLECTION) ("K-RAS-" . SPARSER::PROTEIN)
    ("hoc" . SPARSER::PROTEIN) ("RAS-RAF" . SPARSER::COLLECTION)
    ("the worst 8-week DCR (23.1%) and the shortest PFS (1.84 months)"
     . SPARSER::COLLECTION)
    ("the shortest PFS" . SPARSER::PROTEIN)
    ("prespecified predictive biomarkers" . SPARSER::MOLECULE)
    ("longer PFS" . SPARSER::PROTEIN) ("K-RAS or B-RAF" . SPARSER::COLLECTION)
    ("EGFR and K-RAS" . SPARSER::COLLECTION)
    ("EGFR or K-RAS" . SPARSER::COLLECTION)
    ("DCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pain" . SPARSER::PROTEIN)
    ("hyperglycemia" . SPARSER::PROTEIN) ("AEs" . SPARSER::PROTEIN)
    ("no definitive predictive biomarkers" . SPARSER::MOLECULE)
    ("wt-" . SPARSER::PROTEIN) ("SSS" . SPARSER::PROTEIN)
    ("K-RAS, EGFR , and B-RAF" . SPARSER::COLLECTION)
    ("DCR" . SPARSER::PROTEIN) ("gastrin-releasing peptide" . SPARSER::PROTEIN)
    ("IGFBP-7" . SPARSER::PROTEIN) ("CD55" . SPARSER::PROTEIN)
    ("decay accelerating factor" . SPARSER::PROTEIN)
    ("derived growth factor beta" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("RalA" . SPARSER::PROTEIN)
    ("PKA and PAK1" . SPARSER::COLLECTION) ("IKBKE" . SPARSER::PROTEIN)
    ("rsk" . SPARSER::PROTEIN) ("MLN8237 or siRNA" . SPARSER::COLLECTION)
    ("elevated Aurora-A and positive pERα-Ser167/Ser305" . SPARSER::COLLECTION)
    ("nolvadex" . SPARSER::DRUG)
    ("ERα and ERα-targeted gene CCND1" . SPARSER::COLLECTION)
    ("Aurora A and CCND1" . SPARSER::COLLECTION)
    ("Aurora-A and wild-type ERα" . SPARSER::COLLECTION)
    ("SerS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCF7 and Aurora-A" . SPARSER::COLLECTION)
    ("serine-alanine" . SPARSER::COLLECTION) ("GST-ERα" . SPARSER::COLLECTION)
    ("the amino acid(s) of ERα that is phosphorylated by Aurora-A"
     . SPARSER::PROTEIN)
    ("-orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("Myc-ERα" . SPARSER::COLLECTION)
    ("anti-ERα and -Aurora-A antibodies" . SPARSER::COLLECTION)
    ("-Aurora-A" . SPARSER::COLLECTION) ("GST-Aurora-A" . SPARSER::COLLECTION)
    ("Aurora-A and ERα" . SPARSER::COLLECTION)
    ("GFP-ERα" . SPARSER::COLLECTION)
    ("ERα and Aurora-A" . SPARSER::COLLECTION) ("ERE" . SPARSER::PROTEIN)
    ("E2-" . SPARSER::MOLECULE) ("HA-Aurora-A" . SPARSER::COLLECTION)
    ("ERE-Luc" . SPARSER::COLLECTION)
    ("caspase-3 and Ki-67" . SPARSER::COLLECTION) ("MLN8237-" . SPARSER::DRUG)
    ("tamoxifen and MLN8237" . SPARSER::COLLECTION)
    ("Fa-CI" . SPARSER::COLLECTION) ("Fa" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase-7 (MCF7-TamR) or caspase 3 (BT474)" . SPARSER::COLLECTION)
    ("PARP, caspase-7 (MCF7-TamR) or caspase 3 (BT474)" . SPARSER::COLLECTION)
    ("first treated MCF7-TamR" . SPARSER::COLLECTION)
    ("MLN8237 and tamoxifen" . SPARSER::COLLECTION) ("TamR" . SPARSER::PROTEIN)
    ("MCF7-TamR" . SPARSER::COLLECTION)
    ("Annexin V/FACS" . SPARSER::COLLECTION)
    ("protein and p" . SPARSER::COLLECTION)
    ("a mitotic serine/threonine kinase" . SPARSER::KINASE)
    ("β-cyclodextrin" . SPARSER::MOLECULE) ("TRF1" . SPARSER::PROTEIN)
    ("pp90" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("selective estrogen receptor modulator" . SPARSER::DRUG)
    ("MLN8237" . SPARSER::DRUG) ("p110δ-" . SPARSER::PROTEIN)
    ("p110δ-Akt-mTOR" . SPARSER::COLLECTION)
    ("p110δ and the inter-SH2 (iSH2)" . SPARSER::COLLECTION)
    ("glucose and amino acids" . SPARSER::COLLECTION)
    ("hyperactive PI(3)K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p110δ or mTORC1" . SPARSER::COLLECTION)
    ("IC87114 or rapamycin" . SPARSER::COLLECTION)
    ("PI(3)K-Akt" . SPARSER::COLLECTION)
    ("PI(3)K and Akt" . SPARSER::COLLECTION)
    ("the senescence-associated marker CD57" . SPARSER::PROTEIN)
    ("T-bet and granzyme B" . SPARSER::COLLECTION)
    ("Tetramer" . SPARSER::TETRAMER) ("tetramers" . SPARSER::TETRAMER)
    ("mutational hot" . SPARSER::PROTEIN)
    ("phospholipid" . SPARSER::PHOSPHOLIPID) ("pKa" . SPARSER::PROTEIN)
    ("p110δ and p110α" . SPARSER::COLLECTION)
    ("IgG and IgA" . SPARSER::COLLECTION) ("AICDA" . SPARSER::PROTEIN)
    ("IgM (not shown) and CD5 ( xref )" . SPARSER::COLLECTION)
    ("PI(3)K-Akt-mTOR" . SPARSER::COLLECTION)
    ("proteins and elongation" . SPARSER::COLLECTION)
    ("mTOR, Raptor and GβL" . SPARSER::COLLECTION)
    ("4EBP1 and p70S6K" . SPARSER::COLLECTION)
    ("phosphatase and tensin homolog (PTEN) and SH2 domain-containing inositol 5"
     . SPARSER::COLLECTION)
    ("-phosphatase" . SPARSER::PHOSPHATASE) ("bis" . SPARSER::PROTEIN)
    ("a catalytic p110 subunit and a regulatory p85 subunit"
     . SPARSER::COLLECTION)
    ("H4A" . SPARSER::PROTEIN) ("ARF6" . SPARSER::PROTEIN)
    ("EBNA3A" . SPARSER::PROTEIN) ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("UL83" . SPARSER::PROTEIN) ("pp65" . SPARSER::PROTEIN)
    ("LAMP-1" . SPARSER::PROTEIN) ("anti-CD28" . SPARSER::PROTEIN)
    ("p 110δ" . SPARSER::PROTEIN) ("nSH2" . SPARSER::PROTEIN)
    ("iSH2" . SPARSER::PROTEIN) ("IC87114" . SPARSER::MOLECULE)
    ("p27kip1" . SPARSER::PROTEIN) ("NKG2D" . SPARSER::PROTEIN)
    ("CD57" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("granzyme B" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("Foxo1" . SPARSER::PROTEIN) ("Ras-GTP" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("GβL" . SPARSER::PROTEIN)
    ("Negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("PI(3)Ks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI(3)K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("let-7a or reducing p66Shc" . SPARSER::COLLECTION)
    ("E2F1 and CDC34" . SPARSER::COLLECTION)
    ("Ago2/RISC" . SPARSER::COLLECTION)
    ("let-7a and p66Shc" . SPARSER::COLLECTION)
    ("P66Shc, p52Shc, and p46Shc" . SPARSER::COLLECTION)
    ("Ras-MAPK" . SPARSER::COLLECTION) ("let-7a-Shc" . SPARSER::COLLECTION)
    ("flag-p66Shc" . SPARSER::COLLECTION) ("CRΔ4" . SPARSER::PROTEIN)
    ("phspho-p38" . SPARSER::COLLECTION)
    ("let-7a-p66Shc" . SPARSER::COLLECTION) ("cellular ROS" . SPARSER::PROTEIN)
    ("p66Shc, p52Shc, or p46Shc" . SPARSER::COLLECTION)
    ("phopho-p38" . SPARSER::COLLECTION)
    ("expressed p66Shc shRNA" . SPARSER::PROTEIN)
    ("CDC34, E2F1, or p21" . SPARSER::COLLECTION)
    ("Ras and c-myc" . SPARSER::COLLECTION)
    ("Ras, c-myc, E2F1, and CDC34" . SPARSER::COLLECTION)
    ("MS2-CR" . SPARSER::COLLECTION) ("polysomes" . SPARSER::BIO-COMPLEX)
    ("the seedless REs" . SPARSER::PROTEIN)
    ("UTR or pGL3-CRΔ4" . SPARSER::COLLECTION)
    ("pGL3-CRΔ4" . SPARSER::PROTEIN-PAIR) ("pGL3-Δ4" . SPARSER::PROTEIN-PAIR)
    ("pGL3-" . SPARSER::PROTEIN) ("pGL3-CR" . SPARSER::COLLECTION)
    ("pGL3-3" . SPARSER::COLLECTION) ("the ‘seedless’ REs" . SPARSER::PROTEIN)
    ("UTR and MS2-GFP-MS2-CRΔ4" . SPARSER::COLLECTION)
    ("UTR or MS2-GFP–MS2-CRΔ4" . SPARSER::COLLECTION)
    ("MS2-GFP-flag-MS2-3" . SPARSER::COLLECTION)
    ("MS2-GFP-flag-MS2-CR" . SPARSER::COLLECTION)
    ("all three seedless REs" . SPARSER::PROTEIN)
    ("UTR or pSL-MS2-CRΔ4" . SPARSER::COLLECTION)
    ("MS2-GFP-flag" . SPARSER::COLLECTION)
    ("pSL-MS2-GFP-flag" . SPARSER::COLLECTION)
    ("pSL-MS2-3" . SPARSER::COLLECTION) ("pSL-MS2-CR" . SPARSER::COLLECTION)
    ("pSL-MS2" . SPARSER::COLLECTION)
    ("siRNA or inhibitor" . SPARSER::COLLECTION)
    ("Ago2 and let-7a" . SPARSER::COLLECTION)
    ("Ago2 or let-7a, or co-transfected" . SPARSER::COLLECTION)
    ("let-7a, or co-transfected" . SPARSER::COLLECTION)
    ("nascent GAPDH" . SPARSER::PROTEIN)
    ("let-7a or antisense" . SPARSER::COLLECTION)
    ("methionine and L-" . SPARSER::COLLECTION)
    ("let-7a or miR-30" . SPARSER::COLLECTION) ("let-7a" . SPARSER::PROTEIN)
    ("expressed pre-let-7a" . SPARSER::PROTEIN-PAIR)
    ("AS-let-7a" . SPARSER::COLLECTION) ("pre-let-7a" . SPARSER::COLLECTION)
    ("p66Shc and cellular lifespan" . SPARSER::COLLECTION)
    ("polysome" . SPARSER::BIO-COMPLEX) ("p53 and DNA" . SPARSER::COLLECTION)
    ("oxidoreductase" . SPARSER::PROTEIN)
    ("SOD1 and SOD2" . SPARSER::COLLECTION)
    ("insulin and insulin-like growth factor-1" . SPARSER::COLLECTION)
    ("p66Shc, p52Shc, and p46Shc" . SPARSER::COLLECTION)
    ("mL −1" . SPARSER::PROTEIN) ("P66Shc" . SPARSER::PROTEIN)
    ("CDC34" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("p46" . SPARSER::PROTEIN)
    ("p66Shc" . SPARSER::PROTEIN)
    ("N-terminal 1400 amino acids of MLL" . SPARSER::PROTEIN)
    ("ATR and chk1" . SPARSER::COLLECTION)
    ("ATR or chk1" . SPARSER::COLLECTION)
    ("Shh (sonic hedgehog) and Gli" . SPARSER::COLLECTION)
    ("Gli" . SPARSER::PROTEIN) ("PI-3 kinase and GSK3 β" . SPARSER::COLLECTION)
    ("PTEN/GSK3 β" . SPARSER::COLLECTION)
    ("cyclin D2, and cyclin" . SPARSER::COLLECTION)
    ("p53 and inactive" . SPARSER::COLLECTION)
    ("h, and chk1" . SPARSER::COLLECTION)
    ("cyclin-dependent kinases and cdc7" . SPARSER::COLLECTION)
    ("melting" . SPARSER::DRUG) ("nonfunctional RB" . SPARSER::PROTEIN)
    ("cyclin D2 protein ( xref A) and RNA ( xref B)" . SPARSER::COLLECTION)
    ("cyclin D2 and cyclin" . SPARSER::COLLECTION)
    ("MDM2, p53−/− and p53−/−:MDM2Tr" . SPARSER::COLLECTION)
    ("Intra" . SPARSER::PROTEIN)
    ("MDM2 or a control shRNA" . SPARSER::COLLECTION)
    ("MDM2 or GFP" . SPARSER::COLLECTION) ("p-chk1" . SPARSER::COLLECTION)
    ("known oncogene" . SPARSER::ONCOGENE)
    ("Tr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATM or ATR" . SPARSER::COLLECTION)
    ("caffeine" . SPARSER::MOLECULE)
    ("Incorporated IdU and CldU" . SPARSER::COLLECTION)
    ("using red or green fluorescent-tagged antibodies" . SPARSER::COLLECTION)
    ("IdU" . SPARSER::DRUG) ("H3k4" . SPARSER::PROTEIN)
    ("kinases, ATR and chk1" . SPARSER::COLLECTION)
    ("cdc7/DBf4" . SPARSER::COLLECTION)
    ("the cyclin-dependent kinase inhibitor p16 or the transcription factor BRG1"
     . SPARSER::COLLECTION)
    ("sonic hedgehog" . SPARSER::PROTEIN)
    ("oncoprotein MDM2" . SPARSER::PROTEIN) ("CDC45" . SPARSER::PROTEIN)
    ("SET domain" . SPARSER::PROTEIN) ("precursor protein" . SPARSER::PROTEIN)
    ("AC -3" . SPARSER::PROTEIN) ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PHA767491" . SPARSER::DRUG) ("H3K4Me3" . SPARSER::PROTEIN)
    ("k4" . SPARSER::PROTEIN) ("DBf4" . SPARSER::PROTEIN)
    ("cdc7" . SPARSER::PROTEIN) ("BRG1" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN) ("chk1" . SPARSER::PROTEIN)
    ("double minute2" . SPARSER::PROTEIN)
    ("HIF1α and both PTEN and PI3K" . SPARSER::COLLECTION)
    ("-p53" . SPARSER::COLLECTION) ("SF1126 or LY294002" . SPARSER::COLLECTION)
    ("U87MG and GFAPV12 Ras" . SPARSER::COLLECTION)
    ("LY294002 or the presence of PTEN ( xref & xref )" . SPARSER::COLLECTION)
    ("a key tumor suppressor and dysregulation" . SPARSER::COLLECTION)
    ("PTEN-PI3K-Akt" . SPARSER::COLLECTION)
    ("PTEN or mutants" . SPARSER::COLLECTION)
    ("both the anti-angiogenic and anti-tumor" . SPARSER::COLLECTION)
    ("U373MG-PTEN and LN229vIII" . SPARSER::COLLECTION)
    ("U373-PTEN" . SPARSER::PROTEIN-PAIR) ("intact p53" . SPARSER::PROTEIN)
    ("a retroviral cre recombinase" . SPARSER::PROTEIN)
    ("cre" . SPARSER::PROTEIN) ("U87MG-PTEN" . SPARSER::COLLECTION)
    ("PTEN and pan" . SPARSER::COLLECTION)
    ("PTEN and PI3K" . SPARSER::COLLECTION)
    ("a natural metabolite" . SPARSER::MOLECULE)
    ("PDK1 and plekstrin-homology-domain" . SPARSER::COLLECTION)
    ("concurrent temozolomide and radiation" . SPARSER::COLLECTION)
    ("PTEN-PI3K" . SPARSER::COLLECTION) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SF1126" . SPARSER::DRUG) ("HIF-1β" . SPARSER::PROTEIN)
    ("ME2" . SPARSER::PROTEIN) ("TGF-β1 and FcRL4" . SPARSER::COLLECTION)
    ("HIV-1 viremic individuals FcRL4" . SPARSER::PROTEIN)
    ("FcRL4 and CD80" . SPARSER::COLLECTION)
    ("an α 4 β 7 -reactive gp120 or TGF-β1" . SPARSER::COLLECTION)
    ("gp120 or TGF-β1" . SPARSER::COLLECTION)
    ("significantly more TGF-β1" . SPARSER::PROTEIN)
    ("gp120 and co-culture" . SPARSER::COLLECTION)
    ("highly α 4 β 7 -reactive gp120" . SPARSER::PROTEIN)
    ("an α 4 β 7 -reactive gp120" . SPARSER::PROTEIN)
    ("a weak binding variant" . SPARSER::VARIANT)
    ("CD80 and CD86" . SPARSER::COLLECTION)
    ("CD80 and FcRL4" . SPARSER::COLLECTION)
    ("TGFB1 , SMAD7 and CDKN1A" . SPARSER::COLLECTION)
    ("IL1B , TNFAIP6 , TGFB1 , SMAD6 , SMAD7 , ITGA5 and FCRL4"
     . SPARSER::COLLECTION)
    ("FCRL" . SPARSER::PROTEIN) ("SMAD6 and SMAD7" . SPARSER::COLLECTION)
    ("Interleukin 1β ( IL1B ) and Transforming Growth Factor-β1 ( TGFB1 )"
     . SPARSER::COLLECTION)
    ("Tumor Necrosis Factor ( TNF ), Interleukin 1β ( IL1B ) and Transforming Growth Factor-β1 ( TGFB1 )"
     . SPARSER::COLLECTION)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("Approximately 500 genes" . SPARSER::GENE)
    ("down-modulated genes" . SPARSER::GENE) ("-gp120" . SPARSER::COLLECTION)
    ("Additionally R880F gp120" . SPARSER::PROTEIN)
    ("α 4 β 7 -reactive gp120" . SPARSER::PROTEIN)
    ("92Th14.12 gp120" . SPARSER::PROTEIN)
    ("endothelial MAdCAM-1" . SPARSER::PROTEIN)
    ("Naïve and effector" . SPARSER::COLLECTION) ("Naïve" . SPARSER::PROTEIN)
    ("lectins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the divalent cations" . SPARSER::MOLECULE)
    ("divalent cations" . SPARSER::MOLECULE) ("cations" . SPARSER::MOLECULE)
    ("functional α 4 β 7" . SPARSER::PROTEIN)
    ("the heterodimeric α 4 β 7 molecule" . SPARSER::MOLECULE)
    ("soluble MAdCAM-1" . SPARSER::PROTEIN) ("FIB" . SPARSER::PROTEIN)
    ("immunogens" . SPARSER::MOLECULE)
    ("xref autologous neutralizing antibodies" . SPARSER::ANTIBODY)
    ("autoreactive antibodies" . SPARSER::ANTIBODY) ("GALT" . SPARSER::PROTEIN)
    ("IgA" . SPARSER::PROTEIN)
    ("the immunosuppressive cytokine TGF-β1 and the B cell inhibitory receptor FcRL4"
     . SPARSER::COLLECTION)
    ("RGS16" . SPARSER::PROTEIN) ("endonuclease 1" . SPARSER::PROTEIN)
    ("RD1" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DNA2" . SPARSER::PROTEIN)
    ("BL13" . SPARSER::PROTEIN) ("CD23" . SPARSER::PROTEIN)
    ("L27" . SPARSER::PROTEIN) ("Fc receptor" . SPARSER::PROTEIN)
    ("AN1" . SPARSER::PROTEIN) ("LTBP3" . SPARSER::PROTEIN)
    ("Protein 3" . SPARSER::PROTEIN)
    ("Suppressor of cytokine signaling 1" . SPARSER::PROTEIN)
    ("Bone Morphogenetic Protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNFAIP6" . SPARSER::PROTEIN) ("ITGA5" . SPARSER::PROTEIN)
    ("Integrin Alpha 5" . SPARSER::PROTEIN)
    ("Cyclin-Dependent Kinase inhibitor 1" . SPARSER::PROTEIN)
    ("RGS1" . SPARSER::PROTEIN)
    ("Regulator of G-protein Signaling 1" . SPARSER::PROTEIN)
    ("SMAD6" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("Transforming Growth Factor-β1" . SPARSER::PROTEIN)
    ("IL1B" . SPARSER::PROTEIN) ("Interleukin 1β" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("anti-IgM" . SPARSER::PROTEIN) ("cytidine deaminase" . SPARSER::PROTEIN)
    ("MAdCAM-1" . SPARSER::PROTEIN)
    ("mucosal vascular addressin cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("Fc Receptor-Like protein 4" . SPARSER::PROTEIN)
    ("CD21" . SPARSER::PROTEIN) ("FcRL4" . SPARSER::PROTEIN)
    ("α 4 β 7" . SPARSER::PROTEIN)
    ("AKT, CDK1, CDK2 and p38" . SPARSER::COLLECTION)
    ("neurotrophic genes" . SPARSER::GENE) ("rod" . SPARSER::PROTEIN)
    ("the profound ataxia" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("a non-phosphorylatable mutant (2SA, which has the S652A, S734A mutations) or a phosphorylation mimic mutant (2SD, which has the S652D, S734D mutations)"
     . SPARSER::COLLECTION)
    ("human wild type EZH2, a non-phosphorylatable mutant (2SA, which has the S652A, S734A mutations) or a phosphorylation mimic mutant (2SD, which has the S652D, S734D mutations)"
     . SPARSER::COLLECTION)
    ("lentiviral shezh2" . SPARSER::PROTEIN) ("calbindin" . SPARSER::PROTEIN)
    ("shezh2" . SPARSER::PROTEIN) ("shezh2-GFP" . SPARSER::PROTEIN-PAIR)
    ("ezh2" . SPARSER::PROTEIN) ("pcna and cyclin" . SPARSER::COLLECTION)
    ("pcna" . SPARSER::PROTEIN) ("neuronal genes" . SPARSER::GENE)
    ("lit1, synj2 and nlgn1" . SPARSER::COLLECTION)
    ("specific neuronal genes" . SPARSER::GENE)
    ("2SA-EZH2" . SPARSER::COLLECTION)
    ("EZH2 and H3K27me3" . SPARSER::COLLECTION)
    ("several neuronal genes" . SPARSER::GENE)
    ("mef2a , cdk5rap2 , slit1, synj2 , and nlgn1" . SPARSER::COLLECTION)
    ("nlgn1" . SPARSER::PROTEIN) ("slit1" . SPARSER::PROTEIN)
    ("cdk5rap2" . SPARSER::PROTEIN)
    ("Purkinje cell protein 2 ( pcp2 – also known as L7) and gamma-amino butyric acid A receptor subunit alpha 6 ( gabra6 )"
     . SPARSER::COLLECTION)
    ("gamma-amino butyric acid A receptor subunit alpha 6" . SPARSER::PROTEIN)
    ("cdkn2a and cdkn2b" . SPARSER::COLLECTION) ("cdkn2b" . SPARSER::PROTEIN)
    ("cdkn2a" . SPARSER::PROTEIN)
    ("Slit1, Synj2 , and Nlgn1" . SPARSER::COLLECTION)
    ("Nlgn1" . SPARSER::PROTEIN) ("Slit1" . SPARSER::PROTEIN)
    ("the phosphomimetic mutant" . SPARSER::MUTANT)
    ("the 2SD phosphomimetic mutant" . SPARSER::MUTANT)
    ("EED and Suz12" . SPARSER::COLLECTION)
    ("the EZH2-2SA mutant (lane 6) or the ATM-KD mutant (lane 3)"
     . SPARSER::COLLECTION)
    ("ATM-KD" . SPARSER::COLLECTION) ("EZH2-2SA" . SPARSER::COLLECTION)
    ("Flag-ATM" . SPARSER::COLLECTION) ("GFP-EZH2" . SPARSER::COLLECTION)
    ("an alternate kinase target" . SPARSER::TARGET-PROTEIN)
    ("GST-EZH2" . SPARSER::COLLECTION)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("EZH2 or EZH1" . SPARSER::COLLECTION)
    ("H3K27me3 and Atm" . SPARSER::COLLECTION) ("both neuronal types" . TYPE)
    ("the PRC2 complex and subsequent H3K27 methylation" . SPARSER::COLLECTION)
    ("This phosphorylation normally de-stabilizes EZH2" . SPARSER::PROTEIN)
    ("developmental cues" . SPARSER::PROTEIN-FAMILY)
    ("CDK2/EZH2" . SPARSER::COLLECTION) ("CDK1/EZH2" . SPARSER::COLLECTION)
    ("H3k27me3" . SPARSER::MOLECULE) ("histone3" . SPARSER::PROTEIN)
    ("β–actin" . SPARSER::PROTEIN) ("Aldolase C" . SPARSER::PROTEIN)
    ("P18" . SPARSER::HUMAN-PROTEIN-FAMILY) ("lit1" . SPARSER::PROTEIN)
    ("synj2" . SPARSER::PROTEIN) ("rap2" . SPARSER::PROTEIN)
    ("cdk5" . SPARSER::PROTEIN) ("mef2a" . SPARSER::PROTEIN)
    ("en2" . SPARSER::PROTEIN) ("en1" . SPARSER::PROTEIN)
    ("gabra6" . SPARSER::PROTEIN) ("alpha 6" . SPARSER::PROTEIN)
    ("butyric acid" . SPARSER::MOLECULE) ("pcp2" . SPARSER::PROTEIN)
    ("Purkinje cell protein 2" . SPARSER::PROTEIN)
    ("cdkn2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Synj2" . SPARSER::PROTEIN)
    ("core protein" . SPARSER::PROTEIN)
    ("glutamine residue" . SPARSER::MOLECULE) ("EZH1" . SPARSER::PROTEIN)
    ("embryonic ectoderm development" . SPARSER::PROTEIN)
    ("A-T mutated" . SPARSER::PROTEIN) ("tip" . SPARSER::PROTEIN)
    ("Imatinib" . SPARSER::DRUG) ("CDK6 and p16 INK4a" . SPARSER::COLLECTION)
    ("STAT3 or the AP-1 member c-JUN" . SPARSER::COLLECTION)
    ("the tumour suppressor p16 INK4a or the angiogenic factor VEGF-A"
     . SPARSER::COLLECTION)
    ("the angiogenic factor VEGF-A" . SPARSER::PROTEIN)
    ("the protein's" . SPARSER::PROTEIN) ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("highly homologue kinases" . SPARSER::KINASE)
    ("HK and JK" . SPARSER::COLLECTION) ("JK" . SPARSER::PROTEIN)
    ("a more potent prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GBA and AA" . SPARSER::COLLECTION) ("GBA" . SPARSER::PROTEIN)
    ("pre- and post-contrast" . SPARSER::COLLECTION)
    ("case and pre-contrast and post-contrast" . SPARSER::COLLECTION)
    ("IDH1 or MGMT" . SPARSER::COLLECTION)
    ("an important prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TP53 and K - Ras" . SPARSER::COLLECTION)
    ("prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AA " . SPARSER::MOLECULE) ("OG" . SPARSER::PROTEIN)
    ("in vivo hypoxic biomarkers" . SPARSER::MOLECULE)
    ("IDH" . SPARSER::PROTEIN)
    ("a hypermethylated MGMT promoter" . SPARSER::PROMOTER)
    ("p53 and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("AO" . SPARSER::PROTEIN)
    ("a more reliable prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AO " . SPARSER::PROTEIN) ("AOs" . SPARSER::PROTEIN)
    ("AAs" . SPARSER::PROTEIN) ("isocitrate" . SPARSER::PROTEIN)
    ("K - Ras" . SPARSER::PROTEIN) ("p36" . SPARSER::PROTEIN)
    ("IDH1" . SPARSER::PROTEIN)
    ("APL and a complex karyotype" . SPARSER::COLLECTION)
    ("gemtuzumab" . SPARSER::DRUG) ("ATRA–chemotherapy" . SPARSER::DRUG)
    ("ATO and ATRA" . SPARSER::COLLECTION)
    ("the leukemic blasts genetically more complex" . SPARSER::BIO-COMPLEX)
    ("ATRA and ATO" . SPARSER::COLLECTION) ("UPD" . SPARSER::PROTEIN)
    ("the pediatric component" . SPARSER::COMPONENT)
    ("short PML–RARA isoform and high initial PML–RARA transcript levels [ xref , xref , xref – xref , xref ]"
     . SPARSER::COLLECTION)
    ("previously reported APL" . SPARSER::PROTEIN)
    ("CN-AML" . SPARSER::COLLECTION) ("-AML" . SPARSER::COLLECTION)
    ("CN" . SPARSER::PROTEIN)
    ("either one ACA or a sole t(15;17)" . SPARSER::COLLECTION)
    ("ATRA" . SPARSER::DRUG) ("CR or ID" . SPARSER::COLLECTION)
    ("the two therapeutic arms" . SPARSER::PROTEIN)
    ("isoform and transcript" . SPARSER::COLLECTION)
    ("previously untreated APL" . SPARSER::PROTEIN)
    ("cytogenetically normal AML" . SPARSER::PROTEIN)
    ("bcr" . SPARSER::PROTEIN)
    ("Acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("previously described adverse prognostic factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type or level" . SPARSER::COLLECTION)
    ("type or transcript" . SPARSER::COLLECTION)
    ("PML–RARA" . SPARSER::COLLECTION)
    ("acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("APL" . SPARSER::PROTEIN) ("ATO" . SPARSER::PROTEIN)
    ("Group B" . SPARSER::PROTEIN) ("arsenic trioxide" . SPARSER::MOLECULE)
    ("knocking-down JAK1 and/or JAK2" . SPARSER::COLLECTION)
    ("TrkA, JAK2, Aurora-A, and Flt4" . SPARSER::COLLECTION)
    ("TrkA" . SPARSER::PROTEIN)
    ("AZD1480 and chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("carboplatin and etoposide" . SPARSER::COLLECTION)
    ("JAK2 and FGFR3" . SPARSER::COLLECTION)
    ("JAK2, JAK3, or TYK2" . SPARSER::COLLECTION)
    ("JAK1, JAK2, and JAK3" . SPARSER::COLLECTION)
    ("cleaved-Caspase 3 and PARP" . SPARSER::COLLECTION)
    ("JAK1 protein as well as phospho-STAT3 protein" . SPARSER::COLLECTION)
    ("GLC4 and NCI-N592" . SPARSER::COLLECTION)
    ("pan-JAKs" . SPARSER::COLLECTION) ("GLC4, and AC3" . SPARSER::COLLECTION)
    ("JAK2 and their downstream molecule STAT3 as well as phospho-STAT3"
     . SPARSER::COLLECTION)
    ("their downstream molecule STAT3 as well as phospho-STAT3"
     . SPARSER::COLLECTION)
    ("the JAK inhibitor AZD1480 and JAK1/2 siRNA inhibition in SCLC"
     . SPARSER::COLLECTION)
    ("Trk-A, JAK1, JAK2, Aurora-A, Flt4, and FGFR1" . SPARSER::COLLECTION)
    ("an ATP binding competitive inhibitor" . SPARSER::INHIBITOR)
    ("nearly all polycythemia vera" . SPARSER::PROTEIN)
    ("vera" . SPARSER::PROTEIN)
    ("JAK1, JAK2, JAK3, and TYK2" . SPARSER::COLLECTION)
    ("Janus kinases (JAKs) and signal transducer" . SPARSER::COLLECTION)
    ("navitoclax (ABT-263) and obatoclax ( xref , xref )"
     . SPARSER::COLLECTION)
    ("obatoclax" . SPARSER::DRUG)
    ("cisplatin and etoposide" . SPARSER::COLLECTION)
    ("JAK2 and JAK1" . SPARSER::COLLECTION) ("Jak1" . SPARSER::PROTEIN)
    ("GLC4" . SPARSER::PROTEIN) ("JAK1 or JAK2" . SPARSER::COLLECTION)
    ("AZD1480 or siRNAs" . SPARSER::COLLECTION)
    ("janus" . SPARSER::PROTEIN-FAMILY) ("janus kinase 1" . SPARSER::PROTEIN)
    ("AC3" . SPARSER::PROTEIN) ("INCB16562" . SPARSER::DRUG)
    ("AC-3" . SPARSER::PROTEIN) ("Flt4" . SPARSER::PROTEIN)
    ("Trk-A" . SPARSER::PROTEIN) ("tyrosine kinase 2" . SPARSER::PROTEIN)
    ("TYK2" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("annexin-V" . SPARSER::PROTEIN) ("Jak2" . SPARSER::PROTEIN)
    ("AZD1480" . SPARSER::DRUG) ("VEGF or HER2" . SPARSER::COLLECTION)
    ("VEGF and HER-2" . SPARSER::COLLECTION)
    ("target VEGF-A or its receptors" . SPARSER::COLLECTION)
    ("a new prognostic factor and a novel therapeutic target [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("p  " . SPARSER::PROTEIN)
    ("which targets VEGF and HER2 gene" . SPARSER::PROTEIN)
    ("EGFR/ErbB" . SPARSER::COLLECTION) ("VEGF and HER2" . SPARSER::COLLECTION)
    ("Anti-VEGF" . SPARSER::DRUG) ("siR3" . SPARSER::PROTEIN)
    ("siR4" . SPARSER::PROTEIN) ("ErbB-2" . SPARSER::PROTEIN)
    ("Vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the increased intranuclear Ca 2+" . SPARSER::CALCIUM-ION)
    ("intranuclear Ca 2+ and depolarization" . SPARSER::COLLECTION)
    ("NFκB or SP1" . SPARSER::COLLECTION) ("the outer NE" . SPARSER::PROTEIN)
    ("Arm" . SPARSER::PROTEIN)
    ("Increase Nucleoplasmic Ca 2+ and Depolarization" . SPARSER::COLLECTION)
    ("Ca 2+ and Depolarization" . SPARSER::COLLECTION)
    ("Wnt5A and Wnt11" . SPARSER::COLLECTION)
    ("Wnt4, Wnt5A, Wnt5B, Wnt6, Wnt7A, and Wnt11" . SPARSER::COLLECTION)
    ("Wnt1, Wnt2, Wnt3, Wnt3A, Wnt8, Wnt8B, and Wnt10B" . SPARSER::COLLECTION)
    ("Wnt8B" . SPARSER::PROTEIN)
    ("β-catenin and other Wnts" . SPARSER::COLLECTION)
    ("β-catenin or calcium" . SPARSER::COLLECTION)
    ("a 15-min" . SPARSER::COLLECTION) ("spikes" . SPARSER::PROTEIN)
    ("cGMP/phosphodiesterase" . SPARSER::COLLECTION)
    ("phosphodiesterase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cGMP" . SPARSER::PROTEIN) ("Wnt5A and Wnt9B" . SPARSER::COLLECTION)
    ("β-catenin and DAPI" . SPARSER::COLLECTION)
    ("Wnt 3A and Wnt4" . SPARSER::COLLECTION)
    ("calcium and membrane" . SPARSER::COLLECTION)
    ("Increased Intranuclear Ca 2+" . SPARSER::CALCIUM-ION)
    ("DT" . SPARSER::PROTEIN) ("DTs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt 9B and Wnt4" . SPARSER::COLLECTION)
    ("Wnt3A and Wnt5A" . SPARSER::COLLECTION)
    ("Thapsigargin" . SPARSER::MOLECULE) ("Cos7" . SPARSER::PROTEIN)
    ("MCF7 and 253J" . SPARSER::COLLECTION)
    ("microsomal Ca 2+ -ATPase" . SPARSER::COLLECTION)
    ("fluorochrome" . SPARSER::MOLECULE)
    ("an increased nucleoplasmic Ca 2+ and depolarization"
     . SPARSER::COLLECTION)
    ("Ca 2+ and depolarization" . SPARSER::COLLECTION)
    ("the nucleoplasmic calcium" . SPARSER::CALCIUM)
    ("an electrical barrier" . SPARSER::PROTEIN) ("mV" . SPARSER::PROTEIN)
    ("nucloeplasmic Ca 2+" . SPARSER::CALCIUM-ION)
    ("nucleoplasmic Ca 2+" . SPARSER::CALCIUM-ION)
    ("the supramolecular nuclear pore complex (NPC)" . SPARSER::BIO-COMPLEX)
    ("complex (NPC)" . SPARSER::BIO-COMPLEX) ("NE" . SPARSER::PROTEIN)
    ("Frizzled or FZDs" . SPARSER::COLLECTION)
    ("FZDs" . SPARSER::PROTEIN-FAMILY)
    ("Ca 2+ and β-catenin pathways" . SPARSER::COLLECTION)
    ("PC3, MCF7, and 253J, prostate, breast, and bladder"
     . SPARSER::COLLECTION)
    ("intranuclear calcium" . SPARSER::CALCIUM)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a live assay using calcium" . SPARSER::CALCIUM)
    ("Ca 2+ and β-catenin" . SPARSER::COLLECTION)
    ("intranuclear Ca 2+" . SPARSER::CALCIUM-ION)
    ("β-catenin and Ca 2+" . SPARSER::COLLECTION) ("Wnt6" . SPARSER::PROTEIN)
    ("Wnt5B" . SPARSER::PROTEIN) ("Wnt10B" . SPARSER::PROTEIN)
    ("Wnt8" . SPARSER::PROTEIN) ("Wnt2" . SPARSER::PROTEIN)
    ("Wnt1" . SPARSER::PROTEIN) ("Wnt 3A" . SPARSER::PROTEIN)
    ("Wnt 10B" . SPARSER::PROTEIN) ("Wnt7A" . SPARSER::PROTEIN)
    ("Wnt4" . SPARSER::PROTEIN) ("PC 3" . SPARSER::PROTEIN)
    ("LRP-6" . SPARSER::PROTEIN) ("Fluo4" . SPARSER::DRUG)
    ("Wnt 11" . SPARSER::PROTEIN) ("Fluo-4" . SPARSER::DRUG)
    ("GTPase Ran" . SPARSER::PROTEIN) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("Wnt5A" . SPARSER::PROTEIN) ("Wnt 5A" . SPARSER::PROTEIN)
    ("JNK/C-JUN" . SPARSER::COLLECTION)
    ("C-MYC and BCL-2" . SPARSER::COLLECTION)
    ("miR-184-regulated genes" . SPARSER::GENE)
    ("C-MYC, CCND1, pRb and E2F1, and transcription factor"
     . SPARSER::COLLECTION)
    ("E2F1, and transcription factor" . SPARSER::COLLECTION)
    ("PI3K or specific siRNA" . SPARSER::COLLECTION)
    ("first used small-interfering RNAs" . SPARSER::RNA)
    ("PI3K/AKT/JNK/C-JUN" . SPARSER::COLLECTION)
    ("BCL2 and miR-184" . SPARSER::COLLECTION) ("CDS" . SPARSER::PROTEIN)
    ("pRB, C-MYC, CCND1 and E2F1" . SPARSER::COLLECTION)
    ("p15 and CDK4" . SPARSER::COLLECTION)
    ("CDK4, p15 and p27" . SPARSER::COLLECTION)
    ("C-MYC, CCND1 and E2F1" . SPARSER::COLLECTION)
    ("phos-AKT" . SPARSER::COLLECTION) ("phos-PI3K" . SPARSER::COLLECTION)
    ("phos" . SPARSER::PROTEIN) ("AKT and JNK" . SPARSER::COLLECTION)
    ("a poor independent prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N2–N3" . SPARSER::COLLECTION) ("NPCs" . SPARSER::MOLECULE)
    ("viral, dietary and genetic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a new tumor suppressor gene" . SPARSER::PROTEIN)
    ("eIF4GI and eIF4GII" . SPARSER::COLLECTION) ("eIF4GII" . SPARSER::PROTEIN)
    ("eIF4GI" . SPARSER::PROTEIN) ("JNK/C-Jun" . SPARSER::COLLECTION)
    ("PI3K/AKT/JNK/C-Jun" . SPARSER::COLLECTION)
    ("a tumor-suppressive miRNA" . SPARSER::MICRO-RNA)
    ("BCL2 and C-MYC" . SPARSER::COLLECTION) ("ARF5" . SPARSER::PROTEIN)
    ("pPI3K" . SPARSER::PROTEIN-FAMILY) ("CNE1" . SPARSER::PROTEIN)
    ("CASP9" . SPARSER::PROTEIN) ("Smad/p53" . SPARSER::COLLECTION)
    ("p53 or mutant" . SPARSER::COLLECTION)
    ("TGF-β/Smad" . SPARSER::COLLECTION) ("Smad/N-CoR" . SPARSER::COLLECTION)
    ("neither p53 nor Smads" . SPARSER::COLLECTION)
    ("p53, TGF-β RI, TGF-β
RII and TGF-β"
     . SPARSER::COLLECTION)
    ("RIII" . SPARSER::PROTEIN)
    ("GSE10972, GSE4183, GSE8671, GSE10072, GSE4115 and GSE7670"
     . SPARSER::COLLECTION)
    ("expressing Smad4" . SPARSER::PROTEIN)
    ("REGγ
and mutant"
     . SPARSER::COLLECTION)
    ("REGγ and mutant" . SPARSER::COLLECTION)
    ("ETO and
TGF-β"
     . SPARSER::COLLECTION)
    ("ETO and Adriamycin" . SPARSER::COLLECTION)
    ("p53, TGF-β and
mutant"
     . SPARSER::COLLECTION)
    ("SHR" . SPARSER::PROTEIN)
    ("p53 or
hotspot"
     . SPARSER::COLLECTION)
    ("TGF-β and mutant" . SPARSER::COLLECTION) ("ARO" . SPARSER::PROTEIN)
    ("naturally occurring mutant p53" . SPARSER::PROTEIN)
    ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("REGγ-Luc" . SPARSER::COLLECTION)
    ("REGγ-luciferase" . SPARSER::COLLECTION)
    ("p53 and Smads" . SPARSER::COLLECTION)
    ("Smad3/p53/N-CoR" . SPARSER::COLLECTION) ("2 and" . SPARSER::PROTEIN)
    ("Smad3, p53 and N-CoR" . SPARSER::COLLECTION)
    ("p53 and Smad" . SPARSER::COLLECTION) ("p53/Smad3" . SPARSER::COLLECTION)
    ("TGF-β or Nutlin-3" . SPARSER::COLLECTION)
    ("p53 and
Smad3/4"
     . SPARSER::COLLECTION)
    ("p53 or Smad3/4" . SPARSER::COLLECTION)
    ("p53
or Smad3/4"
     . SPARSER::COLLECTION)
    ("p53RE/SBE-luc" . SPARSER::COLLECTION)
    ("Smad2 and
Smad3"
     . SPARSER::COLLECTION)
    ("p53 and Smad3" . SPARSER::COLLECTION)
    ("cellular Smads" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potentially functional SBE" . SPARSER::PROTEIN)
    ("Smad3 and Smad4" . SPARSER::COLLECTION)
    ("p53 and REGγ" . SPARSER::COLLECTION)
    ("p53 and mSIN3A-HDAC1 co-repressor complex" . SPARSER::COLLECTION)
    ("mSIN3A-HDAC1" . SPARSER::COLLECTION)
    ("Nutlin-3,
cisplatin and etoposide"
     . SPARSER::COLLECTION)
    ("short interfering RNA" . SPARSER::RNA)
    ("p53RE-2 and" . SPARSER::PROTEIN-PAIR) ("REGγ-luc" . SPARSER::COLLECTION)
    ("a new GOF" . SPARSER::PROTEIN) ("p53/REGγ" . SPARSER::COLLECTION)
    ("p53 and TGF-β" . SPARSER::COLLECTION)
    ("Smad3 and
p53"
     . SPARSER::COLLECTION)
    ("large transcriptional competent complexes" . SPARSER::BIO-COMPLEX)
    ("subsequent loss of heterozygosity" . SPARSER::PROTEIN)
    ("heteromeric
Smad"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type I and type II" . SPARSER::COLLECTION)
    ("a ubiquitously expressed pleiotropic
cytokine"
     . SPARSER::PROTEIN)
    ("a sequence-specific transcription
factor"
     . SPARSER::PROTEIN)
    ("the REG or 11S family" . SPARSER::COLLECTION) ("REG" . SPARSER::PROTEIN)
    ("Ali" . SPARSER::PROTEIN) ("REGγ/p53" . SPARSER::COLLECTION)
    ("p53/Smad" . SPARSER::COLLECTION) ("Smad3/N-CoR" . SPARSER::COLLECTION)
    ("Smad3 and p53" . SPARSER::COLLECTION) ("p53RE/SBE" . SPARSER::COLLECTION)
    ("SBE" . SPARSER::PROTEIN) ("p53/TGF-β" . SPARSER::COLLECTION)
    ("p53/p21/p16" . SPARSER::COLLECTION)
    ("Triton
X-100"
     . SPARSER::MOLECULE)
    ("S18" . SPARSER::PROTEIN)
    ("Nonidet
P-40"
     . SPARSER::DRUG)
    ("and
1 "
     . SPARSER::PROTEIN)
    ("Nutlin-3a" . SPARSER::DRUG) ("mSin3a" . SPARSER::PROTEIN)
    ("smad3" . SPARSER::PROTEIN) ("pRK5" . SPARSER::PROTEIN)
    ("R-smad" . SPARSER::PROTEIN-FAMILY) ("ID4" . SPARSER::PROTEIN)
    ("GRO-1" . SPARSER::PROTEIN)
    ("Reverse
transcriptase"
     . SPARSER::PROTEIN)
    ("mSIN3A" . SPARSER::PROTEIN)
    ("Nuclear receptor corepressor" . SPARSER::PROTEIN)
    ("transcription
factor"
     . SPARSER::PROTEIN)
    ("PSME3" . SPARSER::PROTEIN) ("PA28γ" . SPARSER::PROTEIN)
    ("REGγ" . SPARSER::PROTEIN)
    ("Transactive response DNA binding protein 43 kDa" . SPARSER::PROTEIN)
    ("3-phosphoinositide-dependent kinase-1" . SPARSER::PROTEIN)
    ("FUS" . SPARSER::PROTEIN) ("sporadic human ALS" . SPARSER::PROTEIN)
    ("IGF-1 or VEGF" . SPARSER::COLLECTION)
    ("effectors, S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("PP2A [ xref ] and PHLPP1 (or PHLPP2)" . SPARSER::COLLECTION)
    ("PDK-1 and PDK-2" . SPARSER::COLLECTION)
    ("KCTD20 or BTBD10" . SPARSER::COLLECTION)
    ("a novel putative Akt or PP2A-interacting protein" . SPARSER::COLLECTION)
    ("KCTD20 and BTBD10" . SPARSER::COLLECTION)
    ("BTBD10 as well as KCTD20 (Figure  xref A)" . SPARSER::COLLECTION)
    ("BTBD10 or KCTD20" . SPARSER::COLLECTION)
    ("PP1A, and PP2A" . SPARSER::COLLECTION)
    ("PP1A and PP2A" . SPARSER::COLLECTION)
    ("GST-pulldown" . SPARSER::PROTEIN-PAIR)
    ("Akt or a catalytic subunit" . SPARSER::COLLECTION)
    ("BTBD10 and KCTD20" . SPARSER::COLLECTION)
    ("475-amino-acid human BTBD10" . SPARSER::PROTEIN)
    ("419-amino-acid human KCTD20" . SPARSER::PROTEIN)
    ("Akt and PP2A" . SPARSER::COLLECTION)
    ("a unique Akt activator" . SPARSER::ACTIVATOR) ("ALS" . SPARSER::PROTEIN)
    ("the secondary messengers phosphatidylinositol-3, 4-bisphosphate and phosphatidylinositol-3,4,5-trisphosphate"
     . SPARSER::COLLECTION)
    ("phosphatidylinositol-3, 4-bisphosphate and phosphatidylinositol-3,4,5-trisphosphate"
     . SPARSER::COLLECTION)
    ("KCTD20 as well as BTBD10" . SPARSER::COLLECTION)
    ("A 419-amino-acid BTBD10-like protein" . SPARSER::PROTEIN)
    ("Akt and protein phosphatase 2A" . SPARSER::COLLECTION)
    ("Superoxide dismutase 1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("Protein phosphatase 2A" . SPARSER::PROTEIN)
    ("Protein phosphatase 1A" . SPARSER::PROTEIN)
    ("Potassium channel" . SPARSER::PROTEIN) ("CSTP1" . SPARSER::PROTEIN)
    ("PHLPP1" . SPARSER::PROTEIN) ("PP1A" . SPARSER::PROTEIN)
    ("Akt 1" . SPARSER::PROTEIN) ("BLAST2" . SPARSER::PROTEIN)
    ("TDP-43" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN) ("PDK-2" . SPARSER::PROTEIN)
    ("PDK-1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KCTD20" . SPARSER::PROTEIN) ("BTBD10" . SPARSER::PROTEIN)
    ("MSI, PIK3CA, and BRAF" . SPARSER::COLLECTION)
    ("cetuximab or bevacizumab" . SPARSER::COLLECTION)
    ("PTEN, PIK3CA , KRAS , NRAS, and BRAF" . SPARSER::COLLECTION)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("PIK3CA or RAS /" . SPARSER::COLLECTION)
    ("PI3K or MAPK" . SPARSER::COLLECTION)
    ("PIK3CA , KRAS , NRAS , and BRAF" . SPARSER::COLLECTION)
    ("hereditary nonpolyposis CRC" . SPARSER::PROTEIN)
    ("PIK3CA or KRAS" . SPARSER::COLLECTION)
    ("KRAS , NRAS or BRAF" . SPARSER::COLLECTION)
    ("PIK3CA , KRAS , NRAS, and BRAF" . SPARSER::COLLECTION)
    ("PNA" . SPARSER::PROTEIN)
    ("PIK3CA or KRAS/NRAS/BRAF" . SPARSER::COLLECTION)
    ("KRAS/NRAS/BRAF" . SPARSER::COLLECTION)
    ("uninterpretable PTEN" . SPARSER::PROTEIN)
    ("discordant PTEN" . SPARSER::PROTEIN)
    ("uninterpretable or equivocal PTEN" . SPARSER::PROTEIN)
    ("EGFR-targeted monoclonal antibodies" . SPARSER::ANTIBODY)
    ("PI3K-p110β" . SPARSER::COLLECTION)
    ("KRAS , BRAF, and PIK3CA" . SPARSER::COLLECTION)
    ("EGFR-directed monoclonal antibodies" . SPARSER::ANTIBODY)
    ("HR " . SPARSER::PROTEIN) ("RAS or PI3K" . SPARSER::COLLECTION)
    ("RAS and PI3K" . SPARSER::COLLECTION)
    ("KRAS , NRAS , BRAF  , and PIK3CA" . SPARSER::COLLECTION)
    ("S1B" . SPARSER::PROTEIN) ("BubR1 or Mad2" . SPARSER::COLLECTION)
    ("p16Ink4a–Rb" . SPARSER::COLLECTION)
    ("Insufficient BubR1" . SPARSER::PROTEIN)
    ("Bub3 and CDC20" . SPARSER::COLLECTION)
    ("BubR1 and DNA" . SPARSER::COLLECTION) ("p53/BubR1" . SPARSER::COLLECTION)
    ("the essential factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and BubR1" . SPARSER::COLLECTION)
    ("p53 and/or BubR1 siRNA" . SPARSER::COLLECTION)
    ("p53-mutant and p53-null" . SPARSER::COLLECTION)
    ("N -acetylcysteine (NAC)" . SPARSER::DRUG)
    ("G1–S or G2–M" . SPARSER::COLLECTION) ("aberrant SAC" . SPARSER::PROTEIN)
    ("securin and cyclin" . SPARSER::COLLECTION) ("von" . SPARSER::PROTEIN)
    ("BubR1 and Mad2" . SPARSER::COLLECTION) ("Mad2" . SPARSER::PROTEIN)
    ("factors, BubR1, and Mad2" . SPARSER::COLLECTION)
    ("p16Ink4a" . SPARSER::PROTEIN) ("aurora-A" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("N -acetylcysteine" . SPARSER::DRUG)
    ("MAD2L1" . SPARSER::PROTEIN) ("HOTAIR/p21" . SPARSER::COLLECTION)
    ("Cao and colleagues" . SPARSER::COLLECTION)
    ("EZH2-siRNA" . SPARSER::COLLECTION)
    ("p21WAF1 adenoviral gene" . SPARSER::GENE)
    ("EZH2 and SUZ12" . SPARSER::COLLECTION)
    ("the PRC2 and LSD1/CoREST/REST" . SPARSER::COLLECTION)
    ("PRC2 or LSD1/CoREST/REST" . SPARSER::COLLECTION)
    ("LSD1/CoREST/REST" . SPARSER::COLLECTION) ("REST" . SPARSER::PROTEIN)
    ("XIST and HOTAIR" . SPARSER::COLLECTION) ("XIST" . SPARSER::PROTEIN)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CR" . SPARSER::PROTEIN)
    ("HOTAIR and p21" . SPARSER::COLLECTION)
    ("HOTAIR-p21" . SPARSER::COLLECTION)
    ("HOTAIR and p21 protein" . SPARSER::COLLECTION)
    ("siRNA/HOTAIR" . SPARSER::COLLECTION) ("SPCA" . SPARSER::PROTEIN)
    ("EZH2 and H3K27me3" . SPARSER::COLLECTION)
    ("EZH2, SUZ12, and EED" . SPARSER::COLLECTION)
    ("siRNA/HOTAIR2" . SPARSER::COLLECTION)
    ("the few biologically well-documented lncRNAs" . SPARSER::RNA)
    ("employed first-line" . SPARSER::PROTEIN)
    ("the most common histologic type" . TYPE)
    ("pcDNA/p21" . SPARSER::COLLECTION) ("pcDNA/HOTAIR" . SPARSER::COLLECTION)
    ("siRNA/p21" . SPARSER::COLLECTION) ("DDP" . SPARSER::PROTEIN)
    ("HOTAIR " . SPARSER::PROTEIN) ("EZH2 " . SPARSER::PROTEIN)
    ("G 2 /M" . SPARSER::PROTEIN) ("CIP1" . SPARSER::PROTEIN)
    ("Polycomb Repressive Complex 2" . SPARSER::PROTEIN)
    ("LCK-FOXP3" . SPARSER::COLLECTION)
    ("NF-κB as well as FOXP3" . SPARSER::COLLECTION)
    ("NF-κB and SP1" . SPARSER::COLLECTION)
    ("LCK as well as FOXP3" . SPARSER::COLLECTION)
    ("SKP2 , VEGF-A , and MMP9" . SPARSER::COLLECTION)
    ("SKP2 and VEGF-A" . SPARSER::COLLECTION)
    ("uPA and MMP9" . SPARSER::COLLECTION)
    ("each tyrosine of FOXP3" . SPARSER::PROTEIN)
    ("PP2 or emodin" . SPARSER::COLLECTION) ("emodin" . SPARSER::DRUG)
    ("antibodies, PY-20 and 4G10" . SPARSER::COLLECTION)
    ("FOXP3 and LCK" . SPARSER::COLLECTION) ("MBP-FOXP3" . SPARSER::COLLECTION)
    ("FKH" . SPARSER::PROTEIN)
    ("zinc finger and forkhead" . SPARSER::COLLECTION)
    ("LCK and the protein tyrosine kinase syk" . SPARSER::COLLECTION)
    ("syk" . SPARSER::PROTEIN)
    ("S-phase kinase-associated protein 2" . SPARSER::PROTEIN)
    ("HER-2/ErbB2" . SPARSER::COLLECTION)
    ("normal epithelia" . SPARSER::PROTEIN)
    ("the causative gene" . SPARSER::GENE) ("IPEX" . SPARSER::PROTEIN)
    ("forkhead/winged-helix" . SPARSER::PROTEIN-PAIR)
    ("MMP9, SKP2, and VEGF-A" . SPARSER::COLLECTION)
    ("MMP9 , SKP2 , and VEGF-A" . SPARSER::COLLECTION)
    ("tyrosine kinase (LCK)" . SPARSER::PROTEIN) ("MMP 9" . SPARSER::PROTEIN)
    ("C 2 H 2" . SPARSER::MOLECULE)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("interleukin 4" . SPARSER::PROTEIN) ("Forkhead box P3" . SPARSER::PROTEIN)
    ("Forkhead box" . SPARSER::PROTEIN) ("Forkhead Box P3" . SPARSER::PROTEIN)
    ("longer period" . SPARSER::PROTEIN) ("Map" . SPARSER::PROTEIN)
    ("apex" . SPARSER::PROTEIN) ("allele or genotype" . SPARSER::COLLECTION)
    ("severe forms" . SPARSER::FORM) ("GT " . SPARSER::PROTEIN)
    ("AC " . SPARSER::PROTEIN) ("GC " . SPARSER::PROTEIN)
    ("AT " . SPARSER::PROTEIN) ("CC " . SPARSER::PROTEIN)
    ("TC " . SPARSER::PROTEIN) ("TT " . SPARSER::PROTEIN)
    ("GG " . SPARSER::PROTEIN) ("AG " . SPARSER::PROTEIN)
    ("AA " . SPARSER::MOLECULE) ("Cobb" . SPARSER::PROTEIN)
    ("2-L" . SPARSER::PROTEIN) ("ESR2" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("factors/cytokines" . SPARSER::COLLECTION) ("APRIL" . SPARSER::PROTEIN)
    ("myeloid and tumor-lymphoid" . SPARSER::COLLECTION)
    ("STAT5 and its targets genes" . SPARSER::COLLECTION)
    ("SWI/SNF" . SPARSER::COLLECTION) ("SWI" . SPARSER::PROTEIN)
    ("PHD" . SPARSER::PROTEIN)
    ("STATs and other transcription factor target genes" . SPARSER::COLLECTION)
    ("AML and CML" . SPARSER::COLLECTION)
    ("STAT5 and its target genes" . SPARSER::COLLECTION)
    ("STAT5a or STAT5b" . SPARSER::COLLECTION)
    ("the DPF3 gene and/or protein" . SPARSER::COLLECTION)
    ("BAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the respective ChIP DNAs" . SPARSER::DNA)
    ("ChIPs and ChIP" . SPARSER::COLLECTION) ("BirA" . SPARSER::PROTEIN)
    ("/STAT5" . SPARSER::COLLECTION) ("Stat5a or Stat5b" . SPARSER::COLLECTION)
    ("prolactin" . SPARSER::PROTEIN)
    ("at least 90% homology" . SPARSER::PROTEIN)
    ("proteins, STAT5a and STAT5b" . SPARSER::COLLECTION)
    ("cytokine, growth factor or hormone" . SPARSER::COLLECTION)
    ("STAT5a and STAT5b" . SPARSER::COLLECTION) ("STAT5a" . SPARSER::PROTEIN)
    ("Stat5a and Stat5b" . SPARSER::COLLECTION) ("Stat5a" . SPARSER::PROTEIN)
    ("EF1" . SPARSER::PROTEIN) ("growth hormone" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("STAT4" . SPARSER::PROTEIN)
    ("STAT2" . SPARSER::PROTEIN) ("DPF3" . SPARSER::PROTEIN)
    ("STAT5b" . SPARSER::PROTEIN) ("Dpf3" . SPARSER::PROTEIN)
    ("Stat5b" . SPARSER::PROTEIN) ("Stat5" . SPARSER::PROTEIN)
    ("DDAH2 and DUSP1 and protein" . SPARSER::COLLECTION)
    ("DUSP1 and protein" . SPARSER::COLLECTION)
    ("the dual specificity protein phosphatase enzyme" . SPARSER::PROTEIN)
    ("the potential epigenetic biomarkers" . SPARSER::MOLECULE)
    ("a separate cohort" . SPARSER::MOLECULE)
    ("p16 and DUSP1" . SPARSER::COLLECTION)
    ("gene and genes" . SPARSER::COLLECTION)
    ("12 (30%) tongue and 1 (2.5%) lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DUSP1 and DDAH2" . SPARSER::COLLECTION)
    ("p16, DDAH2, and DUSP1" . SPARSER::COLLECTION)
    ("p16, DUSP1 and DDAH2" . SPARSER::COLLECTION)
    ("DDAH2 (P = 3.72E-01) and DUSP1 (P = 1.669e-7)" . SPARSER::COLLECTION)
    ("heat-map" . SPARSER::PROTEIN)
    ("33 promoter-associated hypermethylated genes" . SPARSER::GENE)
    ("one methylated cytosine" . SPARSER::NUCLEOBASE)
    ("Dual Specificity Phosphatase 1 (DUSP1) and Dimethylarginine Dimethylamino hydrolase (DDAH2) genes"
     . SPARSER::COLLECTION)
    ("hydrolase" . SPARSER::PROTEIN) ("Dimethylarginine" . SPARSER::DRUG)
    ("a gene-specific prognostic or diagnostic biomarker" . SPARSER::MOLECULE)
    ("DAPK1, RAR β , E-CADHERIN, CYCLIN A1, p14, p15, p73, RASSF1A, and APC"
     . SPARSER::COLLECTION)
    ("gene's" . SPARSER::GENE)
    ("RARβ, CDH13, MGMT and GSTP1" . SPARSER::COLLECTION)
    ("The major etiological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epigenetic biomarkers" . SPARSER::MOLECULE)
    ("molecular epigenetic biomarkers" . SPARSER::MOLECULE)
    ("diagnostic, prognostic and therapeutic targets"
     . SPARSER::TARGET-PROTEIN)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DDAH2 and DUSP1" . SPARSER::COLLECTION)
    ("p16, DDAH2 and DUSP1" . SPARSER::COLLECTION)
    ("differentially hypermethylated genes" . SPARSER::GENE)
    ("ERK-2" . SPARSER::PROTEIN)
    ("Dual Specificity Phosphatase 1" . SPARSER::PROTEIN)
    ("CYCLIN A1" . SPARSER::PROTEIN) ("E-CADHERIN" . SPARSER::PROTEIN)
    ("RAR β" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA methyltransferase 1" . SPARSER::PROTEIN) ("RARβ" . SPARSER::PROTEIN)
    ("DUSP1" . SPARSER::PROTEIN) ("DDAH2" . SPARSER::PROTEIN)
    ("the precise factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a potent prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-phosphoinositide-dependent kinase (PDK)" . SPARSER::KINASE)
    ("PI3K-protein kinase B" . SPARSER::COLLECTION)
    ("DJ-1/PTEN" . SPARSER::COLLECTION) ("SRC/ERK" . SPARSER::COLLECTION)
    ("pT3-pT4" . SPARSER::COLLECTION)
    ("interfering RNA (siRNA) targets DJ-1" . SPARSER::PROTEIN)
    ("p53-Bax-caspase" . SPARSER::COLLECTION)
    ("Akt/PI3K" . SPARSER::COLLECTION) ("DJ-1 or PTEN" . SPARSER::COLLECTION)
    ("the primary GCs" . SPARSER::PROTEIN)
    ("-protein kinase B" . SPARSER::COLLECTION) ("chemo-" . SPARSER::PROTEIN)
    ("an independent predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("strong independent prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DJ-1 and phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("DJ-1 and PTEN" . SPARSER::COLLECTION) ("pT4" . SPARSER::PROTEIN)
    ("pT3" . SPARSER::PROTEIN)
    ("vital metabolic enzymes or transporters" . SPARSER::COLLECTION)
    ("enzymes or transporters" . SPARSER::COLLECTION)
    ("TRAF6 ( xref ) and TRAF2 ( xref )" . SPARSER::COLLECTION)
    ("EGFR or ERK1/2" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK-ERKs" . SPARSER::COLLECTION)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GITR" . SPARSER::PROTEIN)
    ("TRAFc" . SPARSER::PROTEIN) ("TRAF4-TRAFc" . SPARSER::PROTEIN-PAIR)
    ("TRAF2 and TRAF6" . SPARSER::COLLECTION)
    ("TRAF4 and Akt" . SPARSER::COLLECTION)
    ("Flag-TRAF4-DM-TRAF" . SPARSER::COLLECTION)
    ("Akt1 and TRAF4" . SPARSER::COLLECTION) ("HA-Akt1" . SPARSER::COLLECTION)
    ("Flag-TRAF4" . SPARSER::COLLECTION)
    ("TRAF4 and Akt1" . SPARSER::COLLECTION)
    ("TRAF4, Skp2 and Akt" . SPARSER::COLLECTION)
    ("Skp2 or TRAF4" . SPARSER::COLLECTION)
    ("TRAF6 and Skp2" . SPARSER::COLLECTION) ("sh-TRAF4" . SPARSER::COLLECTION)
    ("TRAFs" . SPARSER::PROTEIN) ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("TRAF6 or Skp2" . SPARSER::COLLECTION)
    ("IGF-1 or ErbB" . SPARSER::COLLECTION)
    ("insulin and EGF, and Akt" . SPARSER::COLLECTION)
    ("EGF, and Akt" . SPARSER::COLLECTION)
    ("Glut1 and HK2" . SPARSER::COLLECTION)
    ("the pivotal cell survival kinase Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hexokinase 2" . SPARSER::PROTEIN) ("NOD2" . SPARSER::PROTEIN)
    ("MEKK4" . SPARSER::PROTEIN) ("RasG12V" . SPARSER::PROTEIN)
    ("creatine kinase" . SPARSER::PROTEIN) ("UbcH5A" . SPARSER::PROTEIN)
    ("Ubc13" . SPARSER::PROTEIN) ("PMD2" . SPARSER::MOLECULE)
    ("TRAF4" . SPARSER::PROTEIN) ("exonuclease" . SPARSER::PROTEIN)
    ("POLE" . SPARSER::PROTEIN) ("HLA-ABC" . SPARSER::COLLECTION)
    ("SH2" . SPARSER::PROTEIN) ("LMP2- and TAP1" . SPARSER::COLLECTION)
    ("the exogenous JAK1" . SPARSER::PROTEIN)
    ("LMP2- or TAP1-promoter" . SPARSER::COLLECTION)
    ("LMP2 and TAP1-promoter" . SPARSER::COLLECTION)
    ("p27 and p21" . SPARSER::COLLECTION)
    ("LMP2- and TAP1-promoter" . SPARSER::COLLECTION)
    ("LMP2-" . SPARSER::PROTEIN)
    ("a shared bidirectional promoter" . SPARSER::PROMOTER)
    ("IRF1, LMP2, and TAP1" . SPARSER::COLLECTION) ("delC" . SPARSER::PROTEIN)
    ("JAK2 and STAT1" . SPARSER::COLLECTION) ("BAM" . SPARSER::PROTEIN)
    ("laboratory-generated JAK1 mutants" . SPARSER::MUTANT)
    ("LMP2/TAP1" . SPARSER::COLLECTION)
    ("methylcholanthrene" . SPARSER::MOLECULE)
    ("proteosome and transporter" . SPARSER::COLLECTION)
    ("secondary response genes" . SPARSER::GENE)
    ("the receptor-associated JAK1/JAK2" . SPARSER::COLLECTION)
    ("JAK1/JAK2" . SPARSER::COLLECTION) ("Ruxolitinib" . SPARSER::DRUG)
    ("JAK1 and JAK2" . SPARSER::COLLECTION)
    ("constitutively active PTKs and/or PTKs" . SPARSER::COLLECTION)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("recurrent JAK1" . SPARSER::PROTEIN)
    ("LMP2 and TAP1" . SPARSER::COLLECTION) ("PTK" . SPARSER::PROTEIN)
    ("βgal" . SPARSER::PROTEIN) ("P286" . SPARSER::PROTEIN)
    ("MHC class I antigen" . SPARSER::PROTEIN) ("IRF1" . SPARSER::PROTEIN)
    ("BCR-ABL fusion gene" . SPARSER::PROTEIN) ("TAP1" . SPARSER::PROTEIN)
    ("LMP2" . SPARSER::PROTEIN)
    ("both BRAF V600E and MEK1/2" . SPARSER::COLLECTION)
    ("MEK1/2 or PI3" . SPARSER::COLLECTION)
    ("ECD or aggressive forms" . SPARSER::COLLECTION)
    ("aggressive forms" . SPARSER::FORM) ("HGF/c-MET" . SPARSER::COLLECTION)
    ("RAF or MEK" . SPARSER::COLLECTION)
    ("classic murine MPN" . SPARSER::PROTEIN) ("MPNs" . SPARSER::PROTEIN)
    ("Mutationally activated BRAF V600E and KRAS G12D oncoproteins"
     . SPARSER::COLLECTION)
    ("PLX470 and PI-103" . SPARSER::COLLECTION)
    ("media (CM)" . SPARSER::PROTEIN) ("AKT and CRAF" . SPARSER::COLLECTION)
    ("MEK and RAF" . SPARSER::COLLECTION)
    ("EPO (4U/ml) and TPO (100ng/ml)" . SPARSER::COLLECTION)
    ("cytokines, IL-3 (10ng/ml), SCF (50ng/ml), EPO (4U/ml) and TPO (100ng/ml)"
     . SPARSER::COLLECTION)
    ("TPO" . SPARSER::PROTEIN) ("IL-3 or GM-CSF" . SPARSER::COLLECTION)
    ("the sole supplemental cytokine" . SPARSER::PROTEIN)
    ("SCF and EPO" . SPARSER::COLLECTION) ("/Gr1" . SPARSER::COLLECTION)
    ("myeloid and erythroid" . SPARSER::COLLECTION)
    ("normal BRAF" . SPARSER::PROTEIN) ("-kinase" . SPARSER::KINASE)
    ("Braf" . SPARSER::PROTEIN)
    ("HCL ( xref ) or ECD/LCH ( xref )" . SPARSER::COLLECTION)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("GEM" . SPARSER::PROTEIN) ("HCL" . SPARSER::PROTEIN)
    ("therapy-related acute monocytic leukemia" . SPARSER::PROTEIN)
    ("RAF and PI3K" . SPARSER::COLLECTION)
    ("a driver oncoprotein and pharmacological target" . SPARSER::COLLECTION)
    ("PLX-4720" . SPARSER::DRUG)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN) ("PLX470" . SPARSER::DRUG)
    ("S100" . SPARSER::PROTEIN) ("CD71" . SPARSER::PROTEIN)
    ("Gr1" . SPARSER::PROTEIN) ("Rag2" . SPARSER::PROTEIN)
    ("poly I:C" . SPARSER::MOLECULE)
    ("interferon-inducible" . SPARSER::PROTEIN)
    ("small-molecule inhibitors ( xref ) or ribozymes" . SPARSER::COLLECTION)
    ("ribozymes" . SPARSER::RNA) ("polymers" . SPARSER::MOLECULE)
    ("AURKA, Plk1, and CDC25" . SPARSER::COLLECTION)
    ("stathmin/Plk1" . SPARSER::COLLECTION)
    ("Stathmin-CFP" . SPARSER::COLLECTION)
    ("stathmin-CFP" . SPARSER::COLLECTION)
    ("stathmin-GFP" . SPARSER::COLLECTION)
    ("exogenously expressed stathmin" . SPARSER::PROTEIN)
    ("expressed stathmin" . SPARSER::PROTEIN)
    ("stathmin–cyan" . SPARSER::PROTEIN-PAIR)
    ("stathmin–green fluorescent protein" . SPARSER::COLLECTION)
    ("either enzyme's" . SPARSER::PROTEIN)
    ("Plk1 and γ-tubulin" . SPARSER::COLLECTION) ("Nocodazole" . SPARSER::DRUG)
    ("AURKA or the active enzyme" . SPARSER::COLLECTION)
    ("AURKA or active" . SPARSER::COLLECTION)
    ("stathmin and these enzymes" . SPARSER::COLLECTION)
    ("the next 14 h" . SPARSER::PROTEIN)
    ("AURKA or Plk1" . SPARSER::COLLECTION)
    ("the residual 50% active AURKA" . SPARSER::PROTEIN)
    ("viral protein E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stathmin and p53" . SPARSER::COLLECTION)
    ("Plk1 and CDC25" . SPARSER::COLLECTION)
    ("AURKA and Plk1" . SPARSER::COLLECTION)
    ("tubulin dimers and/or MTs" . SPARSER::COLLECTION)
    ("kinase (AURKA)" . SPARSER::KINASE) ("mitotic enzymes" . SPARSER::ENZYME)
    ("Plk1 and Aurora A" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase (CDKs) and other protein kinases"
     . SPARSER::COLLECTION)
    ("p53 and stathmin" . SPARSER::COLLECTION)
    ("target MT accessory proteins" . SPARSER::PROTEIN)
    ("stathmin–cyan fluorescent protein" . SPARSER::PROTEIN)
    ("CDC25 and its upstream activators" . SPARSER::COLLECTION)
    ("Aurora A and Plk1" . SPARSER::COLLECTION)
    ("Aurora kinase A and Polo-like kinase 1" . SPARSER::COLLECTION)
    ("d -1" . SPARSER::PROTEIN) ("MAP4" . SPARSER::PROTEIN)
    ("G protein–coupled receptor kinase 5" . SPARSER::PROTEIN)
    ("S16" . SPARSER::PROTEIN) ("s 5" . SPARSER::MOLECULE)
    ("BI 2536" . SPARSER::DRUG) ("Wee 1" . SPARSER::PROTEIN)
    ("CDC25 B" . SPARSER::PROTEIN) ("T160" . SPARSER::PROTEIN)
    ("CAK1" . SPARSER::PROTEIN) ("B/CDK1" . SPARSER::PROTEIN)
    ("Polo-like kinase 1" . SPARSER::PROTEIN) ("dR" . SPARSER::MOLECULE)
    ("U937/TDAG8 and H1299/TDAG8" . SPARSER::COLLECTION)
    ("GGCCGCCTACTCAAGGACCTCTAATTCCAT-3" . SPARSER::COLLECTION)
    ("-ATAAGAATGAATTCACCATGAACAGCACATGTATTGAAGAA-3" . SPARSER::COLLECTION)
    ("TDAG8 and β-Actin" . SPARSER::COLLECTION)
    ("GAPDH (catalog # Hs99999905_m1) and 18S rRNA (catalog # Hs99999901_s1)"
     . SPARSER::COLLECTION)
    ("c-Myc (catalog # Hs00153408_m1), TDAG8 (catalog # Hs00269247_s1), GAPDH (catalog # Hs99999905_m1) and 18S rRNA (catalog # Hs99999901_s1)"
     . SPARSER::COLLECTION)
    ("-AGGTCCAGACGCAGGATG-3" . SPARSER::COLLECTION)
    ("-TGACCCAGATCATGTTTGAGA-3" . SPARSER::COLLECTION)
    ("-AATGCAGCGAATCAGCAACA-3" . SPARSER::COLLECTION)
    ("-GCATTGCCGTTGATCGGTAT-3" . SPARSER::COLLECTION)
    ("-GGCTCAGCAGGACTCCTCAA-3" . SPARSER::COLLECTION)
    ("-TCACCAACCACCGGATTTTC-3" . SPARSER::COLLECTION)
    ("-TGGGCCTCCCTTTGGTAGAT-3" . SPARSER::COLLECTION)
    ("-AACAGGGTGGGAAGGGAAGA-3" . SPARSER::COLLECTION)
    ("-CACTTTCCCCCGAGTCACAG-3" . SPARSER::COLLECTION)
    ("-GCTCCCAGATCCCATCACAG-3" . SPARSER::COLLECTION)
    ("OGR1-" . SPARSER::PROTEIN) ("TDAG8-" . SPARSER::PROTEIN)
    ("G2A-" . SPARSER::PROTEIN) ("GPR4-" . SPARSER::PROTEIN)
    ("Reverse Transcriptase-Polymerase" . SPARSER::COLLECTION)
    ("Anti-β-actin" . SPARSER::COLLECTION)
    ("horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG secondary antibody"
     . SPARSER::ANTIBODY)
    ("-polyacrylamide" . SPARSER::DRUG) ("dithiothreitol" . SPARSER::PROTEIN)
    ("NaOH" . SPARSER::MOLECULE) ("h or 6 h" . SPARSER::COLLECTION)
    ("HEM" . SPARSER::MOLECULE) ("MES" . SPARSER::MOLECULE)
    ("important pharmaceutical targets" . SPARSER::TARGET-PROTEIN)
    ("TDAG8 and related proton-sensing GPCRs" . SPARSER::COLLECTION)
    ("BET" . SPARSER::PROTEIN) ("c-Myc/Max" . SPARSER::COLLECTION)
    ("pro- and anti-tumorigenic" . SPARSER::COLLECTION)
    ("FDG-PET" . SPARSER::COLLECTION)
    ("slightly increases c-Myc" . SPARSER::PROTEIN)
    ("TDAG8 and related pH-sensing GPCRs" . SPARSER::COLLECTION)
    ("c-Myc protein around 59 and 62 kDa" . SPARSER::PROTEIN)
    ("G2A and OGR1" . SPARSER::COLLECTION) ("U937/TDAG8" . SPARSER::PROTEIN)
    ("U937/TDAG8-shRNA" . SPARSER::COLLECTION)
    ("several commercially available TDAG8 antibodies" . SPARSER::ANTIBODY)
    ("GPCRs, TDAG8 and G2A" . SPARSER::COLLECTION)
    ("TDAG8 and G2A" . SPARSER::COLLECTION)
    ("approximately 3 h" . SPARSER::PROTEIN)
    ("approximately 1 h" . SPARSER::PROTEIN)
    ("c-Myc/GAPDH" . SPARSER::COLLECTION)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("mRNA or Protein" . SPARSER::COLLECTION)
    ("the physiological pH 7.4 and the acidic pH 6.4" . SPARSER::COLLECTION)
    ("OGR1 (GPR68) and G2A (GPR132)" . SPARSER::COLLECTION)
    ("GPR4, TDAG8 (GPR65), OGR1 (GPR68) and G2A (GPR132)"
     . SPARSER::COLLECTION)
    ("Ras and Rac" . SPARSER::COLLECTION)
    ("TGF-β, NFκB and Wnt" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK-ERK/MAPK" . SPARSER::COLLECTION)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("TCF4, LEF-1, β-catenin, γ-Catenin, E2F-1, p53 and NFκB"
     . SPARSER::COLLECTION)
    ("BCL-2, RAS and RAF" . SPARSER::COLLECTION) ("-Myc" . SPARSER::COLLECTION)
    ("pCL10" . SPARSER::PROTEIN) ("Sp1-3" . SPARSER::PROTEIN)
    ("Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("T-cell death-associated gene 8" . SPARSER::PROTEIN)
    ("GPR132" . SPARSER::PROTEIN) ("G2A" . SPARSER::PROTEIN)
    ("GPR68" . SPARSER::PROTEIN) ("OGR1" . SPARSER::PROTEIN)
    ("GPR4" . SPARSER::PROTEIN) ("lactic acid" . SPARSER::MOLECULE)
    ("γ-Catenin" . SPARSER::PROTEIN) ("B-Myc" . SPARSER::PROTEIN)
    ("N -Myc" . SPARSER::PROTEIN) ("GPR65" . SPARSER::PROTEIN)
    ("TDAG8" . SPARSER::PROTEIN) ("LO" . SPARSER::PROTEIN)
    ("LM" . SPARSER::PROTEIN)
    ("TERT, rs7736074 and rs4975596" . SPARSER::COLLECTION)
    ("a convenient target" . SPARSER::TARGET-PROTEIN)
    ("EGFR and TERT" . SPARSER::COLLECTION)
    ("informative biomarkers" . SPARSER::MOLECULE)
    ("Heterozygotes" . SPARSER::PROTEIN)
    ("COAD and SKCM" . SPARSER::COLLECTION)
    ("THCA and UCEC" . SPARSER::COLLECTION)
    ("SLC6A19 and TERT" . SPARSER::COLLECTION) ("COAD" . SPARSER::PROTEIN)
    ("THCA" . SPARSER::PROTEIN)
    ("commonly mutated components" . SPARSER::COMPONENT)
    ("EGFR, KRAS, BRAF, PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("EGFR or downstream signaling components" . SPARSER::COLLECTION)
    ("EGF and Cyclin D1" . SPARSER::COLLECTION)
    ("KRAS, BRAF, PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("Monoclonal antibodies" . SPARSER::ANTIBODY)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("allelic variants" . SPARSER::VARIANT)
    ("EGFR, KRAS, BRAF, PTEN and PIK3CA" . SPARSER::COLLECTION)
    ("SLC6A19" . SPARSER::PROTEIN) ("TNF-α/NF-κB" . SPARSER::COLLECTION)
    ("The IKK complex phosphorylates/degrades IκB and releases NF-κB subunits"
     . SPARSER::COLLECTION)
    ("IKK-α, IKK-β and IKK-γ" . SPARSER::COLLECTION)
    ("RUNX2, OSX and OCN" . SPARSER::COLLECTION)
    ("BMP-2/Smad/Runx2" . SPARSER::COLLECTION)
    ("pre-adipocytes" . SPARSER::COLLECTION)
    ("RUNX2 and OSX" . SPARSER::COLLECTION)
    ("protein and DSPP" . SPARSER::COLLECTION)
    ("receptor (OR)" . SPARSER::RECEPTOR)
    ("osteo/odontogenic" . SPARSER::COLLECTION)
    ("odontogenic" . SPARSER::PROTEIN)
    ("ALP , RUNX 2, OSX , OCN and DSPP" . SPARSER::COLLECTION)
    ("IκBα and P65" . SPARSER::COLLECTION)
    ("RUNX2, OSX, OCN, and DSP" . SPARSER::COLLECTION)
    ("ALP , RUNX 2, OCN and OSX" . SPARSER::COLLECTION)
    ("RUNX 2, OCN and DSPP" . SPARSER::COLLECTION)
    ("ALP , RUNX2 , OSX , OCN , and DSPP" . SPARSER::COLLECTION)
    ("profound impact" . SPARSER::PROTEIN)
    ("A natural steroid hormone" . SPARSER::MOLECULE)
    ("IκBα/P65" . SPARSER::COLLECTION) ("/DSP" . SPARSER::COLLECTION)
    ("/OCN" . SPARSER::COLLECTION) ("/OSX" . SPARSER::COLLECTION)
    ("/RUNX2" . SPARSER::COLLECTION) ("DSPP" . SPARSER::PROTEIN)
    ("OCN" . SPARSER::PROTEIN) ("OSX" . SPARSER::PROTEIN)
    ("Alkaline phosphatase and alizarin" . SPARSER::COLLECTION)
    ("alizarin" . SPARSER::DRUG) ("oestradiol" . SPARSER::MOLECULE)
    ("P-P" . SPARSER::PROTEIN) ("IKK-α" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BMP-2" . SPARSER::PROTEIN)
    ("BMS345541" . SPARSER::DRUG) ("β-ACTIN" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("RUNX 2" . SPARSER::PROTEIN) ("P65" . SPARSER::PROTEIN)
    ("human GI tract TC" . SPARSER::PROTEIN)
    ("the possible TC" . SPARSER::PROTEIN)
    ("the myometrial TC" . SPARSER::PROTEIN)
    ("PDGF/PDGFR" . SPARSER::COLLECTION) ("the GI TC" . SPARSER::PROTEIN)
    ("the intramuscular TC and ICC" . SPARSER::COLLECTION)
    ("the intramuscular TC" . SPARSER::PROTEIN)
    ("SK3 and purinergic receptors" . SPARSER::COLLECTION)
    ("purinergic receptors" . SPARSER::PROTEIN) ("nNOS-" . SPARSER::PROTEIN)
    ("PDGFRα and CD34" . SPARSER::COLLECTION)
    ("CD34 or PDGFRα" . SPARSER::COLLECTION)
    ("CD34 and PDGFRα" . SPARSER::COLLECTION) ("-electron" . SPARSER::MOLECULE)
    ("immuno-light" . SPARSER::COLLECTION)
    ("PDGFRα- and CD34-immunoreactivity" . SPARSER::COLLECTION)
    ("c-kit/PGP9.5" . SPARSER::COLLECTION)
    ("intramuscular TC" . SPARSER::PROTEIN)
    ("PDGFRα/PGP9.5" . SPARSER::COLLECTION)
    ("CD31/PECAM-1" . SPARSER::COLLECTION) ("PDGFRα-" . SPARSER::PROTEIN)
    ("SM" . SPARSER::PROTEIN) ("TC and ICC" . SPARSER::COLLECTION)
    ("the intramuscular ICC" . SPARSER::PROTEIN)
    ("ICC-DMP" . SPARSER::COLLECTION) ("ICC-IM" . SPARSER::COLLECTION)
    ("ICC-SM" . SPARSER::PROTEIN-PAIR) ("ICC-MP" . SPARSER::COLLECTION)
    ("DMP" . SPARSER::PROTEIN) ("IM" . SPARSER::PROTEIN)
    ("enteric" . SPARSER::PROTEIN) ("SK3-" . SPARSER::PROTEIN)
    ("CD34-" . SPARSER::PROTEIN)
    ("vimentin, caveolin-1, iNOS and VEGF" . SPARSER::COLLECTION)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD34/c-kit" . SPARSER::COLLECTION) ("PDGFRα/c-kit" . SPARSER::COLLECTION)
    ("PDGFRα/CD34" . SPARSER::COLLECTION) ("FLC" . SPARSER::PROTEIN)
    ("soluble guanylate cyclase" . SPARSER::PROTEIN)
    ("PGP9.5" . SPARSER::PROTEIN) ("B–F" . SPARSER::PROTEIN)
    ("PECAM-1" . SPARSER::PROTEIN) ("MR2" . SPARSER::PROTEIN)
    ("SK3" . SPARSER::PROTEIN) ("type 3" . SPARSER::PROTEIN)
    ("PDGFRα" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("senescent MSCs" . SPARSER::PROTEIN)
    ("p21, and p-Rb" . SPARSER::COLLECTION) ("interfering RNA" . SPARSER::RNA)
    ("p21 and p53" . SPARSER::COLLECTION)
    ("p53, p21, and CDK2" . SPARSER::COLLECTION)
    ("cyclins, CDK, and p-Rb" . SPARSER::COLLECTION)
    ("Cyclin E-CDK2" . SPARSER::COLLECTION)
    ("cyclins and CDK" . SPARSER::COLLECTION)
    ("p53 and CDK" . SPARSER::COLLECTION)
    ("Cyclin E, CDK2, and p-Rb" . SPARSER::COLLECTION)
    ("si-p21" . SPARSER::COLLECTION)
    ("p21 siRNA and a nonspecific siRNA" . SPARSER::COLLECTION)
    ("a nonspecific siRNA" . SPARSER::PROTEIN)
    ("CyclinE-CDK2" . SPARSER::COLLECTION)
    ("CyclinE" . SPARSER::PROTEIN-FAMILY) ("resp" . SPARSER::PROTEIN)
    ("p53 and p21 proteins" . SPARSER::COLLECTION)
    ("Cyclin E and CDK2" . SPARSER::COLLECTION)
    ("Pten/p27 Kip1" . SPARSER::COLLECTION) ("/Rb" . SPARSER::COLLECTION)
    ("p53/p21 Cip1" . SPARSER::COLLECTION) ("p53/p21" . SPARSER::COLLECTION)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("β -tubulin" . SPARSER::PROTEIN) ("p21 proteins" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("p16 INK4A" . SPARSER::PROTEIN)
    ("β -gal" . SPARSER::PROTEIN) ("spring" . SPARSER::PROTEIN)
    ("genes, and genes" . SPARSER::COLLECTION)
    ("GSK3β, and Rev-Erbα" . SPARSER::COLLECTION)
    ("the already longer period" . SPARSER::PROTEIN)
    ("stabilizers" . SPARSER::MOLECULE)
    ("BMAL1, Rev-Erbα and DBP" . SPARSER::COLLECTION)
    ("BMAL1, Rev-Erbα or DBP" . SPARSER::COLLECTION)
    ("the rhythmic component" . SPARSER::COMPONENT)
    ("other rhythmic genes" . SPARSER::GENE)
    ("a longer period" . SPARSER::PROTEIN)
    ("the biological clock" . SPARSER::PROTEIN)
    ("PSA and period" . SPARSER::COLLECTION) ("PSAs" . SPARSER::PROTEIN)
    ("quantitative traits" . SPARSER::PROTEIN)
    ("BMAL1 , CLOCK , or NPAS2" . SPARSER::COLLECTION)
    ("CLOCK and NPAS2" . SPARSER::COLLECTION)
    ("NPAS2/BMAL1" . SPARSER::COLLECTION) ("CLOCK/NPAS2" . SPARSER::COLLECTION)
    ("BMAL1 , CLOCK or NPAS2" . SPARSER::COLLECTION)
    ("BMAL1 , CLOCK and NPAS2" . SPARSER::COLLECTION)
    ("PER2 , BMAL1 and NPAS2" . SPARSER::COLLECTION)
    ("CLOCK:BMAL1 or CLOCK:NPAS2" . SPARSER::COLLECTION)
    ("CLOCK:NPAS2" . SPARSER::BIO-COMPLEX)
    ("CLOCK:BMAL1" . SPARSER::BIO-COMPLEX)
    ("CLOCK, BMAL1 and NPAS2" . SPARSER::COLLECTION)
    ("clock gene variants and clinical subtypes" . SPARSER::COLLECTION)
    ("ERB" . SPARSER::PROTEIN) ("2/3 and CRY1" . SPARSER::COLLECTION)
    ("CRY and PER" . SPARSER::COLLECTION) ("PER" . SPARSER::PROTEIN)
    ("CRY" . SPARSER::PROTEIN) ("the circadian clock's" . SPARSER::PROTEIN)
    ("damped" . SPARSER::MOLECULE) ("PER3 and RORA" . SPARSER::COLLECTION)
    ("RORA" . SPARSER::PROTEIN)
    ("bioluminescent circadian clock reporter gene" . SPARSER::PROTEIN)
    ("Per2::luc" . SPARSER::BIO-COMPLEX) ("CSNK1D" . SPARSER::PROTEIN)
    ("NPAS2" . SPARSER::PROTEIN) ("CRY1" . SPARSER::PROTEIN)
    ("PER1" . SPARSER::PROTEIN) ("PER3" . SPARSER::PROTEIN)
    ("tumour-suppressive miRNAs" . SPARSER::MICRO-RNA)
    ("C/EBP-β and p53" . SPARSER::COLLECTION) ("CD44-" . SPARSER::PROTEIN)
    ("whole gastric epithelium" . SPARSER::PROTEIN)
    ("epithelial PTEN" . SPARSER::PROTEIN)
    ("upstream regulators PTEN, p-Akt and p53, as well as its downstream targets cyclin D1 and cdc25A in patient tissues using qRT–PCR or western blot"
     . SPARSER::COLLECTION)
    ("127 primary GC" . SPARSER::PROTEIN)
    ("the control-mimic-treated wild-type epithelium" . SPARSER::PROTEIN)
    ("p53 and miR-365" . SPARSER::COLLECTION)
    ("Akt1  fl/fl double-mutant gastric epithelium" . SPARSER::PROTEIN)
    ("wild-type p53 ( xref ) or doxorubicin-induced p53 ( xref )"
     . SPARSER::COLLECTION)
    ("p53R175H" . SPARSER::PROTEIN) ("FBS or IGF-1" . SPARSER::COLLECTION)
    ("Sp1 and NF-κB" . SPARSER::COLLECTION)
    ("IGF-1 or Myr-Akt1" . SPARSER::COLLECTION)
    ("Akt1-KD" . SPARSER::COLLECTION)
    ("LY294002 or Wortmannin" . SPARSER::COLLECTION)
    ("insulin or insulin-like growth factor" . SPARSER::COLLECTION)
    ("PHM" . SPARSER::PROTEIN) ("cyclin D1 or cdc25A" . SPARSER::COLLECTION)
    ("epithelia" . SPARSER::PROTEIN) ("using northern blot" . SPARSER::PROTEIN)
    ("PTEN-" . SPARSER::PROTEIN) ("pepsinogen" . SPARSER::PROTEIN)
    ("pit" . SPARSER::PROTEIN) ("CD44 and Lgr5" . SPARSER::COLLECTION)
    ("the normal epithelium" . SPARSER::PROTEIN)
    ("markedly hyperplastic epithelium" . SPARSER::PROTEIN)
    ("glandular epithelium" . SPARSER::PROTEIN)
    ("P40 and P80" . SPARSER::COLLECTION)
    ("gastric epithelium" . SPARSER::PROTEIN)
    ("the gastric epithelium" . SPARSER::PROTEIN)
    ("SP-A-Cre" . SPARSER::COLLECTION) ("PKB/Akt" . SPARSER::COLLECTION)
    ("Guo" . SPARSER::MOLECULE)
    ("Akt, p53, cyclin D1 and cdc25A" . SPARSER::COLLECTION)
    ("cyclin D1 and cdc25A" . SPARSER::COLLECTION)
    ("mouse gastric epithelium" . SPARSER::PROTEIN)
    ("PTEN/Akt" . SPARSER::COLLECTION) ("lgr5" . SPARSER::PROTEIN)
    ("g −1" . SPARSER::PROTEIN) ("Pparα" . SPARSER::PROTEIN)
    ("miR-193b" . SPARSER::MOLECULE) ("P80" . SPARSER::PROTEIN)
    ("SP-A" . SPARSER::PROTEIN) ("single-stranded RNAs" . SPARSER::RNA)
    ("cdc25A" . SPARSER::PROTEIN)
    ("ARMS and metastatic ERMS ( xref ; xref )" . SPARSER::COLLECTION)
    ("protein and full-length" . SPARSER::COLLECTION)
    ("PAX3/FOXO1" . SPARSER::COLLECTION)
    ("a stronger prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("known RMS prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALK/Pol" . SPARSER::COLLECTION) ("NB1" . SPARSER::PROTEIN)
    ("ARMS-t" . SPARSER::COLLECTION)
    ("the dual ALK-MET inhibitor crizotinib" . SPARSER::DRUG)
    ("ALK-MET" . SPARSER::COLLECTION)
    ("putative ligand pleiotrophin (PTN) or ALK agonist monoclonal antibody mAb16-39"
     . SPARSER::COLLECTION)
    ("pleiotrophin (PTN)" . SPARSER::PROTEIN) ("PTN" . SPARSER::PROTEIN)
    ("pleiotrophin" . SPARSER::PROTEIN)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("vs" . SPARSER::PROTEIN) ("ARMS and ERMS" . SPARSER::COLLECTION)
    ("protein kinase or full-length" . SPARSER::COLLECTION)
    ("IGF1R, c-Met, and PDGFR- α" . SPARSER::COLLECTION)
    ("biomarkers and factors" . SPARSER::COLLECTION)
    ("the less frequent pleomorphic subtypes" . SPARSER::PROTEIN)
    ("negative factor" . SPARSER::PROTEIN)
    ("RNA Polymerase" . SPARSER::PROTEIN) ("Protein-G" . SPARSER::PROTEIN)
    ("MyoD1" . SPARSER::PROTEIN) ("RH36" . SPARSER::PROTEIN)
    ("RH18" . SPARSER::PROTEIN) ("RH28" . SPARSER::PROTEIN)
    ("RH4" . SPARSER::PROTEIN) ("RH30" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("PDGFR- α" . SPARSER::PROTEIN) ("erbB2" . SPARSER::PROTEIN)
    ("erbB1" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXO1" . SPARSER::PROTEIN) ("PAX3" . SPARSER::PROTEIN)
    ("p22" . SPARSER::PROTEIN) ("hemoglobin" . SPARSER::PROTEIN)
    ("HL and MS" . SPARSER::COLLECTION)
    ("GATA3 and EOMES" . SPARSER::COLLECTION) ("Il5" . SPARSER::PROTEIN)
    ("Eomes and T-bet" . SPARSER::COLLECTION) ("Eomes" . SPARSER::PROTEIN)
    ("GATA3 and T-bet" . SPARSER::COLLECTION)
    ("UK and German-GWAS" . SPARSER::COLLECTION) ("Duo" . SPARSER::PROTEIN)
    ("Case" . SPARSER::PROTEIN) ("Quad" . SPARSER::DRUG)
    ("using Illumina OmniExpress-12 v1.0" . SPARSER::PROTEIN)
    ("HNR" . SPARSER::PROTEIN) ("classical HL" . SPARSER::PROTEIN)
    ("major histocompatibility complex (MHC)" . SPARSER::PROTEIN)
    ("HRS" . SPARSER::PROTEIN) ("HBS1L and MYB" . SPARSER::COLLECTION)
    ("MYB" . SPARSER::PROTEIN) ("eomesodermin" . SPARSER::PROTEIN)
    ("EOMES" . SPARSER::PROTEIN) ("H4K20me1" . SPARSER::PROTEIN)
    ("10 C" . SPARSER::PROTEIN) ("Gata3" . SPARSER::PROTEIN)
    ("TBR1" . SPARSER::PROTEIN) ("V-MYB" . SPARSER::PROTEIN)
    ("HBS1" . SPARSER::PROTEIN) ("HBS1L" . SPARSER::PROTEIN)
    ("the conformational impact" . SPARSER::PROTEIN)
    ("distinct conformational regulators" . SPARSER::REGULATOR)
    ("whereby one control antibody" . SPARSER::ANTIBODY)
    ("the dual Ab conformation" . SPARSER::BIO-CONFORMATION)
    ("commercially available monoclonal Abs" . SPARSER::PROTEIN)
    ("mAbs" . SPARSER::DRUG) ("biological matrices" . SPARSER::PROTEIN-FAMILY)
    ("biological ECM" . SPARSER::PROTEIN)
    ("commercially-available Abs" . SPARSER::PROTEIN)
    ("treated and untreated matrix" . SPARSER::PROTEIN-FAMILY)
    ("Ctl" . SPARSER::PROTEIN)
    ("their respective fluorescently labeled secondary Abs" . SPARSER::PROTEIN)
    ("a robust Fn matrix" . SPARSER::PROTEIN-FAMILY)
    ("the mechanical strain state" . SPARSER::BIO-STATE)
    ("fluorescently labeled secondary Abs" . SPARSER::PROTEIN)
    ("polydimethylsiloxane (PDMS)" . SPARSER::DRUG)
    ("PDMS" . SPARSER::MOLECULE) ("polydimethylsiloxane" . SPARSER::DRUG)
    ("MAB" . SPARSER::DRUG) ("HRP-conjugated secondary Abs" . SPARSER::PROTEIN)
    ("primary Abs" . SPARSER::PROTEIN) ("associated water" . SPARSER::MOLECULE)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("altered conformational states" . SPARSER::BIO-STATE)
    ("a pervasive component" . SPARSER::COMPONENT)
    ("the mechanical impact" . SPARSER::PROTEIN)
    ("the 12th to 14th type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mechanical strain-based conformation" . SPARSER::BIO-CONFORMATION)
    ("bacterial adhesins" . SPARSER::PROTEIN) ("adhesins" . SPARSER::PROTEIN)
    ("chondroitin" . SPARSER::MOLECULE)
    ("integrins and growth factors" . SPARSER::COLLECTION)
    ("dynamic ECM" . SPARSER::PROTEIN)
    ("proteins and polysaccharides" . SPARSER::COLLECTION)
    ("polysaccharides" . SPARSER::POLYSACCHARIDE)
    ("the conformational state" . SPARSER::BIO-STATE)
    ("commercially available antibodies and simple immunohistochemistry"
     . SPARSER::COLLECTION)
    ("heparin and mechanical strain co-regulate Fn conformation"
     . SPARSER::COLLECTION)
    ("its physiologically-relevant fibrillar state" . SPARSER::BIO-STATE)
    ("mechanical strain co-regulate Fn conformation"
     . SPARSER::BIO-CONFORMATION)
    ("two fluorescent monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Heparin and heparan sulfate" . SPARSER::COLLECTION)
    ("Heparin" . SPARSER::PROTEIN) ("Heparan sulfates" . SPARSER::MOLECULE)
    ("Heparan sulfate" . SPARSER::MOLECULE)
    ("both heterozygous and wild type p53 alleles" . SPARSER::ALLELE)
    ("specific environmental mutagens" . SPARSER::MOLECULE)
    ("MNU" . SPARSER::DRUG) ("methylnitrosourea" . SPARSER::DRUG)
    ("Mgmt" . SPARSER::PROTEIN) ("PARP, and γH2AX" . SPARSER::COLLECTION)
    ("MGMT mRNA and miR-221 levels" . SPARSER::COLLECTION)
    ("MGMT and miR-221" . SPARSER::COLLECTION)
    ("TMZ and ZVAD-fmk" . SPARSER::COLLECTION)
    ("ZVAD-fmk and TMZ" . SPARSER::COLLECTION)
    ("PI staining and flow cytometry" . SPARSER::COLLECTION)
    ("both methylated and unmethylated MGMT promoter" . SPARSER::PROMOTER)
    ("miR-221/222 directly target MGMT -3" . SPARSER::PROTEIN)
    ("a suicide cellular DNA repair enzyme" . SPARSER::PROTEIN)
    ("MeG" . SPARSER::PROTEIN) ("temozolomide (TMZ)" . SPARSER::DRUG)
    ("P-ATM" . SPARSER::PROTEIN) ("ZVAD-fmk" . SPARSER::DRUG)
    ("ZVAD-Fmk" . SPARSER::DRUG)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("E2F/RB" . SPARSER::COLLECTION) ("E2F and RB" . SPARSER::COLLECTION)
    ("Exogenously expressed MDM2 isoform proteins" . SPARSER::PROTEIN)
    ("expressed MDM2 isoform proteins" . SPARSER::PROTEIN)
    ("exogenously and endogenously expressed MDM2-C protein"
     . SPARSER::PROTEIN)
    ("p53 and either MDM2-C or MDM2-FL" . SPARSER::COLLECTION)
    ("approximately 10 fold less p53 protein" . SPARSER::PROTEIN)
    ("co-migrating 98 kDa MDM2-C protein ( xref , lanes 3-8) or MDM2-FL ( xref , lanes 9-14)"
     . SPARSER::COLLECTION)
    ("exogenously expressed p53" . SPARSER::PROTEIN)
    ("expressed p53" . SPARSER::PROTEIN)
    ("probable ATP-dependent RNA helicase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nucleolin" . SPARSER::PROTEIN)
    ("at least five peptides" . SPARSER::PEPTIDE)
    ("LC/MS/MS" . SPARSER::COLLECTION)
    ("the endogenously expressed MDM2-C protein" . SPARSER::PROTEIN)
    ("expressed MDM2-C protein" . SPARSER::PROTEIN)
    ("different MDM2 immunoreactive antibodies" . SPARSER::ANTIBODY)
    ("full length MDM2 and other proteins" . SPARSER::COLLECTION)
    ("Biii" . SPARSER::PROTEIN) ("IGG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a cancer diagnostic biomarker" . SPARSER::MOLECULE)
    ("predominantly nuclear mutant p53" . SPARSER::PROTEIN)
    ("Many exogenously expressed MDM2 spliced isoforms" . SPARSER::ISOFORM)
    ("Cx" . SPARSER::PROTEIN-FAMILY) ("fibrillarin" . SPARSER::PROTEIN)
    ("increased mdm2 spliced variant" . SPARSER::VARIANT)
    ("Ciii" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("strong antibody" . SPARSER::ANTIBODY)
    ("p53 and MDM2-C" . SPARSER::COLLECTION) ("viii" . SPARSER::PROTEIN)
    ("Exogenously expressed MDM2-A and MDM2-B isoforms" . SPARSER::ISOFORM)
    ("expressed MDM2-A and MDM2-B isoforms" . SPARSER::ISOFORM)
    ("full-length and mdm2-C" . SPARSER::COLLECTION)
    ("the MDM2 pan-reactive mouse monoclonal 4B11 antibody"
     . SPARSER::ANTIBODY)
    ("a western blot" . SPARSER::PROTEIN)
    ("at least some co-migrating polypeptides" . SPARSER::PROTEIN)
    ("wild-type p53 and high MDM2" . SPARSER::COLLECTION)
    ("p21 and puma" . SPARSER::COLLECTION)
    ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wild-type p53 and the mdm2 SNP309 T/T alleles" . SPARSER::COLLECTION)
    ("only two protein isoforms" . SPARSER::ISOFORM)
    ("tumor-associated foci" . SPARSER::PROTEIN)
    ("approximately 98 kDa" . SPARSER::PROTEIN)
    ("TWEEN 20" . SPARSER::MOLECULE)
    ("Phenylmethanesulfonyl Fluoride" . SPARSER::MOLECULE)
    ("Sodium Chloride" . SPARSER::DRUG) ("β Estradiol" . SPARSER::MOLECULE)
    ("pT7" . SPARSER::PROTEIN) ("hdm2" . SPARSER::PROTEIN)
    ("KIAA1967" . SPARSER::PROTEIN) ("DDX5" . SPARSER::PROTEIN)
    ("RNA helicase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP90β" . SPARSER::PROTEIN)
    ("Heat Shock protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP7" . SPARSER::PROTEIN) ("ML-1" . SPARSER::PROTEIN)
    ("heterozygous variant GA" . SPARSER::PROTEIN)
    ("homozygous variant AA" . SPARSER::MOLECULE)
    ("preset" . SPARSER::PROTEIN-FAMILY) ("AA and AG" . SPARSER::COLLECTION)
    ("SE" . SPARSER::PROTEIN) ("v" . SPARSER::PROTEIN)
    ("PRISMA" . SPARSER::DRUG) ("Ala or Thr" . SPARSER::COLLECTION)
    ("Many apoptogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Omi/HtrA2" . SPARSER::COLLECTION)
    ("a well-studied tumor suppressor gene" . SPARSER::PROTEIN)
    ("Rb, and p16" . SPARSER::COLLECTION)
    ("The Bcl-2-associated X protein" . SPARSER::PROTEIN)
    ("HtrA2" . SPARSER::PROTEIN) ("dominant and recessive" . SPARSER::PROTEIN)
    ("TUSC2 and LKB1" . SPARSER::COLLECTION)
    ("an essential downstream component" . SPARSER::COMPONENT)
    ("only 1 µM MK2206" . SPARSER::DRUG) ("p-AMPK" . SPARSER::COLLECTION)
    ("TUSC2 or MK2206" . SPARSER::COLLECTION)
    ("EGFR, K-ras, B-raf, PI3K, LKB1 and TUSC2" . SPARSER::COLLECTION)
    ("TUSC2 and MK2206" . SPARSER::COLLECTION)
    ("this pleotropic protein" . SPARSER::PROTEIN)
    ("TUSC2 and p53" . SPARSER::COLLECTION)
    ("EGFR, PDGFR, AKT, c-Abl, and c-Kit" . SPARSER::COLLECTION)
    ("trimethylammonium" . SPARSER::MOLECULE)
    ("AMPK/AKT/mTOR" . SPARSER::COLLECTION) ("LKB1-AMPK" . SPARSER::PROTEIN)
    ("m-TOR" . SPARSER::PROTEIN) ("B-raf" . SPARSER::PROTEIN)
    ("GSK-3α" . SPARSER::PROTEIN) ("Apaf-1" . SPARSER::PROTEIN)
    ("apoptotic protease activating factor 1" . SPARSER::PROTEIN)
    ("FUS1" . SPARSER::PROTEIN)
    ("tumor suppressor candidate 2" . SPARSER::PROTEIN)
    ("TUSC2" . SPARSER::PROTEIN)
    ("age and Ki-67-positive" . SPARSER::COLLECTION)
    ("IHC p53" . SPARSER::PROTEIN)
    ("IDC triple-negative subtypes" . SPARSER::PROTEIN)
    ("No DCIS triple-negative subtypes" . SPARSER::PROTEIN)
    ("P16 and P53" . SPARSER::COLLECTION)
    ("current and potential therapeutics" . SPARSER::THERAPEUTICS)
    ("ER− and PR−" . SPARSER::COLLECTION)
    ("PR−" . SPARSER::HUMAN-PROTEIN-FAMILY) ("almost every type" . TYPE)
    ("hypoxia, and oncogene" . SPARSER::COLLECTION)
    ("p14ARF/mdm2/p53" . SPARSER::COLLECTION)
    ("pRb/p16INK4a/cyclin D1" . SPARSER::COLLECTION)
    ("Luminal" . SPARSER::DRUG) ("triple-negative subtypes" . SPARSER::PROTEIN)
    ("p16 INK4a and p53" . SPARSER::COLLECTION) ("CDK 4" . SPARSER::PROTEIN)
    ("P16" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("p16INK4a" . SPARSER::PROTEIN)
    ("further promoter-associated PARP1" . SPARSER::PROTEIN)
    ("one likely contributory factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("repressive H2A.Z" . SPARSER::PROTEIN) ("H2A.Z/H2B" . SPARSER::COLLECTION)
    ("H2A/H2B" . SPARSER::COLLECTION)
    ("PARP1 and p400 and INO80" . SPARSER::COLLECTION)
    ("PARP1 and its associated branched PAR polymer" . SPARSER::COLLECTION)
    ("its associated branched PAR polymer" . SPARSER::MOLECULE)
    ("enzymes and variant" . SPARSER::COLLECTION)
    ("H2A.Z/p400" . SPARSER::COLLECTION)
    ("H2A.Z and its regulators" . SPARSER::COLLECTION)
    ("INO80 and p400" . SPARSER::COLLECTION)
    ("p400/INO80" . SPARSER::COLLECTION)
    ("p400 and INO80" . SPARSER::COLLECTION)
    ("p400–Tip60" . SPARSER::COLLECTION)
    ("a chromatin-associated complex" . SPARSER::BIO-COMPLEX)
    ("NFI and PARP1" . SPARSER::COLLECTION)
    ("wild-type PARP1 or the catalytically compromised mutant PARP1(E988K)"
     . SPARSER::COLLECTION)
    ("Parp1" . SPARSER::PROTEIN) ("Parp" . SPARSER::PROTEIN)
    ("ERK or ELK1" . SPARSER::COLLECTION)
    ("a key signal-dependent regulator of FOS promoter remodelling and activation"
     . SPARSER::COLLECTION)
    ("the promoter-proximal nucleosome" . SPARSER::PROTEIN)
    ("ADP-ribose (PAR)" . SPARSER::MOLECULE)
    ("the upstream promoter-proximal nucleosome" . SPARSER::PROTEIN)
    ("promoter-associated nucleosomes" . SPARSER::PROTEIN)
    ("NFI" . SPARSER::PROTEIN) ("FOS" . SPARSER::PROTEIN)
    ("P400" . SPARSER::PROTEIN) ("u-PAR" . SPARSER::PROTEIN)
    ("CHD1L" . SPARSER::PROTEIN) ("Ino80" . SPARSER::PROTEIN)
    ("INO80" . SPARSER::PROTEIN) ("KU0058948" . SPARSER::DRUG)
    ("PARP2" . SPARSER::PROTEIN) ("H2Av" . SPARSER::PROTEIN)
    ("KDM5B" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("nuclear factor 1" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("a new monoclonal antibody" . SPARSER::DRUG)
    ("Strong nuclear" . SPARSER::PROTEIN)
    ("a multifunctional transcription factor" . SPARSER::PROTEIN)
    ("glandular epithelial component" . SPARSER::COMPONENT)
    ("the pure type" . TYPE)
    ("pure choriocarcinomas and choriocarcinoma components"
     . SPARSER::COMPONENT)
    ("pilar" . SPARSER::PROTEIN) ("thrombomodulin" . SPARSER::PROTEIN)
    ("ER, PR, or HER2" . SPARSER::COLLECTION)
    ("ER, PR, and HER2" . SPARSER::COLLECTION) ("exo-" . SPARSER::PROTEIN)
    ("Uterine ectocervical squamous epithelium" . SPARSER::PROTEIN)
    ("sac" . SPARSER::PROTEIN) ("GATA 3" . SPARSER::PROTEIN)
    ("type B" . SPARSER::PROTEIN) ("GCDFP-15" . SPARSER::PROTEIN)
    ("T-A" . SPARSER::PROTEIN)
    ("target Cyclin E and other Golgi substrates" . SPARSER::COLLECTION)
    ("RhoBTB3-CUL3" . SPARSER::COLLECTION) ("SCF-Fbw7" . SPARSER::COLLECTION)
    ("Cullin–ubiquitin ligase" . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN)
    ("tightly bound partner proteins" . SPARSER::PROTEIN)
    ("separate ubiquitinated substrates" . SPARSER::SUBSTRATE)
    ("that RhoBTB3’s" . SPARSER::PROTEIN)
    ("the bound nucleotide-determined conformation of the protein and the presence"
     . SPARSER::COLLECTION)
    ("a peripheral Golgi protein" . SPARSER::PROTEIN)
    ("polo-like kinase ( xref ) and Aurora kinase" . SPARSER::COLLECTION)
    ("SCF-FBW7" . SPARSER::COLLECTION)
    ("Cyclin E and CUL3" . SPARSER::COLLECTION)
    ("the unrelated peripheral Golgi protein GRASP55" . SPARSER::PROTEIN)
    ("GFP-RhoBTB3" . SPARSER::COLLECTION) ("exogenous CUL3" . SPARSER::PROTEIN)
    ("GST-Cyclin E1" . SPARSER::COLLECTION)
    ("bacterially expressed GST-Cyclin E" . SPARSER::COLLECTION)
    ("expressed GST-Cyclin E" . SPARSER::COLLECTION)
    ("GST-Cyclin E" . SPARSER::COLLECTION) ("HA-RBX1" . SPARSER::COLLECTION)
    ("GST-CUL3" . SPARSER::COLLECTION)
    ("monomeric Cyclin E1" . SPARSER::PROTEIN)
    ("Myc-RhoBTB3" . SPARSER::COLLECTION) ("FLAG-CUL3" . SPARSER::COLLECTION)
    ("FLAG-RhoBTB3" . SPARSER::COLLECTION) ("CUL3/RBX1" . SPARSER::COLLECTION)
    ("RhoBTB3 and the RING E3 ubiquitin ligase" . SPARSER::COLLECTION)
    ("a BTB protein and a RING domain E3 ubiquitin ligase (i.e., RBX1; xref )"
     . SPARSER::COLLECTION)
    ("RhoBTB3 and GCC185" . SPARSER::COLLECTION)
    ("RhoBTB3–Cyclin E" . SPARSER::COLLECTION)
    ("RhoBTB3 and Cyclin E" . SPARSER::COLLECTION)
    ("Cyclin E1" . SPARSER::PROTEIN) ("Cyclin A2-GFP" . SPARSER::COLLECTION)
    ("Cyclin E1-GFP" . SPARSER::PROTEIN-PAIR)
    ("Cyclin E and RhoBTB3" . SPARSER::COLLECTION)
    ("exogenous Cyclin E–CDK2" . SPARSER::COLLECTION)
    ("Cyclin–CDK" . SPARSER::COLLECTION)
    ("S-phase Cyclin A2 or mitotic Cyclin B1" . SPARSER::COLLECTION)
    ("mitotic Cyclin B1" . SPARSER::PROTEIN)
    ("RhoBTB3–CUL3" . SPARSER::COLLECTION)
    ("a Golgi-localized CUL3–ubiquitin ligase complex" . SPARSER::BIO-COMPLEX)
    ("CUL3–ubiquitin ligase" . SPARSER::COLLECTION)
    ("the most divergent isoform" . SPARSER::PROTEIN)
    ("atypical Rho GTPases" . SPARSER::GTPASE) ("TGN" . SPARSER::PROTEIN)
    ("CUL3–ubiquitin" . SPARSER::COLLECTION)
    ("Cullins" . SPARSER::PROTEIN-FAMILY)
    ("Monomeric (or “free”) Cyclin E" . SPARSER::PROTEIN)
    ("Cyclin E–CDK2" . SPARSER::COLLECTION)
    ("RhoBTB3, CUL3, and RBX1" . SPARSER::COLLECTION)
    ("CUL3 and RBX1" . SPARSER::COLLECTION) ("UbcH5a" . SPARSER::PROTEIN)
    ("phospho-kinase" . SPARSER::PROTEIN) ("Ph1" . SPARSER::PROTEIN)
    ("HE12" . SPARSER::PROTEIN) ("GRASP65" . SPARSER::PROTEIN)
    ("p97" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ras family" . SPARSER::PROTEIN)
    ("Rab9" . SPARSER::PROTEIN) ("FBW7" . SPARSER::PROTEIN)
    ("GRASP55" . SPARSER::PROTEIN) ("domain E" . SPARSER::PROTEIN)
    ("p-RB" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("GM130" . SPARSER::PROTEIN) ("GCC185" . SPARSER::PROTEIN)
    ("phosphate receptor" . SPARSER::PROTEIN)
    ("Broad complex" . SPARSER::PROTEIN) ("Bric-a-brac" . SPARSER::PROTEIN)
    ("Cullin family" . SPARSER::PROTEIN-FAMILY) ("Cullin 3" . SPARSER::PROTEIN)
    ("Cullin3" . SPARSER::PROTEIN) ("Golgi-associated" . SPARSER::PROTEIN)
    ("RBX1" . SPARSER::PROTEIN) ("RhoBTB3" . SPARSER::PROTEIN)
    ("a cell cycle-specific chemotherapeutic drug" . SPARSER::DRUG)
    ("ZEB1 and SP1" . SPARSER::COLLECTION)
    ("Metastatic CRC" . SPARSER::PROTEIN)
    ("UTR-luciferase" . SPARSER::COLLECTION)
    ("ATM and miR-203" . SPARSER::COLLECTION)
    ("pre-miR-203 oligonucleotides and anti-miR-203 oligonucleotides"
     . SPARSER::COLLECTION)
    ("mature human miRNA" . SPARSER::MICRO-RNA)
    ("kinase (ATM)" . SPARSER::KINASE)
    ("guanine-guanine" . SPARSER::COLLECTION)
    ("virtually all metastatic CRCs" . SPARSER::PROTEIN)
    ("FOLFOX" . SPARSER::DRUG)
    ("leucovorin (FOLFOX) and biologics" . SPARSER::COLLECTION)
    ("biologics" . SPARSER::DRUG) ("leucovorin" . SPARSER::DRUG)
    ("chemo" . SPARSER::PROTEIN) ("chemo-naïve" . SPARSER::COLLECTION)
    ("Oxaliplatin" . SPARSER::DRUG) ("targets and drugs" . SPARSER::COLLECTION)
    ("tissue-type" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("OTUD5-p53" . SPARSER::COLLECTION) ("FBP" . SPARSER::PROTEIN)
    ("an essential type I interferon adaptor protein TRAF3" . SPARSER::PROTEIN)
    ("Bax and p21" . SPARSER::COLLECTION)
    ("shRNA or OTUD5" . SPARSER::COLLECTION) ("Myc-ub" . SPARSER::COLLECTION)
    ("HA-p53" . SPARSER::COLLECTION) ("p53-ubiquitin" . SPARSER::COLLECTION)
    ("ub" . SPARSER::PROTEIN) ("GST-p53" . SPARSER::COLLECTION)
    ("OTUD5 and p53" . SPARSER::COLLECTION)
    ("normal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the anti-p53" . SPARSER::ANTIBODY) ("Myc-p53" . SPARSER::COLLECTION)
    ("Flag-OTUD5" . SPARSER::COLLECTION)
    ("p53 and OTUD5" . SPARSER::COLLECTION)
    ("preys" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MIZ1" . SPARSER::PROTEIN)
    ("an essential type I interferon adaptor protein" . SPARSER::PROTEIN)
    ("the MDM2-specific DUB USP2a USP42 [ xref , xref ] and USP5"
     . SPARSER::COLLECTION)
    ("The herpes virus-associated USP" . SPARSER::PROTEIN)
    ("HAUSP or USP7" . SPARSER::COLLECTION) ("HAUSP" . SPARSER::PROTEIN)
    ("the distal ubiquitin" . SPARSER::PROTEIN)
    ("monoubiquitin and polyubiquitin" . SPARSER::COLLECTION)
    ("monoubiquitin" . SPARSER::PROTEIN)
    ("Machado-Joseph disease proteins (MJD) and the Jab1/MPN/Mov34 metalloenzymes (JAMM) [ xref ]"
     . SPARSER::COLLECTION)
    ("metalloenzymes (JAMM)" . SPARSER::PROTEIN-FAMILY)
    ("proteins (MJD)" . SPARSER::PROTEIN)
    ("the ovarian tumour proteases (OTU)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteases (OTU)" . SPARSER::PROTEIN) ("Mov34" . SPARSER::PROTEIN)
    ("JAMM" . SPARSER::PROTEIN-FAMILY)
    ("metalloenzymes" . SPARSER::PROTEIN-FAMILY) ("MPN" . SPARSER::PROTEIN)
    ("MJD" . SPARSER::PROTEIN) ("hydrolases" . SPARSER::PROTEIN)
    ("USPs" . SPARSER::PROTEIN) ("mdmX" . SPARSER::PROTEIN)
    ("HDMX" . SPARSER::PROTEIN)
    ("a direct complex with p53 and controls level of ubiquitination"
     . SPARSER::COLLECTION)
    ("JTV1" . SPARSER::PROTEIN) ("USP42" . SPARSER::PROTEIN)
    ("USP2" . SPARSER::PROTEIN) ("USP10" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("Jab1" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("Double Minute 2" . SPARSER::PROTEIN)
    ("OTUD5" . SPARSER::PROTEIN)
    ("attractive pharmacological targets" . SPARSER::TARGET-PROTEIN)
    ("LEF-1/TCF" . SPARSER::COLLECTION) ("matrilysin" . SPARSER::PROTEIN)
    ("APC–beta-catenin–TCF" . SPARSER::COLLECTION)
    ("matrix-metalloproteinase" . SPARSER::COLLECTION)
    ("MVD" . SPARSER::PROTEIN) ("receptor/HER2" . SPARSER::COLLECTION)
    ("TCF4 and beta-catenin" . SPARSER::COLLECTION)
    ("TCF4, DVL, and axin" . SPARSER::COLLECTION)
    ("Wnt3A and Wnt7B" . SPARSER::COLLECTION) ("LEF-TCF" . SPARSER::COLLECTION)
    ("FDZ-receptors" . SPARSER::COLLECTION)
    ("beta-catenin and cyclin-D1" . SPARSER::COLLECTION)
    ("beta-catenin/Tcf4" . SPARSER::COLLECTION)
    ("TN and basal-like" . SPARSER::COLLECTION)
    ("GSK-3β-beta-catenin-TCF" . SPARSER::COLLECTION)
    ("proteosome" . SPARSER::PROTEIN) ("PTEN null MMP7" . SPARSER::PROTEIN)
    ("PTEN and MMP7" . SPARSER::COLLECTION)
    ("cellular beta-catenin" . SPARSER::PROTEIN) ("axin" . SPARSER::PROTEIN)
    ("beta-catenin and MMP7" . SPARSER::COLLECTION)
    ("comparatively higher RD" . SPARSER::PROTEIN)
    ("highly expressed MMP7 and low expressed PTEN" . SPARSER::COLLECTION)
    ("expressed PTEN" . SPARSER::PROTEIN)
    ("highly expressed MMP7" . SPARSER::PROTEIN)
    ("expressed MMP7" . SPARSER::PROTEIN) ("fig" . SPARSER::PROTEIN)
    ("PNP" . SPARSER::PROTEIN) ("PNN" . SPARSER::PROTEIN)
    ("PPN" . SPARSER::PROTEIN) ("NNN" . SPARSER::MOLECULE)
    ("the Montreal cohort" . SPARSER::MOLECULE)
    ("MMP2, MMP9 and MMP14" . SPARSER::COLLECTION)
    ("MMP1 , MMP2 , MMP3 , MMP9 , and MMP11" . SPARSER::COLLECTION)
    ("Cohorts" . SPARSER::MOLECULE)
    ("TCF4, DVL, and Axin" . SPARSER::COLLECTION)
    ("AXIN , DVL1 , and TCF4" . SPARSER::COLLECTION)
    ("c-Jun, VEGFA and PLAUR" . SPARSER::COLLECTION)
    ("PLAUR" . SPARSER::PROTEIN) ("receptor and LRP6" . SPARSER::COLLECTION)
    ("WNT7B and WNT9B" . SPARSER::COLLECTION)
    ("WNT3A, WNT5A, WNT5B, WNT6, WNT7B, WNT9B, and WNT11"
     . SPARSER::COLLECTION)
    ("AXIN, DVL1, and TCF4" . SPARSER::COLLECTION) ("AXIN" . SPARSER::PROTEIN)
    ("MDA-MB468" . SPARSER::PROTEIN) ("BTRC" . SPARSER::PROTEIN)
    ("BIRC5, CD44, FZD7, c-MET, MMP7, c-MYC, NOTCH1, PPARD , and VEGF"
     . SPARSER::COLLECTION)
    ("MMP7 , c- MYC , BIRC5 , CD44 , PPARD , and c- MET" . SPARSER::COLLECTION)
    ("the high pCR (40%) and low RD (60%)" . SPARSER::COLLECTION)
    ("antagonists or APC" . SPARSER::COLLECTION)
    ("APC/beta-catenin" . SPARSER::COLLECTION)
    ("receptors, And HER2" . SPARSER::COLLECTION)
    ("MMP7 and PTEN" . SPARSER::COLLECTION)
    ("functional PTEN" . SPARSER::PROTEIN)
    ("SiRNA or WP" . SPARSER::COLLECTION)
    ("XAV939 and sulindac" . SPARSER::COLLECTION) ("sulindac" . SPARSER::DRUG)
    ("SiRNA" . SPARSER::PROTEIN)
    ("beta-catenin, FZD7 , DVL1, MMP7 , c- MYC , BIRC5 , CD44 , PPARD , c- MET, and NOTCH1"
     . SPARSER::COLLECTION)
    ("PPARD" . SPARSER::PROTEIN) ("LEF-1" . SPARSER::PROTEIN)
    ("cytokeratin 5" . SPARSER::PROTEIN) ("Wnt7B" . SPARSER::PROTEIN)
    ("Tcf4" . SPARSER::PROTEIN) ("SiRNA-mediated" . SPARSER::PROTEIN)
    ("(beta" . SPARSER::PROTEIN) ("MMP11" . SPARSER::PROTEIN)
    ("MMP3" . SPARSER::PROTEIN) ("FZD4" . SPARSER::PROTEIN)
    ("WNT11" . SPARSER::PROTEIN) ("WNT9B" . SPARSER::PROTEIN)
    ("WNT7B" . SPARSER::PROTEIN) ("WNT6" . SPARSER::PROTEIN)
    ("WNT5B" . SPARSER::PROTEIN) ("WNT5A" . SPARSER::PROTEIN)
    ("WNT3A" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("MMP14" . SPARSER::PROTEIN) ("DVL-1" . SPARSER::PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("XAV939" . SPARSER::DRUG)
    ("c- MET" . SPARSER::PROTEIN) ("c- MYC" . SPARSER::PROTEIN)
    ("FZD7" . SPARSER::PROTEIN)
    ("a potential predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("target genes as well as its potential cooperation with major aberrant signaling pathways in malignant glioma such as EGFR, C-MYC and CCND1"
     . SPARSER::COLLECTION)
    ("EGFR, C-MYC and CCND1" . SPARSER::COLLECTION)
    ("CCND1, cMYC and EGFR" . SPARSER::COLLECTION) ("cMYC" . SPARSER::PROTEIN)
    ("at least c-MYC and CCND1" . SPARSER::COLLECTION)
    ("c-MYC and CCND1" . SPARSER::COLLECTION)
    ("Cdk4 and Cdk6" . SPARSER::COLLECTION)
    ("CCND1 and c-MYC" . SPARSER::COLLECTION)
    ("natively expressed fibronectin receptor" . SPARSER::PROTEIN)
    ("expressed fibronectin receptor" . SPARSER::PROTEIN)
    ("α5β1-integrin" . SPARSER::COLLECTION)
    ("NOTCH1 and NOTCH2" . SPARSER::COLLECTION)
    ("NOTCH1, NOTCH2 and NOTCH4" . SPARSER::COLLECTION)
    ("Cyclin D1 (CCND1) and EGFR proteins" . SPARSER::COLLECTION)
    ("shRNA-" . SPARSER::PROTEIN) ("only positive NOTCH3" . SPARSER::PROTEIN)
    ("CDK1 and CDK7" . SPARSER::COLLECTION)
    ("HEY2, C-MYC and CCND1" . SPARSER::COLLECTION)
    ("ShRNAs" . SPARSER::PROTEIN) ("Log-Rank" . SPARSER::COLLECTION)
    ("Rank" . SPARSER::PROTEIN) ("Log" . SPARSER::PROTEIN)
    ("NOTCH target genes such as HES and HEY families, cyclin D1 (CCND1) and c-MYC xref"
     . SPARSER::COLLECTION)
    ("HEY" . SPARSER::PROTEIN)
    ("the CSL repressor complex (CBF1/RBP-Jk, Suppressor of Hairless, LAG-1) and recruitment"
     . SPARSER::COLLECTION)
    ("CBF1/RBP-Jk" . SPARSER::COLLECTION)
    ("mastermind" . SPARSER::PROTEIN-FAMILY) ("CSL" . SPARSER::PROTEIN)
    ("presenilin–γ-secretase" . SPARSER::COLLECTION) ("ICD" . SPARSER::PROTEIN)
    ("presenilin" . SPARSER::PROTEIN) ("TACE" . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSI- or anti-NOTCH3-" . SPARSER::COLLECTION)
    ("anti-NOTCH3-" . SPARSER::ANTIBODY) ("GSI-" . SPARSER::PROTEIN)
    ("GSI" . SPARSER::PROTEIN) ("Mcl-1 protein" . SPARSER::PROTEIN)
    ("Cdk6" . SPARSER::PROTEIN) ("fibronectin receptor" . SPARSER::PROTEIN)
    ("CDK7" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("HEY2" . SPARSER::PROTEIN) ("NOTCH4" . SPARSER::PROTEIN)
    ("PAX2" . SPARSER::PROTEIN) ("NOTCH2" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN) ("MAML1" . SPARSER::PROTEIN)
    ("LAG-1" . SPARSER::PROTEIN) ("RBP-Jk" . SPARSER::PROTEIN)
    ("CBF1" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN) ("NOTCH1" . SPARSER::PROTEIN)
    ("this regulatory SNP" . SPARSER::PROTEIN)
    ("TNRC9 or CAGF9" . SPARSER::COLLECTION)
    ("a strong protein-DNA complex" . SPARSER::BIO-COMPLEX)
    ("Oct-1/Runx2" . SPARSER::COLLECTION) ("DJ" . SPARSER::PROTEIN)
    ("ZNF365 and rs17221259" . SPARSER::COLLECTION)
    ("ATF7IP and rs3803662" . SPARSER::COLLECTION)
    ("–log" . SPARSER::COLLECTION)
    ("approximately 67 common genetic variants" . SPARSER::VARIANT)
    ("ATM , TP53 , CHEK2 , PTEN , CDH1 , STK11 and PALB2"
     . SPARSER::COLLECTION)
    ("three significantly associated variants" . SPARSER::VARIANT)
    ("TNRC9" . SPARSER::PROTEIN) ("Oct-1" . SPARSER::PROTEIN)
    ("ATF7IP" . SPARSER::PROTEIN) ("p33" . SPARSER::PROTEIN)
    ("RPL17" . SPARSER::PROTEIN) ("MRPS30" . SPARSER::PROTEIN)
    ("ZNF365" . SPARSER::PROTEIN) ("mach2" . SPARSER::DRUG)
    ("X chromosome" . SPARSER::PROTEIN)
    ("the primary biomarker" . SPARSER::MOLECULE)
    ("factors, or STAT3" . SPARSER::COLLECTION)
    ("the Food and Drug Administration" . SPARSER::COLLECTION)
    ("IL-2 and diphtheria toxin" . SPARSER::COLLECTION)
    ("Ontak" . SPARSER::MOLECULE)
    ("IL-10 and its receptor" . SPARSER::COLLECTION)
    ("IL-10 and IL-6" . SPARSER::COLLECTION)
    ("interleukins and interleukin" . SPARSER::COLLECTION)
    ("IL-6 , IL-10 , IL-10RA , and IL-12A" . SPARSER::COLLECTION)
    ("APOL" . SPARSER::PROTEIN) ("AP-1/ATF" . SPARSER::COLLECTION)
    ("BATF" . SPARSER::PROTEIN)
    ("NFKBIZ and the oncogene PIM2" . SPARSER::COLLECTION)
    ("NFKBIZ" . SPARSER::PROTEIN) ("CGH" . SPARSER::PROTEIN)
    ("PRDM1 and SOCS3" . SPARSER::COLLECTION)
    ("multiple nearby BRs" . SPARSER::PROTEIN)
    ("IL-6 and IL-10" . SPARSER::COLLECTION)
    ("Another notable GCB" . SPARSER::PROTEIN)
    ("a major biomarker" . SPARSER::MOLECULE)
    ("PDGF receptor ( PDGFRB )" . SPARSER::PROTEIN)
    ("factors and receptors" . SPARSER::COLLECTION)
    ("PDGFRB" . SPARSER::PROTEIN)
    ("a major lymphangiogenic growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCR7 and CXCR5" . SPARSER::COLLECTION) ("only 21 genes" . SPARSER::GENE)
    ("only 294 genes" . SPARSER::GENE) ("BR" . SPARSER::PROTEIN)
    ("MME" . SPARSER::PROTEIN)
    ("interferon and cytokine" . SPARSER::COLLECTION)
    ("JAK1 and JAK3" . SPARSER::COLLECTION)
    ("SOCS1 , PIAS2 , and PTPRC" . SPARSER::COLLECTION)
    ("PTPRC" . SPARSER::PROTEIN) ("nos" . SPARSER::PROTEIN)
    ("a suspension-tolerant clonal derivative" . SPARSER::DERIVATIVE)
    ("their associated genes" . SPARSER::GENE) ("eIF-3" . SPARSER::COLLECTION)
    ("JAK3:STAT3" . SPARSER::BIO-COMPLEX)
    ("IL-2, IL-7, IL-9, IL-15, and IL-21" . SPARSER::COLLECTION)
    ("ABC and GCB" . SPARSER::COLLECTION) ("no obvious hot" . SPARSER::PROTEIN)
    ("SPP" . SPARSER::PROTEIN) ("total and activated STAT3" . SPARSER::PROTEIN)
    ("GCB and ABC" . SPARSER::COLLECTION) ("BRs" . SPARSER::PROTEIN)
    ("GCB" . SPARSER::PROTEIN) ("overactive STAT3" . SPARSER::PROTEIN)
    ("genes and plays" . SPARSER::COLLECTION)
    ("interleukins and cytokines" . SPARSER::COLLECTION)
    ("chromatin " . SPARSER::PROTEIN)
    ("the germinal center B-cell−like form" . SPARSER::FORM)
    ("CD22" . SPARSER::PROTEIN) ("TRIB2" . SPARSER::PROTEIN)
    ("MYBL1" . SPARSER::PROTEIN) ("diphtheria toxin" . SPARSER::PROTEIN)
    ("denileukin diftitox" . SPARSER::MOLECULE) ("IL-2RA" . SPARSER::PROTEIN)
    ("IL-2RB" . SPARSER::PROTEIN) ("IL-12A" . SPARSER::PROTEIN)
    ("IL-10RA" . SPARSER::PROTEIN) ("BFL1" . SPARSER::PROTEIN)
    ("BCL2A1" . SPARSER::PROTEIN) ("PIM2" . SPARSER::PROTEIN)
    ("PRDM1" . SPARSER::PROTEIN) ("ARNT2" . SPARSER::PROTEIN)
    ("transforming growth factor alpha" . SPARSER::PROTEIN)
    ("CXCR5" . SPARSER::PROTEIN) ("CCR7" . SPARSER::PROTEIN)
    ("MUM1" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("IRF4" . SPARSER::PROTEIN) ("PIAS2" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 3" . SPARSER::PROTEIN)
    ("EIF3B" . SPARSER::PROTEIN) ("IL-15" . SPARSER::PROTEIN)
    ("IL-9" . SPARSER::PROTEIN) ("JAK3" . SPARSER::PROTEIN)
    ("gene-environmental factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adenine" . SPARSER::NUCLEOBASE) ("Val/Val" . SPARSER::COLLECTION)
    ("allele and susceptibility" . SPARSER::COLLECTION)
    ("gene and CRC" . SPARSER::COLLECTION) ("COX" . SPARSER::PROTEIN)
    ("GC/CC" . SPARSER::COLLECTION) ("COX-2 and CRC" . SPARSER::COLLECTION)
    ("protein1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("iron (LPI)" . SPARSER::MOLECULE) ("LPI" . SPARSER::PROTEIN)
    ("labile" . SPARSER::PROTEIN) ("Iron" . SPARSER::MOLECULE)
    ("B cell chronic lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("dietary iron" . SPARSER::MOLECULE)
    ("transfusional iron" . SPARSER::MOLECULE)
    ("GDF15 and APAF-1" . SPARSER::COLLECTION) ("CRP" . SPARSER::PROTEIN)
    ("ASF" . SPARSER::PROTEIN)
    ("caspase-3, caspase-6, and caspase-7" . SPARSER::COLLECTION)
    ("procaspase-9 and forms" . SPARSER::COLLECTION)
    ("dATP or ATP" . SPARSER::COLLECTION) ("dATP" . SPARSER::DATP)
    ("NTBI" . SPARSER::MOLECULE) ("interfering RNAs" . SPARSER::RNA)
    ("endoribonuclease" . SPARSER::PROTEIN)
    ("ferric ammonium citrate (FAC)" . SPARSER::MOLECULE)
    ("citrate (FAC)" . SPARSER::MOLECULE)
    ("mRNA, and protein" . SPARSER::COLLECTION) ("FAC " . SPARSER::PROTEIN)
    ("citrate " . SPARSER::MOLECULE) ("FAC" . SPARSER::PROTEIN)
    ("citrate" . SPARSER::MOLECULE)
    ("flow cytometry, quantitative real-time PCR, and colorimetric assay"
     . SPARSER::COLLECTION)
    ("APAF-1, and caspase-9" . SPARSER::COLLECTION)
    ("Erythroid" . SPARSER::PROTEIN) ("MDS" . SPARSER::PROTEIN)
    ("Caspase-9" . SPARSER::PROTEIN) ("C-reactive protein" . SPARSER::PROTEIN)
    ("CD235a" . SPARSER::PROTEIN) ("CD41" . SPARSER::PROTEIN)
    ("CD13" . SPARSER::PROTEIN) ("caspase-6" . SPARSER::PROTEIN)
    ("Cytochrome C" . SPARSER::PROTEIN) ("procaspase-9" . SPARSER::PROTEIN)
    ("apoptotic protease-activating factor 1" . SPARSER::PROTEIN)
    ("Apoptotic protease-activating factor 1" . SPARSER::PROTEIN)
    ("technical factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIK3CA, and GA0098" . SPARSER::COLLECTION)
    ("c-MET, EGFR, AKT and PI3KC" . SPARSER::COLLECTION)
    ("KC" . SPARSER::PROTEIN) ("associated oncogenes" . SPARSER::ONCOGENE)
    ("IHC demonstrated positive EGFR" . SPARSER::PROTEIN)
    ("GC-PDX" . SPARSER::COLLECTION)
    ("many gastric cancer PDXs" . SPARSER::PROTEIN)
    ("GC-PDXs" . SPARSER::COLLECTION)
    ("EGFR-expressing metastatic CRC" . SPARSER::PROTEIN)
    ("mCRC" . SPARSER::PROTEIN)
    ("a recombinant human/mouse chimeric monoclonal antibody" . SPARSER::DRUG)
    ("and 1 " . SPARSER::PROTEIN)
    ("PALB2 , RAD51C and BRCA2" . SPARSER::COLLECTION)
    ("HR and BRCA" . SPARSER::COLLECTION)
    ("BRCA1 , BRIP1 , ATM , CHEK2 , NBS1 and RAD50" . SPARSER::COLLECTION)
    ("PALB2 , RAD51C , and BRCA2" . SPARSER::COLLECTION)
    ("FANCD2 or FANCI" . SPARSER::COLLECTION)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION) ("FANCI" . SPARSER::PROTEIN)
    ("FANCA" . SPARSER::PROTEIN)
    ("PALB2 , BRCA2 , and RAD51C" . SPARSER::COLLECTION)
    ("a nonfunctional truncated protein" . SPARSER::PROTEIN)
    ("FANCG, FANCD2, BRCA2 and XRCC3" . SPARSER::COLLECTION)
    ("FANCG" . SPARSER::PROTEIN)
    ("RAD51C, XRCC3, BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("PALB2 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA2 or RAD51C" . SPARSER::COLLECTION)
    ("PALB2 , BRCA2 and RAD51C" . SPARSER::COLLECTION)
    ("RAD51, BRCA2, and XRCC3" . SPARSER::COLLECTION)
    ("PALB2 or RAD51C" . SPARSER::COLLECTION)
    ("PALB2 and RAD51" . SPARSER::COLLECTION)
    ("BRCA2 and RAD51C" . SPARSER::COLLECTION)
    ("PALB2, BRCA2, and RAD51C" . SPARSER::COLLECTION)
    ("wild-type PALB2 or the T1030I mutant" . SPARSER::COLLECTION)
    ("the three breast cancer-associated mutants" . SPARSER::MUTANT)
    ("Flag-HA" . SPARSER::COLLECTION)
    ("RAD51C and/or XRCC3" . SPARSER::COLLECTION)
    ("RAD51C, RAD51, and BRCA2 and XRCC3" . SPARSER::COLLECTION)
    ("BRCA2 and XRCC3" . SPARSER::COLLECTION)
    ("RAD51C and XRCC3" . SPARSER::COLLECTION)
    ("RAD51C and RAD51" . SPARSER::COLLECTION)
    ("BRCA2 and the L1143P mutant protein" . SPARSER::COLLECTION)
    ("various HR-associated proteins" . SPARSER::PROTEIN)
    ("HR and FA" . SPARSER::COLLECTION)
    ("BRCA2, RAD51C, and RAD51" . SPARSER::COLLECTION)
    ("BRCA2, RAD51C and RAD51" . SPARSER::COLLECTION)
    ("RAD51C and these other proteins" . SPARSER::COLLECTION)
    ("PALB2-BRCA2-RAD51C-RAD51" . SPARSER::COLLECTION)
    ("neither RAD51C nor BRCA2" . SPARSER::COLLECTION)
    ("BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("Flag-HA-PALB2" . SPARSER::COLLECTION)
    ("RAD51 and RAD51C" . SPARSER::COLLECTION)
    ("BRCA2, PALB2 or RAD51C" . SPARSER::COLLECTION)
    ("PALB2, BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("expressed HF-RAD51C" . SPARSER::COLLECTION)
    ("PALB2, BRCA2, RAD51C and RAD51" . SPARSER::COLLECTION)
    ("MMC" . SPARSER::PROTEIN) ("the only other proteins" . SPARSER::PROTEIN)
    ("HF-RAD51C" . SPARSER::COLLECTION) ("-FLAG-RAD51C" . SPARSER::COLLECTION)
    ("HF" . SPARSER::PROTEIN)
    ("PALB2, RAD51C, and BRCA2" . SPARSER::COLLECTION)
    ("RAD51C, RAD51, and BRCA2" . SPARSER::COLLECTION)
    ("FANCO/RAD51C" . SPARSER::COLLECTION)
    ("FANCN/PALB2" . SPARSER::COLLECTION)
    ("FANCD1/BRCA2" . SPARSER::COLLECTION)
    ("a RAD51B-RAD51C-RAD51D-XRCC2 complex and a RAD51C-XRCC3 complex"
     . SPARSER::COLLECTION)
    ("The RAD51 paralogs form at least two distinct protein"
     . SPARSER::PROTEIN)
    ("RAD51C-XRCC3" . SPARSER::COLLECTION)
    ("RAD51B-RAD51C-RAD51D-XRCC2" . SPARSER::COLLECTION)
    ("RAD51B, RAD51D, XRCC2, and XRCC3" . SPARSER::COLLECTION)
    ("PALB2 and RAD51C" . SPARSER::COLLECTION)
    ("DNA double-strand break-induced HR" . SPARSER::PROTEIN)
    ("PALB2-RAD51C-BRCA2" . SPARSER::COLLECTION)
    ("RAD51C, RAD51 and BRCA2" . SPARSER::COLLECTION)
    ("these homologous recombination (HR) proteins" . SPARSER::PROTEIN)
    ("RAD51C and BRCA2" . SPARSER::COLLECTION)
    ("PALB2 and BRCA2" . SPARSER::COLLECTION) ("RAD50" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("Holliday junction resolvase" . SPARSER::PROTEIN)
    ("RAD18" . SPARSER::PROTEIN) ("RAD51 recombinase" . SPARSER::PROTEIN)
    ("c-Myc and MDM2" . SPARSER::COLLECTION)
    ("p53 and c-Myc" . SPARSER::COLLECTION)
    ("RISC and miRNA" . SPARSER::COLLECTION)
    ("these eukaryotic RPs target c-Myc mRNA" . SPARSER::RNA)
    ("ribosomal proteins and their mRNAs" . SPARSER::COLLECTION)
    ("These two ribosomal proteins" . SPARSER::PROTEIN)
    ("neither RPL23 nor RPL26" . SPARSER::COLLECTION)
    ("subunits, TRBP and Ago2" . SPARSER::COLLECTION)
    ("RNase" . SPARSER::PROTEIN) ("secondary IP" . SPARSER::PROTEIN)
    ("GFP-RPL11" . SPARSER::COLLECTION)
    ("first carried sequential RNP-IP" . SPARSER::COLLECTION)
    ("miR-145-quided RISC" . SPARSER::PROTEIN) ("RNP-IP" . SPARSER::COLLECTION)
    ("subunits and c-Myc" . SPARSER::COLLECTION)
    ("RISC and c-Myc" . SPARSER::COLLECTION)
    ("flag-RPL26" . SPARSER::COLLECTION) ("flag-RPL23" . SPARSER::COLLECTION)
    ("flag-RPL11" . SPARSER::COLLECTION)
    ("other ribosomal proteins" . SPARSER::PROTEIN)
    ("myc-TRBP2" . SPARSER::COLLECTION)
    ("complex and play" . SPARSER::COLLECTION)
    ("RISC, Dicer and Ago2" . SPARSER::COLLECTION)
    ("TRBP2 and Ago2" . SPARSER::COLLECTION)
    ("RPL5 or RPL11" . SPARSER::COLLECTION)
    ("UTR and pcDNA3" . SPARSER::COLLECTION)
    ("RPL5 and c-Myc" . SPARSER::COLLECTION) ("RNP" . SPARSER::PROTEIN)
    ("RPL5, RPL11 or pcDNA" . SPARSER::COLLECTION)
    ("Flag-RPL5" . SPARSER::COLLECTION) ("exogenous RPL5" . SPARSER::PROTEIN)
    ("flag-RPL5" . SPARSER::COLLECTION)
    ("these two ribosomal proteins" . SPARSER::PROTEIN)
    ("a sub-ribosomal complex" . SPARSER::BIO-COMPLEX)
    ("these p53-activating ribosomal proteins" . SPARSER::PROTEIN)
    ("RPL11 and RPL5" . SPARSER::COLLECTION) ("MDM2-p53" . SPARSER::COLLECTION)
    ("ribosomal proteins" . SPARSER::PROTEIN) ("RPS27a" . SPARSER::PROTEIN)
    ("several ribosomal proteins" . SPARSER::PROTEIN)
    ("their own mRNAs" . SPARSER::PROTEIN)
    ("free ribosomal proteins" . SPARSER::PROTEIN)
    ("Ribosome" . SPARSER::BIO-COMPLEX) ("RPs" . SPARSER::PROTEIN)
    ("RPL5 and RPL11" . SPARSER::COLLECTION)
    ("TRBP and Ago2" . SPARSER::COLLECTION) ("TRBP" . SPARSER::PROTEIN)
    ("a global regulator" . SPARSER::PROTEIN) ("Oncogene" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("RPS27" . SPARSER::PROTEIN) ("RPS25" . SPARSER::PROTEIN)
    ("RPS14" . SPARSER::PROTEIN) ("RPS3" . SPARSER::PROTEIN)
    ("RPL26" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribosomal protein L5" . SPARSER::PROTEIN) ("L11" . SPARSER::PROTEIN)
    ("eGFR" . SPARSER::PROTEIN) ("glomerular Claudin-1" . SPARSER::PROTEIN)
    ("glomerular Sirt1" . SPARSER::PROTEIN)
    ("heavy proteinuria" . SPARSER::PROTEIN) ("Mant" . SPARSER::PROTEIN)
    ("Mant-NMN" . SPARSER::COLLECTION) ("-NMN" . SPARSER::COLLECTION)
    ("Sirt1/Claudin-1" . SPARSER::COLLECTION) ("acetophenone" . SPARSER::DRUG)
    ("NMN and NAD" . SPARSER::COLLECTION) ("mannitol" . SPARSER::PROTEIN)
    ("Sirtinol" . SPARSER::DRUG) ("NADH" . SPARSER::MOLECULE)
    ("Nicotinic acid metabolites" . SPARSER::MOLECULE)
    ("glucose (HG)" . SPARSER::MOLECULE)
    ("micro-dissected PECs" . SPARSER::PROTEIN)
    ("CpG and non-CpG" . SPARSER::COLLECTION) ("sirtinol" . SPARSER::DRUG)
    ("Dnmt3a and Dnmt3b" . SPARSER::COLLECTION) ("Dnmt" . SPARSER::PROTEIN)
    ("renal tubular Sirt1" . SPARSER::PROTEIN) ("TG-" . SPARSER::PROTEIN)
    ("Cont" . SPARSER::PROTEIN) ("-Cre" . SPARSER::COLLECTION)
    ("CKO" . SPARSER::PROTEIN) ("β-catenin and Snail" . SPARSER::COLLECTION)
    ("synaptopodin" . SPARSER::PROTEIN)
    ("the slit membrane protein Podocin and the actin-binding protein Synaptopodin"
     . SPARSER::COLLECTION)
    ("β- catenin and Snail" . SPARSER::COLLECTION)
    ("Synaptopodin" . SPARSER::PROTEIN)
    ("β-catenin/Snail" . SPARSER::COLLECTION) ("Podocin" . SPARSER::PROTEIN)
    ("podocin" . SPARSER::PROTEIN) ("PECs" . SPARSER::PROTEIN)
    ("four upregulated genes and four downregulated genes"
     . SPARSER::COLLECTION)
    ("nitrogen and creatinine" . SPARSER::COLLECTION)
    ("STZ" . SPARSER::PROTEIN) ("renal Sirt1" . SPARSER::PROTEIN)
    ("Sirt1 and Claudin-1" . SPARSER::COLLECTION)
    ("proteinuria" . SPARSER::PROTEIN)
    ("photoactivatable NMN" . SPARSER::PROTEIN)
    ("streptozotocin" . SPARSER::DRUG) ("PCR2" . SPARSER::PROTEIN)
    ("PCR1" . SPARSER::PROTEIN) ("AQP1" . SPARSER::PROTEIN)
    ("recombinase activity" . SPARSER::PROTEIN) ("d −1" . SPARSER::PROTEIN)
    ("FK866" . SPARSER::DRUG) ("HK-2" . SPARSER::PROTEIN)
    ("Histone H3K" . SPARSER::PROTEIN) ("Dnmt3b" . SPARSER::PROTEIN)
    ("Dnmt3a" . SPARSER::PROTEIN) ("NPHS2" . SPARSER::PROTEIN)
    ("Claudin-1" . SPARSER::PROTEIN)
    ("CRLF2, IKZF1, rs3824662, and NA" . SPARSER::COLLECTION)
    ("CRLF2, JAK , and IKZF1" . SPARSER::COLLECTION)
    ("the exact causal variant" . SPARSER::VARIANT)
    ("PU.1 and P300" . SPARSER::COLLECTION) ("CHB" . SPARSER::PROTEIN)
    ("the rs3824662 A allele" . SPARSER::ALLELE)
    ("The A risk allele" . SPARSER::ALLELE)
    ("cytokine receptor, and tyrosine kinase" . SPARSER::COLLECTION)
    ("rs3824662 A allele" . SPARSER::ALLELE) ("MEX" . SPARSER::PROTEIN)
    ("Oncology Group (COG) AALL0232 cohort and 6,661 non-ALL"
     . SPARSER::COLLECTION)
    ("CDKN2A/CDKN2B" . SPARSER::COLLECTION) ("CEBPE" . SPARSER::PROTEIN)
    ("receptors and tyrosine" . SPARSER::COLLECTION)
    ("cytokine receptor, and kinase" . SPARSER::COLLECTION)
    ("childhood acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("SNP 1" . SPARSER::PROTEIN) ("P300" . SPARSER::PROTEIN)
    ("p14" . SPARSER::PROTEIN) ("PIP4K2A" . SPARSER::PROTEIN)
    ("ARID5B" . SPARSER::PROTEIN) ("IKZF1" . SPARSER::PROTEIN)
    ("CRLF2" . SPARSER::PROTEIN)
    ("mammalian sensory epithelium" . SPARSER::PROTEIN)
    ("adult vestibular sensory epithelium" . SPARSER::PROTEIN)
    ("BrdU, Pax2, and myosin VIIA" . SPARSER::COLLECTION)
    ("aminoglycoside" . SPARSER::MOLECULE) ("HCR" . SPARSER::PROTEIN)
    ("BrdU and myosin VIIA" . SPARSER::COLLECTION)
    ("/Sox2" . SPARSER::COLLECTION)
    ("non-damaged cochlear epithelium" . SPARSER::PROTEIN)
    ("BrdU and EGFP" . SPARSER::COLLECTION)
    ("cochlear epithelium" . SPARSER::PROTEIN) ("Neomycin" . SPARSER::DRUG)
    ("neomycin-damaged cochlear epithelium" . SPARSER::PROTEIN)
    ("EGFP/Sox2" . SPARSER::COLLECTION)
    ("intact cochlear epithelium" . SPARSER::PROTEIN)
    ("Phalloidin" . SPARSER::MOLECULE) ("Pax2 or Math1" . SPARSER::COLLECTION)
    ("GER" . SPARSER::PROTEIN)
    ("The basic helix-loop-helix transcription factor Math1"
     . SPARSER::PROTEIN)
    ("Atoh1 and Hath1" . SPARSER::COLLECTION)
    ("P27kip1 or pRb" . SPARSER::COLLECTION)
    ("P27kip1, p19ink4d, pRb, and p21cip1" . SPARSER::COLLECTION)
    ("a permanent quiescent state" . SPARSER::BIO-STATE)
    ("Pax2 and Math1" . SPARSER::COLLECTION)
    ("/myosin VIIA" . SPARSER::COLLECTION)
    ("Pax2 and/or Math1" . SPARSER::COLLECTION) ("Myo7a" . SPARSER::PROTEIN)
    ("LY411575" . SPARSER::MOLECULE) ("Paired box 2" . SPARSER::PROTEIN)
    ("Hath1" . SPARSER::PROTEIN) ("Atoh1" . SPARSER::PROTEIN)
    ("p21cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p19ink4d" . SPARSER::PROTEIN)
    ("P27kip1" . SPARSER::PROTEIN) ("myosin VIIA" . SPARSER::PROTEIN)
    ("Math1" . SPARSER::PROTEIN) ("Pax2" . SPARSER::PROTEIN)
    ("Swi/Snf" . SPARSER::COLLECTION) ("Snf" . SPARSER::PROTEIN)
    ("Swi" . SPARSER::PROTEIN) ("PcG" . SPARSER::PROTEIN-FAMILY)
    ("co-factors or mediators" . SPARSER::COLLECTION)
    ("Nrf2 and the ARE ( xref )" . SPARSER::COLLECTION)
    ("RXR and thyroid hormone receptor (TR) [ xref ]" . SPARSER::COLLECTION)
    ("receptor (TR)" . SPARSER::RECEPTOR)
    ("receptors (RXR)" . SPARSER::RECEPTOR)
    ("another repressive chromatin-associated protein" . SPARSER::PROTEIN)
    ("histones and chromatin" . SPARSER::COLLECTION)
    ("p53 and c-fos" . SPARSER::COLLECTION)
    ("a multifunctional nuclear protein" . SPARSER::PROTEIN)
    ("arsenite" . SPARSER::DRUG) ("MafG-Nrf2" . SPARSER::COLLECTION)
    ("PARP-1/MafG/Nrf2" . SPARSER::COLLECTION)
    ("Maf and Nrf2" . SPARSER::COLLECTION)
    ("PARP-1, MafG and Nrf2" . SPARSER::COLLECTION)
    ("Maf-Nrf2" . SPARSER::COLLECTION)
    ("anti-PARP-1 or anti-Nrf2" . SPARSER::COLLECTION)
    ("both MafG and the ARE" . SPARSER::COLLECTION)
    ("Nrf2-Maf" . SPARSER::COLLECTION)
    ("anti-PARP-1 or anti-His" . SPARSER::COLLECTION)
    ("anti-GST and anti-His" . SPARSER::COLLECTION)
    ("Flag-PARP-1" . SPARSER::COLLECTION) ("GST-Nrf2" . SPARSER::COLLECTION)
    ("MafG and PARP-1" . SPARSER::COLLECTION)
    ("anti-MafG antibodies or normal rabbit IgG (negative control)"
     . SPARSER::COLLECTION)
    ("Maf and PARP-1" . SPARSER::COLLECTION)
    ("PARP-1 and MafG" . SPARSER::COLLECTION)
    ("Myc-MafG" . SPARSER::COLLECTION) ("Keap1-CBD" . SPARSER::PROTEIN-PAIR)
    ("anti-HA or anti-GFP" . SPARSER::COLLECTION)
    ("anti-GFP, anti-myc and anti-poly" . SPARSER::COLLECTION)
    ("ADPribose" . SPARSER::MOLECULE) ("GFP-p53" . SPARSER::COLLECTION)
    ("HA-Nrf2" . SPARSER::COLLECTION) ("PJ-34 or 3-AB" . SPARSER::COLLECTION)
    ("known enzyme" . SPARSER::ENZYME)
    ("NQO1 , HO-1 , GCLM , and AKR1C1" . SPARSER::COLLECTION)
    ("siRNA or PARP-1" . SPARSER::COLLECTION)
    ("NQO1, HO-1, GCLM and AKR1C1" . SPARSER::COLLECTION)
    ("NQO1 , HO-1 , GCLM and AKR1C1" . SPARSER::COLLECTION)
    ("Nrf2 and the ARE" . SPARSER::COLLECTION)
    ("Nrf2 and its downstream genes NQO1 and GSTM1" . SPARSER::COLLECTION)
    ("NQO1 and GSTM1" . SPARSER::COLLECTION)
    ("tBHQ or SF" . SPARSER::COLLECTION) ("sulforaphane (SF)" . SPARSER::DRUG)
    ("NQO1-ARE-dependent luciferase" . SPARSER::PROTEIN)
    ("PARP-1 or Nrf2" . SPARSER::COLLECTION)
    ("anti-Nrf2 and anti-PARP-1" . SPARSER::COLLECTION)
    ("PARP-1 and small Maf proteins" . SPARSER::COLLECTION)
    ("PARP-1 and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and PARP-1" . SPARSER::COLLECTION)
    ("a ubiquitous DNA-binding protein" . SPARSER::PROTEIN)
    ("CTCF" . SPARSER::PROTEIN) ("c-fos and p53" . SPARSER::COLLECTION)
    ("RAR" . SPARSER::PROTEIN)
    ("relevant target promoters" . SPARSER::PROMOTER)
    ("polymer" . SPARSER::MOLECULE)
    ("CREB-binding protein (CBP)" . SPARSER::PROTEIN)
    ("the placental form" . SPARSER::FORM)
    ("monocytic leukemia zinc-finger protein (MOZ)" . SPARSER::PROTEIN)
    ("Nrf2–MafK" . SPARSER::COLLECTION) ("GSTP" . SPARSER::PROTEIN)
    ("GCLM" . SPARSER::PROTEIN) ("GCLC" . SPARSER::PROTEIN)
    ("UGT" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("MafG, MafF or MafK" . SPARSER::COLLECTION)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("MafK" . SPARSER::PROTEIN) ("MafF" . SPARSER::PROTEIN)
    ("Cul3/Rbx1/Keap1" . SPARSER::COLLECTION)
    ("MafG and the ARE" . SPARSER::COLLECTION)
    ("Nrf2, MafG and the ARE" . SPARSER::COLLECTION)
    ("MafG" . SPARSER::PROTEIN)
    ("small Maf proteins and the ARE" . SPARSER::COLLECTION)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The basic leucine zipper (bZIP) transcription factor Nrf2"
     . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY) ("C-jun" . SPARSER::PROTEIN)
    ("GSTM1" . SPARSER::PROTEIN) ("PJ-34" . SPARSER::DRUG)
    ("hNQO1" . SPARSER::PROTEIN) ("GSTA1" . SPARSER::PROTEIN)
    ("nrf2" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("Bach1" . SPARSER::PROTEIN)
    ("leukemia zinc-finger protein" . SPARSER::PROTEIN)
    ("Multidrug resistance" . SPARSER::PROTEIN)
    ("UDP-glucuronosyltransferase" . SPARSER::PROTEIN)
    ("AKR1C1" . SPARSER::PROTEIN) ("member C1" . SPARSER::PROTEIN)
    ("aldo-keto reductase family 1" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("Rbx1" . SPARSER::PROTEIN)
    ("NF-E2" . SPARSER::PROTEIN) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("either Delta Max ( xref ) or mTORC2 ( xref )" . SPARSER::COLLECTION)
    ("TGF-beta and RTK" . SPARSER::COLLECTION) ("Ac" . SPARSER::PROTEIN)
    ("Ac-FoxO" . SPARSER::COLLECTION) ("FoxO-Myc" . SPARSER::COLLECTION)
    ("FoxO/c-Myc" . SPARSER::COLLECTION) ("ATP-competitive" . SPARSER::ATP)
    ("LDHA and HK2" . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor XL765" . SPARSER::DRUG)
    ("mTORC2, and PI3K or Akt" . SPARSER::COLLECTION)
    ("FoxO-c-Myc" . SPARSER::COLLECTION)
    ("LDHA, HK2, PDK1 and GLUT1" . SPARSER::COLLECTION)
    ("LDHA" . SPARSER::PROTEIN) ("their anti-miR" . SPARSER::ANTIBODY)
    ("FoxO1/FoxO3" . SPARSER::COLLECTION)
    ("Akt, mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("mTORC2-HDAC-FoxO-Myc" . SPARSER::COLLECTION)
    ("EGFR/mTORC2" . SPARSER::COLLECTION)
    ("HDAC4, HDAC5 and HDAC7" . SPARSER::COLLECTION)
    ("only two genes" . SPARSER::GENE) ("HAT and HDAC" . SPARSER::COLLECTION)
    ("histone acetyltransferases (HATs) and histone deacetylases (HDACs)"
     . SPARSER::COLLECTION)
    ("FoxO1-KR" . SPARSER::COLLECTION)
    ("lactate and glutamate" . SPARSER::COLLECTION)
    ("An acetylation resistant mutant (FoxO1-5KR) and an analogous FoxO3 mutant (FoxO3-4KR, data not shown)"
     . SPARSER::COLLECTION)
    ("FoxO3-TM" . SPARSER::COLLECTION) ("Akti" . SPARSER::PROTEIN)
    ("PI3K or Akt" . SPARSER::COLLECTION) ("FoxOs" . SPARSER::PROTEIN-FAMILY)
    ("Akt or mTORC1" . SPARSER::COLLECTION)
    ("Akt or raptor" . SPARSER::COLLECTION) ("p-NDRG1" . SPARSER::COLLECTION)
    ("galactose" . SPARSER::MOLECULE)
    ("the most common and lethal form" . SPARSER::FORM)
    ("FoxO and c-Myc" . SPARSER::COLLECTION)
    ("this in turn releases c-Myc" . SPARSER::PROTEIN)
    ("FoxO1 and FoxO3" . SPARSER::COLLECTION) ("hnRNPA1" . SPARSER::PROTEIN)
    ("SAR245409" . SPARSER::DRUG) ("XL765" . SPARSER::DRUG)
    ("GLUT1" . SPARSER::PROTEIN) ("HK2" . SPARSER::PROTEIN)
    ("SGK1" . SPARSER::PROTEIN) ("C-Myc" . SPARSER::PROTEIN)
    ("FoxO3" . SPARSER::PROTEIN) ("JE" . SPARSER::PROTEIN)
    ("SH" . SPARSER::PROTEIN) ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("multifocal genesis" . SPARSER::PROTEIN)
    ("fallopian tube" . SPARSER::PROTEIN) ("p53/p16" . SPARSER::COLLECTION)
    ("BRAF or KRAS" . SPARSER::COLLECTION)
    ("a bilateral s-BOT" . SPARSER::COLLECTION)
    ("KRAS/BRAF" . SPARSER::COLLECTION)
    ("highly or moderately expressing p16" . SPARSER::PROTEIN)
    ("expressing p16" . SPARSER::PROTEIN) ("IRS " . SPARSER::PROTEIN)
    ("strongly expressing p53" . SPARSER::PROTEIN)
    ("expressing p53" . SPARSER::PROTEIN)
    ("at least one s-BOT" . SPARSER::COLLECTION)
    ("p53 and p16" . SPARSER::COLLECTION) ("p16 and p53" . SPARSER::COLLECTION)
    ("homolog) and BRAF" . SPARSER::COLLECTION)
    ("v-raf" . SPARSER::PROTEIN-PAIR) ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the ovarian s-BOT" . SPARSER::COLLECTION)
    ("particularly serous s-BOT" . SPARSER::COLLECTION)
    ("p53/p16 INK4a" . SPARSER::COLLECTION) ("BRAF/KRAS" . SPARSER::COLLECTION)
    ("s-BOT" . SPARSER::COLLECTION) ("ICC and ECC" . SPARSER::COLLECTION)
    ("KRAS , BRAF , TP53 and epidermal growth factor receptor ( EGFR )"
     . SPARSER::COLLECTION)
    ("KRAS , BRAF , TP53 and epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("unresectable ICC" . SPARSER::PROTEIN) ("fluke" . SPARSER::PROTEIN)
    ("ECC" . SPARSER::MOLECULE)
    ("both significant prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pregnancy-associated case" . SPARSER::PROTEIN)
    ("other prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA 2" . SPARSER::PROTEIN) ("broadly acting antivirals" . SPARSER::DRUG)
    ("antivirals" . SPARSER::DRUG)
    ("apolipoprotein A1 (APOA1) and nucleobindin 1 (NUCB1)"
     . SPARSER::COLLECTION)
    ("PCNT" . SPARSER::PROTEIN) ("LDs" . SPARSER::PROTEIN)
    ("GT 1" . SPARSER::PROTEIN) ("Lipid-" . SPARSER::LIPID)
    ("multiple viral proteins" . SPARSER::PROTEIN)
    ("single viral proteins" . SPARSER::PROTEIN)
    ("their viral proteins" . SPARSER::PROTEIN)
    ("NS3 and NS5" . SPARSER::COLLECTION)
    ("7 HCV 2a proteins and 94 human proteins" . SPARSER::COLLECTION)
    ("KTN1 and CTNNB1" . SPARSER::COLLECTION)
    ("CUL7, PCM1, RILPL2, RNASET2, or TCF7L2" . SPARSER::COLLECTION)
    ("the unique targets" . SPARSER::TARGET-PROTEIN)
    ("helicases" . SPARSER::PROTEIN) ("DEAD" . SPARSER::PROTEIN)
    ("All unique human gene" . SPARSER::PROTEIN) ("1b" . SPARSER::PROTEIN)
    ("NS5B and NS3" . SPARSER::COLLECTION)
    ("3 viral proteins" . SPARSER::PROTEIN)
    ("a single viral protein" . SPARSER::PROTEIN)
    ("the NS4B and Core proteins" . SPARSER::COLLECTION)
    ("genes or gene" . SPARSER::COLLECTION)
    ("11 mature peptides" . SPARSER::PEPTIDE)
    ("approximately 3000 amino acids" . SPARSER::AMINO-ACID)
    ("orthologous viral proteins" . SPARSER::PROTEIN)
    ("its own genome" . SPARSER::PROTEIN)
    ("CUL7, PCM1, RILPL2, RNASET2, and TCF7L2" . SPARSER::COLLECTION)
    ("lipid and cholesterol" . SPARSER::COLLECTION) ("GT1b" . SPARSER::PROTEIN)
    ("GT1a" . SPARSER::MOLECULE) ("NUCB1" . SPARSER::PROTEIN)
    ("nucleobindin 1" . SPARSER::PROTEIN)
    ("apolipoprotein A1" . SPARSER::PROTEIN) ("NS5" . SPARSER::PROTEIN)
    ("KTN1" . SPARSER::PROTEIN) ("SDCCAG8" . SPARSER::PROTEIN)
    ("GT 1b" . SPARSER::PROTEIN) ("NS5B" . SPARSER::PROTEIN)
    ("NS5A" . SPARSER::PROTEIN) ("NS4B" . SPARSER::PROTEIN)
    ("NS4A" . SPARSER::PROTEIN) ("NS3" . SPARSER::PROTEIN)
    ("NS2" . SPARSER::PROTEIN) ("GT 2" . SPARSER::PROTEIN)
    ("GTs 1" . SPARSER::PROTEIN) ("GT 1a" . SPARSER::MOLECULE)
    ("RNASET2" . SPARSER::PROTEIN) ("RILPL2" . SPARSER::PROTEIN)
    ("PCM1" . SPARSER::PROTEIN) ("CUL7" . SPARSER::PROTEIN)
    ("TRKC" . SPARSER::PROTEIN)
    ("the pro-apoptotic p40 Met fragment" . SPARSER::FRAGMENT)
    ("DCC and Patched" . SPARSER::COLLECTION)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("Patched and DCC" . SPARSER::COLLECTION) ("DISC" . SPARSER::BIO-COMPLEX)
    ("FAS" . SPARSER::PROTEIN)
    ("DRAL, TUCAN and caspase-9" . SPARSER::COLLECTION)
    ("TUCAN" . SPARSER::PROTEIN) ("DRAL" . SPARSER::PROTEIN)
    ("DCC and UNC5H" . SPARSER::COLLECTION)
    ("the pro-apoptotic fragment p40 Met" . SPARSER::AMINO-ACID)
    ("Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl-xL" . SPARSER::COLLECTION) ("h" . SPARSER::PROTEIN)
    ("both the full-length receptor and the p40 Met ( xref )"
     . SPARSER::COLLECTION)
    ("HGF/SF" . SPARSER::COLLECTION) ("a 3-h" . SPARSER::COLLECTION)
    ("optimal Bak" . SPARSER::PROTEIN) ("apoptotic MCF-10A" . SPARSER::PROTEIN)
    ("the pro-apoptotic fragment" . SPARSER::FRAGMENT)
    ("percoll" . SPARSER::DRUG) ("nuclear and GAPDH" . SPARSER::COLLECTION)
    ("nuclear and mitochondrial" . SPARSER::COLLECTION)
    ("p40 Met and SMS-p40 Met" . SPARSER::COLLECTION)
    ("SMS-p40" . SPARSER::COLLECTION) ("SMS" . SPARSER::PROTEIN)
    ("ectopically expressed p40 Met" . SPARSER::AMINO-ACID)
    ("expressed p40 Met" . SPARSER::AMINO-ACID)
    ("a constitutively dimerized form" . SPARSER::FORM)
    ("TPR" . SPARSER::PROTEIN) ("TNF-CHX" . SPARSER::COLLECTION)
    ("/cycloheximide" . SPARSER::COLLECTION) ("Doxycycline" . SPARSER::DRUG)
    ("both full-length Met and p40 Met" . SPARSER::COLLECTION)
    ("staurosporin" . SPARSER::MOLECULE)
    ("previously described dependence receptors" . SPARSER::RECEPTOR)
    ("pro-apoptotic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DCC, Patched and UNC5" . SPARSER::COLLECTION)
    ("RAS-ERK" . SPARSER::COLLECTION) ("SF" . SPARSER::PROTEIN)
    ("integrins and multipass" . SPARSER::COLLECTION)
    ("bifunctional receptors" . SPARSER::PROTEIN)
    ("The receptor tyrosine kinase Met and its ligand" . SPARSER::COLLECTION)
    ("beta-2-microglobulin" . SPARSER::PROTEIN) ("BcL-xL" . SPARSER::PROTEIN)
    ("zVAD-FMK" . SPARSER::DRUG) ("SU-11274" . SPARSER::DRUG)
    ("TNF α" . SPARSER::PROTEIN)
    ("myosin light chains" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cox IV" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("UNC5" . SPARSER::PROTEIN) ("scatter factor" . SPARSER::PROTEIN)
    ("single-pass" . SPARSER::PROTEIN-FAMILY) ("p40" . SPARSER::PROTEIN)
    ("Sequential redox" . SPARSER::PROTEIN) ("oxidants" . SPARSER::MOLECULE)
    ("DMPK/HK II/Src" . SPARSER::COLLECTION)
    ("specific respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("HK II, DMPK and Src" . SPARSER::COLLECTION)
    ("HK II and the tyrosine kinase Src" . SPARSER::COLLECTION)
    ("shDMPK" . SPARSER::PROTEIN) ("RD-shDMPK" . SPARSER::COLLECTION)
    ("myogenic" . SPARSER::PROTEIN) ("DMPK and HK II" . SPARSER::COLLECTION)
    ("glutathione reductase and thioredoxin reductase" . SPARSER::COLLECTION)
    ("RD" . SPARSER::PROTEIN) ("DMPK and Src" . SPARSER::COLLECTION)
    ("Src and DMPK" . SPARSER::COLLECTION)
    ("a specific dual site Src inhibitor" . SPARSER::INHIBITOR)
    ("HK II/Src" . SPARSER::COLLECTION) ("HK II/DMPK" . SPARSER::COLLECTION)
    ("HK II and DMPK" . SPARSER::COLLECTION)
    ("a cell permeable synthetic peptide" . SPARSER::PEPTIDE)
    ("TAT-HK II" . SPARSER::COLLECTION) ("TAT" . SPARSER::PROTEIN)
    ("CsH" . SPARSER::PROTEIN) ("cyclosporin" . SPARSER::DRUG)
    ("CsA" . SPARSER::PROTEIN)
    ("glutathione and manganese superoxide dismutase" . SPARSER::COLLECTION)
    ("pentose" . SPARSER::MOLECULE)
    ("pyruvate and glutamine" . SPARSER::COLLECTION)
    ("AIF and Omi" . SPARSER::COLLECTION) ("CyP" . SPARSER::PROTEIN)
    ("Omi" . SPARSER::PROTEIN) ("expressed DMPK" . SPARSER::PROTEIN)
    ("SAOS-2-DMPK and SAOS-2-DMPK" . SPARSER::COLLECTION)
    ("DMPK, HK II and Src" . SPARSER::COLLECTION)
    ("DMPK  −/− mice display swollen mitochondria" . SPARSER::PROTEIN)
    ("phospholemman and phospholamban" . SPARSER::COLLECTION)
    ("HSP25/HSPB1" . SPARSER::COLLECTION)
    ("α B-crystallin" . SPARSER::PROTEIN-PAIR)
    ("MKBP/HSPB2" . SPARSER::COLLECTION)
    ("CUG-BP/hNab50" . SPARSER::COLLECTION) ("crystallin" . SPARSER::PROTEIN)
    ("MKBP" . SPARSER::PROTEIN) ("phospholamban" . SPARSER::PROTEIN)
    ("phospholemman" . SPARSER::PROTEIN)
    ("myotonic dystrophy type 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("a multimolecular complex" . SPARSER::BIO-COMPLEX)
    ("HK II and Src" . SPARSER::COLLECTION)
    ("antioxidant and pro-survival" . SPARSER::COLLECTION)
    ("proteins and tyrosine" . SPARSER::COLLECTION)
    ("a multimeric complex" . SPARSER::BIO-COMPLEX)
    ("whose gene mutations cause myotonic dystrophy type 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DMPK" . SPARSER::PROTEIN) ("complex I" . SPARSER::PROTEIN)
    ("Glutathione reductase" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("Na +" . SPARSER::MOLECULE) ("Thioredoxin reductase" . SPARSER::PROTEIN)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("cPLA2" . SPARSER::PROTEIN)
    ("Mn-SOD" . SPARSER::PROTEIN) ("slow)" . SPARSER::PROTEIN)
    ("voltage-dependent" . SPARSER::PROTEIN) ("HK I" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thioredoxin reductase" . SPARSER::PROTEIN)
    ("glutathione reductase" . SPARSER::PROTEIN) ("VDAC1" . SPARSER::PROTEIN)
    ("cyclosporin A" . SPARSER::MOLECULE)
    ("oxidized glutathione" . SPARSER::DRUG)
    ("ATP synthase" . SPARSER::PROTEIN) ("cyclophilin D" . SPARSER::PROTEIN)
    ("HSPB1" . SPARSER::PROTEIN) ("HSP25" . SPARSER::PROTEIN)
    ("HSPB5" . SPARSER::PROTEIN) ("HSPB2" . SPARSER::PROTEIN)
    ("subunit 1" . SPARSER::PROTEIN) ("myosin phosphatase" . SPARSER::PROTEIN)
    ("hNab50" . SPARSER::PROTEIN) ("HK II" . SPARSER::PROTEIN)
    ("myotonic dystrophy protein kinase" . SPARSER::PROTEIN)
    ("mRNA and pFGFR1" . SPARSER::COLLECTION)
    ("primary and metastatic CRC" . SPARSER::PROTEIN)
    ("total ERK1/2 and total Akt" . SPARSER::COLLECTION)
    ("mRNA or pFGFR1" . SPARSER::COLLECTION) ("LLA" . SPARSER::PROTEIN)
    ("the 515 primary CRCs" . SPARSER::PROTEIN)
    ("primary and metastasized CRC" . SPARSER::PROTEIN)
    ("a relevant cohort" . SPARSER::MOLECULE)
    ("FRS2 and phospholipase-Cγ" . SPARSER::COLLECTION)
    ("18 revealed membranous activated pFGFR1 protein" . SPARSER::PROTEIN)
    ("454 primary CRCs" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("as 3" . SPARSER::PROTEIN) ("phospholipase-Cγ" . SPARSER::PROTEIN-FAMILY)
    ("FRS2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("prolactin receptor ( xref ) or Rb1/Nras ( xref )" . SPARSER::COLLECTION)
    ("RET/RAS" . SPARSER::COLLECTION)
    ("the INK4 and CIP/KIP families" . SPARSER::COLLECTION)
    ("CIP/KIP" . SPARSER::COLLECTION) ("KIP" . SPARSER::PROTEIN)
    ("CIP" . SPARSER::PROTEIN)
    ("Rb or other pro-proliferative downstream effectors"
     . SPARSER::COLLECTION)
    ("aberrant Cdk5" . SPARSER::PROTEIN)
    ("the phospho-Rb-dependent neoplastic state" . SPARSER::BIO-STATE)
    ("Cyclin A-Cdk2" . SPARSER::COLLECTION)
    ("Cyclin D-Cdk4" . SPARSER::PROTEIN-PAIR)
    ("cyclin/cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("RET or RAS" . SPARSER::COLLECTION) ("Cdk5/p35" . SPARSER::COLLECTION)
    ("Cdk2 and Cyclin A" . SPARSER::COLLECTION)
    ("peptide (SIP)" . SPARSER::PEPTIDE) ("SIP" . SPARSER::PROTEIN)
    ("Cdk5-Rb" . SPARSER::COLLECTION)
    ("Cdk5, p35 and p25" . SPARSER::COLLECTION)
    ("two alternate Cdk5 inhibitors" . SPARSER::INHIBITOR)
    ("expressed p25-GFP" . SPARSER::COLLECTION)
    ("Cdk5 or p35" . SPARSER::COLLECTION) ("fibrous septa" . SPARSER::PROTEIN)
    ("septa" . SPARSER::PROTEIN)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p25-GFP" . SPARSER::COLLECTION) ("transgene" . SPARSER::PROTEIN)
    ("FDG" . SPARSER::PROTEIN) ("NSE" . SPARSER::PROTEIN)
    ("CP681301-treated MTC-SK" . SPARSER::COLLECTION)
    ("Cdk5 or Cdk2" . SPARSER::COLLECTION)
    ("metastatic sporadic MTC" . SPARSER::PROTEIN)
    ("MTC-SK" . SPARSER::COLLECTION) ("SIN" . SPARSER::PROTEIN)
    ("CP" . SPARSER::PROTEIN) ("Cdk5 or p25" . SPARSER::COLLECTION)
    ("NDF" . SPARSER::PROTEIN) ("Cdk5 and p35" . SPARSER::COLLECTION)
    ("at least some hereditary and sporadic forms" . SPARSER::FORM)
    ("Cdk5, p35, and p25" . SPARSER::COLLECTION)
    ("p35/p25" . SPARSER::COLLECTION)
    ("Cdk5 and its activators" . SPARSER::COLLECTION)
    ("p35 and p25" . SPARSER::COLLECTION)
    ("cofactors, p35 or p39" . SPARSER::COLLECTION)
    ("metastatic MTC" . SPARSER::PROTEIN) ("Vandetanib" . SPARSER::DRUG)
    ("sporadic MTC" . SPARSER::PROTEIN)
    ("GDNF, neurturin, artemin and persephin" . SPARSER::COLLECTION)
    ("persephin" . SPARSER::PROTEIN) ("artemin" . SPARSER::PROTEIN)
    ("neurturin" . SPARSER::PROTEIN) ("the more severe form" . SPARSER::FORM)
    ("Cdk5 and its cofactors, p35 and p25" . SPARSER::COLLECTION)
    ("cofactors, p35 and p25" . SPARSER::COLLECTION) ("MTC" . SPARSER::PROTEIN)
    ("prolactin receptor" . SPARSER::PROTEIN) ("CDKN2B" . SPARSER::PROTEIN)
    ("p19 INK4D" . SPARSER::PROTEIN) ("CDKN2D" . SPARSER::PROTEIN)
    ("CDKN2C" . SPARSER::PROTEIN) ("INK4" . SPARSER::PROTEIN)
    ("Cyclin D" . SPARSER::PROTEIN)
    ("Retinoblastoma protein" . SPARSER::PROTEIN)
    ("neuron specific enolase" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 5" . SPARSER::PROTEIN)
    ("RAS family" . SPARSER::PROTEIN) ("p25" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdk5" . SPARSER::PROTEIN) ("EGFR-EGFRvIII-STAT" . SPARSER::COLLECTION)
    ("EGFRvIII and STAT3" . SPARSER::COLLECTION)
    ("EGFR, EGFRvIII and STAT" . SPARSER::COLLECTION)
    ("phenylalanines" . SPARSER::AMINO-ACID)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("EGFR and its deletion mutant" . SPARSER::COLLECTION)
    ("EGFR and STAT3" . SPARSER::COLLECTION)
    ("Stattic and erlotinib" . SPARSER::COLLECTION) ("Stattic" . SPARSER::DRUG)
    ("down STAT3 or EGFR/EGFRvIII" . SPARSER::COLLECTION)
    ("EGFRvIII/STAT3" . SPARSER::COLLECTION)
    ("p-EGFRvIII" . SPARSER::COLLECTION)
    ("EGFRvIII, or STAT" . SPARSER::COLLECTION)
    ("subcellular fractions" . SPARSER::COMPONENT)
    ("Kinase dead alleles EGFR D813N and EGFRvIII D813N" . SPARSER::COLLECTION)
    ("wt and EGFRvIII" . SPARSER::COLLECTION)
    ("EGFRvIII I682Q or EGFRvIII V924R" . SPARSER::COLLECTION)
    ("EGFR I682Q and EGFR V924R" . SPARSER::COLLECTION)
    ("only one kinase" . SPARSER::KINASE) ("DY" . SPARSER::MOLECULE)
    ("both EGFRvIII as3 and p-STAT3" . SPARSER::COLLECTION)
    ("as3 , EGFRvIII, and STAT3" . SPARSER::COLLECTION)
    ("/EGFRvIII" . SPARSER::COLLECTION)
    ("as3 and EGFRvIII" . SPARSER::COLLECTION) ("ATP-analogue" . SPARSER::ATP)
    ("TB" . SPARSER::PROTEIN)
    ("EGFR (EGFR as3 ) or EGFRvIII (vIII as3 )" . SPARSER::COLLECTION)
    ("as3" . SPARSER::PROTEIN)
    ("analogue-sensitive (as) alleles" . SPARSER::ALLELE)
    ("EGFR-EGFRVIII" . SPARSER::COLLECTION) ("EGFRVIII" . SPARSER::PROTEIN)
    ("EGFRvIII-STAT" . SPARSER::COLLECTION)
    ("EGFR, EGFRvIII, and STAT3" . SPARSER::COLLECTION)
    ("receptors and STAT3" . SPARSER::COLLECTION)
    ("EGFRvIII, STAT3, or STAT5" . SPARSER::COLLECTION)
    ("EGFRvIII ( xref ) and co-localization" . SPARSER::COLLECTION)
    ("EGFRvIII and p-STAT proteins ( xref )" . SPARSER::COLLECTION)
    ("EGFR, EGFRvIII and p-STAT proteins ( xref )" . SPARSER::COLLECTION)
    ("p-STAT" . SPARSER::COLLECTION) ("STAT3 and STAT5" . SPARSER::COLLECTION)
    ("EGFR, and EGFRvIII" . SPARSER::COLLECTION)
    ("p-STAT5" . SPARSER::COLLECTION) ("p-ERK" . SPARSER::COLLECTION)
    ("EGFR, or EGFRvIII" . SPARSER::COLLECTION)
    ("Antibody" . SPARSER::ANTIBODY)
    ("using EGFR- and EGFRvIII-specific antibodies" . SPARSER::COLLECTION)
    ("EGFR-" . SPARSER::PROTEIN) ("EGFR/EGFRvIII" . SPARSER::COLLECTION)
    ("EGFRvIII and EGFR" . SPARSER::COLLECTION)
    ("interleukin 6 and leukemia inhibitory factor" . SPARSER::COLLECTION)
    ("EGFRvIII-HB-EGF-EGFR" . SPARSER::COLLECTION)
    ("EGFR or EGFRvIII" . SPARSER::COLLECTION)
    ("EGFRvIII-STAT3" . SPARSER::COLLECTION)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION) ("p-S6" . SPARSER::PROTEIN)
    ("Lamin B1" . SPARSER::PROTEIN) ("N protein" . SPARSER::PROTEIN)
    ("LN, CW and ZY" . SPARSER::COLLECTION) ("WR" . SPARSER::PROTEIN)
    ("t-PA and PAI-1" . SPARSER::COLLECTION) ("simvastatin" . SPARSER::DRUG)
    ("t-PA" . SPARSER::PROTEIN) ("PAI-2" . SPARSER::PROTEIN)
    ("Plasminogen activator" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("HAS2 and α-SMA" . SPARSER::COLLECTION)
    ("CaMKII, Rho-GTPase, PI3K, Akt and mTOR" . SPARSER::COLLECTION)
    ("α-SMA nor CD44" . SPARSER::COLLECTION)
    ("neither HAS2, α-SMA nor CD44" . SPARSER::COLLECTION)
    ("sites revealed potential targets" . SPARSER::TARGET-PROTEIN)
    ("Akt and HAS2" . SPARSER::COLLECTION) ("Akt/mTOR" . SPARSER::COLLECTION)
    ("EGFR and components" . SPARSER::COLLECTION)
    ("EGFR and HAS2" . SPARSER::COLLECTION)
    ("miR-7 and in turn EGFR mRNA" . SPARSER::COLLECTION)
    ("in turn EGFR mRNA" . SPARSER::RNA)
    ("miR-7 and EGFR" . SPARSER::COLLECTION) ("HA-" . SPARSER::PROTEIN)
    ("negative control LNA (Fig. xref ) and miR-7 LNA (Fig. xref )"
     . SPARSER::COLLECTION)
    ("fraction (MF)" . SPARSER::COMPONENT) ("MF" . SPARSER::PROTEIN)
    ("the essential components" . SPARSER::COMPONENT)
    ("EDA-FN" . SPARSER::COLLECTION) ("EDA" . SPARSER::PROTEIN)
    ("α-SMA (Fig. xref ) and HAS2 (Fig. xref ) mRNA" . SPARSER::COLLECTION)
    ("previously overexpressed EGFR" . SPARSER::PROTEIN)
    ("EGFR and CD44" . SPARSER::COLLECTION)
    ("CD44 and EGFR" . SPARSER::COLLECTION)
    ("HA and CD44" . SPARSER::COLLECTION) ("TGF-β1-" . SPARSER::PROTEIN)
    ("CD44-epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("hyaluronan (HA)" . SPARSER::PROTEIN)
    ("synthase (HAS)" . SPARSER::PROTEIN) ("synthase" . SPARSER::PROTEIN)
    ("CD44/EGFR" . SPARSER::COLLECTION) ("pre-miR-7" . SPARSER::COLLECTION)
    ("CD44-EGFR" . SPARSER::COLLECTION) ("/Smad2" . SPARSER::COLLECTION)
    ("DNA ligase" . SPARSER::PROTEIN) ("α- SMA" . SPARSER::PROTEIN)
    ("HA-CD44" . SPARSER::PROTEIN) ("co- receptor" . SPARSER::PROTEIN)
    ("miR-7" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-βR" . SPARSER::PROTEIN)
    ("transforming growth factor-beta 1" . SPARSER::PROTEIN)
    ("HAS2" . SPARSER::PROTEIN) ("hyaluronan synthase 2" . SPARSER::PROTEIN)
    ("JH" . SPARSER::PROTEIN) ("hypoxia and normoxia" . SPARSER::COLLECTION)
    ("regulating local RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRS-1 and ACE2" . SPARSER::COLLECTION)
    ("Myocardial hypoxia" . SPARSER::PROTEIN)
    ("Arg 972 -IRS-1 variants and the ACE2 1075AA, 16854GG or 8790AA genotypes"
     . SPARSER::COLLECTION)
    ("soluble ACE2" . SPARSER::PROTEIN)
    ("shRNA and LY294002" . SPARSER::COLLECTION)
    ("shRNA and PI3K" . SPARSER::COLLECTION)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("wild type IRS-1 and Arg 972 IRS-1" . SPARSER::COLLECTION)
    ("the GG and the GA+AA genotype" . SPARSER::COLLECTION)
    ("GG" . SPARSER::PROTEIN) ("heterozygotes" . SPARSER::PROTEIN)
    ("low-density lipoprotein cholesterol and triglycerides"
     . SPARSER::COLLECTION)
    ("insulin/IRS-1" . SPARSER::COLLECTION) ("Gly/Arg" . SPARSER::COLLECTION)
    ("Insulin" . SPARSER::PROTEIN)
    ("an activated cardiac RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cardiac ACE2" . SPARSER::PROTEIN) ("Ang-" . SPARSER::PROTEIN)
    ("Ang" . SPARSER::PROTEIN) ("IRS-1, or PI3K" . SPARSER::COLLECTION)
    ("-IRS-1" . SPARSER::COLLECTION)
    ("insulin/IRS-1/PI3K" . SPARSER::COLLECTION)
    ("wild type IRS-1 or Arg 972 IRS-1" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("insulin/insulin receptor substrate-1" . SPARSER::COLLECTION)
    ("PI-3" . SPARSER::PROTEIN) ("Ang II" . SPARSER::PROTEIN)
    ("HAb18G/CD147-CD44s-STAT3" . SPARSER::COLLECTION)
    ("hyaluronan-CD44" . SPARSER::COLLECTION) ("hyaluronan" . SPARSER::PROTEIN)
    ("CD147 and CD44" . SPARSER::COLLECTION)
    ("CD44s, and CD44s" . SPARSER::COLLECTION)
    ("basigin-3" . SPARSER::COLLECTION) ("MCT" . SPARSER::PROTEIN)
    ("/CD44s" . SPARSER::COLLECTION)
    ("HAb18G/CD147 and STAT3" . SPARSER::COLLECTION)
    ("anti-apoptotic gene survivin and proliferative gene cyclin D1 ( xref )"
     . SPARSER::COLLECTION)
    ("survivin and cyclin D1" . SPARSER::COLLECTION)
    ("either anti-EGFR antibodies or small-molecule tyrosine kinase inhibitors"
     . SPARSER::COLLECTION)
    ("CyPA and STAT3" . SPARSER::COLLECTION)
    ("CyPA-HAb18G/CD147-STAT3" . SPARSER::COLLECTION)
    ("HAb18G/CD147, CD44s, and pSTAT3" . SPARSER::COLLECTION)
    ("HAb18G/CD147-CD44s-pSTAT3" . SPARSER::COLLECTION)
    ("the clinical pathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD44s" . SPARSER::PROTEIN) ("CD44s-pSTAT3" . SPARSER::PROTEIN-PAIR)
    ("type, size and location" . SPARSER::COLLECTION)
    ("HAb18G/CD147, CD44s and STAT3" . SPARSER::COLLECTION)
    ("HAb18G/CD147 and CD44s" . SPARSER::COLLECTION)
    ("siRNA and CD44s" . SPARSER::COLLECTION)
    ("HAb18G/CD147" . SPARSER::PROTEIN)
    ("CyPA and either STAT3 inhibitor FLLL32/WP1066 or survivin inhibitor YM155"
     . SPARSER::COLLECTION)
    ("CyPA-HAb18G/CD147" . SPARSER::COLLECTION)
    ("STAT3, cyclin D1 and survivin" . SPARSER::COLLECTION)
    ("pSTAT3/cyclin D1/survivin" . SPARSER::COLLECTION)
    ("STAT3 and the downstream genes cyclin D1 and survivin"
     . SPARSER::COLLECTION)
    ("cyclin D1 and survivin" . SPARSER::COLLECTION)
    ("pGIPZ" . SPARSER::PROTEIN) ("shRNA and pTRIPZ" . SPARSER::COLLECTION)
    ("pGIPZ-CD147" . SPARSER::PROTEIN-PAIR)
    ("CD147-shRNA" . SPARSER::COLLECTION) ("RFP" . SPARSER::PROTEIN)
    ("siRNA ( xref , xref ) or monoclonal antibody ( xref , xref )"
     . SPARSER::COLLECTION)
    ("Highly expressed CD147" . SPARSER::PROTEIN)
    ("expressed CD147" . SPARSER::PROTEIN) ("primary HCC" . SPARSER::PROTEIN)
    ("a cancer-associated biomarker" . SPARSER::MOLECULE)
    ("EMMPRIN or basigin" . SPARSER::COLLECTION) ("basigin" . SPARSER::PROTEIN)
    ("EMMPRIN" . SPARSER::PROTEIN)
    ("growth factor and cytokine receptor" . SPARSER::COLLECTION)
    ("a proneoplastic fate" . SPARSER::PROTEIN)
    ("survivin, cyclin D1 and matrix metalloproteinase" . SPARSER::COLLECTION)
    ("DPC4/SMAD4" . SPARSER::COLLECTION) ("p16/CDKN2A" . SPARSER::COLLECTION)
    ("advanced unresectable PDCA" . SPARSER::PROTEIN)
    ("PDCA" . SPARSER::PROTEIN) ("STAT3 and survivin" . SPARSER::COLLECTION)
    ("cyclin D1/survivin" . SPARSER::COLLECTION) ("CyPA" . SPARSER::PROTEIN)
    ("CD98" . SPARSER::PROTEIN) ("WP1066" . SPARSER::DRUG)
    ("GL3" . SPARSER::PROTEIN) ("YM155" . SPARSER::DRUG)
    ("FLLL32" . SPARSER::DRUG) ("MMP7" . SPARSER::PROTEIN)
    ("DPC4" . SPARSER::PROTEIN) ("CD147" . SPARSER::PROTEIN)
    ("IL6-STAT3" . SPARSER::COLLECTION) ("Dai" . SPARSER::PROTEIN)
    ("the small molecule STAT3 inhibitor LLL12 ( xref ) completely abrogated phospho-STAT3"
     . SPARSER::PROTEIN)
    ("phosho-STAT3" . SPARSER::COLLECTION)
    ("BIM and PARP" . SPARSER::COLLECTION) ("IL6/STAT3" . SPARSER::COLLECTION)
    ("DUSP, LGALS3 and SLCO4A1" . SPARSER::COLLECTION)
    ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP3K8 (COT)" . SPARSER::PROTEIN) ("COT" . SPARSER::PROTEIN)
    ("CRAF" . SPARSER::PROTEIN) ("trametinib" . SPARSER::DRUG)
    ("dabrafenib" . SPARSER::DRUG) ("MEK or STAT3" . SPARSER::COLLECTION)
    ("selumetinib and the combination" . SPARSER::COLLECTION)
    ("STAT3 and phospho-STAT3" . SPARSER::COLLECTION)
    ("In contrast phosphorylated Rel-A" . SPARSER::PROTEIN)
    ("the 12 compensatory resistance genes" . SPARSER::GENE)
    ("12 compensatory genes" . SPARSER::GENE)
    ("FZD2 and IL6" . SPARSER::COLLECTION)
    ("the compensatory signature genes" . SPARSER::GENE)
    ("DUSP4, LGALS3, SLCO4A1 , and IL6" . SPARSER::COLLECTION)
    ("the compensatory signature gene" . SPARSER::PROTEIN)
    ("DUSP4, LGALS3 , and SLCO4A1" . SPARSER::COLLECTION)
    ("LOX (FC = −2.0) and SERPINE1 (FC= 2.5)" . SPARSER::COLLECTION)
    ("FC" . SPARSER::PROTEIN)
    ("interleukin 6 ( IL6 ) and SERPINE1" . SPARSER::COLLECTION)
    ("COL5A1 and LOX" . SPARSER::COLLECTION)
    ("DUSP4, LGALS3 and SLCO4A1" . SPARSER::COLLECTION)
    ("STAC" . SPARSER::PROTEIN)
    ("SLCO4A1 (signal-to-noise=0.51) and DUSP4 (signal-to-noise=0.50)"
     . SPARSER::COLLECTION)
    ("LGALS3, PROS1, SERPINB1, DUSP6, MAP2K3 and SPRY2" . SPARSER::COLLECTION)
    ("RAS or upstream RTKs ( xref )" . SPARSER::COLLECTION)
    ("phospho-MEK and phospho-ERK2" . SPARSER::COLLECTION)
    ("BRAF/MEK" . SPARSER::COLLECTION) ("REV" . SPARSER::PROTEIN-FAMILY)
    ("6 acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("EFS" . SPARSER::PROTEIN) ("RAS or RAF" . SPARSER::COLLECTION)
    ("KIAA1549-BRAF" . SPARSER::COLLECTION) ("Radical" . SPARSER::MOLECULE)
    ("histologic subtypes" . SPARSER::PROTEIN) ("Selumetinib" . SPARSER::DRUG)
    ("the MEK inhibitor and a STAT3 inhibitor (LLL12)" . SPARSER::COLLECTION)
    ("LLL" . SPARSER::MOLECULE) ("selumetinib" . SPARSER::DRUG)
    ("cucurbitacin I" . SPARSER::DRUG) ("IL6 receptor" . SPARSER::PROTEIN)
    ("MAP3K8" . SPARSER::PROTEIN) ("IL6Rα" . SPARSER::PROTEIN)
    ("Rel-A" . SPARSER::PROTEIN) ("FZD2" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN) ("COL5A1" . SPARSER::PROTEIN)
    ("MAP2K3" . SPARSER::PROTEIN) ("SERPINB1" . SPARSER::PROTEIN)
    ("PROS1" . SPARSER::PROTEIN) ("LGALS3" . SPARSER::PROTEIN)
    ("DUSP4" . SPARSER::PROTEIN) ("SLCO4A1" . SPARSER::PROTEIN)
    ("MAS5" . SPARSER::PROTEIN) ("KIAA1549" . SPARSER::PROTEIN)
    ("PDK1, mTOR, and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS, p16, p53, and SMAD4" . SPARSER::COLLECTION)
    ("ME" . SPARSER::PROTEIN) ("invasive components" . SPARSER::COMPONENT)
    ("PTEN, PDK1 and Ki67" . SPARSER::COLLECTION)
    ("AKT1 and PIK3CA" . SPARSER::COLLECTION)
    ("PTEN and PDK1" . SPARSER::COLLECTION) ("GAG-AKT" . SPARSER::COLLECTION)
    ("AKT1 or PIK3CA" . SPARSER::COLLECTION) ("lox/lox" . SPARSER::COLLECTION)
    ("lox" . SPARSER::PROTEIN) ("ACG" . SPARSER::PROTEIN)
    ("PDK1/PDPK1" . SPARSER::COLLECTION)
    ("TP53 and ERBB2" . SPARSER::COLLECTION)
    ("STK11/LKB1" . SPARSER::COLLECTION) ("cyst" . SPARSER::PROTEIN)
    ("PIK3CA ( xref ) and BRAF ( xref )" . SPARSER::COLLECTION)
    ("KRAS ( xref , xref , xref ), GNAS ( xref , xref ), PIK3CA ( xref ) and BRAF ( xref )"
     . SPARSER::COLLECTION)
    ("GNAS" . SPARSER::PROTEIN)
    ("an invasive adenocarcinoma component" . SPARSER::COMPONENT)
    ("associated invasive PDAC" . SPARSER::PROTEIN)
    ("four histological subtypes" . SPARSER::PROTEIN)
    ("MUC1 and MUC2" . SPARSER::COLLECTION) ("CDX2−" . SPARSER::PROTEIN)
    ("MUC2−" . SPARSER::PROTEIN) ("MUC1−" . SPARSER::PROTEIN)
    ("a mucinous epithelium" . SPARSER::PROTEIN)
    ("normal ductal epithelium" . SPARSER::PROTEIN)
    ("ductal epithelium" . SPARSER::PROTEIN)
    ("PTEN and Ki67" . SPARSER::COLLECTION)
    ("PDPK1/PDK1" . SPARSER::COLLECTION)
    ("PIK3CA and AKT1" . SPARSER::COLLECTION)
    ("Loss of Heterozygosity" . SPARSER::PROTEIN)
    ("dehydrogenase/reductase (SDR family) member 4" . SPARSER::PROTEIN)
    ("alpha 1" . SPARSER::PROTEIN) ("type VII" . SPARSER::PROTEIN)
    ("COL7A1" . SPARSER::PROTEIN) ("AKT 1" . SPARSER::PROTEIN)
    ("– 3" . SPARSER::PROTEIN) ("MUC5" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3-phosphoinositide dependent protein kinase-1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("CDX2" . SPARSER::PROTEIN) ("MUC6" . SPARSER::PROTEIN)
    ("MUC5AC" . SPARSER::PROTEIN) ("MUC2" . SPARSER::PROTEIN)
    ("MUC1" . SPARSER::PROTEIN) ("PDPK1" . SPARSER::PROTEIN)
    ("BRCA1, BRCA2, and PalB2" . SPARSER::COLLECTION)
    ("PalB" . SPARSER::PROTEIN) ("RAD52 and SUMO-1" . SPARSER::COLLECTION)
    ("the PTEN’s" . SPARSER::PROTEIN) ("centromeres" . SPARSER::PROTEIN)
    ("UBL1" . SPARSER::PROTEIN) ("SUMO-1" . SPARSER::PROTEIN)
    ("Rad52" . SPARSER::PROTEIN) ("RAD52" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("WL" . SPARSER::MOLECULE)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ib (T2N0M0) and IIa (T3N0M0)" . SPARSER::COLLECTION)
    ("Ib" . SPARSER::DRUG) ("expressed EGFR" . SPARSER::PROTEIN)
    ("the important prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("steroid hormone and HER2" . SPARSER::COLLECTION)
    ("LS" . SPARSER::PROTEIN) ("EK" . SPARSER::PROTEIN)
    ("p70 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("v-erb-b2 erythroblastic leukemia viral oncogene homolog 2"
     . SPARSER::PROTEIN)
    ("Protein kinase B/v-akt murine thymoma viral oncogene homologue"
     . SPARSER::PROTEIN)
    ("a possible target gene" . SPARSER::PROTEIN)
    ("the 11q chromosomal arm" . SPARSER::PROTEIN)
    ("the proximal part" . SPARSER::COMPONENT)
    ("the three available cohorts" . SPARSER::MOLECULE)
    ("S6K2/4EBP1" . SPARSER::COLLECTION) ("a functional ER" . SPARSER::PROTEIN)
    ("insulin-like growth factor/PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("4EBP1 and nuclear receptors" . SPARSER::COLLECTION)
    ("4EBP1 and p4EBP1_S65" . SPARSER::COLLECTION)
    ("4EBP1, and recognises" . SPARSER::COLLECTION)
    ("cytoplasmic p21-activated kinase 1 (PAK1) and p4EBP1 (data not shown)"
     . SPARSER::COLLECTION)
    ("4EBP1 and 4EBP1" . SPARSER::COLLECTION)
    ("High S6K2 and/or 4EBP1 mRNA" . SPARSER::COLLECTION)
    ("ER and S6K1" . SPARSER::COLLECTION)
    ("strong nuclear 4EBP1" . SPARSER::PROTEIN)
    ("High S6K2 and/or 4EBP1" . SPARSER::COLLECTION)
    ("S6K2 and/or 4EBP1 and high S-phase fraction" . SPARSER::COLLECTION)
    ("4EBP1 and high S-phase fraction" . SPARSER::COLLECTION)
    ("high S6K2 and/or 4EBP1" . SPARSER::COLLECTION)
    ("The combined variable S6K2 and/or 4EBP1 mRNA" . SPARSER::COLLECTION)
    ("cohort, S6K2 and 4EBP1" . SPARSER::COLLECTION)
    ("S6K1, S6K2 and 4EBP1" . SPARSER::COLLECTION)
    ("high S6K2 and/or 4EBP1 mRNA" . SPARSER::COLLECTION)
    ("a significant independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6K1 , S6K2 and 4EBP1" . SPARSER::COLLECTION)
    ("S6K1 and ER" . SPARSER::COLLECTION)
    ("the three public cohorts" . SPARSER::MOLECULE)
    ("S6K1 and 4EBP1" . SPARSER::COLLECTION)
    ("4EBP1 and S6K2" . SPARSER::COLLECTION)
    ("S6K2 and/or 4EBP1" . SPARSER::COLLECTION)
    ("mTOR as well as the S6 kinases and 4EBP1" . SPARSER::COLLECTION)
    ("S6 kinases and 4EBP1" . SPARSER::COLLECTION)
    ("the translational initiation complex" . SPARSER::BIO-COMPLEX)
    ("mTORC1/S6K/4EBP1" . SPARSER::COLLECTION) ("p12" . SPARSER::PROTEIN)
    ("ERBB2 and CCND1" . SPARSER::COLLECTION)
    ("The genes RPS6KB1 ( S6K1 ) and RPS6KB2 ( S6K2 )" . SPARSER::COLLECTION)
    ("S6K1 as well as S6K2" . SPARSER::COLLECTION)
    ("the receptor and its cofactors" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("GTPases and PKCα" . SPARSER::COLLECTION)
    ("The most well-known substrates" . SPARSER::SUBSTRATE)
    ("essential proteins" . SPARSER::PROTEIN)
    ("hypoxia and energy/ATP" . SPARSER::COLLECTION)
    ("more specific biomarkers as well as new therapeutic targets"
     . SPARSER::COLLECTION)
    ("ER and mTOR" . SPARSER::COLLECTION) ("ER/PgR" . SPARSER::COLLECTION)
    ("S6K2 and 4EBP1" . SPARSER::COLLECTION)
    ("4EBP1 and p4EBP1" . SPARSER::COLLECTION)
    ("Three publicly available breast cancer cohorts" . SPARSER::MOLECULE)
    ("4EBP1, S6K1 and S6K2" . SPARSER::COLLECTION)
    ("mTOR and its downstream effectors" . SPARSER::COLLECTION)
    ("the 4E-binding protein 1 (4EBP1) and the p70 ribosomal S6 kinases (S6K1 and S6K2)"
     . SPARSER::COLLECTION)
    ("receptor (ER)" . SPARSER::RECEPTOR)
    ("the p70 ribosomal S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("S6K1 and S6K2" . SPARSER::COLLECTION)
    ("Phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homolog 2" . SPARSER::PROTEIN) ("v-erb" . SPARSER::PROTEIN)
    ("Cyclin D 1" . SPARSER::PROTEIN) ("cyclin A 2" . SPARSER::PROTEIN)
    ("Ribonuclease inhibitor" . SPARSER::PROTEIN) ("EIF4E" . SPARSER::PROTEIN)
    ("RPS6KB2" . SPARSER::PROTEIN) ("EBP1" . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S6K2" . SPARSER::PROTEIN)
    ("the HIV-1 protein Nef and human β-catenin" . SPARSER::COLLECTION)
    ("TCF-4 and NFκB" . SPARSER::COLLECTION)
    ("β-catenin and TCF-4" . SPARSER::COLLECTION)
    ("TCF-4 and β-catenin" . SPARSER::COLLECTION)
    ("TCF-4/β-catenin" . SPARSER::COLLECTION)
    ("β-catenin/TCF-4" . SPARSER::COLLECTION) ("CAAAG-3" . SPARSER::COLLECTION)
    ("Los" . SPARSER::MOLECULE) ("Phe/Tyr" . SPARSER::COLLECTION)
    ("TCF-" . SPARSER::PROTEIN) ("a tolerogenic state" . SPARSER::BIO-STATE)
    ("CD25-" . SPARSER::PROTEIN)
    ("T-cells directly targets matrix metalloproteinase (MMP) promoters"
     . SPARSER::PROMOTER)
    ("β-catenin, and F191A-Nef" . SPARSER::COLLECTION)
    ("known ligand" . SPARSER::LIGAND)
    ("TCF4 and β-catenin" . SPARSER::COLLECTION)
    ("anti-β-catenin" . SPARSER::COLLECTION) ("glucoside" . SPARSER::MOLECULE)
    ("aspartic acid and phenylalanine" . SPARSER::COLLECTION)
    ("E-cadherin/β-catenin" . SPARSER::COLLECTION) ("EH" . SPARSER::PROTEIN)
    ("alanine scanning of APC, TCF4 and E-cadherin" . SPARSER::COLLECTION)
    ("APC, TCF4 and E-cadherin" . SPARSER::COLLECTION)
    ("a flexible alpha helix" . SPARSER::PROTEIN)
    ("E-cadherin (DSLLVFDY)" . SPARSER::PROTEIN)
    ("a previously unrecognized β-catenin ligand" . SPARSER::MOLECULE)
    ("expressed protein" . SPARSER::PROTEIN) ("MGF" . SPARSER::PROTEIN)
    ("novel viral ligands" . SPARSER::LIGAND)
    ("phenylalanine or tyrosine" . SPARSER::COLLECTION)
    ("FY" . SPARSER::PROTEIN) ("MER" . SPARSER::PROTEIN)
    ("β-catenin-TCF" . SPARSER::COLLECTION) ("ICAT" . SPARSER::PROTEIN)
    ("receptor (TCR)" . SPARSER::RECEPTOR) ("LEF/TCF" . SPARSER::COLLECTION)
    ("Lymphoid" . SPARSER::PROTEIN)
    ("ubiquitin-proteosome" . SPARSER::PROTEIN-PAIR)
    ("-cat" . SPARSER::COLLECTION) ("wingless" . SPARSER::PROTEIN)
    ("proteins and CD4" . SPARSER::COLLECTION)
    ("an accessory protein" . SPARSER::PROTEIN)
    ("protein and β-catenin" . SPARSER::COLLECTION) ("B8)" . SPARSER::PROTEIN)
    ("β-catenin " . SPARSER::PROTEIN) ("C/EBP β" . SPARSER::PROTEIN)
    ("SMAR1" . SPARSER::PROTEIN) ("TCF-4" . SPARSER::PROTEIN)
    ("nucleocapsid protein" . SPARSER::PROTEIN) ("APC 15" . SPARSER::PROTEIN)
    ("GSK-3 β" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("lovastatin and celecoxib" . SPARSER::COLLECTION)
    ("lovastatin" . SPARSER::DRUG) ("MKK3/p38" . SPARSER::COLLECTION)
    ("TNF-alpha and IL-6" . SPARSER::COLLECTION)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("calcium and lipid" . SPARSER::COLLECTION)
    ("nonspecific siRNA" . SPARSER::PROTEIN)
    ("CAV1 or AXL" . SPARSER::COLLECTION)
    ("CAV1 and AXL" . SPARSER::COLLECTION)
    ("both AXL [ xref ] and Caveolin-1 (CAV1)" . SPARSER::COLLECTION)
    ("33 genes and 26 genes" . SPARSER::COLLECTION)
    ("Monocytes/microglia" . SPARSER::COLLECTION) ("MKK3" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("CAV1" . SPARSER::PROTEIN) ("AR and full-length" . SPARSER::COLLECTION)
    ("the original yeast two-hybrid screening identified AR-interacting PAK6 fragment"
     . SPARSER::FRAGMENT)
    ("Akt or Erk" . SPARSER::COLLECTION)
    ("a ternary membrane-associated signal complex" . SPARSER::BIO-COMPLEX)
    ("the PAK6’s" . SPARSER::PROTEIN)
    ("androgen and PAK6" . SPARSER::COLLECTION)
    ("AR-PAK6" . SPARSER::COLLECTION) ("LN-tetON-PAK6" . SPARSER::COLLECTION)
    ("LNCap cell lines (LNCap-tetON-PAK6) ectopically expressing PAK6"
     . SPARSER::PROTEIN)
    ("expressing PAK6" . SPARSER::PROTEIN)
    ("LNCap-tetON-PAK6" . SPARSER::COLLECTION)
    ("the exogenous histone H4 substrate" . SPARSER::SUBSTRATE)
    ("the anti-PAK6" . SPARSER::ANTIBODY)
    ("the phospho-mimetic PAK6-5E mutant" . SPARSER::MUTANT)
    ("serines/threonine" . SPARSER::COLLECTION)
    ("the serine (at residues #308, 346 and 360) and threonine (residue #326 and 354) residues"
     . SPARSER::COLLECTION)
    ("PAK6-AR" . SPARSER::COLLECTION) ("PAK6 and AR" . SPARSER::COLLECTION)
    ("PAK5 and PAK6" . SPARSER::COLLECTION)
    ("divergent downstream targets" . SPARSER::TARGET-PROTEIN)
    ("PAK1 and PAK5" . SPARSER::COLLECTION)
    ("a functional AID" . SPARSER::PROTEIN)
    ("PAKs, PAK4 and PAK6" . SPARSER::COLLECTION)
    ("-Rac" . SPARSER::COLLECTION)
    ("AR and PAK6 and PAK6" . SPARSER::COLLECTION)
    ("PAK6 and PAK6" . SPARSER::COLLECTION)
    ("AR and PAK6" . SPARSER::COLLECTION) ("LNCap" . SPARSER::PROTEIN)
    ("p 21-" . SPARSER::PROTEIN) ("Amino Acid" . SPARSER::AMINO-ACID)
    ("VP-16" . SPARSER::DRUG) ("pG5" . SPARSER::PROTEIN)
    ("Ste20" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PAK5" . SPARSER::PROTEIN)
    ("PAK4" . SPARSER::PROTEIN) ("PAK 4" . SPARSER::PROTEIN)
    ("PAK 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dc42" . SPARSER::PROTEIN)
    ("PAK6" . SPARSER::PROTEIN) ("p 21" . SPARSER::PROTEIN)
    ("IL-10 and phospho-Elk-1" . SPARSER::COLLECTION)
    ("SLE and IBD" . SPARSER::COLLECTION) ("-eQTL" . SPARSER::COLLECTION)
    ("AA and HS" . SPARSER::COLLECTION)
    ("other SLE-associated variant" . SPARSER::VARIANT)
    ("AS, AA or HS" . SPARSER::COLLECTION)
    ("EA, AS, AA and HS" . SPARSER::COLLECTION)
    ("ERK and Elk-1" . SPARSER::COLLECTION)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("BCR-TLR9" . SPARSER::COLLECTION)
    ("antibody and IL-10" . SPARSER::COLLECTION)
    ("TLR9-CpG" . SPARSER::COLLECTION)
    ("IL-17 and IL-17-related cytokines" . SPARSER::COLLECTION)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("the more distal promoter" . SPARSER::PROMOTER)
    ("LD, rs3024505, rs3024495, rs3024493 and rs3122605" . SPARSER::COLLECTION)
    ("JNK (SP 600125) or p38 (SB 203580)" . SPARSER::COLLECTION)
    ("a pivotal cytokine" . SPARSER::PROTEIN)
    ("IL-10 and p-Elk-1 in PBMCs" . SPARSER::COLLECTION)
    ("JNK (c-Jun N-terminal kinases) and p38" . SPARSER::COLLECTION)
    ("ERK (extracellular-signal-regulated kinases), JNK (c-Jun N-terminal kinases) and p38"
     . SPARSER::COLLECTION)
    ("ETS" . SPARSER::PROTEIN)
    ("EA and the underlying causal variant(s)" . SPARSER::COLLECTION)
    ("AS, AA and HS" . SPARSER::COLLECTION)
    ("Asian (AS, 1,252 vs. 1,249) and Amerindian/Hispanic (HS, 1,445 vs. 781)"
     . SPARSER::COLLECTION)
    ("an important immunoregulatory cytokine" . SPARSER::PROTEIN)
    ("IBD" . SPARSER::PROTEIN)
    ("IL10 and its gene family member IL19 , IL20 and IL24"
     . SPARSER::COLLECTION)
    ("Systemic lupus erythematosus (SLE)" . SPARSER::PROTEIN)
    ("pathogenic autoantibodies" . SPARSER::PROTEIN)
    ("Systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("p-Elk-1" . SPARSER::COLLECTION)
    ("The previously reported IL10 variant" . SPARSER::VARIANT)
    ("EA" . SPARSER::PROTEIN) ("IL19 , IL20 and IL24" . SPARSER::COLLECTION)
    ("systemic lupus erythematosus (SLE)" . SPARSER::PROTEIN)
    ("Immunoregulatory cytokine interleukin-10" . SPARSER::PROTEIN)
    ("Msn4" . SPARSER::PROTEIN) ("MZF1" . SPARSER::PROTEIN)
    ("ADR1" . SPARSER::PROTEIN) ("Brefeldin A" . SPARSER::MOLECULE)
    ("interferon alpha" . SPARSER::PROTEIN) ("RPLP0" . SPARSER::PROTEIN)
    ("CD27" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("T-bet" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN) ("SP 600125" . SPARSER::PROTEIN)
    ("PD 98059" . SPARSER::MOLECULE) ("ElK-1" . SPARSER::PROTEIN)
    ("transcription factor 1" . SPARSER::PROTEIN) ("FAIM3" . SPARSER::PROTEIN)
    ("interleukin 10" . SPARSER::PROTEIN) ("Elk-1" . SPARSER::PROTEIN)
    ("IL24" . SPARSER::PROTEIN) ("IL20" . SPARSER::PROTEIN)
    ("IL19" . SPARSER::PROTEIN) ("IFN or its production" . SPARSER::COLLECTION)
    ("CD95 and Bak" . SPARSER::COLLECTION) ("pDCs" . SPARSER::PROTEIN)
    ("ISG" . SPARSER::GENE) ("gene (ISG)" . SPARSER::PROTEIN)
    ("death-receptor" . SPARSER::PROTEIN) ("Bak/Bax" . SPARSER::COLLECTION)
    ("c-FLIP and FADD" . SPARSER::COLLECTION)
    ("death receptor and ligand" . SPARSER::COLLECTION)
    ("TRAIL and TNFα" . SPARSER::COLLECTION)
    ("IFN and viremia" . SPARSER::COLLECTION) ("naïve" . SPARSER::PROTEIN)
    ("ART-naïve" . SPARSER::COLLECTION) ("deoxyribose" . SPARSER::MOLECULE)
    ("TLR7 and TLR9" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, FADD, Bid, Bim or Bax" . SPARSER::COLLECTION)
    ("Bax (MFI = 271±56 vs. 296±52) or Bim (MFI = 767±125 vs. 673±29)"
     . SPARSER::COLLECTION)
    ("Bid and FADD" . SPARSER::COLLECTION)
    ("Bax and Bim" . SPARSER::COLLECTION) ("Bak and Bax" . SPARSER::COLLECTION)
    ("the Bcl-2 family and other signaling molecules" . SPARSER::COLLECTION)
    ("pro-apoptotic Bim and Bak" . SPARSER::COLLECTION)
    ("anti-CD95/Fas" . SPARSER::COLLECTION)
    ("neither TNFα nor TRAIL" . SPARSER::COLLECTION)
    ("antibody, TNFα or TRAIL" . SPARSER::COLLECTION)
    ("TNFα and TRAIL" . SPARSER::COLLECTION)
    ("acute infection Type I IFN" . SPARSER::PROTEIN)
    ("IFN and Bak" . SPARSER::COLLECTION)
    ("TRAIL or TNFα" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic molecules and the apoptosis sensitivity of T cells"
     . SPARSER::COLLECTION)
    ("/death receptor (DR)" . SPARSER::COLLECTION)
    ("/death receptor" . SPARSER::COLLECTION)
    ("antiviral cytokines" . SPARSER::PROTEIN)
    ("CD95/Fas" . SPARSER::COLLECTION) ("pro-apoptotic Bak" . SPARSER::PROTEIN)
    ("Interferon Alpha" . SPARSER::PROTEIN) ("c-FLIP" . SPARSER::PROTEIN)
    ("IFI6" . SPARSER::PROTEIN) ("TLR9" . SPARSER::PROTEIN)
    ("SPR" . SPARSER::PROTEIN)
    ("The CFP and YFP fluorescent proteins form" . SPARSER::FORM)
    ("CFP and YFP" . SPARSER::COLLECTION) ("stearoyl" . SPARSER::MOLECULE)
    ("previously described xref Nrf2-derived 7-mer peptides"
     . SPARSER::PEPTIDE)
    ("Keap1−Nrf2" . SPARSER::COLLECTION) ("Keap1–Nrf2" . SPARSER::COLLECTION)
    ("biologically relevant Nrf2-derived peptides" . SPARSER::PEPTIDE)
    ("molecules and peptides" . SPARSER::COLLECTION)
    ("NaCl, and ∼0%" . SPARSER::COLLECTION)
    ("a significant electrostatic component" . SPARSER::COMPONENT)
    ("peptide and Arg" . SPARSER::COLLECTION) ("Kelch" . SPARSER::PROTEIN)
    ("YFP-Kelch" . SPARSER::COLLECTION) ("CFP-Nrf2" . SPARSER::COLLECTION)
    ("HTS" . SPARSER::PROTEIN) ("Keap1 and Nrf2" . SPARSER::COLLECTION)
    ("Glu and Asp" . SPARSER::COLLECTION)
    ("Nrf2 and Arg" . SPARSER::COLLECTION) ("curcumin" . SPARSER::DRUG)
    ("DLG" . SPARSER::PROTEIN)
    ("protein 1 (Keap1) and the transcription factor nuclear factor erythroid related factor 2 (Nrf2)"
     . SPARSER::COLLECTION)
    ("Keap1-Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and Kelch-like" . SPARSER::COLLECTION)
    ("antioxidant and free radical detoxification gene products"
     . SPARSER::COLLECTION)
    ("1-L" . SPARSER::PROTEIN) ("Not1" . SPARSER::PROTEIN)
    ("peptide 1" . SPARSER::PROTEIN) ("bric-a-brac" . SPARSER::PROTEIN)
    ("broad complex" . SPARSER::PROTEIN) ("Neh2" . SPARSER::PROTEIN)
    ("erythroid related factor 2" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN) ("Src and Lyn" . SPARSER::COLLECTION)
    ("Lyn" . SPARSER::PROTEIN) ("FAK and Src" . SPARSER::COLLECTION)
    ("BRaf ( xref ) and DDR2 ( xref )" . SPARSER::COLLECTION)
    ("a dual Src/Abl kinase inhibitor" . SPARSER::INHIBITOR)
    ("FRK, BRK, and ACK" . SPARSER::COLLECTION)
    ("receptors, DDR1, EGFR, and PDGFR" . SPARSER::COLLECTION)
    ("Src/Abl" . SPARSER::COLLECTION) ("ACK" . SPARSER::PROTEIN)
    ("BRK" . SPARSER::PROTEIN) ("FRK" . SPARSER::PROTEIN)
    ("LCK" . SPARSER::PROTEIN) ("FYN" . SPARSER::PROTEIN)
    ("LYN" . SPARSER::PROTEIN) ("Abl" . SPARSER::PROTEIN)
    ("enzyme and creatinine" . SPARSER::COLLECTION)
    ("Dasatinib (25 mg/kg) and PF562271 (25 mg/gk)" . SPARSER::COLLECTION)
    ("dasatinib and PF562271 in vivo" . SPARSER::COLLECTION)
    ("IGFBP2 and FAK" . SPARSER::COLLECTION)
    ("dasatinib and PF562271" . SPARSER::COLLECTION)
    ("dasatinib and a FAK inhibitor in the dasatinib-resistant NSCLC cells"
     . SPARSER::COLLECTION)
    ("p-FAK" . SPARSER::COLLECTION) ("FAK, and Src" . SPARSER::COLLECTION)
    ("KRas , NRas , EGFR , or p53" . SPARSER::COLLECTION)
    ("NRas" . SPARSER::PROTEIN) ("KRas" . SPARSER::PROTEIN)
    ("BRaf" . SPARSER::PROTEIN)
    ("dasatinib and saracatinib" . SPARSER::COLLECTION)
    ("IGF1R and integrin" . SPARSER::COLLECTION)
    ("IGFI/IGF1R" . SPARSER::COLLECTION) ("IGFI" . SPARSER::PROTEIN)
    ("/NF-κB" . SPARSER::COLLECTION) ("its RGD" . SPARSER::COLLECTION)
    ("IGF1R or integrin" . SPARSER::COLLECTION) ("RGD" . SPARSER::COLLECTION)
    ("docetaxel or paclitaxel" . SPARSER::COLLECTION)
    ("Gly-Arg-Asp (RGD)" . SPARSER::COLLECTION)
    ("Gly-Arg-Asp" . SPARSER::COLLECTION)
    ("IGF-I and IGF-II" . SPARSER::COLLECTION)
    ("Src and FAK" . SPARSER::COLLECTION) ("IGFBP2/FAK" . SPARSER::COLLECTION)
    ("dasatinib and FAK" . SPARSER::COLLECTION) ("dasatinib" . SPARSER::DRUG)
    ("IGF1R, Src, FAK, MEK, and AKT" . SPARSER::COLLECTION)
    ("DDR2" . SPARSER::PROTEIN) ("DDR1" . SPARSER::PROTEIN)
    ("IGFBP-2" . SPARSER::PROTEIN) ("sulforhodamine B" . SPARSER::MOLECULE)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OSI-906" . SPARSER::DRUG) ("BMS-754807" . SPARSER::DRUG)
    ("IGFR1" . SPARSER::PROTEIN) ("IGF-II" . SPARSER::PROTEIN)
    ("PTEN and SOCS3" . SPARSER::COLLECTION)
    ("CNTF and LIF" . SPARSER::COLLECTION)
    ("PIAS3 or Cyclin D1" . SPARSER::COLLECTION)
    ("CBP/p300" . SPARSER::COLLECTION) ("JAKs" . SPARSER::PROTEIN)
    ("pSTAT3" . SPARSER::PROTEIN) ("Socs3" . SPARSER::PROTEIN)
    ("Stat3 and Klf4" . SPARSER::COLLECTION)
    ("the intravitreal space ofKlf4 f/f retina" . SPARSER::DRUG)
    ("Alexa fluor 594-conjugated cholera toxin beta subunit (CTB)"
     . SPARSER::PROTEIN)
    ("beta subunit (CTB)" . SPARSER::PROTEIN) ("CTB" . SPARSER::PROTEIN)
    ("fluor" . SPARSER::MOLECULE) ("KLF4-pSTAT3" . SPARSER::PROTEIN-PAIR)
    ("Nrcam or Sprr1a" . SPARSER::COLLECTION)
    ("neither STAT3 nor KLF4" . SPARSER::COLLECTION)
    ("Nrcam and Sprr1a" . SPARSER::COLLECTION) ("Nrcam" . SPARSER::PROTEIN)
    ("GFP and GFPCre" . SPARSER::COLLECTION)
    ("GFP and Cre" . SPARSER::COLLECTION)
    ("exogenous wild-type STAT3" . SPARSER::PROTEIN)
    ("STAT3 and/or KLF4" . SPARSER::COLLECTION)
    ("Sprr1a-Luc" . SPARSER::COLLECTION)
    ("STAT3 and KLF4" . SPARSER::COLLECTION)
    ("a pleiotropic IL6-like cytokine" . SPARSER::PROTEIN)
    ("OSM" . SPARSER::PROTEIN)
    ("HA-tagged KLF4 and various FLAG-tagged STAT3 mutants"
     . SPARSER::COLLECTION)
    ("dimerized form" . SPARSER::FORM) ("retinas" . SPARSER::DRUG)
    ("endogenously expressed KLF4 and pSTAT3" . SPARSER::COLLECTION)
    ("expressed KLF4 and pSTAT3" . SPARSER::COLLECTION)
    ("KLF4 and pSTAT3" . SPARSER::COLLECTION)
    ("KLF4 and STAT3" . SPARSER::COLLECTION)
    ("KLF4 and JAK-STAT" . SPARSER::COLLECTION)
    ("ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF)"
     . SPARSER::COLLECTION)
    ("CNTF" . SPARSER::PROTEIN) ("Cytokines" . SPARSER::PROTEIN)
    ("-STAT3" . SPARSER::COLLECTION) ("subunit B" . SPARSER::PROTEIN)
    ("F10" . SPARSER::PROTEIN) ("MYC-tagged" . SPARSER::PROTEIN)
    ("PIAS3" . SPARSER::PROTEIN) ("C-Jun" . SPARSER::PROTEIN)
    ("AG490" . SPARSER::DRUG) ("beta subunit" . SPARSER::PROTEIN)
    ("synapsin I" . SPARSER::PROTEIN) ("Sprr1a" . SPARSER::PROTEIN)
    ("M67" . SPARSER::PROTEIN) ("oncostatin M" . SPARSER::PROTEIN)
    ("COS7" . SPARSER::PROTEIN)
    ("ciliary neurotrophic factor" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 3" . SPARSER::PROTEIN)
    ("KLF4" . SPARSER::PROTEIN)
    ("VCL ( xref ) and TFG ( xref )" . SPARSER::COLLECTION)
    ("ALK/EML4" . SPARSER::COLLECTION) ("C2orf44" . SPARSER::PROTEIN)
    ("2.5% (1 out of 40) and 2.4% (2 out of 83) CRCs" . SPARSER::PROTEIN)
    ("EML4-ALK" . SPARSER::COLLECTION) ("C2orf44-ALK" . SPARSER::PROTEIN-PAIR)
    ("MET or ROS1" . SPARSER::COLLECTION) ("NSCL" . SPARSER::PROTEIN)
    ("crizotinib" . SPARSER::DRUG) ("protein and ALK" . SPARSER::COLLECTION)
    ("Saudi Arabian CRC" . SPARSER::PROTEIN)
    ("a strong biomarker" . SPARSER::MOLECULE)
    ("other uncommon fusion genes" . SPARSER::GENE)
    ("TFG and KIF5B" . SPARSER::COLLECTION)
    ("EML4 and C2orf44" . SPARSER::COLLECTION)
    ("VCL ( xref ) and TFG ( xref ) genes" . SPARSER::COLLECTION)
    ("KIF5B ( xref ), NPM1 ( xref ), RET ( xref ), ROS ( xref ), VCL ( xref ) and TFG ( xref ) genes"
     . SPARSER::COLLECTION)
    ("TFG" . SPARSER::PROTEIN) ("VCL" . SPARSER::PROTEIN)
    ("FISH and ALK" . SPARSER::COLLECTION)
    ("anaplastic lymphoma kinase (ALK)" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN)
    ("ALK tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("asparagine residue" . SPARSER::MOLECULE) ("CEP2" . SPARSER::PROTEIN)
    ("EML4" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("a concurrent HRAS p" . SPARSER::PROTEIN)
    ("NS and p" . SPARSER::COLLECTION) ("HRAS and KRAS" . SPARSER::COLLECTION)
    ("arginine, aspartic acid or valine" . SPARSER::COLLECTION)
    ("larger amino acids" . SPARSER::AMINO-ACID)
    ("WHN and NS" . SPARSER::COLLECTION)
    ("HRAS , KRAS , PIK3CA , FGFR3 , and NRAS" . SPARSER::COLLECTION)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("A somatic heterozygous HRAS c" . SPARSER::PROTEIN)
    ("DSP , DSC1 , DSG1 , JUP , PKP2, and TMEM43" . SPARSER::COLLECTION)
    ("DSP" . SPARSER::PROTEIN) ("cardiac MRI" . SPARSER::PROTEIN)
    ("ophthalmic" . SPARSER::DRUG) ("Given concurrent PPK" . SPARSER::PROTEIN)
    ("PPK" . SPARSER::PROTEIN) ("wine" . SPARSER::MOLECULE)
    ("WHN" . SPARSER::PROTEIN) ("TMEM43" . SPARSER::PROTEIN)
    ("PKP2" . SPARSER::PROTEIN) ("DSC1" . SPARSER::PROTEIN)
    ("histone deacetylase and c-Myc" . SPARSER::COLLECTION)
    ("sirtuin 1 and c-Myc" . SPARSER::COLLECTION)
    ("H2A.Z and c-Myc" . SPARSER::COLLECTION)
    ("the ATP dependent nucleosome remodeler SNF-2-related CREB-binding protein activator protein (SRCAP)"
     . SPARSER::PROTEIN)
    ("activator protein (SRCAP)" . SPARSER::PROTEIN)
    ("nucleosomes and deposits" . SPARSER::COLLECTION)
    ("SNF" . SPARSER::PROTEIN)
    ("an inhibitor (nicotinamide) and an activator (resveratrol) of sirtuin 1"
     . SPARSER::COLLECTION)
    ("the canonical histone" . SPARSER::PROTEIN)
    ("an oncogene and a tumor suppressor" . SPARSER::COLLECTION)
    ("localized primary PCa" . SPARSER::PROTEIN)
    ("H2A.Z and acH2A" . SPARSER::COLLECTION)
    ("TSA or 5-aza-dC" . SPARSER::COLLECTION)
    ("the H3K27me3 repressive mark" . SPARSER::PROTEIN)
    ("the repressive mark H3K27me3" . SPARSER::MOLECULE)
    ("H2A and H2A.Z" . SPARSER::COLLECTION) ("dC" . SPARSER::MOLECULE)
    ("DU145 and PC-3" . SPARSER::COLLECTION)
    ("LNCaP, DU145 and PC-3" . SPARSER::COLLECTION)
    ("LNCaP, DU145, and PC-3" . SPARSER::COLLECTION)
    ("PIN and PCa" . SPARSER::COLLECTION) ("primary PCa" . SPARSER::PROTEIN)
    ("NPT" . SPARSER::PROTEIN) ("PIN" . SPARSER::PROTEIN)
    ("SIRT1 and H2AFZ" . SPARSER::COLLECTION)
    ("a relevant therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("an oncogene or a TSG" . SPARSER::COLLECTION) ("acH" . SPARSER::PROTEIN)
    ("AF" . SPARSER::PROTEIN) ("p400/Tip60" . SPARSER::COLLECTION)
    ("SRCAP" . SPARSER::PROTEIN) ("sirtuin 1 and H2A.Z" . SPARSER::COLLECTION)
    ("H2AFZ and SIRT1" . SPARSER::COLLECTION)
    ("H2A.Z and SIRT1" . SPARSER::COLLECTION)
    ("suppressor or oncogene" . SPARSER::COLLECTION)
    ("H2A.Z and its acetylated form" . SPARSER::COLLECTION)
    ("activator protein" . SPARSER::PROTEIN)
    ("ATP dependent" . SPARSER::PROTEIN) ("β- catenin" . SPARSER::PROTEIN)
    ("H2AZ" . SPARSER::PROTEIN) ("C-MYC" . SPARSER::PROTEIN)
    ("TIP48" . SPARSER::PROTEIN) ("p400" . SPARSER::PROTEIN)
    ("2'-deoxycytidine" . SPARSER::MOLECULE) ("H2AFZ" . SPARSER::PROTEIN)
    ("H2A.Z" . SPARSER::PROTEIN)
    ("IRF-8, PU.1, and C/EBP-β" . SPARSER::COLLECTION)
    ("C/EBP-β, and PU.1" . SPARSER::COLLECTION)
    ("PLCγ2- and β-catenin–null" . SPARSER::COLLECTION)
    ("PLCγ2-" . SPARSER::PROTEIN) ("HSC" . SPARSER::PROTEIN)
    ("receptor (PIR)" . SPARSER::RECEPTOR) ("PIR" . SPARSER::PROTEIN)
    ("ITAM-containing immune receptors, growth factor receptors, and G protein"
     . SPARSER::COLLECTION)
    ("receptors, growth factor receptors, and G protein" . SPARSER::COLLECTION)
    ("osteoclasts" . SPARSER::PROTEIN) ("type and stage" . SPARSER::COLLECTION)
    ("CD11b and the common myeloid marker CD33 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("phosphorylated-PLCγ2 (p-PLCγ2) and β-catenin" . SPARSER::COLLECTION)
    ("PLCγ2/β-catenin" . SPARSER::COLLECTION)
    ("CTR-, PLCγ2cKO-, and PLCγ2cKO/β-cat" . SPARSER::COLLECTION)
    ("CTR, PLCγ2cKO, and PLCγ2cKO/β-cat" . SPARSER::COLLECTION)
    ("CTR- and β-cat" . SPARSER::COLLECTION) ("CTR-" . SPARSER::PROTEIN)
    ("CTR and β-cat" . SPARSER::COLLECTION)
    ("cKO or CTR" . SPARSER::COLLECTION)
    ("the Cre recombinase (LysM-Cre/β-catenin wt/wt ) or the floxed allele (β-catenin flox/flox )"
     . SPARSER::COLLECTION)
    ("CTR" . SPARSER::PROTEIN) ("LysM-Cre/β-catenin" . SPARSER::COLLECTION)
    ("Lysozyme" . SPARSER::PROTEIN) ("DAG-analogue" . SPARSER::DAG)
    ("PDBu" . SPARSER::MOLECULE)
    ("β-catenin and phosphorylated-GSK3β" . SPARSER::COLLECTION)
    ("p-GSK3β" . SPARSER::COLLECTION) ("p-PKC" . SPARSER::COLLECTION)
    ("soluble oxidizers" . SPARSER::MOLECULE)
    ("PMA (300 nM) or LPS (1 µg/ml)" . SPARSER::COLLECTION)
    ("antigen-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("OT" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xl, and Bax" . SPARSER::COLLECTION)
    ("LysM-Cre" . SPARSER::COLLECTION) ("LysM" . SPARSER::PROTEIN)
    ("cKO" . SPARSER::PROTEIN)
    ("diacylglycerol (DAG) and inositol triphosphate (IP3)"
     . SPARSER::COLLECTION)
    ("PU.1 (Spi-1) or CAAT/enhancer binding protein-β (C/EBP-β)"
     . SPARSER::COLLECTION)
    ("Spi-1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3 (STAT3) and STAT1"
     . SPARSER::COLLECTION)
    ("TLRs, and TGFβ" . SPARSER::COLLECTION)
    ("IL-6, and granulocyte/macrophage" . SPARSER::COLLECTION)
    ("monocytic and mononuclear CD11b + Ly6G" . SPARSER::PROTEIN)
    ("Ly6C and Ly6G" . SPARSER::COLLECTION)
    ("Gr-1 and α m integrin (CD11b)" . SPARSER::COLLECTION)
    ("cytokines and angiogenic factors ( xref )" . SPARSER::COLLECTION)
    ("angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("essential amino acids" . SPARSER::AMINO-ACID)
    ("small soluble oxidizers" . SPARSER::MOLECULE)
    ("oxidizers" . SPARSER::MOLECULE) ("PLCγ2–β-catenin" . SPARSER::COLLECTION)
    ("p-PLCγ2" . SPARSER::COLLECTION) ("Myeloid" . SPARSER::PROTEIN)
    ("PLCγ2 and β-catenin" . SPARSER::COLLECTION) ("anti–β" . SPARSER::PROTEIN)
    ("PO4" . SPARSER::PROTEIN) ("1 C" . SPARSER::PROTEIN)
    ("IRF-8" . SPARSER::PROTEIN) ("PIR-B" . SPARSER::PROTEIN)
    ("wt/wt" . SPARSER::PROTEIN) ("B7.2" . SPARSER::PROTEIN)
    ("IP3" . SPARSER::IP3) ("C/EBP-β" . SPARSER::PROTEIN)
    ("enhancer binding protein" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ly6G" . SPARSER::PROTEIN) ("Ly6C" . SPARSER::PROTEIN)
    ("PLCγ2" . SPARSER::PROTEIN) ("Fgf5" . SPARSER::PROTEIN)
    ("Fgf" . SPARSER::PROTEIN)
    ("the pluripotency-associated genes" . SPARSER::GENE)
    ("Gata4 and Gata6" . SPARSER::COLLECTION)
    ("the differentiation marker genes and down-regulation"
     . SPARSER::COLLECTION)
    ("Trp53-antibody, and RT-qPCR" . SPARSER::COLLECTION)
    ("recombinase" . SPARSER::PROTEIN) ("FLP" . SPARSER::PROTEIN)
    ("β-galactosidase and neomycin" . SPARSER::COLLECTION)
    ("neomycin" . SPARSER::DRUG) ("serial gene" . SPARSER::GENE)
    ("−LIF" . SPARSER::COLLECTION)
    ("LIF (data not shown) and its nuclear" . SPARSER::COLLECTION)
    ("These strong nuclear" . SPARSER::PROTEIN)
    ("gene and Rex1" . SPARSER::COLLECTION) ("Egfp" . SPARSER::PROTEIN)
    ("anti-Trp53 mouse monoclonal antibody 1C12" . SPARSER::PROTEIN)
    ("the pluripotency-associated transcription factor Nanog"
     . SPARSER::PROTEIN)
    ("leukemia inhibitory factor (LIF)" . SPARSER::PROTEIN)
    ("Mdm2 or Mdmx" . SPARSER::COLLECTION) ("Mdmx" . SPARSER::PROTEIN)
    ("sequential gene" . SPARSER::GENE)
    ("pluripotency-associated transcription factor Nanog" . SPARSER::PROTEIN)
    ("a 15 " . SPARSER::PROTEIN) ("type IV collagen" . SPARSER::PROTEIN)
    ("Gata6" . SPARSER::PROTEIN) ("Gata4" . SPARSER::PROTEIN)
    ("Lhx1" . SPARSER::PROTEIN) ("Mixl1" . SPARSER::PROTEIN)
    ("for 3 " . SPARSER::PROTEIN) ("Rex1" . SPARSER::PROTEIN)
    ("Oct3" . SPARSER::PROTEIN) ("Aurora kinase A" . SPARSER::PROTEIN)
    ("SNAI1, ZEB1 and TWIST2" . SPARSER::COLLECTION)
    ("SNAIL1, TWIST1 and TWIST2" . SPARSER::COLLECTION)
    ("homotypic cadherin molecules" . SPARSER::MOLECULE)
    ("typical cell adhesion molecules" . SPARSER::MOLECULE)
    ("med" . SPARSER::PROTEIN) ("fluorescent substrates" . SPARSER::SUBSTRATE)
    ("patched" . SPARSER::PROTEIN) ("mesenchymal traits" . SPARSER::PROTEIN)
    ("CD49f, EpCAM, CD29, CD10 and Muc1" . SPARSER::COLLECTION)
    ("CD44 and CD24" . SPARSER::COLLECTION) ("insC" . SPARSER::PROTEIN)
    ("NSF and STSF" . SPARSER::COLLECTION) ("bFGF" . SPARSER::PROTEIN)
    ("NSF" . SPARSER::PROTEIN) ("Mani" . SPARSER::PROTEIN)
    ("a perpetual self-renewal barrier" . SPARSER::PROTEIN)
    ("MaSCs" . SPARSER::PROTEIN) ("MaSC" . SPARSER::PROTEIN)
    ("SNAI1" . SPARSER::PROTEIN) ("TWIST2" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("SNAIL1" . SPARSER::PROTEIN)
    ("Muc1" . SPARSER::PROTEIN) ("CD10" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("Aldehyde Dehydrogenase" . SPARSER::PROTEIN) ("Blast2" . SPARSER::PROTEIN)
    ("TWIST 1" . SPARSER::PROTEIN) ("ZEB 1" . SPARSER::PROTEIN)
    ("SNAIL 1" . SPARSER::PROTEIN) ("this largest cohort" . SPARSER::MOLECULE)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("Central Asians, and Europeans" . SPARSER::COLLECTION)
    ("Asians, and Europeans" . SPARSER::COLLECTION) ("CK 5" . SPARSER::PROTEIN)
    ("Napsin A" . SPARSER::PROTEIN)
    ("cetuximab and gefitinib" . SPARSER::COLLECTION)
    ("HRAS or HRAS" . SPARSER::COLLECTION) ("p-MAPK" . SPARSER::COLLECTION)
    ("-MAPK" . SPARSER::COLLECTION)
    ("phosphorylation-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("erlotinib and EGF" . SPARSER::COLLECTION)
    ("erlotinib and their growth" . SPARSER::COLLECTION)
    ("/phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("siRNA or shRNA" . SPARSER::COLLECTION) ("Erlotinib" . SPARSER::DRUG)
    ("HN5" . SPARSER::PROTEIN)
    ("a novel biochemical target" . SPARSER::TARGET-PROTEIN)
    ("c-Myc and ErbB2" . SPARSER::COLLECTION)
    ("ErbB2-NF-κB" . SPARSER::COLLECTION)
    ("a noncompetitive inhibitor" . SPARSER::INHIBITOR)
    ("a pleiotropic transcription factor" . SPARSER::PROTEIN)
    ("supplemental Figure S2" . SPARSER::MOLECULE)
    ("transporters and GLS1" . SPARSER::COLLECTION)
    ("serine, aspartate and glycine" . SPARSER::COLLECTION)
    ("polyamines and other non-essential amino acids" . SPARSER::COLLECTION)
    ("polyamines" . SPARSER::MOLECULE)
    ("glutamine and glutamate" . SPARSER::COLLECTION)
    ("a nonessential amino acid" . SPARSER::AMINO-ACID)
    ("Glutamine" . SPARSER::AMINO-ACID) ("INHIBITOR" . SPARSER::INHIBITOR)
    ("BAY 11-7082 and p65" . SPARSER::COLLECTION)
    ("two well-studied NF-κB activators PMA or TNF-α" . SPARSER::COLLECTION)
    ("PMA or TNF-α" . SPARSER::COLLECTION)
    ("Erk, and Myr-Akt" . SPARSER::COLLECTION)
    ("PI3k-Akt" . SPARSER::COLLECTION) ("NOT" . SPARSER::PROTEIN)
    ("a natural growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("line, and MCF10A-NeuT" . SPARSER::COLLECTION)
    ("glucose and glutamine" . SPARSER::COLLECTION)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("MAPK/Erk" . SPARSER::COLLECTION) ("Oncogenes" . SPARSER::ONCOGENE)
    ("GLS1 and GLS2" . SPARSER::COLLECTION)
    ("novel biochemical targets" . SPARSER::TARGET-PROTEIN)
    ("GLS" . SPARSER::PROTEIN) ("glutaminase" . SPARSER::PROTEIN)
    ("α-ketoglutarate" . SPARSER::MOLECULE) ("miR-23a" . SPARSER::MOLECULE)
    ("Bis-2" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("BAY 11-7082" . SPARSER::DRUG) ("c-ErbB2" . SPARSER::PROTEIN)
    ("glutaminase activity" . SPARSER::PROTEIN) ("GLS2" . SPARSER::PROTEIN)
    ("GLS1" . SPARSER::PROTEIN) ("AP1 and NFkB" . SPARSER::COLLECTION)
    ("deceive Caspase-3" . SPARSER::PROTEIN)
    ("Caspase-3 and Met" . SPARSER::COLLECTION)
    ("DNAD-CHO" . SPARSER::PROTEIN-PAIR) ("PI3K–Akt" . SPARSER::COLLECTION)
    ("BclxL" . SPARSER::PROTEIN) ("STATs" . SPARSER::PROTEIN)
    ("Ron tyrosine kinase (Met’s closely related cousin) or EGF receptor"
     . SPARSER::COLLECTION)
    ("a particular RTK" . SPARSER::PROTEIN)
    ("DDD (C-12) and anti-Caspase-3 (L-18)" . SPARSER::COLLECTION)
    ("Caspase-3-DDD" . SPARSER::COLLECTION)
    ("Both anti-Caspase-3 antibody (L-18) and anti-Met C-terminal tail antibody (C-12)"
     . SPARSER::COLLECTION)
    ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DDD and Caspase-3" . SPARSER::COLLECTION)
    ("DDD and the protease" . SPARSER::COLLECTION)
    ("Asp or Thr" . SPARSER::COLLECTION)
    ("pure Caspase-3 and synthetic peptide substrates" . SPARSER::COLLECTION)
    ("pure Caspase-3" . SPARSER::PROTEIN) ("an intact DDD" . SPARSER::PROTEIN)
    ("DDD (PSLLSSEDNADDEVDTRPASFWETS)" . SPARSER::PROTEIN)
    ("hMet" . SPARSER::PROTEIN) ("Caspase-3 and DDD" . SPARSER::COLLECTION)
    ("Gly or Ala" . SPARSER::COLLECTION) ("Hepa" . SPARSER::PROTEIN)
    ("KW" . SPARSER::MOLECULE) ("intact DDD" . SPARSER::PROTEIN)
    ("CrmA" . SPARSER::PROTEIN)
    ("peptide (DDEVDTRPASFWETS)" . SPARSER::PEPTIDE) ("DL" . SPARSER::MOLECULE)
    ("Caspase-3-CytoMet" . SPARSER::PROTEIN-PAIR)
    ("western blot (WB)" . SPARSER::PROTEIN)
    ("fluorogenic synthetic peptides" . SPARSER::PEPTIDE)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("aldehyde" . SPARSER::MOLECULE)
    ("tetra" . SPARSER::MOLECULE)
    ("four contiguous amino acids" . SPARSER::AMINO-ACID)
    ("Hepatocyte Growth Factor Receptor (HGFR)" . SPARSER::PROTEIN)
    ("HGFR" . SPARSER::PROTEIN) ("apoptotic caspases" . SPARSER::PROTEIN)
    ("Met’s" . SPARSER::AMINO-ACID) ("DDD" . SPARSER::PROTEIN)
    ("the transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Z-VAD-fmk" . SPARSER::DRUG) ("Hep1" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN) ("beta chain" . SPARSER::PROTEIN)
    ("Caspase 3" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor Receptor" . SPARSER::PROTEIN)
    ("DEVD-CHO" . SPARSER::DRUG) ("types and grades" . SPARSER::COLLECTION)
    ("hg" . SPARSER::MOLECULE)
    ("a useful urinary biomarker" . SPARSER::MOLECULE)
    ("CIS" . SPARSER::PROTEIN) ("pTis" . SPARSER::PROTEIN)
    ("pTa" . SPARSER::PROTEIN) ("NMP22" . SPARSER::PROTEIN)
    ("composite low ErbB2" . SPARSER::PROTEIN)
    ("the primary acinus" . SPARSER::PROTEIN) ("acinus" . SPARSER::PROTEIN)
    ("a complex and heterogeneous collection" . SPARSER::COLLECTION)
    ("ErB" . SPARSER::PROTEIN)
    ("Smooth muscle actin (SMA) and ErbB2" . SPARSER::COLLECTION)
    ("actin (SMA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smooth muscle" . SPARSER::PROTEIN) ("abnormal acini" . SPARSER::PROTEIN)
    ("PD-0332991 (PD)" . SPARSER::DRUG) ("multi-acini" . SPARSER::COLLECTION)
    ("a dramatic impact" . SPARSER::PROTEIN)
    ("minimal impact" . SPARSER::PROTEIN)
    ("around RB-proficient ErbB2" . SPARSER::PROTEIN)
    ("normal acini" . SPARSER::PROTEIN)
    ("Laminin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SFN" . SPARSER::PROTEIN)
    ("JUP" . SPARSER::PROTEIN) ("spherical acini" . SPARSER::PROTEIN)
    ("phalloidin" . SPARSER::MOLECULE)
    ("a noticeable impact" . SPARSER::PROTEIN)
    ("ErbB2- and RB-pathways" . SPARSER::COLLECTION)
    ("ErbB2-" . SPARSER::PROTEIN) ("Cyclin A and MCM7" . SPARSER::COLLECTION)
    ("RB/E2F" . SPARSER::COLLECTION) ("miRB" . SPARSER::PROTEIN)
    ("RB and ErbB2" . SPARSER::COLLECTION)
    ("p16ink4a and Ki67" . SPARSER::COLLECTION)
    ("tumor suppressive signaling proteins" . SPARSER::PROTEIN)
    ("These architectural components" . SPARSER::COMPONENT)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("cytokeratins" . SPARSER::PROTEIN-FAMILY)
    ("the cooperative impact" . SPARSER::PROTEIN)
    ("ErbB2 and RB" . SPARSER::COLLECTION) ("insulin 1" . SPARSER::PROTEIN)
    ("SP3" . SPARSER::PROTEIN) ("RNR2" . SPARSER::PROTEIN)
    ("Erbb2" . SPARSER::PROTEIN) ("PD-0332991" . SPARSER::DRUG)
    ("E-Cadherin" . SPARSER::PROTEIN) ("DSG1" . SPARSER::PROTEIN)
    ("ITGB4" . SPARSER::PROTEIN) ("KRT17" . SPARSER::PROTEIN)
    ("KRT15" . SPARSER::PROTEIN) ("KRT18" . SPARSER::PROTEIN)
    ("p16ink4a" . SPARSER::PROTEIN) ("ErbB2" . SPARSER::PROTEIN)
    ("proteasomal substrates" . SPARSER::SUBSTRATE)
    ("p53, and Mdm2" . SPARSER::COLLECTION) ("p53:Mdm2" . SPARSER::BIO-COMPLEX)
    ("p53 or Mdm2" . SPARSER::COLLECTION)
    ("A contributory factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polyubiquitination and the type" . SPARSER::COLLECTION)
    ("an E3 ligase and its substrate" . SPARSER::COLLECTION)
    ("hHR23A and hHR23B" . SPARSER::COLLECTION) ("hHR23B" . SPARSER::PROTEIN)
    ("UBA/UBL" . SPARSER::COLLECTION)
    ("bortezomib and nutlin-3" . SPARSER::COLLECTION)
    ("p21 or Bax" . SPARSER::COLLECTION)
    ("doxorubicin and 5-fluorouracil" . SPARSER::COLLECTION)
    ("dominant-negative truncated p53" . SPARSER::PROTEIN)
    ("p21 and Bax" . SPARSER::COLLECTION)
    ("p53 and its E3 ligase Mdm2" . SPARSER::COLLECTION)
    ("The former protein" . SPARSER::PROTEIN)
    ("p53 and anti-ubiquitin" . SPARSER::COLLECTION)
    ("other intrinsic proteasomal subunits" . SPARSER::PROTEIN)
    ("UBL" . SPARSER::PROTEIN) ("ADRM1/Rpn13" . SPARSER::COLLECTION)
    ("Ubiquitin" . SPARSER::PROTEIN)
    ("an E3 ubiquitin ligase and its substrate" . SPARSER::COLLECTION)
    ("UIM" . SPARSER::PROTEIN) ("p53 and Mdm2" . SPARSER::COLLECTION)
    ("p53 and its major E3 ligase Mdm2" . SPARSER::COLLECTION)
    ("PSMA2" . SPARSER::PROTEIN) ("Rpn11" . SPARSER::PROTEIN)
    ("PSMD14" . SPARSER::PROTEIN) ("Rpt2" . SPARSER::PROTEIN)
    ("PSMC1" . SPARSER::PROTEIN) ("Rpn1" . SPARSER::PROTEIN)
    ("PSMD2" . SPARSER::PROTEIN) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PSMB5" . SPARSER::PROTEIN) ("von Willebrand factor" . SPARSER::PROTEIN)
    ("PSMB3" . SPARSER::PROTEIN) ("Rpn6" . SPARSER::PROTEIN)
    ("PSMD11" . SPARSER::PROTEIN) ("USP5" . SPARSER::PROTEIN)
    ("Rpn13" . SPARSER::PROTEIN) ("ADRM1" . SPARSER::PROTEIN)
    ("Rpn10" . SPARSER::PROTEIN) ("PSMD4" . SPARSER::PROTEIN)
    ("oligomerized prepore BAK" . SPARSER::PROTEIN)
    ("an oligomeric conformation" . SPARSER::BIO-CONFORMATION)
    ("Activator" . SPARSER::ACTIVATOR)
    ("ligand or receptor" . SPARSER::COLLECTION)
    ("Conformation" . SPARSER::BIO-CONFORMATION) ("Mutant" . SPARSER::MUTANT)
    ("a BH3-domain-dependent step" . SPARSER::PROTEIN)
    ("The antiapoptotic arm" . SPARSER::PROTEIN)
    ("cysteines" . SPARSER::AMINO-ACID) ("Cysteines" . SPARSER::AMINO-ACID)
    ("protein " . SPARSER::PROTEIN) ("Cysteines " . SPARSER::AMINO-ACID)
    ("acetamido" . SPARSER::MOLECULE)
    ("a BAK L78A or an N-terminal-truncated BAK ΔN83" . SPARSER::COLLECTION)
    ("oligomer" . SPARSER::MOLECULE)
    ("solely monomeric BAK" . SPARSER::PROTEIN) ("Step" . SPARSER::PROTEIN)
    ("detergents" . SPARSER::MOLECULE) ("BAK " . SPARSER::PROTEIN)
    ("associated BAK" . SPARSER::PROTEIN)
    ("BAK and the BCL-X L :BAK complex" . SPARSER::COLLECTION)
    ("GLY" . SPARSER::PROTEIN)
    ("BH3-domain-exposed conformation" . SPARSER::BIO-CONFORMATION)
    ("the preferential target" . SPARSER::TARGET-PROTEIN)
    ("BCL-2 or BCL-X" . SPARSER::COLLECTION)
    (":BIM or BCL-2:BIM" . SPARSER::COLLECTION)
    ("BCL-2:BIM" . SPARSER::BIO-COMPLEX) ("MCL-1:BAK" . SPARSER::BIO-COMPLEX)
    ("sink" . SPARSER::PROTEIN) ("Bak or Bax" . SPARSER::COLLECTION)
    ("Complexes" . SPARSER::BIO-COMPLEX)
    ("BCL-2 or MCL-1" . SPARSER::COLLECTION)
    ("caspase-3 and poly (ADP-ribose) polymerase (PARP) ( xref A and 1B)"
     . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("the BH3 Mimetic ABT-737" . SPARSER::DRUG)
    ("BH3-domain-exposed BAK" . SPARSER::PROTEIN)
    ("multimeric mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BIM and tBID" . SPARSER::COLLECTION)
    ("the pivotal step" . SPARSER::PROTEIN)
    ("proteins, BAK and BAX" . SPARSER::COLLECTION)
    ("oligomeric BAK" . SPARSER::PROTEIN)
    ("the BH3 mimetic ABT-737" . SPARSER::DRUG) (":BIM" . SPARSER::BIO-COMPLEX)
    (":BAK" . SPARSER::BIO-COMPLEX) ("BIM-2" . SPARSER::PROTEIN)
    ("BIM-1" . SPARSER::PROTEIN) ("1,10-phenanthroline" . SPARSER::MOLECULE)
    ("ABT-737-" . SPARSER::DRUG)
    ("the corresponding pathogenic mutants" . SPARSER::MUTANT)
    ("fully active dimers" . SPARSER::DIMER)
    ("the FGFR dimeric state" . SPARSER::BIO-STATE)
    ("Neu and EGF" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("the symmetric conformation" . SPARSER::BIO-CONFORMATION)
    ("fgf and heparin" . SPARSER::COLLECTION) ("fgf" . SPARSER::PROTEIN)
    ("Gly, Ser and Ala" . SPARSER::COLLECTION)
    ("symmetric kinase dimers" . SPARSER::DIMER)
    ("the symmetric kinase dimer" . SPARSER::DIMER)
    ("inactive EGFR kinase dimers" . SPARSER::DIMER)
    ("EC and kinase" . SPARSER::COLLECTION)
    ("FGFR1 and FGFR2" . SPARSER::COLLECTION)
    ("The dimeric adaptor protein Grb2" . SPARSER::PROTEIN)
    ("CRLR" . SPARSER::PROTEIN)
    ("phenylalanine and glycine" . SPARSER::COLLECTION)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("an aromatic ring patch" . SPARSER::PROTEIN) ("patch" . SPARSER::PROTEIN)
    ("valine, isoleucine and leucine" . SPARSER::COLLECTION)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("a left-handed dimer" . SPARSER::DIMER) ("YA" . SPARSER::PROTEIN)
    ("a left-handed symmetric dimer" . SPARSER::DIMER)
    ("the α-helical part" . SPARSER::COMPONENT)
    ("dimeric and monomeric 1 H N chemical" . SPARSER::MOLECULE)
    ("the monomeric state" . SPARSER::BIO-STATE)
    ("monomeric and dimeric forms" . SPARSER::FORM)
    ("the dimeric state" . SPARSER::BIO-STATE)
    ("EC and TM" . SPARSER::COLLECTION)
    ("the dimeric complex" . SPARSER::BIO-COMPLEX)
    ("proteoglycans" . SPARSER::PROTEIN)
    ("an enzyme and a C-terminal lobe" . SPARSER::COLLECTION)
    ("These bitopic membrane proteins" . SPARSER::PROTEIN)
    ("helix-helix" . SPARSER::COLLECTION)
    ("a symmetric left-handed dimer" . SPARSER::DIMER)
    ("DPC" . SPARSER::MOLECULE) ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("FGFR3" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor 3" . SPARSER::PROTEIN)
    ("dominant-negative CaR, Trio, and filamin peptides" . SPARSER::PEPTIDE)
    ("CaR, Trio, and filamin" . SPARSER::COLLECTION)
    ("cadherin and effectors" . SPARSER::COLLECTION)
    ("filamin-integrin" . SPARSER::COLLECTION)
    ("integrins and membrane glycoproteins" . SPARSER::COLLECTION)
    ("abnormal neuronal migration" . SPARSER::PROTEIN)
    ("EDS" . SPARSER::PROTEIN) ("EDS-PH" . SPARSER::COLLECTION)
    ("intracellular cytoskeletal complexes" . SPARSER::BIO-COMPLEX)
    ("aberrant vasculature" . SPARSER::PROTEIN) ("Flna" . SPARSER::PROTEIN)
    ("myotube" . SPARSER::PROTEIN) ("Trio and Rac1" . SPARSER::COLLECTION)
    ("DH-GEF" . SPARSER::COLLECTION)
    ("Trio, Rho-GTPase and CaR" . SPARSER::COLLECTION)
    ("a CaR C-terminus peptide (CaRL, amino acid 907–980) or a filamin A peptide"
     . SPARSER::COLLECTION)
    ("Trio and filamin A" . SPARSER::COLLECTION)
    ("Trio or filamin" . SPARSER::COLLECTION)
    ("these dominant-negative peptides" . SPARSER::PEPTIDE)
    ("a V5-tagged filamin A peptide" . SPARSER::PEPTIDE)
    ("filamin A, Trio, and Rho" . SPARSER::COLLECTION)
    ("CaR, Trio and Rho family" . SPARSER::COLLECTION)
    ("transglutaminase (TG)" . SPARSER::PROTEIN)
    ("loricrin and filaggrin" . SPARSER::COLLECTION)
    ("filaggrin" . SPARSER::PROTEIN) ("loricrin" . SPARSER::PROTEIN)
    ("involucrin" . SPARSER::PROTEIN)
    ("E-cadherin-catenin-Rho" . SPARSER::PROTEIN-PAIR)
    ("E-cadherin and catenins" . SPARSER::COLLECTION)
    ("p120-catenins" . SPARSER::COLLECTION) ("siRNA-" . SPARSER::PROTEIN)
    ("CaR or Rho" . SPARSER::COLLECTION)
    ("filamin or Trio" . SPARSER::COLLECTION)
    ("associated CaR, filamin A, Trio, and E-cadherin" . SPARSER::COLLECTION)
    ("CaR, filamin A, Trio, and E-cadherin" . SPARSER::COLLECTION)
    ("a Rho A antibody" . SPARSER::ANTIBODY) ("sepharose" . SPARSER::MOLECULE)
    ("Meanwhile neither Ca 2+" . SPARSER::CALCIUM-ION)
    ("E-cadherin, β-catenin, or γ-catenin" . SPARSER::COLLECTION)
    ("filamin A (siFLNA) and Trio (siTrio)" . SPARSER::COLLECTION)
    ("filamin and Trio" . SPARSER::COLLECTION)
    ("Trio, and Rho" . SPARSER::COLLECTION)
    ("CaR ( xref ) and Trio ( xref )" . SPARSER::COLLECTION)
    ("Dbl-homology" . SPARSER::COLLECTION) ("PH" . SPARSER::PROTEIN)
    ("Rac 1 and Rho" . SPARSER::COLLECTION) ("Dbl" . SPARSER::PROTEIN)
    ("Rho-like GTPases and a guanine nucleotide exchange factor (GEF)"
     . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("mitogen-activated protein kinase [ xref , xref , xref ] and Rho [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("CaR and filamin" . SPARSER::COLLECTION)
    ("intracellular signaling proteins, ion channels, and transmembrane receptors"
     . SPARSER::COLLECTION)
    ("CaR and filamin A" . SPARSER::COLLECTION)
    ("receptor (GPCR)" . SPARSER::RECEPTOR)
    ("Rho and Rac" . SPARSER::COLLECTION)
    ("small GTPases and the Src family" . SPARSER::COLLECTION)
    ("Fyn" . SPARSER::PROTEIN) ("Akt and PLCγ 1" . SPARSER::COLLECTION)
    ("cytoskeletal actin" . SPARSER::PROTEIN)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CaR, Trio and Rho" . SPARSER::COLLECTION)
    ("dominant-negative peptides" . SPARSER::PEPTIDE)
    ("CaR-filamin" . SPARSER::COLLECTION) ("filamin-Rho" . SPARSER::COLLECTION)
    ("filamin-Trio" . SPARSER::COLLECTION)
    ("filamin A or Trio" . SPARSER::COLLECTION)
    ("complex, and keratinocyte" . SPARSER::COLLECTION)
    ("CaR-Rho" . SPARSER::COLLECTION) ("Trio and Rho" . SPARSER::COLLECTION)
    ("filamin A and Trio" . SPARSER::COLLECTION)
    ("CaR, Trio, and Rho" . SPARSER::COLLECTION)
    ("a cytoskeletal actin-binding protein" . SPARSER::PROTEIN)
    ("Trio" . SPARSER::PROTEIN) ("CaR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Extracellular" . SPARSER::PROTEIN)
    ("neuronal migration" . SPARSER::PROTEIN) ("M-cadherin" . SPARSER::PROTEIN)
    ("γ-catenin" . SPARSER::PROTEIN) ("Rho-GEF" . SPARSER::PROTEIN)
    ("PAK-1" . SPARSER::PROTEIN) ("keratin 14" . SPARSER::PROTEIN)
    ("keratin 1" . SPARSER::PROTEIN) ("transglutaminase 1" . SPARSER::PROTEIN)
    ("Rac 1" . SPARSER::PROTEIN) ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("PLCγ 1" . SPARSER::PROTEIN)
    ("Filamin A" . SPARSER::PROTEIN) ("p53-SNP" . SPARSER::COLLECTION)
    ("a strong genetic component" . SPARSER::COMPONENT)
    ("KITLG, SPRY4, and BAK1" . SPARSER::COLLECTION)
    ("nonfunctional p53-REs" . SPARSER::COLLECTION)
    ("polymorphic p53-REs" . SPARSER::COLLECTION)
    ("p53-occupied polymorphic p53-REs" . SPARSER::COLLECTION)
    ("only one SNP" . SPARSER::PROTEIN)
    ("the KITLG p53-RE SNP’s" . SPARSER::PROTEIN)
    ("a functional SNP" . SPARSER::PROTEIN)
    ("the testicular cancer cells GH" . SPARSER::PROTEIN)
    ("DNAs" . SPARSER::DNA) ("a closely linked exonic SNP" . SPARSER::PROTEIN)
    ("-SNP" . SPARSER::COLLECTION) ("UO" . SPARSER::PROTEIN)
    ("integrase" . SPARSER::PROTEIN) ("Hsp68-LacZ" . SPARSER::COLLECTION)
    ("trap" . SPARSER::PROTEIN)
    ("three p53 mutant or null cell lines (CRL-2073, germ cell tumor; H1299, lung; and Soas2, osteosarcoma)"
     . SPARSER::COLLECTION)
    ("CRL" . SPARSER::PROTEIN) ("its isogenic p53 null form" . SPARSER::FORM)
    ("ultraviolet (UV) light" . SPARSER::PROTEIN) ("UVR" . SPARSER::PROTEIN)
    ("p53-Kitlg" . SPARSER::COLLECTION) ("Kitlg" . SPARSER::PROTEIN)
    ("KITLG and its receptor" . SPARSER::COLLECTION)
    ("KITLG and p21" . SPARSER::COLLECTION)
    ("the most well-studied default p53 target genes CDKN1A"
     . SPARSER::PROTEIN)
    ("iHS" . SPARSER::MOLECULE) ("RITA" . SPARSER::PROTEIN)
    ("GM11992" . SPARSER::PROTEIN)
    ("at least one cancer GWAS SNP" . SPARSER::PROTEIN)
    ("extremely cancer-prone families" . SPARSER::PROTEIN-FAMILY)
    ("purine and Y" . SPARSER::COLLECTION) ("p53-REs" . SPARSER::COLLECTION)
    ("homotetramer" . SPARSER::HOMOTETRAMER) ("KITLG" . SPARSER::PROTEIN)
    ("a beta" . SPARSER::PROTEIN) ("Hspa1b" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SPRY4" . SPARSER::PROTEIN)
    ("beta-galactosidase activity" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN) ("Hsp68" . SPARSER::PROTEIN)
    ("m2" . SPARSER::MOLECULE) ("c-Kit" . SPARSER::PROTEIN)
    ("C-KIT" . SPARSER::PROTEIN) ("actinomycin-D" . SPARSER::MOLECULE)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("RG and LC" . SPARSER::COLLECTION) ("GJ and RG" . SPARSER::COLLECTION)
    ("GJ" . SPARSER::PROTEIN) ("LC and DG" . SPARSER::COLLECTION)
    ("an important biomarker and metastatic gene" . SPARSER::COLLECTION)
    ("a powerful prognostic biomarker" . SPARSER::MOLECULE)
    ("the functionally relevant signalling molecule" . SPARSER::MOLECULE)
    ("a common upstream yet parallel effector" . SPARSER::EFFECTOR)
    ("pERK and Cav-1" . SPARSER::COLLECTION)
    ("ERK and NF-kappaB" . SPARSER::COLLECTION)
    ("Hif [ xref ] and VEGF [ xref ]" . SPARSER::COLLECTION)
    ("normoxic conditions Cav-1" . SPARSER::PROTEIN)
    ("YB-1 in breast cancer [ xref ] and spastin [ xref ] in glioma"
     . SPARSER::COLLECTION)
    ("spastin" . SPARSER::PROTEIN)
    ("an immediate upstream effector" . SPARSER::EFFECTOR)
    ("an immediate downstream effector molecule" . SPARSER::MOLECULE)
    ("cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("negligible Hif" . SPARSER::PROTEIN-FAMILY) ("ACHN" . SPARSER::PROTEIN)
    ("VHL-" . SPARSER::PROTEIN) ("Hif" . SPARSER::PROTEIN-FAMILY)
    ("Kappa" . SPARSER::PROTEIN-FAMILY)
    ("the one discordant case" . SPARSER::PROTEIN)
    ("the two discordant cases Cav-1" . SPARSER::PROTEIN)
    ("only 3.33 yrs" . SPARSER::PROTEIN)
    ("PI3-K/AKT/mTOR" . SPARSER::COLLECTION)
    ("an independent prognostic biomarker" . SPARSER::MOLECULE)
    ("pERK-1" . SPARSER::PROTEIN)
    ("the most common and aggressive form" . SPARSER::FORM)
    ("preclinical models Cav-1" . SPARSER::PROTEIN) ("VHL" . SPARSER::PROTEIN)
    ("Cav-1 and pERK" . SPARSER::COLLECTION)
    ("Cav-1 and phosphorylated-ERK" . SPARSER::COLLECTION)
    ("caveolin-1/ERK" . SPARSER::COLLECTION) ("RCC" . SPARSER::PROTEIN)
    ("NEU3" . SPARSER::PROTEIN) ("Cav-2" . SPARSER::PROTEIN)
    ("caveolin-2" . SPARSER::PROTEIN)
    ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-KappaB" . SPARSER::PROTEIN) ("LY-294002" . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN) ("Cav-1" . SPARSER::PROTEIN)
    ("fetuses" . SPARSER::PROTEIN) ("an immediate impact" . SPARSER::PROTEIN)
    ("CycD1 or Lin52" . SPARSER::COLLECTION)
    ("CycD1 and Lin52" . SPARSER::COLLECTION)
    ("a rapidly cycling state" . SPARSER::BIO-STATE)
    ("CycD1 and p21 protein" . SPARSER::COLLECTION)
    ("CycD1/p21" . SPARSER::COLLECTION) ("mTurq" . SPARSER::PROTEIN)
    ("p21, CycD1, and phospho-Rb" . SPARSER::COLLECTION)
    ("phosho-Rb" . SPARSER::COLLECTION)
    ("CycD1 or Dyrk1a" . SPARSER::COLLECTION)
    ("relatively higher CycD1" . SPARSER::PROTEIN)
    ("a well-known dual cyclin D-CDK4/6 and cyclin E-CDK2 substrate"
     . SPARSER::SUBSTRATE)
    ("cyclin E-CDK2" . SPARSER::COLLECTION)
    ("cyclin D-CDK4/6" . SPARSER::COLLECTION)
    ("cyclin D/CDK4" . SPARSER::COLLECTION)
    ("p21/CycD1/CDK4" . SPARSER::COLLECTION) ("Nutlin" . SPARSER::DRUG)
    ("CycD1 or p21" . SPARSER::COLLECTION) ("si-Ctrl" . SPARSER::COLLECTION)
    ("Ctrl" . SPARSER::PROTEIN) ("CycD1/CDK4/p21" . SPARSER::COLLECTION)
    ("p21 or CycD1" . SPARSER::COLLECTION)
    ("CycD/CDK4/6" . SPARSER::COLLECTION) ("CycD" . SPARSER::PROTEIN)
    ("inactive or active" . SPARSER::COLLECTION)
    ("CDK/Cyclin" . SPARSER::COLLECTION) ("CycD1/CDK4/6" . SPARSER::COLLECTION)
    ("CKIs" . SPARSER::PROTEIN) ("GST-CycD1" . SPARSER::COLLECTION)
    ("mCit-fused" . SPARSER::COLLECTION) ("si-Dyrk1a" . SPARSER::COLLECTION)
    ("mCit-Dyrk1a" . SPARSER::COLLECTION) ("Dyrk1a (WT)" . SPARSER::PROTEIN)
    ("H2B-mTurq" . SPARSER::COLLECTION)
    ("tet-mCit-Dyrk1a" . SPARSER::COLLECTION) ("Harmine" . SPARSER::DRUG)
    ("two fluorescent protein" . SPARSER::PROTEIN)
    ("mChy-Geminin" . SPARSER::COLLECTION)
    ("mCherry-Geminin" . SPARSER::COLLECTION) ("Geminin" . SPARSER::PROTEIN)
    ("p21 and CycD1" . SPARSER::COLLECTION)
    ("Lin52 and DREAM" . SPARSER::COLLECTION) ("Lin52" . SPARSER::PROTEIN)
    ("whose gene" . SPARSER::GENE) ("tyrosine-" . SPARSER::AMINO-ACID)
    ("CycD1 and p21" . SPARSER::COLLECTION) ("p21-CycD1" . SPARSER::COLLECTION)
    ("co-stabilizing CycD1 and the CDK inhibitor p21" . SPARSER::COLLECTION)
    ("DS" . SPARSER::PROTEIN) ("p-Rb" . SPARSER::PROTEIN)
    ("CycD3" . SPARSER::PROTEIN) ("protein kinase 1" . SPARSER::PROTEIN)
    ("CycD1" . SPARSER::PROTEIN) ("Dyrk1a" . SPARSER::PROTEIN)
    ("IκBα-SR" . SPARSER::COLLECTION) ("SR" . SPARSER::PROTEIN)
    ("lenti-hTERT" . SPARSER::COLLECTION) ("CGN and NPC" . SPARSER::COLLECTION)
    ("CGN" . SPARSER::PROTEIN) ("protein and hTERT" . SPARSER::COLLECTION)
    ("Bip, IRE1α, CHOP, and XBP-1" . SPARSER::COLLECTION)
    ("Ron" . SPARSER::PROTEIN) ("hTR or hTERC" . SPARSER::COLLECTION)
    ("hTERC" . SPARSER::RNA) ("enzyme or DNA" . SPARSER::COLLECTION)
    ("XBP-1" . SPARSER::PROTEIN) ("IRE1α" . SPARSER::PROTEIN)
    ("p53, HTF9C, CEACAM5, NDRG1 and SLC7A5" . SPARSER::COLLECTION)
    ("strong p53 nuclear" . SPARSER::PROTEIN)
    ("ER, PR, HER2 and Ki-67" . SPARSER::COLLECTION)
    ("Clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("biological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a strong prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("strong nuclear" . SPARSER::PROTEIN) ("Hela" . SPARSER::PROTEIN)
    ("clinicopatholoical factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER2 and Ki-67" . SPARSER::COLLECTION)
    ("Functional p53" . SPARSER::PROTEIN)
    ("anastrozole, letrozole and exemestane" . SPARSER::COLLECTION)
    ("exemestane" . SPARSER::DRUG) ("letrozole" . SPARSER::DRUG)
    ("anastrozole" . SPARSER::DRUG)
    ("ER, progesterone receptor, HER2 and Ki-67" . SPARSER::COLLECTION)
    ("Aromatase" . SPARSER::PROTEIN) ("BIG 1" . SPARSER::PROTEIN)
    ("SLC7A5" . SPARSER::PROTEIN) ("NDRG1" . SPARSER::PROTEIN)
    ("CEACAM5" . SPARSER::PROTEIN) ("HTF9C" . SPARSER::PROTEIN)
    ("MIB-1" . SPARSER::PROTEIN) ("3–2" . SPARSER::PROTEIN)
    ("TP 53" . SPARSER::PROTEIN)
    ("Hsp90α and its kinase client PKCγ" . SPARSER::COLLECTION)
    ("a multifunctional cyclic nucleotide-independent serine/threonine protein kinase"
     . SPARSER::PROTEIN)
    ("Hsp90α–Cdc37" . SPARSER::COLLECTION)
    ("Hsp90α and its novel kinase client PKCγ" . SPARSER::COLLECTION)
    ("PKCγ/Hsp90α" . SPARSER::COLLECTION)
    ("Hsp90α or PKCγ" . SPARSER::COLLECTION)
    ("PKCγ, K380A-PKCγ, and a constitutively active form"
     . SPARSER::COLLECTION)
    ("A25E" . SPARSER::PROTEIN)
    ("PKCγ and the Hsp90α non-phospho-" . SPARSER::COLLECTION)
    ("PKCγ and PKCγ-mediated threonine-phosphorylated Hsp90α"
     . SPARSER::COLLECTION)
    ("Myc–PKCγ" . SPARSER::COLLECTION)
    ("intrinsic ATPase activity and co-chaperones" . SPARSER::COLLECTION)
    ("ATPase activity and co-chaperones" . SPARSER::COLLECTION)
    ("Cdc37, Aha1 and PP5" . SPARSER::COLLECTION)
    ("Hsp70 and the Hsp90α T603E mutant" . SPARSER::COLLECTION)
    ("Hsp90α and Cdc37" . SPARSER::COLLECTION)
    ("Myc–Hsp90α" . SPARSER::COLLECTION) ("HA–Cdc37" . SPARSER::COLLECTION)
    ("Cdc37 and Hsp70" . SPARSER::COLLECTION)
    ("the ATP–agarose" . SPARSER::ATP) ("ATP–agarose" . SPARSER::ATP)
    ("Hsp90α and the three forms" . SPARSER::COLLECTION)
    ("A25E-PKCγ" . SPARSER::COLLECTION)
    ("the K380A kinase-dead form and the A25E kinase open form [ xref ]"
     . SPARSER::COLLECTION)
    ("two mutated forms" . SPARSER::FORM) ("chelerythrine" . SPARSER::DRUG)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("Hsp70 and Cdc37" . SPARSER::COLLECTION)
    ("Hsp90α, PKCγ, Hsp70 and Cdc37" . SPARSER::COLLECTION)
    ("Hsp90α indeed chaperones PKCγ" . SPARSER::PROTEIN)
    ("Hsp90α and PKCγ" . SPARSER::COLLECTION) ("geldanamycin" . SPARSER::DRUG)
    ("Hsp90α" . SPARSER::PROTEIN)
    ("PKCγ and vice versa ( xref D and xref E)" . SPARSER::COLLECTION)
    ("fragments and PKCγ" . SPARSER::COLLECTION)
    ("HA–PKCγ" . SPARSER::COLLECTION) ("FLAG–Hsp90α" . SPARSER::PROTEIN-PAIR)
    ("a flexible homodimer" . SPARSER::HOMODIMER)
    ("a monoclonal anti-Hsp90α antibody" . SPARSER::ANTIBODY)
    ("a multifunctional serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("complex, and tyrosine" . SPARSER::COLLECTION)
    ("kinase–Hsp90" . SPARSER::COLLECTION)
    ("ATPase and co-chaperones" . SPARSER::COLLECTION)
    ("Aha1 (activator of HSP90 ATPase homologue 1) and Cdc37"
     . SPARSER::COLLECTION)
    ("PKA" . SPARSER::PROTEIN) ("kinases and Hsp90" . SPARSER::COLLECTION)
    ("Hsp70 and Hsp90" . SPARSER::COLLECTION) ("HOP" . SPARSER::PROTEIN)
    ("PKCγ and Hsp90α" . SPARSER::COLLECTION)
    ("ATP and co-chaperones" . SPARSER::COLLECTION)
    ("its intrinsic ATPase activity" . SPARSER::PROTEIN)
    ("Sch9" . SPARSER::PROTEIN)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Cdc37 " . SPARSER::PROTEIN) ("Hsp70 " . SPARSER::PROTEIN)
    ("pHM6" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("pp60 v−src" . SPARSER::PROTEIN) ("ATP-dependent" . SPARSER::PROTEIN)
    ("Aha1" . SPARSER::PROTEIN) ("protein kinase A" . SPARSER::PROTEIN)
    ("Wee1" . SPARSER::PROTEIN) ("α at" . SPARSER::PROTEIN)
    ("Hsp90 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cdc37" . SPARSER::PROTEIN)
    ("PKCγ" . SPARSER::PROTEIN) ("ATPase activity" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ser and Pro" . SPARSER::COLLECTION) ("QM/MM" . SPARSER::COLLECTION)
    ("alkene" . SPARSER::MOLECULE) ("FKBP and hCyPA" . SPARSER::COLLECTION)
    ("no crystallographic water" . SPARSER::MOLECULE) ("QM" . SPARSER::PROTEIN)
    ("amine" . SPARSER::MOLECULE) ("EX" . SPARSER::PROTEIN)
    ("Vis" . SPARSER::DRUG) ("Solvent" . SPARSER::MOLECULE)
    ("deuteriums" . SPARSER::MOLECULE)
    ("a tetrahedral transition state" . SPARSER::BIO-STATE)
    ("substrate and solvent deuterium KIEs" . SPARSER::COLLECTION)
    ("pyrrolidine" . SPARSER::DRUG) ("ketone" . SPARSER::MOLECULE)
    ("Ala–Pro" . SPARSER::COLLECTION)
    ("FKBP and cyclophilin" . SPARSER::COLLECTION)
    ("cyclophilin" . SPARSER::PROTEIN) ("esters" . SPARSER::MOLECULE)
    ("amides" . SPARSER::MOLECULE) ("PPIases" . SPARSER::PROTEIN)
    ("NIMA" . SPARSER::PROTEIN) ("syn-exo" . SPARSER::COLLECTION)
    ("exo" . SPARSER::PROTEIN) ("syn" . SPARSER::PROTEIN)
    ("amide" . SPARSER::MOLECULE) ("Pro-" . SPARSER::AMINO-ACID)
    ("Ser-" . SPARSER::AMINO-ACID) ("deuterium" . SPARSER::MOLECULE)
    ("N -methylformamide" . SPARSER::DRUG) ("β-CD" . SPARSER::MOLECULE)
    ("β-2" . SPARSER::PROTEIN) ("α-2" . SPARSER::PROTEIN)
    ("k  3" . SPARSER::PROTEIN) ("FK506" . SPARSER::DRUG)
    ("FK506 binding protein" . SPARSER::PROTEIN)
    ("cyclophilin A" . SPARSER::PROTEIN) ("sp 3" . SPARSER::PROTEIN)
    ("sp 2" . SPARSER::PROTEIN) ("Cul4A and DDB1" . SPARSER::COLLECTION)
    ("Akt, Dlg and Scribble" . SPARSER::COLLECTION)
    ("Scribble" . SPARSER::PROTEIN) ("Dlg" . SPARSER::PROTEIN)
    ("Vpr-ZIP" . SPARSER::COLLECTION) ("RbAp46 and HAT1" . SPARSER::COLLECTION)
    ("dotted-line" . SPARSER::PROTEIN)
    ("RbAp46, HDAC1 and MTA2" . SPARSER::COLLECTION)
    ("Vpr, DCAF1, DDB1 and Cul4A" . SPARSER::COLLECTION)
    ("complex and (iii) these two proteins play" . SPARSER::COLLECTION)
    ("ZIP and its isoform sZIP" . SPARSER::COLLECTION)
    ("Env" . SPARSER::PROTEIN) ("VSV" . SPARSER::PROTEIN)
    ("VLPs" . SPARSER::PROTEIN) ("VprS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("previously characterized Vpr mutants" . SPARSER::MUTANT)
    ("ZIP/GFP" . SPARSER::COLLECTION)
    ("RbAp46, HAT1, ZIP and sZIP" . SPARSER::COLLECTION)
    ("exogenous ZIP or sZIP" . SPARSER::COLLECTION)
    ("both Vpr and the Cul4A DDB1 ubiquitin ligase subunits (DCAF1, DDB1, and Cul4A)"
     . SPARSER::COLLECTION)
    ("DCAF1, DDB1, and Cul4A" . SPARSER::COLLECTION)
    ("the insoluble fraction" . SPARSER::COMPONENT)
    ("valid antibodies" . SPARSER::ANTIBODY) ("HA-Vpr" . SPARSER::COLLECTION)
    ("the chromatin-associated fraction" . SPARSER::COMPONENT)
    ("the soluble fraction (SN)" . SPARSER::COMPONENT)
    ("HDAC1 and MTA2" . SPARSER::COLLECTION)
    ("insoluble proteins" . SPARSER::PROTEIN)
    ("Vpr and ZIP/sZIP" . SPARSER::COLLECTION)
    ("Vpr and ZIP" . SPARSER::COLLECTION)
    ("Vpr and sZIP" . SPARSER::COLLECTION)
    ("DCAF1, UNG2 or SAP145" . SPARSER::COLLECTION)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral protein" . SPARSER::PROTEIN) ("ZGPAT" . SPARSER::PROTEIN)
    ("CHD3 or Mi2-α" . SPARSER::COLLECTION) ("hHR23A" . SPARSER::PROTEIN)
    ("Vif and Vpu" . SPARSER::COLLECTION)
    ("integrated proviral DNA" . SPARSER::DNA) ("the viral DNA" . SPARSER::DNA)
    ("tetherin/BST-2" . SPARSER::COLLECTION) ("dNTP" . SPARSER::MOLECULE)
    ("Vpx" . SPARSER::PROTEIN) ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vpu" . SPARSER::PROTEIN)
    ("so-called viral auxiliary proteins" . SPARSER::PROTEIN)
    ("ZIP or sZIP" . SPARSER::COLLECTION)
    ("exogenous ZIP and sZIP" . SPARSER::COLLECTION)
    ("ZIP and sZIP" . SPARSER::COLLECTION)
    ("transcriptional regulators, ZIP and sZIP" . SPARSER::COLLECTION)
    ("ZIP" . SPARSER::PROTEIN) ("type 1 and type 2" . SPARSER::COLLECTION)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glycoprotein G" . SPARSER::PROTEIN) ("delta-" . SPARSER::PROTEIN)
    ("Cullin4A" . SPARSER::PROTEIN) ("Monoclonal antibody" . SPARSER::DRUG)
    ("micrococcal nuclease" . SPARSER::PROTEIN) ("CAP3" . SPARSER::PROTEIN)
    ("L40" . SPARSER::PROTEIN) ("GEM2" . SPARSER::PROTEIN)
    ("Mfn2" . SPARSER::PROTEIN) ("MTA-2" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("HAT1" . SPARSER::PROTEIN)
    ("Histone acetyltransferase 1" . SPARSER::PROTEIN)
    ("MTA2" . SPARSER::PROTEIN) ("SAP145" . SPARSER::PROTEIN)
    ("G-patch" . SPARSER::PROTEIN-FAMILY) ("RBBP7" . SPARSER::PROTEIN)
    ("RbAp46" . SPARSER::PROTEIN) ("CHD4" . SPARSER::PROTEIN)
    ("Mi2" . SPARSER::PROTEIN) ("CHD3" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN) ("UNG2" . SPARSER::PROTEIN)
    ("SAMHD1" . SPARSER::PROTEIN) ("BST-2" . SPARSER::PROTEIN)
    ("Cul4A" . SPARSER::PROTEIN) ("DCAF1" . SPARSER::PROTEIN)
    ("TW" . SPARSER::PROTEIN) ("octamer" . SPARSER::PROTEIN)
    ("Pang" . SPARSER::PROTEIN) ("apo" . SPARSER::PROTEIN)
    ("the two conformations and the complex" . SPARSER::COLLECTION)
    ("RCSB" . SPARSER::PROTEIN)
    ("the principal components" . SPARSER::COMPONENT)
    ("aqueous solution" . SPARSER::MOLECULE)
    ("implicit solvents" . SPARSER::MOLECULE) ("solvents" . SPARSER::MOLECULE)
    ("explicit solvent" . SPARSER::MOLECULE)
    ("explicit water" . SPARSER::MOLECULE) ("PCs" . SPARSER::PROTEIN)
    ("Principal components (PC)" . SPARSER::COMPONENT)
    ("Principal Components" . SPARSER::COMPONENT)
    ("Components" . SPARSER::COMPONENT) ("bak" . SPARSER::PROTEIN)
    ("polar solvent molecules" . SPARSER::MOLECULE)
    ("D583 Bak and N586 Bak" . SPARSER::COLLECTION)
    ("helix" . SPARSER::PROTEIN)
    ("only one conformation" . SPARSER::BIO-CONFORMATION)
    ("e.g. E129-R576 Bak" . SPARSER::PROTEIN)
    ("SC and SC" . SPARSER::COLLECTION) ("intra-helix" . SPARSER::PROTEIN-PAIR)
    ("Bcl-w and Bax" . SPARSER::COLLECTION) ("pro/anti" . SPARSER::COLLECTION)
    ("pro or anti-apoptotic" . SPARSER::COLLECTION)
    ("heterodimeric complexes" . SPARSER::BIO-COMPLEX)
    ("Principal components" . SPARSER::COMPONENT)
    ("‘pro’ and ‘anti’" . SPARSER::COLLECTION) ("‘anti’" . SPARSER::PROTEIN)
    ("‘pro’" . SPARSER::PROTEIN) ("PCs 1" . SPARSER::PROTEIN)
    ("Bcl- x" . SPARSER::PROTEIN) ("TIP3" . SPARSER::PROTEIN)
    ("alpha1" . SPARSER::PROTEIN) ("ID 1" . SPARSER::PROTEIN)
    ("BH2" . SPARSER::MOLECULE) ("ABT263" . SPARSER::DRUG)
    ("ABT737" . SPARSER::DRUG) ("PP1 and PP1" . SPARSER::COLLECTION)
    ("LAP1B and lamin B" . SPARSER::COLLECTION)
    ("both the outer and inner nuclear" . SPARSER::PROTEIN)
    ("AKAP" . SPARSER::PROTEIN)
    ("specific kinases and/or phosphatases" . SPARSER::COLLECTION)
    ("Lamins" . SPARSER::PROTEIN)
    ("REVRF (amino acids 55-59) and KVNF (amino acids 212-215)"
     . SPARSER::COLLECTION)
    ("PP1α and PP1γ1" . SPARSER::COLLECTION)
    ("Typically such variants" . SPARSER::VARIANT)
    ("PP2A and PP1" . SPARSER::COLLECTION)
    ("LAP1 and PP1" . SPARSER::COLLECTION) ("emerin" . SPARSER::PROTEIN)
    ("PP1γ and PP1α" . SPARSER::COLLECTION)
    ("approximately 37 kDa" . SPARSER::PROTEIN)
    ("namely rat striatum and cerebellum" . SPARSER::COLLECTION)
    ("striatum and cerebellum" . SPARSER::COLLECTION)
    ("striatum" . SPARSER::PROTEIN)
    ("PP1α or γ antibodies" . SPARSER::COLLECTION)
    ("PP1α and PP1γ" . SPARSER::COLLECTION) ("Myc-LAP1B" . SPARSER::COLLECTION)
    ("BM3" . SPARSER::PROTEIN) ("BM2 and" . SPARSER::PROTEIN)
    ("PP1α, PP1γ and LAP1B" . SPARSER::COLLECTION) ("REVRF" . SPARSER::PROTEIN)
    ("LAP1B-BM3" . SPARSER::COLLECTION) ("LAP1B-BM2 and" . SPARSER::COLLECTION)
    ("full-length LAP1B and different PP1 isoforms (α, γ1 or γ2)"
     . SPARSER::COLLECTION)
    ("Galactosidase" . SPARSER::PROTEIN) ("BM1 (REVRF)" . SPARSER::PROTEIN)
    ("the BM2 or the BM3 ( xref )" . SPARSER::COLLECTION)
    ("BM2" . SPARSER::PROTEIN) ("LAP1B-BM2" . SPARSER::PROTEIN-PAIR)
    ("LAP1B-BM1" . SPARSER::COLLECTION)
    ("both full-length and deletion mutants" . SPARSER::COLLECTION)
    ("full-length and mutants" . SPARSER::COLLECTION)
    ("both full-length LAP1B and the different deletion mutants"
     . SPARSER::COLLECTION)
    ("LAP1B and PP1" . SPARSER::COLLECTION)
    ("BM1 and BM3" . SPARSER::COLLECTION) ("Rat" . SPARSER::PROTEIN)
    ("BM1, BM2, BM3 and SILK" . SPARSER::COLLECTION)
    ("BM1 and BM2" . SPARSER::COLLECTION) ("lamins" . SPARSER::PROTEIN)
    ("the only human isoform" . SPARSER::ISOFORM)
    ("using monoclonal antibodies" . SPARSER::ANTIBODY)
    ("named lamina associated polypeptide 1" . SPARSER::PROTEIN)
    ("protein 1 (TOR1AIP1) or lamina" . SPARSER::COLLECTION)
    ("PP1α, PP1γ1 and PP1γ2" . SPARSER::COLLECTION)
    ("the conformation and activity of PP1" . SPARSER::COLLECTION)
    ("any amino acid and X B" . SPARSER::COLLECTION)
    ("a ubiquitous PP1γ1 variant and a PP1γ2 variant" . SPARSER::COLLECTION)
    ("a ubiquitous PP1γ1 variant" . SPARSER::VARIANT)
    ("PP1Beta/Delta" . SPARSER::COLLECTION) ("Delta" . SPARSER::PROTEIN)
    ("glycogen" . SPARSER::PROTEIN)
    ("a ubiquitous serine/threonine phosphatase" . SPARSER::PROTEIN)
    ("LAP1B:PP1" . SPARSER::BIO-COMPLEX) ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("AKAP149" . SPARSER::PROTEIN) ("lamin A/C" . SPARSER::PROTEIN)
    ("LAP2" . SPARSER::PROTEIN) ("Nek2A" . SPARSER::PROTEIN)
    ("transmembrane domain (TM)" . SPARSER::PROTEIN)
    ("ADE2" . SPARSER::PROTEIN) ("AH109" . SPARSER::DRUG)
    ("BM1" . SPARSER::PROTEIN) ("lamin B1" . SPARSER::PROTEIN)
    ("CBC2" . SPARSER::PROTEIN) ("LAP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TOR1AIP1" . SPARSER::PROTEIN) ("PP1γ" . SPARSER::PROTEIN)
    ("PP1gamma" . SPARSER::PROTEIN) ("PP1β" . SPARSER::PROTEIN)
    ("PP1Beta" . SPARSER::PROTEIN) ("PP1α" . SPARSER::PROTEIN)
    ("PP1alpha" . SPARSER::PROTEIN) ("DYT1" . SPARSER::PROTEIN)
    ("LAP1B" . SPARSER::PROTEIN) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protein phosphatase 1" . SPARSER::PROTEIN)
    ("Another possible confounding factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MS-MLPA" . SPARSER::COLLECTION) ("BOT" . SPARSER::PROTEIN)
    ("genes ( TSG )" . SPARSER::GENE) ("protein 1A" . SPARSER::PROTEIN)
    ("an unfavorable prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("translational factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NPC, and lymphomas" . SPARSER::COLLECTION)
    ("cyclin D2 and cyclin E2" . SPARSER::COLLECTION)
    ("Cyclin D2 and cyclin E2" . SPARSER::COLLECTION)
    ("tumor-suppressor or oncogenic miRNAs" . SPARSER::COLLECTION)
    ("cyclin E2 and EZH2" . SPARSER::COLLECTION)
    ("cyclin E2 or EZH2" . SPARSER::COLLECTION)
    ("cyclin E2 and cyclin D2" . SPARSER::COLLECTION)
    ("Cyclin D2, Cyclin E2, and PCNA" . SPARSER::COLLECTION)
    ("conventional clinical prognostic factors and miR-26a"
     . SPARSER::COLLECTION)
    ("factors and miR-26a" . SPARSER::COLLECTION) ("n  " . SPARSER::PROTEIN)
    ("gemcitabine and oxaliplatin" . SPARSER::COLLECTION)
    ("oxaliplatin" . SPARSER::DRUG) ("ISH" . SPARSER::PROTEIN)
    ("LNA-ISH" . SPARSER::PROTEIN-PAIR) ("LNA" . SPARSER::PROTEIN)
    ("a hAFP–TERT dual promoter" . SPARSER::PROMOTER)
    ("p53, cyclin D2, and E2" . SPARSER::COLLECTION)
    ("hAFP–TERT" . SPARSER::PROTEIN-PAIR)
    ("a novel prognostic factor and therapeutic target" . SPARSER::COLLECTION)
    ("Cyclin D2, E2, EZH2, and PCNA" . SPARSER::COLLECTION)
    ("SW" . SPARSER::PROTEIN) ("Cyclin D2" . SPARSER::PROTEIN)
    ("DTCs" . SPARSER::MOLECULE)
    ("histological types and HP infection" . SPARSER::COLLECTION)
    ("histological types" . TYPE) ("Ras, Rap1 and Rap2" . SPARSER::COLLECTION)
    ("triphosphatases" . SPARSER::PROTEIN) ("guanosine" . SPARSER::MOLECULE)
    ("types and ethnicities" . SPARSER::COLLECTION) ("EAC" . SPARSER::PROTEIN)
    ("the secondary messengers inositol 1,4,5-trisphosphate and diacylglycerol (DAG)"
     . SPARSER::COLLECTION)
    ("inositol 1,4,5-trisphosphate and diacylglycerol (DAG)"
     . SPARSER::MOLECULE)
    ("inositol 1,4,5-trisphosphate and diacylglycerol" . SPARSER::COLLECTION)
    ("phospholipase" . SPARSER::PROTEIN)
    ("type, ethnicity, and source" . SPARSER::COLLECTION)
    ("DTC" . SPARSER::PROTEIN) ("VEGFR2" . SPARSER::PROTEIN)
    ("Rap2" . SPARSER::PROTEIN) ("Rap1" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("PLCε1" . SPARSER::PROTEIN) ("PLCE1" . SPARSER::PROTEIN)
    ("epsilon 1" . SPARSER::PROTEIN)
    ("the immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("IL-6 and VEGF" . SPARSER::COLLECTION)
    ("VEGF and survivin" . SPARSER::COLLECTION)
    ("IL-6, survivin and VEGF" . SPARSER::COLLECTION)
    ("IL-6, survivin, STAT3 and VEGF" . SPARSER::COLLECTION)
    ("STAT3, and VEGF" . SPARSER::COLLECTION)
    ("JAK/STAT3" . SPARSER::COLLECTION)
    ("metalloproteinases and vascular endothelial growth factor"
     . SPARSER::COLLECTION)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Janus-associated kinase (JAK)" . SPARSER::KINASE)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("mitogen activated protein kinase (MAPK) and phoshatidylinositol-triphosphate kinase (PI-3 kinase)"
     . SPARSER::COLLECTION)
    ("IL-6 and STAT3" . SPARSER::COLLECTION)
    ("IL-10 and VEGF" . SPARSER::COLLECTION) ("p-STAT3" . SPARSER::COLLECTION)
    ("IL-6, IL-10 and VEGF" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("T-Cell" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("gp130" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("PI-3 kinase" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("odd" . SPARSER::PROTEIN) ("Van" . SPARSER::PROTEIN)
    ("eight showed longer CAG allele" . SPARSER::ALLELE)
    ("smaller alleles" . SPARSER::ALLELE) ("shorter alleles" . SPARSER::ALLELE)
    ("post-hoc" . SPARSER::PROTEIN-PAIR) ("t " . SPARSER::PROTEIN)
    ("ligand-" . SPARSER::LIGAND) ("adrenals" . SPARSER::DRUG)
    ("SD " . SPARSER::PROTEIN) ("PCOS" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN)
    ("YAP1 and its Ser127 phosphoprotein" . SPARSER::COLLECTION)
    ("genes or genes" . SPARSER::COLLECTION)
    ("nuclear and active" . SPARSER::COLLECTION)
    ("self-renewal targets" . SPARSER::TARGET-PROTEIN)
    ("differential YAP1" . SPARSER::PROTEIN)
    ("simultaneous nuclear and cytosolic YAP1" . SPARSER::PROTEIN)
    ("YAP1 and p-YAP1" . SPARSER::COLLECTION) ("WTs" . SPARSER::PROTEIN)
    ("NCAM" . SPARSER::PROTEIN)
    ("a previously established WT biomarker" . SPARSER::MOLECULE)
    ("FH" . SPARSER::PROTEIN)
    ("The Yes-associated protein-1" . SPARSER::PROTEIN)
    ("approximately 40 years ago" . SPARSER::PROTEIN)
    ("nuclear p-YAP1" . SPARSER::PROTEIN)
    ("total and phosphorylated YAP1" . SPARSER::PROTEIN)
    ("CITED1" . SPARSER::PROTEIN) ("Wilms Tumor" . SPARSER::PROTEIN)
    ("FGF2" . SPARSER::PROTEIN) ("TGF-α" . SPARSER::PROTEIN)
    ("SIX2" . SPARSER::PROTEIN) ("Fat4" . SPARSER::PROTEIN)
    ("FAT4" . SPARSER::PROTEIN) ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("VPS35 and ATP13A2" . SPARSER::COLLECTION) ("ApoE4" . SPARSER::PROTEIN)
    ("ApoE" . SPARSER::PROTEIN) ("LRRK2, GSK3β, and tau" . SPARSER::COLLECTION)
    ("oligomers" . SPARSER::MOLECULE)
    ("LRRK2 , GSK3B , or MAPT" . SPARSER::COLLECTION)
    ("MAPT" . SPARSER::PROTEIN)
    ("protein ( xref ; xref ) and LRRK2" . SPARSER::COLLECTION)
    ("MAPs" . SPARSER::PROTEIN)
    ("neuronal GSK3β substrates" . SPARSER::SUBSTRATE)
    ("dynamin-1 and gephyrin" . SPARSER::COLLECTION)
    ("gephyrin" . SPARSER::PROTEIN) ("GSK3α and GSK3β" . SPARSER::COLLECTION)
    ("Nurr1 and Wnt" . SPARSER::COLLECTION)
    ("β-catenin and Nurr1" . SPARSER::COLLECTION)
    ("Wnt and Nurr1" . SPARSER::COLLECTION)
    ("VPS35 and Wntless" . SPARSER::COLLECTION)
    ("Wntless" . SPARSER::PROTEIN-FAMILY)
    ("LRRK2 and VPS35" . SPARSER::COLLECTION)
    ("Vacuolar sorting protein 35 homologue" . SPARSER::PROTEIN)
    ("these autosomal recessive PD genes" . SPARSER::GENE)
    ("other early onset autosomal recessive forms" . SPARSER::FORM)
    ("PARK6 or DJ-1" . SPARSER::COLLECTION)
    ("an atypical form" . SPARSER::FORM) ("Parkin" . SPARSER::PROTEIN)
    ("the β-catenin destruction complex and LRP6" . SPARSER::COLLECTION)
    ("complex and pathway" . SPARSER::COLLECTION)
    ("LRRK2 and GSK3β" . SPARSER::COLLECTION)
    ("Axin1, GSK3β, and β-catenin" . SPARSER::COLLECTION)
    ("Wnt3a-" . SPARSER::PROTEIN) ("proteins and LRP6" . SPARSER::COLLECTION)
    ("LRRK2–LRP6" . SPARSER::COLLECTION) ("GTPase-" . SPARSER::GTPASE)
    ("COR, and kinase" . SPARSER::COLLECTION) ("DVL1-3" . SPARSER::COLLECTION)
    ("pleckstrin" . SPARSER::PROTEIN)
    ("LRRK2 and all three mammalian DVL proteins ( xref )"
     . SPARSER::COLLECTION)
    ("a key scaffold protein" . SPARSER::PROTEIN)
    ("a reproducible kinase substrate" . SPARSER::SUBSTRATE)
    ("COR" . SPARSER::PROTEIN) ("kinase and GTPase" . SPARSER::COLLECTION)
    ("mortem" . SPARSER::PROTEIN) ("post-mortem" . SPARSER::COLLECTION)
    ("Roco" . SPARSER::PROTEIN-FAMILY) ("a persuasive case" . SPARSER::PROTEIN)
    ("genes and loci" . SPARSER::COLLECTION)
    ("families and genome-wide" . SPARSER::COLLECTION)
    ("hereditary forms" . SPARSER::FORM)
    ("transcription factor/lymphoid enhancer binding factor"
     . SPARSER::COLLECTION)
    ("signalosomes" . SPARSER::BIO-COMPLEX)
    ("extracellular ligand" . SPARSER::LIGAND)
    ("‘signalosome’" . SPARSER::PROTEIN) ("signalosome" . SPARSER::PROTEIN)
    ("DVLs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DVL" . SPARSER::PROTEIN)
    ("FZD and LRP5/6" . SPARSER::COLLECTION) ("morphogens" . SPARSER::PROTEIN)
    ("FZD" . SPARSER::PROTEIN-FAMILY) ("frizzled" . SPARSER::PROTEIN)
    ("PCP" . SPARSER::PROTEIN) ("pars" . SPARSER::PROTEIN)
    ("Wingless/Int" . SPARSER::COLLECTION) ("Int" . SPARSER::PROTEIN)
    ("Wingless" . SPARSER::PROTEIN) ("6-hydroxydopamine" . SPARSER::DRUG)
    ("PARK9" . SPARSER::PROTEIN) ("ATP13A2" . SPARSER::PROTEIN)
    ("Dkk1" . SPARSER::PROTEIN) ("Dickkopf-1" . SPARSER::PROTEIN)
    ("WNT3" . SPARSER::PROTEIN) ("MAP1B" . SPARSER::PROTEIN)
    ("response mediator protein" . SPARSER::PROTEIN)
    ("cAMP response element binding protein" . SPARSER::PROTEIN)
    ("dynamin-1" . SPARSER::PROTEIN) ("brain-specific" . SPARSER::PROTEIN)
    ("KCNIP4" . SPARSER::PROTEIN) ("NR4A2" . SPARSER::PROTEIN)
    ("Nurr1" . SPARSER::PROTEIN) ("PARK17" . SPARSER::PROTEIN)
    ("VPS35" . SPARSER::PROTEIN) ("DJ-1" . SPARSER::PROTEIN)
    ("PARK6" . SPARSER::PROTEIN) ("PINK1" . SPARSER::PROTEIN)
    ("PARK2" . SPARSER::PROTEIN) ("Axin1" . SPARSER::PROTEIN)
    ("Wnt3a" . SPARSER::PROTEIN) ("LRP6" . SPARSER::PROTEIN)
    ("DVL1" . SPARSER::PROTEIN) ("PARK8" . SPARSER::PROTEIN)
    ("LRRK2" . SPARSER::PROTEIN) ("Cav3.1" . SPARSER::PROTEIN)
    ("lymphoid enhancer binding factor" . SPARSER::PROTEIN)
    ("LRP5/6" . SPARSER::PROTEIN) ("α-synuclein" . SPARSER::PROTEIN)
    ("perivascular GSCs" . SPARSER::PROTEIN)
    ("Oct4, Klf4 and Nanog" . SPARSER::COLLECTION)
    ("Nanog, Oct4 and Klf4" . SPARSER::COLLECTION) ("iPS" . SPARSER::PROTEIN)
    ("Sox2, Oct4 and Nanog" . SPARSER::COLLECTION)
    ("Klf4 and the stem cell chromatin regulator Bmi1" . SPARSER::COLLECTION)
    ("CD44 [ xref ] and L1CAM [ xref ]" . SPARSER::COLLECTION)
    ("a trivial task" . SPARSER::PROTEIN)
    ("quiescent (G0) GSCs" . SPARSER::PROTEIN)
    ("EGFR-driven Cdkn2a −/−" . SPARSER::PROTEIN)
    ("Sox2, Klf4, c-Myc, Oct4, and Nanog" . SPARSER::COLLECTION)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID) ("LDA" . SPARSER::PROTEIN)
    ("NSC" . SPARSER::PROTEIN)
    ("CD44, CD133, L1CAM and Nestin" . SPARSER::COLLECTION)
    ("Nestin" . SPARSER::PROTEIN) ("astrocytes (GFAP)" . SPARSER::PROTEIN)
    ("GFAP" . SPARSER::PROTEIN) ("mCherry or mGFP" . SPARSER::COLLECTION)
    ("mCherry and mGFP fluorescent proteins" . SPARSER::PROTEIN)
    ("mCherry and mGFP" . SPARSER::COLLECTION)
    ("gefitinib and MET" . SPARSER::COLLECTION)
    ("saracatinib and imatinib" . SPARSER::COLLECTION)
    ("saracatinib" . SPARSER::DRUG) ("Cdkn2a and PTEN" . SPARSER::COLLECTION)
    ("Cdkn2a" . SPARSER::PROTEIN) ("concurrent temozolomide" . SPARSER::DRUG)
    ("Oct4, Nanog and Klf4" . SPARSER::COLLECTION) ("GSCs" . SPARSER::PROTEIN)
    ("Olig2" . SPARSER::PROTEIN) ("Prominin 1" . SPARSER::PROTEIN)
    ("L1CAM" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p19 ARF" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("TGFα" . SPARSER::PROTEIN)
    ("PTEN 2" . SPARSER::PROTEIN) ("Cdkn2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("post-MEK/ERK" . SPARSER::COLLECTION)
    ("IL-1β, IL-6 and CXCL8" . SPARSER::COLLECTION)
    ("Light" . SPARSER::PROTEIN) ("two separate arms" . SPARSER::PROTEIN)
    ("a dominant-negative form" . SPARSER::FORM) ("XII" . SPARSER::PROTEIN)
    ("MAPK/NFkB" . SPARSER::COLLECTION)
    ("the p38 inhibitor and the IKK inhibitor" . SPARSER::COLLECTION)
    ("MAPK and NFkB" . SPARSER::COLLECTION)
    ("IKK α and β kinases" . SPARSER::COLLECTION) ("myelin" . SPARSER::PROTEIN)
    ("CCL5 or IL-6" . SPARSER::COLLECTION)
    ("CCL5, and IL-6" . SPARSER::COLLECTION)
    ("U0126, and pifithrin-μ" . SPARSER::COLLECTION)
    ("IL-6 or CCL5" . SPARSER::COLLECTION)
    ("CXCL8 and CXCL" . SPARSER::COLLECTION)
    ("CCL2 or CXCL" . SPARSER::COLLECTION)
    ("the human oligodendrocyte cell line MO3.13" . SPARSER::PROTEIN)
    ("MEK and p53" . SPARSER::COLLECTION)
    ("inflammatory chemokine" . SPARSER::PROTEIN)
    ("CCL2 and IL-6" . SPARSER::COLLECTION) ("pifithrin" . SPARSER::DRUG)
    ("chemokine/cytokine" . SPARSER::COLLECTION)
    ("CCL2, CXCL8, and CCL5" . SPARSER::COLLECTION)
    ("the p38 inhibitor and the IKK α and β kinase inhibitor"
     . SPARSER::COLLECTION)
    ("the IKK α and β kinase inhibitor" . SPARSER::COLLECTION)
    ("at least two chemokines/cytokines" . SPARSER::COLLECTION)
    ("chemokines/cytokines" . SPARSER::COLLECTION)
    ("NFkB and MAPK" . SPARSER::COLLECTION)
    ("IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-7, IL-10, IL-12 p40 or p70"
     . SPARSER::COLLECTION)
    ("CCL4/MIP 1β" . SPARSER::COLLECTION) ("CCL13/MCP-4" . SPARSER::COLLECTION)
    ("CCL2, IL-6, and CXCL8" . SPARSER::COLLECTION)
    ("CCL5/RANTES" . SPARSER::COLLECTION) ("/GRO" . SPARSER::COLLECTION)
    ("GRO" . SPARSER::PROTEIN) ("MCP-1, IL-6, and CXCL8" . SPARSER::COLLECTION)
    ("dexamethasone" . SPARSER::PROTEIN)
    ("IL-6, CXCL8, CCL2 and CXCL13" . SPARSER::COLLECTION)
    ("DRG" . SPARSER::PROTEIN) ("CSF" . SPARSER::PROTEIN)
    ("IL-6, CXCL8, IL-1β and CXCL13" . SPARSER::COLLECTION)
    ("the most morbid form" . SPARSER::FORM) ("LB" . SPARSER::PROTEIN)
    ("divergent arms" . SPARSER::PROTEIN) ("arms" . SPARSER::PROTEIN)
    ("ERK or p53" . SPARSER::COLLECTION)
    ("JNK, p38 and NFkB" . SPARSER::COLLECTION)
    ("microglia" . SPARSER::PROTEIN) ("caspase - 3" . SPARSER::PROTEIN)
    ("MEK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IKK α" . SPARSER::PROTEIN)
    ("SDF1" . SPARSER::PROTEIN) ("MIP 1β" . SPARSER::PROTEIN)
    ("CCL4" . SPARSER::PROTEIN) ("MCP-4" . SPARSER::PROTEIN)
    ("CCL13" . SPARSER::PROTEIN) ("MCP-2" . SPARSER::DRUG)
    ("CCL8" . SPARSER::PROTEIN) ("IP-10" . SPARSER::PROTEIN)
    ("I-309" . SPARSER::PROTEIN) ("FGF-2" . SPARSER::PROTEIN)
    ("BCA-1" . SPARSER::PROTEIN) ("IL-13" . SPARSER::PROTEIN)
    ("IL-12 p40" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("IL-1α" . SPARSER::PROTEIN)
    ("TOPRO-3" . SPARSER::MOLECULE) ("min-1" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("myelin oligodendrocyte glycoprotein" . SPARSER::PROTEIN)
    ("myelin basic protein" . SPARSER::PROTEIN) ("CXCL13" . SPARSER::PROTEIN)
    ("MO3" . SPARSER::PROTEIN)
    ("anti-SEMA4D and anti-VEGF" . SPARSER::COLLECTION)
    ("available PDGF-B" . SPARSER::PROTEIN)
    ("RGS5, NG2 and α-SMA" . SPARSER::COLLECTION)
    ("The classic examples" . SPARSER::EXAMPLE)
    ("PDGF-B and ANGPTL-4" . SPARSER::COLLECTION) ("PDGFB" . SPARSER::PROTEIN)
    ("HN" . SPARSER::PROTEIN) ("Media" . SPARSER::PROTEIN)
    ("chemoattractants" . SPARSER::PROTEIN)
    ("SEMA4D or Plexin-B1" . SPARSER::COLLECTION)
    ("the appropriate shRNAs" . SPARSER::PROTEIN)
    ("SEMA4D and Plexin-B1" . SPARSER::COLLECTION)
    ("hPC-PL" . SPARSER::COLLECTION)
    ("had functional Plexin-B1" . SPARSER::PROTEIN)
    ("0.1% BSA (negative control) or media" . SPARSER::COLLECTION)
    ("IgG or anti-PDGF-B" . SPARSER::COLLECTION)
    ("RGS5, αSMA and NG2" . SPARSER::COLLECTION)
    ("αSMA [ xref ] and NG2 [ xref ]" . SPARSER::COLLECTION)
    ("VEGF and sSEMA4D" . SPARSER::COLLECTION)
    ("residual VEGF" . SPARSER::PROTEIN)
    ("PDGF-B and ANGPTL4" . SPARSER::COLLECTION)
    ("an excellent form" . SPARSER::FORM)
    ("soluble SEMA4D and SEMA4D" . SPARSER::COLLECTION)
    ("SEMA4D and SEMA4D" . SPARSER::COLLECTION)
    ("VEGF and its receptor" . SPARSER::COLLECTION)
    ("SEMAs and plexins" . SPARSER::COLLECTION) ("NPs" . SPARSER::PROTEIN)
    ("neuropilins" . SPARSER::PROTEIN-FAMILY)
    ("SEMA" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GPI" . SPARSER::PROTEIN)
    ("VI" . SPARSER::PROTEIN) ("SEMAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("plexin" . SPARSER::PROTEIN) ("plexins" . SPARSER::PROTEIN)
    ("Plexins" . SPARSER::PROTEIN) ("SEMA4D and VEGF" . SPARSER::COLLECTION)
    ("platelet-derived growth factor-B (PDGF-B) and angiopoietin-like protein 4 (ANGPTL4)"
     . SPARSER::COLLECTION)
    ("VE-cadherin" . SPARSER::COLLECTION) ("angiopoietin" . SPARSER::PROTEIN)
    ("VEGF and SEMA4D" . SPARSER::COLLECTION) ("BV6" . SPARSER::MOLECULE)
    ("Texas red" . SPARSER::DRUG) ("NG2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("αSMA" . SPARSER::PROTEIN) ("RGS5" . SPARSER::PROTEIN)
    ("NP 40" . SPARSER::MOLECULE) ("lipoprotein lipase" . SPARSER::PROTEIN)
    ("anti-VEGF" . SPARSER::DRUG) ("PDGFR-β" . SPARSER::PROTEIN)
    ("VEGFR-2" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("ANGPTL4" . SPARSER::PROTEIN) ("protein 4" . SPARSER::PROTEIN)
    ("PDGF-B" . SPARSER::PROTEIN)
    ("derived growth factor-B" . SPARSER::PROTEIN)
    ("Plexin-B1" . SPARSER::PROTEIN) ("SEMA4D" . SPARSER::PROTEIN)
    ("Semaphorin 4D" . SPARSER::PROTEIN) ("new light" . SPARSER::PROTEIN)
    ("glutamine and arginine" . SPARSER::COLLECTION)
    ("Bid and Bak" . SPARSER::COLLECTION)
    ("the various pro-apoptotic BH3 ligands" . SPARSER::LIGAND)
    ("Class I and III ligands" . SPARSER::COLLECTION)
    ("III ligands" . SPARSER::LIGAND)
    ("high-affinity Class I (LXXX[A/S]D) and Class III ([R/Q]XLXXXGD) ligands"
     . SPARSER::COLLECTION)
    ("a slightly smaller ΔC p" . SPARSER::PROTEIN) ("cal" . SPARSER::PROTEIN)
    ("/dT" . SPARSER::COLLECTION)
    ("an alanine or a glycine" . SPARSER::COLLECTION)
    ("Bik (Bik_L-2R) and Hrk (Hrk_A-2Q) peptides" . SPARSER::COLLECTION)
    ("an arginine (R-2) or a glutamine (Q-2)" . SPARSER::COLLECTION)
    ("glycine-alanine" . SPARSER::COLLECTION) ("Hrk" . SPARSER::PROTEIN)
    ("alanine/serine" . SPARSER::COLLECTION)
    ("BclXL and other apoptotic repressors" . SPARSER::COLLECTION)
    ("Our detailed biophysical analysis sheds new light" . SPARSER::PROTEIN)
    ("an amphipathic α-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("activators and effectors" . SPARSER::COLLECTION)
    ("the most attractive targets" . SPARSER::TARGET-PROTEIN)
    ("cytochrome c and Smac/Diablo" . SPARSER::COLLECTION)
    ("apoptogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smac/Diablo" . SPARSER::COLLECTION) ("Diablo" . SPARSER::PROTEIN)
    ("bacterial toxins" . SPARSER::MOLECULE) ("MOM" . SPARSER::PROTEIN)
    ("Bid and Bad" . SPARSER::COLLECTION)
    ("BclXL and Bcl2" . SPARSER::COLLECTION)
    ("activator, effector and repressor" . SPARSER::COLLECTION)
    ("activators, effectors and repressors" . SPARSER::COLLECTION)
    ("arginine/glutamine" . SPARSER::COLLECTION)
    ("pro-apoptotic BH3 ligands" . SPARSER::LIGAND)
    ("pro-apoptotic regulators" . SPARSER::REGULATOR)
    ("Q-2" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("siRNA and CHK1" . SPARSER::COLLECTION)
    ("PMX and MK-8776" . SPARSER::COLLECTION)
    ("PMX or MK-8776" . SPARSER::COLLECTION) ("MK" . SPARSER::PROTEIN)
    ("CMA" . SPARSER::PROTEIN)
    ("Western Blot ( xref ) and ELISA ( xref )" . SPARSER::COLLECTION)
    ("Western Blot (WB)" . SPARSER::PROTEIN)
    ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("variably-expressed genes" . SPARSER::GENE)
    ("pemetrexed (PMX)" . SPARSER::DRUG)
    ("differentiation state and genomic complexity" . SPARSER::COLLECTION)
    ("differential CHK1 mRNA and CHK1 protein levels" . SPARSER::COLLECTION)
    ("PMX" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("β- actin" . SPARSER::PROTEIN) ("HR 2" . SPARSER::PROTEIN)
    ("MK-8776" . SPARSER::DRUG) ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("JNK-2 and JNK-1" . SPARSER::COLLECTION) ("GCG" . SPARSER::PROTEIN)
    ("the dimeric AP-1 transcription factor" . SPARSER::PROTEIN)
    ("JNKs/c-Jun" . SPARSER::COLLECTION)
    ("a lithium-sensitive kinase" . SPARSER::KINASE)
    ("T91/T93" . SPARSER::PROTEIN) ("Jun-HA" . SPARSER::COLLECTION)
    ("p-T91/T93" . SPARSER::PROTEIN-PAIR)
    ("JNK or GSK3 β" . SPARSER::COLLECTION)
    ("the lithium-sensitive kinase GSK3 β" . SPARSER::PROTEIN)
    ("c-Jun-HA" . SPARSER::COLLECTION)
    ("the b 10 (m/z 1107.7) and b 9 (m/z 926.7) ions" . SPARSER::COLLECTION)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("ions" . SPARSER::MOLECULE) ("Da" . SPARSER::MOLECULE)
    ("HAP" . SPARSER::PROTEIN) ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MALDI MS and MS/MS" . SPARSER::COLLECTION)
    ("MS/MS" . SPARSER::COLLECTION) ("JNKs" . SPARSER::PROTEIN)
    ("JunD" . SPARSER::PROTEIN)
    ("growth factor (NGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Jun-wt-HA" . SPARSER::COLLECTION)
    ("HA or c-JunA95-HA" . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY) ("c-Jun-wt" . SPARSER::COLLECTION)
    ("either total c-Jun or c-Jun-p63 antibodies" . SPARSER::COLLECTION)
    ("c-Jun-p91" . SPARSER::PROTEIN-PAIR) ("c-Jun-p63" . SPARSER::COLLECTION)
    ("DV" . SPARSER::MOLECULE) ("JNK/c-Jun" . SPARSER::COLLECTION)
    ("Puma (p53 upregulated modulator of apoptosis) and Bim (Bcl2-interacting mediator of cell death)"
     . SPARSER::COLLECTION)
    ("anisomycin" . SPARSER::DRUG)
    ("homodimer or heterodimer" . SPARSER::COLLECTION)
    ("Fos or ATF" . SPARSER::COLLECTION) ("ATF" . SPARSER::PROTEIN)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic c-Jun/AP-1 target genes" . SPARSER::GENE)
    ("c-Jun/AP-1" . SPARSER::COLLECTION)
    ("c-Jun/activator protein 1" . SPARSER::COLLECTION)
    ("G0S7" . SPARSER::PROTEIN) ("P39" . SPARSER::PROTEIN)
    ("C-JUN" . SPARSER::PROTEIN) ("PROTO-ONCOGENE" . SPARSER::PROTO-ONCOGENE)
    ("TRANSCRIPTION FACTOR AP-1" . SPARSER::PROTEIN)
    ("P05412" . SPARSER::PROTEIN) ("beta-mercaptoethanol" . SPARSER::MOLECULE)
    ("B12" . SPARSER::PROTEIN) ("MCM7" . SPARSER::PROTEIN)
    ("SP2" . SPARSER::PROTEIN) ("Ara-C" . SPARSER::DRUG)
    ("JNK-2" . SPARSER::PROTEIN) ("p-S" . SPARSER::PROTEIN)
    ("JNK-1" . SPARSER::PROTEIN) ("b 14" . SPARSER::PROTEIN)
    ("b 10" . SPARSER::PROTEIN) ("p91" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN)
    ("glycogen synthase kinase 3 beta" . SPARSER::PROTEIN)
    ("Bcl2-interacting mediator of cell death" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN)
    ("potentially use antioxidants" . SPARSER::DRUG)
    ("ROS and cytokines" . SPARSER::COLLECTION)
    ("CYP2E1, NOX, and FWH" . SPARSER::COLLECTION)
    ("caspase-3 and NF- κ B" . SPARSER::COLLECTION)
    ("ferritin and protein" . SPARSER::COLLECTION)
    ("aldehydes" . SPARSER::MOLECULE) ("stimulants" . SPARSER::DRUG)
    ("CYP2E1 and CYP2B" . SPARSER::COLLECTION) ("ethanol" . SPARSER::PROTEIN)
    ("Amphetamine" . SPARSER::DRUG) ("gp120 and CYP" . SPARSER::COLLECTION)
    ("CYP2D6 and CYP2E1" . SPARSER::COLLECTION) ("alcohol-" . SPARSER::DRUG)
    ("nicotine" . SPARSER::DRUG) ("xenobiotics" . SPARSER::MOLECULE)
    ("Substance" . SPARSER::SUBSTANCE)
    ("enzymes, and FWH" . SPARSER::COLLECTION) ("ferritin" . SPARSER::PROTEIN)
    ("Superoxides" . SPARSER::MOLECULE)
    ("enzymes, NOX2 and NOX4" . SPARSER::COLLECTION)
    ("electrons" . SPARSER::MOLECULE)
    ("CYP2D6 and CYP2B6" . SPARSER::COLLECTION)
    ("CYP2B6 and CYP2D6" . SPARSER::COLLECTION)
    ("paroxetine and OP" . SPARSER::COLLECTION)
    ("fluoxetine and paroxetine" . SPARSER::COLLECTION)
    ("CYP2D6, and orphenadrine" . SPARSER::COLLECTION)
    ("paroxetine" . SPARSER::DRUG) ("fluoxetine" . SPARSER::DRUG)
    ("gp120-" . SPARSER::PROTEIN)
    ("CYP2E1, CYP2B6, and CYP2D6" . SPARSER::COLLECTION)
    ("human fetal astrocytes (HFA)" . SPARSER::PROTEIN)
    ("HFA" . SPARSER::MOLECULE) ("CYP2E1 and CYP2D6" . SPARSER::COLLECTION)
    ("CYP2D6 and nonsignificant" . SPARSER::COLLECTION)
    ("cysteine (NAC)" . SPARSER::AMINO-ACID) ("-acetyl" . SPARSER::MOLECULE)
    ("a water-soluble form" . SPARSER::FORM) ("TROLOX" . SPARSER::MOLECULE)
    ("vit" . SPARSER::PROTEIN)
    ("primary human fetal astrocytes" . SPARSER::PROTEIN)
    ("gp120, and 54.8±13.1%" . SPARSER::COLLECTION)
    ("two-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("maximal ROS" . SPARSER::PROTEIN) ("exogenous gp120" . SPARSER::PROTEIN)
    ("IIIB" . SPARSER::DRUG) ("Astrocytes" . SPARSER::PROTEIN)
    ("viral protein gp120" . SPARSER::PROTEIN) ("CYPs" . SPARSER::PROTEIN)
    ("CYP2D6" . SPARSER::PROTEIN) ("reactive metabolites" . SPARSER::PROTEIN)
    ("illicit substances" . SPARSER::SUBSTANCE)
    ("morphine, cocaine, and methamphetamine" . SPARSER::COLLECTION)
    ("cocaine" . SPARSER::DRUG) ("morphine" . SPARSER::MOLECULE)
    ("substances" . SPARSER::SUBSTANCE)
    ("DAS, DPI, and DFO" . SPARSER::COLLECTION)
    ("CYP and NOX" . SPARSER::COLLECTION)
    ("NOX2 and NOX4" . SPARSER::COLLECTION) ("DFO" . SPARSER::MOLECULE)
    ("deferoxamine" . SPARSER::MOLECULE) ("DAS" . SPARSER::PROTEIN)
    ("diallylsulfide" . SPARSER::DRUG)
    ("cytochrome P 450 (CYP)" . SPARSER::PROTEIN-FAMILY)
    ("gp120 and methamphetamine" . SPARSER::COLLECTION)
    ("CYP" . SPARSER::PROTEIN) ("methamphetamine" . SPARSER::DRUG)
    ("CYP3A4" . SPARSER::PROTEIN) ("CYP1A1" . SPARSER::PROTEIN)
    ("procaspase3" . SPARSER::PROTEIN) ("B12)" . SPARSER::PROTEIN)
    ("CYP2B" . SPARSER::PROTEIN) ("NF- κ B" . SPARSER::PROTEIN)
    ("ferritin heavy chain" . SPARSER::PROTEIN)
    ("hydroxyl radical" . SPARSER::MOLECULE) ("CYP2B6" . SPARSER::PROTEIN)
    ("vitamin C" . SPARSER::MOLECULE) ("as 2 " . SPARSER::PROTEIN)
    ("CYP2" . SPARSER::PROTEIN) ("CYP46" . SPARSER::PROTEIN)
    ("terminal deoxynucleotidyltransferase" . SPARSER::PROTEIN)
    ("CYP2E1" . SPARSER::PROTEIN)
    ("cytochrome P 450" . SPARSER::PROTEIN-FAMILY)
    ("glycoprotein 120" . SPARSER::PROTEIN)
    ("kinases and antagonists" . SPARSER::COLLECTION)
    ("N-CoR, and HDAC1" . SPARSER::COLLECTION)
    ("N-CoR and HDAC1" . SPARSER::COLLECTION)
    ("p300, and histone" . SPARSER::COLLECTION) ("MAML" . SPARSER::PROTEIN)
    ("minimal promoter" . SPARSER::PROMOTER)
    ("the PTEN minimal promoter" . SPARSER::PROMOTER)
    ("AKT1/NF κ B" . SPARSER::COLLECTION)
    ("PTEN minimal promoter" . SPARSER::PROMOTER)
    ("AKT1 and PTEN" . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("gastric cancer cells doxorubicin" . SPARSER::PROTEIN)
    ("shRNA, and Notch1" . SPARSER::COLLECTION)
    ("AKT1, NF κ B, and Notch1" . SPARSER::COLLECTION)
    ("a tumor promoter or a suppressor depending on the cell type and context"
     . SPARSER::COLLECTION)
    ("Notch1 and its downstream target CBF-1" . SPARSER::COLLECTION)
    ("Oligonucleotides" . SPARSER::MOLECULE)
    ("AKT1 shRNA, pyrrolidinedithiocarbamic acid (PDTC), and p65 small interference RNA (siRNA)"
     . SPARSER::COLLECTION)
    ("LY294002 or AKT1" . SPARSER::COLLECTION)
    ("using lentiviral-mediated short-hairpin RNA" . SPARSER::RNA)
    ("AKT1, Notch1 and PTEN" . SPARSER::COLLECTION)
    ("AKT, Notch1, and PTEN" . SPARSER::COLLECTION)
    ("Notch1, and PTEN" . SPARSER::COLLECTION)
    ("AKT1, Notch1, and PTEN" . SPARSER::COLLECTION)
    ("AKT1/NF κ B/Notch1/PTEN" . SPARSER::COLLECTION)
    ("/JAK2/STAT3" . SPARSER::COLLECTION)
    ("Jagged-1, Jagged-2, Delta 1, Delta 3, and Delta 4" . SPARSER::COLLECTION)
    ("a strong apoptotic trigger" . SPARSER::PROTEIN)
    ("AKT1/NF-kappaB/Notch1/PTEN" . SPARSER::COLLECTION)
    ("Notch1 and PTEN" . SPARSER::COLLECTION)
    ("trypsin inhibitor" . SPARSER::PROTEIN) ("PGL2" . SPARSER::PROTEIN)
    ("pGL2" . SPARSER::PROTEIN) ("N -acetyl- L -cysteine" . SPARSER::MOLECULE)
    ("N-CoR" . SPARSER::PROTEIN) ("Hes-1" . SPARSER::PROTEIN)
    ("IGF-1-" . SPARSER::PROTEIN) ("Dual-luciferase" . SPARSER::PROTEIN)
    ("MZF-1" . SPARSER::PROTEIN) ("RREB-1" . SPARSER::PROTEIN)
    ("Jagged1" . SPARSER::PROTEIN) ("γ -secretase" . SPARSER::PROTEIN)
    ("Delta 4" . SPARSER::PROTEIN) ("Delta 3" . SPARSER::PROTEIN)
    ("Delta 1" . SPARSER::PROTEIN) ("Jagged-2" . SPARSER::PROTEIN)
    ("Jagged-1" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("CBF-1" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("Akt, NOX4 and ROS" . SPARSER::COLLECTION) ("XIAP" . SPARSER::PROTEIN)
    ("cytochrome c and Smac" . SPARSER::COLLECTION)
    ("cytochrome c , Smac and AIF" . SPARSER::COLLECTION)
    ("wortmannin and simultaneous Bcl-2 inactivation by TRAIL-induced tBid ( xref )"
     . SPARSER::COLLECTION)
    ("wortmannin and TRAIL" . SPARSER::COLLECTION)
    ("ASK-1, JNK, p38, ERK1/2, PKC and CDKs" . SPARSER::COLLECTION)
    ("ROS and Bcl-2" . SPARSER::COLLECTION) ("NOX" . SPARSER::PROTEIN)
    ("caspase-8 and Bid" . SPARSER::COLLECTION)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("phosphorylation-specific antibodies and flow cytometry"
     . SPARSER::COLLECTION)
    ("Bax/Bak" . SPARSER::COLLECTION)
    ("Mcl-1 or proapoptotic proteins Bax, Noxa, Puma and Bad ( xref )"
     . SPARSER::COLLECTION)
    ("antiapoptotic proteins Bcl-2, Mcl-1 or proapoptotic proteins Bax, Noxa, Puma and Bad ( xref )"
     . SPARSER::COLLECTION)
    ("Bax, Noxa, Puma and Bad" . SPARSER::COLLECTION)
    ("cytochrome c , Smac and apoptosis-inducing" . SPARSER::COLLECTION)
    ("A-375-TS, and TRAIL" . SPARSER::COLLECTION)
    ("wortmannin/TRAIL" . SPARSER::COLLECTION)
    ("TRAIL/wortmannin" . SPARSER::COLLECTION)
    ("caspase and Bid" . SPARSER::COLLECTION)
    ("TRAIL and 4–8  μ M wortmannin" . SPARSER::COLLECTION)
    ("Wortmannin" . SPARSER::PROTEIN) ("Mel-HO-TS" . SPARSER::COLLECTION)
    ("Mel-HO" . SPARSER::COLLECTION) ("Mel" . SPARSER::PROTEIN)
    ("DR4 and DR5" . SPARSER::COLLECTION)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("Puma, Noxa and Bid" . SPARSER::COLLECTION)
    ("ROS and Bax" . SPARSER::COLLECTION)
    ("wortmannin and MK-2206" . SPARSER::COLLECTION)
    ("VDAC 1" . SPARSER::PROTEIN) ("FL2" . SPARSER::PROTEIN)
    ("endonuclease G" . SPARSER::PROTEIN) ("VDAC2" . SPARSER::PROTEIN)
    ("ASK-1" . SPARSER::PROTEIN) ("NOX1" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("NADPH oxidase 4" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("ADNI" . SPARSER::PROTEIN) ("GSK3β and two genes" . SPARSER::COLLECTION)
    ("APP and APBB2" . SPARSER::COLLECTION) ("ADNI-GO" . SPARSER::PROTEIN-PAIR)
    ("AV" . SPARSER::MOLECULE) ("fewer MCI and mild MCI" . SPARSER::COLLECTION)
    ("mild MCI" . SPARSER::PROTEIN) ("MCI" . SPARSER::PROTEIN)
    ("FE65-AICD" . SPARSER::COLLECTION) ("AICD" . SPARSER::PROTEIN)
    ("APP and GSK-3" . SPARSER::COLLECTION)
    ("the APBB2 A allele" . SPARSER::ALLELE) ("the A allele" . SPARSER::ALLELE)
    ("GSK3β and APBB2" . SPARSER::COLLECTION)
    ("APP and GSK3 β" . SPARSER::COLLECTION)
    ("GSK3B and Amyloid" . SPARSER::COLLECTION) ("Amyloid" . SPARSER::PROTEIN)
    ("FOXA, POL2, and STAT3" . SPARSER::COLLECTION) ("FOXA" . SPARSER::PROTEIN)
    ("myoblasts" . SPARSER::PROTEIN) ("were run" . SPARSER::PROTEIN)
    ("SNP-SNP" . SPARSER::COLLECTION)
    ("kinases and genes" . SPARSER::COLLECTION)
    ("tau and APP" . SPARSER::COLLECTION) ("tau and Aβ" . SPARSER::COLLECTION)
    ("the Aβ cause autosomal dominantly inherited forms" . SPARSER::FORM)
    ("GSK3β and APP" . SPARSER::COLLECTION) ("APP" . SPARSER::PROTEIN)
    ("PET" . SPARSER::PROTEIN)
    ("GSK-3 and comparable tau kinases" . SPARSER::COLLECTION)
    ("amyloid and tau" . SPARSER::COLLECTION)
    ("tau and amyloid" . SPARSER::COLLECTION) ("FE65" . SPARSER::PROTEIN)
    ("GSK3 β" . SPARSER::PROTEIN) ("POL2" . SPARSER::PROTEIN)
    ("SOAT1" . SPARSER::PROTEIN) ("DHCR24" . SPARSER::PROTEIN)
    ("ABCG1" . SPARSER::PROTEIN) ("PSEN2" . SPARSER::PROTEIN)
    ("PSEN1" . SPARSER::PROTEIN) ("DYRK1A" . SPARSER::PROTEIN)
    ("Dual specificity tyrosine-phosphorylation-regulated kinase 1A"
     . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 5" . SPARSER::PROTEIN)
    ("GSk-3" . SPARSER::PROTEIN) ("amyloid-β" . SPARSER::MOLECULE)
    ("APBB2" . SPARSER::PROTEIN) ("drugs or drug" . SPARSER::COLLECTION)
    ("SB590885 or GDC0879" . SPARSER::COLLECTION)
    ("SB590885, RAF265 and GDC0879" . SPARSER::COLLECTION)
    ("BRAF and BRAFV600E" . SPARSER::COLLECTION)
    ("all relevant mutants" . SPARSER::MUTANT)
    ("all relevant single mutants" . SPARSER::MUTANT)
    ("the oncogenic protein kinase BRAFV600E and its inhibitor vemurafenib"
     . SPARSER::COLLECTION)
    ("SB590885 and GDC0879" . SPARSER::COLLECTION)
    ("BRAFV600E or BRAFV600E/L505H" . SPARSER::COLLECTION)
    ("BRAFV600E and BRAFV600E/L505H" . SPARSER::COLLECTION)
    ("PLX4720, SB590885, RAF265 and U0126" . SPARSER::COLLECTION)
    ("BRAFV600E, BRAFV600E/F516G or BRAFV600E/T529N" . SPARSER::COLLECTION)
    ("SB590885 (0.8 μM) or U0126 (4 μM)" . SPARSER::COLLECTION)
    ("BRAFV600E or BRAFV600E/T529N" . SPARSER::COLLECTION)
    ("FOSL1 , SPRY2 and DUSP6" . SPARSER::COLLECTION)
    ("BRAF-MEK-ERK" . SPARSER::COLLECTION)
    ("SB590885 ( xref ) and RAF265 ( xref )" . SPARSER::COLLECTION)
    ("phospho-MEK and phospho-ERK1/2" . SPARSER::COLLECTION)
    ("MEK and ERK1/2" . SPARSER::COLLECTION)
    ("MEK and phospho-ERK1/2" . SPARSER::COLLECTION)
    ("a previously characterized mutant" . SPARSER::MUTANT)
    ("the mutated amino acid" . SPARSER::AMINO-ACID)
    ("Vemurafenib" . SPARSER::DRUG) ("valine" . SPARSER::AMINO-ACID)
    ("extracellular signal regulated kinase (MEK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an immediate downstream effector" . SPARSER::EFFECTOR)
    ("BRAFV" . SPARSER::PROTEIN) ("vemurafenib" . SPARSER::DRUG)
    ("GDC0879" . SPARSER::DRUG) ("interleukin-3" . SPARSER::PROTEIN)
    ("DUSP6" . SPARSER::PROTEIN) ("FOSL1" . SPARSER::PROTEIN)
    ("RAF265" . SPARSER::DRUG) ("SB590885" . SPARSER::DRUG)
    ("protein kinase domain" . SPARSER::PROTEIN-FAMILY)
    ("PLX4032" . SPARSER::DRUG)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLX4720" . SPARSER::DRUG) ("LG" . SPARSER::MOLECULE)
    ("JG" . SPARSER::PROTEIN) ("Dexamethasone" . SPARSER::PROTEIN)
    ("Glucocorticoid" . SPARSER::PROTEIN) ("Nucleophosmin" . SPARSER::PROTEIN)
    ("effectors, p70S6K1 and 4E-BP1" . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("ALK + " . SPARSER::PROTEIN)
    ("AKT and downstream molecules" . SPARSER::COLLECTION)
    ("4E-BP1 and p70SK6" . SPARSER::COLLECTION)
    ("NPM-ALK + " . SPARSER::PROTEIN-PAIR) ("17 p" . SPARSER::PROTEIN)
    ("III " . SPARSER::PROTEIN) ("anti-p-mTOR" . SPARSER::COLLECTION)
    ("17 p-AKT" . SPARSER::PROTEIN-PAIR) ("anti-p-AKT" . SPARSER::COLLECTION)
    ("different histological subtypes" . SPARSER::PROTEIN)
    ("antigen (EMA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIA1/Granzyme B" . SPARSER::COLLECTION) ("EMA" . SPARSER::PROTEIN)
    ("CD3 and/ or CD45RO" . SPARSER::COLLECTION)
    ("lymphohistiocytic type" . TYPE) ("common or classic type" . TYPE)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("ALK/AKT/mTOR" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("ALK-" . SPARSER::PROTEIN)
    ("normally shuttles ribonucleoproteins" . SPARSER::PROTEIN)
    ("normal NPM" . SPARSER::PROTEIN) ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("at least 15 variant-ALK fusion genes" . SPARSER::GENE)
    ("tropomyosin 3 (TPM3) or 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC)"
     . SPARSER::PROTEIN)
    ("ATIC" . SPARSER::PROTEIN) ("nucleophosmin-ALK" . SPARSER::COLLECTION)
    ("NHL" . SPARSER::PROTEIN) ("GCs" . SPARSER::PROTEIN)
    ("glucocorticoids" . SPARSER::PROTEIN) ("p-p70S6K1" . SPARSER::COLLECTION)
    ("p-4E-BP1" . SPARSER::COLLECTION) ("p-mTOR" . SPARSER::COLLECTION)
    ("ATK/mTOR" . SPARSER::COLLECTION) ("ALK " . SPARSER::PROTEIN)
    ("ATK" . SPARSER::PROTEIN)
    ("ALK fusion proteins and the AKT/mTOR signaling phosphoproteins"
     . SPARSER::COLLECTION)
    ("NPM-ALK" . SPARSER::COLLECTION)
    ("nucleophosmin-anaplastic lymphoma kinase" . SPARSER::COLLECTION)
    ("protein kinase B/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("NPM" . SPARSER::PROTEIN) ("nucleophosmin" . SPARSER::PROTEIN)
    ("Tropomyosin 3" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("Granzyme B" . SPARSER::PROTEIN) ("TIA1" . SPARSER::PROTEIN)
    ("CD45RO" . SPARSER::PROTEIN) ("CD30" . SPARSER::PROTEIN)
    ("NVP-BEZ235" . SPARSER::DRUG) ("ALK1" . SPARSER::PROTEIN)
    ("ALK-1" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"
     . SPARSER::PROTEIN)
    ("TPM3" . SPARSER::PROTEIN) ("tropomyosin 3" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("p70S6K1" . SPARSER::PROTEIN)
    ("polypeptide 1" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("our results shed new light" . SPARSER::PROTEIN)
    ("Rac1 and Tiam1" . SPARSER::COLLECTION)
    ("Cdc42, Rho and Rac" . SPARSER::COLLECTION)
    ("GEFs and Rho" . SPARSER::COLLECTION) ("Kalirin" . SPARSER::PROTEIN)
    ("GTPAses" . SPARSER::GTPASE)
    ("Eph receptors (including EphA2, EphB2, EphA4 and EphA8) and Tiam1 ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("EphA2, EphB2, EphA4 and EphA8" . SPARSER::COLLECTION)
    ("EphA4" . SPARSER::PROTEIN) ("soluble Rac1" . SPARSER::PROTEIN)
    ("soluble Tiam1" . SPARSER::PROTEIN)
    ("Tiam1 and Rac1" . SPARSER::COLLECTION)
    ("Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab21 and EGFR" . SPARSER::COLLECTION)
    ("Rab4 and EphA2/Rab11" . SPARSER::COLLECTION)
    ("VEGFR ( xref ) and MET RTKs ( xref )" . SPARSER::COLLECTION)
    ("EGFR ( xref , xref ), PDGFR ( xref , xref , xref ), VEGFR ( xref ) and MET RTKs ( xref )"
     . SPARSER::COLLECTION)
    ("Rab4, Rab5, Rab7, Rab11 and Rab21" . SPARSER::COLLECTION)
    ("receptors or transferrin" . SPARSER::COLLECTION)
    ("Receptors" . SPARSER::PROTEIN)
    ("internalized EphA2" . SPARSER::PROTEIN-FAMILY)
    ("Ras and Tiam1" . SPARSER::COLLECTION) ("Tiam-HA" . SPARSER::COLLECTION)
    ("Tiam" . SPARSER::PROTEIN-FAMILY) ("Rac1/Tiam1" . SPARSER::COLLECTION)
    ("Tiam1-HA" . SPARSER::COLLECTION)
    ("Tiam1 and EphA2" . SPARSER::COLLECTION)
    ("the mutated tyrosines" . SPARSER::AMINO-ACID)
    ("kinase dead (KD) EphA2 mutant and the non phosphorylable double-mutant"
     . SPARSER::COLLECTION)
    ("EphA8" . SPARSER::PROTEIN) ("The internal pH" . SPARSER::PROTEIN)
    ("internally Eph receptors" . SPARSER::RECEPTOR)
    ("labelled transferrin" . SPARSER::PROTEIN)
    ("Rab4 and EphA2" . SPARSER::COLLECTION)
    ("Rab11 and EphA2" . SPARSER::COLLECTION)
    ("Rab4 and Rab11" . SPARSER::COLLECTION)
    ("internalized biotinylated EphA2" . SPARSER::PROTEIN-FAMILY)
    ("ephrinA1/Fc" . SPARSER::COLLECTION)
    ("EGF, PDGF or EphB1" . SPARSER::COLLECTION) ("EphB1" . SPARSER::PROTEIN)
    ("RTKs and other tyrosine kinases" . SPARSER::COLLECTION)
    ("Cbl" . SPARSER::PROTEIN)
    ("bafilomycin A1 and proteasomal inhibitors" . SPARSER::COLLECTION)
    ("proteasomal inhibitors" . SPARSER::INHIBITOR)
    ("bortezomib, MG132 and lactacystin" . SPARSER::COLLECTION)
    ("EphA3" . SPARSER::PROTEIN)
    ("β-actin and caveolin-1" . SPARSER::COLLECTION)
    ("cell surface-associated EphA2 receptors" . SPARSER::RECEPTOR)
    ("ephrin mimetic peptides" . SPARSER::PEPTIDE)
    ("a soluble recombinant ephrinA1 fused" . SPARSER::PROTEIN)
    ("EphrinA1/Fc" . SPARSER::COLLECTION)
    ("Rac1 and EphA2" . SPARSER::COLLECTION) ("Vav" . SPARSER::PROTEIN)
    ("EGFR and PDGFR" . SPARSER::COLLECTION)
    ("Eph and ephrin" . SPARSER::COLLECTION)
    ("our findings shed new light" . SPARSER::PROTEIN)
    ("Eph/ephrin" . SPARSER::COLLECTION) ("ephrin" . SPARSER::PROTEIN)
    ("Eph receptors and their membrane-bound ligands" . SPARSER::COLLECTION)
    ("ephrins" . SPARSER::PROTEIN) ("Eph" . SPARSER::PROTEIN)
    ("Cell membrane" . SPARSER::PROTEIN) ("Tiam-1" . SPARSER::PROTEIN)
    ("Arf6" . SPARSER::PROTEIN) ("ephrinA2" . SPARSER::PROTEIN)
    ("EphB2" . SPARSER::PROTEIN) ("Rab21" . SPARSER::PROTEIN)
    ("Rab7" . SPARSER::PROTEIN) ("TGF-a" . SPARSER::PROTEIN)
    ("VAB-1" . SPARSER::PROTEIN) ("Ras-binding" . SPARSER::PROTEIN)
    ("Rac-GEF" . SPARSER::PROTEIN) ("surface protein" . SPARSER::PROTEIN)
    ("Rab5" . SPARSER::PROTEIN) ("Rab family" . SPARSER::PROTEIN)
    ("Rab11" . SPARSER::PROTEIN) ("Rab4" . SPARSER::PROTEIN)
    ("EphrinA1" . SPARSER::PROTEIN) ("ephrinA5" . SPARSER::PROTEIN)
    ("nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("ephrinA1" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("accession number GSE52100" . SPARSER::PROTEIN)
    ("at least one transcription factor" . SPARSER::PROTEIN)
    ("LIN9 and B-MYB" . SPARSER::COLLECTION) ("MuvB" . SPARSER::PROTEIN)
    ("PLK1, CDC25B, and CCNB1" . SPARSER::COLLECTION)
    ("E2F1 or FOXM1" . SPARSER::COLLECTION)
    ("common periodic genes" . SPARSER::GENE)
    ("previously known cell cycle–regulated genes" . SPARSER::GENE)
    ("CEP70, UBE2D3, BAIAP2, and PDGFA" . SPARSER::COLLECTION)
    ("PDGFA" . SPARSER::PROTEIN)
    ("PLK1, CCNB1, CDC25B, CDC25C, CENPA, CENPE, CENPF, and TOP2A"
     . SPARSER::COLLECTION)
    ("CENPF" . SPARSER::PROTEIN) ("CENPA" . SPARSER::PROTEIN)
    ("RRM2, PRIM1, RBBP8, and RFC2" . SPARSER::COLLECTION)
    ("CHAF1A, CHAF1B, as well as CCNE1 and CCNE2" . SPARSER::COLLECTION)
    ("CCNE1 and CCNE2" . SPARSER::COLLECTION)
    ("report 1871 unique genes" . SPARSER::GENE)
    ("651 unique genes" . SPARSER::GENE)
    ("double-thymidine or thymidine–nocodazole" . SPARSER::COLLECTION)
    ("less well-studied proteins" . SPARSER::PROTEIN)
    ("PLK1, CCNB1, E2F1, and CCNE2" . SPARSER::COLLECTION)
    ("HMGB3, TROAP, SHCBP1, ANP32E, GPR126, HJURP, SLC38A2, and C14orf130"
     . SPARSER::COLLECTION)
    ("HJURP" . SPARSER::PROTEIN) ("FAM" . SPARSER::PROTEIN)
    ("the 651 unique cell cycle-regulated genes" . SPARSER::GENE)
    ("FOXM1 or E2F4" . SPARSER::COLLECTION)
    ("the repressive DREAM complex" . SPARSER::BIO-COMPLEX)
    ("the mitotic genes" . SPARSER::GENE)
    ("KIF11, KIF2C, and KIF4A" . SPARSER::COLLECTION)
    ("CCNA2, CCNF, and CDC25C" . SPARSER::COLLECTION)
    ("E2F1 or E2F4" . SPARSER::COLLECTION) ("the unique genes" . SPARSER::GENE)
    ("E2F1, CDC6, CDC25A, CCNE1, and RBBP8" . SPARSER::COLLECTION)
    ("UNG, BARD1, BRIP1, and RAD51" . SPARSER::COLLECTION)
    ("UNG" . SPARSER::PROTEIN)
    ("PCNA, CLSPN, EXO1, POLD3, RFC4, and DCC1" . SPARSER::COLLECTION)
    ("CHAF1A, CHAF1B, and SLBP" . SPARSER::COLLECTION)
    ("CLSPN" . SPARSER::PROTEIN) ("FOXM1 and FOXK1" . SPARSER::COLLECTION)
    ("E2F1, E2F4, E2F6, and GA-binding protein transcription factor"
     . SPARSER::COLLECTION)
    ("GABP" . SPARSER::PROTEIN) ("MCM8 and RMI1" . SPARSER::COLLECTION)
    ("MCM8, RPS6KB1, and RMI1" . SPARSER::COLLECTION)
    ("CENPE, PLK1, and TOP2A" . SPARSER::COLLECTION)
    ("CENPE" . SPARSER::PROTEIN) ("pBABE-puro" . SPARSER::COLLECTION)
    ("puro" . SPARSER::PROTEIN)
    ("AURKA, PLK1, CCNB1, and RACGAP1" . SPARSER::COLLECTION)
    ("NS" . SPARSER::PROTEIN)
    ("AURKB, CCNB1, CCNB2, PLK1, and TOP2A" . SPARSER::COLLECTION)
    ("the 1871 unique cell cycle–regulated genes" . SPARSER::GENE)
    ("B-Myb and LIN9" . SPARSER::COLLECTION)
    ("B-Myb/LIN9" . SPARSER::COLLECTION) ("FOXM1/LIN9" . SPARSER::COLLECTION)
    ("FOXM1/B-Myb" . SPARSER::COLLECTION)
    ("ChIP-reChIP" . SPARSER::PROTEIN-PAIR)
    ("B-Myb and FOXM1" . SPARSER::COLLECTION)
    ("PLK1, CCNB1, and AURKA" . SPARSER::COLLECTION)
    ("2367 unique genes" . SPARSER::GENE) ("Hg" . SPARSER::MOLECULE)
    ("PLK" . SPARSER::PROTEIN) ("MCM" . SPARSER::PROTEIN)
    ("E2F1 and E2F7, PLK3, RMI2, CDC45L, RBBP8, DHFR, BRIP1, PRIM1, RRM2, and RFC4"
     . SPARSER::COLLECTION)
    ("E2F7, PLK3, RMI2, CDC45L, RBBP8, DHFR, BRIP1, PRIM1, RRM2, and RFC4"
     . SPARSER::COLLECTION)
    ("RMI1, DSCC1, and MCM6" . SPARSER::COLLECTION)
    ("PCNA, CDT1, CHAF1A, CHAF1B, E2F2, and E2F8" . SPARSER::COLLECTION)
    ("S-phase genes and the G2- and M-phase genes" . SPARSER::COLLECTION)
    ("G2/M, or M/G1" . SPARSER::COLLECTION)
    ("the first two principal components" . SPARSER::COMPONENT)
    ("FNR" . SPARSER::PROTEIN)
    ("RAD21, CDKN3, and PTTG1" . SPARSER::COLLECTION)
    ("CCNB1, CCNB2, BUB1, BUB1B, and CDC25B" . SPARSER::COLLECTION)
    ("TOP2A, CDC2, CCNA2, and CCNF" . SPARSER::COLLECTION)
    ("CCNF" . SPARSER::PROTEIN)
    ("HIST1H4B, HIST1H4C, SLBP, RRM2, and RFC4" . SPARSER::COLLECTION)
    ("SLBP" . SPARSER::PROTEIN)
    ("CCNE1, CCNE2, E2F2, PCNA, and MCM2" . SPARSER::COLLECTION)
    ("periodic cell cycle–regulated genes" . SPARSER::GENE)
    ("G2/M, and M/G1" . SPARSER::COLLECTION)
    ("CCNB1 and FOXM1" . SPARSER::COLLECTION)
    ("thymidine–thymidine" . SPARSER::COLLECTION) ("Noc" . SPARSER::PROTEIN)
    ("Thy" . SPARSER::MOLECULE) ("double-thymidine" . SPARSER::PROTEIN)
    ("FOXA2, FOXA1, and FOXL2" . SPARSER::COLLECTION)
    ("FOXK1 and FOXJ3" . SPARSER::COLLECTION)
    ("cyclin B1/Cdk1" . SPARSER::COLLECTION)
    ("cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("cyclin D1/Cdk4" . SPARSER::COLLECTION)
    ("cyclin-CDK" . SPARSER::COLLECTION)
    ("CCNB1, PLK1, CDC25B, CDC25C, AURKB, and BIRC5" . SPARSER::COLLECTION)
    ("B-Myb-MuvB" . SPARSER::COLLECTION)
    ("other mitotic cell cycle genes" . SPARSER::GENE)
    ("PLK1 and CCNB1" . SPARSER::COLLECTION)
    ("LIN9, LIN37, LIN52, LIN54, and RBBP4" . SPARSER::COLLECTION)
    ("E2F1, E2F4, E2F6, and GABPA" . SPARSER::COLLECTION)
    ("GABPA" . SPARSER::PROTEIN)
    ("1871 unique cell cycle–regulated genes" . SPARSER::GENE)
    ("1871 unique genes" . SPARSER::GENE) ("Anti–" . SPARSER::ANTIBODY)
    ("cyclinB1" . SPARSER::PROTEIN) ("FoxM1" . SPARSER::PROTEIN)
    ("L15" . SPARSER::PROTEIN) ("Phenol red" . SPARSER::DRUG)
    ("B-MYB" . SPARSER::PROTEIN) ("BAIAP2" . SPARSER::PROTEIN)
    ("UBE2D3" . SPARSER::PROTEIN) ("CEP70" . SPARSER::PROTEIN)
    ("RFC2" . SPARSER::PROTEIN) ("SLC38A2" . SPARSER::PROTEIN)
    ("GPR126" . SPARSER::PROTEIN) ("ANP32E" . SPARSER::PROTEIN)
    ("SHCBP1" . SPARSER::PROTEIN) ("HMGB3" . SPARSER::PROTEIN)
    ("DLGAP5" . SPARSER::PROTEIN) ("DLG7" . SPARSER::PROTEIN)
    ("ARL6" . SPARSER::PROTEIN) ("Transcription factor" . SPARSER::PROTEIN)
    ("STK6" . SPARSER::PROTEIN) ("KIF4A" . SPARSER::PROTEIN)
    ("KIF2C" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("DCC1" . SPARSER::PROTEIN) ("POLD3" . SPARSER::PROTEIN)
    ("EXO1" . SPARSER::PROTEIN)
    ("GA-binding protein transcription factor" . SPARSER::PROTEIN)
    ("Transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("PDCD4" . SPARSER::PROTEIN) ("RPS6KB1" . SPARSER::PROTEIN)
    ("MCM8" . SPARSER::PROTEIN) ("SKP2" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("RACGAP1" . SPARSER::PROTEIN)
    ("C20" . SPARSER::PROTEIN) ("BAG3" . SPARSER::PROTEIN)
    ("PRIM1" . SPARSER::PROTEIN) ("RBBP8" . SPARSER::PROTEIN)
    ("CDC45L" . SPARSER::PROTEIN) ("RMI2" . SPARSER::PROTEIN)
    ("PLK3" . SPARSER::PROTEIN) ("MCM6" . SPARSER::PROTEIN)
    ("DSCC1" . SPARSER::PROTEIN) ("RMI1" . SPARSER::PROTEIN)
    ("E2F8" . SPARSER::PROTEIN) ("CHAF1B" . SPARSER::PROTEIN)
    ("CHAF1A" . SPARSER::PROTEIN) ("CDT1" . SPARSER::PROTEIN)
    ("MCM 2" . SPARSER::PROTEIN) ("CDKN3" . SPARSER::PROTEIN)
    ("RAD21" . SPARSER::PROTEIN) ("BUB1B" . SPARSER::PROTEIN)
    ("BUB1" . SPARSER::PROTEIN) ("CCNB2" . SPARSER::PROTEIN)
    ("CCNA2" . SPARSER::PROTEIN) ("TOP2A" . SPARSER::PROTEIN)
    ("RFC4" . SPARSER::PROTEIN) ("RRM2" . SPARSER::PROTEIN)
    ("HIST1H4C" . SPARSER::PROTEIN) ("HIST1H4B" . SPARSER::PROTEIN)
    ("MCM2" . SPARSER::PROTEIN) ("CCNE2" . SPARSER::PROTEIN)
    ("Thy 1" . SPARSER::PROTEIN) ("FOXL2" . SPARSER::PROTEIN)
    ("FOXK1" . SPARSER::PROTEIN) ("CCNB1" . SPARSER::PROTEIN)
    ("B-Myb" . SPARSER::PROTEIN) ("RBL2" . SPARSER::PROTEIN)
    ("TFDP1" . SPARSER::PROTEIN) ("RBBP4" . SPARSER::PROTEIN)
    ("LIN54" . SPARSER::PROTEIN) ("LIN52" . SPARSER::PROTEIN)
    ("LIN37" . SPARSER::PROTEIN) ("LIN9" . SPARSER::PROTEIN)
    ("E2F6" . SPARSER::PROTEIN)
    ("delta, Ku80, and Werner" . SPARSER::COLLECTION)
    ("delta" . SPARSER::PROTEIN)
    ("proteasomal inhibitor MG132" . SPARSER::PROTEIN)
    ("ATM, MDC1, 53BP1, BRCA1, and MRN" . SPARSER::COLLECTION)
    ("Mre11-Rad50-Nbs1" . SPARSER::COLLECTION)
    ("truncated YB-1 influenced genes" . SPARSER::GENE)
    ("nonspecific 660-bp double-stranded (ds) DNA" . SPARSER::DNA)
    ("only cleavable YB-1 proteins" . SPARSER::PROTEIN)
    ("PABP" . SPARSER::PROTEIN) ("pcDNA" . SPARSER::PROTEIN)
    ("YB-1-CSD" . SPARSER::COLLECTION) ("YB-1 (WT)" . SPARSER::PROTEIN)
    ("asparagine and alanine" . SPARSER::COLLECTION)
    ("HA-YB-1" . SPARSER::COLLECTION)
    ("its more efficient nuclear" . SPARSER::PROTEIN)
    ("Akt or other kinases" . SPARSER::COLLECTION)
    ("cisplatin or doxorubicin" . SPARSER::COLLECTION)
    ("growth factors, and cytokines" . SPARSER::COLLECTION)
    ("CRS" . SPARSER::PROTEIN) ("dbpB or NSEP-1" . SPARSER::COLLECTION)
    ("dbpB" . SPARSER::PROTEIN) ("mRNPs" . SPARSER::BIO-COMPLEX)
    ("CSD" . SPARSER::PROTEIN) ("Mre11 and Rad50" . SPARSER::COLLECTION)
    ("a DNA/RNA-binding nucleocytoplasmic shuttling protein"
     . SPARSER::PROTEIN)
    ("CH 3" . SPARSER::MOLECULE) ("Mre 11" . SPARSER::PROTEIN)
    ("Ku80" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("ornithine decarboxylase" . SPARSER::PROTEIN)
    ("H2A.X" . SPARSER::PROTEIN) ("DNA topoisomerase II" . SPARSER::PROTEIN)
    ("NSEP-1" . SPARSER::PROTEIN) ("anticonvulsant" . SPARSER::DRUG)
    ("the most abundant noncollagenous protein" . SPARSER::PROTEIN)
    ("HDAC3 or HDAC1" . SPARSER::COLLECTION)
    ("HDAC4 and HDAC5" . SPARSER::COLLECTION)
    ("HDAC3, HDAC6, and HDAC7" . SPARSER::COLLECTION)
    ("VPA and MS275" . SPARSER::COLLECTION)
    ("OPN and bone-sialoprotein" . SPARSER::COLLECTION)
    ("OC and BSP" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("OPN and BSP" . SPARSER::COLLECTION) ("Alizarin" . SPARSER::DRUG)
    ("BSP and OPN" . SPARSER::COLLECTION)
    ("ALP , BSP , and OPN" . SPARSER::COLLECTION)
    ("BSP , and OPN" . SPARSER::COLLECTION) ("ALP" . SPARSER::PROTEIN)
    ("OC" . SPARSER::PROTEIN) ("POU5F1 and NANOG" . SPARSER::COLLECTION)
    ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("VPA and Histone" . SPARSER::COLLECTION)
    ("cyclin E/cdk2" . SPARSER::COLLECTION)
    ("cyclin D/cdk4" . SPARSER::COLLECTION)
    ("HDAC1 as well as HDAC2" . SPARSER::COLLECTION)
    ("osteopontin (OPN) and bone sialoprotein (BSP)" . SPARSER::COLLECTION)
    ("sialoprotein (BSP)" . SPARSER::PROTEIN) ("BSP" . SPARSER::PROTEIN)
    ("OPN" . SPARSER::PROTEIN)
    ("most class I and II HDACs" . SPARSER::COLLECTION)
    ("epoxides" . SPARSER::MOLECULE) ("HDACi" . SPARSER::MOLECULE)
    ("class I (HDAC1, HDAC2, HDAC3, and HDAC8) and class II (HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, and HDAC10) HDACs"
     . SPARSER::COLLECTION)
    ("at least 18 genes" . SPARSER::GENE)
    ("HDAC1, HDAC2, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, and HDAC10" . SPARSER::COLLECTION)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("acetyltransferases and histone" . SPARSER::COLLECTION)
    ("sialoprotein" . SPARSER::PROTEIN) ("osteopontin" . SPARSER::PROTEIN)
    ("valproic acid (VPA)" . SPARSER::MOLECULE)
    ("deacetylases (HDAC)" . SPARSER::PROTEIN)
    ("osteocalcin" . SPARSER::PROTEIN) ("VPA" . SPARSER::PROTEIN)
    ("Runx2" . SPARSER::PROTEIN) ("MS275" . SPARSER::DRUG)
    ("a 3D" . SPARSER::PROTEIN) ("HDAC-1" . SPARSER::PROTEIN)
    ("MS-275" . SPARSER::DRUG) ("RUNX2" . SPARSER::PROTEIN)
    ("POU5F1" . SPARSER::PROTEIN) ("3B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cdk4" . SPARSER::PROTEIN) ("short-chain fatty acid" . SPARSER::MOLECULE)
    ("Valproic acid" . SPARSER::MOLECULE) ("HDAC11" . SPARSER::PROTEIN)
    ("sir2" . SPARSER::PROTEIN) ("HDAC10" . SPARSER::PROTEIN)
    ("NRAS, PIK3CA, MET, MMR, and PTEN" . SPARSER::COLLECTION)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("bevacizumab" . SPARSER::DRUG) ("preoperative BRAF" . SPARSER::PROTEIN)
    ("a highly significant poor prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tran" . SPARSER::PROTEIN) ("metastatic CRC" . SPARSER::PROTEIN)
    ("a significantly poor prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GCT" . SPARSER::PROTEIN) ("TGT" . SPARSER::PROTEIN)
    ("the postoperative period" . SPARSER::PROTEIN)
    ("APC and p53" . SPARSER::COLLECTION) ("CEA" . SPARSER::PROTEIN)
    ("its prognostic impact" . SPARSER::PROTEIN)
    ("this surgical cohort" . SPARSER::MOLECULE)
    ("other clinicopathologic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("carcinoembryonic antigen" . SPARSER::PROTEIN)
    ("KRAS-HKDC1" . SPARSER::COLLECTION) ("PTTG1-DHFR" . SPARSER::COLLECTION)
    ("EGFR/KRAS" . SPARSER::COLLECTION) ("PTTG1-ZC3H13" . SPARSER::COLLECTION)
    ("PTTG1-TTC31" . SPARSER::COLLECTION) ("PTTG1-ESPL1" . SPARSER::COLLECTION)
    ("BLM-TOPBP1" . SPARSER::COLLECTION)
    ("FANCD2/USP1/UAF1-MUS81" . SPARSER::COLLECTION)
    ("EGFR/KRAS-CD83" . SPARSER::COLLECTION)
    ("PTEN-RASSF2" . SPARSER::COLLECTION) ("PTEN-ENO2" . SPARSER::COLLECTION)
    ("MUS81 or BLM" . SPARSER::COLLECTION)
    ("BLM , MUS81 and PTEN" . SPARSER::COLLECTION)
    ("functionally relevant classes" . CLASS)
    ("PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("PTEN/PI3K" . SPARSER::COLLECTION) ("PTEN/PI3K/AKT" . SPARSER::COLLECTION)
    ("HKDC1 and HRAS" . SPARSER::COLLECTION) ("HRAS" . SPARSER::PROTEIN)
    ("bromopyruvate" . SPARSER::DRUG) ("DLD1" . SPARSER::PROTEIN)
    ("hexokinase" . SPARSER::PROTEIN) ("Pten and Eno1" . SPARSER::COLLECTION)
    ("Eno1" . SPARSER::PROTEIN) ("Pten" . SPARSER::PROTEIN)
    ("ENO1 and ENO2" . SPARSER::COLLECTION)
    ("PTEN and the glycolytic enzyme ENO2 ( xref )" . SPARSER::COLLECTION)
    ("PTEN/AKT" . SPARSER::COLLECTION)
    ("RASSF2 and PTEN" . SPARSER::COLLECTION)
    ("either RASSF2 or the Hippo pathway component LATS1"
     . SPARSER::COLLECTION)
    ("PTEN and RASSF2" . SPARSER::COLLECTION)
    ("AKT and RASSF2" . SPARSER::COLLECTION) ("sham" . SPARSER::DRUG)
    ("Cetuximab and CD83" . SPARSER::COLLECTION)
    ("sh1R-CD83-GFP" . SPARSER::COLLECTION)
    ("Cetuximab or KRAS" . SPARSER::COLLECTION)
    ("KRAS  G13D and CD83" . SPARSER::COLLECTION)
    ("DHFR and PTTG1" . SPARSER::COLLECTION)
    ("MTX and PDS1" . SPARSER::COLLECTION)
    ("a temperature-sensitive hypomorphic allele" . SPARSER::ALLELE)
    ("PDS1 and DHFR" . SPARSER::COLLECTION)
    ("methotrexate (MTX)" . SPARSER::DRUG) ("MTX" . SPARSER::PROTEIN)
    ("PTTG1 and DHFR" . SPARSER::COLLECTION)
    ("TTC31 and ZC3H13" . SPARSER::COLLECTION)
    ("proteins, BUBR1 and CENP-E" . SPARSER::COLLECTION)
    ("BUBR1 and CENP-E" . SPARSER::COLLECTION)
    ("centromeric proteins" . SPARSER::PROTEIN)
    ("the centrosomal marker NEDD1" . SPARSER::PROTEIN)
    ("PTTG1/securin" . SPARSER::COLLECTION)
    ("PDS1/securin" . SPARSER::COLLECTION)
    ("a previously uncharacterized gene" . SPARSER::PROTEIN)
    ("TTC31 and PTTG1" . SPARSER::COLLECTION) ("-GFP" . SPARSER::COLLECTION)
    ("/Pericentrin" . SPARSER::COLLECTION) ("Pericentrin" . SPARSER::PROTEIN)
    ("UAF1 , USP1 and FANCD2" . SPARSER::COLLECTION)
    ("DNA and help" . SPARSER::COLLECTION)
    ("USP1 or FANCD2" . SPARSER::COLLECTION)
    ("Chromatin-associated FANCD2" . SPARSER::PROTEIN)
    ("genome, and UAF1 and USP1" . SPARSER::COLLECTION)
    ("UAF1 and USP1" . SPARSER::COLLECTION) ("ICLs" . SPARSER::PROTEIN)
    ("FANCD2 , UAF1 and USP1" . SPARSER::COLLECTION)
    ("the orthologous genes" . SPARSER::GENE)
    ("SGS1 and DPB11" . SPARSER::COLLECTION)
    ("BLM and TOPBP1" . SPARSER::COLLECTION)
    ("securin and separase" . SPARSER::COLLECTION)
    ("securin or separase" . SPARSER::COLLECTION)
    ("PTTG1 and ESPL1" . SPARSER::COLLECTION)
    ("/separase" . SPARSER::COLLECTION) ("separase" . SPARSER::PROTEIN)
    ("UNC62 and Q8l120" . SPARSER::COLLECTION)
    ("PP2A , MPIP and TFDP" . SPARSER::COLLECTION)
    ("highly conserved essential genes" . SPARSER::GENE)
    ("eggNOG" . SPARSER::PROTEIN) ("MP-eggNOG" . SPARSER::COLLECTION)
    ("the most probable orthologs" . SPARSER::PROTEIN)
    ("PTTG1 and MUS81" . SPARSER::COLLECTION) ("Mixtures" . SPARSER::MOLECULE)
    ("red fluorescent protein" . SPARSER::PROTEIN) ("GARP" . SPARSER::PROTEIN)
    ("shARP" . SPARSER::PROTEIN) ("78 432 unique shRNAs" . SPARSER::PROTEIN)
    ("‘mutant'" . SPARSER::MUTANT)
    ("PTEN  −/− and KRAS  +/− ( xref )" . SPARSER::COLLECTION)
    ("RAD54B and FEN1" . SPARSER::COLLECTION)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("paralogous genes" . SPARSER::GENE)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION) ("SSL" . SPARSER::PROTEIN)
    ("differentially essential genes" . SPARSER::GENE)
    ("differentially essential or differential essentiality (DiE) genes"
     . SPARSER::GENE)
    ("ENO2" . SPARSER::PROTEIN) ("LATS1" . SPARSER::PROTEIN)
    ("MST1" . SPARSER::PROTEIN) ("Family 2" . SPARSER::PROTEIN)
    ("e6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pds1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CENP-E" . SPARSER::PROTEIN)
    ("CENP-A" . SPARSER::PROTEIN) ("G1–S" . SPARSER::PROTEIN)
    ("PDS1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ZC3H13" . SPARSER::PROTEIN)
    ("NEDD1" . SPARSER::PROTEIN) ("TTC31" . SPARSER::PROTEIN)
    ("USP1" . SPARSER::PROTEIN) ("UAF1" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("γ-H2AX" . SPARSER::PROTEIN)
    ("DPB11" . SPARSER::PROTEIN) ("SGS1" . SPARSER::PROTEIN)
    ("TOPBP1" . SPARSER::PROTEIN) ("UNC62" . SPARSER::PROTEIN)
    ("ESP1" . SPARSER::PROTEIN) ("RASSF2" . SPARSER::PROTEIN)
    ("ESPL1" . SPARSER::PROTEIN) ("KPNA6" . SPARSER::PROTEIN)
    ("HKDC1" . SPARSER::PROTEIN) ("MUS81" . SPARSER::PROTEIN)
    ("FEN1" . SPARSER::PROTEIN) ("RAD54B" . SPARSER::PROTEIN)
    ("etiological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("different etiological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARMS" . SPARSER::PROTEIN)
    ("EGFR, erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("monoclonal antibodies (for example, cetuximab, panitumumab) or small molecule tyrosine kinase inhibitors (for example, erlotinib, gefitinib)"
     . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("the major histological type" . TYPE)
    ("Formalin" . SPARSER::MOLECULE) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("Ki-ras" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("TD or E2F3" . SPARSER::COLLECTION) ("CM and Rb" . SPARSER::COLLECTION)
    ("the Rb-E2F growth-repressive complex" . SPARSER::BIO-COMPLEX)
    ("Rb-E2F2" . SPARSER::COLLECTION)
    ("Rb and the activating E2Fs" . SPARSER::COLLECTION)
    ("IDL and RbC" . SPARSER::COLLECTION) ("Rb-E2F3" . SPARSER::COLLECTION)
    ("TD and E2F3" . SPARSER::COLLECTION)
    ("repressive E2F4 and E2F5" . SPARSER::COLLECTION)
    ("E2F4 and E2F5" . SPARSER::COLLECTION)
    ("TD and E2F2" . SPARSER::COLLECTION) ("PL and Rb" . SPARSER::COLLECTION)
    ("E2F-DP1" . SPARSER::COLLECTION)
    ("unlabeledE2F1-DP1" . SPARSER::COLLECTION) ("-Rb" . SPARSER::COLLECTION)
    ("Rb-E2F1" . SPARSER::COLLECTION) ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("paralogous ‘activating’ E2F TD" . SPARSER::PROTEIN)
    ("E2F1-3" . SPARSER::COLLECTION) ("IDL and Rb" . SPARSER::COLLECTION)
    ("E2F1-DP1" . SPARSER::COLLECTION) ("Rb and E2F" . SPARSER::COLLECTION)
    ("IDL" . SPARSER::MOLECULE) ("PL" . SPARSER::PROTEIN)
    ("Rb" . SPARSER::PROTEIN)
    ("E2F and its heterodimerization partner DP" . SPARSER::COLLECTION)
    ("DP" . SPARSER::PROTEIN) ("Rb-E2F" . SPARSER::COLLECTION)
    ("the tumor suppressor protein's" . SPARSER::PROTEIN)
    ("proteinC" . SPARSER::DRUG) ("GS4" . SPARSER::PROTEIN)
    ("E2F5" . SPARSER::PROTEIN) ("2F1" . SPARSER::PROTEIN)
    ("cell cycle regulatory protein" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("G 1 -S" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the simian virus 40 promoter" . SPARSER::PROMOTER)
    ("RAD" . SPARSER::PROTEIN)
    ("forkhead transcription factor FoxO1 ( xref ) and checkpoint protein hRAD9 ( xref )"
     . SPARSER::COLLECTION)
    ("coiled-coil" . SPARSER::PROTEIN) ("trichostatin" . SPARSER::MOLECULE)
    ("PPC" . SPARSER::PROTEIN) ("antiandrogens" . SPARSER::DRUG)
    ("NCoR and TIF2" . SPARSER::COLLECTION)
    ("SMRT ( xref ; xref ) and NCoR ( xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("cyclin D1 ( xref , xref ), SMRT ( xref ; xref ) and NCoR ( xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("NCoR" . SPARSER::PROTEIN) ("SMRT" . SPARSER::PROTEIN)
    ("TIF2 ( xref ) and p300 ( xref )" . SPARSER::COLLECTION)
    ("Shu" . SPARSER::PROTEIN) ("the glandular epithelium" . SPARSER::PROTEIN)
    ("thin" . SPARSER::PROTEIN) ("AR and MMTV-Luc" . SPARSER::COLLECTION)
    ("CV-1" . SPARSER::PROTEIN) ("sequence 175 FQEAA" . SPARSER::PROTEIN)
    ("MAGE-A11, TIF2 or p300" . SPARSER::COLLECTION)
    ("PSA-Enh-Luc" . SPARSER::COLLECTION) ("MAGE" . SPARSER::PROTEIN-FAMILY)
    ("Enh" . SPARSER::PROTEIN) ("TIF2 and p300" . SPARSER::COLLECTION)
    ("antigen-A11" . SPARSER::COLLECTION) ("Melanoma" . SPARSER::PROTEIN)
    ("LF" . SPARSER::PROTEIN) ("XX" . SPARSER::PROTEIN)
    ("GST-AR" . SPARSER::COLLECTION) ("Gal" . SPARSER::PROTEIN)
    ("GAL" . SPARSER::PROTEIN) ("XGal" . SPARSER::MOLECULE)
    ("MMTV-Luc" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("Repressor" . SPARSER::REPRESSOR)
    ("AR and CKβBP2/CRIF1" . SPARSER::COLLECTION) ("CAM" . SPARSER::PROTEIN)
    ("DNA and ligand" . SPARSER::COLLECTION)
    ("AR and its natural ligand" . SPARSER::COLLECTION)
    ("Epithelium" . SPARSER::PROTEIN)
    ("castration recurrent epithelium" . SPARSER::PROTEIN)
    ("The transcription factor coregulator Casein kinase IIβbinding protein 2 or CR6-interacting factor 1 (CKβBP2/CRIF1)"
     . SPARSER::COLLECTION)
    ("hRAD9" . SPARSER::PROTEIN) ("HDAC-4" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("MAGE-A11" . SPARSER::PROTEIN) ("A11" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("GAL4" . SPARSER::PROTEIN)
    ("β galactosidase" . SPARSER::PROTEIN)
    ("peptidylprolyl isomerase A" . SPARSER::PROTEIN)
    ("βgalactosidase" . SPARSER::PROTEIN) ("GADD45" . SPARSER::PROTEIN)
    ("GADD45γ" . SPARSER::PROTEIN) ("p160" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("CRIF1" . SPARSER::PROTEIN) ("BP2" . SPARSER::PROTEIN)
    ("CR6" . SPARSER::PROTEIN) ("INT and fibrinogen" . SPARSER::COLLECTION)
    ("fibrinogen and DR" . SPARSER::COLLECTION)
    ("fibrin and fibrinogen" . SPARSER::COLLECTION)
    ("Fibrinogen" . SPARSER::PROTEIN)
    ("the retinal vasculature" . SPARSER::PROTEIN)
    ("PAI-1 and DR" . SPARSER::COLLECTION)
    ("fibrinolytic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Neither PAI-1 nor fibrinogen" . SPARSER::COLLECTION)
    ("triglycerides and lower PAI-1" . SPARSER::COLLECTION)
    ("these hemostatic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genesis" . SPARSER::PROTEIN)
    ("both type 1 DM and newly diagnosed T2DM ( xref , xref )"
     . SPARSER::COLLECTION)
    ("PAI-1 and fibrinogen" . SPARSER::COLLECTION) ("dL" . SPARSER::PROTEIN)
    ("DM" . SPARSER::PROTEIN) ("INT" . SPARSER::PROTEIN)
    ("STD" . SPARSER::PROTEIN) ("fibrinogen" . SPARSER::PROTEIN)
    ("PAI" . SPARSER::PROTEIN) ("plasminogen" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("HbA 1" . SPARSER::PROTEIN) ("YAP and TAZ" . SPARSER::COLLECTION)
    ("KIBRA ( xref ) and Lats1 ( xref )" . SPARSER::COLLECTION)
    ("YAP ( xref ) and KIBRA ( xref )" . SPARSER::COLLECTION)
    ("supernumerary centrosomes" . SPARSER::PROTEIN)
    ("the mitotic phosphorylation controls YAP’s" . SPARSER::PROTEIN)
    ("the mitotic phosphorylation controls YAP" . SPARSER::PROTEIN)
    ("YAP or YAP-3A" . SPARSER::COLLECTION)
    ("YAP or YAP" . SPARSER::COLLECTION)
    ("phospho-mimetic YAP" . SPARSER::PROTEIN)
    ("α-tubulin and γ-tubulin" . SPARSER::COLLECTION)
    ("YAP, and YAP3D" . SPARSER::COLLECTION)
    ("Phospho-mimetic YAP" . SPARSER::PROTEIN)
    ("RO3306 or roscovitine" . SPARSER::COLLECTION)
    ("YAP or corresponding non-phosphorylatable mutants" . SPARSER::COLLECTION)
    ("TEAD" . SPARSER::PROTEIN) ("OB-LCA" . SPARSER::PROTEIN-PAIR)
    ("LCA" . SPARSER::PROTEIN) ("OB" . SPARSER::PROTEIN)
    ("MAPK-p38α" . SPARSER::COLLECTION)
    ("RO3306 or SP600125" . SPARSER::COLLECTION)
    ("CDK1 and/or JNK1/2 kinases" . SPARSER::COLLECTION)
    ("p-c-Jun" . SPARSER::COLLECTION) ("MAPK-p38" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION)
    ("several mitotic kinases" . SPARSER::KINASE)
    ("Aurora and Plk1" . SPARSER::COLLECTION)
    ("c-Abl, p38, and JNK" . SPARSER::COLLECTION)
    ("Taxol or nocodazole" . SPARSER::COLLECTION)
    ("mitotic kinases Aurora and CDK1" . SPARSER::COLLECTION)
    ("Aurora and CDK1" . SPARSER::COLLECTION) ("KIBRA" . SPARSER::PROTEIN)
    ("Salvador" . SPARSER::PROTEIN) ("YAP/TAZ" . SPARSER::COLLECTION)
    ("TAZ" . SPARSER::PROTEIN) ("Warts" . SPARSER::PROTEIN)
    ("the phosphomimetic mutant YAP3D" . SPARSER::PROTEIN)
    ("YAP3D" . SPARSER::PROTEIN)
    ("a phosphomimetic YAP mutant" . SPARSER::MUTANT)
    ("Hippo-mediated phosphorylation YAP" . SPARSER::PROTEIN)
    ("The Yes-associated protein YAP" . SPARSER::PROTEIN)
    ("YAP" . SPARSER::PROTEIN) ("R-roscovitine" . SPARSER::DRUG)
    ("p-YAP" . SPARSER::PROTEIN) ("P202" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-mitotic" . SPARSER::MOLECULE) ("Lats2" . SPARSER::PROTEIN)
    ("Mst2" . SPARSER::PROTEIN) ("Myelin basic protein" . SPARSER::PROTEIN)
    ("SB216763" . SPARSER::DRUG) ("MK5108" . SPARSER::DRUG)
    ("Plk1" . SPARSER::PROTEIN) ("Aurora-B" . SPARSER::PROTEIN)
    ("ZM447439" . SPARSER::DRUG) ("Aurora-A" . SPARSER::PROTEIN)
    ("VX680" . SPARSER::DRUG) ("Mob1a" . SPARSER::PROTEIN)
    ("TEAD1" . SPARSER::PROTEIN) ("Mob1" . SPARSER::PROTEIN)
    ("WW45" . SPARSER::PROTEIN) ("Lats1" . SPARSER::PROTEIN)
    ("Drosophila )" . SPARSER::PROTEIN) ("YAP3" . SPARSER::PROTEIN)
    ("strong transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("LacR-Cdk2" . SPARSER::COLLECTION) ("GFP-H1.2" . SPARSER::COLLECTION)
    ("GFP-H1.5" . SPARSER::COLLECTION)
    ("transcriptionally competent chromatin" . SPARSER::PROTEIN)
    ("mcherry-LacR" . SPARSER::COLLECTION) ("LacR" . SPARSER::PROTEIN)
    ("mcherry" . SPARSER::PROTEIN) ("YFP-MS2" . SPARSER::COLLECTION)
    ("CFP-SKL" . SPARSER::PROTEIN-PAIR)
    ("a minimal CMV promoter" . SPARSER::PROMOTER)
    ("cyclophilins and FKBP" . SPARSER::COLLECTION)
    ("cis-trans" . SPARSER::COLLECTION) ("FKBP" . SPARSER::PROTEIN)
    ("cyclophilins" . SPARSER::PROTEIN) ("isomerases" . SPARSER::ISOMERASE)
    ("acrylamide" . SPARSER::MOLECULE) ("Ala/Ser/Thr" . SPARSER::COLLECTION)
    ("the weakly bound H1 fraction" . SPARSER::COMPONENT)
    ("Ser-Pro" . SPARSER::COLLECTION) ("heterochromatin" . SPARSER::PROTEIN)
    ("euchromatin" . SPARSER::BIO-COMPLEX) ("FRAP" . SPARSER::PROTEIN)
    ("RatioA" . SPARSER::PROTEIN) ("Pin1 or 1:1.4" . SPARSER::COLLECTION)
    ("the nucleosomal bound H1 state" . SPARSER::BIO-STATE)
    ("Cdc25 and tau" . SPARSER::COLLECTION)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("Pin1 and PP2A" . SPARSER::COLLECTION) ("Juglone" . SPARSER::DRUG)
    ("sub-stoichiometric concentrations (molar ratio of H1/Pin1 = 1:0.0005 to 1:0.1) Pin1"
     . SPARSER::PROTEIN)
    ("H1.2/H1.5" . SPARSER::COLLECTION) ("isomer" . SPARSER::PROTEIN)
    ("trans-isomer" . SPARSER::PROTEIN-PAIR)
    ("Cdc25 and Tau" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("calf intestinal phosphatases" . SPARSER::PHOSPHATASE)
    ("the only histone protein" . SPARSER::PROTEIN)
    ("active and inactive" . SPARSER::COLLECTION)
    ("RNA polymerase II and Cdc25" . SPARSER::COLLECTION)
    ("peptidyl" . SPARSER::PROTEIN) ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("PPIase" . SPARSER::PROTEIN) ("prolines" . SPARSER::AMINO-ACID)
    ("CTD" . SPARSER::PROTEIN) ("Thr and Ser" . SPARSER::COLLECTION)
    ("a basic amino acid" . SPARSER::AMINO-ACID)
    ("CDC2/CDK2" . SPARSER::COLLECTION) ("isomerase" . SPARSER::ISOMERASE)
    ("prolyl" . SPARSER::PROTEIN) ("α-amanitin" . SPARSER::MOLECULE)
    ("MS2" . SPARSER::PROTEIN) ("3 B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phos-tag" . SPARSER::DRUG) ("net 1" . SPARSER::PROTEIN)
    ("H1.4" . SPARSER::PROTEIN) ("H1.2" . SPARSER::PROTEIN)
    ("Pin-1" . SPARSER::PROTEIN) ("Thr-Pro" . SPARSER::MOLECULE)
    ("two domains" . SPARSER::PROTEIN) ("Cdc25" . SPARSER::PROTEIN)
    ("H1.5" . SPARSER::PROTEIN) ("Pin1" . SPARSER::PROTEIN)
    ("MAD2L2 and the GTPase RAN ( xref )" . SPARSER::COLLECTION)
    ("Rev7/Mad2l2" . SPARSER::COLLECTION)
    ("no clear homologue" . SPARSER::PROTEIN) ("Cdh1" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN) ("CDK1/Cyclin" . SPARSER::COLLECTION)
    ("MAD2 and the mitotic checkpoint complex ( xref )" . SPARSER::COLLECTION)
    ("Cyclin B1/CDK1" . SPARSER::COLLECTION)
    ("residual APC/C CDH1" . SPARSER::PROTEIN)
    ("MAD2, Emi1, and Acm1" . SPARSER::COLLECTION)
    ("exogenous CDH1" . SPARSER::PROTEIN)
    ("CDH1 or CDC20" . SPARSER::COLLECTION)
    ("CDC20 and MAD2L2" . SPARSER::COLLECTION)
    ("CDC27 and CDH1" . SPARSER::COLLECTION)
    ("CDC27 and CDC16" . SPARSER::COLLECTION)
    ("MAD2L2 and CDC20" . SPARSER::COLLECTION)
    ("MAD2L2 and CDH1" . SPARSER::COLLECTION)
    ("CDC27 or CDC16" . SPARSER::COLLECTION)
    ("MAD2L2-myc" . SPARSER::COLLECTION)
    ("CDC20 and AURKA" . SPARSER::COLLECTION)
    ("Cyclin B1, Securin, CDC20, and AURKA" . SPARSER::COLLECTION)
    ("rev1 or rev3" . SPARSER::COLLECTION) ("rev3" . SPARSER::PROTEIN)
    ("rev" . SPARSER::PROTEIN)
    ("REV3 (the catalytic subunit of Pol ζ) and REV1" . SPARSER::COLLECTION)
    ("Pol" . SPARSER::PROTEIN)
    ("solely APC/C CDH1 or both APC/C CDH1 and APC/C CDC20"
     . SPARSER::COLLECTION)
    ("solely APC/C CDH1" . SPARSER::PROTEIN)
    ("CDH1 and APC/C" . SPARSER::COLLECTION)
    ("the mitotic checkpoint complex component MAD2" . SPARSER::PROTEIN)
    ("paralogue" . SPARSER::PROTEIN) ("Acm1" . SPARSER::PROTEIN)
    ("Cyclin E/Cyclin A–CDK" . SPARSER::COLLECTION)
    ("mitotic Cyclin/CDK complexes" . SPARSER::BIO-COMPLEX)
    ("Cyclin/CDK" . SPARSER::COLLECTION)
    ("Aurora A (AURKA)" . SPARSER::PROTEIN)
    ("mitotic regulators" . SPARSER::REGULATOR) ("AURKB" . SPARSER::PROTEIN)
    ("Aurora" . SPARSER::PROTEIN) ("AURKA" . SPARSER::PROTEIN)
    ("the mitotic checkpoint complex" . SPARSER::BIO-COMPLEX)
    ("the main mitotic kinase CDK1" . SPARSER::PROTEIN)
    ("Cyclin B1–CDK1" . SPARSER::COLLECTION) ("cohesin" . SPARSER::PROTEIN)
    ("Separase" . SPARSER::PROTEIN)
    ("Securin and Cyclin B1" . SPARSER::COLLECTION)
    ("subunits, CDC20 and CDH1" . SPARSER::COLLECTION)
    ("key mitotic regulatory proteins" . SPARSER::PROTEIN)
    ("CDC20 and APC/C" . SPARSER::COLLECTION)
    ("CDC20 and CDH1" . SPARSER::COLLECTION)
    ("CDH1 and the APC/C" . SPARSER::COLLECTION)
    ("Cyclin B1 and Securin" . SPARSER::COLLECTION)
    ("Securin" . SPARSER::PROTEIN) ("IAK1" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("rev7" . SPARSER::PROTEIN)
    ("mad2l2" . SPARSER::PROTEIN) ("l -Glutamine" . SPARSER::MOLECULE)
    ("Mad2l2" . SPARSER::PROTEIN) ("Rev7" . SPARSER::PROTEIN)
    ("Emi1" . SPARSER::PROTEIN) ("CDC16" . SPARSER::PROTEIN)
    ("CDC27" . SPARSER::PROTEIN) ("UBCH10" . SPARSER::PROTEIN)
    ("hMAD2" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("rev1" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("REV3" . SPARSER::PROTEIN)
    ("REV7" . SPARSER::PROTEIN) ("EMI1" . SPARSER::PROTEIN)
    ("polo-like kinase" . SPARSER::PROTEIN) ("BUB3" . SPARSER::PROTEIN)
    ("BUBR1" . SPARSER::PROTEIN) ("MAD3" . SPARSER::PROTEIN)
    ("MAD2" . SPARSER::PROTEIN) ("MAD2L2" . SPARSER::PROTEIN)
    ("intact AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Kinases" . SPARSER::KINASE)
    ("DHT-induced AR or LBD nuclear" . SPARSER::COLLECTION)
    ("the intact NTD" . SPARSER::PROTEIN) ("AR and AR" . SPARSER::COLLECTION)
    ("the classical leucine-rich NES" . SPARSER::PROTEIN)
    ("CRM-1/Exportin 1" . SPARSER::COLLECTION)
    ("a classical leucine-rich NES" . SPARSER::PROTEIN)
    ("GFP-NES" . SPARSER::COLLECTION) ("PKI" . SPARSER::PROTEIN-FAMILY)
    ("AR 1" . SPARSER::PROTEIN) ("GFP-" . SPARSER::PROTEIN)
    ("the entire NTD" . SPARSER::PROTEIN)
    ("the smaller GFP-DBDH-LBD fusion protein" . SPARSER::PROTEIN)
    ("GFP-AR" . SPARSER::COLLECTION)
    ("AR and other steroid receptors ( xref )" . SPARSER::COLLECTION)
    ("liganded" . SPARSER::MOLECULE) ("Androgens" . SPARSER::DRUG)
    ("Snurportin 1" . SPARSER::PROTEIN) ("Exportin 1" . SPARSER::PROTEIN)
    ("nuclear pores" . SPARSER::BIO-COMPLEX) ("CRM-1" . SPARSER::PROTEIN)
    ("COS1" . SPARSER::PROTEIN) ("NL2" . SPARSER::PROTEIN)
    ("exportin 1" . SPARSER::PROTEIN) ("MDM2 and A20" . SPARSER::COLLECTION)
    ("colon cancer and colon polyp epithelium" . SPARSER::COLLECTION)
    ("A20, and A20" . SPARSER::COLLECTION)
    ("A20 and p53" . SPARSER::COLLECTION) ("IBS" . SPARSER::DRUG)
    ("A20 and other ubiquitin E3 ligases" . SPARSER::COLLECTION)
    ("a crucial regulator of cell cycle" . SPARSER::PROTEIN)
    ("homolog)" . SPARSER::PROTEIN) ("-3 " . SPARSER::PROTEIN)
    ("Age1" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("Wang and Yunli" . SPARSER::COLLECTION) ("Peng-jun" . SPARSER::COLLECTION)
    ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ZEB1, ZEB2, Slug and E-cadherin" . SPARSER::COLLECTION)
    ("proteins and lncRNAs" . SPARSER::COLLECTION)
    ("DMR1, DMR2 and DMR3" . SPARSER::COLLECTION)
    ("MEG3-DMR" . SPARSER::COLLECTION) ("DMR" . SPARSER::PROTEIN)
    ("aza" . SPARSER::DRUG) ("MEG3-MDR" . SPARSER::COLLECTION)
    ("n  " . SPARSER::PROTEIN)
    ("the intergenic differentially" . SPARSER::PROTEIN)
    ("a predominant form" . SPARSER::FORM)
    ("MDM2 and p53" . SPARSER::COLLECTION) ("pCDNA-MEG3" . SPARSER::COLLECTION)
    ("pCDNA" . SPARSER::PROTEIN) ("cancer-associated lncRNAs" . SPARSER::RNA)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ZEB2" . SPARSER::PROTEIN)
    ("panobinostat and standard chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("panobinostat and DNA damaging agents" . SPARSER::COLLECTION)
    ("standard chemotherapeutic drugs" . SPARSER::DRUG)
    ("CDK1 and CDC25C" . SPARSER::COLLECTION)
    ("CDK1, CHK1 and cyclin B1" . SPARSER::COLLECTION)
    ("AnnexinV" . SPARSER::PROTEIN)
    ("panobinostat and etoposide, doxorubicin, or cisplatin"
     . SPARSER::COLLECTION)
    ("CDC25C(S216) and CDK1(Y15)" . SPARSER::COLLECTION)
    ("p-CDC25C" . SPARSER::COLLECTION) ("p-CDK1" . SPARSER::COLLECTION)
    ("panobinostat and the standard chemotherapeutic drugs"
     . SPARSER::COLLECTION)
    ("the standard chemotherapeutic drugs" . SPARSER::DRUG)
    ("panobinostat and etoposide, doxorubicin or cisplatin"
     . SPARSER::COLLECTION)
    ("etoposide, doxorubicin or cisplatin" . SPARSER::COLLECTION)
    ("panobinostat and cisplatin or etoposide" . SPARSER::COLLECTION)
    ("cisplatin or etoposide" . SPARSER::COLLECTION)
    ("panobinostat and doxorubicin" . SPARSER::COLLECTION)
    ("Panobinostat and Etoposide, Doxorubicin, or Cisplatin"
     . SPARSER::COLLECTION)
    ("Etoposide, Doxorubicin, or Cisplatin" . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG) ("Etoposide" . SPARSER::PROTEIN)
    ("SK" . SPARSER::PROTEIN) ("Panobinostat" . SPARSER::DRUG)
    ("etoposide, doxorubicin, or cisplatin" . SPARSER::COLLECTION)
    ("CHK1 and CHK2" . SPARSER::COLLECTION)
    ("ATM and ATR" . SPARSER::COLLECTION)
    ("The frontline chemotherapeutic drugs" . SPARSER::DRUG)
    ("etoposide, doxorubicin and cisplatin" . SPARSER::COLLECTION)
    ("panobinostat and cisplatin, doxorubicin, or etoposide"
     . SPARSER::COLLECTION)
    ("panobinostat and LY2603618" . SPARSER::COLLECTION)
    ("cisplatin, doxorubicin, or etoposide" . SPARSER::COLLECTION)
    ("panobinostat" . SPARSER::DRUG) ("HDACI" . SPARSER::MOLECULE)
    ("HDACIs" . SPARSER::MOLECULE) ("LY2603618" . SPARSER::DRUG)
    ("LBH589" . SPARSER::DRUG) ("-isoform" . SPARSER::COLLECTION)
    ("GNNK" . SPARSER::COLLECTION) ("CBL" . SPARSER::PROTEIN)
    ("addressing letter" . SPARSER::MOLECULE)
    ("glycine-asparagine-asparagine-lysine (GNNK)" . SPARSER::COLLECTION)
    ("severe MCAD" . SPARSER::PROTEIN)
    ("glycine-asparagine-asparagine-lysine" . SPARSER::COLLECTION)
    ("asparagine" . SPARSER::AMINO-ACID) ("tetrapeptide" . SPARSER::MOLECULE)
    ("MCL" . SPARSER::PROTEIN) ("KIT and other proteins" . SPARSER::COLLECTION)
    ("more systemic MCAD" . SPARSER::PROTEIN)
    ("systemic MCAD" . SPARSER::PROTEIN) ("MCAD" . SPARSER::PROTEIN)
    ("mast cell" . SPARSER::PROTEIN) ("MS4A2" . SPARSER::PROTEIN)
    ("SRSF2" . SPARSER::PROTEIN) ("U2AF1" . SPARSER::PROTEIN)
    ("ASXL1" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("TET2" . SPARSER::PROTEIN) ("JAK2" . SPARSER::PROTEIN)
    ("CD117" . SPARSER::PROTEIN) ("Asians and Africans" . SPARSER::COLLECTION)
    ("Asian and African" . SPARSER::COLLECTION)
    ("p53-MDM2–related genes" . SPARSER::GENE) ("Cao" . SPARSER::MOLECULE)
    ("dietary factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T-G" . SPARSER::PROTEIN) ("SNP309" . SPARSER::PROTEIN)
    ("Akt as well as cyclin D1" . SPARSER::COLLECTION)
    ("PIK3R1 (p85) and Akt ( xref , 6, S6, and xref )" . SPARSER::COLLECTION)
    ("a hAFP (human alpha fetoprotein) -hTERT (human telomerase reverse transcriptase) dual promoter"
     . SPARSER::PROMOTER)
    ("estrogen receptor, progesterone receptor and p53" . SPARSER::COLLECTION)
    ("cyclin D2 or cyclin E2" . SPARSER::COLLECTION)
    ("-hTERT" . SPARSER::COLLECTION) ("HCC, and HCC" . SPARSER::COLLECTION)
    ("NF-κB and IL-6" . SPARSER::COLLECTION)
    ("prometastatic targets" . SPARSER::TARGET-PROTEIN)
    ("Frizzled-7 and MAP3K1" . SPARSER::COLLECTION)
    ("Smads" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("urokinase-type plasminogen activator (uPA) and c-Met"
     . SPARSER::COLLECTION)
    ("KLF" . SPARSER::PROTEIN) ("SFPQ" . SPARSER::PROTEIN)
    ("both PTEN and the key components" . SPARSER::COLLECTION)
    ("relevant miRNAs" . SPARSER::MICRO-RNA)
    ("inhibitor or siRNA#2" . SPARSER::COLLECTION)
    ("p110α, p110δ, p85 or Akt" . SPARSER::COLLECTION)
    ("PTEN inhibitor and PTEN siRNA#2" . SPARSER::COLLECTION)
    ("the PI3-kinase catalytic subunits [ xref ] and miR-26a ( xref and xref )"
     . SPARSER::COLLECTION)
    ("the antagonistic regulators" . SPARSER::REGULATOR)
    ("p110α, p110δ, p85 and Akt" . SPARSER::COLLECTION)
    ("p110α, p110β and p110δ" . SPARSER::COLLECTION)
    ("PI3-kinase, p85, and iii" . SPARSER::COLLECTION) ("Class" . CLASS)
    ("the four miRNAs and the PI3K/Akt pathway" . SPARSER::COLLECTION)
    ("the relevant anti-miR inhibitors" . SPARSER::INHIBITOR)
    ("relevant miRNA" . SPARSER::MICRO-RNA)
    ("LNCaP and PC-3" . SPARSER::COLLECTION) ("RV" . SPARSER::PROTEIN)
    ("the corresponding anti-miR" . SPARSER::ANTIBODY)
    ("Part" . SPARSER::COMPONENT)
    ("relevant anti-miRNA inhibitors" . SPARSER::INHIBITOR)
    ("relevant anti-miR inhibitors" . SPARSER::INHIBITOR)
    ("its relevant truncated fragment" . SPARSER::FRAGMENT)
    ("PUA, PUB, PUC or PUD" . SPARSER::COLLECTION) ("PUB" . SPARSER::PROTEIN)
    ("PUA" . SPARSER::PROTEIN-FAMILY) ("PU" . SPARSER::PROTEIN)
    ("three key pro-apoptotic genes" . SPARSER::GENE)
    ("p53, Puma and Bak1" . SPARSER::COLLECTION) ("Shi" . SPARSER::PROTEIN)
    ("PIK3CA, PIK3CD, PIK3R1 and Akt" . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("Phosphatase and tensin" . SPARSER::COLLECTION)
    ("cyclin E2" . SPARSER::PROTEIN) ("alpha fetoprotein" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase 1" . SPARSER::PROTEIN)
    ("Frizzled-7" . SPARSER::PROTEIN)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("KLF2" . SPARSER::PROTEIN) ("Akt-mTOR" . SPARSER::PROTEIN)
    ("MYBL2" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("p110β" . SPARSER::PROTEIN) ("p110δ" . SPARSER::PROTEIN)
    ("U44" . SPARSER::PROTEIN) ("pri-miRNA" . SPARSER::RNA)
    ("let7" . SPARSER::RNA) ("Bak1" . SPARSER::PROTEIN)
    ("miR-125b" . SPARSER::MOLECULE) ("PIK3R1" . SPARSER::PROTEIN)
    ("PIK3CD" . SPARSER::PROTEIN) ("miR-92a" . SPARSER::MOLECULE)
    ("amyloid" . SPARSER::PROTEIN) ("RIP1 and CYLD" . SPARSER::COLLECTION)
    ("CYLD and RIP1" . SPARSER::COLLECTION)
    ("the soluble fractions" . SPARSER::COMPONENT)
    ("the NP-40 soluble S25 fraction" . SPARSER::COMPONENT)
    ("the NP-40 insoluble fractions" . SPARSER::COMPONENT)
    ("both NP-40 soluble and insoluble fractions" . SPARSER::COMPONENT)
    ("the insoluble pellet fractions" . SPARSER::COMPONENT)
    ("the NP-40 insoluble fraction" . SPARSER::COMPONENT)
    ("phospho-RIP1 and phospho-RIP3" . SPARSER::COLLECTION)
    ("the NP-40 insoluble SDS fraction" . SPARSER::COMPONENT)
    ("NP-40 and SDS" . SPARSER::COLLECTION)
    ("RIP1 and FADD" . SPARSER::COLLECTION) ("detergent" . SPARSER::MOLECULE)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("the major substrate of CYLD and yet RIP1 ubiquitination"
     . SPARSER::COLLECTION)
    ("RIP1, RIP3 and CYLD" . SPARSER::COLLECTION)
    ("CG1 and CG2" . SPARSER::COLLECTION) ("Glycine" . SPARSER::AMINO-ACID)
    ("CG1" . SPARSER::PROTEIN) ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("The normal TNFR-1" . SPARSER::PROTEIN)
    ("TRAIL, FasL or staurosporine" . SPARSER::COLLECTION)
    ("TNF and CHX" . SPARSER::COLLECTION) ("TNF-" . SPARSER::PROTEIN)
    ("MEFs and CYLD" . SPARSER::COLLECTION)
    ("CHX or SMAC" . SPARSER::COLLECTION)
    ("cycloheximide (CHX) and zVAD ( xref )" . SPARSER::COLLECTION)
    ("CHX" . SPARSER::PROTEIN) ("TNF or TNF and zVAD" . SPARSER::COLLECTION)
    ("TNF and zVAD" . SPARSER::COLLECTION)
    ("TNF, zVAD and Smac" . SPARSER::COLLECTION)
    ("RIP1 or RIP3" . SPARSER::COLLECTION) ("HEPES" . SPARSER::MOLECULE)
    ("S25 and P25" . SPARSER::COLLECTION) ("spin" . SPARSER::PROTEIN)
    ("sequential IP" . SPARSER::PROTEIN)
    ("50 mM TrisCl pH7.4" . SPARSER::PROTEIN) ("DTT" . SPARSER::MOLECULE)
    ("1X Complete protease inhibitors (Roche) and Phosphatase inhibitor cocktail I (Sigma)"
     . SPARSER::COLLECTION)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("deoxycholate" . SPARSER::MOLECULE)
    ("RIPA" . SPARSER::PROTEIN) ("NaF" . SPARSER::PROTEIN)
    ("HD" . SPARSER::PROTEIN) ("x" . SPARSER::PROTEIN)
    ("Solution" . SPARSER::MOLECULE)
    ("FADD and caspase-8" . SPARSER::COLLECTION)
    ("0.5-1 µg/ml cycloheximide (CHX) and 20 µM zVAD-fmk"
     . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN) ("puromycin" . SPARSER::DRUG)
    ("the membrane-associated TNFR-1 complex" . SPARSER::BIO-COMPLEX)
    ("its relevant target" . SPARSER::TARGET-PROTEIN)
    ("a deubiquitinase and tumor suppressor" . SPARSER::COLLECTION)
    ("Smac" . SPARSER::PROTEIN) ("FADD and caspase 8" . SPARSER::COLLECTION)
    ("the essential necrosome component RIP1" . SPARSER::PROTEIN)
    ("the RIP3 substrates mixed lineage kinase domain-like (MLKL) and phosphoglycerate mutase family member 5 (Pgam5)"
     . SPARSER::COLLECTION)
    ("mixed lineage kinase domain-like (MLKL)" . SPARSER::PROTEIN)
    ("Pgam5" . SPARSER::PROTEIN) ("MLKL" . SPARSER::PROTEIN)
    ("The essential programmed necrosis regulators RIP1 and RIP3"
     . SPARSER::COLLECTION)
    ("programmed necrosis regulators RIP1 and RIP3" . SPARSER::COLLECTION)
    ("cIAP1 and cIAP2" . SPARSER::COLLECTION)
    ("RIP1 and RIP3" . SPARSER::COLLECTION)
    ("cycloheximide or SMAC" . SPARSER::COLLECTION) ("CYLD" . SPARSER::PROTEIN)
    ("a prototypic inducer" . SPARSER::PROTEIN)
    ("RIP1-RIP3" . SPARSER::COLLECTION) ("RIPK1/RIP1" . SPARSER::COLLECTION)
    ("CLIPR-59" . SPARSER::PROTEIN) ("Nec-1" . SPARSER::PROTEIN)
    ("CG2" . SPARSER::PROTEIN) ("necrostatin-1" . SPARSER::MOLECULE)
    ("TRAIL-R4" . SPARSER::PROTEIN) ("P25" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S25" . SPARSER::PROTEIN) ("P10" . SPARSER::PROTEIN)
    ("TNFR2" . SPARSER::PROTEIN) ("s 5A" . SPARSER::PROTEIN)
    ("TR4" . SPARSER::PROTEIN) ("CM-H" . SPARSER::MOLECULE)
    ("zVAD-fmk" . SPARSER::DRUG) ("Necrostatin-1" . SPARSER::MOLECULE)
    ("TRAF2" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("phosphoglycerate mutase family member 5" . SPARSER::PROTEIN)
    ("mixed lineage kinase domain-like" . SPARSER::PROTEIN)
    ("cIAP2" . SPARSER::PROTEIN) ("cIAP1" . SPARSER::PROTEIN)
    ("TNFR-1" . SPARSER::PROTEIN) ("RIP3" . SPARSER::PROTEIN)
    ("RIPK1" . SPARSER::PROTEIN)
    ("Receptor interacting protein" . SPARSER::PROTEIN)
    ("PTEN and the master nuclear exporter Crm1" . SPARSER::COLLECTION)
    ("PTEN or WT-PTEN" . SPARSER::COLLECTION)
    ("potentially other therapeutics" . SPARSER::THERAPEUTICS)
    ("a relevant disease state" . SPARSER::BIO-STATE)
    ("Crm1-PTEN" . SPARSER::COLLECTION)
    ("the previously discovered Crm1-mediated S6K" . SPARSER::PROTEIN)
    ("PI3K, mTOR, and S6K1" . SPARSER::COLLECTION)
    ("classical direct nuclear" . SPARSER::PROTEIN)
    ("S1PR2 and Akt" . SPARSER::COLLECTION)
    ("sphingosine kinase, S1PR2, and Akt" . SPARSER::COLLECTION)
    ("Akt and its downstream targets" . SPARSER::COLLECTION)
    ("AC and S1P" . SPARSER::COLLECTION) ("AC/S1P" . SPARSER::COLLECTION)
    ("Alanine or Glutamate" . SPARSER::COLLECTION)
    ("Alanine" . SPARSER::AMINO-ACID) ("Leucine" . SPARSER::AMINO-ACID)
    ("a weak NES" . SPARSER::PROTEIN) ("NES" . SPARSER::PROTEIN)
    ("FLAG-PTEN" . SPARSER::COLLECTION) ("FLAG-Crm1" . SPARSER::COLLECTION)
    ("AC- ( xref ) and S1P- ( xref , xref )" . SPARSER::COLLECTION)
    ("S1P-" . SPARSER::PROTEIN) ("AC-" . SPARSER::PROTEIN)
    ("Leptomycin B (LMB)" . SPARSER::MOLECULE) ("LMB" . SPARSER::MOLECULE)
    ("S1PR2 or Akt" . SPARSER::COLLECTION) ("exogenous S1P" . SPARSER::PROTEIN)
    ("PTEN and PTEN" . SPARSER::COLLECTION) ("SphK" . SPARSER::PROTEIN)
    ("whose tumor AC" . SPARSER::PROTEIN)
    ("benign nuclear PTEN" . SPARSER::PROTEIN) ("Docetaxel" . SPARSER::DRUG)
    ("PTEN and Crm1" . SPARSER::COLLECTION)
    ("acid ceramidase (AC)" . SPARSER::PROTEIN) ("RAN" . SPARSER::PROTEIN)
    ("melanoma and colon cancer" . SPARSER::COLLECTION)
    ("Akt and its activating kinase PDK1" . SPARSER::COLLECTION)
    ("a critically important tumor suppressor" . SPARSER::SUPPRESSOR)
    ("Crm1 and PTEN" . SPARSER::COLLECTION)
    ("acid ceramidase and sphingosine 1-phosphate" . SPARSER::COLLECTION)
    ("Crm1" . SPARSER::PROTEIN) ("exportin" . SPARSER::PROTEIN)
    ("S1PR2" . SPARSER::PROTEIN) ("sphingosine kinase" . SPARSER::PROTEIN)
    ("PPC1" . SPARSER::PROTEIN) ("Acid ceramidase" . SPARSER::PROTEIN)
    ("Histone-H3" . SPARSER::PROTEIN) ("P30" . SPARSER::PROTEIN)
    ("ToPro3" . SPARSER::MOLECULE) ("DG2" . SPARSER::PROTEIN)
    ("JTE013" . SPARSER::DRUG) ("Leptomycin B" . SPARSER::MOLECULE)
    ("S1P" . SPARSER::PROTEIN) ("Major Vault Protein" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("leptomycin B" . SPARSER::MOLECULE)
    ("sphingosine 1-phosphate" . SPARSER::DRUG)
    ("acid ceramidase" . SPARSER::PROTEIN)
    ("JNK and its downstream effecter c-jun [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("DH" . SPARSER::PROTEIN) ("the only known RhoA" . SPARSER::PROTEIN)
    ("GTPases-" . SPARSER::GTPASE)
    ("total cellular p27 kip1" . SPARSER::PROTEIN)
    ("SP600125 and imatinib" . SPARSER::COLLECTION)
    ("Annexin V-" . SPARSER::PROTEIN)
    ("imatinib and SP600125" . SPARSER::COLLECTION)
    ("pro-caspase3" . SPARSER::COLLECTION)
    ("dominant negative RhoA (RhoAN19) or constitutively active RhoA (RhoAL63)"
     . SPARSER::COLLECTION)
    ("treated with/without imatinib" . SPARSER::DRUG)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("RhoA and p27 kip1" . SPARSER::COLLECTION)
    ("STAT5 and STAT3" . SPARSER::COLLECTION) ("immuno" . SPARSER::PROTEIN)
    ("GTP and GDP" . SPARSER::COLLECTION)
    ("p27 kip1 and RhoA" . SPARSER::COLLECTION)
    ("aggressive metastatic forms" . SPARSER::FORM)
    ("Cdk2-cyclinA" . SPARSER::COLLECTION)
    ("Cdk2-cyclinE" . SPARSER::COLLECTION) ("cyclinA" . SPARSER::PROTEIN)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY) ("A prominent CDKI" . SPARSER::DRUG)
    ("cyclin-dependent kinases and their regulatory inhibitors (CDKIs)"
     . SPARSER::COLLECTION)
    ("CDKIs" . SPARSER::DRUG) ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("SAPK/JNK" . SPARSER::COLLECTION) ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Chronic Myeloid Leukemia (CML)" . SPARSER::PROTEIN)
    ("bcr-abl" . SPARSER::PROTEIN) ("filamentous actin" . SPARSER::BIO-COMPLEX)
    ("skp2" . SPARSER::PROTEIN) ("GTPγS" . SPARSER::PROTEIN)
    ("ROCK2" . SPARSER::PROTEIN) ("ROCK1" . SPARSER::PROTEIN)
    ("IL3" . SPARSER::PROTEIN) ("IL-3" . SPARSER::PROTEIN)
    ("Flt3 ligand" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("b2a" . SPARSER::PROTEIN) ("p21 Ras" . SPARSER::PROTEIN)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("p210" . SPARSER::PROTEIN)
    ("Myeloid Leukemia" . SPARSER::PROTEIN) ("SOX9/AMH" . SPARSER::COLLECTION)
    ("an immature state" . SPARSER::BIO-STATE)
    ("AR and AMH" . SPARSER::COLLECTION) ("exogenous SOX9" . SPARSER::PROTEIN)
    ("SOX9 and SF1" . SPARSER::COLLECTION)
    ("SF1, WT1, DAX1 and FSH" . SPARSER::COLLECTION)
    ("age-" . SPARSER::PROTEIN) ("DHT or flutamide" . SPARSER::COLLECTION)
    ("flutamide" . SPARSER::DRUG) ("Sox9 and AMH" . SPARSER::COLLECTION)
    ("Androgen/AR" . SPARSER::COLLECTION) ("LH and FSH" . SPARSER::COLLECTION)
    ("FSH" . SPARSER::PROTEIN) ("LH" . SPARSER::PROTEIN)
    ("strong SOX9 and AMH" . SPARSER::COLLECTION)
    ("significantly stronger SOX9 and AMH" . SPARSER::COLLECTION)
    ("SOX9 and AR" . SPARSER::COLLECTION) ("AR and SOX9" . SPARSER::COLLECTION)
    ("AMH and SOX9" . SPARSER::COLLECTION) ("HMG" . SPARSER::PROTEIN)
    ("Sry" . SPARSER::PROTEIN) ("AMH and testosterone" . SPARSER::COLLECTION)
    ("anti-Mullerian hormone (AMH)" . SPARSER::PROTEIN)
    ("Androgen and the androgen receptor (AR)" . SPARSER::COLLECTION)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION)
    ("SOX9 and AMH" . SPARSER::COLLECTION)
    ("AR, SOX9 and AMH" . SPARSER::COLLECTION)
    ("androgen/AR" . SPARSER::COLLECTION) ("AMH" . SPARSER::PROTEIN)
    ("Testosterone" . SPARSER::MOLECULE) ("SF-1" . SPARSER::PROTEIN)
    ("DAX1" . SPARSER::PROTEIN) ("SF1" . SPARSER::PROTEIN)
    ("Sox9" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("RT3" . SPARSER::MOLECULE) ("steroid hormone" . SPARSER::MOLECULE)
    ("steroidogenic factor 1" . SPARSER::PROTEIN) ("TM4" . SPARSER::PROTEIN)
    ("anti-Mullerian hormone" . SPARSER::PROTEIN) ("SOX9" . SPARSER::PROTEIN)
    ("candesartan" . SPARSER::DRUG) ("fructose" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::COLLECTION) ("MAPK-ERK" . SPARSER::COLLECTION)
    ("insulin/IGF-I" . SPARSER::COLLECTION)
    ("the latter evodiamine" . SPARSER::DRUG)
    ("the antiadipogenic alkaloid evodiamine" . SPARSER::DRUG)
    ("typical downstream Akt effectors" . SPARSER::EFFECTOR)
    ("insulin or SFB" . SPARSER::COLLECTION) ("SFB" . SPARSER::PROTEIN)
    ("U0126 and PD98059" . SPARSER::COLLECTION)
    ("human omental fat" . SPARSER::PROTEIN)
    ("FoxO1 ( xref ) and FoxO4 ( xref )" . SPARSER::COLLECTION)
    ("FoxO1 and FoxO4" . SPARSER::COLLECTION) ("SGBS" . SPARSER::PROTEIN)
    ("effectors, FoxO1 and FoxO4" . SPARSER::COLLECTION)
    ("Akt, FoxO1 and FoxO4" . SPARSER::COLLECTION)
    ("p-ERK/β-actin" . SPARSER::COLLECTION) ("/ERK 1" . SPARSER::COLLECTION)
    ("scr" . SPARSER::PROTEIN) ("/β-actin" . SPARSER::COLLECTION)
    ("/ERK 2" . SPARSER::COLLECTION)
    ("adipogenic inducers" . SPARSER::MOLECULE) ("/Akt" . SPARSER::COLLECTION)
    ("evodiamine" . SPARSER::DRUG) ("alkaloid" . SPARSER::MOLECULE)
    ("the key adipogenic transcription factor PPAR-gamma" . SPARSER::PROTEIN)
    ("PDGF, IGF-1 and EGF" . SPARSER::COLLECTION)
    ("arrestin and G protein-coupled" . SPARSER::COLLECTION)
    ("ERK 1 and ERK 2" . SPARSER::COLLECTION)
    ("far more complex" . SPARSER::BIO-COMPLEX)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("losartan" . SPARSER::PROTEIN) ("mature adipocytes" . SPARSER::PROTEIN)
    ("AT1 and AT2" . SPARSER::COLLECTION)
    ("binding type 1 (AT1) or type 2 (AT2) angiotensin II receptors"
     . SPARSER::COLLECTION)
    ("larger dysfunctional adipocytes" . SPARSER::PROTEIN)
    ("their epididymal fat" . SPARSER::PROTEIN)
    ("Angiotensinogen" . SPARSER::PROTEIN) ("angiotensin" . SPARSER::PROTEIN)
    ("renin and angiotensin converting enzyme" . SPARSER::COLLECTION)
    ("ACE" . SPARSER::PROTEIN) ("renin" . SPARSER::PROTEIN)
    ("visceral fat" . SPARSER::PROTEIN) ("angiotensinogen" . SPARSER::PROTEIN)
    ("whose impact" . SPARSER::PROTEIN)
    ("U0126 or PD98059" . SPARSER::COLLECTION)
    ("p-Akt/Akt" . SPARSER::COLLECTION)
    ("angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("IGF-I" . SPARSER::PROTEIN) ("p-ERK 1" . SPARSER::PROTEIN)
    ("endothelin 1" . SPARSER::PROTEIN) ("PPAR-gamma" . SPARSER::PROTEIN)
    ("MAPK/ERK kinase 1" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("ERK 2" . SPARSER::PROTEIN) ("PD123319" . SPARSER::DRUG)
    ("AT2" . SPARSER::PROTEIN) ("AT1" . SPARSER::PROTEIN)
    ("ACE2" . SPARSER::PROTEIN)
    ("angiotensin converting enzyme" . SPARSER::PROTEIN)
    ("Angiotensin II" . SPARSER::PROTEIN) ("Akt/PKB" . SPARSER::PROTEIN)
    ("a new prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src/Erk" . SPARSER::COLLECTION) ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pAkt and CIP2A" . SPARSER::COLLECTION)
    ("ß-catenin" . SPARSER::COLLECTION)
    ("siRNAs or shRNAs" . SPARSER::COLLECTION)
    ("CIP2A and Myc" . SPARSER::COLLECTION)
    ("the tumour suppressor APC and the oncogene KRAS" . SPARSER::COLLECTION)
    ("virtually all CRCs" . SPARSER::PROTEIN) ("CRCs" . SPARSER::PROTEIN)
    ("Mek1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PI3K/mTor" . SPARSER::COLLECTION)
    ("mTor" . SPARSER::PROTEIN) ("Fbw7" . SPARSER::PROTEIN)
    ("Pi3K" . SPARSER::PROTEIN) ("Colon Cancer" . SPARSER::PROTEIN)
    ("Colon cancer" . SPARSER::PROTEIN)
    ("gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("beta-actin" . SPARSER::PROTEIN)
    ("beta-2" . SPARSER::PROTEIN) ("CIP2A" . SPARSER::PROTEIN)
    ("ATM-" . SPARSER::PROTEIN) ("E4orf3 and E4orf6" . SPARSER::COLLECTION)
    ("a reliable phosphorylation mark" . SPARSER::PROTEIN)
    ("viral DNA" . SPARSER::DNA) ("Mre11 and CtIP" . SPARSER::COLLECTION)
    ("CtIP" . SPARSER::PROTEIN) ("TopBP1 and Rad9" . SPARSER::COLLECTION)
    ("DNA or dsDNA" . SPARSER::COLLECTION)
    ("dimer or higher-order" . SPARSER::COLLECTION)
    ("viral and cellular proteins" . SPARSER::PROTEIN)
    ("other essential ATR pathway proteins Rad9, TopBP1, and Claspin"
     . SPARSER::COLLECTION)
    ("Rad9, TopBP1, and Claspin" . SPARSER::COLLECTION)
    ("the essential ATR cofactors Rad9 and TopBP1" . SPARSER::COLLECTION)
    ("TopBP1-AAD" . SPARSER::COLLECTION)
    ("a previously described TopBP1 mutant" . SPARSER::MUTANT)
    ("these essential ATR signaling co-factors" . SPARSER::MOLECULE)
    ("Rad9, TopBP1, or Claspin" . SPARSER::COLLECTION)
    ("Claspin" . SPARSER::PROTEIN) ("GFP-RPA70" . SPARSER::COLLECTION)
    ("Rad51 and γH2AX" . SPARSER::COLLECTION)
    ("helicase and polymerase" . SPARSER::COLLECTION)
    ("Three internal deletion mutants" . SPARSER::MUTANT)
    ("UL8" . SPARSER::PROTEIN) ("EE-UL8" . SPARSER::COLLECTION)
    ("EE" . SPARSER::PROTEIN)
    ("Untransfected cells exhibited phosphorylated RPA-S33"
     . SPARSER::COLLECTION)
    ("RPA-S33" . SPARSER::COLLECTION) ("Foci" . SPARSER::PROTEIN)
    ("viral mutants" . SPARSER::MUTANT)
    ("both helicase/primase inhibitors and polymerase inhibitors ( xref )"
     . SPARSER::COLLECTION)
    ("UL5, UL52, and UL30" . SPARSER::COLLECTION)
    ("ICP0 and ICP22" . SPARSER::COLLECTION)
    ("ICP4 and ICP27" . SPARSER::COLLECTION)
    ("both immediate early (IE) and early (E) genes" . SPARSER::COLLECTION)
    ("the viral proteins" . SPARSER::PROTEIN)
    ("the viral factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Chk1 and RPA" . SPARSER::COLLECTION) ("HU" . SPARSER::DRUG)
    ("hydroxyurea" . SPARSER::DRUG) ("Rad9 and TopBP1" . SPARSER::COLLECTION)
    ("essential ATR pathway proteins" . SPARSER::PROTEIN)
    ("UL5 and UL52" . SPARSER::COLLECTION)
    ("a polymerase accessory factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("seven essential replication proteins" . SPARSER::PROTEIN)
    ("DNA-PK and ATR" . SPARSER::COLLECTION)
    ("ATRIP, RPA, TopBP1, and CINP" . SPARSER::COLLECTION)
    ("CINP" . SPARSER::PROTEIN) ("RPA and Chk1" . SPARSER::COLLECTION)
    ("the viral encoded ubiquitin ligase" . SPARSER::PROTEIN)
    ("DNA-PK and ATM" . SPARSER::COLLECTION)
    ("ATM (ataxia-telangiectasia-mutated) and ATR (ATM and Rad3 related)"
     . SPARSER::COLLECTION)
    ("the phosphoinositide 3-kinase-related kinases DNA-PK (DNA-dependent protein kinase), ATM (ataxia-telangiectasia-mutated) and ATR (ATM and Rad3 related)"
     . SPARSER::COLLECTION)
    ("ATM and Rad3" . SPARSER::COLLECTION)
    ("viral DNA replication proteins masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DDR" . SPARSER::PROTEIN) ("clamp and TopBP1" . SPARSER::COLLECTION)
    ("viral DNA replication proteins" . SPARSER::PROTEIN)
    ("these four viral proteins" . SPARSER::PROTEIN)
    ("ATR/ATRIP" . SPARSER::COLLECTION) ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("ATRIP" . SPARSER::PROTEIN) ("helicase/primase" . SPARSER::COLLECTION)
    ("primase" . SPARSER::PROTEIN) ("ICP" . SPARSER::PROTEIN)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE) ("CS3" . SPARSER::PROTEIN)
    ("HD2" . SPARSER::PROTEIN) ("E4orf6" . SPARSER::PROTEIN)
    ("E4orf3" . SPARSER::PROTEIN) ("replication/repair" . SPARSER::PROTEIN)
    ("ICP27" . SPARSER::PROTEIN) ("ICP4" . SPARSER::PROTEIN)
    ("ICP22" . SPARSER::PROTEIN) ("RPA32" . SPARSER::PROTEIN)
    ("9-1-1 complex" . SPARSER::|9-1-1|)
    ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UL42" . SPARSER::PROTEIN)
    ("UL30" . SPARSER::PROTEIN) ("DNA binding protein" . SPARSER::PROTEIN)
    ("UL9" . SPARSER::PROTEIN) ("ICP0" . SPARSER::PROTEIN)
    ("Checkpoint kinase 1" . SPARSER::PROTEIN)
    ("ATR interacting protein" . SPARSER::PROTEIN)
    ("Replication protein" . SPARSER::PROTEIN)
    ("Rad9-Rad1-Hus1" . SPARSER::PROTEIN) ("UL5" . SPARSER::PROTEIN)
    ("single stranded DNA binding protein" . SPARSER::PROTEIN)
    ("AMPK or mTOR" . SPARSER::COLLECTION)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("pyruvate or amino acids" . SPARSER::COLLECTION)
    ("pyruvate" . SPARSER::PROTEIN) ("Nutrients" . SPARSER::MOLECULE)
    ("starch" . SPARSER::MOLECULE)
    ("fatty acid and lipid synthesis" . SPARSER::COLLECTION)
    ("AMPK or Inducing mTOR" . SPARSER::COLLECTION)
    ("Essential Substrates" . SPARSER::SUBSTRATE)
    ("ribosome" . SPARSER::BIO-COMPLEX)
    ("macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("mTOR and AMPK" . SPARSER::COLLECTION)
    ("kinase, and mTOR" . SPARSER::COLLECTION)
    ("AMPK and mTOR" . SPARSER::COLLECTION) ("AMPK/mTOR" . SPARSER::COLLECTION)
    ("the host AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) kinases"
     . SPARSER::COLLECTION)
    ("anabolic precursor metabolites" . SPARSER::MOLECULE)
    ("catabolic substrates" . SPARSER::SUBSTRATE) ("iron" . SPARSER::MOLECULE)
    ("GP63" . SPARSER::PROTEIN) ("T antigens" . SPARSER::MOLECULE)
    ("small T antigen" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("UL38" . SPARSER::PROTEIN) ("elF4" . SPARSER::PROTEIN)
    ("NMR and x-ray" . SPARSER::COLLECTION) ("x-ray" . SPARSER::COLLECTION)
    ("alanine and glutamate" . SPARSER::COLLECTION)
    ("the principal regulator" . SPARSER::PROTEIN)
    ("antagonists and paclitaxel" . SPARSER::COLLECTION)
    ("paclitaxel-treated cells pulls down proportionately more Bak and Bim"
     . SPARSER::COLLECTION)
    ("tipifarnib and etoposide" . SPARSER::COLLECTION)
    ("phosphorylated Bcl-2 as well as Bcl-2 S70E and S70A"
     . SPARSER::COLLECTION)
    ("Bcl-2 or Bcl-x" . SPARSER::COLLECTION) ("Paclitaxel" . SPARSER::DRUG)
    ("Bcl-2 and Bcl-x" . SPARSER::COLLECTION) ("Bim-" . SPARSER::PROTEIN)
    ("tipifarnib" . SPARSER::DRUG) ("EGFP-Bim" . SPARSER::COLLECTION)
    ("EGFP-Bak" . SPARSER::COLLECTION)
    ("Bcl-2 S70A or Bcl-2 S70E" . SPARSER::COLLECTION)
    ("wt Bcl-2, Bcl-2 S70A or Bcl-2 S70E" . SPARSER::COLLECTION)
    ("alanine or glutamate" . SPARSER::COLLECTION)
    ("CDK1/cyclin B1" . SPARSER::COLLECTION)
    ("phosphorylated Bcl-2 or the S70E mutant not only bound Bak and Bim"
     . SPARSER::COLLECTION)
    ("the S70E mutant not only bound Bak and Bim" . SPARSER::COLLECTION)
    ("paclitaxel and ABT-737 or navitoclax" . SPARSER::COLLECTION)
    ("ABT-737 or navitoclax" . SPARSER::COLLECTION) ("taxanes" . SPARSER::DRUG)
    ("ABT-737 and navitoclax" . SPARSER::COLLECTION)
    ("at least one possible Bcl-2 kinase" . SPARSER::KINASE)
    ("phosphomimetic mutants" . SPARSER::MUTANT)
    ("the total cellular Bak" . SPARSER::PROTEIN)
    ("Mcl-1 and Bcl-x" . SPARSER::COLLECTION)
    ("directly activating Bax and/or Bak" . SPARSER::COLLECTION)
    ("Bim, Puma, Bid, Noxa, Bik, Bad and Bmf" . SPARSER::COLLECTION)
    ("Bid, Bim and Noxa" . SPARSER::COLLECTION) ("Bmf" . SPARSER::PROTEIN)
    ("Bik" . SPARSER::PROTEIN) ("Noxa" . SPARSER::PROTEIN)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY) ("taxane" . SPARSER::DRUG)
    ("navitoclax or ABT-199" . SPARSER::COLLECTION)
    ("navitoclax" . SPARSER::DRUG) ("Bak and Bim" . SPARSER::COLLECTION)
    ("Bcl-2 S70E and Bcl-2 S70A" . SPARSER::COLLECTION)
    ("phosphorylated Bcl-2, Bcl-2 S70E and Bcl-2 S70A" . SPARSER::COLLECTION)
    ("Bim and Bak" . SPARSER::COLLECTION) ("T200" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("Anti-S" . SPARSER::ANTIBODY) ("Q-VD-OPh" . SPARSER::DRUG)
    ("Bcl-x" . SPARSER::PROTEIN) ("ABT-199" . SPARSER::DRUG)
    ("alleles and other variants" . SPARSER::COLLECTION)
    ("sphingomyelin" . SPARSER::MOLECULE)
    ("HDL-associated variants" . SPARSER::VARIANT)
    ("sphingolipids" . SPARSER::MOLECULE)
    ("HDL, LDL, and triglycerides" . SPARSER::COLLECTION)
    ("LDL and triglycerides" . SPARSER::COLLECTION)
    ("CAD, T2D, BMI, SBP, and DBP" . SPARSER::COLLECTION)
    ("many strongly associated (and potentially causal) variants"
     . SPARSER::VARIANT)
    ("an attractive pharmaceutical target" . SPARSER::TARGET-PROTEIN)
    ("Gpr146" . SPARSER::PROTEIN) ("Gpr" . SPARSER::PROTEIN)
    ("LDL and triglyceride" . SPARSER::COLLECTION)
    ("individual lipids" . SPARSER::LIPID)
    ("CAD, T2D, SBP, and DBP" . SPARSER::COLLECTION) ("FTO" . SPARSER::PROTEIN)
    ("SBP (96/155, P = 2.7×10 −3 ) and WHR" . SPARSER::COLLECTION)
    ("LDL-" . SPARSER::PROTEIN)
    ("RBM5 (rs2013208, P  HDL = 9×10 −12 , P  CAD = 7×10 −5 ) and CMTM6 (rs7640978, P  LDL = 1×10 −8 , P  CAD = 4×10 −4 )"
     . SPARSER::COLLECTION)
    ("CMTM" . SPARSER::PROTEIN) ("SBP and DBP" . SPARSER::COLLECTION)
    ("CETP, SORT1 , and APOA5" . SPARSER::COLLECTION)
    ("LDLR" . SPARSER::PROTEIN)
    ("PCSK9 (top GWAS variant with minor allele frequency f = 0.24 and P = 9×10 −24 ; fine-mapping variant with f = 0.03, P = 2×10 −136 ) and APOE (GWAS variant f = 0.20, P = 3×10 −44 , fine-mapping variant f = 0.07, P = 3×10 −651 )"
     . SPARSER::COLLECTION)
    ("at least one SNP" . SPARSER::PROTEIN)
    ("transcription factors HNF4A ( P = 6×10 −10 ) and CEBP/B ( P = 1×10 −5 )"
     . SPARSER::COLLECTION)
    ("CEBP" . SPARSER::PROTEIN) ("DNase" . SPARSER::PROTEIN)
    ("at least one nonsynonymous variant" . SPARSER::VARIANT)
    ("APOH" . SPARSER::PROTEIN)
    ("RBM5, ADH5, TMEM176A , and GPR146" . SPARSER::COLLECTION)
    ("DAGLB, SPTLC3 , and PXK" . SPARSER::COLLECTION)
    ("PXK" . SPARSER::PROTEIN)
    ("omental fat, or subcutaneous fat" . SPARSER::PROTEIN)
    ("associated variants" . SPARSER::VARIANT)
    ("AKT1 and GSK3B" . SPARSER::COLLECTION)
    ("PLTP, APOE, APOB , and LIPC" . SPARSER::COLLECTION)
    ("VLDLR, APOE, APOB, CETP , and LPL" . SPARSER::COLLECTION)
    ("LPL" . SPARSER::PROTEIN) ("CETP" . SPARSER::PROTEIN)
    ("LIPC" . SPARSER::PROTEIN) ("PLTP" . SPARSER::PROTEIN)
    ("DAPPLE" . SPARSER::PROTEIN) ("Protein-protein" . SPARSER::COLLECTION)
    ("PPARA, ABCB11 , and UGT1A1" . SPARSER::COLLECTION)
    ("PPARA" . SPARSER::PROTEIN) ("retinoic" . SPARSER::PROTEIN)
    ("DAGLB" . SPARSER::PROTEIN) ("at least one gene" . SPARSER::PROTEIN)
    ("APOE" . SPARSER::PROTEIN) ("APOB" . SPARSER::PROTEIN)
    ("RXR" . SPARSER::PROTEIN) ("retinoid" . SPARSER::PROTEIN)
    ("triglyceride and HDL" . SPARSER::COLLECTION) ("VEGFB" . SPARSER::PROTEIN)
    ("VEGFA" . SPARSER::PROTEIN) ("VIM" . SPARSER::PROTEIN)
    ("VLDLR" . SPARSER::PROTEIN) ("related traits" . SPARSER::PROTEIN)
    ("Mendelian forms" . SPARSER::FORM) ("CAD" . SPARSER::PROTEIN)
    ("cardiovascular and metabolic traits" . SPARSER::PROTEIN)
    ("Asian, and African" . SPARSER::COLLECTION) ("HDL" . SPARSER::PROTEIN)
    ("lipoprotein" . SPARSER::PROTEIN) ("ABCA1" . SPARSER::PROTEIN)
    ("SLC39A8" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("APOA5" . SPARSER::PROTEIN) ("SORT1" . SPARSER::PROTEIN)
    ("COBLL1" . SPARSER::PROTEIN) ("MED1" . SPARSER::PROTEIN)
    ("ST3GAL4" . SPARSER::PROTEIN) ("NPC1L1" . SPARSER::PROTEIN)
    ("IGF2R" . SPARSER::PROTEIN) ("LRP4" . SPARSER::PROTEIN)
    ("PCSK9" . SPARSER::PROTEIN) ("H3K9" . SPARSER::PROTEIN)
    ("H3K27ac" . SPARSER::MOLECULE) ("GPR146" . SPARSER::PROTEIN)
    ("TMEM176A" . SPARSER::PROTEIN) ("ADH5" . SPARSER::PROTEIN)
    ("RBM5" . SPARSER::PROTEIN) ("SPTLC3" . SPARSER::PROTEIN)
    ("GSK3B" . SPARSER::PROTEIN) ("UGT1A1" . SPARSER::PROTEIN)
    ("ABCB11" . SPARSER::PROTEIN) ("AKR1C4" . SPARSER::PROTEIN)
    ("INSIG2" . SPARSER::PROTEIN) ("lipase activity" . SPARSER::PROTEIN)
    ("APOA1" . SPARSER::PROTEIN) ("CYP7A1" . SPARSER::PROTEIN)
    ("vascular endothelial growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LRPAP1" . SPARSER::PROTEIN) ("supplemental oxygen" . SPARSER::MOLECULE)
    ("an apoptotic transcription factor" . SPARSER::PROTEIN)
    ("HDAC1 or SIRT1" . SPARSER::COLLECTION)
    ("BAX and PUMA" . SPARSER::COLLECTION) ("TIP60/KAT5" . SPARSER::COLLECTION)
    ("p53 downstream apoptotic genes" . SPARSER::GENE)
    ("siRNA and TIP60" . SPARSER::COLLECTION)
    ("SD and SD + Oxy-treated RNC" . SPARSER::PROTEIN)
    ("NOS3 and BAX" . SPARSER::COLLECTION)
    ("siRNA or TIP60" . SPARSER::COLLECTION)
    ("p53 and its acetylase TIP60" . SPARSER::COLLECTION)
    ("H9c2 p53 −/− and H9c2 p53-Lys 118 (Mut) cells" . SPARSER::COLLECTION)
    ("MOZ, TIF2, AIB1, p300, MOF, RIP160, CBP, TIP60, PCAF and BRPF1"
     . SPARSER::COLLECTION)
    ("MOF" . SPARSER::PROTEIN) ("MOZ" . SPARSER::PROTEIN)
    ("RNC p53-Lys 118 (Mut) cells only NOS3 gene" . SPARSER::PROTEIN)
    ("BAX and NOS" . SPARSER::COLLECTION)
    ("RNC p53 −/− and RNC p53-Lys 118 (Mut) cells" . SPARSER::COLLECTION)
    ("RNC p53 −/− and RNC p53-Lys 118 (Mut) cells using luciferase activity"
     . SPARSER::COLLECTION)
    ("SD-treated RNC p53 −/− and RNC p53-Lys 118 (Mut) cells showed higher survival compared to RNC (Wt) cells ( xref C)"
     . SPARSER::COLLECTION)
    ("SD-treated RNC p53 −/−" . SPARSER::PROTEIN)
    ("RNC p53 −/− and RNC p53-Lys 118 (Mut) cells using Annexin V staining"
     . SPARSER::COLLECTION)
    ("RNC" . SPARSER::PROTEIN)
    ("the H9c2 p53-Lys 118 (Mut) cells only NOS3 gene" . SPARSER::PROTEIN)
    ("BAX and NO3" . SPARSER::COLLECTION) ("apoptotic BAX" . SPARSER::PROTEIN)
    ("Oxy" . SPARSER::MOLECULE) ("Wt" . SPARSER::PROTEIN)
    ("cellular p53" . SPARSER::PROTEIN) ("IPP" . SPARSER::PROTEIN)
    ("BAX or NOS3" . SPARSER::COLLECTION)
    ("either pro-death BAX promoter or the pro-survival NOS3 promoter"
     . SPARSER::COLLECTION)
    ("serine, threonine and lysine" . SPARSER::COLLECTION)
    ("Oxygen" . SPARSER::MOLECULE)
    ("NOS3 promoter instead of BAX promoter ( xref E)" . SPARSER::COLLECTION)
    ("bax" . SPARSER::PROTEIN)
    ("p53 and its downstream effector protein BAX (Ripa et al, xref )"
     . SPARSER::COLLECTION)
    ("p53-NOS3-p53RE" . SPARSER::COLLECTION)
    ("BAX and NOS3" . SPARSER::COLLECTION) ("Pifithrin" . SPARSER::DRUG)
    ("This NOS3 minimal promoter" . SPARSER::PROMOTER)
    ("resveratrol" . SPARSER::PROTEIN)
    ("anti-p53 and anti-p300" . SPARSER::COLLECTION)
    ("p53-p300" . SPARSER::COLLECTION)
    ("anti-p53 and anti-Mdm2" . SPARSER::COLLECTION)
    ("the nuclear fraction and not the cytoplasmic fraction"
     . SPARSER::COLLECTION)
    ("PARP and tubulin" . SPARSER::COLLECTION)
    ("ischemia-reflow" . SPARSER::PROTEIN-PAIR)
    ("acetylase" . SPARSER::PROTEIN) ("p53RE" . SPARSER::PROTEIN)
    ("LAD" . SPARSER::PROTEIN)
    ("the pro-apoptotic p53 gene" . SPARSER::PROTEIN)
    ("Cop1 (constitutively photomorphogenic 1) and Pirh2 (p53-induced protein with a Ring-H2 domain) proteins (Dornan et al, xref ; Fuchs et al, xref ; Leng et al, xref )"
     . SPARSER::COLLECTION)
    ("discoidin domain receptor 1 (Ongusaha et al, xref ) and cyclooxygenase 2 (Han et al, xref )"
     . SPARSER::COLLECTION)
    ("hematopoietic zinc finger" . SPARSER::PROTEIN)
    ("sestrin 2 (Budanov et al, xref ; Masutani et al, xref ; Velasco-Miguel et al, xref ) and Slug (Wu et al, xref )"
     . SPARSER::COLLECTION)
    ("PA26 and Hi95" . SPARSER::COLLECTION)
    ("sestrin" . SPARSER::PROTEIN-FAMILY) ("TIGAR" . SPARSER::PROTEIN)
    ("Janicke" . SPARSER::PROTEIN) ("p53 and NOS3" . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("eNOS or NOS3" . SPARSER::COLLECTION)
    ("NOS3-promoting prosurvival form" . SPARSER::FORM)
    ("NOS3-p53RE" . SPARSER::COLLECTION) ("BAX-p53RE" . SPARSER::COLLECTION)
    ("mdm2" . SPARSER::PROTEIN) ("pifithrin-alpha" . SPARSER::DRUG)
    ("KAT5" . SPARSER::PROTEIN) ("acetyl-transferase" . SPARSER::PROTEIN)
    ("BRPF1" . SPARSER::PROTEIN) ("RIP160" . SPARSER::PROTEIN)
    ("AIB1" . SPARSER::PROTEIN) ("TIF2" . SPARSER::PROTEIN)
    ("NO3" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("discoidin domain receptor 1" . SPARSER::PROTEIN)
    ("zinc finger" . SPARSER::PROTEIN) ("Pirh2" . SPARSER::PROTEIN)
    ("Cop1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("factor 4" . SPARSER::PROTEIN)
    ("sestrin 2" . SPARSER::PROTEIN) ("sestrin 1" . SPARSER::PROTEIN)
    ("Hi95" . SPARSER::PROTEIN) ("PA26" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN) ("NOS3" . SPARSER::PROTEIN)
    ("p53 indirect targets" . SPARSER::TARGET-PROTEIN)
    ("RB and p107" . SPARSER::COLLECTION) ("DREAM" . SPARSER::PROTEIN)
    ("p130 and/or p107" . SPARSER::COLLECTION)
    ("the other pocket proteins, p130 and/or p107" . SPARSER::COLLECTION)
    ("proximal genes" . SPARSER::GENE) ("functional RB" . SPARSER::PROTEIN)
    ("p130 and p107" . SPARSER::COLLECTION)
    ("p21 and E2F4" . SPARSER::COLLECTION)
    ("p21 or E2F4 repressive complexes" . SPARSER::BIO-COMPLEX)
    ("alternative reading frame (ARF)" . SPARSER::PROTEIN)
    ("p21 or E2F4" . SPARSER::COLLECTION)
    ("repressive E2F4 complexes" . SPARSER::BIO-COMPLEX)
    ("E2F1 and CDC6" . SPARSER::COLLECTION)
    ("CDC2 or cyclin" . SPARSER::COLLECTION)
    ("E2F1 and E2F4" . SPARSER::COLLECTION)
    ("CDC2, E2F1, CDC6, and cyclin" . SPARSER::COLLECTION)
    ("neither E2F1 nor E2F4" . SPARSER::COLLECTION)
    ("p107 and p130" . SPARSER::COLLECTION)
    ("survivin and CDC25C" . SPARSER::COLLECTION)
    ("E2F1, E2F4, and E2F7" . SPARSER::COLLECTION)
    ("p21 or p16" . SPARSER::COLLECTION) ("p21 and p16" . SPARSER::COLLECTION)
    ("E2F1, CDC6, CDC2, and cyclin" . SPARSER::COLLECTION)
    ("p53, p21, or p16" . SPARSER::COLLECTION) ("RB-E2F" . SPARSER::COLLECTION)
    ("EJp53 and EJp21" . SPARSER::COLLECTION) ("EJp53" . SPARSER::PROTEIN)
    ("EJp53-shp21" . SPARSER::PROTEIN-PAIR)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous p53" . SPARSER::PROTEIN) ("tet" . SPARSER::PROTEIN)
    ("MDM2 and PIG3" . SPARSER::COLLECTION)
    ("doxorubicin and nutlin-3" . SPARSER::COLLECTION)
    ("p53 and its negative regulator" . SPARSER::COLLECTION)
    ("Doxorubicin and nutlin-3" . SPARSER::COLLECTION)
    ("its isogenic derivatives" . SPARSER::DERIVATIVE)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("doxorubicin or nutlin-3" . SPARSER::COLLECTION)
    ("hTERT, EZH2, and CHK1" . SPARSER::COLLECTION) ("Cip" . SPARSER::PROTEIN)
    ("p53 or p21" . SPARSER::COLLECTION) ("-E2F" . SPARSER::COLLECTION)
    ("survivin, CDC25C, and CDC25B" . SPARSER::COLLECTION)
    ("E2F3" . SPARSER::PROTEIN) ("SUV39H1" . SPARSER::PROTEIN)
    ("alternative reading frame" . SPARSER::PROTEIN)
    ("acetylcholine receptor" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("E2F7" . SPARSER::PROTEIN)
    ("CDC2" . SPARSER::PROTEIN) ("CDC6" . SPARSER::PROTEIN)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("p16 Ink4A" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN) ("PIG3" . SPARSER::PROTEIN)
    ("RECQL4" . SPARSER::PROTEIN) ("CKS1B" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("BIRC5" . SPARSER::PROTEIN)
    ("CDC25B" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("AH6809 and EGCG" . SPARSER::COLLECTION)
    ("EGCG or AH6809" . SPARSER::COLLECTION)
    ("PGE 2 and an EP2 antagonist" . SPARSER::COLLECTION)
    ("PGE 2 and β-catenin" . SPARSER::COLLECTION)
    ("PI3K/p-Akt" . SPARSER::COLLECTION)
    ("both the p85 (regulatory) and p110 (catalytic) subunits"
     . SPARSER::COLLECTION)
    ("CK1α and GSK-3β" . SPARSER::COLLECTION)
    ("MMPs, c-Myc and VEGF" . SPARSER::COLLECTION)
    ("regulators and biomarkers" . SPARSER::COLLECTION)
    ("COX-2 and prostaglandins" . SPARSER::COLLECTION)
    ("COX-2 and PGE 2" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN)
    ("VEGF and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc and VEGF" . SPARSER::COLLECTION)
    ("PI3K protein subunits (p110 and p85) and p-Akt proteins"
     . SPARSER::COLLECTION)
    ("p110 and p85" . SPARSER::COLLECTION) ("p-Akt" . SPARSER::COLLECTION)
    ("cAMP and EGCG" . SPARSER::COLLECTION) ("EP1-EP4" . SPARSER::COLLECTION)
    ("EP1" . SPARSER::PROTEIN)
    ("cyclin D1, cyclin D2 and CDK2" . SPARSER::COLLECTION)
    ("p-GSK-3β" . SPARSER::COLLECTION) ("p-β-catenin" . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG)
    ("β-catenin and its signaling molecules" . SPARSER::COLLECTION)
    ("EGCG and a possible molecular target" . SPARSER::COLLECTION)
    ("a possible molecular target" . SPARSER::TARGET-PROTEIN)
    ("keratinocytes and UVB-irradiated" . SPARSER::COLLECTION)
    ("-epigallocatechin-3-gallate (EGCG)" . SPARSER::DRUG)
    ("phytochemical" . SPARSER::DRUG) ("phytochemicals" . SPARSER::DRUG)
    ("sunscreens" . SPARSER::DRUG)
    ("melanoma and non-melanoma" . SPARSER::COLLECTION)
    ("-epigallocatechin-3-gallate" . SPARSER::DRUG) ("EGCG" . SPARSER::DRUG)
    ("EP2 receptor" . SPARSER::PROTEIN) ("EP4" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN) ("CK1α" . SPARSER::PROTEIN)
    ("anti-oxidant" . SPARSER::DRUG) ("tea polyphenols" . SPARSER::MOLECULE)
    ("AH6809" . SPARSER::DRUG) ("EP2" . SPARSER::PROTEIN)
    ("prostaglandin E2" . SPARSER::MOLECULE)
    ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("tea polyphenol" . SPARSER::MOLECULE)
    ("potential new predictive and therapeutic targets"
     . SPARSER::TARGET-PROTEIN)
    ("MEK and BRAF" . SPARSER::COLLECTION)
    ("PTC and pMEK" . SPARSER::COLLECTION)
    ("SPRY2 and pMEK" . SPARSER::COLLECTION)
    ("SPRY2, pMEK and pERK" . SPARSER::COLLECTION)
    ("other biological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTCs" . SPARSER::PROTEIN) ("PTC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sprouty-2" . SPARSER::PROTEIN) ("Sprouty-2" . SPARSER::PROTEIN)
    ("ERK 1" . SPARSER::PROTEIN) ("MEK 1" . SPARSER::PROTEIN)
    ("PLX 4720" . SPARSER::DRUG) ("PD 184352" . SPARSER::DRUG)
    ("Sprouty 2" . SPARSER::PROTEIN) ("SPRY2" . SPARSER::PROTEIN)
    ("Bcl-2 or Mcl-1" . SPARSER::COLLECTION) ("thermolysin" . SPARSER::PROTEIN)
    ("Bcl-xL/Mcl-1" . SPARSER::COLLECTION)
    ("those expressing phospho-defective Bcl-2/Bcl-xL" . SPARSER::COLLECTION)
    ("the phospho-defective Bcl-2/Bcl-xL mutants" . SPARSER::MUTANT)
    ("vinblastine, and caspase-3" . SPARSER::COLLECTION)
    ("Bcl-xL or S62A-Bcl-xL" . SPARSER::COLLECTION)
    ("phospho-defective Bcl-xL" . SPARSER::PROTEIN)
    ("Bcl-xL and SA62-Bcl-xL" . SPARSER::COLLECTION)
    ("SA62-Bcl-xL" . SPARSER::PROTEIN-PAIR)
    ("pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("the exogenous protein" . SPARSER::PROTEIN)
    ("extra-mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vinblastine" . SPARSER::DRUG) ("HA-Bcl-xL" . SPARSER::COLLECTION)
    ("HA-Bcl-2" . SPARSER::COLLECTION)
    ("siRNA and mutant" . SPARSER::COLLECTION)
    ("AAA-Bcl-2" . SPARSER::COLLECTION)
    ("full-length wild-type HA-tagged Bcl-2 or HA-tagged Bcl-xL"
     . SPARSER::COLLECTION)
    ("Cdk1/cyclin B1" . SPARSER::COLLECTION)
    ("cyclin B1 and phospho-histone" . SPARSER::COLLECTION)
    ("phospho-histone" . SPARSER::PROTEIN) ("vinblastine" . SPARSER::DRUG)
    ("phospho-defective Bcl-2 or Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2/Bcl-xL/Mcl-1" . SPARSER::COLLECTION)
    ("phospho-defective mutants" . SPARSER::MUTANT)
    ("Bcl-2, Bcl-xL or Mcl-1" . SPARSER::COLLECTION)
    ("individual anti-apoptotic Bcl-2 proteins and their phosphorylated forms"
     . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("MIAs" . SPARSER::PROTEIN) ("Ac-DEVD-CHO" . SPARSER::DRUG)
    ("P81" . SPARSER::PROTEIN) ("Mitotracker Red" . SPARSER::MOLECULE)
    ("Cyclin B1" . SPARSER::PROTEIN) ("ABT-263" . SPARSER::DRUG)
    ("Caspase-3" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("cortical actin" . SPARSER::PROTEIN)
    ("MEK/ERK/FAK/ERK" . SPARSER::COLLECTION)
    ("ras/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("ago, Harrison and Turley" . SPARSER::COLLECTION)
    ("p35 or p39" . SPARSER::COLLECTION) ("p35 and p39" . SPARSER::COLLECTION)
    ("ERK and CDK5" . SPARSER::COLLECTION)
    ("EGFR/MEK//ERK/CDK5" . SPARSER::COLLECTION)
    ("MITF and melanoma differentiation antigens" . SPARSER::COLLECTION)
    ("MART-1 and gp100" . SPARSER::COLLECTION)
    ("the mitotic centromere-associated kinesin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("MCAK" . SPARSER::PROTEIN) ("Dynein" . SPARSER::PROTEIN)
    ("Cos, HeLa cells and ECs" . SPARSER::COLLECTION)
    ("Cos" . SPARSER::MOLECULE) ("Roscovitine" . SPARSER::DRUG)
    ("soluble and polymerized α -tubulin fractions" . SPARSER::COMPONENT)
    ("polymerized tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rho/ROCK" . SPARSER::COLLECTION) ("ERK and Rho" . SPARSER::COLLECTION)
    ("UO126 and Y27632" . SPARSER::COLLECTION)
    ("MEK and ROCK" . SPARSER::COLLECTION) ("wt and Mut" . SPARSER::COLLECTION)
    ("GFP-FAK" . SPARSER::COLLECTION)
    ("α -tubulin and dynein" . SPARSER::COLLECTION) ("Abs" . SPARSER::PROTEIN)
    ("soluble tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the cortical actin" . SPARSER::PROTEIN)
    ("Confocal IF" . SPARSER::PROTEIN) ("the principal form" . SPARSER::FORM)
    ("the melanocyte transcription factor MITF and melanoma differentiation antigens"
     . SPARSER::COLLECTION)
    ("FRNK" . SPARSER::PROTEIN) ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR/MEK/ERK/CDK5" . SPARSER::COLLECTION) ("roscovitine" . SPARSER::DRUG)
    ("MTs" . SPARSER::PROTEIN) ("EGFR/MEK/ERK" . SPARSER::COLLECTION)
    ("MAPK1" . SPARSER::PROTEIN) ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E -cadherin" . SPARSER::PROTEIN) ("TPC1" . SPARSER::PROTEIN)
    ("H-ras" . SPARSER::PROTEIN) ("p39" . SPARSER::PROTEIN)
    ("p35" . SPARSER::PROTEIN) ("gp100" . SPARSER::PROTEIN)
    ("MART-1" . SPARSER::PROTEIN) ("P-ERK" . SPARSER::PROTEIN)
    ("UO126" . SPARSER::DRUG) ("γ -tubulin" . SPARSER::PROTEIN)
    ("CDK5" . SPARSER::PROTEIN) ("α -tubulin" . SPARSER::PROTEIN)
    ("anti-SirT1/SirT2" . SPARSER::COLLECTION)
    ("UP-dependent client proteins" . SPARSER::PROTEIN)
    ("UP" . SPARSER::PROTEIN) ("non-functional" . SPARSER::PROTEIN)
    ("7-AAD-based flow cytometry" . SPARSER::PROTEIN)
    ("p53 and LC3" . SPARSER::COLLECTION) ("p53 or LC3" . SPARSER::COLLECTION)
    ("SirT1 and SirT2" . SPARSER::COLLECTION) ("SirT1" . SPARSER::PROTEIN)
    ("‘puncta'" . SPARSER::PROTEIN) ("actins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-ATPase" . SPARSER::COLLECTION) ("ATPase" . SPARSER::PROTEIN)
    ("p62/Sequestosome 1" . SPARSER::COLLECTION)
    ("the autophagy-associated proteins LC3 and p62" . SPARSER::COLLECTION)
    ("LC3 and p62" . SPARSER::COLLECTION) ("TEM" . SPARSER::PROTEIN)
    ("AAD" . SPARSER::PROTEIN) ("IL-2/CpG" . SPARSER::COLLECTION)
    ("ODN" . SPARSER::PROTEIN)
    ("the genotoxic drug fludarabine" . SPARSER::DRUG)
    ("fludarabine" . SPARSER::DRUG) ("p53 or proteins" . SPARSER::COLLECTION)
    ("the autophagy-associated protein LC3" . SPARSER::PROTEIN)
    ("bafilomycin-A1" . SPARSER::DRUG) ("SirT2" . SPARSER::PROTEIN)
    ("Sequestosome 1" . SPARSER::PROTEIN) ("light chain 3 " . SPARSER::PROTEIN)
    ("1 A" . SPARSER::PROTEIN) ("waf1" . SPARSER::PROTEIN)
    ("SMP" . SPARSER::PROTEIN) ("AMG, LNK and IB" . SPARSER::COLLECTION)
    ("FW" . SPARSER::MOLECULE) ("HO" . SPARSER::PROTEIN)
    ("LNK" . SPARSER::PROTEIN) ("AMG" . SPARSER::PROTEIN)
    ("transverse colon cancer" . SPARSER::PROTEIN)
    ("MSH6/MSH3" . SPARSER::COLLECTION)
    ("Danish colorectal cancer families" . SPARSER::PROTEIN-FAMILY)
    ("nine intronic variants" . SPARSER::VARIANT)
    ("the neighboring exon" . SPARSER::PROTEIN) ("c" . SPARSER::PROTEIN)
    ("MLH1 c" . SPARSER::PROTEIN) ("a-i" . SPARSER::PROTEIN)
    ("all nine intronic variants" . SPARSER::VARIANT)
    ("moderate risk families (two patients) or non-HNPCC families (one patient)"
     . SPARSER::COLLECTION)
    ("Amsterdam positive families (six patients), Amsterdam-like families (six patients), moderate risk families (two patients) or non-HNPCC families (one patient)"
     . SPARSER::COLLECTION)
    ("families and MLH1" . SPARSER::COLLECTION)
    ("these intronic variants" . SPARSER::VARIANT)
    ("several intronic variants" . SPARSER::VARIANT)
    ("MSH6 and MLPA" . SPARSER::COLLECTION) ("MLPA" . SPARSER::PROTEIN)
    ("exon-intron" . SPARSER::COLLECTION)
    ("nine intronic MLH1 , MSH2 , and MSH6 variants" . SPARSER::VARIANT)
    ("MLH1, MSH2, and MSH6" . SPARSER::COLLECTION) ("MIM" . SPARSER::PROTEIN)
    ("HNPCC" . SPARSER::PROTEIN) ("intronic variants" . SPARSER::VARIANT)
    ("MLH1/MSH2/MSH6" . SPARSER::COLLECTION)
    ("MLH1/MSH2" . SPARSER::COLLECTION)
    ("Intronic MLH1 , MSH2 , or MSH6 variants" . SPARSER::VARIANT)
    ("MLH1 , MSH2 , or MSH6" . SPARSER::COLLECTION)
    ("MLH1 , MSH2 , and MSH6" . SPARSER::COLLECTION)
    ("MSH3" . SPARSER::PROTEIN)
    ("reagents, materials, and analysis" . SPARSER::COLLECTION)
    ("CK and YPC" . SPARSER::COLLECTION)
    ("a potential prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a peripheral tumor biomarker" . SPARSER::MOLECULE)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("methylated-PTPRO and HER2-positivity" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION)
    ("newly developed targeted drugs" . SPARSER::DRUG)
    ("Trastuzumab and Lapatinib" . SPARSER::COLLECTION)
    ("a prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("whose encoding gene" . SPARSER::PROTEIN) ("PTPRO" . SPARSER::PROTEIN)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("a 3 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("Protein Tyrosine Phosphatase" . SPARSER::PROTEIN)
    ("a relevant target" . SPARSER::TARGET-PROTEIN)
    ("previously validated target genes" . SPARSER::GENE)
    ("PLK1 and KSP1" . SPARSER::COLLECTION)
    ("Axin2 and MYC" . SPARSER::COLLECTION)
    ("siRNAs and 25/27mer" . SPARSER::COLLECTION)
    ("previously undruggable targets" . SPARSER::TARGET-PROTEIN)
    ("efficacious gene" . SPARSER::GENE) ("Hep" . SPARSER::PROTEIN)
    ("-RACE" . SPARSER::COLLECTION) ("shorter RNA" . SPARSER::RNA)
    ("-OMe–modified immunostimulatory siRNA" . SPARSER::PROTEIN)
    ("alphafetoprotein (AFP)" . SPARSER::PROTEIN) ("AFP" . SPARSER::PROTEIN)
    ("alphafetoprotein" . SPARSER::PROTEIN)
    ("HPRT1 and a nonspecific control DsiRNA" . SPARSER::COLLECTION)
    ("a nonspecific control DsiRNA" . SPARSER::PROTEIN)
    ("MCL1 and HIF1α" . SPARSER::COLLECTION)
    ("KSP1 and PLK1" . SPARSER::COLLECTION)
    ("KSP1 , PLK1 , or β-catenin" . SPARSER::COLLECTION)
    ("LNP2072" . SPARSER::PROTEIN) ("DsiRNA-LNP" . SPARSER::COLLECTION)
    ("PPIB" . SPARSER::PROTEIN)
    ("which uses gene-specific oligonucleotide" . SPARSER::MOLECULE)
    ("LNP2072-DsiRNA" . SPARSER::COLLECTION)
    ("β-catenin or Axin2" . SPARSER::COLLECTION)
    ("Wnt-β-catenin" . SPARSER::COLLECTION) ("DsiRNAs" . SPARSER::PROTEIN)
    ("DsiRNA" . SPARSER::PROTEIN) ("LNP-DsiRNA" . SPARSER::PROTEIN-PAIR)
    ("anti-PEG-IgM" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("cat" . SPARSER::PROTEIN) ("the mature RISC" . SPARSER::PROTEIN)
    ("RNA-based duplex oligonucleotides" . SPARSER::MOLECULE)
    ("LNP" . SPARSER::PROTEIN) ("SHARP" . SPARSER::PROTEIN)
    ("Sorafenib" . SPARSER::DRUG) ("an undruggable protein" . SPARSER::PROTEIN)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX) ("homologous RNA" . SPARSER::RNA)
    ("undruggable targets" . SPARSER::TARGET-PROTEIN)
    ("MYC, HIF1α, and β-catenin" . SPARSER::COLLECTION)
    ("target mitotic genes" . SPARSER::GENE)
    ("PLK1 and KIF11" . SPARSER::COLLECTION)
    ("nanoparticles" . SPARSER::MOLECULE)
    ("traditionally undruggable protein" . SPARSER::PROTEIN)
    ("which uses small RNAs" . SPARSER::RNA) ("Fox-1" . SPARSER::PROTEIN)
    ("SFRS9" . SPARSER::PROTEIN) ("NC1" . SPARSER::PROTEIN)
    ("SRSF9" . SPARSER::PROTEIN) ("M15" . SPARSER::DRUG)
    ("S14" . SPARSER::PROTEIN) ("S13" . SPARSER::PROTEIN)
    ("S12" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("KSP1" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("Ago2" . SPARSER::PROTEIN) ("no 2" . SPARSER::MOLECULE)
    ("KIF11" . SPARSER::PROTEIN) ("IFNα-2b" . SPARSER::COLLECTION)
    ("cytokines, chemokines, and growth factors" . SPARSER::COLLECTION)
    ("some inflammatory cytokines" . SPARSER::PROTEIN)
    ("CD4-Cre" . SPARSER::COLLECTION) ("Lck-Cre" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("flox" . SPARSER::PROTEIN)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("certain inflammatory cytokines" . SPARSER::PROTEIN)
    ("the circulating inflammatory cytokines" . SPARSER::PROTEIN)
    ("state, phenotype and effector" . SPARSER::COLLECTION)
    ("the anti-IL-6" . SPARSER::ANTIBODY)
    ("PCNA and CD31" . SPARSER::COLLECTION)
    ("IL-6-STAT3" . SPARSER::COLLECTION) ("angiogenic genes" . SPARSER::GENE)
    ("IL-6, IL-17, TNF-α and IFN-γ" . SPARSER::COLLECTION)
    ("IL-10, TNF-α, IL-17, IFN-γ and IL-4" . SPARSER::COLLECTION)
    ("CCL2, MMP9 and VEGF" . SPARSER::COLLECTION)
    ("prometastatic and angiogenic genes" . SPARSER::GENE)
    ("Hematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("TIL" . SPARSER::PROTEIN) ("PD-1 and CTLA-4" . SPARSER::COLLECTION)
    ("TILs" . SPARSER::PROTEIN) ("BL6" . SPARSER::PROTEIN)
    ("CD69 and CD44, and SHP-2" . SPARSER::COLLECTION)
    ("CD44, and SHP-2" . SPARSER::COLLECTION)
    ("polarized protumorigenic inflammatory states" . SPARSER::BIO-STATE)
    ("Shp -2" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("T–cell" . SPARSER::PROTEIN)
    ("IL-6 " . SPARSER::PROTEIN) ("CD69" . SPARSER::PROTEIN)
    ("JAK-STAT" . SPARSER::PROTEIN) ("shp -2" . SPARSER::PROTEIN)
    ("PTPN 11" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("cytokine receptor" . SPARSER::PROTEIN)
    ("Src-homology" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("These microRNAs as well as others" . SPARSER::COLLECTION)
    ("HR and chemoresistance" . SPARSER::COLLECTION)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("cyclin E and CDK2" . SPARSER::COLLECTION)
    ("H2AX and BRCA1" . SPARSER::COLLECTION)
    ("RAD51 and/or RAD51D" . SPARSER::COLLECTION)
    ("Dicer and TRBP2" . SPARSER::COLLECTION)
    ("paralogs, XRCC2 and XRCC3" . SPARSER::COLLECTION)
    ("cancer-associated microRNAs" . SPARSER::MICRO-RNA)
    ("BRCA2 and some RAD51 paralogs" . SPARSER::COLLECTION)
    ("RAD51D or several other target mRNAs" . SPARSER::COLLECTION)
    ("Antisense" . SPARSER::PROTEIN)
    ("cisplatin and AZD2281" . SPARSER::COLLECTION)
    ("FLAG-RAD51" . SPARSER::COLLECTION)
    ("miR-103/107 directly target RAD51" . SPARSER::PROTEIN)
    ("topoisomerase poisons (e.g. camptothecin and etoposide) and PARP inhibitors"
     . SPARSER::COLLECTION)
    ("Proficient HR" . SPARSER::PROTEIN)
    ("camptothecin and etoposide" . SPARSER::COLLECTION)
    ("DR-GFP" . SPARSER::COLLECTION) ("DR" . SPARSER::MOLECULE)
    ("HR and RAD51" . SPARSER::COLLECTION) ("PEO1" . SPARSER::PROTEIN)
    ("paralogous microRNAs" . SPARSER::MICRO-RNA)
    ("the breast cancer-associated microRNAs miR-182 and miR-146a/b-5p target BRCA1"
     . SPARSER::PROTEIN)
    ("approximately 1000 microRNAs" . SPARSER::MICRO-RNA)
    ("poly(ADP-ribose) polymerases (PARP) and topoisomerases ( xref )"
     . SPARSER::COLLECTION)
    ("polymerases (PARP)" . SPARSER::PROTEIN)
    ("BRCA1, BRCA2, PALB2, RAD51C and RAD51D" . SPARSER::COLLECTION)
    ("ovarian cancer susceptibility proteins (BRCA1, BRCA2/FANCD1, and PALB2/FANCN) and the RAD51 paralogs (RAD51B, RAD51C/FANCO, RAD51D, XRCC2 and XRCC3)"
     . SPARSER::COLLECTION)
    ("ovarian cancer susceptibility proteins" . SPARSER::PROTEIN)
    ("RAD51D, XRCC2 and XRCC3" . SPARSER::COLLECTION)
    ("RAD51C/FANCO" . SPARSER::COLLECTION)
    ("PALB2/FANCN" . SPARSER::COLLECTION)
    ("BRCA2/FANCD1" . SPARSER::COLLECTION) ("FANCO" . SPARSER::PROTEIN)
    ("FANCN" . SPARSER::PROTEIN) ("RAD51 and RAD51D" . SPARSER::COLLECTION)
    ("an essential protein" . SPARSER::PROTEIN)
    ("paralogs, and breast/ovarian" . SPARSER::COLLECTION)
    ("TRBP2" . SPARSER::PROTEIN) ("PI-103" . SPARSER::DRUG)
    ("I- SceI" . SPARSER::PROTEIN) ("AZD2281" . SPARSER::DRUG)
    ("I-SceI" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("RPA70" . SPARSER::PROTEIN) ("RAD51C" . SPARSER::PROTEIN)
    ("RAD51B" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("FANCD1" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("a special type" . TYPE) ("the central AD" . SPARSER::PROTEIN)
    ("no exogenous DNA" . SPARSER::DNA)
    ("enzymatically less active" . SPARSER::ACTIVE)
    ("radioactively labelled NAD +" . SPARSER::MOLECULE)
    ("labelled NAD +" . SPARSER::MOLECULE) ("exogenous DNA" . SPARSER::DNA)
    ("siRNA or siRNA" . SPARSER::COLLECTION)
    ("SET7/9 or ARTD1" . SPARSER::COLLECTION) ("SAM" . SPARSER::PROTEIN)
    ("SET7/9-" . SPARSER::PROTEIN) ("STA" . SPARSER::PROTEIN)
    ("neither GST nor ARTD2" . SPARSER::COLLECTION)
    ("flavin" . SPARSER::MOLECULE) ("Peptides" . SPARSER::PEPTIDE)
    ("H2A and H2B" . SPARSER::COLLECTION)
    ("MyoD and Tat protein" . SPARSER::COLLECTION)
    ("pRb, p65, MyoD and Tat protein" . SPARSER::COLLECTION)
    ("nucleosomes" . SPARSER::PROTEIN) ("Setd7 or KMT7" . SPARSER::COLLECTION)
    ("the primary acceptor" . SPARSER::MOLECULE) ("ART" . SPARSER::PROTEIN)
    ("p53 or DNMT1" . SPARSER::COLLECTION)
    ("polymeric ADP-ribose (PAR)" . SPARSER::MOLECULE)
    ("LSM 5" . SPARSER::PROTEIN) ("anti-PAR" . SPARSER::DRUG)
    ("Glu-C" . SPARSER::PROTEIN) ("SET7" . SPARSER::PROTEIN)
    ("macroH2A1" . SPARSER::PROTEIN) ("3 b" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARTD2" . SPARSER::PROTEIN) ("LSD2" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("H2A" . SPARSER::PROTEIN)
    ("polymerase II" . SPARSER::PROTEIN) ("TAF10" . SPARSER::PROTEIN)
    ("Dnmt1" . SPARSER::PROTEIN) ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("KMT7" . SPARSER::PROTEIN)
    ("Setd7" . SPARSER::PROTEIN) ("SET7/9" . SPARSER::PROTEIN)
    ("ARTD1" . SPARSER::PROTEIN)
    ("ADP-ribosyltransferase diphtheria toxin-like 1" . SPARSER::PROTEIN)
    ("ALR or vacuole" . SPARSER::COLLECTION) ("ALR" . SPARSER::PROTEIN)
    ("the vacuolar H(+)-adenosine triphosphatase" . SPARSER::PROTEIN)
    ("-adenosine" . SPARSER::COLLECTION) ("triphosphatase" . SPARSER::PROTEIN)
    ("full media or amino acid–free media (Supplemental Figure S6)"
     . SPARSER::COLLECTION)
    ("Lamp1-GFP" . SPARSER::COLLECTION)
    ("first added red fluorescent dextran" . SPARSER::DEXTRAN)
    ("dextran" . SPARSER::DEXTRAN) ("tracer" . SPARSER::MOLECULE)
    ("Lamp1–green fluorescent protein" . SPARSER::COLLECTION)
    ("nearly all mCherry puncta" . SPARSER::PROTEIN)
    ("Lamp1" . SPARSER::PROTEIN) ("LysoTracker" . SPARSER::DRUG)
    ("Lamp" . SPARSER::PROTEIN) ("RagC" . SPARSER::PROTEIN)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rag" . SPARSER::PROTEIN)
    ("exogenous amino acids" . SPARSER::AMINO-ACID)
    ("corpse-derived H2B-mCherry protein" . SPARSER::PROTEIN)
    ("H2B-mCherry" . SPARSER::COLLECTION) ("ConA" . SPARSER::PROTEIN)
    ("concanamycin" . SPARSER::MOLECULE) ("PS" . SPARSER::PROTEIN)
    ("starved macrophages restored pS6K" . SPARSER::PROTEIN)
    ("phosphatidylserine (PS)" . SPARSER::PROTEIN)
    ("Atg5 and Atg7" . SPARSER::COLLECTION)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lysosomal hydrolytic enzymes" . SPARSER::ENZYME)
    ("Lysosomal" . SPARSER::PROTEIN) ("L-31" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY) ("anti–S" . SPARSER::ANTIBODY)
    ("Ku-0063794" . SPARSER::DRUG) ("Torin-1" . SPARSER::DRUG)
    ("latrunculin B" . SPARSER::DRUG) ("8B" . SPARSER::PROTEIN)
    ("TORC1" . SPARSER::PROTEIN) ("Rab-11" . SPARSER::PROTEIN)
    ("v-ATPase" . SPARSER::PROTEIN-FAMILY)
    ("leucyl-tRNA synthetase" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN)
    ("Amino acids" . SPARSER::AMINO-ACID) ("Y-27632" . SPARSER::MOLECULE)
    ("1D" . SPARSER::PROTEIN) ("Torin1" . SPARSER::DRUG)
    ("FIP200" . SPARSER::PROTEIN) ("Atg7" . SPARSER::PROTEIN)
    ("Atg5" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("PN" . SPARSER::PROTEIN) ("CK" . SPARSER::PROTEIN)
    ("BS" . SPARSER::PROTEIN) ("FK" . SPARSER::PROTEIN)
    ("class I and II HDACs" . SPARSER::COLLECTION)
    ("II HDACs" . SPARSER::PROTEIN) ("EGFR/Sirt1" . SPARSER::COLLECTION)
    ("a synergistic impact" . SPARSER::PROTEIN) ("Sirt1-" . SPARSER::PROTEIN)
    ("the remaining functionally intact p53" . SPARSER::PROTEIN)
    ("either shRNA or the small molecule inhibitor tenovin-6"
     . SPARSER::COLLECTION)
    ("Sirt1-p53" . SPARSER::COLLECTION)
    ("nuclear localized Sirt1" . SPARSER::PROTEIN)
    ("a clinically applicable drug" . SPARSER::DRUG)
    ("which uses cambinol" . SPARSER::DRUG) ("Gemcitabine" . SPARSER::DRUG)
    ("Cambinol" . SPARSER::DRUG) ("y-H2AX" . SPARSER::COLLECTION)
    ("cambinol or gefitinib" . SPARSER::COLLECTION)
    ("gemcitabine and cambinol" . SPARSER::COLLECTION)
    ("cambinol and gefitinib" . SPARSER::COLLECTION)
    ("cambinol, gemcitabine and gefitinib" . SPARSER::COLLECTION)
    ("cambinol" . SPARSER::DRUG)
    ("Nicotinamide and gefitinib" . SPARSER::COLLECTION)
    ("Nicotinamide" . SPARSER::PROTEIN) ("flag" . SPARSER::PROTEIN-FAMILY)
    ("IRS" . SPARSER::PROTEIN) ("yrs" . SPARSER::PROTEIN)
    ("RelA/p65" . SPARSER::COLLECTION) ("NICD" . SPARSER::PROTEIN)
    ("an evolutionary conserved NAD dependent histone/protein deacetylase"
     . SPARSER::PROTEIN)
    ("histone/protein" . SPARSER::COLLECTION)
    ("a novel chemotherapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD34" . SPARSER::PROTEIN) ("Sirt 1" . SPARSER::PROTEIN)
    ("beta-Actin" . SPARSER::PROTEIN) ("beta-glycerophosphate" . SPARSER::DRUG)
    ("citric acid" . SPARSER::MOLECULE) ("EA1" . SPARSER::PROTEIN)
    ("n-myc" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KH, BW, KUE and KUA" . SPARSER::COLLECTION) ("BW" . SPARSER::PROTEIN)
    ("KH" . SPARSER::PROTEIN) ("AK" . SPARSER::PROTEIN)
    ("KUA" . SPARSER::PROTEIN) ("Cyclosporine" . SPARSER::DRUG)
    ("a retrospective cohort" . SPARSER::MOLECULE)
    ("BK virus large T antigen and antigen-dependent T-cell expansion"
     . SPARSER::COLLECTION)
    ("CyA and mTORi" . SPARSER::COLLECTION)
    ("ATG or rituximab" . SPARSER::COLLECTION)
    ("BK viral infection and vice versa" . SPARSER::PROTEIN)
    ("BK viremia (13.6%) and PyVAN (6.2%)" . SPARSER::COLLECTION)
    ("sirolimus" . SPARSER::DRUG) ("creatinine" . SPARSER::PROTEIN)
    ("their original immunosuppressants" . SPARSER::DRUG)
    ("immunosuppressants" . SPARSER::DRUG) ("ECD" . SPARSER::PROTEIN)
    ("his" . SPARSER::AMINO-ACID) ("Viremia and PyVAN" . SPARSER::COLLECTION)
    ("Viremia" . SPARSER::PROTEIN) ("CNI, or CNI" . SPARSER::COLLECTION)
    ("ATG or basiliximab" . SPARSER::COLLECTION) ("CyA" . SPARSER::PROTEIN)
    ("basiliximab" . SPARSER::DRUG) ("IgG-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LDL" . SPARSER::PROTEIN) ("ESP" . SPARSER::PROTEIN)
    ("viremia or PyVAN" . SPARSER::COLLECTION)
    ("HLA-mismatch" . SPARSER::COLLECTION) ("CNI" . SPARSER::PROTEIN)
    ("IA" . SPARSER::MOLECULE) ("SPK" . SPARSER::PROTEIN)
    ("n " . SPARSER::PROTEIN) ("viremia and PyVAN" . SPARSER::COLLECTION)
    ("leflunomide" . SPARSER::DRUG) ("fluoroquinolones" . SPARSER::DRUG)
    ("viremia" . SPARSER::PROTEIN)
    ("the urogenital epithelium" . SPARSER::PROTEIN)
    ("cyclosporine" . SPARSER::DRUG) ("BK-viremia" . SPARSER::PROTEIN-PAIR)
    ("BK" . SPARSER::PROTEIN) ("Calcineurin inhibitor" . SPARSER::PROTEIN)
    ("mycophenolate mofetil" . SPARSER::DRUG)
    ("neurotrophic factor and neuronal growth factor receptors"
     . SPARSER::COLLECTION)
    ("neuronal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("5-HT receptors and multiple RTKs" . SPARSER::COLLECTION)
    ("ROS and the resulting H 2 O 2 (or the exogenous application of H 2 O 2 )"
     . SPARSER::COLLECTION)
    ("-linked GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("functional oxidase" . SPARSER::PROTEIN)
    ("apocynin and diphenyleneiodonium" . SPARSER::COLLECTION)
    ("/NOX2" . SPARSER::COLLECTION) ("RTKs and GPCRs" . SPARSER::COLLECTION)
    ("Superoxide" . SPARSER::MOLECULE)
    ("oxygen and a donated electron" . SPARSER::COLLECTION)
    ("the receptor’s" . SPARSER::RECEPTOR) ("thiolate" . SPARSER::MOLECULE)
    ("5-HT- and H 2 O 2" . SPARSER::COLLECTION) ("5-HT-" . SPARSER::PROTEIN)
    ("TrkB and PDGFβ" . SPARSER::COLLECTION)
    ("the NADPH oxidase inhibitors, diphenyleneiodonium chloride and apocynin, as well as the PKC inhibitor Go 6983"
     . SPARSER::COLLECTION)
    ("PDGFβ and TrkB" . SPARSER::COLLECTION)
    ("RTKs and GPCRs, and RTK" . SPARSER::COLLECTION)
    ("GPCRs, and RTK" . SPARSER::COLLECTION)
    ("ERK1/2 and RTK" . SPARSER::COLLECTION) ("PDGFβ" . SPARSER::PROTEIN)
    ("5-HT-PDGFβ" . SPARSER::PROTEIN-PAIR)
    ("fibroblast growth factor and epidermal growth factor receptors"
     . SPARSER::COLLECTION)
    ("Rap1A and Rac1/2" . SPARSER::COLLECTION)
    ("neuronal PDGFβ receptors" . SPARSER::RECEPTOR)
    ("ROS and NADPH oxidase" . SPARSER::COLLECTION) ("PLC" . SPARSER::PROTEIN)
    ("monoamine" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor (BDNF) and neurotrophin-4 as well as neurotrophin-3 [ xref ]"
     . SPARSER::COLLECTION)
    ("neurotrophin-4 as well as neurotrophin-3 [ xref ]" . SPARSER::COLLECTION)
    ("neurotrophic factor (BDNF)" . SPARSER::PROTEIN)
    ("leukotrienes" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neurotransmitter" . SPARSER::MOLECULE) ("Serotonin" . SPARSER::MOLECULE)
    ("GPCR" . SPARSER::PROTEIN) ("receptor and ERK1/2" . SPARSER::COLLECTION)
    ("apocynin" . SPARSER::MOLECULE) ("diphenyleneiodonium" . SPARSER::DRUG)
    ("the platelet-derived growth factor (PDGF) type β receptor as well as the TrkB receptor"
     . SPARSER::COLLECTION)
    ("TrkB" . SPARSER::PROTEIN) ("serotonin" . SPARSER::MOLECULE)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("p47 phox" . SPARSER::PROTEIN)
    ("NOX2" . SPARSER::PROTEIN) ("gp91 phox" . SPARSER::PROTEIN)
    ("pK a" . SPARSER::PROTEIN) ("SHP-2" . SPARSER::PROTEIN)
    ("PDGF receptor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rap1A" . SPARSER::PROTEIN)
    ("growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Go 6983" . SPARSER::DRUG)
    ("6,7- dimethoxy- 2- phenylquinoxaline" . SPARSER::DRUG)
    ("AG 1296" . SPARSER::DRUG) ("5-HT 1A" . SPARSER::PROTEIN)
    ("neurotrophin-3" . SPARSER::PROTEIN) ("neurotrophin-4" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("angiotensin II" . SPARSER::PROTEIN)
    ("ligand-gated ion channel" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN)
    ("N -acetyl- l -cysteine" . SPARSER::MOLECULE) ("5-HT" . SPARSER::PROTEIN)
    ("additional contextual cues" . SPARSER::PROTEIN-FAMILY)
    ("an essential repressive component" . SPARSER::COMPONENT)
    ("family and HDAC1" . SPARSER::COLLECTION)
    ("RNA binding, and chemokine" . SPARSER::COLLECTION)
    ("151 cellular mRNAs" . SPARSER::PROTEIN)
    ("revealed differentially expressed miRNAs" . SPARSER::MICRO-RNA)
    ("HDAC1 and IFNβ" . SPARSER::COLLECTION)
    ("PB1 or β-actin" . SPARSER::COLLECTION)
    ("protein and RNA" . SPARSER::COLLECTION)
    ("miR-449b directly targets HDAC1" . SPARSER::PROTEIN)
    ("the antiviral cytokine" . SPARSER::PROTEIN)
    ("freshly-prepared RNA" . SPARSER::RNA)
    ("the small viral RNAs" . SPARSER::RNA)
    ("their respective virus genome" . SPARSER::PROTEIN)
    ("snoRNA" . SPARSER::RNA) ("snRNA" . SPARSER::RNA)
    ("the influenza A virus polymerase subunit PB1" . SPARSER::PROTEIN)
    ("PB1" . SPARSER::PROTEIN)
    ("the antiviral chemokine CCL5" . SPARSER::PROTEIN)
    ("separate high molecular weight RNA" . SPARSER::RNA)
    ("RNA and virus" . SPARSER::COLLECTION)
    ("cellular miRNA and long non-coding RNA expression in macaques"
     . SPARSER::COLLECTION)
    ("the IFN-stimulated gene, ISG56/IFIT1, as well as other pro-inflammatory genes"
     . SPARSER::COLLECTION)
    ("TNFα and IL-24" . SPARSER::COLLECTION)
    ("ISG56/IFIT1" . SPARSER::COLLECTION) ("Cytokine" . SPARSER::PROTEIN)
    ("additional antiviral signaling molecules" . SPARSER::MOLECULE)
    ("p300 and MAPK3" . SPARSER::COLLECTION)
    ("IRAK1, IRAK2, and TRAF6" . SPARSER::COLLECTION)
    ("TLR and RLR" . SPARSER::COLLECTION) ("RLR" . SPARSER::PROTEIN)
    ("a mature 17-24 bp miRNA" . SPARSER::MICRO-RNA)
    ("primary RNA polymerase II" . SPARSER::PROTEIN)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("HDAC1 and HDAC8" . SPARSER::COLLECTION)
    ("enhanceosome" . SPARSER::BIO-COMPLEX)
    ("These cytokines and antiviral genes" . SPARSER::COLLECTION)
    ("the type I interferon (IFN) family as well as diverse effectors"
     . SPARSER::COLLECTION)
    ("the antiviral state" . SPARSER::BIO-STATE)
    ("primary antiviral cytokines" . SPARSER::PROTEIN)
    ("antiviral genes" . SPARSER::GENE)
    ("antiviral effectors" . SPARSER::EFFECTOR) ("NS1" . SPARSER::PROTEIN)
    ("miR-199a-5p" . SPARSER::MOLECULE) ("IL-24" . SPARSER::PROTEIN)
    ("IFIT1" . SPARSER::PROTEIN) ("ISG56" . SPARSER::PROTEIN)
    ("MAPK3" . SPARSER::PROTEIN) ("IRAK2" . SPARSER::PROTEIN)
    ("IRAK1" . SPARSER::PROTEIN) ("HDAC8" . SPARSER::PROTEIN)
    ("IFNβ" . SPARSER::PROTEIN) ("p62 and dynein" . SPARSER::COLLECTION)
    ("perinuclear aggresome-like aggregates containing HDAC6"
     . SPARSER::PROTEIN)
    ("cortactin/F-actin" . SPARSER::PROTEIN) ("Nbr1" . SPARSER::PROTEIN)
    ("both the autophagic marker protein LC3" . SPARSER::PROTEIN)
    ("Jip-1" . SPARSER::PROTEIN) ("kinesin and dynein" . SPARSER::COLLECTION)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC6, p62 and aPKC" . SPARSER::COLLECTION)
    ("microtubules" . SPARSER::PROTEIN)
    ("many essential proteins" . SPARSER::PROTEIN)
    ("HDAC6-cortactin/F-actin" . SPARSER::PROTEIN-PAIR)
    ("HDAC6-cortactin" . SPARSER::COLLECTION)
    ("HDAC6 and cortactin" . SPARSER::COLLECTION)
    ("actin and cortactin" . SPARSER::COLLECTION)
    ("cortactin/HDAC6" . SPARSER::COLLECTION)
    ("Exogenous p62" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a commercial acetylated substrate" . SPARSER::SUBSTRATE)
    ("p62 and HDAC6 and map" . SPARSER::COLLECTION)
    ("HDAC6 and map" . SPARSER::COLLECTION)
    ("the protein’s" . SPARSER::PROTEIN) ("FLAG-HDAC6" . SPARSER::COLLECTION)
    ("HEK" . SPARSER::PROTEIN)
    ("exogenous HA-tagged HDAC6 protein" . SPARSER::PROTEIN)
    ("characteristic acetylated tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tubacin" . SPARSER::DRUG) ("NAD+-" . SPARSER::MOLECULE)
    ("acetyl" . SPARSER::MOLECULE) ("hyper" . SPARSER::PROTEIN)
    ("p62 and HDAC6" . SPARSER::COLLECTION) ("parkin" . SPARSER::PROTEIN)
    ("UBA" . SPARSER::PROTEIN)
    ("both misfolded proteins and dysfunctional organelles"
     . SPARSER::COLLECTION)
    ("sequestosome 1/p62" . SPARSER::COLLECTION) ("aPKC" . SPARSER::PROTEIN)
    ("mito" . SPARSER::PROTEIN) ("tau" . SPARSER::PROTEIN)
    ("HDAC6 and tubulin" . SPARSER::COLLECTION)
    ("dysferlin" . SPARSER::PROTEIN)
    ("tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dynein, and polyubiquitinated" . SPARSER::COLLECTION)
    ("polyubiquitinated" . SPARSER::PROTEIN) ("dynein" . SPARSER::PROTEIN)
    ("Polyubiquitinated" . SPARSER::PROTEIN)
    ("DD1 and DD2" . SPARSER::COLLECTION) ("BUZ/ZnF-UBP" . SPARSER::COLLECTION)
    ("UBP" . SPARSER::PROTEIN) ("mis-functional proteins" . SPARSER::PROTEIN)
    ("α-tubulin and cortactin" . SPARSER::COLLECTION)
    ("HDAC6 and p62" . SPARSER::COLLECTION) ("/p62" . SPARSER::COLLECTION)
    ("STAT5A" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("K 2" . SPARSER::PROTEIN)
    ("atypical protein kinase" . SPARSER::PROTEIN)
    ("casein kinase 2" . SPARSER::PROTEIN) ("DD2" . SPARSER::PROTEIN)
    ("DD1" . SPARSER::PROTEIN) ("deacetylase activity" . SPARSER::PROTEIN)
    ("TRIM50" . SPARSER::PROTEIN) ("p62" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SQSTM1" . SPARSER::PROTEIN) ("sequestosome 1" . SPARSER::PROTEIN)
    ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("E 2 and overexpression of ER-α and NF-Y" . SPARSER::COLLECTION)
    ("camptothecin, topotecan and irinotecan" . SPARSER::COLLECTION)
    ("topo" . SPARSER::PROTEIN)
    ("a UBC9 dominant-negative mutant" . SPARSER::MUTANT)
    ("UBC9-DN" . SPARSER::COLLECTION) ("DN" . SPARSER::PROTEIN)
    ("glucocorticoid receptor [ xref , xref ] and ER-α [ xref ]"
     . SPARSER::COLLECTION)
    ("the isoform and/or amount of recruited NF-YA" . SPARSER::COLLECTION)
    ("E 2 and NF-Y" . SPARSER::COLLECTION) ("/NF-Y" . SPARSER::COLLECTION)
    ("ERs" . SPARSER::PROTEIN) ("NF-Y or Sp1" . SPARSER::COLLECTION)
    ("a hetero-trimeric protein" . SPARSER::PROTEIN)
    ("an essential enzyme" . SPARSER::ENZYME)
    ("its receptor (ER)" . SPARSER::PROTEIN)
    ("the proximal promoter fragment" . SPARSER::FRAGMENT)
    ("ER-α and two CCAAT" . SPARSER::COLLECTION)
    ("the UBC9 proximal promoter" . SPARSER::PROMOTER)
    ("ChIP and siRNA" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("si-ER-α and si-NF-YA" . SPARSER::COLLECTION)
    ("si-NF-YA" . SPARSER::PROTEIN-PAIR) ("si-ER-α" . SPARSER::PROTEIN-PAIR)
    ("ER-α and NF-YA" . SPARSER::COLLECTION)
    ("anti-ER-α and anti-NF-YA" . SPARSER::COLLECTION)
    ("ER-α-" . SPARSER::PROTEIN) ("ER-α or NF-Y" . SPARSER::COLLECTION)
    ("Mut-3" . SPARSER::COLLECTION) ("Mut" . SPARSER::PROTEIN)
    ("the minimal UBC9 promoter" . SPARSER::PROMOTER)
    ("pGL" . SPARSER::PROTEIN) ("UBC9 and ER-α" . SPARSER::COLLECTION)
    ("a dominant-negative mutant UBC9" . SPARSER::PROTEIN)
    ("topoisomerase I and topoisomerase II" . SPARSER::COLLECTION)
    ("ER-α, progesterone receptor and androgen receptor" . SPARSER::COLLECTION)
    ("PML, WRN, BLM, c-JUN, c-FOS, TP53, MDM2 and EZH2" . SPARSER::COLLECTION)
    ("BLM" . SPARSER::PROTEIN)
    ("the only E2 conjugating enzyme" . SPARSER::PROTEIN)
    ("isopeptidases" . SPARSER::PROTEIN)
    ("enzyme UBC9 and several E3 ligases" . SPARSER::COLLECTION)
    ("SAE1/SAE2" . SPARSER::COLLECTION) ("SUMO 1-3" . SPARSER::COLLECTION)
    ("PIAS" . SPARSER::PROTEIN-FAMILY) ("Substrate" . SPARSER::SUBSTRATE)
    ("modifiers (SUMO)" . SPARSER::MOLECULE)
    ("the proximal UBC9 promoter" . SPARSER::PROMOTER)
    ("ER-α and NF-Y" . SPARSER::COLLECTION)
    ("ER-α or NF-YA" . SPARSER::COLLECTION) ("CCAAT" . SPARSER::PROTEIN)
    ("SUMO" . SPARSER::PROTEIN) ("cdc2" . SPARSER::PROTEIN)
    ("subunit A" . SPARSER::PROTEIN) ("anti-Histone" . SPARSER::PROTEIN)
    ("pGL 4" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("UBE2I" . SPARSER::PROTEIN) ("ICI 182,780" . SPARSER::DRUG)
    ("anti-estrogen" . SPARSER::DRUG) ("c-FOS" . SPARSER::PROTEIN)
    ("c-JUN" . SPARSER::PROTEIN) ("SAE2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SAE1" . SPARSER::PROTEIN) ("SUMO 1" . SPARSER::PROTEIN)
    ("NF-YA" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("E 2" . SPARSER::MOLECULE)
    ("small ubiquitin-related modifier" . SPARSER::PROTEIN)
    ("UBC9" . SPARSER::PROTEIN) ("CARs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bispecific molecules" . SPARSER::MOLECULE)
    ("Fc-receptors" . SPARSER::COLLECTION) ("FcRs" . SPARSER::PROTEIN-FAMILY)
    ("scFv or BiTE" . SPARSER::COLLECTION) ("scFv" . SPARSER::PROTEIN)
    ("BiTE" . SPARSER::PROTEIN) ("one-step" . SPARSER::PROTEIN)
    ("RI" . SPARSER::PROTEIN) ("HARA" . SPARSER::PROTEIN)
    ("intact bsAb" . SPARSER::DRUG)
    ("Several promising bispecific antibodies" . SPARSER::ANTIBODY)
    ("BLI" . SPARSER::PROTEIN)
    ("K562-luc and B16F10-luc" . SPARSER::COLLECTION)
    ("Prism" . SPARSER::PROTEIN)
    ("expressed neither CD3 nor HER2 ( xref )" . SPARSER::COLLECTION)
    ("CD3 and HER2" . SPARSER::COLLECTION)
    ("a homogenous dimer" . SPARSER::DIMER)
    ("35 kDa and around 60 kDa" . SPARSER::COLLECTION)
    ("around 60 kDa" . SPARSER::PROTEIN) ("kDa and Fcab" . SPARSER::COLLECTION)
    ("Bispecific antibodies" . SPARSER::ANTIBODY)
    ("FcR" . SPARSER::PROTEIN-FAMILY)
    ("markedly increase antibody’s" . SPARSER::ANTIBODY)
    ("the salvage neonatal Fc-receptor" . SPARSER::PROTEIN)
    ("markedly increase antibody" . SPARSER::ANTIBODY)
    ("Fc" . SPARSER::PROTEIN)
    ("heterodimeric ScFvs or Fabs" . SPARSER::COLLECTION)
    ("new bispecific antibody" . SPARSER::DRUG)
    ("ScFvs or Fabs" . SPARSER::COLLECTION) ("ScFvs" . SPARSER::PROTEIN)
    ("The most successful bispecific antibodies" . SPARSER::ANTIBODY)
    ("bispecific antibody and Blinatumomab" . SPARSER::COLLECTION)
    ("anti-CD19/CD3" . SPARSER::COLLECTION)
    ("anti-EpCAM/CD3" . SPARSER::COLLECTION) ("Blinatumomab" . SPARSER::DRUG)
    ("bsAb" . SPARSER::DRUG)
    ("toxins and other functional proteins [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("bispecific antibodies" . SPARSER::ANTIBODY)
    ("receptors or CD3" . SPARSER::COLLECTION)
    ("star" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD64" . SPARSER::PROTEIN)
    ("interleukin-2" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("or 2 µ" . SPARSER::MOLECULE) ("MgSO 4" . SPARSER::DRUG)
    ("CCK8" . SPARSER::PROTEIN) ("Serum Albumin" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("Fc-receptor" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("bispecific antibody" . SPARSER::DRUG) ("FcγR" . SPARSER::PROTEIN-FAMILY)
    ("single chain variable fragment" . SPARSER::PROTEIN)
    ("human primary macrophages" . SPARSER::PROTEIN)
    ("TNF-α, VCAM-1 and MMP9" . SPARSER::COLLECTION)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("XO and MKP-1" . SPARSER::COLLECTION)
    ("orthovanadate or Ro-31-8220" . SPARSER::COLLECTION)
    ("Thr/Tyr" . SPARSER::COLLECTION) ("exogenous XO" . SPARSER::PROTEIN)
    ("protein phosphatase inhibitor and MKP-1 inhibitor" . SPARSER::COLLECTION)
    ("orthovanadate and Ro-31-8220" . SPARSER::COLLECTION)
    ("orthovanadate" . SPARSER::MOLECULE)
    ("ERK and MEK1" . SPARSER::COLLECTION)
    ("NF-κB and MAPKs" . SPARSER::COLLECTION)
    ("iNOS, COX-2 and TNF-α" . SPARSER::COLLECTION)
    ("PMA-treated THP-1 cells allopurinol or oxypurinol" . SPARSER::COLLECTION)
    ("allopurinol or oxypurinol" . SPARSER::COLLECTION)
    ("XOR" . SPARSER::PROTEIN)
    ("allopurinol and oxypurinol" . SPARSER::COLLECTION)
    ("human primary monocyte-derived M1 and M2 macrophages" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine (NAC)" . SPARSER::MOLECULE)
    ("a potent chemotactic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("febuxostat, allopurinol and oxypurinol" . SPARSER::COLLECTION)
    ("oxypurinol" . SPARSER::DRUG) ("allopurinol" . SPARSER::DRUG)
    ("LPS, hypoxia, and cytokines" . SPARSER::COLLECTION)
    ("xanthine and hypoxanthine" . SPARSER::COLLECTION)
    ("uric acid and ROS" . SPARSER::COLLECTION)
    ("hypoxanthine" . SPARSER::DRUG) ("xanthine" . SPARSER::MOLECULE)
    ("purine" . SPARSER::DRUG) ("XDH" . SPARSER::PROTEIN)
    ("febuxostat" . SPARSER::DRUG) ("Febuxostat" . SPARSER::DRUG)
    ("XO" . SPARSER::PROTEIN) ("MKP-3" . SPARSER::PROTEIN)
    ("Ro-31-8220" . SPARSER::DRUG) ("H 2 DCFDA" . SPARSER::DRUG)
    ("L35A" . SPARSER::PROTEIN) ("IκB-α" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine" . SPARSER::MOLECULE)
    ("xanthine dehydrogenase" . SPARSER::PROTEIN)
    ("Xanthine oxidase" . SPARSER::PROTEIN) ("MKP-1" . SPARSER::PROTEIN)
    ("phosphatase-1" . SPARSER::PROTEIN)
    ("xanthine oxidase" . SPARSER::PROTEIN)
    ("HCCs and cHC" . SPARSER::COLLECTION)
    ("Snail or Twist" . SPARSER::COLLECTION)
    ("morphologically pure HCCs" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("adverse prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type and intermediate-cell" . SPARSER::COLLECTION)
    ("EpCAM(+)/K19(+) HCC" . SPARSER::PROTEIN)
    ("EpCAM(−)/K19(−) HCC" . SPARSER::PROTEIN)
    ("both EpCAM(−)/K19(−) HCCs and EpCAM(+)/K19(+) HCCs" . SPARSER::PROTEIN)
    ("each histological component" . SPARSER::COMPONENT)
    ("24/38 (63.2%) classical type cHC-CCs" . SPARSER::COLLECTION)
    ("20/36 (55.6%) EpCAM(+)/K19(+) HCCs, and 39/58 (67.2%) cHC-CCs"
     . SPARSER::COLLECTION)
    ("11/64 (17.2%) EpCAM(−)/K19(−) HCCs" . SPARSER::PROTEIN)
    ("HCCs, and 39/58" . SPARSER::COLLECTION)
    ("EpCAM(−)/K19(−) HCCs and EpCAM(+)/K19(+) HCCs" . SPARSER::PROTEIN)
    ("HCCs and EpCAM" . SPARSER::COLLECTION)
    ("Both EpCAM(+)/K19(+) HCCs" . SPARSER::PROTEIN)
    ("proteasomes" . SPARSER::PROTEIN)
    ("CD90, and CD133" . SPARSER::COLLECTION) ("CC" . SPARSER::PROTEIN)
    ("classical type cHC-CCs" . SPARSER::COLLECTION)
    ("EpCAM(−)/K19(−) HCCs" . SPARSER::PROTEIN)
    ("EpCAM(+)/K19(+) HCCs" . SPARSER::PROTEIN) ("/K19" . SPARSER::COLLECTION)
    ("the classical type" . TYPE) ("EpCAM and K19" . SPARSER::COLLECTION)
    ("cHC-CCs" . SPARSER::COLLECTION) ("CCs" . SPARSER::PROTEIN)
    ("Yes-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epithelial adhesion molecule (EpCAM) and keratin 19 (K19)"
     . SPARSER::COLLECTION)
    ("epithelial adhesion molecule" . SPARSER::PROTEIN)
    ("cHC-CC" . SPARSER::COLLECTION) ("cHC" . SPARSER::PROTEIN)
    ("K19" . SPARSER::PROTEIN) ("keratin 19" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN)
    ("-methylguanine" . SPARSER::MOLECULE) ("leucines" . SPARSER::AMINO-ACID)
    ("allele and cancer" . SPARSER::COLLECTION)
    ("ATase, AGT, or AGAT" . SPARSER::COLLECTION) ("AGAT" . SPARSER::PROTEIN)
    ("ATase" . SPARSER::PROTEIN)
    ("a 207 amino acid zinc-bound protein" . SPARSER::PROTEIN)
    ("HDAC4 and component" . SPARSER::COLLECTION)
    ("AMPK and CaMKII" . SPARSER::COLLECTION) ("CaMKII" . SPARSER::PROTEIN)
    ("AMPK, PDK and CamKII" . SPARSER::COLLECTION)
    ("CamKII" . SPARSER::PROTEIN) ("PDK" . SPARSER::PROTEIN)
    ("preadipocytes" . SPARSER::PROTEIN)
    ("STAT3 [ xref ] and the insulin receptor substrate-1 (IRS-1)"
     . SPARSER::COLLECTION)
    ("NF-κB [ xref , xref ], HSF-1 [ xref ], STAT3 [ xref ] and the insulin receptor substrate-1 (IRS-1)"
     . SPARSER::COLLECTION)
    ("IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("glucose and insulin" . SPARSER::COLLECTION)
    ("associated TSP1" . SPARSER::PROTEIN)
    ("a multifunctional adipokine" . SPARSER::PROTEIN-FAMILY)
    ("shotgun" . SPARSER::PROTEIN)
    ("several behavioral, environmental and genetic factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK and HDAC4" . SPARSER::COLLECTION)
    ("pCMV-HDAC4" . SPARSER::COLLECTION)
    ("JNK and NF-κB" . SPARSER::COLLECTION)
    ("HDAC4 and NF-κB" . SPARSER::COLLECTION)
    ("PBF, SBP and DBP" . SPARSER::COLLECTION)
    ("DBP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SBP" . SPARSER::PROTEIN)
    ("TSP1 and V O2 Max" . SPARSER::COLLECTION)
    ("PBF and PAI-1" . SPARSER::COLLECTION)
    ("HDAC4 and PAI-1" . SPARSER::COLLECTION)
    ("PBF (r 2 =-0.58; P = 0.0012 ) and RANTES (r 2 =-0.8; P = 0.001 )"
     . SPARSER::COLLECTION)
    ("Lamin B, Tubulin and HSF-1" . SPARSER::COLLECTION)
    ("Tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC4 and TSP1" . SPARSER::COLLECTION)
    ("histone deacetylase 4 (HDAC4) and the angiogenic factor AGGF1 mRNA ( P < 0.05 )"
     . SPARSER::COLLECTION)
    ("the angiogenic factor AGGF1 mRNA" . SPARSER::RNA)
    ("peptides and proteins" . SPARSER::COLLECTION)
    ("MS and protein" . SPARSER::COLLECTION) ("nano-LC" . SPARSER::COLLECTION)
    ("IPI" . SPARSER::PROTEIN) ("TNF-α and IL-6" . SPARSER::COLLECTION)
    ("leptin and PAI-1" . SPARSER::COLLECTION) ("leptin" . SPARSER::PROTEIN)
    ("glucose, HbA1C, insulin and C-peptide" . SPARSER::COLLECTION)
    ("TSP1 and HDAC4" . SPARSER::COLLECTION)
    ("soluble proteins" . SPARSER::PROTEIN) ("omental fat" . SPARSER::PROTEIN)
    ("only ENOA, PARK7 and β-actin proteins" . SPARSER::PROTEIN)
    ("ENOA, PARK7 and β-actin" . SPARSER::COLLECTION)
    ("FAA" . SPARSER::PROTEIN) ("ENOA" . SPARSER::PROTEIN)
    ("the omental fat" . SPARSER::PROTEIN)
    ("the c-Jun N-terminal kinase (JNK) and the inhibitor"
     . SPARSER::COLLECTION)
    ("differentially expressed proteins" . SPARSER::PROTEIN)
    ("shot" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("GLUT4" . SPARSER::PROTEIN) ("THBS1" . SPARSER::PROTEIN)
    ("HSF-1" . SPARSER::PROTEIN) ("C-peptide" . SPARSER::MOLECULE)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY) ("HSF1" . SPARSER::PROTEIN)
    ("HCO 3" . SPARSER::MOLECULE) ("HbA1" . SPARSER::PROTEIN)
    ("thrombospondin 1" . SPARSER::PROTEIN) ("PARK7" . SPARSER::PROTEIN)
    ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("histone deacetylase 4" . SPARSER::PROTEIN) ("TSP1" . SPARSER::PROTEIN)
    ("Thrombospondin 1" . SPARSER::PROTEIN)
    ("protein-hTERT" . SPARSER::COLLECTION)
    ("the collective activator and repressor" . SPARSER::COLLECTION)
    ("carboxy-" . SPARSER::MOLECULE)
    ("activator and repressor" . SPARSER::COLLECTION)
    ("SMO" . SPARSER::PROTEIN)
    ("GLI1 or a constitutively active mutant" . SPARSER::COLLECTION)
    ("enzyme, hTERT and telomerase" . SPARSER::COLLECTION)
    ("hTR" . SPARSER::PROTEIN) ("nucleoprotein" . SPARSER::PROTEIN)
    ("TRAP" . SPARSER::PROTEIN) ("HH/GLI/hTERT" . SPARSER::COLLECTION)
    ("GLI1 and GLI2ΔN" . SPARSER::COLLECTION)
    ("GLI1 or GLI2 or hTERT" . SPARSER::COLLECTION)
    ("GLI2 or hTERT" . SPARSER::COLLECTION) ("pRL-TK" . SPARSER::COLLECTION)
    ("TK" . SPARSER::PROTEIN) ("pRL" . SPARSER::PROTEIN)
    ("GLI2 and hTERT" . SPARSER::COLLECTION) ("GLI1-" . SPARSER::PROTEIN)
    ("GLI1 and GLI2" . SPARSER::COLLECTION)
    ("GLI1, GLI2 and hTERT" . SPARSER::COLLECTION)
    ("mRNA, protein or hTERT" . SPARSER::COLLECTION)
    ("GLI1/GLI2 proteins and the hTERT promoter" . SPARSER::COLLECTION)
    ("mRNA, protein and hTERT" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("catalytic subunit (TERT)" . SPARSER::PROTEIN)
    ("component (TR)" . SPARSER::COMPONENT)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribonucleoprotein" . SPARSER::PROTEIN) ("polymerases" . SPARSER::PROTEIN)
    ("activator and N-terminal" . SPARSER::COLLECTION)
    ("GLI2 and GLI3" . SPARSER::COLLECTION)
    ("activator or repressor" . SPARSER::COLLECTION)
    ("GLI1, GLI2 and GLI3" . SPARSER::COLLECTION)
    ("Indian (IHH) HH" . SPARSER::PROTEIN)
    ("the soluble HH ligands" . SPARSER::LIGAND) ("Ptch" . SPARSER::PROTEIN)
    ("Patched" . SPARSER::PROTEIN) ("IHH" . SPARSER::PROTEIN)
    ("DHH" . SPARSER::PROTEIN) ("SHH" . SPARSER::PROTEIN)
    ("Sonic" . SPARSER::PROTEIN) ("GLI1 or GLI2ΔN" . SPARSER::COLLECTION)
    ("mRNA and protein, or hTERT" . SPARSER::COLLECTION)
    ("protein, or hTERT" . SPARSER::COLLECTION)
    ("GLI1 or GLI2" . SPARSER::COLLECTION) ("GLI1/GLI2" . SPARSER::COLLECTION)
    ("HH/GLI" . SPARSER::COLLECTION) ("GLI" . SPARSER::PROTEIN)
    ("HH" . SPARSER::PROTEIN) ("Telomerase activity" . SPARSER::PROTEIN)
    ("32P" . SPARSER::|32P|) ("P32" . SPARSER::PROTEIN)
    ("GANT61" . SPARSER::DRUG) ("GLI3R" . SPARSER::PROTEIN)
    ("GLI3" . SPARSER::PROTEIN) ("GLI2" . SPARSER::PROTEIN)
    ("GLI1" . SPARSER::PROTEIN)
    ("MACH and miniMac and default" . SPARSER::COLLECTION)
    ("sph" . SPARSER::PROTEIN) ("MACH" . SPARSER::PROTEIN)
    ("phen" . SPARSER::MOLECULE) ("a complete exon" . SPARSER::PROTEIN)
    ("aura" . SPARSER::PROTEIN) ("migraine" . SPARSER::PROTEIN)
    ("monogenic forms" . SPARSER::FORM) ("NOTCH 1" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NOTCH3" . SPARSER::PROTEIN)
    ("MAPK and Akt" . SPARSER::COLLECTION) ("TNFα/TNFR" . SPARSER::COLLECTION)
    ("growth factor and chemokine" . SPARSER::COLLECTION)
    ("formin" . SPARSER::PROTEIN)
    ("TNFα, IL6, IL8 and cyclooxygenase-2" . SPARSER::COLLECTION)
    ("RhoA and RhoB" . SPARSER::COLLECTION) ("toxin" . SPARSER::PROTEIN)
    ("toxins or Rho" . SPARSER::COLLECTION) ("toxins" . SPARSER::MOLECULE)
    ("RhoA or RhoB" . SPARSER::COLLECTION)
    ("the immediate-early gene" . SPARSER::GENE)
    ("trypsinization" . SPARSER::PROTEIN) ("biotin" . SPARSER::PROTEIN)
    ("biotin-TNFα" . SPARSER::PROTEIN-PAIR)
    ("VCAM-1 and ICAM-1" . SPARSER::COLLECTION)
    ("IL8 and IL6" . SPARSER::COLLECTION)
    ("stress-activated MAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-JNK, phospho-p38 and phospho-hsp27" . SPARSER::COLLECTION)
    ("p38α and heat shock protein 27" . SPARSER::COLLECTION)
    ("RhoB siRNA or control siRNA" . SPARSER::COLLECTION)
    ("NFκB and MAPK" . SPARSER::COLLECTION)
    ("sc-514 and the ROS scavenger N-acetyl-cysteine (NAC)"
     . SPARSER::COLLECTION)
    ("NFκB, sc-514 and the ROS scavenger N-acetyl-cysteine (NAC)"
     . SPARSER::COLLECTION)
    ("N-acetyl-cysteine (NAC)" . SPARSER::DRUG) ("NAC" . SPARSER::PROTEIN)
    ("NFκB and p38 and JNK" . SPARSER::COLLECTION)
    ("NFκB and MAP kinase" . SPARSER::COLLECTION)
    ("Cycloheximide" . SPARSER::PROTEIN)
    ("subsequently added cycloheximide and/or MG132" . SPARSER::COLLECTION)
    ("rhotekin" . SPARSER::PROTEIN)
    ("TGFβ and vascular endothelial growth factor" . SPARSER::COLLECTION)
    ("INF" . SPARSER::PROTEIN)
    ("IL1β and bacterial lipopolysaccharide (LPS)" . SPARSER::COLLECTION)
    ("TNFα, IL1β and bacterial lipopolysaccharide (LPS)" . SPARSER::COLLECTION)
    ("an immediate-early gene" . SPARSER::GENE)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNFα and interleukin 1β" . SPARSER::COLLECTION)
    ("growth factor and cytokine" . SPARSER::COLLECTION)
    ("a constitutively expressed GTPase and a well-established regulator"
     . SPARSER::COLLECTION)
    ("EGF and PDGF" . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("TRAF-2 (TNFR-associated factor 2) and RIP1 (receptor interacting protein 1)"
     . SPARSER::COLLECTION)
    ("TNFα-receptor" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("VCAM-1, ICAM-1 and E-selectin" . SPARSER::COLLECTION)
    ("a pleiotropic pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("IL6 and IL8" . SPARSER::COLLECTION)
    ("RhoB and RhoA" . SPARSER::COLLECTION)
    ("TNFα, IL1β and LPS" . SPARSER::COLLECTION) ("RhoB" . SPARSER::PROTEIN)
    ("receptor (TNFR)" . SPARSER::RECEPTOR) ("TNFR" . SPARSER::PROTEIN)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("TNFα and IL1β" . SPARSER::COLLECTION) ("EEA-1" . SPARSER::PROTEIN)
    ("GEF-H1" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("hsp27" . SPARSER::PROTEIN) ("heat shock protein 27" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("sc-514" . SPARSER::DRUG)
    ("Rho-GDI" . SPARSER::PROTEIN) ("EEA1" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN) ("SC-514" . SPARSER::DRUG)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("IFNγ" . SPARSER::PROTEIN)
    ("interleukin 1β" . SPARSER::PROTEIN)
    ("receptor interacting protein 1" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("TRAF-2" . SPARSER::PROTEIN)
    ("molecules and events" . SPARSER::COLLECTION)
    ("diagnostic and therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("grainyhead-like 1 ( Drosophila ) ( GRHL1 ) and E3 ubiquitin-protein ligase RING2 ( RNF2 )"
     . SPARSER::COLLECTION)
    ("ERBB receptor feedback inhibitor 1 ( ERRFI1 ), grainyhead-like 1 ( Drosophila ) ( GRHL1 ) and E3 ubiquitin-protein ligase RING2 ( RNF2 )"
     . SPARSER::COLLECTION)
    ("two candidates lysl oxidase (LOX) and fatty acid desaturase 2 (FADS2)"
     . SPARSER::COLLECTION)
    ("oxidase (LOX)" . SPARSER::PROTEIN) ("LOX" . SPARSER::PROTEIN)
    ("oxidase" . SPARSER::PROTEIN)
    ("Similarly Cysteine-rich angiogenic inducer" . SPARSER::PROTEIN)
    ("Cysteine" . SPARSER::AMINO-ACID)
    ("Fibroblast Growth Factor Receptor 2 (FGFR2) and acyl-CoA dehydrogenase"
     . SPARSER::COLLECTION)
    ("ACADSB" . SPARSER::PROTEIN) ("dehydrogenase" . SPARSER::PROTEIN)
    ("GDF15 and GPRC5A" . SPARSER::COLLECTION) ("GPL" . SPARSER::PROTEIN)
    ("organic substance" . SPARSER::SUBSTANCE)
    ("substance" . SPARSER::SUBSTANCE) ("CTSL" . SPARSER::PROTEIN)
    ("an aggressive form" . SPARSER::FORM)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteoglycan" . SPARSER::PROTEIN)
    ("LOXL2 and CTSB" . SPARSER::COLLECTION)
    ("Lumican ( LUM )" . SPARSER::PROTEIN)
    ("Cathepsin B ( CTSB )" . SPARSER::PROTEIN) ("CTSB" . SPARSER::PROTEIN)
    ("LIPG" . SPARSER::PROTEIN) ("lipase" . SPARSER::PROTEIN)
    ("LUM" . SPARSER::PROTEIN) ("Lumican" . SPARSER::PROTEIN)
    ("using western blot" . SPARSER::PROTEIN)
    ("a very aggressive form" . SPARSER::FORM)
    ("Tamoxifen or Fulvestrant or aromatase" . SPARSER::COLLECTION)
    ("Fulvestrant or aromatase" . SPARSER::COLLECTION)
    ("Trastuzumab" . SPARSER::DRUG) ("Herceptin" . SPARSER::DRUG)
    ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("three therapeutically relevant receptors" . SPARSER::PROTEIN)
    ("the developed part" . SPARSER::COMPONENT)
    ("underlying isogenic components" . SPARSER::COMPONENT)
    ("a comprehensive gene" . SPARSER::GENE) ("RNF2" . SPARSER::PROTEIN)
    ("E3 ubiquitin-protein ligase RING2" . SPARSER::PROTEIN)
    ("GRHL1" . SPARSER::PROTEIN)
    ("grainyhead-like 1 ( Drosophila )" . SPARSER::PROTEIN)
    ("ERRFI1" . SPARSER::PROTEIN)
    ("ERBB receptor feedback inhibitor 1" . SPARSER::PROTEIN)
    ("FADS2" . SPARSER::PROTEIN) ("fatty acid desaturase 2" . SPARSER::PROTEIN)
    ("CYR61" . SPARSER::PROTEIN) ("short/branched chain" . SPARSER::PROTEIN)
    ("acyl-CoA" . SPARSER::MOLECULE) ("GPRC5A" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN) ("lysyl oxidase" . SPARSER::PROTEIN)
    ("Cathepsin B" . SPARSER::PROTEIN) ("LOXL2" . SPARSER::PROTEIN)
    ("Lysyl oxidase homolog 2" . SPARSER::PROTEIN)
    ("IgG2B" . SPARSER::BIO-COMPLEX) ("RSK2-" . SPARSER::PROTEIN)
    ("MEFs and CLS" . SPARSER::COLLECTION)
    ("a radiomimetic reagent" . SPARSER::MOLECULE)
    ("reagent" . SPARSER::MOLECULE) ("Neocarzinostatin" . SPARSER::PROTEIN)
    ("Atm and RSK2" . SPARSER::COLLECTION)
    ("chromatin remodeling and regulation of gene expression"
     . SPARSER::COLLECTION)
    ("Atm, Atr, and DNA-PKs" . SPARSER::COLLECTION)
    ("RSK2-Atm" . SPARSER::COLLECTION) ("ERK and JNK" . SPARSER::COLLECTION)
    ("RSKs" . SPARSER::PROTEIN) ("PKR" . SPARSER::PROTEIN)
    ("very few foci" . SPARSER::PROTEIN)
    ("kinases and forms" . SPARSER::COLLECTION)
    ("Iodide (PI)" . SPARSER::PROTEIN)
    ("AD-treated RSK2 KO and WT MEFs" . SPARSER::COLLECTION)
    ("AD-treated RSK2 KO" . SPARSER::PROTEIN)
    ("inhibitor (CDKI)" . SPARSER::INHIBITOR) ("CDKI" . SPARSER::DRUG)
    ("functional RSK2" . SPARSER::PROTEIN)
    ("DNA-PK, Rad51, and HMGB1" . SPARSER::COLLECTION)
    ("SSBs" . SPARSER::PROTEIN) ("task" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia (A-T) and Seckel Syndrome-1 (SCKL1)"
     . SPARSER::COLLECTION)
    ("microcephaly and mental retardation" . SPARSER::COLLECTION)
    ("microcephaly" . SPARSER::PROTEIN) ("Atm and Atr" . SPARSER::COLLECTION)
    ("p53, Chk1, Chk2, and H2AX" . SPARSER::COLLECTION)
    ("Mre11-Rad50-NBS" . SPARSER::COLLECTION) ("NBS" . SPARSER::PROTEIN)
    ("Atm, Atr and DNA-PKcs" . SPARSER::COLLECTION) ("Atr" . SPARSER::PROTEIN)
    ("exogenous or endogenous factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rps6ka3" . SPARSER::PROTEIN) ("RSK2 and Atm" . SPARSER::COLLECTION)
    ("Atm" . SPARSER::PROTEIN) ("CLS" . SPARSER::PROTEIN)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("activated Protein Kinase" . SPARSER::PROTEIN)
    ("DNA-PK" . SPARSER::PROTEIN) ("Ataxia Telangiectasia" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("Rps6ka" . SPARSER::PROTEIN-FAMILY)
    ("RPS6KA3" . SPARSER::PROTEIN) ("Ribosomal S6 Kinase 2" . SPARSER::PROTEIN)
    ("healthy epithelium" . SPARSER::PROTEIN)
    ("an excellent target" . SPARSER::TARGET-PROTEIN)
    ("particular Rac1 and RhoA" . SPARSER::COLLECTION)
    ("Well-studied proteins" . SPARSER::PROTEIN)
    ("RICH1, OPHN1, SH3BP1, and GRAF1" . SPARSER::COLLECTION)
    ("a highly immunogenic nonameric peptide" . SPARSER::PEPTIDE)
    ("RhoG" . SPARSER::PROTEIN) ("neither Rac1 nor Rac2" . SPARSER::COLLECTION)
    ("CRIB" . SPARSER::DRUG) ("Rac1- or RhoA" . SPARSER::COLLECTION)
    ("Rac1-" . SPARSER::PROTEIN)
    ("HMHA1 full-length (FL), the N-terminal region (N-term), and C-terminal"
     . SPARSER::COLLECTION)
    ("full-length (FL)" . SPARSER::PROTEIN)
    ("a genuine RhoGAP" . SPARSER::PROTEIN)
    ("full-length HMHA1 as well as HMHA1 N-term" . SPARSER::COLLECTION)
    ("Rac1, RhoA, and Cdc42" . SPARSER::COLLECTION)
    ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("RhoGAPs and other GAPs" . SPARSER::COLLECTION)
    ("Bank (PDB)" . SPARSER::PROTEIN)
    ("p50RhoGAP, GRAF1, and OPHN1" . SPARSER::COLLECTION)
    ("bar" . SPARSER::PROTEIN) ("RhoGAPs" . SPARSER::PROTEIN)
    ("a prototypical RhoGAP" . SPARSER::PROTEIN)
    ("RhoA and HMHA1" . SPARSER::COLLECTION)
    ("both constitutively active Rac1 as well as HMHA1 C1-GAPtail"
     . SPARSER::COLLECTION)
    ("mCherry-EV" . SPARSER::COLLECTION)
    ("mCherry-Rac1Q61L" . SPARSER::COLLECTION)
    ("Rac1 (Rac1G12V and Q61L) or Cdc42 (G12V)" . SPARSER::COLLECTION)
    ("Rac1 and RhoA" . SPARSER::COLLECTION)
    ("GDP or GppNHp" . SPARSER::COLLECTION)
    ("PACSIN2 and caveolin" . SPARSER::COLLECTION)
    ("GppNHp" . SPARSER::MOLECULE) ("GST-Rac1" . SPARSER::COLLECTION)
    ("Rac1 and HMHA1" . SPARSER::COLLECTION)
    ("Subsequent FACS" . SPARSER::PROTEIN)
    ("HMHA1 and Rac1" . SPARSER::COLLECTION) ("Jurkat" . SPARSER::PROTEIN)
    ("Cdc42 (G12V; xref ) or RhoA (V14; xref )" . SPARSER::COLLECTION)
    ("Paxillin" . SPARSER::PROTEIN) ("HMHA1-N-term" . SPARSER::COLLECTION)
    ("HMHA1 (FL)" . SPARSER::PROTEIN) ("OPHN1 and GRAF1" . SPARSER::COLLECTION)
    ("GRAF" . SPARSER::PROTEIN) ("RhoGDI" . SPARSER::PROTEIN)
    ("coil" . SPARSER::PROTEIN)
    ("particular Rac1, Cdc42, and RhoA" . SPARSER::COLLECTION)
    ("Amphiphysin" . SPARSER::PROTEIN) ("Bin" . SPARSER::PROTEIN)
    ("Leukemia" . SPARSER::PROTEIN)
    ("the first autosomal minor H antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTLs" . SPARSER::PROTEIN)
    ("specific intracellular polymorphic proteins" . SPARSER::PROTEIN)
    ("Minor" . SPARSER::PROTEIN) ("SCT" . SPARSER::PROTEIN)
    ("RhoGAP" . SPARSER::PROTEIN)
    ("Rac1, Cdc42, and RhoA" . SPARSER::COLLECTION)
    ("Antigen" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RICH1" . SPARSER::PROTEIN)
    ("Rac2" . SPARSER::PROTEIN) ("Rac1 C" . SPARSER::PROTEIN)
    ("PACSIN2" . SPARSER::PROTEIN) ("p50RhoGAP" . SPARSER::PROTEIN)
    ("Pak1" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("Texas-Red" . SPARSER::DRUG) ("F-Actin" . SPARSER::BIO-COMPLEX)
    ("OPHN1" . SPARSER::PROTEIN) ("Oligophrenin-1" . SPARSER::PROTEIN)
    ("SH3BP1" . SPARSER::PROTEIN)
    ("Guanine nucleotide Exchange Factors" . SPARSER::GEF)
    ("Cdc42" . SPARSER::PROTEIN) ("Activating Protein" . SPARSER::PROTEIN)
    ("HMHA1" . SPARSER::PROTEIN) ("tau " . SPARSER::PROTEIN)
    ("LKB1 and pAMPKα" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("TMAs" . SPARSER::MOLECULE)
    ("the bronchial epithelium" . SPARSER::PROTEIN)
    ("adeno-Cre" . SPARSER::COLLECTION) ("Sprr2f-Cre" . SPARSER::COLLECTION)
    ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only one antibody" . SPARSER::ANTIBODY)
    ("RB or PTEN" . SPARSER::COLLECTION) ("mTOR and SRC" . SPARSER::COLLECTION)
    ("TSC2 and raptor" . SPARSER::COLLECTION) ("raptor" . SPARSER::PROTEIN)
    ("the accessory proteins STRAD and MO25" . SPARSER::COLLECTION)
    ("STRAD and MO25" . SPARSER::COLLECTION) ("STRAD" . SPARSER::PROTEIN)
    ("AMP-activated protein kinase (AMPK) and other downstream targets"
     . SPARSER::COLLECTION)
    ("serine-threonine" . SPARSER::COLLECTION) ("ddH 2" . SPARSER::PROTEIN)
    ("CCL-2" . SPARSER::PROTEIN) ("1 L" . SPARSER::PROTEIN)
    ("Sprr2f" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("TSC2" . SPARSER::PROTEIN) ("MO25" . SPARSER::PROTEIN)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("the autologous control group" . SPARSER::MOLECULE)
    ("heterogeneous control group" . SPARSER::MOLECULE)
    ("real-time quantitative MSP" . SPARSER::PROTEIN)
    ("a DNA damage reversal protein" . SPARSER::PROTEIN)
    ("methyl-transferase (MGMT)" . SPARSER::PROTEIN)
    ("two histological types" . TYPE) ("gene and NSCLC" . SPARSER::COLLECTION)
    ("methylguanine" . SPARSER::MOLECULE)
    ("methyl-transferase" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN) ("LLH" . SPARSER::PROTEIN)
    ("CH and JYY" . SPARSER::COLLECTION) ("CH" . SPARSER::PROTEIN)
    ("AKT1, CCNA, CDK2, CCND1/D2, and BMI-1" . SPARSER::COLLECTION)
    ("CCNA" . SPARSER::PROTEIN) ("CCND1 and CDK2" . SPARSER::COLLECTION)
    ("CCND1-CDK2" . SPARSER::COLLECTION)
    ("CCND1, CCND2, and CCNE1" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("EGFR/AKT/NF-kB/CCND1" . SPARSER::COLLECTION)
    ("Grb2 or Shc" . SPARSER::COLLECTION)
    ("PI3K/AKT/CCND1" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/MAPK" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bio" . SPARSER::MOLECULE)
    ("EGFR/HER1" . SPARSER::COLLECTION) ("EGFR/HER/ErbB" . SPARSER::COLLECTION)
    ("family and miR-101" . SPARSER::COLLECTION)
    ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("miR-302b and siEGFR suppressed cell proliferation" . SPARSER::COLLECTION)
    ("wt" . SPARSER::PROTEIN) ("ctrl" . SPARSER::PROTEIN)
    ("UTR-mut" . SPARSER::COLLECTION) ("UTR-wt" . SPARSER::COLLECTION)
    ("pmirGLO-EGFR-3" . SPARSER::COLLECTION) ("HL" . SPARSER::PROTEIN)
    ("CCND-CDK4/6" . SPARSER::COLLECTION) ("CCNE-CDK2" . SPARSER::COLLECTION)
    ("CCND1 and CDK4" . SPARSER::COLLECTION)
    ("genes or oncogenes" . SPARSER::COLLECTION)
    ("EGFR/AKT2/CCND1" . SPARSER::COLLECTION)
    ("AKT2, CCND1, and CDK2" . SPARSER::COLLECTION)
    ("HCC and non-tumorous" . SPARSER::COLLECTION)
    ("miR-302b and EGFR" . SPARSER::COLLECTION) ("BMI-1" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("Let-7" . SPARSER::RNA) ("MiR-302b" . SPARSER::MOLECULE)
    ("mir-302b" . SPARSER::MOLECULE) ("AKT2" . SPARSER::PROTEIN)
    ("miR-302b" . SPARSER::MOLECULE) ("Figueroa-Vega" . SPARSER::COLLECTION)
    ("Qin" . SPARSER::PROTEIN) ("Vega" . SPARSER::PROTEIN)
    ("Irf4, Batf, and Nfibiz" . SPARSER::COLLECTION)
    ("Irf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rorc" . SPARSER::PROTEIN)
    ("IL21, and IL23r" . SPARSER::COLLECTION) ("IL23r" . SPARSER::PROTEIN)
    ("hyper-IgE" . SPARSER::PROTEIN-PAIR) ("IgE" . SPARSER::PROTEIN)
    ("IFNs, EGF, IL5, IL6, HGF, LIF, and BMP2" . SPARSER::COLLECTION)
    ("LIF" . SPARSER::PROTEIN) ("IFNs" . SPARSER::DRUG)
    ("the receptor-associated kinases" . SPARSER::KINASE)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("Allele and genotype" . SPARSER::COLLECTION) ("Han" . SPARSER::PROTEIN)
    ("IL-6, IL-21, and IL-23" . SPARSER::COLLECTION)
    ("Chen" . SPARSER::PROTEIN) ("IL-17A and IL-17F" . SPARSER::COLLECTION)
    ("Yan" . SPARSER::PROTEIN)
    ("thyroid peroxidase antibodies (TPOAb) or antibodies"
     . SPARSER::COLLECTION)
    ("thyroglobulin" . SPARSER::PROTEIN)
    ("gene and AITD" . SPARSER::COLLECTION) ("GD" . SPARSER::PROTEIN)
    ("Rorγt" . SPARSER::PROTEIN) ("CCR6" . SPARSER::PROTEIN)
    ("IL23" . SPARSER::PROTEIN) ("IL21" . SPARSER::PROTEIN)
    ("IL17" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("IL5" . SPARSER::PROTEIN) ("chromosome17" . SPARSER::PROTEIN)
    ("type1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IL-21" . SPARSER::PROTEIN)
    ("IL-17A" . SPARSER::PROTEIN) ("IL-17F" . SPARSER::PROTEIN)
    ("interleukin-17" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("thyroid peroxidase" . SPARSER::PROTEIN)
    ("thyrotropin receptor" . SPARSER::PROTEIN) ("RS" . SPARSER::PROTEIN)
    ("LC" . SPARSER::PROTEIN) ("SP" . SPARSER::PROTEIN)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("GO and KEGG" . SPARSER::COLLECTION)
    ("cytokine-cytokine" . SPARSER::COLLECTION)
    ("Factors " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("unique genetic variants" . SPARSER::VARIANT)
    ("EZH2 or HDAC4" . SPARSER::COLLECTION)
    ("distinct biologic" . SPARSER::DRUG)
    ("HDAC4 and EZH2" . SPARSER::COLLECTION)
    ("types, locations, and stages" . SPARSER::COLLECTION)
    ("EZH2 and SIRT1" . SPARSER::COLLECTION)
    ("EZH2/HDAC4" . SPARSER::COLLECTION)
    ("HDAC1, SIRT1, and HDAC4" . SPARSER::COLLECTION)
    ("the Mesenchymal and Neural subtypes" . SPARSER::PROTEIN)
    ("HDAC4 and SIRT1" . SPARSER::COLLECTION)
    ("high EZH2 and low HDAC4" . SPARSER::COLLECTION)
    ("EZH2, SIRT1, and DNMT2" . SPARSER::COLLECTION)
    ("HDAC4 and HDAC1" . SPARSER::COLLECTION) ("Subtypes" . SPARSER::PROTEIN)
    ("well-defined subtypes" . SPARSER::PROTEIN)
    ("EZH2 and HDAC1" . SPARSER::COLLECTION)
    ("HDAC1 and SIRT1" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("GSK" . SPARSER::PROTEIN) ("azacytidine" . SPARSER::DRUG)
    ("EM-EXP1581" . SPARSER::COLLECTION) ("EXP" . SPARSER::PROTEIN)
    ("deacetylases, and RNA" . SPARSER::COLLECTION)
    ("HDAC4 and the histone methylase EZH2" . SPARSER::COLLECTION)
    ("both histones and other proteins" . SPARSER::COLLECTION)
    ("methylase" . SPARSER::PROTEIN)
    ("methylases and demethylases" . SPARSER::COLLECTION)
    ("methylases" . SPARSER::PROTEIN)
    ("histone acetyltransferases (HATs) and the three classes"
     . SPARSER::COLLECTION)
    ("HDAC1-3" . SPARSER::COLLECTION)
    ("TGF and phosphatidylinositol" . SPARSER::COLLECTION)
    ("EZH2 and HDAC4" . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("Green fluorescent protein" . SPARSER::PROTEIN)
    ("Histone deacetylase" . SPARSER::PROTEIN)
    ("Histone acetyltransferase" . SPARSER::PROTEIN)
    ("TNFRSF10D" . SPARSER::PROTEIN) ("TGF-beta" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN) ("MAS 5" . SPARSER::PROTEIN)
    ("class 1" . SPARSER::PROTEIN-FAMILY) ("histone 3" . SPARSER::PROTEIN)
    ("class 2" . SPARSER::PROTEIN) ("Class 1" . SPARSER::PROTEIN-FAMILY)
    ("DNMT2" . SPARSER::PROTEIN) ("DNA methyltransferase" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("anti-PD-1 and CTLA-4" . SPARSER::COLLECTION)
    ("soluble ligands" . SPARSER::LIGAND)
    ("EGFR and Kras" . SPARSER::COLLECTION)
    ("anti-PD-1 and PD-L1" . SPARSER::COLLECTION) ("GEMMs" . SPARSER::PROTEIN)
    ("EGFR (TD)" . SPARSER::PROTEIN)
    ("EGFR and its ligands" . SPARSER::COLLECTION)
    ("Il-6 , Tgf-β and Pgrn" . SPARSER::COLLECTION)
    ("IL-6, TGF-β1 and progranulin" . SPARSER::COLLECTION)
    ("PGRN" . SPARSER::PROTEIN) ("progranulin" . SPARSER::PROTEIN)
    ("a secondary anti-rat IgG2a antibody as well as the same anti-PD-1 antibody"
     . SPARSER::COLLECTION)
    ("a secondary anti-rat IgG2a antibody" . SPARSER::ANTIBODY)
    ("tumor-associated macrophages" . SPARSER::PROTEIN)
    ("MRI" . SPARSER::PROTEIN)
    ("a rat monoclonal blocking anti-PD-1 antibody" . SPARSER::ANTIBODY)
    ("AM" . SPARSER::PROTEIN)
    ("immunosuppressive cytokines, growth factors and chemokines"
     . SPARSER::COLLECTION)
    ("cytokines, growth factors and chemokines" . SPARSER::COLLECTION)
    ("sick" . SPARSER::PROTEIN) ("PD-1 and PD-L1" . SPARSER::COLLECTION)
    ("LAG-3 and Tim-3" . SPARSER::COLLECTION)
    ("CTLA-4, LAG-3 and Tim-3" . SPARSER::COLLECTION)
    ("PD-1 and Foxp3" . SPARSER::COLLECTION) ("/Foxp3" . SPARSER::COLLECTION)
    ("cytometry and immunohistochemistry" . SPARSER::COLLECTION)
    ("Exon" . SPARSER::PROTEIN)
    ("Ctla-4 , Il-6 , Tgf-β1 , and granulin" . SPARSER::COLLECTION)
    ("Il-6" . SPARSER::PROTEIN) ("Ctla-4" . SPARSER::PROTEIN)
    ("Cd274" . SPARSER::PROTEIN) ("Pd-1" . SPARSER::PROTEIN)
    ("granulin" . SPARSER::PROTEIN) ("PD-L1 and PD-L2" . SPARSER::COLLECTION)
    ("PD-1 or PD-L1" . SPARSER::COLLECTION)
    ("anti-CTLA-4 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("ipilimumab" . SPARSER::DRUG) ("PD-L1, and PD-L1" . SPARSER::COLLECTION)
    ("multiple tumor-promoting inflammatory cytokines" . SPARSER::PROTEIN)
    ("CCL17" . SPARSER::PROTEIN) ("MFG-E8" . SPARSER::PROTEIN)
    ("TGF-beta1" . SPARSER::PROTEIN) ("CC10" . SPARSER::PROTEIN)
    ("PDL1" . SPARSER::PROTEIN) ("PD1" . SPARSER::PROTEIN)
    ("PDCD1LG2" . SPARSER::PROTEIN) ("CXCR3" . SPARSER::PROTEIN)
    ("CXCL10" . SPARSER::PROTEIN) ("Tim-3" . SPARSER::PROTEIN)
    ("LAG-3" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("M/L" . SPARSER::PROTEIN) ("WZ4002" . SPARSER::DRUG)
    ("CCL27" . SPARSER::PROTEIN) ("chemo-attractant" . SPARSER::PROTEIN)
    ("CD274" . SPARSER::PROTEIN) ("PD-L2" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("CTLA-4" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NAR" . SPARSER::PROTEIN)
    ("DNA damage-induced targets" . SPARSER::TARGET-PROTEIN)
    ("DNA damage-specific p53 gene" . SPARSER::PROTEIN)
    ("p63 or p73" . SPARSER::COLLECTION)
    ("considerable impact" . SPARSER::PROTEIN)
    ("FOXA2, HNF1A, HNF4A, HNF6A and CEBPA" . SPARSER::COLLECTION)
    ("CEBPA" . SPARSER::PROTEIN)
    ("PTCH1 , TBX5 and HOXA" . SPARSER::COLLECTION)
    ("bivalent genes" . SPARSER::GENE)
    ("UTX, UTY and JMJD3" . SPARSER::COLLECTION) ("UTY" . SPARSER::PROTEIN)
    ("OCT4 or NANOG" . SPARSER::COLLECTION)
    ("CBX2 and CBX4" . SPARSER::COLLECTION) ("CBX" . SPARSER::PROTEIN)
    ("TBX" . SPARSER::PROTEIN-FAMILY) ("PAX" . SPARSER::PROTEIN)
    ("developmental transcription factor genes" . SPARSER::GENE)
    ("CDKN1A , HOXA , PTCH1 and TBX5" . SPARSER::COLLECTION)
    ("CDKN1A and PTCH1" . SPARSER::COLLECTION)
    ("developmental genes" . SPARSER::GENE) ("mES" . SPARSER::PROTEIN)
    ("p53–chromatin" . SPARSER::COLLECTION)
    ("differentiation-associated genes" . SPARSER::GENE)
    ("PTCH1 , TBX5 and HOXA1" . SPARSER::COLLECTION)
    ("HOXA1 and HOXA2" . SPARSER::COLLECTION)
    ("JMJD3 and UTX" . SPARSER::COLLECTION) ("HOXA" . SPARSER::PROTEIN)
    ("p53, UTX and JMJD3" . SPARSER::COLLECTION)
    ("UTX and JMJD3" . SPARSER::COLLECTION)
    ("developmentally poised genes" . SPARSER::GENE)
    ("p53/OCT4/NANOG" . SPARSER::COLLECTION)
    ("bivalent histone" . SPARSER::PROTEIN)
    ("repressive (H3K27me3) histone" . SPARSER::PROTEIN)
    ("OCT4 and/or NANOG" . SPARSER::COLLECTION) ("TP53-" . SPARSER::PROTEIN)
    ("PTCH1 , TBX5 and CDKN1A" . SPARSER::COLLECTION)
    ("repressive chromatin" . SPARSER::PROTEIN)
    ("Developmental genes" . SPARSER::GENE)
    ("repressive histone" . SPARSER::PROTEIN)
    ("p53 and OCT4" . SPARSER::COLLECTION) ("OCT4-OCT4" . SPARSER::COLLECTION)
    ("sequential ChIPs" . SPARSER::PROTEIN)
    ("OCT4 and p53" . SPARSER::COLLECTION)
    ("PTCH1 and TBX5" . SPARSER::COLLECTION) ("ChIPs" . SPARSER::PROTEIN)
    ("PTCH1 , HOXA1 and TBX5" . SPARSER::COLLECTION)
    ("PTCH1 , HOXA1 , TBX5 and CDKN1A" . SPARSER::COLLECTION)
    ("HOXA1 , PTCH1 and TBX5" . SPARSER::COLLECTION)
    ("CDKN1A and MDM2" . SPARSER::COLLECTION)
    ("MSX2 and GBX2" . SPARSER::COLLECTION)
    ("BMI1 and histone" . SPARSER::COLLECTION) ("polycomb" . SPARSER::PROTEIN)
    ("HOX and GATA" . SPARSER::COLLECTION)
    ("quantitative RNA and p53 ChIP-PCR" . SPARSER::COLLECTION)
    ("quantitative RNA" . SPARSER::RNA)
    ("HOXA1, HOXA3, HHEX and HOXB1" . SPARSER::COLLECTION)
    ("GATA2, LHX8, ZIC1 and TCF7L2" . SPARSER::COLLECTION)
    ("RARA and RARB" . SPARSER::COLLECTION) ("RARB" . SPARSER::PROTEIN)
    ("RARA" . SPARSER::PROTEIN) ("an essential activator" . SPARSER::ACTIVATOR)
    ("HDAC5 and HDAC9" . SPARSER::COLLECTION)
    ("p53 and NANOG" . SPARSER::COLLECTION)
    ("p53:OCT4:NANOG" . SPARSER::BIO-COMPLEX)
    ("RA or Adr" . SPARSER::COLLECTION) ("OCT4/NANOG" . SPARSER::COLLECTION)
    ("OCT4, NANOG and H3K27me3" . SPARSER::COLLECTION)
    ("e.g. HOX genes" . SPARSER::GENE)
    ("The bivalent state" . SPARSER::BIO-STATE)
    ("both repressive H3K27me3 and activation-associated H3K4"
     . SPARSER::COLLECTION)
    ("activation-associated H3K4" . SPARSER::PROTEIN)
    ("both repressive H3K27me3" . SPARSER::MOLECULE)
    ("Specific developmental genes" . SPARSER::GENE)
    ("OCT4, SOX2 and NANOG" . SPARSER::COLLECTION)
    ("congenital malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("ZIC" . SPARSER::PROTEIN)
    ("Zic" . SPARSER::PROTEIN) ("SOX" . SPARSER::PROTEIN)
    ("damage-specific p53" . SPARSER::PROTEIN)
    ("Homeobox" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OCT4 and SOX2" . SPARSER::COLLECTION) ("OCT4-SOX2" . SPARSER::COLLECTION)
    ("OCT4-" . SPARSER::PROTEIN) ("basal p53" . SPARSER::PROTEIN)
    ("highly diverse p53" . SPARSER::PROTEIN)
    ("a pluripotent state" . SPARSER::BIO-STATE)
    ("p53-chromatin" . SPARSER::COLLECTION)
    ("Alkaline phosphatase (AP)" . SPARSER::PROTEIN-FAMILY)
    ("Adr" . SPARSER::PROTEIN) ("Adriamycin" . SPARSER::DRUG)
    ("conventional ChIP and sequential ChIP" . SPARSER::COLLECTION)
    ("specific developmental genes" . SPARSER::GENE)
    ("sequential ChIP" . SPARSER::PROTEIN) ("RA" . SPARSER::PROTEIN)
    ("p53 and H3K27me3-specific demethylases, UTX and JMJD3"
     . SPARSER::COLLECTION)
    ("demethylases, UTX and JMJD3" . SPARSER::COLLECTION)
    ("UTX" . SPARSER::PROTEIN) ("demethylases" . SPARSER::PROTEIN)
    ("OCT4 and NANOG" . SPARSER::COLLECTION)
    ("H3K27me3 and H3K4" . SPARSER::COLLECTION) ("NANOG" . SPARSER::PROTEIN)
    ("HNF6A" . SPARSER::PROTEIN) ("HNF4A" . SPARSER::PROTEIN)
    ("HNF1A" . SPARSER::PROTEIN) ("FOXA2" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("Sox17" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("CBX4" . SPARSER::PROTEIN) ("CBX2" . SPARSER::PROTEIN)
    ("HOXA2" . SPARSER::PROTEIN) ("KDM2B" . SPARSER::PROTEIN)
    ("BMI1" . SPARSER::PROTEIN) ("TLE3" . SPARSER::PROTEIN)
    ("PTCH1" . SPARSER::PROTEIN) ("hedgehog receptor" . SPARSER::PROTEIN)
    ("GBX2" . SPARSER::PROTEIN) ("MSX2" . SPARSER::PROTEIN)
    ("TBX5" . SPARSER::PROTEIN) ("TCF7L2" . SPARSER::PROTEIN)
    ("LHX8" . SPARSER::PROTEIN) ("GATA2" . SPARSER::PROTEIN)
    ("HOXB1" . SPARSER::PROTEIN) ("HOXA3" . SPARSER::PROTEIN)
    ("HOXA1" . SPARSER::PROTEIN) ("TERF1" . SPARSER::PROTEIN)
    ("HDAC9" . SPARSER::PROTEIN) ("HDAC5" . SPARSER::PROTEIN)
    ("KLF6" . SPARSER::PROTEIN) ("forkhead box" . SPARSER::PROTEIN)
    ("SOX2" . SPARSER::PROTEIN) ("LaminB1" . SPARSER::PROTEIN)
    ("Histone 3" . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("micro-RNAs" . SPARSER::MICRO-RNA)
    ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("Tumor suppressor protein" . SPARSER::PROTEIN)
    ("JMJD3" . SPARSER::PROTEIN) ("OCT4" . SPARSER::PROTEIN)
    ("trigger other proinflammatory cytokines" . SPARSER::PROTEIN)
    ("MCP-1 and CD14" . SPARSER::COLLECTION)
    ("MCP-1 (A-2518G, P = 0.001) and CD14 (C-260T, P = 0.009)"
     . SPARSER::COLLECTION)
    ("antihypertensive" . SPARSER::DRUG) ("CHD" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("ICAM-1 and MCP-1" . SPARSER::COLLECTION)
    ("IL-6 , IL10 , ICAM-1 , TNF-α , MCP-1 , and NF-κB" . SPARSER::COLLECTION)
    ("TLR4/CD14" . SPARSER::COLLECTION) ("1 µL" . SPARSER::PROTEIN)
    ("uric acid" . SPARSER::MOLECULE) ("HDL-C" . SPARSER::MOLECULE)
    ("high-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("IL10" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("P50" . SPARSER::PROTEIN) ("factor-κB" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN) ("LDL-C" . SPARSER::MOLECULE)
    ("low-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("heat shock proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCP-1" . SPARSER::PROTEIN) ("IQGAP1 and 14-3-3ε" . SPARSER::COLLECTION)
    ("FGFR-2 IIIb or IIIc" . SPARSER::COLLECTION)
    ("nearly all multi-exon human genes" . SPARSER::GENE)
    ("multi-exon" . SPARSER::COLLECTION)
    ("FGF ligands and an intense desmoplasia ( xref , xref )"
     . SPARSER::COLLECTION)
    ("Smad4 (55%) and p16 (85%)" . SPARSER::COLLECTION)
    ("receptors and ligands" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("EV9" . SPARSER::PROTEIN) ("PANC-EV9" . SPARSER::COLLECTION)
    ("EV2" . SPARSER::PROTEIN) ("NOG" . SPARSER::PROTEIN)
    ("CD44s/CD44" . SPARSER::COLLECTION)
    ("FGFR-1, FGFR-3, and CD44" . SPARSER::COLLECTION)
    ("vimentin, HSP70, VCP, and ENO1" . SPARSER::COLLECTION)
    ("anti-IQGAP1, FLNA and PLIN3" . SPARSER::COLLECTION)
    ("FLNA and its splicing variant" . SPARSER::COLLECTION)
    ("VCP, ENO1, and FLNA" . SPARSER::COLLECTION)
    ("Vimentin, 14-3-3ε, HSP 70, and IQGAP1" . SPARSER::COLLECTION)
    ("perilipin" . SPARSER::PROTEIN) ("FLNA" . SPARSER::PROTEIN)
    ("filamin" . SPARSER::PROTEIN) ("VCP" . SPARSER::PROTEIN)
    ("An irrelevant siRNA" . SPARSER::PROTEIN)
    ("siRNA and FGFR-2" . SPARSER::COLLECTION) ("cyt" . SPARSER::PROTEIN)
    ("FGFR-2 IIIb and IIIc levels" . SPARSER::COLLECTION)
    ("PANC-EV2" . SPARSER::COLLECTION)
    ("ESRP1, and PANC-EV2 and PANC-EV9" . SPARSER::COLLECTION)
    ("EV" . SPARSER::PROTEIN) ("PANC-EV" . SPARSER::COLLECTION)
    ("PANC-ESRP1" . SPARSER::COLLECTION) ("PANC" . SPARSER::PROTEIN)
    ("PK" . SPARSER::PROTEIN)
    ("tegafur, gimeracil and oteracil" . SPARSER::COLLECTION)
    ("oteracil" . SPARSER::DRUG) ("gimeracil" . SPARSER::DRUG)
    ("UFT" . SPARSER::DRUG) ("uracil" . SPARSER::NUCLEOBASE)
    ("tegafur" . SPARSER::DRUG)
    ("other clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ESRP1 and FGFR-2" . SPARSER::COLLECTION)
    ("IIIb, and FGFR-2" . SPARSER::COLLECTION) ("mod" . SPARSER::PROTEIN)
    ("ESRP1 and ESRP2" . SPARSER::COLLECTION)
    ("p120-catenin" . SPARSER::COLLECTION) ("ENAH" . SPARSER::PROTEIN)
    ("auxiliary cis-elements and RNA binding proteins" . SPARSER::PROTEIN)
    ("IIIb and FGF7" . SPARSER::COLLECTION)
    ("almost identical transmembrane-type receptors" . SPARSER::RECEPTOR)
    ("growth factors and their receptors" . SPARSER::COLLECTION)
    ("a favorable prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("using anti-ESRP1" . SPARSER::ANTIBODY)
    ("IIIb and FGFR-2" . SPARSER::COLLECTION) ("PDAC" . SPARSER::PROTEIN)
    ("the FGFR-2 auxiliary cis-element ISE/ISS-3" . SPARSER::COLLECTION)
    ("ISE/ISS-3" . SPARSER::COLLECTION) ("IIIb" . SPARSER::DRUG)
    ("ISS" . SPARSER::PROTEIN) ("full-length " . SPARSER::PROTEIN)
    ("CK19" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("filamin A" . SPARSER::PROTEIN) ("TGF-βs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16" . SPARSER::PROTEIN) ("Smad4" . SPARSER::PROTEIN)
    ("FGFR-3" . SPARSER::PROTEIN) ("FGFR-1" . SPARSER::PROTEIN)
    ("PLIN3" . SPARSER::PROTEIN) ("ENO1" . SPARSER::PROTEIN)
    ("valosin containing protein" . SPARSER::PROTEIN)
    ("IQGAP1" . SPARSER::PROTEIN)
    ("IQ motif containing GTPase activating protein 1" . SPARSER::PROTEIN)
    ("HSP 70" . SPARSER::PROTEIN) ("heat shock protein 70" . SPARSER::PROTEIN)
    ("1-B" . SPARSER::PROTEIN) ("ESRP2" . SPARSER::PROTEIN)
    ("p120" . SPARSER::PROTEIN) ("RNA binding protein" . SPARSER::PROTEIN)
    ("RNA binding" . SPARSER::PROTEIN) ("FGFR-2" . SPARSER::PROTEIN)
    ("ESRP1" . SPARSER::PROTEIN)
    ("Epithelial splicing regulatory protein 1" . SPARSER::PROTEIN)
    ("TGF-alpha, and betacellulin" . SPARSER::COLLECTION)
    ("EGFRwt-EGFRvIII-HBEGF" . SPARSER::COLLECTION)
    ("the dimerization arm and a part" . SPARSER::COLLECTION)
    ("multiple receptor tyrosine kinase families such as Met and EphA2 that may mediate"
     . SPARSER::COLLECTION)
    ("EphA2" . SPARSER::PROTEIN) ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("CHO" . SPARSER::PROTEIN) ("EGFRvIII-EGFRwt" . SPARSER::COLLECTION)
    ("HB-EGF and EGFRwt" . SPARSER::COLLECTION)
    ("IHC using antibodies" . SPARSER::ANTIBODY)
    ("EGFRwt, EGFRvIII and HB-EGF" . SPARSER::COLLECTION)
    ("HB-EGF and TGF-alpha" . SPARSER::COLLECTION)
    ("EGFRwt or HB-EGF" . SPARSER::COLLECTION)
    ("EGFR or HB-EGF" . SPARSER::COLLECTION)
    ("HB-EGF and other EGFRwt ligands" . SPARSER::COLLECTION)
    ("EGFRvIII-HBEGF-EGFRwt-EGFRvIII" . SPARSER::COLLECTION)
    ("EGFRvIII and HB-EGF" . SPARSER::COLLECTION)
    ("EGFR and HB-EGF" . SPARSER::COLLECTION)
    ("less complete EGFRwt" . SPARSER::PROTEIN)
    ("EGFRwt and EGFRvIII" . SPARSER::COLLECTION)
    ("food and water" . SPARSER::COLLECTION)
    ("U251-vIII" . SPARSER::PROTEIN-PAIR)
    ("EGFRwt and HB-EGF" . SPARSER::COLLECTION)
    ("IR, IGF1R, AXL, RET and EPHA2" . SPARSER::COLLECTION)
    ("AXL" . SPARSER::PROTEIN) ("EGFRwt-EGFRvIII-HB-EGF" . SPARSER::COLLECTION)
    ("vIII" . SPARSER::PROTEIN) ("Myc-tagged-HB-EGF" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN)
    ("TGF-alpha and IL-8" . SPARSER::COLLECTION)
    ("HB-EGF, TGFA and BTC" . SPARSER::COLLECTION) ("BTC" . SPARSER::PROTEIN)
    ("TGFA" . SPARSER::PROTEIN) ("HB-EGF and IL-8" . SPARSER::COLLECTION)
    ("a physical complex" . SPARSER::BIO-COMPLEX)
    ("EGFRvIII and EGFRwt" . SPARSER::COLLECTION)
    ("HA antibody and Western blot" . SPARSER::COLLECTION)
    ("mutant (CR1) mutant" . SPARSER::MUTANT) ("COS" . SPARSER::MOLECULE)
    ("EGFRwt-Myc and EGFRvIII-HA in COS-7 cells" . SPARSER::COLLECTION)
    ("EGFRvIII-HA" . SPARSER::COLLECTION) ("EGFRwt-Myc" . SPARSER::COLLECTION)
    ("EGFRwt" . SPARSER::PROTEIN)
    ("U87-vIII and U251-vIII" . SPARSER::COLLECTION)
    ("U87-vIII" . SPARSER::PROTEIN-PAIR) ("EGFRwt-HA" . SPARSER::COLLECTION)
    ("HB-EGF ( xref ) or cytokines" . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("HBEGF" . SPARSER::PROTEIN)
    ("EGFRvIII" . SPARSER::PROTEIN) ("Vitamin A" . SPARSER::MOLECULE)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY) ("EPHA2" . SPARSER::PROTEIN)
    ("TGF-alpha" . SPARSER::PROTEIN) ("tissue factor" . SPARSER::PROTEIN)
    ("BS 3" . SPARSER::PROTEIN) ("CR1" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HB-EGF" . SPARSER::PROTEIN) ("PI3K or MEK" . SPARSER::COLLECTION)
    ("PI3K and RAS/MEK" . SPARSER::COLLECTION)
    ("a tumor suppressive transcription factor" . SPARSER::PROTEIN)
    ("Drugs" . SPARSER::DRUG)
    ("the PI3K and the MEK inhibitors" . SPARSER::COLLECTION)
    ("LY294002 and U0126" . SPARSER::COLLECTION)
    ("PI3K-AKT" . SPARSER::COLLECTION) ("p42/p44-MAPK" . SPARSER::COLLECTION)
    ("pS" . SPARSER::PROTEIN) ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT and ERK" . SPARSER::COLLECTION) ("cytidines" . SPARSER::MOLECULE)
    ("CEP" . SPARSER::PROTEIN) ("CDKN1B/p27 kip1" . SPARSER::COLLECTION)
    ("using Hematoxylin and Eosin (H&E)" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE)
    ("both normal epithelium" . SPARSER::PROTEIN)
    ("formalin" . SPARSER::MOLECULE)
    ("mixed FTE and immortalized FTSECs" . SPARSER::COLLECTION)
    ("EpCAM and cytokeratin 7" . SPARSER::COLLECTION)
    ("the fallopian tube epithelium (FTE)" . SPARSER::PROTEIN)
    ("favorable impact" . SPARSER::PROTEIN)
    ("cyclin D1, MnSOD, catalase, and GADD45a" . SPARSER::COLLECTION)
    ("MnSOD" . SPARSER::PROTEIN) ("Targets" . SPARSER::TARGET-PROTEIN)
    ("genes and pathways" . SPARSER::COLLECTION) ("FTE" . SPARSER::PROTEIN)
    ("epithelium (FTE)" . SPARSER::PROTEIN) ("FT" . SPARSER::PROTEIN)
    ("Müllerian epithelium" . SPARSER::PROTEIN)
    ("the ovarian surface epithelium (OSE)" . SPARSER::PROTEIN)
    ("epithelium (OSE)" . SPARSER::PROTEIN) ("OSE" . SPARSER::PROTEIN)
    ("a possible target" . SPARSER::TARGET-PROTEIN)
    ("PI3K and MEK" . SPARSER::COLLECTION)
    ("DNA, RNA and protein" . SPARSER::COLLECTION)
    ("the tumor suppressive transcription factor FOXO3a" . SPARSER::PROTEIN)
    ("p44-MAPK" . SPARSER::PROTEIN) ("p42" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("micro-RNA" . SPARSER::MICRO-RNA)
    ("p11" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RP11" . SPARSER::PROTEIN)
    ("Pax8" . SPARSER::PROTEIN) ("cytokeratin 7" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("GADD45a" . SPARSER::PROTEIN)
    ("CD95L" . SPARSER::PROTEIN) ("p27 kip1" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN) ("FOXO3a" . SPARSER::PROTEIN)
    ("substrates and products" . SPARSER::COLLECTION)
    ("NADP + and NADPH" . SPARSER::COLLECTION)
    ("NADP + (~20 µM vs ~2 mM) and THF (~0.3 µM vs ~13 µM)"
     . SPARSER::COLLECTION)
    ("supplemental thymidine" . SPARSER::PROTEIN) ("thyA" . SPARSER::PROTEIN)
    ("exogenous thymidine" . SPARSER::PROTEIN)
    ("the hinge-open state" . SPARSER::BIO-STATE) ("AI" . SPARSER::PROTEIN)
    ("For example C. elegans DHFR" . SPARSER::PROTEIN)
    ("fungi" . SPARSER::PROTEIN)
    ("the ancestral enzyme and the other extant DHFR" . SPARSER::COLLECTION)
    ("the other extant DHFR" . SPARSER::PROTEIN)
    ("the ancestral enzyme" . SPARSER::ENZYME)
    ("an ancestral DHFR" . SPARSER::PROTEIN) ("Enzymes" . SPARSER::ENZYME)
    ("a few archaeal enzymes" . SPARSER::ENZYME)
    ("the hinge-open conformation" . SPARSER::BIO-CONFORMATION)
    ("NADP and Ser119" . SPARSER::COLLECTION)
    ("Bacterial DHFR" . SPARSER::PROTEIN)
    ("a eukaryotic DHFR" . SPARSER::PROTEIN) ("pig" . SPARSER::PROTEIN)
    ("the model Michaelis complex and the product ternary complex ( xref and xref )"
     . SPARSER::COLLECTION)
    ("the product ternary complex" . SPARSER::BIO-COMPLEX)
    ("NADP + and THF" . SPARSER::COLLECTION) ("hydride" . SPARSER::PROTEIN)
    ("pre- and post-hydride" . SPARSER::COLLECTION)
    ("post-hydride" . SPARSER::COLLECTION) ("PW" . SPARSER::MOLECULE)
    ("PP" . SPARSER::PROTEIN)
    ("all available fully sequenced genomes" . SPARSER::PROTEIN)
    ("all available DHFR" . SPARSER::PROTEIN)
    ("hE–NADPH and hE–NADP +" . SPARSER::COLLECTION)
    ("subdomains" . SPARSER::PROTEIN) ("Asp" . SPARSER::AMINO-ACID)
    ("adenosine" . SPARSER::PROTEIN)
    ("the hE–NADPH binary complex" . SPARSER::BIO-COMPLEX)
    ("NMR" . SPARSER::PROTEIN) ("Carr" . SPARSER::PROTEIN)
    ("substrate and cofactor flux xref" . SPARSER::COLLECTION)
    ("–THF" . SPARSER::MOLECULE)
    ("the Michaelis complex and product ternary complex"
     . SPARSER::BIO-COMPLEX)
    ("complex and product" . SPARSER::COLLECTION) ("ecE" . SPARSER::PROTEIN)
    ("thymidylate" . SPARSER::MOLECULE) ("THF" . SPARSER::MOLECULE)
    ("tetrahydrofolate" . SPARSER::MOLECULE)
    ("dihydrofolate" . SPARSER::PROTEIN)
    ("thermophilic and mesophilic enzymes" . SPARSER::ENZYME)
    ("three-dimensional protein" . SPARSER::PROTEIN)
    ("e  2" . SPARSER::MOLECULE) ("ammonium chloride" . SPARSER::MOLECULE)
    ("RX2" . SPARSER::PROTEIN) ("RX1" . SPARSER::PROTEIN)
    ("NADP +" . SPARSER::MOLECULE)
    ("BKM120 and the Shh pathway inhibitor" . SPARSER::COLLECTION)
    ("Shh or PI3K" . SPARSER::COLLECTION)
    ("Akt, mTOR and S6K" . SPARSER::COLLECTION)
    ("PTEN and Shh" . SPARSER::COLLECTION)
    ("single drugs or combination therapy" . SPARSER::COLLECTION)
    ("BKM120 and LDE225 each successfully attack appropriate targets"
     . SPARSER::TARGET-PROTEIN)
    ("PI3K- and Shh" . SPARSER::COLLECTION) ("PI3K-" . SPARSER::PROTEIN)
    ("PI3K, Shh and S6K" . SPARSER::COLLECTION)
    ("pS6K and pS6" . SPARSER::COLLECTION)
    ("gli1 and ptc1" . SPARSER::COLLECTION) ("ptc1" . SPARSER::PROTEIN)
    ("ptc" . SPARSER::HUMAN-PROTEIN-FAMILY) ("centrosomes" . SPARSER::PROTEIN)
    ("-dioctadecyl-3" . SPARSER::COLLECTION)
    ("perchlorate" . SPARSER::MOLECULE) ("DiI" . SPARSER::MOLECULE)
    ("NuMA" . SPARSER::PROTEIN) ("MRIs" . SPARSER::PROTEIN)
    ("both BKM120 and combination therapy" . SPARSER::COLLECTION)
    ("DFd" . SPARSER::PROTEIN) ("ANOVA" . SPARSER::PROTEIN)
    ("BKM120 and LDE225" . SPARSER::COLLECTION) ("Smo" . SPARSER::PROTEIN)
    ("Smoothened" . SPARSER::PROTEIN) ("gli2" . SPARSER::PROTEIN)
    ("gli1 and gli2" . SPARSER::COLLECTION) ("gli" . SPARSER::PROTEIN)
    ("pten" . SPARSER::PROTEIN) ("PI3K and Shh" . SPARSER::COLLECTION)
    ("Shh and PI3K" . SPARSER::COLLECTION)
    ("type2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("γ-tubulin" . SPARSER::PROTEIN)
    ("PTEN2" . SPARSER::PROTEIN) ("PTEN1" . SPARSER::PROTEIN)
    ("PF-4708671" . SPARSER::DRUG) ("LEQ506" . SPARSER::DRUG)
    ("log2" . SPARSER::PROTEIN) ("pS6" . SPARSER::PROTEIN)
    ("LDE225" . SPARSER::DRUG) ("p110α" . SPARSER::PROTEIN)
    ("NVP-BKM120" . SPARSER::DRUG) ("gli1" . SPARSER::PROTEIN)
    ("S6kinase" . SPARSER::PROTEIN-FAMILY) ("PI3kinase" . SPARSER::PROTEIN)
    ("endophilin and PI" . SPARSER::COLLECTION)
    ("EGFR and Mena" . SPARSER::COLLECTION)
    ("N-WASP-Arp2/3" . SPARSER::COLLECTION)
    ("endophilin or Lpd" . SPARSER::COLLECTION)
    ("endophilin-Lpd" . SPARSER::COLLECTION)
    ("neither Lpd nor Ena/VASP" . SPARSER::COLLECTION)
    ("synaptojanin and dynamin" . SPARSER::COLLECTION)
    ("synaptojanin" . SPARSER::PROTEIN)
    ("Arp2/3 and dynamin" . SPARSER::COLLECTION)
    ("endophilin, Lpd and Mena" . SPARSER::COLLECTION)
    ("omega" . SPARSER::PROTEIN)
    ("endogenous Lpd ( xref ) and Mena ( xref )" . SPARSER::COLLECTION)
    ("endophilin, N-WASP, α-adaptin, and F-actin" . SPARSER::COLLECTION)
    ("dynamin" . SPARSER::PROTEIN) ("Endo3-GFP" . SPARSER::COLLECTION)
    ("endophilin and Lpd" . SPARSER::COLLECTION)
    ("CCPs, and Mena" . SPARSER::COLLECTION)
    ("Lpd, Mena, and F-actin" . SPARSER::COLLECTION)
    ("Mena and F-actin" . SPARSER::COLLECTION)
    ("two independent Mena or VASP-specific shRNAs" . SPARSER::COLLECTION)
    ("Mena or VASP" . SPARSER::COLLECTION) ("transferrin" . SPARSER::PROTEIN)
    ("Lpd and Ena/VASP" . SPARSER::COLLECTION)
    ("Lpd-GFP" . SPARSER::COLLECTION) ("Clc" . SPARSER::PROTEIN)
    ("mRFP-Clc" . SPARSER::COLLECTION) ("GFP-VASP" . SPARSER::COLLECTION)
    ("GFP-Mena" . SPARSER::COLLECTION) ("mRFP" . SPARSER::PROTEIN)
    ("mRFP-clathrin" . SPARSER::PROTEIN-PAIR)
    ("the actin cytoskeletal regulator Lpd and the EGFR form"
     . SPARSER::COLLECTION)
    ("the actin cytoskeletal regulator Lpd" . SPARSER::PROTEIN)
    ("Lpd and EGFR" . SPARSER::COLLECTION) ("EGFR-GFP" . SPARSER::COLLECTION)
    ("the predominant isoform" . SPARSER::PROTEIN)
    ("consecutive 12mer peptides" . SPARSER::PEPTIDE)
    ("MBP-endophilin A1" . SPARSER::COLLECTION)
    ("protein (MBP)" . SPARSER::PROTEIN) ("GST-Lpd" . SPARSER::COLLECTION)
    ("maltose" . SPARSER::MOLECULE)
    ("Lpd and endophilin" . SPARSER::COLLECTION)
    ("Lpd-N2" . SPARSER::COLLECTION) ("Lpd-N1" . SPARSER::COLLECTION)
    ("GFP-endophilin A3" . SPARSER::COLLECTION)
    ("mCherry-Lpd" . SPARSER::COLLECTION)
    ("GFP-endophilin" . SPARSER::COLLECTION)
    ("endophilins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lpd and endophilin A3" . SPARSER::COLLECTION)
    ("endophilin A1 (Endo1, SH3GL2) and endophilin A3 (Endo3, SH3GL3)"
     . SPARSER::COLLECTION)
    ("EGFP-Lpd" . SPARSER::COLLECTION) ("EGFP" . SPARSER::PROTEIN)
    ("CCP" . SPARSER::PROTEIN) ("that Lpd's" . SPARSER::PROTEIN)
    ("endophilin, Lpd, and Mena" . SPARSER::COLLECTION)
    ("Ena/VASP" . SPARSER::PROTEIN)
    ("endophilin and the EGFR" . SPARSER::COLLECTION)
    ("Lpd-Ena/VASP" . SPARSER::COLLECTION)
    ("Lamellipodin and proteins" . SPARSER::COLLECTION)
    ("complex and Ena/VASP" . SPARSER::COLLECTION)
    ("Lpd and RIAM" . SPARSER::COLLECTION)
    ("MIG10-RIAM-Lpd" . SPARSER::COLLECTION) ("MRL" . SPARSER::PROTEIN)
    ("RIAM" . SPARSER::PROTEIN)
    ("a BAR domain protein and a regulator" . SPARSER::COLLECTION)
    ("Endophilin, Lamellipodin, and Mena" . SPARSER::COLLECTION)
    ("EGF-receptor" . SPARSER::COLLECTION)
    ("Endophilin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CCPs" . SPARSER::PROTEIN)
    ("endophilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and Lpd and Mena" . SPARSER::COLLECTION)
    ("Lpd and Mena" . SPARSER::COLLECTION) ("clathrin" . SPARSER::PROTEIN)
    ("Mena" . SPARSER::PROTEIN) ("VASP" . SPARSER::PROTEIN)
    ("Lpd" . SPARSER::PROTEIN) ("Lamellipodin" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("Sulfo-NHS" . SPARSER::DRUG)
    ("L -glutamine" . SPARSER::MOLECULE) ("Hsc70" . SPARSER::PROTEIN)
    ("alpha-adaptin" . SPARSER::PROTEIN) ("No 2" . SPARSER::MOLECULE)
    ("aa1" . SPARSER::PROTEIN) ("endophilin A 1" . SPARSER::PROTEIN)
    ("Endophilin A3" . SPARSER::PROTEIN) ("Endophilin A1" . SPARSER::PROTEIN)
    ("Rvs167" . SPARSER::PROTEIN) ("α-adaptin" . SPARSER::PROTEIN)
    ("dynamin1" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("Latrunculin B" . SPARSER::DRUG) ("SH3GL1" . SPARSER::PROTEIN)
    ("Endo2" . SPARSER::PROTEIN) ("endophilin A2" . SPARSER::PROTEIN)
    ("endophilin A" . SPARSER::PROTEIN) ("SH3GL3" . SPARSER::PROTEIN)
    ("Endo3" . SPARSER::PROTEIN) ("endophilin A3" . SPARSER::PROTEIN)
    ("SH3GL2" . SPARSER::PROTEIN) ("Endo1" . SPARSER::PROTEIN)
    ("endophilin A1" . SPARSER::PROTEIN) ("N-WASP" . SPARSER::PROTEIN)
    ("MIG10" . SPARSER::PROTEIN) ("consequent impact" . SPARSER::PROTEIN)
    ("the symmetric arginine methylation mark" . SPARSER::PROTEIN)
    ("E2F-1, Cyclin E, Cdc6 and DHFR" . SPARSER::COLLECTION)
    ("APAF-1 and p73" . SPARSER::COLLECTION)
    ("only R111/113 SDMA and not" . SPARSER::COLLECTION)
    ("only R111/113 SDMA" . SPARSER::MOLECULE) ("SN" . SPARSER::PROTEIN)
    ("TD" . SPARSER::PROTEIN)
    ("the fluorescently labelled streptavidin" . SPARSER::PROTEIN)
    ("labelled streptavidin" . SPARSER::PROTEIN)
    ("streptavidin" . SPARSER::PROTEIN)
    ("the symmetrical arginine methylation mark" . SPARSER::PROTEIN)
    ("a cyclin A binding defective E2F-1 derivative" . SPARSER::DERIVATIVE)
    ("E2F-1, and DNA" . SPARSER::COLLECTION)
    ("E2F-1 and cyclin" . SPARSER::COLLECTION)
    ("cyclin A siRNA" . SPARSER::PROTEIN)
    ("PRMT1 and/or PRMT5" . SPARSER::COLLECTION)
    ("doxorubicin or etoposide" . SPARSER::COLLECTION)
    ("PARP and sub-G1" . SPARSER::COLLECTION)
    ("Arginine" . SPARSER::AMINO-ACID)
    ("p73, APAF1 and E2F-1" . SPARSER::COLLECTION)
    ("APAF1, E2F-1 and p73" . SPARSER::COLLECTION)
    ("PRMT1 and PRTM5" . SPARSER::COLLECTION)
    ("E2F-1, R111/113K and KKK" . SPARSER::COLLECTION)
    ("the methylated peptide" . SPARSER::PEPTIDE)
    ("the asymmetrically methylated R109 (R109-ADMA) peptide"
     . SPARSER::PEPTIDE)
    ("an enhanced asymmetric and decreased symmetric mark" . SPARSER::PROTEIN)
    ("E2F-1 and PRMT5" . SPARSER::COLLECTION)
    ("PRMT1 and E2F-1" . SPARSER::COLLECTION)
    ("E2F-1 and the other PRMT enzyme" . SPARSER::COLLECTION)
    ("SDMA" . SPARSER::MOLECULE)
    ("the triple KKK mutant derivatives" . SPARSER::DERIVATIVE)
    ("ADMA" . SPARSER::MOLECULE) ("PRMT1 or PRMT5" . SPARSER::COLLECTION)
    ("GST-E2F-1" . SPARSER::COLLECTION)
    ("the relevant arginine methylation mark" . SPARSER::PROTEIN)
    ("E2F-1 and PRMT1 and PRMT5" . SPARSER::COLLECTION)
    ("GST-PRMT5" . SPARSER::COLLECTION) ("GST-PRMT1" . SPARSER::COLLECTION)
    ("E2F-1 and PRMT1" . SPARSER::COLLECTION)
    ("which controls E2F-1" . SPARSER::PROTEIN)
    ("PRMT1 and PRMT5" . SPARSER::COLLECTION)
    ("considerable sequence homology" . SPARSER::PROTEIN)
    ("yin" . SPARSER::PROTEIN) ("ATM/ATR" . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN) ("/E2F-1" . SPARSER::COLLECTION)
    ("a direct physical target" . SPARSER::TARGET-PROTEIN)
    ("pRb-E2F" . SPARSER::COLLECTION) ("cyclin/cdk" . SPARSER::COLLECTION)
    ("a pivotal negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("the symmetric methylation mark" . SPARSER::PROTEIN)
    ("p100-TSN" . SPARSER::COLLECTION) ("TSN" . SPARSER::PROTEIN)
    ("the asymmetric dimethylating protein arginine methyltransferase (PRMT) 1 and symmetric dimethylating PRMT5"
     . SPARSER::COLLECTION)
    ("symmetric dimethylating PRMT5" . SPARSER::PROTEIN)
    ("methyltransferase (PRMT)" . SPARSER::PROTEIN) ("PRMT" . SPARSER::PROTEIN)
    ("dimethyl-arginine" . SPARSER::DRUG) ("PARP-1" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("APAF-1" . SPARSER::PROTEIN)
    ("staphylococcal nuclease" . SPARSER::PROTEIN)
    ("TDRD11" . SPARSER::PROTEIN) ("cdk2" . SPARSER::PROTEIN)
    ("APAF1" . SPARSER::PROTEIN) ("Chk2" . SPARSER::PROTEIN)
    ("PRMT1" . SPARSER::PROTEIN) ("PRMT5" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::PROTEIN) ("ramp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a continued G0 state" . SPARSER::BIO-STATE)
    ("DHFR and mCherry" . SPARSER::COLLECTION) ("mCherry" . SPARSER::PROTEIN)
    ("acutely increase exogenous p21 protein" . SPARSER::PROTEIN)
    ("-trimethoprim" . SPARSER::DRUG) ("TMP" . SPARSER::PROTEIN)
    ("AX" . SPARSER::PROTEIN) ("cMyc" . SPARSER::PROTEIN)
    ("path" . SPARSER::PROTEIN) ("EdU" . SPARSER::DRUG)
    ("Cer-Cdt1" . SPARSER::COLLECTION) ("Cer" . SPARSER::PROTEIN)
    ("cyclin E/CDK2" . SPARSER::COLLECTION)
    ("cyclin E and cyclin" . SPARSER::COLLECTION) ("track" . SPARSER::PROTEIN)
    ("Mitogen" . SPARSER::MITOGEN) ("Cdc6 and Rb" . SPARSER::COLLECTION)
    ("CDK4/6, EGFR, MEK, p38, Akt, or PI3K" . SPARSER::COLLECTION)
    ("CDK6/cyclin D" . SPARSER::COLLECTION)
    ("CDK4/cyclin D" . SPARSER::COLLECTION)
    ("CDK1/cyclin" . SPARSER::COLLECTION)
    ("CDK2/cyclin E" . SPARSER::COLLECTION)
    ("CDK2/cyclin" . SPARSER::COLLECTION) ("CDK/cyclin" . SPARSER::COLLECTION)
    ("Nuc" . SPARSER::PROTEIN) ("Cyt" . SPARSER::MOLECULE)
    ("mask" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin E and other proteins" . SPARSER::COLLECTION)
    ("Metazoans" . SPARSER::PROTEIN-FAMILY)
    ("metazoans" . SPARSER::PROTEIN-FAMILY) ("cyclin E1" . SPARSER::PROTEIN)
    ("RO3306" . SPARSER::DRUG) ("VX-680" . SPARSER::DRUG)
    ("GDC-0941" . SPARSER::DRUG) ("MK-2206" . SPARSER::MOLECULE)
    ("SB 203580" . SPARSER::DRUG) ("PD0325901" . SPARSER::DRUG)
    ("Histone 2B" . SPARSER::PROTEIN) ("cyclin A2" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cdc6" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("DNA helicase B" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("BAK and BID" . SPARSER::COLLECTION) ("mer" . SPARSER::PROTEIN)
    ("Fas/FasL" . SPARSER::COLLECTION) ("FasL and BID" . SPARSER::COLLECTION)
    ("FasL" . SPARSER::PROTEIN) ("tBID:BAK" . SPARSER::BIO-COMPLEX)
    ("held" . SPARSER::PROTEIN) ("analog" . SPARSER::ANALOG)
    ("nucleoside" . SPARSER::MOLECULE) ("gemcitabine" . SPARSER::DRUG)
    ("topotecan, etoposide, doxorubicin and mitoxantrone"
     . SPARSER::COLLECTION)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG) ("BID and BAK" . SPARSER::COLLECTION)
    ("TRAIL and topoisomerase" . SPARSER::COLLECTION)
    ("the topoisomerase II inhibitor etoposide (data not shown) and the topoisomerase II inhibitor mitoxantrone"
     . SPARSER::COLLECTION)
    ("Annexin V and propidium" . SPARSER::COLLECTION)
    ("cisplatin and paclitaxel" . SPARSER::COLLECTION)
    ("TRAIL-" . SPARSER::PROTEIN)
    ("cisplatin, the microtubule inhibitor paclitaxel," . SPARSER::DRUG)
    ("cisplatin, the microtubule inhibitor paclitaxel, or the kinase inhibitor staurosporine"
     . SPARSER::COLLECTION)
    ("staurosporine" . SPARSER::DRUG)
    ("etoposide, topotecan, and doxorubicin" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-X" . SPARSER::COLLECTION) ("tBid" . SPARSER::PROTEIN)
    ("target topoisomerase I (topotecan and irinotecan) or topoisomerase II (etoposide, mitoxantrone and doxorubicin)"
     . SPARSER::COLLECTION)
    ("topotecan and irinotecan" . SPARSER::COLLECTION)
    ("etoposide, mitoxantrone and doxorubicin" . SPARSER::COLLECTION)
    ("mitoxantrone" . SPARSER::DRUG) ("irinotecan" . SPARSER::DRUG)
    ("topotecan" . SPARSER::DRUG) ("Topoisomerase" . SPARSER::PROTEIN)
    ("BID −/− and BIM −/− MEFs" . SPARSER::COLLECTION)
    ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("a predictable impact" . SPARSER::PROTEIN) ("EL" . SPARSER::PROTEIN)
    ("BAX and/or BAK( xref )" . SPARSER::COLLECTION)
    ("BIM, BID or p53" . SPARSER::COLLECTION)
    ("oligomerized BAX and BAK proteins" . SPARSER::PROTEIN)
    ("peptide or protein" . SPARSER::COLLECTION)
    ("Mitochondria" . SPARSER::PROTEIN) ("cBID or BIM" . SPARSER::COLLECTION)
    ("full-length pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("BAX or BAK" . SPARSER::COLLECTION) ("digitonin" . SPARSER::MOLECULE)
    ("exogenous BAX and BAK" . SPARSER::COLLECTION)
    ("MEFs and BMKs" . SPARSER::COLLECTION)
    ("this case BAX and BAK loss roughly equally affected cBID-induced MOMP"
     . SPARSER::PROTEIN)
    ("cBID and BIM" . SPARSER::COLLECTION)
    ("dominant-negative p53" . SPARSER::PROTEIN)
    ("BID and BAX" . SPARSER::COLLECTION) ("BMK" . SPARSER::PROTEIN)
    ("cBID" . SPARSER::PROTEIN-FAMILY) ("BIM-" . SPARSER::PROTEIN)
    ("max" . SPARSER::PROTEIN) ("BIM, BID, BAX and BAK" . SPARSER::COLLECTION)
    ("BIM or BID" . SPARSER::COLLECTION)
    ("3μM BID peptide and 10μM BIM peptide ( xref , upper left panel)"
     . SPARSER::COLLECTION)
    ("Peptide" . SPARSER::PEPTIDE) ("ionophore" . SPARSER::MOLECULE)
    ("FCCP" . SPARSER::MOLECULE) ("BAX, or BAK" . SPARSER::COLLECTION)
    ("cytochrome" . SPARSER::PROTEIN)
    ("either recombinant proteins or BH3 domain peptides"
     . SPARSER::COLLECTION)
    ("BAK and BIM" . SPARSER::COLLECTION)
    ("a potential-sensitive fluorescent dye" . SPARSER::MOLECULE)
    ("topoisomerase I and/or II inhibitors" . SPARSER::COLLECTION)
    ("II inhibitors" . SPARSER::INHIBITOR)
    ("Fas, TNF and TRAIL" . SPARSER::COLLECTION)
    ("BIM and BID" . SPARSER::COLLECTION)
    ("the pro-apoptotic BH3-only proteins, BIM and BID" . SPARSER::COLLECTION)
    ("proteins, BIM and BID" . SPARSER::COLLECTION)
    ("BCL-2-associated X protein (BAX) and BCL-2 antagonist or killer (BAK)"
     . SPARSER::COLLECTION)
    ("antagonist or killer (BAK)" . SPARSER::COLLECTION)
    ("BCL-2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("protein (BAX)" . SPARSER::PROTEIN)
    ("antagonist or killer" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins PUMA, BIM, BID, BAD, BIK, NOXA, and BMF"
     . SPARSER::COLLECTION)
    ("PUMA, BIM, BID, BAD, BIK, NOXA, and BMF" . SPARSER::COLLECTION)
    ("BMF" . SPARSER::PROTEIN) ("BIK" . SPARSER::PROTEIN)
    ("BCL-2, BCL-w, MCL-1, BFL-1, and BCL-X" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("caspases, caspase 3 and caspase 7" . SPARSER::COLLECTION)
    ("BID and BIM" . SPARSER::COLLECTION) ("TRAIL" . SPARSER::PROTEIN)
    ("topoisomerase" . SPARSER::PROTEIN) ("BID or BIM" . SPARSER::COLLECTION)
    ("BAK or BAX" . SPARSER::COLLECTION) ("Fas ligand" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("PUMA protein" . SPARSER::PROTEIN) ("MTCH2" . SPARSER::PROTEIN)
    ("L protein" . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("JC1" . SPARSER::MOLECULE) ("BCL-X" . SPARSER::PROTEIN)
    ("BFL-1" . SPARSER::PROTEIN) ("BCL-w" . SPARSER::PROTEIN)
    ("BAK1" . SPARSER::PROTEIN)
    ("negative and positive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("activators and repressors" . SPARSER::COLLECTION)
    ("Sip1, Menin, Wt1 and Mzf-2" . SPARSER::COLLECTION)
    ("Alternatively many proteins" . SPARSER::PROTEIN)
    ("Maz and Sp1" . SPARSER::COLLECTION)
    ("Tip60 and Gcn5" . SPARSER::COLLECTION) ("TRRAP" . SPARSER::PROTEIN)
    ("mSin3A-HDAC" . SPARSER::COLLECTION) ("mSin3A" . SPARSER::PROTEIN)
    ("the previously known hTERT regulators Myc and Sp1" . SPARSER::COLLECTION)
    ("Maz and Foxc1" . SPARSER::COLLECTION) ("acetylases" . SPARSER::PROTEIN)
    ("Gcn5 and Tip60" . SPARSER::COLLECTION)
    ("promoters and increase gene expression ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("acetyltransferases" . SPARSER::PROTEIN)
    ("transcriptional activators and repressors" . SPARSER::COLLECTION)
    ("Max and Myc" . SPARSER::COLLECTION) ("Max" . SPARSER::PROTEIN)
    ("Maz" . SPARSER::PROTEIN) ("HA-Maz" . SPARSER::PROTEIN-PAIR)
    ("AcH" . SPARSER::PROTEIN) ("Myc and Sp1" . SPARSER::COLLECTION)
    ("LacO" . SPARSER::PROTEIN)
    ("at least two unique peptides" . SPARSER::PEPTIDE)
    ("LacI-Flag" . SPARSER::COLLECTION) ("Sp1 and Maz" . SPARSER::COLLECTION)
    ("forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("previously identified hTERT transcriptional regulators"
     . SPARSER::PROTEIN-FAMILY)
    ("Myc/Max and Sp1" . SPARSER::COLLECTION)
    ("Foxc1 and Maz" . SPARSER::COLLECTION)
    ("protein and DNA" . SPARSER::COLLECTION)
    ("hTERT and increases telomerase activity" . SPARSER::COLLECTION)
    ("complex (HDAC)" . SPARSER::BIO-COMPLEX)
    ("mSin3A-histone deacetylase" . SPARSER::PROTEIN-PAIR)
    ("the endogenous E6-Associated cellular Protein" . SPARSER::PROTEIN)
    ("p53, Mad, Wt1, Mzf-2, Sip1 and Menin" . SPARSER::COLLECTION)
    ("Myc, Sp1 and Ets" . SPARSER::COLLECTION)
    ("Sip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Wt1" . SPARSER::PROTEIN)
    ("Menin" . SPARSER::PROTEIN) ("Sip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mad" . SPARSER::PROTEIN) ("repressors" . SPARSER::REPRESSOR)
    ("cis and trans" . SPARSER::COLLECTION) ("LacO-LacI" . SPARSER::COLLECTION)
    ("LacI" . SPARSER::PROTEIN) ("Casein Kinase 2" . SPARSER::PROTEIN)
    ("FoxC1" . SPARSER::PROTEIN) ("Tip60" . SPARSER::PROTEIN)
    ("p150" . SPARSER::PROTEIN) ("Gcn5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Histone H4" . SPARSER::PROTEIN) ("CA5" . SPARSER::PROTEIN)
    ("T-antigen" . SPARSER::PROTEIN) ("Foxc1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Myc/Max" . SPARSER::PROTEIN) ("Myc protein" . SPARSER::PROTEIN)
    ("NFX1" . SPARSER::PROTEIN) ("E6AP" . SPARSER::PROTEIN)
    ("viral factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T antigen and adenovirus" . SPARSER::COLLECTION)
    ("At least 14 LKB1 phosphorylation substrates" . SPARSER::SUBSTRATE)
    ("the two different kinase-defective LKB1-mutants" . SPARSER::MUTANT)
    ("the kinase-defective LKB1-K78I and LKB1-D194A mutants" . SPARSER::MUTANT)
    ("The kinase-defective LKB1-D194A mutant" . SPARSER::MUTANT)
    ("different lentiviral shRNAs" . SPARSER::PROTEIN)
    ("kinase-defective mutants" . SPARSER::MUTANT)
    ("the kinase-defective LKB1-K78I mutant" . SPARSER::MUTANT)
    ("LKB" . SPARSER::PROTEIN) ("deoxyglucose" . SPARSER::MOLECULE)
    ("wild type LKB1 (LKB1-WT) or the kinase defective LKB1-K78I mutant"
     . SPARSER::COLLECTION)
    ("LKB1 or kinase" . SPARSER::COLLECTION)
    ("a kinase-defective LKB1 mutant" . SPARSER::MUTANT)
    ("PJS" . SPARSER::PROTEIN) ("NUAK2 and NUAK1" . SPARSER::COLLECTION)
    ("ARK5 and SNARK" . SPARSER::COLLECTION)
    ("SNRK and SIK1–3" . SPARSER::COLLECTION) ("SNRK" . SPARSER::PROTEIN)
    ("SNARK" . SPARSER::PROTEIN) ("sun" . SPARSER::PROTEIN)
    ("p53 and pRB" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("Mg 2+" . SPARSER::MOLECULE) ("LKB-1" . SPARSER::PROTEIN)
    ("NUAK2" . SPARSER::PROTEIN) ("SIK1" . SPARSER::PROTEIN)
    ("ARK5" . SPARSER::PROTEIN) ("NUAK1" . SPARSER::PROTEIN)
    ("BRSK1" . SPARSER::PROTEIN) ("MARK1" . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("CS and UG" . SPARSER::COLLECTION) ("JP" . SPARSER::PROTEIN)
    ("UG" . SPARSER::PROTEIN) ("CS" . SPARSER::PROTEIN)
    ("macromolecule" . SPARSER::MOLECULE)
    ("Tti1 [ xref ] and Tel2 [ xref ]" . SPARSER::COLLECTION)
    ("Tti1" . SPARSER::PROTEIN) ("EBP" . SPARSER::PROTEIN)
    ("Raptor" . SPARSER::PROTEIN) ("AMPK, GSK3 or Akt" . SPARSER::COLLECTION)
    ("NUP98-HHEX" . SPARSER::COLLECTION) ("HHEX" . SPARSER::PROTEIN)
    ("SET-NUP214" . SPARSER::COLLECTION) ("SET" . SPARSER::PROTEIN)
    ("almost two decades ago" . SPARSER::PROTEIN)
    ("Everolimus" . SPARSER::MOLECULE)
    ("lactate and glucose" . SPARSER::COLLECTION)
    ("AMPK and GSK3" . SPARSER::COLLECTION)
    ("protein and mTOR" . SPARSER::COLLECTION)
    ("previously established deletion mutants" . SPARSER::MUTANT)
    ("geneticin" . SPARSER::MOLECULE) ("DEK or NUP214" . SPARSER::COLLECTION)
    ("the highly specific mTORC1 inhibitors everolimus (RAD001) and temserolimus (CCI-779)"
     . SPARSER::COLLECTION)
    ("currently several inhibitors" . SPARSER::INHIBITOR)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("an invariable fusion protein" . SPARSER::PROTEIN)
    ("nucleoporin" . SPARSER::PROTEIN) ("everolimus" . SPARSER::DRUG)
    ("kinase and Akt" . SPARSER::COLLECTION)
    ("DEK-NUP214" . SPARSER::COLLECTION) ("DEK" . SPARSER::PROTEIN)
    ("Tel2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CRM1" . SPARSER::PROTEIN)
    ("S Protein" . SPARSER::PROTEIN) ("UP50" . SPARSER::PROTEIN)
    ("CCI-779" . SPARSER::DRUG)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("RAD001" . SPARSER::DRUG) ("p70 S6" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("NUP214" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN) ("EB" . SPARSER::PROTEIN)
    ("VP" . SPARSER::PROTEIN) ("BRAF-" . SPARSER::PROTEIN)
    ("a significant prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HR " . SPARSER::PROTEIN) ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("MEK/ERK" . SPARSER::COLLECTION) ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prognostic biomarker" . SPARSER::MOLECULE)
    ("BRAF and KRAS" . SPARSER::COLLECTION) ("WT2" . SPARSER::PROTEIN)
    ("PHYL" . SPARSER::PROTEIN) ("ShRNA" . SPARSER::PROTEIN)
    ("diphenyl" . SPARSER::DRUG)
    ("These findings shed new light" . SPARSER::PROTEIN)
    ("a progressive de-differentiated state" . SPARSER::BIO-STATE)
    ("receptors and Smad" . SPARSER::COLLECTION)
    ("FGF, and TGF-β" . SPARSER::COLLECTION)
    ("β-catenin and the critical role E-cadherin" . SPARSER::COLLECTION)
    ("EMT and cadherin" . SPARSER::COLLECTION)
    ("EMT genes or its regulators" . SPARSER::COLLECTION)
    ("p53 , RB1, and WT1" . SPARSER::COLLECTION)
    ("GSK3A (−9.9-fold) and the TLE repressor AES (−9.6-fold)"
     . SPARSER::COLLECTION)
    ("AES" . SPARSER::PROTEIN) ("CD24 and CD133" . SPARSER::COLLECTION)
    ("Nanog , Oct4, Sox2, and Klf4" . SPARSER::COLLECTION)
    ("RB1 and WT1" . SPARSER::COLLECTION)
    ("β-catenin and c-Myc" . SPARSER::COLLECTION)
    ("β-catenin, Axin2, and E-cadherin" . SPARSER::COLLECTION)
    ("Bio" . SPARSER::MOLECULE)
    ("markers and regulators such as Twist, Snail, Cyclin D1 , Slug , Fn1, and E-cadherin"
     . SPARSER::REGULATOR)
    ("Nanog and Oct4 , and EMT" . SPARSER::COLLECTION)
    ("Oct4 , and EMT" . SPARSER::COLLECTION)
    ("Twist, Snail, Cyclin D1 , Slug , Fn1, and E-cadherin"
     . SPARSER::COLLECTION)
    ("Slug" . SPARSER::PROTEIN) ("Snail" . SPARSER::PROTEIN)
    ("β-catenin and Axin2" . SPARSER::COLLECTION) ("BIO" . SPARSER::MOLECULE)
    ("Bromoindirubin-3" . SPARSER::COLLECTION) ("Hedgehog" . SPARSER::PROTEIN)
    ("family and Wnt" . SPARSER::COLLECTION)
    ("receptors, FZD3, FZD5, and FZD6" . SPARSER::COLLECTION)
    ("BMP and Activin" . SPARSER::COLLECTION)
    ("many other relevant genes" . SPARSER::GENE)
    ("HOXA9, RB1, ZIC1, WRN, TDGF1, LIN28B , and WT1" . SPARSER::COLLECTION)
    ("Sox2, Klf4, Oct4, and Nanog" . SPARSER::COLLECTION)
    ("/CD44" . SPARSER::COLLECTION) ("CD24 and CD44" . SPARSER::COLLECTION)
    ("N-cadherin and Nanog" . SPARSER::COLLECTION)
    ("β-catenin, E-cadherin, Sox2, Zeb1, and Fn1" . SPARSER::COLLECTION)
    ("Zeb" . SPARSER::PROTEIN)
    ("Nanog , Oct4 , Sox2 , and Klf4" . SPARSER::COLLECTION)
    ("exogenous β-catenin" . SPARSER::PROTEIN)
    ("Nanog and Oct4" . SPARSER::COLLECTION)
    ("relevant exogenous genes" . SPARSER::GENE)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("β-catenin, E-cadherin , and Cyclin D1" . SPARSER::COLLECTION)
    ("Wnt/TCF" . SPARSER::COLLECTION) ("Wnt/TCF/LEF" . SPARSER::COLLECTION)
    ("β-catenin, Axin2, Nanog, and Oct4" . SPARSER::COLLECTION)
    ("Nanog, Oct4 , and Klf4" . SPARSER::COLLECTION)
    ("Tcf1, Tcf3, and c-Myc" . SPARSER::COLLECTION)
    ("Tcf1 and Tcf3" . SPARSER::COLLECTION)
    ("E-cadherin and EMT" . SPARSER::COLLECTION) ("FGF" . SPARSER::PROTEIN)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("other possible TSGs" . SPARSER::PROTEIN) ("TSGs" . SPARSER::PROTEIN)
    ("MCH" . SPARSER::PROTEIN) ("TSG" . SPARSER::PROTEIN)
    ("NPC" . SPARSER::MOLECULE)
    ("CD9, CD24, CD44, CD90, and CD133" . SPARSER::COLLECTION)
    ("TGF-β, Activin, BMPR, FGFR2, and LIFR-" . SPARSER::COLLECTION)
    ("LIFR-" . SPARSER::PROTEIN) ("LIFR" . SPARSER::PROTEIN)
    ("BMPR" . SPARSER::PROTEIN) ("Activin" . SPARSER::PROTEIN)
    ("p53- and RB1" . SPARSER::COLLECTION) ("p53-" . SPARSER::PROTEIN)
    ("Nanog" . SPARSER::PROTEIN) ("haploid" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("pMD2" . SPARSER::MOLECULE) ("ACVR2A" . SPARSER::PROTEIN)
    ("GSK3A" . SPARSER::PROTEIN) ("FBXW2" . SPARSER::PROTEIN)
    ("Wnt11" . SPARSER::PROTEIN) ("DKK1" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("Tumor suppressor gene" . SPARSER::PROTEIN)
    ("MCH3" . SPARSER::PROTEIN) ("FZD6" . SPARSER::PROTEIN)
    ("FZD5" . SPARSER::PROTEIN) ("FZD3" . SPARSER::PROTEIN)
    ("LIN28B" . SPARSER::PROTEIN) ("TDGF1" . SPARSER::PROTEIN)
    ("ZIC1" . SPARSER::PROTEIN) ("Fn1" . SPARSER::PROTEIN)
    ("MCH4" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("Tcf3" . SPARSER::PROTEIN) ("Tcf1" . SPARSER::PROTEIN)
    ("CD9" . SPARSER::PROTEIN) ("IL6ST" . SPARSER::PROTEIN)
    ("Klf4" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("alkylator" . SPARSER::MOLECULE)
    ("MLH1 or MSH2" . SPARSER::COLLECTION) ("sporadic CRC" . SPARSER::PROTEIN)
    ("MSH2 and MLH1" . SPARSER::COLLECTION)
    ("the associated genes" . SPARSER::GENE) ("cytosine" . SPARSER::NUCLEOBASE)
    ("the study cohort and the validation cohort" . SPARSER::COLLECTION)
    ("statistically significant independent prognostic factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the prognostic impact" . SPARSER::PROTEIN) ("Impact" . SPARSER::PROTEIN)
    ("MLH1 , MSH2 or MSH6" . SPARSER::COLLECTION) ("MSS" . SPARSER::PROTEIN)
    ("MLH1 and MSH6" . SPARSER::COLLECTION)
    ("MLH1 and MSH2" . SPARSER::COLLECTION)
    ("case, MLH1 and MSH6" . SPARSER::COLLECTION)
    ("MSH2 and MSH6" . SPARSER::COLLECTION)
    ("MLH1 , MSH2 and MSH6" . SPARSER::COLLECTION)
    ("the associated protein" . SPARSER::PROTEIN)
    ("MSH2 or MLH1" . SPARSER::COLLECTION)
    ("MSH6 or PMS2" . SPARSER::COLLECTION) ("Mismatch" . SPARSER::PROTEIN)
    ("at least one MMR protein" . SPARSER::PROTEIN)
    ("MLH1, MSH2 and MSH6" . SPARSER::COLLECTION) ("MLH1" . SPARSER::PROTEIN)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PAX6" . SPARSER::PROTEIN)
    ("D5S346" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("larger sample cohort" . SPARSER::MOLECULE)
    ("usher" . SPARSER::PROTEIN-FAMILY)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("the traditional biomarker" . SPARSER::MOLECULE)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BPH" . SPARSER::PROTEIN)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("prostate specific antigen (PSA)" . SPARSER::PROTEIN)
    ("PSA" . SPARSER::PROTEIN) ("PCa" . SPARSER::PROTEIN)
    ("plasma)" . SPARSER::PROTEIN) ("protein1A" . SPARSER::PROTEIN)
    ("RASSF1" . SPARSER::PROTEIN) ("Nore1" . SPARSER::PROTEIN)
    ("GSTP1" . SPARSER::PROTEIN) ("RASSF1A" . SPARSER::PROTEIN)
    ("protein 1 A" . SPARSER::PROTEIN)
    ("prostate specific antigen" . SPARSER::PROTEIN)
    ("a pathogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immunogen" . SPARSER::MOLECULE) ("PD-1/PD-L1" . SPARSER::COLLECTION)
    ("Tat-induced immunosuppressive IDO" . SPARSER::PROTEIN)
    ("the mucosal barrier" . SPARSER::PROTEIN)
    ("FOXP3 and CTLA4" . SPARSER::COLLECTION)
    ("soluble gp120" . SPARSER::PROTEIN)
    ("internal viral proteins" . SPARSER::PROTEIN) ("Ada" . SPARSER::PROTEIN)
    ("MN" . SPARSER::PROTEIN) ("gp120-CD4" . SPARSER::COLLECTION)
    ("IL-10 and IDO" . SPARSER::COLLECTION)
    ("αvβ3, and α5β1" . SPARSER::COLLECTION)
    ("Tat-deleted mutants" . SPARSER::MUTANT)
    ("protein or IFN-γ" . SPARSER::COLLECTION)
    ("MoDC-PBL" . SPARSER::COLLECTION) ("autologous PBL" . SPARSER::PROTEIN)
    ("Mab" . SPARSER::DRUG) ("Jak, and Ly 294002" . SPARSER::COLLECTION)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("Tat-induced IFN-γ and IFN-α" . SPARSER::COLLECTION)
    ("IFN-γ and IFN-α" . SPARSER::COLLECTION)
    ("Tat-induced IFN-γ" . SPARSER::PROTEIN)
    ("TNF-α, IL-10, IL-12, IL-6, IFN-α and IFN-γ" . SPARSER::COLLECTION)
    ("Tat-induced cytokines" . SPARSER::PROTEIN)
    ("GST (1.6% IDO positive cells) or LPS (0.4% IDO positive cells)"
     . SPARSER::COLLECTION)
    ("specific inducers such as IFN-γ or HIV-1 Tat" . SPARSER::COLLECTION)
    ("MoDC" . SPARSER::PROTEIN) ("pDC" . SPARSER::PROTEIN)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("Different viral proteins" . SPARSER::PROTEIN)
    ("indirect viral factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a highly immunosuppressive cytokine" . SPARSER::PROTEIN)
    ("cytokine, and IL-10" . SPARSER::COLLECTION)
    ("two major cytokines, IFN-γ and TGF-β" . SPARSER::COLLECTION)
    ("cytokines, IFN-γ and TGF-β" . SPARSER::COLLECTION)
    ("Jak/stat" . SPARSER::COLLECTION) ("stat" . SPARSER::PROTEIN)
    ("histidine and kynurenine" . SPARSER::COLLECTION)
    ("a homotetrameric protein" . SPARSER::PROTEIN) ("TDO" . SPARSER::PROTEIN)
    ("hydroxykynurenine" . SPARSER::MOLECULE)
    ("an intracellular monomeric protein of 45 kDa" . SPARSER::PROTEIN)
    ("oxygenase" . SPARSER::PROTEIN)
    ("an essential amino acid" . SPARSER::AMINO-ACID)
    ("catabolism" . SPARSER::PROTEIN) ("soluble protein" . SPARSER::PROTEIN)
    ("the nascent viral RNA" . SPARSER::RNA)
    ("cyclin T1 and CDK9" . SPARSER::COLLECTION) ("TAK" . SPARSER::PROTEIN)
    ("the viral factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gp120-DC-SIGN" . SPARSER::COLLECTION)
    ("a viral pathogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kynurenine" . SPARSER::MOLECULE) ("MT" . SPARSER::PROTEIN)
    ("Tat-induced IDO" . SPARSER::PROTEIN)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PD-L1" . SPARSER::PROTEIN)
    ("PD-1" . SPARSER::PROTEIN) ("CTLA4" . SPARSER::PROTEIN)
    ("low density lipoprotein receptor" . SPARSER::PROTEIN)
    ("b-FGF" . SPARSER::DRUG) ("CCR3" . SPARSER::PROTEIN)
    ("CCR2" . SPARSER::PROTEIN) ("CD26" . SPARSER::PROTEIN)
    ("αvβ3" . SPARSER::PROTEIN) ("A–F" . SPARSER::PROTEIN)
    ("Ly 294002" . SPARSER::MOLECULE) ("Tat1" . SPARSER::PROTEIN)
    ("Cell Membrane" . SPARSER::PROTEIN) ("L-Tryptophan" . SPARSER::MOLECULE)
    ("SO4" . SPARSER::PROTEIN) ("IL-12p70" . SPARSER::PROTEIN)
    ("inhibitor 1" . SPARSER::PROTEIN) ("IgG2b" . SPARSER::BIO-COMPLEX)
    ("interleukin-4" . SPARSER::PROTEIN) ("CD1a" . SPARSER::PROTEIN)
    ("IgG2a" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("LY 294002" . SPARSER::MOLECULE) ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("Chemical products" . SPARSER::CHEMICAL-PRODUCT)
    ("SF2" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("TLR7" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tryptophan 2,3-dioxygenase" . SPARSER::PROTEIN)
    ("quinolinic acid" . SPARSER::MOLECULE)
    ("L-tryptophan" . SPARSER::MOLECULE) ("of 45" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN) ("cyclin T1" . SPARSER::PROTEIN)
    ("DC-SIGN" . SPARSER::PROTEIN) ("gp120" . SPARSER::PROTEIN)
    ("Ly294002" . SPARSER::MOLECULE) ("Tat 1" . SPARSER::PROTEIN)
    ("indoleamine 2,3 dioxygenase" . SPARSER::PROTEIN)
    ("anti-angiogenic and chemotherapeutic regimens" . SPARSER::COLLECTION)
    ("ruthenium" . SPARSER::MOLECULE) ("celecoxib" . SPARSER::DRUG)
    ("cyclooxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAK" . SPARSER::PROTEIN) ("Phox" . SPARSER::PROTEIN)
    ("anti-HER2/neu" . SPARSER::COLLECTION)
    ("NSC23766 and RAC1" . SPARSER::COLLECTION)
    ("RAC-GEF" . SPARSER::COLLECTION) ("TRIO or TIAM1" . SPARSER::COLLECTION)
    ("CDC42 or RHOA" . SPARSER::COLLECTION) ("RHOA" . SPARSER::PROTEIN)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("G-protein (ARF)" . SPARSER::PROTEIN)
    ("G-protein-GEF" . SPARSER::COLLECTION) ("antibiotic" . SPARSER::DRUG)
    ("RAC1 and its primary regulators (GEFs and GAPs)" . SPARSER::COLLECTION)
    ("GEFs and GAPs" . SPARSER::COLLECTION) ("HER2/neu" . SPARSER::COLLECTION)
    ("RAC1-NF2" . SPARSER::COLLECTION) ("NFkB" . SPARSER::PROTEIN)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("RAC1 and both its upstream activators" . SPARSER::COLLECTION)
    ("integrin and TIAM1" . SPARSER::COLLECTION) ("PTHrP" . SPARSER::PROTEIN)
    ("NEDD9 (a metastasis-related gene) and DOCK3 (a RAC GEF)"
     . SPARSER::COLLECTION)
    ("RAC and RHO" . SPARSER::COLLECTION)
    ("RAC1 and RAC3" . SPARSER::COLLECTION)
    ("TRIO, ECT2, and VAV3" . SPARSER::COLLECTION) ("TRIO" . SPARSER::PROTEIN)
    ("FLK-1" . SPARSER::PROTEIN) ("A robust line" . SPARSER::PROTEIN)
    ("dominant-negative RAC" . SPARSER::PROTEIN)
    ("RHO and CDC42" . SPARSER::COLLECTION)
    ("new vasculature" . SPARSER::PROTEIN)
    ("CDC42 (Cell division control protein 42 homolog) and RAC1"
     . SPARSER::COLLECTION)
    ("three-dimensional collagen matrices" . SPARSER::PROTEIN-FAMILY)
    ("sacs" . SPARSER::PROTEIN) ("RAC" . SPARSER::PROTEIN)
    ("RAC1 and MYC" . SPARSER::COLLECTION)
    ("integrin and PAK2" . SPARSER::COLLECTION)
    ("The classical GEF activators" . SPARSER::ACTIVATOR)
    ("VAV1 and VAV2, DBL, and TIAM1" . SPARSER::COLLECTION)
    ("VAV2, DBL, and TIAM1" . SPARSER::COLLECTION)
    ("RhoGAP1, RacGAP1, ABR, and BCR" . SPARSER::COLLECTION)
    ("BCR" . SPARSER::PROTEIN) ("ABR" . SPARSER::PROTEIN)
    ("DBL" . SPARSER::PROTEIN)
    ("RAC1, and GTPase activating" . SPARSER::COLLECTION)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GDP" . SPARSER::NUCLEOTIDE)
    ("GEFs" . SPARSER::GEF) ("JNK/p38" . SPARSER::COLLECTION)
    ("NCK" . SPARSER::PROTEIN)
    ("kinases, LIMK1 and LIMK2" . SPARSER::COLLECTION)
    ("LIM" . SPARSER::PROTEIN) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("PAK1, PAK2, and PAK3" . SPARSER::COLLECTION)
    ("RHO, RAC1, and CDC42" . SPARSER::COLLECTION)
    ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY) ("OS2" . SPARSER::MOLECULE)
    ("IPA-3" . SPARSER::MOLECULE) ("MAPKK1" . SPARSER::PROTEIN)
    ("OSU 03012" . SPARSER::DRUG) ("p67 phox" . SPARSER::PROTEIN)
    ("p21-activated kinase 1" . SPARSER::PROTEIN) ("TIAM-1" . SPARSER::PROTEIN)
    ("G15" . SPARSER::PROTEIN) ("Vav2" . SPARSER::PROTEIN)
    ("EHT 1864" . SPARSER::DRUG) ("NSC23766" . SPARSER::DRUG)
    ("NF2" . SPARSER::PROTEIN) ("DOCK3" . SPARSER::PROTEIN)
    ("PREX1" . SPARSER::PROTEIN) ("LMCD1" . SPARSER::PROTEIN)
    ("RAC3" . SPARSER::PROTEIN) ("D4-GDI" . SPARSER::PROTEIN)
    ("VAV3" . SPARSER::PROTEIN) ("ECT2" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("B16" . SPARSER::PROTEIN)
    ("si-RNAs" . SPARSER::RNA)
    ("Cell division control protein 42 homolog" . SPARSER::PROTEIN)
    ("RacGAP1" . SPARSER::PROTEIN) ("RhoGAP1" . SPARSER::PROTEIN)
    ("TIAM1" . SPARSER::PROTEIN) ("VAV2" . SPARSER::PROTEIN)
    ("VAV1" . SPARSER::PROTEIN) ("GTPase activating" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("WAVE1" . SPARSER::PROTEIN)
    ("ARP2" . SPARSER::PROTEIN) ("LIMK2" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("PAK3" . SPARSER::PROTEIN)
    ("RAC-1" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("RAC1" . SPARSER::PROTEIN)
    ("APC , BRCA1 , CDH1 , CDH13 , HIC1 , hMLH1 , RUNX3 , and SOCS1"
     . SPARSER::COLLECTION)
    ("whole-genome or exome" . SPARSER::COLLECTION)
    ("some heterogeneously methylated molecules" . SPARSER::MOLECULE)
    ("MCA" . SPARSER::PROTEIN) ("Melting" . SPARSER::DRUG)
    ("RL" . SPARSER::PROTEIN)
    ("heterogeneously methylated molecules" . SPARSER::MOLECULE)
    ("Examples" . SPARSER::EXAMPLE) ("only one allele" . SPARSER::ALLELE)
    ("MIP" . SPARSER::PROTEIN) ("Bisulfite" . SPARSER::MOLECULE)
    ("the rs16906252 MGMT and the rs13300553 DAPK1 SNPs" . SPARSER::COLLECTION)
    ("MGMT or DAPK1" . SPARSER::COLLECTION)
    ("cytosines and CpG" . SPARSER::COLLECTION)
    ("cytosines" . SPARSER::NUCLEOBASE) ("bisulfite" . SPARSER::MOLECULE)
    ("traditional MSP" . SPARSER::PROTEIN)
    ("using traditional MSP" . SPARSER::PROTEIN)
    ("a pro-apoptotic gene" . SPARSER::GENE)
    ("cyclophosphamide, doxorubicin, vincristine, and prednisone"
     . SPARSER::COLLECTION)
    ("CHOP" . SPARSER::PROTEIN) ("prednisone" . SPARSER::DRUG)
    ("vincristine" . SPARSER::DRUG) ("rituximab" . SPARSER::DRUG)
    ("SNP and MGMT" . SPARSER::COLLECTION) ("MSP" . SPARSER::PROTEIN)
    ("MGMT and DAPK1" . SPARSER::COLLECTION) ("M.SssI" . SPARSER::PROTEIN)
    ("CD43" . SPARSER::PROTEIN) ("hMLH1" . SPARSER::PROTEIN)
    ("HIC1" . SPARSER::PROTEIN) ("CDH13" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("DAPK1" . SPARSER::PROTEIN)
    ("proteasomal inhibitor bortezomib" . SPARSER::DRUG)
    ("neither siRNA -resistant OTUB1 C91S mutant (catalytically inactive, SMAD3-interaction deficient but able to inhibit SMAD3 ubiquitylation) nor OTUB1 ΔN mutant (catalytically active, interacts with SMAD3 but unable inhibit SMAD3 ubiquitylation)"
     . SPARSER::COLLECTION)
    ("PAI-1 and CTGF" . SPARSER::COLLECTION)
    ("OTUB1 and UBE2N or UBE2D1" . SPARSER::COLLECTION)
    ("UBE2N or UBE2D1" . SPARSER::COLLECTION)
    ("SMAD2/3-TP" . SPARSER::COLLECTION)
    ("phosho-SMAD2/3" . SPARSER::COLLECTION) ("DUB" . SPARSER::PROTEIN)
    ("recombinant OTUB1 as well as endogenous OTUB1" . SPARSER::COLLECTION)
    ("an active SMAD2/3/4 transcription complex" . SPARSER::BIO-COMPLEX)
    ("FLAG-OTUB1" . SPARSER::COLLECTION)
    ("SMAD2/3 or SMAD4" . SPARSER::COLLECTION) ("Bortezomib" . SPARSER::DRUG)
    ("bortezomib or MG132" . SPARSER::COLLECTION)
    ("phospho-SMAD2/3 and E2" . SPARSER::COLLECTION) ("Ub" . SPARSER::PROTEIN)
    ("E3 ligase NEDD4L and its substrate SMAD3" . SPARSER::COLLECTION)
    ("C91S or OTUB1" . SPARSER::COLLECTION)
    ("ATP and E1" . SPARSER::COLLECTION)
    ("almost every molecule" . SPARSER::MOLECULE)
    ("E3 and recombinant human SMAD3 in the presence or absence of 0.5 μM GST-OTUB1 ( xref )"
     . SPARSER::COLLECTION)
    ("UBE2D and UBE2N" . SPARSER::COLLECTION)
    ("UBE2D and UBE2E" . SPARSER::COLLECTION)
    ("GFP-OTUB1" . SPARSER::COLLECTION)
    ("neither OTUB1 C91S (catalytically inactive, inhibits polyubiquitylation of SMAD3 in vitro but does not interact with SMAD3) nor OTUB1 ΔN (catalytically active and interacts with SMAD3 but does not inhibit polyubiquitylation of SMAD3 in vitro )"
     . SPARSER::COLLECTION)
    ("E1, E2 and E3" . SPARSER::COLLECTION)
    ("OTUB1 and mutants" . SPARSER::COLLECTION)
    ("SMAD2/3/4" . SPARSER::PROTEIN)
    ("wild-type OTUB1 or catalytically inactive OTUB1 C91S"
     . SPARSER::COLLECTION)
    ("E2 or E3" . SPARSER::COLLECTION) ("OTUB1 or OTUB1" . SPARSER::COLLECTION)
    ("UBE2D1 (E2) and NEDD4L (E3)" . SPARSER::COLLECTION)
    ("recombinant SMAD2 in vitro using UBE1 (E1), UBE2D1 (E2) and NEDD4L (E3)"
     . SPARSER::COLLECTION)
    ("Wild-type OTUB1 and the ΔN mutant" . SPARSER::COLLECTION)
    ("FLAG-SMAD2/3/4" . SPARSER::COLLECTION)
    ("TGFβ and bortezomib" . SPARSER::COLLECTION)
    ("HA-NEDD4L" . SPARSER::COLLECTION) ("FLAG-SMAD2/3" . SPARSER::COLLECTION)
    ("proteasomal inhibitors bortezomib and lactacystin" . SPARSER::COLLECTION)
    ("bortezomib and lactacystin" . SPARSER::COLLECTION)
    ("lactacystin" . SPARSER::DRUG) ("HA-ubiquitin" . SPARSER::COLLECTION)
    ("HA-OTUB1 C91S and HA-OTUB1 D/C/H mutants" . SPARSER::COLLECTION)
    ("HA-OTUB1" . SPARSER::COLLECTION) ("-OTUB1" . SPARSER::COLLECTION)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C91S" . SPARSER::PROTEIN)
    ("K48-linked diubiquitin ( xref ) as well as longer K48-linked polyubiquitin"
     . SPARSER::COLLECTION)
    ("longer K48-linked polyubiquitin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("diubiquitin" . SPARSER::PROTEIN)
    ("The catalytic cysteine of OTUB1" . SPARSER::PROTEIN)
    ("OTUB1 and forms" . SPARSER::COLLECTION) ("Mutants" . SPARSER::MUTANT)
    ("CTGF" . SPARSER::PROTEIN)
    ("human OTUB1#1 siRNA or a stable short hairpin RNA ( shRNA )"
     . SPARSER::COLLECTION)
    ("a control siRNA (human iFoxO4) , human OTUB1#1 siRNA or a stable short hairpin RNA ( shRNA )"
     . SPARSER::COLLECTION)
    ("Otub1" . SPARSER::PROTEIN) ("CAGA-luciferase" . SPARSER::COLLECTION)
    ("CAGA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OTUB1 and phospho-SMAD2" . SPARSER::COLLECTION)
    ("GST-OTUB1" . SPARSER::COLLECTION) ("hSMAD2" . SPARSER::PROTEIN)
    ("phospho-mimetic mutant" . SPARSER::MUTANT)
    ("FLAG-SMAD3" . SPARSER::COLLECTION)
    ("OTUB1 and phospho-SMAD2/3" . SPARSER::COLLECTION)
    ("the active phospho-SMAD2/3-SMAD4 complex" . SPARSER::BIO-COMPLEX)
    ("OTUB1 and SMAD2/3" . SPARSER::COLLECTION) ("SMAD2/3" . SPARSER::PROTEIN)
    ("OTUB1–SMAD2/3" . SPARSER::COLLECTION) ("SMAD1-TP" . SPARSER::COLLECTION)
    ("SMAD2-TP" . SPARSER::COLLECTION) ("LP" . SPARSER::PROTEIN)
    ("OTUB1 and SMAD3" . SPARSER::COLLECTION)
    ("the active SMAD2/3/4 complex" . SPARSER::BIO-COMPLEX)
    ("Four OTUB1 tryptic peptides" . SPARSER::PEPTIDE)
    ("SMAD4, LEMD3, TRIM33 and SKI" . SPARSER::COLLECTION)
    ("SKI" . SPARSER::PROTEIN) ("BMP and TGFβ" . SPARSER::COLLECTION)
    ("GFP-SMAD1" . SPARSER::COLLECTION) ("trypsin" . SPARSER::PROTEIN)
    ("IPs" . SPARSER::PROTEIN) ("SMAD1 or SMAD3" . SPARSER::COLLECTION)
    ("GFP-SMAD3" . SPARSER::COLLECTION) ("GRAIL" . SPARSER::PROTEIN)
    ("ubiquitin and the target or another ubiquitin molecule"
     . SPARSER::COLLECTION)
    ("the target or another ubiquitin molecule" . SPARSER::COLLECTION)
    ("the ovarian tumour domain protease (OTU) family"
     . SPARSER::PROTEIN-FAMILY)
    ("OTU" . SPARSER::PROTEIN) ("-SMAD3" . SPARSER::COLLECTION)
    ("interactors" . SPARSER::PROTEIN)
    ("active SMADs and either deubiquitylate" . SPARSER::COLLECTION)
    ("polyubiquitin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMURF1/NEDD4L" . SPARSER::COLLECTION)
    ("bone morphogenetic protein (BMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type II and type I" . SPARSER::COLLECTION)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("the proteasomal inhibitor bortezomib" . SPARSER::DRUG)
    ("the active phospho-SMAD2/3 complex" . SPARSER::BIO-COMPLEX)
    ("SMADs" . SPARSER::PROTEIN) ("transducers" . SPARSER::PROTEIN)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RPL13A" . SPARSER::PROTEIN)
    ("microcystin-LR" . SPARSER::MOLECULE) ("C48" . SPARSER::PROTEIN)
    ("bis-tris" . SPARSER::MOLECULE) ("FoxO4" . SPARSER::PROTEIN)
    ("ALK4" . SPARSER::PROTEIN) ("SB505124" . SPARSER::DRUG)
    ("TGFβ 1" . SPARSER::PROTEIN) ("BMP 2" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN) ("L -Glutamine" . SPARSER::MOLECULE)
    ("UBE2L3" . SPARSER::PROTEIN) ("UBE2V1" . SPARSER::PROTEIN)
    ("UBE2" . SPARSER::PROTEIN) ("UBE2D" . SPARSER::PROTEIN)
    ("E3s" . SPARSER::MOLECULE) ("E2s" . SPARSER::MOLECULE)
    ("UBE2D1" . SPARSER::PROTEIN) ("UBE1" . SPARSER::PROTEIN)
    ("K63" . SPARSER::PROTEIN) ("siRNA -mediated" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA) ("PAI-1" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("tail peptide" . SPARSER::PROTEIN) ("SW480" . SPARSER::PROTEIN)
    ("SMAD7" . SPARSER::PROTEIN) ("TRIM33" . SPARSER::PROTEIN)
    ("LEMD3" . SPARSER::PROTEIN) ("N-terminally" . SPARSER::PROTEIN)
    ("SMAD1" . SPARSER::PROTEIN) ("R-SMAD" . SPARSER::PROTEIN-FAMILY)
    ("UBC13" . SPARSER::PROTEIN) ("UBE2N" . SPARSER::PROTEIN)
    ("C91" . SPARSER::PROTEIN)
    ("ubiquitin aldehyde binding 1" . SPARSER::PROTEIN)
    ("OTU domain" . SPARSER::PROTEIN) ("NEDD4L" . SPARSER::PROTEIN)
    ("SMURF1" . SPARSER::PROTEIN) ("GSK-3" . SPARSER::PROTEIN)
    ("CDK8" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMADs 2" . SPARSER::PROTEIN) ("R-SMADs" . SPARSER::PROTEIN-FAMILY)
    ("SMAD2" . SPARSER::PROTEIN) ("OTUB1" . SPARSER::PROTEIN)
    ("a well-known fibrogenic chemical TAA" . SPARSER::PROTEIN)
    ("FoxO1 or HIF1α" . SPARSER::COLLECTION)
    ("H-Ras and β-catenin" . SPARSER::COLLECTION)
    ("DEN/PB" . SPARSER::COLLECTION) ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("chemotaxin" . SPARSER::PROTEIN)
    ("Dickkopf (Dkk) and β-transducing" . SPARSER::COLLECTION)
    ("Dkk" . SPARSER::PROTEIN) ("Dickkopf" . SPARSER::PROTEIN)
    ("C/N" . SPARSER::PROTEIN) ("Wnt/Frizzled" . SPARSER::COLLECTION)
    ("FRP" . SPARSER::PROTEIN) ("pericentral hepatocytes" . SPARSER::PROTEIN)
    ("C/N-β-catenin" . SPARSER::COLLECTION)
    ("cyclin-D1 and GS" . SPARSER::COLLECTION)
    ("gene or genes" . SPARSER::COLLECTION) ("Frizzled" . SPARSER::PROTEIN)
    ("predominantly M/C β-catenin" . SPARSER::PROTEIN)
    ("N/C or C/N" . SPARSER::COLLECTION) ("N/C" . SPARSER::PROTEIN)
    ("N/C-β-catenin" . SPARSER::COLLECTION)
    ("C/N-β-catenin-positive HCCs" . SPARSER::PROTEIN)
    ("β-catenin gene or other components" . SPARSER::COLLECTION)
    ("the other showed predominant C/N β-catenin" . SPARSER::PROTEIN)
    ("only 7% HCCs" . SPARSER::PROTEIN) ("spontaneous HCC" . SPARSER::PROTEIN)
    ("axin-1 (5–14%) and axin–2 (3–10%)" . SPARSER::COLLECTION)
    ("Wnt3/Fz7" . SPARSER::COLLECTION)
    ("c-myc , cyclin-D1 , and survivin" . SPARSER::COLLECTION)
    ("HCCs" . SPARSER::PROTEIN) ("TG and Con" . SPARSER::COLLECTION)
    ("cirrhosis" . SPARSER::PROTEIN) ("predominant nuclear" . SPARSER::PROTEIN)
    ("mutant-" . SPARSER::MUTANT) ("thioacetamide (TAA)" . SPARSER::MOLECULE)
    ("thioacetamide" . SPARSER::MOLECULE) ("Con" . SPARSER::PROTEIN)
    ("glutamine synthetase (GS)" . SPARSER::PROTEIN)
    ("TMA" . SPARSER::MOLECULE) ("FoxO1" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("Lect2" . SPARSER::PROTEIN)
    ("βTrCP" . SPARSER::PROTEIN) ("AXIN1" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN)
    ("cytochrome P450s" . SPARSER::PROTEIN-FAMILY)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN) ("S33" . SPARSER::PROTEIN)
    ("axin–2" . SPARSER::PROTEIN) ("axin-1" . SPARSER::PROTEIN)
    ("Fz7" . SPARSER::PROTEIN) ("Wnt3" . SPARSER::PROTEIN)
    ("cyclin-D1" . SPARSER::PROTEIN)
    ("glutamine synthetase" . SPARSER::PROTEIN)
    ("β-Catenin" . SPARSER::PROTEIN)
    ("dual specificity phosphatases and tumor suppressors"
     . SPARSER::COLLECTION)
    ("dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("lipid and protein" . SPARSER::COLLECTION)
    ("DuSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatase and PTP" . SPARSER::COLLECTION)
    ("The larger Ins(1,3,4)P3 head group" . SPARSER::MOLECULE)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("substrate and substrate" . SPARSER::COLLECTION)
    ("lysines" . SPARSER::AMINO-ACID)
    ("optimal phosphoprotein substrates" . SPARSER::SUBSTRATE)
    ("PTEN and INPP4B" . SPARSER::COLLECTION)
    ("FAK, SMAD3, and PDGFR" . SPARSER::COLLECTION)
    ("a bacterial protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("PtpB" . SPARSER::PROTEIN) ("aa" . SPARSER::MOLECULE)
    ("3xFLAG-WT INPP4B and a phosphatase dead mutant" . SPARSER::COLLECTION)
    ("3xFLAG-WT INPP4B" . SPARSER::PROTEIN)
    ("INPP4B and PTEN" . SPARSER::COLLECTION)
    ("para-nitrophenyl" . SPARSER::PROTEIN-PAIR) ("DifMUP" . SPARSER::DRUG)
    ("Akt and PDK1" . SPARSER::COLLECTION)
    ("INPP4B and phospholipase C" . SPARSER::COLLECTION)
    ("Substrates" . SPARSER::SUBSTRATE)
    ("DuSP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a poor prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN, INPP4B, and SHIP" . SPARSER::COLLECTION)
    ("SHIP" . SPARSER::PROTEIN) ("phosphatidyl" . SPARSER::MOLECULE)
    ("a robust downstream target" . SPARSER::TARGET-PROTEIN)
    ("Akt1 and both the lipid" . SPARSER::COLLECTION)
    ("PTP" . SPARSER::PROTEIN) ("analogs" . SPARSER::ANALOG)
    ("DiFMUP" . SPARSER::DRUG) ("para" . SPARSER::PROTEIN-FAMILY)
    ("Lipid" . SPARSER::LIPID) ("SMAD3" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase activity" . SPARSER::PROTEIN)
    ("6,8-difluoro-4-methylumbelliferyl phosphate" . SPARSER::DRUG)
    ("phospho-Tyrosine" . SPARSER::MOLECULE) ("DiC8" . SPARSER::DRUG)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospholipase C" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("PI5" . SPARSER::PROTEIN) ("PI4K" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("CX 5" . SPARSER::PROTEIN) ("phosphatidyl-inositol" . SPARSER::MOLECULE)
    ("INPP4B" . SPARSER::PROTEIN)
    ("fibronectin and tissue transglutaminase" . SPARSER::COLLECTION)
    ("transglutaminase" . SPARSER::PROTEIN)
    ("fibronectin or unknown adapter molecules" . SPARSER::COLLECTION)
    ("parts" . SPARSER::COMPONENT)
    ("fibrillins and fibronectin" . SPARSER::COLLECTION)
    ("fibronectin and fibrillin" . SPARSER::COLLECTION)
    ("enigma" . SPARSER::PROTEIN)
    ("Fibrillin-1 and fibronectin" . SPARSER::COLLECTION)
    ("anti-fibronectin and anti-fibrillin-1" . SPARSER::COLLECTION)
    ("Fractions" . SPARSER::COMPONENT) ("HSF" . SPARSER::PROTEIN)
    ("fibronectin or fibrillin-1" . SPARSER::COLLECTION)
    ("fragment and FNI" . SPARSER::COLLECTION)
    ("the bacterial adhesin F1 protein" . SPARSER::PROTEIN)
    ("The monoclonal anti-FN 5C3 antibody" . SPARSER::ANTIBODY)
    ("FITC-gelatin also colocalized" . SPARSER::MOLECULE)
    ("fibrillin-1 and fibronectin" . SPARSER::COLLECTION)
    ("Several other monoclonal antibodies" . SPARSER::ANTIBODY)
    ("the control anti-FN" . SPARSER::ANTIBODY)
    ("fibrillin-fibronectin" . SPARSER::COLLECTION)
    ("glutaraldehyde" . SPARSER::MOLECULE)
    ("18-nm gold-conjugated secondary antibodies" . SPARSER::ANTIBODY)
    ("The primary anti-fibrillin-1 antibody (anti-rFBN1-C, 1/100) and anti-fibronectin (anti-FN clone 15, 1/100)"
     . SPARSER::COLLECTION)
    ("paraformaldehyde" . SPARSER::DRUG)
    ("17% (v/v) methanol and 0.02% (v/v) H 2 O 2" . SPARSER::COLLECTION)
    ("naphthol" . SPARSER::MOLECULE)
    ("collagenase and guanidine" . SPARSER::COLLECTION)
    ("l/min" . SPARSER::COLLECTION)
    ("to 2.5 ml cyanogen bromide-activated Sepharose" . SPARSER::MOLECULE)
    ("Monoclonal anti-FN" . SPARSER::ANTIBODY)
    ("either 1 mg/ml crude collagenase" . SPARSER::PROTEIN)
    ("cm 2" . SPARSER::PROTEIN)
    ("collagenase or guanidine" . SPARSER::COLLECTION)
    ("guanidine" . SPARSER::MOLECULE)
    ("FITC-gelatin or equivalent volumes" . SPARSER::COLLECTION)
    ("FITC-gelatin" . SPARSER::MOLECULE) ("HPO" . SPARSER::PROTEIN)
    ("KCl" . SPARSER::MOLECULE)
    ("fibronectin and fibrillin-1" . SPARSER::COLLECTION)
    ("adhesin" . SPARSER::PROTEIN) ("antisera" . SPARSER::PROTEIN)
    ("each subsequent step" . SPARSER::PROTEIN)
    ("full-length or recombinant fragments" . SPARSER::COLLECTION)
    ("TBS" . SPARSER::PROTEIN)
    ("100 µg/ml streptomycin and 10% FCS" . SPARSER::COLLECTION)
    ("PED" . SPARSER::PROTEIN) ("HSFs" . SPARSER::PROTEIN)
    ("NaCl (TBS)" . SPARSER::PROTEIN)
    ("fibrillin and fibronectin" . SPARSER::COLLECTION)
    ("methionine" . SPARSER::AMINO-ACID)
    ("Cy3-conjugated AffiniPure goat anti-rabbit IgG (H+L) and Alexa-488-"
     . SPARSER::COLLECTION)
    ("12 nm colloidal gold-AffiniPure Donkey anti-mouse IgG (H+L) and 18 nm colloidal gold-AffiniPure Donkey anti-rabbit IgG (H+L) antibodies"
     . SPARSER::COLLECTION)
    ("18 nm colloidal gold-AffiniPure Donkey anti-rabbit IgG (H+L) antibodies"
     . SPARSER::ANTIBODY)
    ("12 nm colloidal gold-AffiniPure Donkey anti-mouse IgG"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Peroxidase" . SPARSER::PROTEIN) ("AB" . SPARSER::PROTEIN)
    ("mFN" . SPARSER::PROTEIN) ("agarose" . SPARSER::MOLECULE)
    ("heparin-" . SPARSER::PROTEIN) ("heparin" . SPARSER::PROTEIN)
    ("fibrin" . SPARSER::PROTEIN)
    ("fibronectin and the role fibronectin" . SPARSER::COLLECTION)
    ("whereby integrin α5β1" . SPARSER::PROTEIN)
    ("Improper matrix" . SPARSER::PROTEIN-FAMILY)
    ("the relevant fibrillin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("latent transforming growth factor-binding protein-1 (LTBP-1) and fibulin-1 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("cryptic" . SPARSER::PROTEIN)
    ("α5β1 integrin and other surface components" . SPARSER::COLLECTION)
    ("soluble dimers" . SPARSER::DIMER) ("disulfide" . SPARSER::MOLECULE)
    ("soluble plasma fibronectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cellular fibronectin" . SPARSER::PROTEIN)
    ("a modular protein" . SPARSER::PROTEIN)
    ("fibrillin-1, and congenital contractural arachnodactyly"
     . SPARSER::COLLECTION)
    ("fibrillin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("Fibronectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibrillins" . SPARSER::PROTEIN) ("Fibrillins" . SPARSER::PROTEIN)
    ("tissue transglutaminase" . SPARSER::PROTEIN) ("1 -C" . SPARSER::PROTEIN)
    ("heparan sulfate" . SPARSER::MOLECULE) ("pH 3" . SPARSER::PROTEIN)
    ("N -ethylmaleimide" . SPARSER::MOLECULE) ("PO 4" . SPARSER::PROTEIN)
    ("signal peptide" . SPARSER::PROTEIN) ("1-C" . SPARSER::PROTEIN)
    ("fibulin-1" . SPARSER::PROTEIN) ("LTBP-1" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN) ("thrombospondin-1" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("congenital contractural arachnodactyly" . SPARSER::PROTEIN)
    ("Fibrillin-1" . SPARSER::PROTEIN) ("fibrillin-1" . SPARSER::PROTEIN)
    ("Marfan syndrome" . SPARSER::PROTEIN)
    ("Long intergenic non-coding RNA" . SPARSER::RNA) ("Tgf" . SPARSER::DRUG)
    ("seq" . SPARSER::PROTEIN) ("mESC" . SPARSER::PROTEIN)
    ("Mapk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("the PRC2 and Lysine-specific demethylase 1 complexes [ xref ]"
     . SPARSER::COLLECTION)
    ("ribosomal genes" . SPARSER::GENE)
    ("extranuclear components" . SPARSER::COMPONENT)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE)
    ("post-transcriptional regulators" . SPARSER::COLLECTION)
    ("linc-RoR" . SPARSER::COLLECTION) ("RoR" . SPARSER::PROTEIN-FAMILY)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("MAPK, Wnt, and TGF-β" . SPARSER::COLLECTION)
    ("peroxisome" . SPARSER::PROTEIN) ("Genomes" . SPARSER::PROTEIN)
    ("S5B and S3A" . SPARSER::COLLECTION)
    ("ECM-receptor" . SPARSER::COLLECTION)
    ("the Wdr5 antibody or control IgG (Figure xref )" . SPARSER::COLLECTION)
    ("Wdr5" . SPARSER::PROTEIN) ("RIP-seq" . SPARSER::COLLECTION)
    ("secondary targets" . SPARSER::TARGET-PROTEIN)
    ("Ikbke, Dgka, Adam8 , and Serpine2" . SPARSER::COLLECTION)
    ("Serpine2" . SPARSER::PROTEIN) ("Ikbke" . SPARSER::PROTEIN)
    ("Cdkn1A , Fas , and Perp" . SPARSER::COLLECTION)
    ("Cdkn1A" . SPARSER::PROTEIN) ("Perp" . SPARSER::PROTEIN)
    ("Fas" . SPARSER::PROTEIN)
    ("p53 siRNA or a control siRNA" . SPARSER::COLLECTION)
    ("Tgfβ1, Serpina3n, Nkx2-9 , and Il1r1" . SPARSER::COLLECTION)
    ("Gadd45b and Egr2" . SPARSER::COLLECTION) ("Egr2" . SPARSER::PROTEIN)
    ("Gadd45b" . SPARSER::PROTEIN) ("Il1r1" . SPARSER::PROTEIN)
    ("-receptor" . SPARSER::COLLECTION) ("TGF" . SPARSER::PROTEIN)
    ("LKR" . SPARSER::PROTEIN) ("ASO" . SPARSER::PROTEIN)
    ("siRNAs and short hairpin RNAs (shRNAs)" . SPARSER::COLLECTION)
    ("active promoters" . SPARSER::PROMOTER)
    ("the longer Pint A variant" . SPARSER::VARIANT) ("EST" . SPARSER::PROTEIN)
    ("doxorubicin-treated MEFs" . SPARSER::PROTEIN) ("RACE" . SPARSER::PROTEIN)
    ("total and phosphorylated p53" . SPARSER::PROTEIN)
    ("LSL/LSL" . SPARSER::COLLECTION)
    ("the most studied biological molecules" . SPARSER::MOLECULE)
    ("possible attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("Ezh2" . SPARSER::PROTEIN) ("Suppressor" . SPARSER::SUPPRESSOR)
    ("LincRNAs" . SPARSER::RNA)
    ("long intergenic non-coding RNAs" . SPARSER::RNA)
    ("orthologs" . SPARSER::PROTEIN) ("PINT" . SPARSER::PROTEIN)
    ("tri" . SPARSER::PROTEIN) ("TGF-β, MAPK and p53" . SPARSER::COLLECTION)
    ("lincRNA" . SPARSER::RNA)
    ("several long intergenic noncoding RNAs" . SPARSER::RNA)
    ("lincRNAs" . SPARSER::RNA) ("X-linked" . SPARSER::PROTEIN)
    ("Glo 3" . SPARSER::PROTEIN) ("doxorubicin hydrochloride" . SPARSER::DRUG)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("S6D" . SPARSER::PROTEIN) ("demethylase activity" . SPARSER::PROTEIN)
    ("WD repeat domain 5" . SPARSER::PROTEIN) ("Adam8" . SPARSER::PROTEIN)
    ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Serpina3n" . SPARSER::PROTEIN)
    ("Tgfβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("K-RAS" . SPARSER::PROTEIN)
    ("Mkln1" . SPARSER::PROTEIN)
    ("Enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("Embryonic Ectoderm Development" . SPARSER::PROTEIN)
    ("zeste 12" . SPARSER::PROTEIN)
    ("Polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("Caveolin-1 and cavin-1" . SPARSER::COLLECTION)
    ("aspartate" . SPARSER::MOLECULE)
    ("PD98059, LY294002 and TNFα" . SPARSER::COLLECTION)
    ("neither cavin-3 nor EGR1" . SPARSER::COLLECTION)
    ("yet both cavin-3 and EGR1" . SPARSER::COLLECTION)
    ("Akt/ERK" . SPARSER::COLLECTION) ("pAkt/pERK" . SPARSER::COLLECTION)
    ("trophic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1 and ERK2" . SPARSER::COLLECTION) ("Talin" . SPARSER::PROTEIN)
    ("myosin-XV" . SPARSER::COLLECTION) ("XV" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ezrin" . SPARSER::PROTEIN)
    ("cofilin" . SPARSER::PROTEIN) ("Myosin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEFs and SV589" . SPARSER::COLLECTION)
    ("cavin-3 or EGR1" . SPARSER::COLLECTION)
    ("a viral promoter" . SPARSER::PROMOTER)
    ("pERK/pAkt" . SPARSER::COLLECTION)
    ("cavin-1, cavin-3, caveolin-1 and myosin-1c" . SPARSER::COLLECTION)
    ("caveolin-1/cavin-1" . SPARSER::COLLECTION)
    ("caveolin-1 or cavin-1" . SPARSER::COLLECTION)
    ("ERK and pAkt" . SPARSER::COLLECTION) ("letter" . SPARSER::MOLECULE)
    ("cavin-2 and cavin-4" . SPARSER::COLLECTION)
    ("triglycerides" . SPARSER::MOLECULE)
    ("lactate and hepatocytes" . SPARSER::COLLECTION)
    ("the final phenotypic state" . SPARSER::BIO-STATE)
    ("survivin, pS6K and HIF1α" . SPARSER::COLLECTION)
    ("Cavin-3 and EGR1" . SPARSER::COLLECTION)
    ("EGR1 and cavin-3" . SPARSER::COLLECTION)
    ("caveolar components" . SPARSER::COMPONENT)
    ("the motor molecule, myosin-1c, and the use" . SPARSER::COLLECTION)
    ("receptor-actin" . SPARSER::COLLECTION)
    ("Peripheral F-actin" . SPARSER::BIO-COMPLEX)
    ("spectrins" . SPARSER::PROTEIN-FAMILY)
    ("pERK, EGR1, and PTEN" . SPARSER::COLLECTION)
    ("pAkt and HIF1α" . SPARSER::COLLECTION)
    ("pS6K and HIF1α" . SPARSER::COLLECTION)
    ("cavin-3 and EGR1" . SPARSER::COLLECTION)
    ("neither EGR1 nor cavin-3" . SPARSER::COLLECTION)
    ("EGR1 or cavin-3" . SPARSER::COLLECTION)
    ("GFP and EGR1" . SPARSER::COLLECTION)
    ("pERK-EGR1-PTEN" . SPARSER::COLLECTION)
    ("pERK and EGR1" . SPARSER::COLLECTION)
    ("pAkt, HIF1α and pS6K" . SPARSER::COLLECTION)
    ("cavin-1, cavin-3, and myosin-1c" . SPARSER::COLLECTION)
    ("GFP and cavin-3" . SPARSER::COLLECTION) ("mitogens" . SPARSER::MITOGEN)
    ("cavin-1, caveolin-1, myosin-1c and actin" . SPARSER::COLLECTION)
    ("ERK/Akt" . SPARSER::COLLECTION) ("Akt/mTORC1" . SPARSER::COLLECTION)
    ("complex and myosin-1c" . SPARSER::COLLECTION)
    ("cavin-1/caveolin-1" . SPARSER::COLLECTION)
    ("cavin-1 or caveolin-1" . SPARSER::COLLECTION)
    ("pAkt/Akt" . SPARSER::COLLECTION) ("pERK/ERK" . SPARSER::COLLECTION)
    ("cavin-1, cavin-3 or caveolin-1" . SPARSER::COLLECTION)
    ("cavin-3 and myosin-1c" . SPARSER::COLLECTION)
    ("caveolin-1 and cavin-1" . SPARSER::COLLECTION)
    ("pERK and pAkt" . SPARSER::COLLECTION)
    ("cavin-1, cavin-3, caveolin-1 or myosin-1c" . SPARSER::COLLECTION)
    ("cavin-1 and caveolin-1" . SPARSER::COLLECTION)
    ("cavin-1 and cavin-3" . SPARSER::COLLECTION)
    ("caveolin-1 and other cavins ( xref ; xref )" . SPARSER::COLLECTION)
    ("caveolin-1 and other cavins" . SPARSER::COLLECTION)
    ("cavin-3, myosin-1c and F-actin" . SPARSER::COLLECTION)
    ("EGFRs" . SPARSER::PROTEIN) ("EGFR and caveolin-1" . SPARSER::COLLECTION)
    ("EGFR, caveolin-1, MEK and ERK" . SPARSER::COLLECTION)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("receptors and caveolin-1" . SPARSER::COLLECTION)
    ("peripheral actin" . SPARSER::PROTEIN) ("anchors" . SPARSER::ANCHOR)
    ("the principal caveolae coat protein" . SPARSER::PROTEIN)
    ("light and electron" . SPARSER::COLLECTION)
    ("receptors and ERK" . SPARSER::COLLECTION)
    ("pERK, EGR1 and PTEN" . SPARSER::COLLECTION)
    ("survivin, pAkt, pS6K and HIF1α" . SPARSER::COLLECTION)
    ("Prkcdbp" . SPARSER::PROTEIN) ("Akt/mTORC1/HIF1" . SPARSER::COLLECTION)
    ("Glucose" . SPARSER::PROTEIN) ("Akt and mTORC1" . SPARSER::COLLECTION)
    ("part of protein and nucleic acid biosynthetic pathways ( xref )"
     . SPARSER::COLLECTION)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IAPs" . SPARSER::PROTEIN)
    ("pAkt" . SPARSER::PROTEIN-FAMILY) ("protein (PTEN)" . SPARSER::PROTEIN)
    ("cFos" . SPARSER::PROTEIN) ("pERK" . SPARSER::PROTEIN)
    ("fell" . SPARSER::PROTEIN) ("immediate early (IE)" . SPARSER::PROTEIN)
    ("IE" . SPARSER::PROTEIN) ("Cavin-2 and Cavin-4" . SPARSER::COLLECTION)
    ("the principal caveolin" . SPARSER::PROTEIN)
    ("caveolin" . SPARSER::PROTEIN)
    ("EGF, PDGF, and insulin" . SPARSER::COLLECTION)
    ("immuno-EM" . SPARSER::PROTEIN-PAIR) ("EM" . SPARSER::PROTEIN)
    ("hSRBC" . SPARSER::PROTEIN) ("PRKCDBP" . SPARSER::PROTEIN)
    ("proteins, EGR1 and PTEN" . SPARSER::COLLECTION)
    ("external cues" . SPARSER::PROTEIN-FAMILY) ("lactate" . SPARSER::LACTATE)
    ("EGR1 and PTEN" . SPARSER::COLLECTION)
    ("ERK and Akt" . SPARSER::COLLECTION) ("ERK1" . SPARSER::PROTEIN)
    ("Myosin-X" . SPARSER::PROTEIN)
    ("Myosin heavy chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myosin heavy chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rev1" . SPARSER::PROTEIN) ("pBS2" . SPARSER::PROTEIN)
    ("K4" . SPARSER::PROTEIN) ("M1" . SPARSER::MOLECULE)
    ("3 d" . SPARSER::PROTEIN-FAMILY) ("Latrunculin-A" . SPARSER::DRUG)
    ("Lysophosphatidic acid" . SPARSER::LPA)
    ("12-O-Tetradecanoylphorbol-13-Acetate" . SPARSER::DRUG)
    ("Myo1c" . SPARSER::PROTEIN) ("Anti-ERK" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("cavin-2" . SPARSER::PROTEIN)
    ("Cav1" . SPARSER::PROTEIN) ("calcium channel" . SPARSER::PROTEIN)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("cavin-1" . SPARSER::PROTEIN)
    ("latrunculin-A" . SPARSER::DRUG) ("Myosin-1" . SPARSER::PROTEIN)
    ("coat protein" . SPARSER::PROTEIN)
    ("hypoxia induced factor 1" . SPARSER::PROTEIN)
    ("Poly [ADP-Ribose] Polymerase 1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("early growth response protein 1" . SPARSER::PROTEIN)
    ("Cavin-2" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("Cavin-1" . SPARSER::PROTEIN) ("myosin-1" . SPARSER::PROTEIN)
    ("cavin-3" . SPARSER::PROTEIN) ("Cavin-3" . SPARSER::PROTEIN)
    ("Avastin and Dasatinib" . SPARSER::COLLECTION) ("Avastin" . SPARSER::DRUG)
    ("p-glycoprotein and breast cancer resistance protein"
     . SPARSER::COLLECTION)
    ("Elacridar" . SPARSER::DRUG)
    ("Src, p-AKT-273, and p-AKT-308" . SPARSER::COLLECTION)
    ("WASP-Arp2/3" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIP2 and cdc42" . SPARSER::COLLECTION)
    ("cdc42 and PIP2" . SPARSER::COLLECTION)
    ("both Phosphatidylinositol 4,5-bisphosphate or PtdIns(4,5)P2 (PIP2) and Cell Division Control Protein 42 Homolog (cdc42)"
     . SPARSER::COLLECTION)
    ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PtdIns" . SPARSER::PROTEIN)
    ("Arp2 and Arp3" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("our experiments control ambient oxygen" . SPARSER::MOLECULE)
    ("src- and p-NWASP-mediated" . SPARSER::COLLECTION)
    ("src-" . SPARSER::PROTEIN) ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p  " . SPARSER::PROTEIN) ("Src and NWASP" . SPARSER::COLLECTION)
    ("and-Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF1and HIF2" . SPARSER::COLLECTION)
    ("and-catenin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p" . SPARSER::PROTEIN)
    ("p-Cofilin" . SPARSER::COLLECTION) ("p-NWASP" . SPARSER::COLLECTION)
    ("HIF1-" . SPARSER::PROTEIN) ("normoxia" . SPARSER::PROTEIN)
    ("21%, 5% or 1% ambient oxygen" . SPARSER::MOLECULE)
    ("21% ambient oxygen" . SPARSER::MOLECULE)
    ("21% and 5% ambient oxygen" . SPARSER::MOLECULE) ("LN" . SPARSER::PROTEIN)
    ("1% ambient oxygen" . SPARSER::MOLECULE)
    ("5% ambient oxygen" . SPARSER::MOLECULE)
    ("c-Src and neural Wiskott-Aldrich syndrome protein" . SPARSER::COLLECTION)
    ("ambient oxygen" . SPARSER::MOLECULE)
    ("a hetero-dimeric basic helix-loop-helix protein" . SPARSER::PROTEIN)
    ("factor (HIF)" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HIF" . SPARSER::PROTEIN)
    ("linking hypoxia" . SPARSER::PROTEIN)
    ("approximately 21 percent oxygen" . SPARSER::MOLECULE)
    ("Normoxia" . SPARSER::PROTEIN) ("3 percent oxygen" . SPARSER::MOLECULE)
    ("Hypoxia" . SPARSER::PROTEIN) ("an antiangiogenic drug" . SPARSER::DRUG)
    ("Bevacizumab" . SPARSER::DRUG) ("c-Src and NWASP" . SPARSER::COLLECTION)
    ("c-Src or NWASP" . SPARSER::COLLECTION)
    ("neural Wiskott-Aldrich syndrome protein (NWASP)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-Catenin" . SPARSER::COLLECTION) ("Cofilin" . SPARSER::PROTEIN)
    ("Catenin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NWASP" . SPARSER::PROTEIN)
    ("Dasatinib" . SPARSER::DRUG) ("low ambient oxygen" . SPARSER::MOLECULE)
    ("p-glycoprotein" . SPARSER::PROTEIN)
    ("phosphatidyl-inositol-3-kinase" . SPARSER::PROTEIN-FAMILY)
    ("cdc42" . SPARSER::PROTEIN)
    ("Cell Division Control Protein 42 Homolog" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("Arp3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Arp2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Arp2/3" . SPARSER::PROTEIN)
    ("protein 2" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("HIF2" . SPARSER::PROTEIN) ("DEC2" . SPARSER::PROTEIN)
    ("DEC1" . SPARSER::PROTEIN) ("Hes1" . SPARSER::PROTEIN)
    ("Dynamin2" . SPARSER::PROTEIN) ("Dynamin1" . SPARSER::PROTEIN)
    ("DDEF1" . SPARSER::PROTEIN) ("ASAP1" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("p-Src" . SPARSER::PROTEIN)
    ("PP5" . SPARSER::PROTEIN) ("PAK2" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN) ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Notch1" . SPARSER::PROTEIN) ("MYPT1" . SPARSER::PROTEIN)
    ("MyPT1" . SPARSER::PROTEIN) ("v-Src" . SPARSER::PROTEIN)
    ("HIF-1" . SPARSER::PROTEIN) ("mental retardation" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN)
    ("neural Wiskott-Aldrich syndrome protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-angiogenic" . SPARSER::DRUG)
    ("IGFBP2/integrin/ILK/NF-kB" . SPARSER::COLLECTION)
    ("ILK" . SPARSER::PROTEIN) ("Ink4a-Arf" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bank" . SPARSER::PROTEIN)
    ("a secretory protein" . SPARSER::PROTEIN)
    ("possible biomarkers" . SPARSER::MOLECULE) ("IGFs" . SPARSER::PROTEIN)
    ("very few serological biomarkers" . SPARSER::MOLECULE)
    ("Biomarkers" . SPARSER::MOLECULE)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("whose blood IGFBP2" . SPARSER::PROTEIN) ("Ink4a" . SPARSER::PROTEIN)
    ("IGFBP3" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("IGFBP2" . SPARSER::PROTEIN) ("GAS5/CDK6" . SPARSER::COLLECTION)
    ("essential cell cycle enzymes and regulators" . SPARSER::COLLECTION)
    ("enzymes and regulators" . SPARSER::COLLECTION)
    ("E1, or E2" . SPARSER::COLLECTION) ("CDK4/CDK6" . SPARSER::COLLECTION)
    ("response element (GRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("GR" . SPARSER::PROTEIN)
    ("abnormal and dysregulated GAS5" . SPARSER::PROTEIN)
    ("microRNAs and lncRNAs" . SPARSER::COLLECTION) ("ncRNAs" . SPARSER::RNA)
    ("antisense and non-coding" . SPARSER::COLLECTION)
    ("the GAS5 and the CDK6" . SPARSER::COLLECTION)
    ("siRNAs" . SPARSER::PROTEIN) ("GAS5 or CDK6" . SPARSER::COLLECTION)
    ("CDK2 and CDK4" . SPARSER::COLLECTION)
    ("GAS5 and CDK6" . SPARSER::COLLECTION) ("RIP" . SPARSER::PROTEIN)
    ("pcDNA-GAS5" . SPARSER::PROTEIN-PAIR) ("siRNA" . SPARSER::PROTEIN)
    ("GAS5 or GAS5-siRNA" . SPARSER::COLLECTION)
    ("GAS5-siRNA" . SPARSER::COLLECTION) ("LncRNA" . SPARSER::RNA)
    ("SUZ12, EZH2, and H3K27me3" . SPARSER::COLLECTION)
    ("HOTAIR" . SPARSER::PROTEIN) ("The most common histological type" . TYPE)
    ("lncRNA" . SPARSER::RNA) ("lncRNAs" . SPARSER::RNA)
    ("E2F" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("RNA polymerase" . SPARSER::PROTEIN) ("DSH1" . SPARSER::PROTEIN)
    ("gene 3" . SPARSER::PROTEIN) ("MEG3" . SPARSER::PROTEIN)
    ("SUZ12" . SPARSER::PROTEIN) ("E-cad" . SPARSER::PROTEIN)
    ("ID2" . SPARSER::PROTEIN) ("GAS5" . SPARSER::PROTEIN)
    ("the distal part" . SPARSER::COMPONENT) ("The A allele" . SPARSER::ALLELE)
    ("hydroxyapatite" . SPARSER::MOLECULE)
    ("these results shed new light" . SPARSER::PROTEIN)
    ("DGKD , GCKR , CASR , and CYP24A1" . SPARSER::COLLECTION)
    ("NAP1L4 and CDKN1C" . SPARSER::COLLECTION)
    ("GATA3 , KIAA0564 and CARS" . SPARSER::COLLECTION)
    ("DGKD and DGKH" . SPARSER::COLLECTION)
    ("DGKD , DGKH , CARS , KIAA0564 and CYP24A1" . SPARSER::COLLECTION)
    ("limb, and GATA3" . SPARSER::COLLECTION)
    ("CARS , NAP1L4 and CDKN1C" . SPARSER::COLLECTION)
    ("DGKH and KIAA0564" . SPARSER::COLLECTION)
    ("biologically plausible gene" . SPARSER::GENE)
    ("CASR ( P  = 0.025; previously reported xref , xref ) and rs780094 ( GCKR )"
     . SPARSER::COLLECTION)
    ("endocrine phenotypic traits" . SPARSER::PROTEIN)
    ("related phenotypic traits" . SPARSER::PROTEIN)
    ("traits" . SPARSER::PROTEIN) ("polypeptide" . SPARSER::PROTEIN)
    ("Prefoldin" . SPARSER::PROTEIN-FAMILY) ("metabolites" . SPARSER::MOLECULE)
    ("ATP-ase" . SPARSER::ATP)
    ("an organic cation transporter" . SPARSER::PROTEIN)
    ("SLC22A18 and SLC22A18AS" . SPARSER::COLLECTION)
    ("solute carrier family 22, member 1 and solute carrier family 22"
     . SPARSER::COLLECTION)
    ("orf" . SPARSER::PROTEIN) ("MAS" . SPARSER::PROTEIN)
    ("MRGPRG" . SPARSER::PROTEIN) ("oxysterol" . SPARSER::PROTEIN)
    ("PTHLH" . SPARSER::PROTEIN) ("NAP1L1 and NAP1L4" . SPARSER::COLLECTION)
    ("nucleosome" . SPARSER::PROTEIN) ("hypercalciuria" . SPARSER::PROTEIN)
    ("tRNA" . SPARSER::RNA)
    ("hypoparathyroidism and hypocalcemia" . SPARSER::COLLECTION)
    ("deafness" . SPARSER::PROTEIN) ("HDR" . SPARSER::PROTEIN)
    ("hypoparathyroidism" . SPARSER::PROTEIN) ("GATA" . SPARSER::PROTEIN)
    ("gene and rs1550532" . SPARSER::COLLECTION)
    ("peptidase" . SPARSER::PROTEIN) ("USP" . SPARSER::PROTEIN)
    ("small Cajal body-specific RNAs" . SPARSER::RNA)
    ("Cajal" . SPARSER::PROTEIN) ("Arrestin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a rare autosomal recessive form" . SPARSER::FORM)
    ("the retina and pineal gland" . SPARSER::COLLECTION)
    ("a soluble photoreceptor protein expressed in" . SPARSER::PROTEIN)
    ("retina" . SPARSER::DRUG) ("arrestin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SAG" . SPARSER::PROTEIN) ("parathyroid" . SPARSER::PROTEIN-FAMILY)
    ("diacylglycerol (DAG)" . SPARSER::DAG) ("PA" . SPARSER::PROTEIN)
    ("DAG" . SPARSER::DAG) ("diacylglycerol" . SPARSER::PROTEIN)
    ("DGKs" . SPARSER::PROTEIN) ("DGK" . SPARSER::PROTEIN)
    ("an intronic SNP" . SPARSER::PROTEIN)
    ("cellular components and molecular functions" . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN) ("KIAA0564 and DGKH" . SPARSER::COLLECTION)
    ("CARS and rs1570669" . SPARSER::COLLECTION)
    ("receptor (CASR)" . SPARSER::RECEPTOR) ("calcitonin" . SPARSER::PROTEIN)
    ("PTH" . SPARSER::PROTEIN) ("Family" . SPARSER::PROTEIN-FAMILY)
    ("Our results shed new light" . SPARSER::PROTEIN)
    ("dietary calcium" . SPARSER::CALCIUM) ("GCKR" . SPARSER::PROTEIN)
    ("GATA3 ( P  = 4.8E-09) and rs7481584" . SPARSER::COLLECTION)
    ("DGKH/KIAA0564" . SPARSER::COLLECTION) ("DGKH" . SPARSER::PROTEIN)
    ("DGKD" . SPARSER::PROTEIN) ("CARS" . SPARSER::PROTEIN)
    ("CASR" . SPARSER::PROTEIN)
    ("solute carrier family 34 (sodium phosphate)" . SPARSER::PROTEIN)
    ("NPT2" . SPARSER::PROTEIN) ("NAPI-3" . SPARSER::PROTEIN)
    ("CD109" . SPARSER::PROTEIN) ("SLC34A1" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN) ("2–L" . SPARSER::PROTEIN)
    ("1–L" . SPARSER::PROTEIN) ("prefoldin subunit4" . SPARSER::PROTEIN)
    ("PFDN4" . SPARSER::PROTEIN)
    ("breast carcinoma amplified sequence 1" . SPARSER::PROTEIN)
    ("BCAS1" . SPARSER::PROTEIN) ("FGF-23" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("diacylglycerol kinase eta" . SPARSER::PROTEIN)
    ("KCNQ1OT1" . SPARSER::PROTEIN) ("KQT-like subfamily" . SPARSER::PROTEIN)
    ("potassium voltage-gated channel" . SPARSER::PROTEIN)
    ("KCNQ1" . SPARSER::PROTEIN) ("Kip2" . SPARSER::PROTEIN)
    ("p57" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("CDKN1C" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("solute carrier family 22" . SPARSER::PROTEIN)
    ("SLC22A18AS" . SPARSER::PROTEIN) ("SLC22A18" . SPARSER::PROTEIN)
    ("small nucleolar RNA" . SPARSER::RNA) ("RNA 1" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("OSBPL5" . SPARSER::PROTEIN)
    ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("family A" . SPARSER::PROTEIN)
    ("pleckstrin homology-like domain" . SPARSER::PROTEIN)
    ("PHLDA2" . SPARSER::PROTEIN) ("NAP1L1" . SPARSER::PROTEIN)
    ("nucleosome assembly protein 1-like 4" . SPARSER::PROTEIN)
    ("NAP1L4" . SPARSER::PROTEIN)
    ("inositol polyphosphate-5-phosphatase" . SPARSER::PROTEIN)
    ("INPP5D" . SPARSER::PROTEIN) ("small nuclear RNAs" . SPARSER::RNA)
    ("ATG16L1" . SPARSER::PROTEIN)
    ("calcium-binding protein" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN)
    ("diacylglycerol kinase delta" . SPARSER::PROTEIN)
    ("VKORC1L1" . SPARSER::PROTEIN) ("vitamin D" . SPARSER::MOLECULE)
    ("parathyroid hormone" . SPARSER::PROTEIN)
    ("diacylglycerol kinase" . SPARSER::PROTEIN)
    ("KIAA0564" . SPARSER::PROTEIN) ("CYP24A1" . SPARSER::PROTEIN)
    ("different viral proteins" . SPARSER::PROTEIN)
    ("the viral CXCL1" . SPARSER::PROTEIN)
    ("IE1 and UL76" . SPARSER::COLLECTION)
    ("The only HCMV gene" . SPARSER::PROTEIN)
    ("a functional endonuclease activity" . SPARSER::PROTEIN)
    ("the approximately 40 core genes" . SPARSER::GENE)
    ("possibly other gene" . SPARSER::PROTEIN)
    ("the viral protein UL44" . SPARSER::PROTEIN)
    ("AP-1 and NF-kB" . SPARSER::COLLECTION)
    ("ATM, NEMO and IkB" . SPARSER::COLLECTION)
    ("the HCMV immediate-early 1 (IE1) protein" . SPARSER::PROTEIN)
    ("a genotoxic drug" . SPARSER::DRUG)
    ("UL76 or etoposide" . SPARSER::COLLECTION) ("UL76" . SPARSER::PROTEIN)
    ("UL76-HA" . SPARSER::PROTEIN-PAIR) ("p53 and H2AX" . SPARSER::COLLECTION)
    ("a functional IKKβ" . SPARSER::PROTEIN) ("nucleolin" . SPARSER::PROTEIN)
    ("IKKβ and IkBα" . SPARSER::COLLECTION)
    ("a catalytically inactive mutant IKKβ and a mutant IkBα (IkBαS32/36A)"
     . SPARSER::COLLECTION)
    ("AP-1 or NF-IL-6" . SPARSER::COLLECTION)
    ("NF-kB, AP-1 and NF-IL-6" . SPARSER::COLLECTION)
    ("beta and gamma-subfamilies" . SPARSER::COLLECTION)
    ("the mitotic Cdc2-cyclin B complex" . SPARSER::BIO-COMPLEX)
    ("Cdc2-cyclin" . SPARSER::COLLECTION) ("homologues" . SPARSER::PROTEIN)
    ("Hjc and Hje" . SPARSER::COLLECTION) ("Hjc" . SPARSER::PROTEIN-FAMILY)
    ("Cfr" . SPARSER::DRUG) ("endonucleases" . SPARSER::PROTEIN)
    ("XK" . SPARSER::PROTEIN) ("the only core gene" . SPARSER::PROTEIN)
    ("PARP1, PIASy and Ubc9" . SPARSER::COLLECTION)
    ("PIASy" . SPARSER::PROTEIN) ("TNFα or IL-1β" . SPARSER::COLLECTION)
    ("p65/p50" . SPARSER::COLLECTION) ("IkB" . SPARSER::PROTEIN)
    ("subunits, IKKα and IKKβ" . SPARSER::COLLECTION)
    ("IKKγ/NEMO" . SPARSER::COLLECTION)
    ("AP-1 and NF-IL-6" . SPARSER::COLLECTION)
    ("CXCR1 and CXCR2" . SPARSER::COLLECTION)
    ("study viral proteins" . SPARSER::PROTEIN)
    ("genotoxic drugs" . SPARSER::DRUG) ("NEMO" . SPARSER::PROTEIN)
    ("Histone H2AX" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("Immediate Early" . SPARSER::PROTEIN) ("UL44" . SPARSER::PROTEIN)
    ("IE1" . SPARSER::PROTEIN) ("KU55933" . SPARSER::DRUG)
    ("IkBα" . SPARSER::PROTEIN) ("ORF20" . SPARSER::PROTEIN)
    ("Cdc2" . SPARSER::PROTEIN) ("endonuclease activity" . SPARSER::PROTEIN)
    ("Ubc9" . SPARSER::PROTEIN) ("PARP1" . SPARSER::PROTEIN)
    ("NF-IL-6" . SPARSER::PROTEIN) ("interferon-α" . SPARSER::DRUG)
    ("TNFα" . SPARSER::PROTEIN) ("CXCR2" . SPARSER::PROTEIN)
    ("CXCR1" . SPARSER::PROTEIN) ("Interleukin-8" . SPARSER::PROTEIN)
    ("interleukin-8" . SPARSER::PROTEIN) ("anti-viral" . SPARSER::DRUG)
    ("IKK-β" . SPARSER::PROTEIN) ("a sizable fraction" . SPARSER::COMPONENT)
    ("the sedentary control group" . SPARSER::MOLECULE)
    ("insulin and insulin-like growth factor (IGF)" . SPARSER::COLLECTION)
    ("insulin and insulin-like growth factor" . SPARSER::COLLECTION)
    ("MET-hours/ week" . SPARSER::PROTEIN-PAIR)
    ("the distant past" . SPARSER::PROTEIN)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("other known prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("western New York State" . SPARSER::BIO-STATE)
    ("State" . SPARSER::BIO-STATE)
    ("glucose and fatty acid" . SPARSER::COLLECTION)
    ("pre- and post-diagnostic" . SPARSER::COLLECTION)
    ("pre-" . SPARSER::PROTEIN) ("ER and TP53" . SPARSER::COLLECTION)
    ("ER or TP53" . SPARSER::COLLECTION) ("IGFBP-1" . SPARSER::PROTEIN)
    ("Complex I" . SPARSER::PROTEIN)
    ("leukocytes/macrophages" . SPARSER::COLLECTION)
    ("/loss of heterozygosity" . SPARSER::COLLECTION)
    ("MSI" . SPARSER::PROTEIN) ("TGF-β-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vimentin and type I" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN) ("cytokeratin" . SPARSER::PROTEIN)
    ("TGF-β, and telomerase" . SPARSER::COLLECTION)
    ("a known fibrogenic gene" . SPARSER::GENE)
    ("TGF-β, and h-TERT" . SPARSER::COLLECTION)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("neutrophils" . SPARSER::PROTEIN)
    ("p53, TGF-β, Wilms tumor-1 (Wt-1) and murine double minute 2 (Mdm2)"
     . SPARSER::COLLECTION)
    ("Wt-1" . SPARSER::PROTEIN) ("focal hypoxia" . SPARSER::PROTEIN)
    ("h-TERT/h-TERC" . SPARSER::COLLECTION)
    ("the RNA subunit (h-TERC) and dyskerin ( xref )" . SPARSER::COLLECTION)
    ("the telomerase reverse transcriptase (h-TERT), the RNA subunit (h-TERC) and dyskerin ( xref )"
     . SPARSER::COLLECTION)
    ("The active telomerase ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("dyskerin" . SPARSER::PROTEIN) ("repetitive DNA" . SPARSER::DNA)
    ("the alveolar epithelium" . SPARSER::PROTEIN)
    ("h-TERC" . SPARSER::COLLECTION)
    ("ribonucleo-protein" . SPARSER::COLLECTION) ("TERC" . SPARSER::PROTEIN)
    ("Telomerase" . SPARSER::PROTEIN) ("β-globin" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("autosomal dominant" . SPARSER::PROTEIN) ("h-TERT" . SPARSER::PROTEIN)
    ("WNK" . SPARSER::PROTEIN-FAMILY) ("GFP-fused" . SPARSER::COLLECTION)
    ("GFP-protein" . SPARSER::COLLECTION) ("MBP-KLHL22" . SPARSER::COLLECTION)
    ("MBP" . SPARSER::PROTEIN) ("Polo" . SPARSER::PROTEIN)
    ("propeller" . SPARSER::PROTEIN-FAMILY) ("KLHL" . SPARSER::PROTEIN)
    ("DAPK" . SPARSER::PROTEIN) ("SPOP" . SPARSER::PROTEIN)
    ("PLK1 and KLHL22" . SPARSER::COLLECTION)
    ("the HA-tagged KLHL22 ( xref ) and the endogenous KLHL22 ( xref )"
     . SPARSER::COLLECTION)
    ("Taxol or specific small-molecule inhibitor of PLK1"
     . SPARSER::COLLECTION)
    ("Taxol" . SPARSER::DRUG) ("CUL3/KEAP1" . SPARSER::COLLECTION)
    ("KEN" . SPARSER::PROTEIN)
    ("other protein kinases ( xref ) and substrates" . SPARSER::COLLECTION)
    ("some mitotic kinases" . SPARSER::KINASE) ("CRLs" . SPARSER::PROTEIN)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("E1 and E2" . SPARSER::COLLECTION)
    ("E1, E2, and E3" . SPARSER::COLLECTION)
    ("kinases and substrates" . SPARSER::COLLECTION)
    ("CUL3/KLHL22" . SPARSER::COLLECTION)
    ("the mitotic kinase PLK1" . SPARSER::PROTEIN)
    ("KLHL22 and PLK1" . SPARSER::COLLECTION) ("ligases" . SPARSER::LIGASE)
    ("N-term" . SPARSER::PROTEIN) ("KLHL3" . SPARSER::PROTEIN)
    ("Aurora A" . SPARSER::PROTEIN) ("KLHL20" . SPARSER::PROTEIN)
    ("PIPKIIβ" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("BI2536" . SPARSER::DRUG) ("CDH1" . SPARSER::PROTEIN)
    ("CDC20" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("Cullin 1" . SPARSER::PROTEIN) ("KLHL22" . SPARSER::PROTEIN)
    ("CUL3" . SPARSER::PROTEIN)
    ("docetaxel, cisplatin and fluorouracil" . SPARSER::COLLECTION)
    ("clear molecular prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("several other predictive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitomycin C and cisplatin" . SPARSER::COLLECTION)
    ("CDDP" . SPARSER::DRUG)
    ("demographic and clinical factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pCR" . SPARSER::PROTEIN)
    ("an independent prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Clinicopathological Factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Factors" . SPARSER::HUMAN-PROTEIN-FAMILY) ("aims" . SPARSER::PROTEIN)
    ("One predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rad51 and clinicopathological factors" . SPARSER::COLLECTION)
    ("clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitomycin C" . SPARSER::DRUG) ("5-FU" . SPARSER::PROTEIN)
    ("pT1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("targets and drug" . SPARSER::COLLECTION)
    ("indirect drug" . SPARSER::DRUG) ("CDK4-RB" . SPARSER::COLLECTION)
    ("-RB" . SPARSER::COLLECTION)
    ("RPPA and Western Blot" . SPARSER::COLLECTION)
    ("CDK4-EGFR" . SPARSER::COLLECTION) ("CDK4-AKT" . SPARSER::COLLECTION)
    ("clinically relevant PD0332991" . SPARSER::DRUG)
    ("CDK4 and AKT" . SPARSER::COLLECTION)
    ("cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("IGF1R or EGFR" . SPARSER::COLLECTION)
    ("AKT or effectors" . SPARSER::COLLECTION)
    ("the MEK inhibitor AZD6244 nor the ERK inhibitor FR180204"
     . SPARSER::COLLECTION)
    ("CDK4 inhibitor, IGF1R inhibitor, and EGFR inhibitor ( xref )"
     . SPARSER::COLLECTION)
    ("AKT and CDK4" . SPARSER::COLLECTION)
    ("MK2206 and PD0332991" . SPARSER::COLLECTION)
    ("PD0332991 and R1507" . SPARSER::COLLECTION)
    ("PD0332991 or CDK4" . SPARSER::COLLECTION)
    ("phosphor-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inhibitor and antibody" . SPARSER::COLLECTION)
    ("two IGF1R inhibitors (the IGF1R antibody R1507 and the small molecule IGF1R inhibitor NVP-AEW541) and the CKD4 inhibitor PD0332991 as well as CDK4-targeted siRNA"
     . SPARSER::COLLECTION)
    ("the CKD4 inhibitor PD0332991 as well as CDK4-targeted siRNA"
     . SPARSER::COLLECTION)
    ("IGF1R, PI3K/AKT, and mTOR signaling in the two cell lines"
     . SPARSER::COLLECTION)
    ("AKT-pSer" . SPARSER::COLLECTION) ("RB-pSer" . SPARSER::COLLECTION)
    ("CDK4-IGF1R" . SPARSER::COLLECTION)
    ("IGF1R and CDK4" . SPARSER::COLLECTION)
    ("new potential synergistic drug" . SPARSER::DRUG)
    ("4EBP1-pSer" . SPARSER::COLLECTION) ("pThr" . SPARSER::PROTEIN)
    ("pSer" . SPARSER::PROTEIN) ("bipartite" . SPARSER::PROTEIN)
    ("quantitative network models using three types" . TYPE)
    ("MEK and PI3K" . SPARSER::COLLECTION)
    ("quantitatively link proteins" . SPARSER::PROTEIN)
    ("PD0332991 (a CDK4 inhibitor) and R1507 (an IGF1R antibody) in two DDLS cell lines"
     . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("retinoblastoma" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR) and IGF1R" . SPARSER::COLLECTION)
    ("MEK and either PI3K or AKT" . SPARSER::COLLECTION)
    ("PI3K or AKT" . SPARSER::COLLECTION)
    ("AKT and MEK, ERK and HDAC" . SPARSER::COLLECTION)
    ("MEK, ERK and HDAC" . SPARSER::COLLECTION)
    ("ERK and MET, IGF1R and CDK4, IGF1R and EGFR, IGF1R and STAT3"
     . SPARSER::COLLECTION)
    ("MET, IGF1R and CDK4, IGF1R and EGFR, IGF1R and STAT3"
     . SPARSER::COLLECTION)
    ("CDK4, IGF1R and EGFR, IGF1R and STAT3" . SPARSER::COLLECTION)
    ("EGFR, IGF1R and STAT3" . SPARSER::COLLECTION)
    ("MEK and MET, PDGFR and MEK, PI3K and MEK" . SPARSER::COLLECTION)
    ("MET, PDGFR and MEK, PI3K and MEK" . SPARSER::COLLECTION)
    ("MEK, PI3K and MEK" . SPARSER::COLLECTION) ("Resazurin" . SPARSER::DRUG)
    ("the canonical mTOR" . SPARSER::PROTEIN)
    ("proteins and phosphoproteins" . SPARSER::COLLECTION)
    ("three-step" . SPARSER::PROTEIN)
    ("several identified synergistic drug" . SPARSER::DRUG)
    ("paclitaxel or docetaxel" . SPARSER::COLLECTION)
    ("pan-CDK" . SPARSER::COLLECTION) ("flavopiridol" . SPARSER::DRUG)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Synergistic drugs" . SPARSER::DRUG)
    ("BRAF and MEK" . SPARSER::COLLECTION)
    ("AKT and MEK" . SPARSER::COLLECTION)
    ("PD0332991 and the aromatase inhibitor Letrozole (clinical trial number NCT01740427)"
     . SPARSER::COLLECTION)
    ("NCT" . SPARSER::PROTEIN) ("Letrozole" . SPARSER::DRUG)
    ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("CDK4 and MDM2" . SPARSER::COLLECTION)
    ("receptor (PDGFR)" . SPARSER::RECEPTOR)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR)
    ("AKT or epidermal growth factor receptor (EGFR)" . SPARSER::COLLECTION)
    ("AKT or epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("CDK4 and IGF1R" . SPARSER::COLLECTION)
    ("synergistic drug" . SPARSER::DRUG) ("N  2" . SPARSER::PROTEIN)
    ("EC 45" . SPARSER::PROTEIN) ("FR180204" . SPARSER::DRUG)
    ("AZD6244" . SPARSER::DRUG) ("MK2206" . SPARSER::DRUG)
    ("pS6K" . SPARSER::PROTEIN) ("GSK3α" . SPARSER::PROTEIN)
    ("N 2" . SPARSER::PROTEIN) ("NVP-AEW541" . SPARSER::DRUG)
    ("PD0332991" . SPARSER::DRUG) ("CDK6" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the heat shock protein and its client proteins" . SPARSER::COLLECTION)
    ("HSP90 inhibitors as well as deacetylase inhibitors"
     . SPARSER::COLLECTION)
    ("its client proteins" . SPARSER::PROTEIN) ("SAHA" . SPARSER::DRUG)
    ("an oncomorphic p53 protein" . SPARSER::PROTEIN)
    ("SCH" . SPARSER::PROTEIN)
    ("oncomorphic p53-associated biomarkers" . SPARSER::MOLECULE)
    ("clearly all TP53 mutants" . SPARSER::MUTANT)
    ("NF-κB (p52) and ABCB1 (MDR1)" . SPARSER::COLLECTION)
    ("EGFR/PI3K/AKT" . SPARSER::COLLECTION)
    ("the mammary epithelium" . SPARSER::PROTEIN)
    ("adriamycin and cisplatin" . SPARSER::COLLECTION)
    ("adriamycin" . SPARSER::DRUG)
    ("an arginine or a proline (P72 or R72)" . SPARSER::COLLECTION)
    ("factors or co-factors" . SPARSER::COLLECTION)
    ("MRE11, p63, and TopBP1" . SPARSER::COLLECTION)
    ("ABCB1 or P -glycoprotein" . SPARSER::COLLECTION)
    ("doxorubicin and paclitaxel" . SPARSER::COLLECTION)
    ("tryptophan or glutamine" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID) ("tryptophan" . SPARSER::AMINO-ACID)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the larger MRN DNA damage complex" . SPARSER::BIO-COMPLEX)
    ("Mre11, Rad50, and Nbs1" . SPARSER::COLLECTION)
    ("nuclease" . SPARSER::PROTEIN) ("statin and sterol" . SPARSER::COLLECTION)
    ("sterol" . SPARSER::PROTEIN) ("statin" . SPARSER::MOLECULE)
    ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("integrins and EGFR" . SPARSER::COLLECTION)
    ("R273H/C mutant p53 and other proteins" . SPARSER::COLLECTION)
    ("p300, the histone acetyltransferase, and the transcriptional co-factor TopBP1 [ xref ]"
     . SPARSER::COLLECTION)
    ("cdc25c" . SPARSER::PROTEIN)
    ("the p53 R273 mutant proteins and the transcription factors NF-Y, SP1, SREBP-2, MRE11, and p63"
     . SPARSER::COLLECTION)
    ("NF-Y, SP1, SREBP-2, MRE11, and p63" . SPARSER::COLLECTION)
    ("histidine or cysteine" . SPARSER::COLLECTION)
    ("histidine" . SPARSER::AMINO-ACID)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("the oncomorphic p53 mutant family" . SPARSER::PROTEIN-FAMILY)
    ("an oncomorphic allele" . SPARSER::ALLELE)
    ("Oncomorphic p53 proteins" . SPARSER::PROTEIN) ("ago" . SPARSER::PROTEIN)
    ("oncomorphic p53" . SPARSER::PROTEIN)
    ("a highly-stable p53 protein" . SPARSER::PROTEIN)
    ("Partial" . SPARSER::PROTEIN) ("alternate p53" . SPARSER::PROTEIN)
    ("RB1 or APC" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("hub" . SPARSER::PROTEIN)
    ("platinum and paclitaxel" . SPARSER::COLLECTION)
    ("GOF" . SPARSER::PROTEIN) ("CA125" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IGF1R" . SPARSER::PROTEIN)
    ("P -glycoprotein" . SPARSER::PROTEIN) ("MDR1" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nbs1" . SPARSER::PROTEIN)
    ("Rad50" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("cdk1" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("SREBP-2" . SPARSER::PROTEIN) ("NF-Y" . SPARSER::PROTEIN)
    ("topoisomerase II" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("aberrant stromal p53" . SPARSER::PROTEIN)
    ("CFSE and p53" . SPARSER::COLLECTION)
    ("p53 and CXCL12" . SPARSER::COLLECTION)
    ("p53 as well as its target p21" . SPARSER::COLLECTION)
    ("Nutlin-3 and MDA-MB-231" . SPARSER::COLLECTION)
    ("Apc" . SPARSER::PROTEIN) ("stromal p53" . SPARSER::PROTEIN)
    ("transcription factor and tumor suppressor gene" . SPARSER::COLLECTION)
    ("adipocytes, chondrocytes and myocytes" . SPARSER::COLLECTION)
    ("Stromal p53" . SPARSER::PROTEIN) ("exogenous CXCL12" . SPARSER::PROTEIN)
    ("CAFs" . SPARSER::PROTEIN) ("nutlin-3" . SPARSER::DRUG)
    ("double minute 2" . SPARSER::PROTEIN) ("Messenger RNA" . SPARSER::RNA)
    ("Nutlin-3 as" . SPARSER::DRUG) ("penicillin G" . SPARSER::MOLECULE)
    ("Rag  2" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("SDF-1" . SPARSER::PROTEIN) ("derived factor" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN)
    ("BIBW 2992 or afatinib" . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("MET" . SPARSER::PROTEIN)
    ("mutant, Ex19Del and Ex20Ins" . SPARSER::COLLECTION)
    ("total and phosphorylated mutant EGFR" . SPARSER::PROTEIN)
    ("the Ex20Ins mutant or T790M double mutants" . SPARSER::COLLECTION)
    ("The therapeutic monoclonal antibody" . SPARSER::DRUG)
    ("The Ex19Del and Ex20Ins mutants and the LTM double mutants"
     . SPARSER::COLLECTION)
    ("lobes" . SPARSER::PROTEIN)
    ("anti-EGFR or anti-phosphotyrosine" . SPARSER::COLLECTION)
    ("exogenous growth factors" . SPARSER::GROWTH-FACTOR)
    ("Tyrosine" . SPARSER::AMINO-ACID)
    ("LTM mutants as well as their cis dimerization-impaired mutants"
     . SPARSER::COLLECTION)
    ("the receiver-impairing P699G mutant and activator-impairing M952R mutant"
     . SPARSER::COLLECTION)
    ("additional dimerization-disrupting mutants, the receiver-impairing P699G mutant and activator-impairing M952R mutant"
     . SPARSER::COLLECTION)
    ("exogenous EGF" . SPARSER::PROTEIN)
    ("L858R/T790M (LTM) mutants or wild-type EGFR" . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("the respective EGFR mutants" . SPARSER::MUTANT)
    ("monomer" . SPARSER::MONOMER) ("lobe" . SPARSER::PROTEIN)
    ("ADCC" . SPARSER::PROTEIN) ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("a human-mouse chimeric monoclonal antibody" . SPARSER::DRUG)
    ("Erbitux" . SPARSER::DRUG) ("Cetuximab" . SPARSER::DRUG)
    ("Ins" . SPARSER::PROTEIN) ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("ErbB" . SPARSER::PROTEIN) ("cetuximab" . SPARSER::DRUG)
    ("wild-type EGFR and the L858R mutant" . SPARSER::COLLECTION)
    ("BIBW 2992" . SPARSER::DRUG) ("ERBB3" . SPARSER::PROTEIN)
    ("PC9" . SPARSER::PROTEIN) ("Myc-tagged" . SPARSER::PROTEIN)
    ("anti-EGFR" . SPARSER::PROTEIN) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DLB" . SPARSER::PROTEIN) ("LW" . SPARSER::PROTEIN)
    ("polyacrylamide" . SPARSER::DRUG) ("sulfate" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE) ("Casein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP2A and PP6" . SPARSER::COLLECTION) ("beclin" . SPARSER::PROTEIN)
    ("PP6c and SAPS" . SPARSER::COLLECTION)
    ("a heterotrimeric enzyme" . SPARSER::ENZYME)
    ("an epigenetic mark" . SPARSER::PROTEIN) ("enhancers" . SPARSER::PROTEIN)
    ("LSS" . SPARSER::PROTEIN) ("CK2 and GSK3" . SPARSER::COLLECTION)
    ("Line" . SPARSER::PROTEIN) ("PP2A or E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("occludin or ZO-1" . SPARSER::COLLECTION)
    ("PP6c and E-cadherin" . SPARSER::COLLECTION)
    ("α-catenin and β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin, β-catenin and α-catenin" . SPARSER::COLLECTION)
    ("beta-integrin" . SPARSER::COLLECTION) ("occludin" . SPARSER::PROTEIN)
    ("PP6c and PP2Ac" . SPARSER::COLLECTION)
    ("a proximal promoter" . SPARSER::PROMOTER) ("run" . SPARSER::PROTEIN)
    ("at least two miRNA" . SPARSER::MICRO-RNA)
    ("significantly (p<0.05) more PP6c mRNA" . SPARSER::RNA)
    ("the atypical subunit" . SPARSER::FRAGMENT)
    ("PP2A, PP4 and PP6" . SPARSER::COLLECTION)
    ("the closely related phosphatase PP2A catalytic subunit (PP2Ac) or its specific scaffolding subunit (PP2A-A)"
     . SPARSER::COLLECTION)
    ("Actin" . SPARSER::PROTEIN) ("PP6R1 and PP6R3" . SPARSER::COLLECTION)
    ("the intestinal epithelium" . SPARSER::PROTEIN)
    ("intense PP6c" . SPARSER::PROTEIN) ("CK1 and CK2" . SPARSER::COLLECTION)
    ("E-cadherin/catenin" . SPARSER::COLLECTION)
    ("the transmembrane E-cadherin" . SPARSER::PROTEIN)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin-catenin" . SPARSER::PROTEIN) ("SAPS" . SPARSER::PROTEIN)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("SP5" . SPARSER::PROTEIN) ("IC261" . SPARSER::DRUG)
    ("PP6C" . SPARSER::PROTEIN) ("RNA Polymerase II" . SPARSER::PROTEIN)
    ("Microcystin-LR" . SPARSER::MOLECULE)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("H3K27Ac" . SPARSER::MOLECULE)
    ("PPP6C" . SPARSER::PROTEIN) ("S-protein" . SPARSER::PROTEIN)
    ("S-tag" . SPARSER::PROTEIN) ("α-catenin" . SPARSER::PROTEIN)
    ("PP4" . SPARSER::PROTEIN) ("PP2Ac" . SPARSER::PROTEIN)
    ("PP6R3" . SPARSER::PROTEIN) ("PP6R1" . SPARSER::PROTEIN)
    ("Protein phosphatase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP6" . SPARSER::PROTEIN) ("Skp2" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("Casein kinase 2" . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("PP6c" . SPARSER::PROTEIN)
    ("protein phosphatases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CPC" . SPARSER::PROTEIN)
    ("AEG-1 and its associated proteins" . SPARSER::COLLECTION)
    ("its associated proteins" . SPARSER::PROTEIN)
    ("CBP and AEG-1" . SPARSER::COLLECTION)
    ("p65 and CBP" . SPARSER::COLLECTION)
    ("associated protein kinases" . SPARSER::KINASE)
    ("AEG-1-p65" . SPARSER::COLLECTION) ("CBP and p300" . SPARSER::COLLECTION)
    ("ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("Serine" . SPARSER::AMINO-ACID) ("RANKL" . SPARSER::PROTEIN)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("macromolecules" . SPARSER::MOLECULE)
    ("its principle interstitial substrates" . SPARSER::SUBSTRATE)
    ("the stereotypical secreted collagenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VIII" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("AEG-1, p65 and CBP" . SPARSER::COLLECTION)
    ("NF-κB and CBP" . SPARSER::COLLECTION)
    ("both phosphorylated p65 (serine 536) and MMP1" . SPARSER::COLLECTION)
    ("p65 and MMP1" . SPARSER::COLLECTION)
    ("Akt and GSK3β" . SPARSER::COLLECTION)
    ("NF-κB and AP1" . SPARSER::COLLECTION)
    ("the metastatic foci" . SPARSER::PROTEIN)
    ("pulmonary metastatic foci" . SPARSER::PROTEIN)
    ("the biological impact" . SPARSER::PROTEIN)
    ("Nod" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FB" . SPARSER::PROTEIN)
    ("a negative prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N2 and N3" . SPARSER::COLLECTION) ("focal nuclear" . SPARSER::PROTEIN)
    ("the associated proteins" . SPARSER::PROTEIN)
    ("PI3K and NF-κB" . SPARSER::COLLECTION) ("AP1" . SPARSER::PROTEIN)
    ("Membranous AEG-1" . SPARSER::PROTEIN)
    ("also known as metadherin (MTDH) or LYsine-RIch CEACAM1 co-isolated (LYRIC)"
     . SPARSER::COLLECTION)
    ("Astrocyte elevated gene-1 (AEG-1), also known as metadherin (MTDH) or LYsine-RIch CEACAM1 co-isolated (LYRIC)"
     . SPARSER::COLLECTION)
    ("metadherin (MTDH)" . SPARSER::PROTEIN) ("LYRIC" . SPARSER::PROTEIN)
    ("LYsine" . SPARSER::AMINO-ACID) ("MTDH" . SPARSER::PROTEIN)
    ("metadherin" . SPARSER::PROTEIN)
    ("antibodies or tyrosine kinase" . SPARSER::COLLECTION)
    ("RelA" . SPARSER::PROTEIN) ("metastatic foci" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN) ("pGL4" . SPARSER::PROTEIN)
    ("DP2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TBK1" . SPARSER::PROTEIN)
    ("TANK binding kinase 1" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S3B" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("N3" . SPARSER::PROTEIN)
    ("N2" . SPARSER::PROTEIN) ("perinuclear region" . SPARSER::PROTEIN)
    ("CEACAM1" . SPARSER::PROTEIN)
    ("Astrocyte elevated gene-1" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN) ("transmembrane protein" . SPARSER::PROTEIN)
    ("AEG-1" . SPARSER::PROTEIN)
    ("astrocyte elevated gene-1" . SPARSER::PROTEIN) ("TDG" . SPARSER::PROTEIN)
    ("PEI" . SPARSER::MOLECULE) ("Polymerase" . SPARSER::PROTEIN)
    ("intron" . SPARSER::PROTEIN) ("introns" . SPARSER::PROTEIN)
    ("its proximal promoter" . SPARSER::PROMOTER)
    ("the proximal MIR155HG promoter" . SPARSER::PROMOTER)
    ("p65 and REL" . SPARSER::COLLECTION)
    ("ICAM-1 , and CD166" . SPARSER::COLLECTION)
    ("pro-IL1β" . SPARSER::COLLECTION) ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("c- rel and GAPDH" . SPARSER::COLLECTION)
    ("intron-exon" . SPARSER::PROTEIN-PAIR) ("GH" . SPARSER::PROTEIN)
    ("mature MIR155HG mRNA" . SPARSER::RNA)
    ("mature miR-155" . SPARSER::PROTEIN) ("p65 or REL" . SPARSER::COLLECTION)
    ("low NF-κB/low miR155" . SPARSER::PROTEIN) ("miR155" . SPARSER::PROTEIN)
    ("p65, REL, and PARP" . SPARSER::COLLECTION)
    ("substantially more miR-155" . SPARSER::PROTEIN)
    ("FLAG-p50" . SPARSER::COLLECTION) ("FLAG-p65" . SPARSER::COLLECTION)
    ("nfkb2" . SPARSER::PROTEIN) ("nfkb1" . SPARSER::PROTEIN)
    ("crel" . SPARSER::PROTEIN) ("relb" . SPARSER::PROTEIN)
    ("FLAG, p65, and p50" . SPARSER::COLLECTION)
    ("p65 and p50" . SPARSER::COLLECTION) ("mut" . SPARSER::PROTEIN)
    ("p65, REL, and p50" . SPARSER::COLLECTION)
    ("REL and p50" . SPARSER::COLLECTION)
    ("p65, REL (human c-Rel)," . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p65, REL (human c-Rel), or p50" . SPARSER::COLLECTION)
    ("REL" . SPARSER::PROTEIN) ("p50 and p65" . SPARSER::COLLECTION)
    ("pcDNA-FLAG" . SPARSER::COLLECTION) ("p50/p50" . SPARSER::COLLECTION)
    ("homodimer" . SPARSER::HOMODIMER)
    ("NF-κB and miR-155" . SPARSER::COLLECTION)
    ("the mature form" . SPARSER::FORM)
    ("p65, PARP and β-tubulin" . SPARSER::COLLECTION)
    ("/miR-155" . SPARSER::COLLECTION)
    ("the human MIR155HG proximal promoter" . SPARSER::PROMOTER)
    ("C/EBPβ, SOCS1, MITF, and FADD" . SPARSER::COLLECTION)
    ("FADD" . SPARSER::PROTEIN) ("MITF" . SPARSER::PROTEIN)
    ("AID" . SPARSER::PROTEIN) ("miR-155/RISC" . SPARSER::COLLECTION)
    ("RISC" . SPARSER::PROTEIN) ("Dicer" . SPARSER::PROTEIN)
    ("The mature form" . SPARSER::FORM) ("miRs" . SPARSER::MICRO-RNA)
    ("the MIR155HG proximal promoter" . SPARSER::PROMOTER)
    ("p50/p65" . SPARSER::COLLECTION) ("HG" . SPARSER::MOLECULE)
    ("MicroRNA" . SPARSER::MICRO-RNA) ("CD166" . SPARSER::PROTEIN)
    ("IL1β" . SPARSER::PROTEIN) ("c- rel" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN) ("LMP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SOCS1" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("PU.1" . SPARSER::PROTEIN) ("pre-miRNA" . SPARSER::RNA)
    ("MIR155" . SPARSER::PROTEIN) ("miR-155" . SPARSER::PROTEIN)
    ("mTORC1/p70 S6K1" . SPARSER::COLLECTION)
    ("both RSK and MSK proteins" . SPARSER::COLLECTION)
    ("ERK, JNK or p38" . SPARSER::COLLECTION)
    ("S6K1 or RSK" . SPARSER::COLLECTION)
    ("RSK and MSK proteins [ xref ]" . SPARSER::COLLECTION)
    ("RSK and MSK proteins ( xref )" . SPARSER::COLLECTION)
    ("S6K1 and MAPK" . SPARSER::COLLECTION)
    ("mTOR/p70 S6K1" . SPARSER::COLLECTION)
    ("kinases and GST-S6" . SPARSER::COLLECTION)
    ("RSK and MSK isoforms" . SPARSER::COLLECTION)
    ("simultaneous mix" . SPARSER::PROTEIN)
    ("RSK or MSK isoforms" . SPARSER::COLLECTION)
    ("RSK1 and RSK2" . SPARSER::COLLECTION) ("MSK1/MSK2" . SPARSER::COLLECTION)
    ("RSK or MSK proteins" . SPARSER::COLLECTION)
    ("ERK, p38, RSK or MSK proteins" . SPARSER::COLLECTION)
    ("p38 and ERK" . SPARSER::COLLECTION)
    ("concretely anti-P-S380-RSK and anti-P-S376-MSK antibodies"
     . SPARSER::ANTIBODY)
    ("RSK and MSK proteins around 85-90 kDa" . SPARSER::COLLECTION)
    ("MSK proteins around 85-90 kDa" . SPARSER::PROTEIN)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("rapamycin and wortmannin" . SPARSER::COLLECTION)
    ("rapamycin or wortmannin" . SPARSER::COLLECTION)
    ("mTORC1 and PI3K and mTOR" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION) ("wortmannin" . SPARSER::PROTEIN)
    ("S6K1 or S6 proteins ( xref )" . SPARSER::COLLECTION)
    ("the ribosomal S6 protein" . SPARSER::PROTEIN)
    ("a commercial monoclonal anti-P-T389-S6K1 antibody" . SPARSER::ANTIBODY)
    ("p85 and S6 ribosomal proteins" . SPARSER::COLLECTION)
    ("S6 ribosomal proteins" . SPARSER::PROTEIN)
    ("p38-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fast" . SPARSER::PROTEIN)
    ("phosphorylated RSK and MSK proteins" . SPARSER::COLLECTION)
    ("-S6K1" . SPARSER::COLLECTION)
    ("kinases (MSK) and the p90 ribosomal S6 kinases (RSK)"
     . SPARSER::COLLECTION)
    ("the RSK and MSK proteins [ xref ]" . SPARSER::COLLECTION)
    ("the p90 ribosomal S6 kinases (RSK)" . SPARSER::PROTEIN-FAMILY)
    ("mitogen-" . SPARSER::MITOGEN) ("/threonine" . SPARSER::COLLECTION)
    ("mTOR/S6K1" . SPARSER::COLLECTION) ("Ser/Thr" . SPARSER::COLLECTION)
    ("c-Jun N-terminal kinases (JNK) and p38" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinases (JNK) and p38"
     . SPARSER::COLLECTION)
    ("kinases (JNK)" . SPARSER::KINASE) ("p38 or ERK" . SPARSER::COLLECTION)
    ("RSK and MSK kinases" . SPARSER::COLLECTION)
    ("RSK and MSK proteins" . SPARSER::COLLECTION) ("MSK" . SPARSER::PROTEIN)
    ("mTOR and PI3K" . SPARSER::COLLECTION)
    ("the commercial anti-phospho-Thr389-S6K1 antibody" . SPARSER::ANTIBODY)
    ("S6K1/MAPK" . SPARSER::COLLECTION) ("MAPK or p53" . SPARSER::COLLECTION)
    ("P-S6" . SPARSER::PROTEIN) ("p70 S6K1" . SPARSER::PROTEIN)
    ("p70" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN) ("MSK2" . SPARSER::PROTEIN)
    ("MSK1" . SPARSER::PROTEIN) ("RSK2" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("K1" . SPARSER::PROTEIN) ("anti-S" . SPARSER::ANTIBODY)
    ("P-S" . SPARSER::PROTEIN) ("P-ERK1/2" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE)
    ("S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("S6K1" . SPARSER::PROTEIN)
    ("the potential hormonal regulators" . SPARSER::REGULATOR)
    ("the pro-apoptotic protein" . SPARSER::PROTEIN)
    ("the potential tocolytic enzyme CASP3" . SPARSER::PROTEIN)
    ("DDIT3, CASP3 and HSPA5" . SPARSER::COLLECTION)
    ("Chaperone" . SPARSER::PROTEIN)
    ("anti-apoptotic adaptive arm" . SPARSER::PROTEIN)
    ("Atf4, DditT3 and Casp12" . SPARSER::COLLECTION)
    ("/DDIT3" . SPARSER::COLLECTION) ("uterine DDIT3" . SPARSER::PROTEIN)
    ("the pro-apoptotic molecule BID" . SPARSER::PROTEIN)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("ATF4 or ATF6" . SPARSER::COLLECTION)
    ("Atf4 and Ddit3" . SPARSER::COLLECTION)
    ("Atf4 , Ddit3, Casp12, Atf6 and Hspa5" . SPARSER::COLLECTION)
    ("Hspa5" . SPARSER::PROTEIN) ("Atf6" . SPARSER::PROTEIN)
    ("Ddit3" . SPARSER::PROTEIN) ("Atf4" . SPARSER::PROTEIN)
    ("Hspa" . SPARSER::PROTEIN-FAMILY) ("Casp" . SPARSER::PROTEIN)
    ("Immunoreactive HSPA5" . SPARSER::PROTEIN)
    ("cleaved uterine CASP3" . SPARSER::PROTEIN)
    ("CASP3 and HSPA5" . SPARSER::COLLECTION)
    ("DDIT3, CASP3, HSPA5 and PDI" . SPARSER::COLLECTION)
    ("full length CASP12" . SPARSER::PROTEIN)
    ("DDIT3 and XBP1" . SPARSER::COLLECTION) ("CASP" . SPARSER::PROTEIN)
    ("the mitochondrial and cytosolic fractions" . SPARSER::COLLECTION)
    ("GAPDH and COX4I1" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("The mitochondrial protein COX4I1 and the cytosolic protein GAPDH"
     . SPARSER::COLLECTION)
    ("BID" . SPARSER::PROTEIN) ("CASP8 and tBID" . SPARSER::COLLECTION)
    ("tBID" . SPARSER::PROTEIN)
    ("Our previously published mouse uterine CASP3" . SPARSER::PROTEIN)
    ("PDI" . SPARSER::PROTEIN) ("cytochrome C (CYCS)" . SPARSER::PROTEIN)
    ("CYCS" . SPARSER::PROTEIN) ("E6–E19" . SPARSER::COLLECTION)
    ("hypoxia and glucose" . SPARSER::COLLECTION)
    ("uterine CASP3" . SPARSER::PROTEIN) ("progesterone" . SPARSER::PROTEIN)
    ("uterine caspase-3" . SPARSER::PROTEIN) ("CASP4" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor" . SPARSER::PROTEIN)
    ("death receptor" . SPARSER::PROTEIN) ("ATF6" . SPARSER::PROTEIN)
    ("ATF4" . SPARSER::PROTEIN) ("Truncated BID" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("truncated BID" . SPARSER::PROTEIN)
    ("DDIT3" . SPARSER::PROTEIN) ("HSPA5" . SPARSER::PROTEIN)
    ("COX4I1" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("subunit 4" . SPARSER::PROTEIN) ("NCOA3" . SPARSER::PROTEIN)
    ("protein disulfide isomerase" . SPARSER::PROTEIN)
    ("CASP8" . SPARSER::PROTEIN) ("caspase 8" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("E19" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CASP3" . SPARSER::PROTEIN)
    ("keratins, ER and CD45" . SPARSER::COLLECTION)
    ("a larger cohort" . SPARSER::MOLECULE)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("the considered prognostic impact" . SPARSER::PROTEIN)
    ("A larger cohort" . SPARSER::MOLECULE) ("keratin" . SPARSER::PROTEIN)
    ("healthy volunteers spiked" . SPARSER::PROTEIN)
    ("spiked" . SPARSER::PROTEIN) ("Spiking" . SPARSER::PROTEIN)
    ("EpCAM (epithelial cell adhesion molecule) and keratins"
     . SPARSER::COLLECTION)
    ("EpCAM" . SPARSER::PROTEIN)
    ("tamoxifen, or aromatase" . SPARSER::COLLECTION)
    ("the luminal A type" . TYPE) ("CTC" . SPARSER::PROTEIN)
    ("growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K+" . SPARSER::MOLECULE) ("K8" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN)
    ("estrogen receptor 1" . SPARSER::PROTEIN) ("X-Gal" . SPARSER::MOLECULE)
    ("Beta-galactosidase" . SPARSER::PROTEIN)
    ("leukocyte common antigen" . SPARSER::PROTEIN)
    ("epithelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("Keratin 8" . SPARSER::PROTEIN)
    ("keratin 8" . SPARSER::PROTEIN) ("HATs and HDACs" . SPARSER::COLLECTION)
    ("CoREST" . SPARSER::PROTEIN) ("NRD" . SPARSER::PROTEIN)
    ("HDACs" . SPARSER::PROTEIN) ("HATs" . SPARSER::PROTEIN)
    ("Fli1/HDAC1/p300" . SPARSER::COLLECTION)
    ("TIP60 and HDAC7" . SPARSER::COLLECTION)
    ("HAT/HDAC" . SPARSER::COLLECTION) ("MyoD and p53" . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION) ("Ets1 and Smad3" . SPARSER::COLLECTION)
    ("TGF-β-Smad" . SPARSER::COLLECTION)
    ("Ets1 and Fli1" . SPARSER::COLLECTION)
    ("PCAF and HDAC1" . SPARSER::COLLECTION)
    ("Fli1 and HDAC1 and Fli1" . SPARSER::COLLECTION)
    ("HDAC1 and Fli1" . SPARSER::COLLECTION)
    ("HDAC1 and p300" . SPARSER::COLLECTION)
    ("“Fli1-p300-HDAC1" . SPARSER::COLLECTION)
    ("arginine" . SPARSER::AMINO-ACID)
    ("Collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ets1, p300, and Ac-H3" . SPARSER::COLLECTION)
    ("Fli1, Ets1, p300, and HDAC1" . SPARSER::COLLECTION)
    ("Trichostatin" . SPARSER::MOLECULE)
    ("subsequent chromatin condensation" . SPARSER::PROTEIN-FAMILY)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("Ets1/p300" . SPARSER::COLLECTION) ("Fli1/HDAC1" . SPARSER::COLLECTION)
    ("Histone" . SPARSER::PROTEIN)
    ("wild type Fli1 and a phosphorylation resistant mutant"
     . SPARSER::COLLECTION)
    ("p300 and HDAC1" . SPARSER::COLLECTION)
    ("Threonine" . SPARSER::AMINO-ACID) ("Fli1 and PCAF" . SPARSER::COLLECTION)
    ("p300 or p300/ΔHAT" . SPARSER::COLLECTION)
    ("Lysine" . SPARSER::AMINO-ACID) ("pilot" . SPARSER::PROTEIN)
    ("PCAF or PCAF/" . SPARSER::COLLECTION) ("HAT" . SPARSER::PROTEIN)
    ("Fli1 and Ets1" . SPARSER::COLLECTION) ("Ets1/Fli1" . SPARSER::COLLECTION)
    ("the human α2(I) collagen (COL1A2) promoter" . SPARSER::PROMOTER)
    ("erythroid" . SPARSER::PROTEIN) ("HDAC1/p300" . SPARSER::COLLECTION)
    ("entinostat" . SPARSER::DRUG) ("Fli1 and HDAC1" . SPARSER::COLLECTION)
    ("Ets1 and p300" . SPARSER::COLLECTION)
    ("quiescent dermal fibroblasts Fli1, HDAC1, and p300"
     . SPARSER::COLLECTION)
    ("Fli1, HDAC1, and p300" . SPARSER::COLLECTION)
    ("Fli1-HDAC1-p300" . SPARSER::COLLECTION)
    ("the human α2(I) collagen (COL1A2) gene" . SPARSER::GENE)
    ("HDAC7" . SPARSER::PROTEIN) ("TIP60" . SPARSER::PROTEIN)
    ("FOXP3" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("HDAC3" . SPARSER::PROTEIN)
    ("a 20 µ" . SPARSER::PROTEIN) ("streptavidin-agarose" . SPARSER::DRUG)
    ("protein can" . SPARSER::PROTEIN)
    ("histone acetyltransferase" . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("CREB-binding protein" . SPARSER::PROTEIN)
    ("PKC-δ" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN) ("tenascin-C" . SPARSER::PROTEIN)
    ("Ets1" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("COL1A2" . SPARSER::PROTEIN) ("Fli1" . SPARSER::PROTEIN)
    ("NEDD9 and FAK or SRC, and E-cadherin" . SPARSER::COLLECTION)
    ("FAK or SRC, and E-cadherin" . SPARSER::COLLECTION)
    ("SRC, and E-cadherin" . SPARSER::COLLECTION)
    ("EMT-associated protein E-cadherin" . SPARSER::PROTEIN)
    ("the viral E6 and E7 oncogenes" . SPARSER::ONCOGENE)
    ("p53 and pRb" . SPARSER::COLLECTION)
    ("the most important etiologic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin and NEDD9" . SPARSER::COLLECTION)
    ("an indispensable step" . SPARSER::PROTEIN)
    ("Persistently reduced FAK [ xref ] and SRC [ xref ]"
     . SPARSER::COLLECTION)
    ("PF-228 and PP2" . SPARSER::COLLECTION)
    ("NEDD9 and FAK" . SPARSER::COLLECTION)
    ("the most important associated proteins" . SPARSER::PROTEIN)
    ("polyproline" . SPARSER::PROTEIN) ("JT" . SPARSER::PROTEIN)
    ("trunk neural tube" . SPARSER::PROTEIN)
    ("human bronchiolar epithelium" . SPARSER::PROTEIN)
    ("E6 and E7" . SPARSER::COLLECTION) ("E6/E7" . SPARSER::COLLECTION)
    ("a suppressive regulatory protein" . SPARSER::PROTEIN)
    ("Vimentin and E-cadherin" . SPARSER::COLLECTION)
    ("PF-228 or PP2" . SPARSER::COLLECTION) ("Sigma" . SPARSER::PROTEIN)
    ("total FAK and total SRC" . SPARSER::COLLECTION)
    ("phospho-FAK (Tyr397) and phospho-Src (Tyr416)" . SPARSER::COLLECTION)
    ("total FAK and total SRC protein" . SPARSER::COLLECTION)
    ("two NEDD9-associated proteins" . SPARSER::PROTEIN)
    ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ACC" . SPARSER::PROTEIN)
    ("ACA" . SPARSER::PROTEIN)
    ("lymphocyte-type Crk-associated substrate" . SPARSER::SUBSTRATE)
    ("Crk" . SPARSER::PROTEIN) ("radical" . SPARSER::MOLECULE)
    ("NEDD9, FAK and SRC" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN)
    ("NEDD9 and FAK or SRC" . SPARSER::COLLECTION)
    ("FAK or SRC" . SPARSER::COLLECTION) ("FAK and SRC" . SPARSER::COLLECTION)
    ("PP2" . SPARSER::PROTEIN) ("Phospho-Tyrosine" . SPARSER::MOLECULE)
    ("Cas-L" . SPARSER::PROTEIN) ("p130Cas" . SPARSER::PROTEIN)
    ("105 kD" . SPARSER::PROTEIN) ("HEF1" . SPARSER::PROTEIN)
    ("Enhancer of Filamentation 1" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("NEDD9" . SPARSER::PROTEIN)
    ("poisons" . SPARSER::MOLECULE) ("poison" . SPARSER::MOLECULE)
    ("nocodazole or taxol" . SPARSER::COLLECTION)
    ("poisoning" . SPARSER::MOLECULE)
    ("the microtubule-disrupting agent nocodazole and the microtubule-stabilizing agent taxol"
     . SPARSER::COLLECTION)
    ("YFP and BG430" . SPARSER::COLLECTION)
    ("a double-chimeric cyclin B reporter molecule" . SPARSER::MOLECULE)
    ("stabilizer" . SPARSER::MOLECULE) ("taxol" . SPARSER::DRUG)
    ("The depicted cell expressed CYS" . SPARSER::PROTEIN)
    ("YFP- and BG430-fluorescence" . SPARSER::COLLECTION)
    ("YFP-" . SPARSER::PROTEIN) ("BG" . SPARSER::PROTEIN)
    ("the longer UTR" . SPARSER::PROTEIN) ("CPEs" . SPARSER::PROTEIN)
    ("SNAP (CYS)" . SPARSER::PROTEIN) ("CYS" . SPARSER::PROTEIN)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nocodazole" . SPARSER::DRUG)
    ("fluorescent SNAP substrates" . SPARSER::SUBSTRATE)
    ("a SNAP" . SPARSER::PROTEIN) ("SNAP" . SPARSER::PROTEIN)
    ("SAC" . SPARSER::PROTEIN)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("cyclosome" . SPARSER::PROTEIN) ("hTERT" . SPARSER::PROTEIN)
    ("antimitotic" . SPARSER::MOLECULE) ("Antimitotic" . SPARSER::MOLECULE)
    ("Cdc20" . SPARSER::PROTEIN) ("and 1µ" . SPARSER::PROTEIN)
    ("alpha-Tubulin" . SPARSER::PROTEIN)
    ("Histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("H2B" . SPARSER::PROTEIN)
    ("SLE and SSc" . SPARSER::COLLECTION) ("SSc and SLE" . SPARSER::COLLECTION)
    ("autoantigen" . SPARSER::DRUG) ("rho " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fate" . SPARSER::PROTEIN) ("rho  " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Scl" . SPARSER::PROTEIN) ("Antibodies" . SPARSER::ANTIBODY)
    ("functional membrane-associated ERα" . SPARSER::PROTEIN)
    ("SLE" . SPARSER::PROTEIN) ("particular 17β-estradiol" . SPARSER::PROTEIN)
    ("Estrogens" . SPARSER::MOLECULE) ("bright" . SPARSER::PROTEIN)
    ("membrane-associated ER" . SPARSER::PROTEIN)
    ("ERα and ERβ" . SPARSER::COLLECTION) ("estrogens" . SPARSER::MOLECULE)
    ("autoantibody" . SPARSER::PROTEIN) ("SSc" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("CD62L" . SPARSER::PROTEIN)
    ("NaHCO3" . SPARSER::DRUG) ("Carbon monoxide" . SPARSER::MOLECULE)
    ("topoisomerase I" . SPARSER::PROTEIN) ("17β-estradiol" . SPARSER::PROTEIN)
    ("FoxP3" . SPARSER::PROTEIN) ("CD45RA" . SPARSER::PROTEIN)
    ("ERβ" . SPARSER::PROTEIN) ("PI-3K/Akt" . SPARSER::COLLECTION)
    ("cyclins and CDKs" . SPARSER::COLLECTION)
    ("STIM1 and Orai1" . SPARSER::COLLECTION)
    ("NFAT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Factor" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKi" . SPARSER::DRUG)
    ("CDKs" . SPARSER::PROTEIN)
    ("cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Orai1 or Orai2" . SPARSER::COLLECTION)
    ("Orai (1–3) and Stim (1–2)" . SPARSER::COLLECTION)
    ("SOC" . SPARSER::PROTEIN) ("TRPC1 and Orai1" . SPARSER::COLLECTION)
    ("Orai and STIM" . SPARSER::COLLECTION) ("STIM" . SPARSER::PROTEIN)
    ("Stim/Orai" . SPARSER::COLLECTION)
    ("Orai1, Orai2, Stim1 and Stim2" . SPARSER::COLLECTION)
    ("thapsigargin (TG)" . SPARSER::MOLECULE) ("si-CTL" . SPARSER::COLLECTION)
    ("Cyclins and cdk" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Iodide" . SPARSER::PROTEIN)
    ("Propidium" . SPARSER::MOLECULE) ("Trypan" . SPARSER::DRUG)
    ("si-Orai3" . SPARSER::COLLECTION) ("APB" . SPARSER::PROTEIN)
    ("Orai1 and Orai2" . SPARSER::COLLECTION)
    ("si-Orai2" . SPARSER::COLLECTION) ("si-Orai1" . SPARSER::COLLECTION)
    ("Orai2" . SPARSER::PROTEIN)
    ("Orai1, Orai2, Orai3, Stim1 and Stim2" . SPARSER::COLLECTION)
    ("Stim2" . SPARSER::PROTEIN) ("thapsigargin" . SPARSER::MOLECULE)
    ("functional Orai3" . SPARSER::PROTEIN)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("Orai1 and TRPC1" . SPARSER::COLLECTION)
    ("principal components" . SPARSER::COMPONENT)
    ("Orai1 and Stim1" . SPARSER::COLLECTION)
    ("calmodulin, CaM-Kinase, and calcineurin" . SPARSER::COLLECTION)
    ("calcineurin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("calmodulin" . SPARSER::PROTEIN) ("Calcium" . SPARSER::CALCIUM)
    ("cyclin D1, cyclin E, CDK4 and CDK2" . SPARSER::COLLECTION)
    ("Orai" . SPARSER::PROTEIN-FAMILY)
    ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TRPC6" . SPARSER::PROTEIN)
    ("TRPV6" . SPARSER::PROTEIN) ("CDKs 4" . SPARSER::PROTEIN)
    ("STIM1" . SPARSER::PROTEIN) ("STIM2" . SPARSER::PROTEIN)
    ("Cdk2" . SPARSER::PROTEIN) ("Cdk4" . SPARSER::PROTEIN)
    ("M 2" . SPARSER::MOLECULE) ("2-APB" . SPARSER::MOLECULE)
    ("Gd 3" . SPARSER::MOLECULE) ("Stat 3" . SPARSER::PROTEIN)
    ("Fast)" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("TRPC1" . SPARSER::PROTEIN) ("Stim1" . SPARSER::PROTEIN)
    ("Orai1" . SPARSER::PROTEIN) ("CaM-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK2" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("Orai3" . SPARSER::PROTEIN) ("prostanoids" . SPARSER::MOLECULE)
    ("other bacterial components" . SPARSER::COMPONENT)
    ("NF κ B and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("auxiliary subunits" . SPARSER::PROTEIN) ("GABA" . SPARSER::MOLECULE)
    ("the vascular endothelial growth factor family and the class 3 semaphorins"
     . SPARSER::COLLECTION)
    ("polypeptides" . SPARSER::PROTEIN)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY) ("coreceptor" . SPARSER::PROTEIN)
    ("BPs" . SPARSER::PROTEIN)
    ("a neural cell adhesion protein" . SPARSER::PROTEIN)
    ("neurotrimin" . SPARSER::PROTEIN) ("polyphosphates" . SPARSER::MOLECULE)
    ("inositol" . SPARSER::PROTEIN) ("Syt7" . SPARSER::PROTEIN)
    ("CTL" . SPARSER::PROTEIN) ("Syt" . SPARSER::PROTEIN)
    ("Synaptotagmins" . SPARSER::PROTEIN-FAMILY)
    ("GCF and gingiva" . SPARSER::COLLECTION)
    ("GCF and human gingiva" . SPARSER::COLLECTION)
    ("specifically type I collagen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCL2 and MMP-1" . SPARSER::COLLECTION)
    ("JNK, NF κ B, and p38" . SPARSER::COLLECTION)
    ("p38, MEK1/2 and PI3K" . SPARSER::COLLECTION)
    ("HSPB3, TM4SF20, and RGS4" . SPARSER::COLLECTION)
    ("EGR1, MMP-1, SYT7, ITPKA, CCL2, NTM, IGF2BP3, NRP1, and KCTD12"
     . SPARSER::COLLECTION)
    ("9 genes and a significant downregulation of 3 genes in PDL cells"
     . SPARSER::COLLECTION)
    ("GCF" . SPARSER::PROTEIN)
    ("macrophages and adipocytes" . SPARSER::COLLECTION)
    ("factor-kappaB" . SPARSER::COLLECTION) ("kappaB" . SPARSER::PROTEIN)
    ("Adipokines" . SPARSER::PROTEIN-FAMILY) ("visfatin" . SPARSER::PROTEIN)
    ("adipokine" . SPARSER::PROTEIN-FAMILY)
    ("MMP-1 and CCL2" . SPARSER::COLLECTION)
    ("EGR1, MMP-1, SYT7, ITPKA, CCL2, NTM, IGF2BP3, and NRP1"
     . SPARSER::COLLECTION)
    ("NTM" . SPARSER::PROTEIN) ("ITPKA" . SPARSER::PROTEIN)
    ("9 genes and downregulation of 3 genes" . SPARSER::COLLECTION)
    ("PDL" . SPARSER::MOLECULE) ("NAMPT" . SPARSER::PROTEIN)
    ("adipokines" . SPARSER::PROTEIN-FAMILY)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY) ("IGF2" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("RGS4" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("TM4SF20" . SPARSER::PROTEIN)
    ("transmembrane 4 L six family member 20" . SPARSER::PROTEIN)
    ("HSPB3" . SPARSER::PROTEIN) ("KCTD12" . SPARSER::PROTEIN)
    ("potassium channel" . SPARSER::PROTEIN)
    ("neuropilin 1" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("synaptotagmin 7" . SPARSER::PROTEIN)
    ("early growth response 1" . SPARSER::PROTEIN) ("PI3 K" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("type 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NF κ B" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("cyclooxygenase 2" . SPARSER::PROTEIN) ("IL-1 β" . SPARSER::PROTEIN)
    ("interleukin-1 β" . SPARSER::PROTEIN) ("NRP1" . SPARSER::PROTEIN)
    ("IGF2BP3" . SPARSER::PROTEIN) ("CCL2" . SPARSER::PROTEIN)
    ("SYT7" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("Akt, K-ras, and COX-2" . SPARSER::COLLECTION)
    ("COX-2 and its product PGE2" . SPARSER::COLLECTION)
    ("p27, XPA, and RPA" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("XPA" . SPARSER::PROTEIN) ("eIF3a" . SPARSER::PROTEIN)
    ("dramatically more purified eIF3i" . SPARSER::PROTEIN)
    ("an irrelevant protein" . SPARSER::PROTEIN) ("cRNA" . SPARSER::PROTEIN)
    ("COX-2 and β-catenin" . SPARSER::COLLECTION)
    ("COX-2 or β-catenin" . SPARSER::COLLECTION)
    ("effectors, β-catenin and TCF4" . SPARSER::COLLECTION)
    ("a known proto-oncogene and major mediator" . SPARSER::COLLECTION)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NOD" . SPARSER::PROTEIN)
    ("i-1 and eIF3" . SPARSER::COLLECTION)
    ("Ras and RIE-iH" . SPARSER::COLLECTION) ("IPTG" . SPARSER::MOLECULE)
    ("iH" . SPARSER::MOLECULE)
    ("proteins, eIF3b and eIF3g" . SPARSER::COLLECTION)
    ("eIF3g" . SPARSER::PROTEIN) ("eIF3b" . SPARSER::PROTEIN)
    ("the largest eIF complex" . SPARSER::BIO-COMPLEX)
    ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("β-catenin/TCF4" . SPARSER::COLLECTION) ("eIF3i" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("Ha- Ras" . SPARSER::PROTEIN) ("K- Ras" . SPARSER::PROTEIN)
    ("COX2" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("β-Actin" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("its 3" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("PGE-2" . SPARSER::DRUG) ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("Prostaglandin E2" . SPARSER::MOLECULE)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("i-2" . SPARSER::MOLECULE)
    ("i-1" . SPARSER::PROTEIN) ("TCF4" . SPARSER::PROTEIN)
    ("eIF3" . SPARSER::BIO-COMPLEX) ("ligand-receptor" . SPARSER::PROTEIN)
    ("EGF/CSF-1" . SPARSER::COLLECTION)
    ("the perivascular macrophages" . SPARSER::PROTEIN)
    ("perivascular macrophages" . SPARSER::PROTEIN)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("G14V-RhoA or F30L-RhoA" . SPARSER::COLLECTION)
    ("RhoC" . SPARSER::PROTEIN)
    ("physically contact macrophages" . SPARSER::PROTEIN)
    ("KD" . SPARSER::PROTEIN) ("cortactin and tks5" . SPARSER::COLLECTION)
    ("subcellular punctate" . SPARSER::PROTEIN)
    ("tks5 and cortactin" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN) ("apical ZO-1" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN)
    ("a perivascular macrophage" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("prep" . SPARSER::PROTEIN) ("Macrophage" . SPARSER::PROTEIN)
    ("intra-" . SPARSER::PROTEIN) ("intra" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("CSF-1R" . SPARSER::PROTEIN)
    ("CSF-1 receptor" . SPARSER::PROTEIN) ("L-asparagine" . SPARSER::MOLECULE)
    ("N-Wasp" . SPARSER::PROTEIN) ("GM6001" . SPARSER::DRUG)
    ("tight junction" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN) ("Tks5" . SPARSER::PROTEIN)
    ("tks5" . SPARSER::PROTEIN) ("BAC1" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN) ("AMP/ATP" . SPARSER::PROTEIN-PAIR)
    ("AMP" . SPARSER::AMP) ("CaMKK" . SPARSER::PROTEIN)
    ("a strong inhibitor" . SPARSER::INHIBITOR)
    ("a strong Nrf2 inducer" . SPARSER::MOLECULE)
    ("the acid-sensitive GFP" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("a soluble form" . SPARSER::FORM) ("glycine" . SPARSER::AMINO-ACID)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("a widely-used Nrf2 activator" . SPARSER::ACTIVATOR)
    ("Bip" . SPARSER::PROTEIN) ("MEK/ERK1/2" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("a strong Nrf2 activator" . SPARSER::ACTIVATOR)
    ("Baf and CQ" . SPARSER::COLLECTION) ("CQ" . SPARSER::PROTEIN)
    ("autophagosome-associated LC3-II" . SPARSER::PROTEIN)
    ("mRFP-GFP-LC3" . SPARSER::COLLECTION)
    ("palmitate-treated hepatocytes" . SPARSER::PROTEIN)
    ("puncta and LC3-II" . SPARSER::COLLECTION)
    ("cytometry and LDH" . SPARSER::COLLECTION)
    ("bafilomycin A1 (Baf) and chloroquine (CQ)" . SPARSER::COLLECTION)
    ("tBHQ and palmitate" . SPARSER::COLLECTION)
    ("chloroquine" . SPARSER::PROTEIN) ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a strong autophagy inducer" . SPARSER::MOLECULE)
    ("amino acid and serum" . SPARSER::COLLECTION)
    ("HO-1 and NQO1" . SPARSER::COLLECTION) ("Palmitate" . SPARSER::PROTEIN)
    ("the widely-used Nrf2 activators" . SPARSER::ACTIVATOR)
    ("LDH" . SPARSER::PROTEIN) ("a strong inducer" . SPARSER::PROTEIN)
    ("phase II detoxification enzymes and certain antioxidants"
     . SPARSER::COLLECTION)
    ("oxidative stress inducers" . SPARSER::MOLECULE)
    ("dopamine" . SPARSER::PROTEIN)
    ("a synthetic phenolic antioxidant" . SPARSER::PROTEIN)
    ("food" . SPARSER::MOLECULE) ("oleate" . SPARSER::MOLECULE)
    ("Bim and PUMA" . SPARSER::COLLECTION) ("Bcl-2/Bax" . SPARSER::COLLECTION)
    ("palmitate" . SPARSER::PROTEIN) ("lipids" . SPARSER::PROTEIN)
    ("triglyceride" . SPARSER::MOLECULE) ("skeletal muscle" . SPARSER::PROTEIN)
    ("FFAs" . SPARSER::PROTEIN)
    ("AMP-activated protein kinase (AMPK) and siRNA-mediated AMPK gene"
     . SPARSER::COLLECTION)
    ("protein kinase (AMPK)" . SPARSER::PROTEIN) ("puncta" . SPARSER::PROTEIN)
    ("tBHQ" . SPARSER::DRUG) ("PP2A" . SPARSER::PROTEIN)
    ("protein phosphatase 2A" . SPARSER::PROTEIN)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("liver kinase B1" . SPARSER::PROTEIN)
    ("Calcium/calmodulin-dependent protein kinase kinase 2" . SPARSER::PROTEIN)
    ("Keap-1" . SPARSER::PROTEIN) ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("butylated hydroxyanisole" . SPARSER::MOLECULE)
    ("LC-3" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("MAP1" . SPARSER::PROTEIN)
    ("microtubule associated protein" . SPARSER::PROTEIN)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("heme oxygenase 1" . SPARSER::PROTEIN) ("NQO1" . SPARSER::PROTEIN)
    ("GADD 153" . SPARSER::PROTEIN) ("IRE1" . SPARSER::PROTEIN)
    ("keap1" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("LC3B" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("A15" . SPARSER::PROTEIN) ("sodium hydroxide" . SPARSER::MOLECULE)
    ("Amino acid" . SPARSER::AMINO-ACID) ("U0126" . SPARSER::DRUG)
    ("bafilomycin A1" . SPARSER::DRUG) ("Keap1" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("Tert-butylhydroquinone" . SPARSER::DRUG)
    ("oleic acid" . SPARSER::MOLECULE) ("fatty acid" . SPARSER::MOLECULE)
    ("LC3-II" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("tert-butylhydroquinone" . SPARSER::DRUG) ("Nrf2" . SPARSER::PROTEIN)
    ("Nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("KRAS and EGFR" . SPARSER::COLLECTION) ("PAH" . SPARSER::PROTEIN)
    ("PAHs" . SPARSER::PROTEIN) ("natural gas" . SPARSER::PROTEIN)
    ("BRAF, NRAS, PIK3CA, MEK1, HER2, AKT1 , or PTEN" . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("EGFR, KRAS, BRAF, HER2, NRAS, PIK3CA, MEK1, AKT1 , and PTEN"
     . SPARSER::COLLECTION)
    ("SCCs" . SPARSER::PROTEIN) ("ADCs" . SPARSER::PROTEIN)
    ("NRAS" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("pRb" . SPARSER::PROTEIN)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TERT" . SPARSER::PROTEIN)
    ("Hox" . SPARSER::PROTEIN) ("murine mammary epithelium" . SPARSER::PROTEIN)
    ("Med12 and Med13" . SPARSER::COLLECTION) ("Med12" . SPARSER::PROTEIN)
    ("Lgl/BCL9" . SPARSER::COLLECTION) ("Med" . SPARSER::PROTEIN)
    ("Lgl" . SPARSER::PROTEIN)
    ("Axin2 , Lgr5 , CD44 , Cyclin D1 , and c-Myc" . SPARSER::COLLECTION)
    ("BAT-gal" . SPARSER::COLLECTION) ("gal" . SPARSER::PROTEIN)
    ("BAT" . SPARSER::PROTEIN) ("foci" . SPARSER::PROTEIN)
    ("hematoxylin" . SPARSER::MOLECULE)
    ("STOP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LSL" . SPARSER::PROTEIN)
    ("Cre" . SPARSER::PROTEIN) ("iPAF" . SPARSER::PROTEIN)
    ("TetO" . SPARSER::PROTEIN) ("–PAF" . SPARSER::COLLECTION)
    ("GST-β-catenin" . SPARSER::COLLECTION)
    ("β-catenin or PAF" . SPARSER::COLLECTION)
    ("EZH2-β-catenin" . SPARSER::COLLECTION) ("GST-PAF" . SPARSER::COLLECTION)
    ("β-catenin-EZH2" . SPARSER::COLLECTION)
    ("PAF and EZH2" . SPARSER::COLLECTION)
    ("β-catenin and EZH2" . SPARSER::COLLECTION)
    ("EZH2 and β-catenin" . SPARSER::COLLECTION)
    ("proximal promoters" . SPARSER::PROMOTER)
    ("c-Myc , Axin2 , Cyclin D1 , and DCC" . SPARSER::COLLECTION)
    ("DCC" . SPARSER::PROTEIN) ("EZH2 and PAF" . SPARSER::COLLECTION)
    ("Med1/RNA polymerase II" . SPARSER::COLLECTION)
    ("Axin2 and Cyclin D1" . SPARSER::COLLECTION)
    ("the proximal promoters" . SPARSER::PROMOTER)
    ("Lef1 , Lgr5 , c-Myc , and Axin2" . SPARSER::COLLECTION)
    ("Lef1" . SPARSER::PROTEIN) ("the proximal promoter" . SPARSER::PROMOTER)
    ("c-Myc and Axin2" . SPARSER::COLLECTION)
    ("PAF, EZH2, and β-catenin" . SPARSER::COLLECTION)
    ("c-Myc , Cyclin D1 , and Axin2" . SPARSER::COLLECTION)
    ("PCNA, EED, and Suz12" . SPARSER::COLLECTION)
    ("LiCl or Wnt3A" . SPARSER::COLLECTION)
    ("PCNA or β-catenin" . SPARSER::COLLECTION)
    ("EZH2-PAF" . SPARSER::COLLECTION) ("β-catenin-PAF" . SPARSER::COLLECTION)
    ("PAF or β-catenin" . SPARSER::COLLECTION) ("PRCs" . SPARSER::PROTEIN)
    ("PAF-EZH2" . SPARSER::COLLECTION) ("Sirt1" . SPARSER::PROTEIN)
    ("PRC" . SPARSER::PROTEIN) ("PRC2, EED, and Suz12" . SPARSER::COLLECTION)
    ("EED" . SPARSER::PROTEIN) ("lysine" . SPARSER::AMINO-ACID)
    ("Bmi1 and EZH2" . SPARSER::COLLECTION)
    ("Bmi1 and enhancer of zeste homolog 2" . SPARSER::COLLECTION)
    ("Bmi1 or EZH2" . SPARSER::COLLECTION)
    ("PRC1 and PRC2" . SPARSER::COLLECTION)
    ("Bmi1 and its associated components" . SPARSER::COLLECTION)
    ("its associated components" . SPARSER::COMPONENT)
    ("Polycomb" . SPARSER::PROTEIN)
    ("intestinal epithelium" . SPARSER::PROTEIN)
    ("epithelium" . SPARSER::PROTEIN) ("ISCs" . SPARSER::PROTEIN)
    ("proximal promoter" . SPARSER::PROMOTER)
    ("c-Myc and Cyclin D1" . SPARSER::COLLECTION)
    ("PAF-β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and TCF3" . SPARSER::COLLECTION)
    ("β-catenin and TCF" . SPARSER::COLLECTION)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("PAF-EZH2-β-catenin" . SPARSER::COLLECTION) ("FoxO" . SPARSER::PROTEIN)
    ("BMP/Smad" . SPARSER::COLLECTION) ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt3A or LiCl" . SPARSER::COLLECTION) ("LiCl" . SPARSER::DRUG)
    ("Siamois and Xnr3" . SPARSER::COLLECTION) ("Siamois" . SPARSER::PROTEIN)
    ("β-catenin and β-galactosidase" . SPARSER::COLLECTION)
    ("β-catenin and x" . SPARSER::COLLECTION) ("-oxime" . SPARSER::MOLECULE)
    ("oxime" . SPARSER::MOLECULE) ("Axin2-LacZ" . SPARSER::COLLECTION)
    ("LacZ" . SPARSER::PROTEIN) ("AER" . SPARSER::PROTEIN)
    ("MAPK or PI3K" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("wild-type Akt or constitutively active form" . SPARSER::COLLECTION)
    ("Myr" . SPARSER::MOLECULE) ("myristoylated" . SPARSER::PROTEIN)
    ("Ras/MAPK" . SPARSER::COLLECTION) ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nt" . SPARSER::PROTEIN) ("Cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("both shRNA non-targetable wild-type PAF (nt-PAF) and PIP mutant PAF (mutPIP-PAF)"
     . SPARSER::COLLECTION)
    ("mutPIP-PAF" . SPARSER::COLLECTION) ("nt-PAF" . SPARSER::COLLECTION)
    ("PAF-PCNA" . SPARSER::COLLECTION) ("PIP" . SPARSER::PROTEIN)
    ("sh-PAF" . SPARSER::COLLECTION) ("TLS" . SPARSER::PROTEIN)
    ("/KIAA0101" . SPARSER::COLLECTION)
    ("APC or β-catenin" . SPARSER::COLLECTION) ("edu" . SPARSER::DRUG)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin-TCF/LEF" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("TCF" . SPARSER::PROTEIN) ("casein" . SPARSER::PROTEIN-FAMILY)
    ("Axin , and β-catenin" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("tumor suppressor genes and activation of oncogenes"
     . SPARSER::COLLECTION)
    ("PAF" . SPARSER::PROTEIN) ("LY294002" . SPARSER::MOLECULE)
    ("Pygo1" . SPARSER::PROTEIN) ("Nkd1" . SPARSER::PROTEIN)
    ("Med13" . SPARSER::PROTEIN) ("BCL9" . SPARSER::PROTEIN)
    ("R-Spondin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("X-gal" . SPARSER::MOLECULE)
    ("Ki67" . SPARSER::PROTEIN) ("Pol II" . SPARSER::PROTEIN)
    ("Med1" . SPARSER::PROTEIN) ("Lgr5" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("Suz12" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::MOLECULE)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("TCF3" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("Xnr3" . SPARSER::PROTEIN) ("Wnt3A" . SPARSER::PROTEIN)
    ("K-Ras" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN) ("KIAA0101" . SPARSER::PROTEIN)
    ("PCNA-associated factor" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("EZH2" . SPARSER::PROTEIN)
    ("more effectively target mutant" . SPARSER::MUTANT)
    ("a static genome" . SPARSER::PROTEIN) ("POLH" . SPARSER::PROTEIN)
    ("late-line" . SPARSER::PROTEIN)
    ("this particular lumenal PDX" . SPARSER::PROTEIN)
    ("HER2−" . SPARSER::PROTEIN)
    ("PIK3R4 ( xref ; xref ) and KRAS ( xref )" . SPARSER::COLLECTION)
    ("WHIM2 and WHIM5" . SPARSER::COLLECTION)
    ("low-estradiol" . SPARSER::PROTEIN) ("ESR1 and YFP" . SPARSER::COLLECTION)
    ("western
blot"
     . SPARSER::PROTEIN)
    ("charcoal-stripped serum (CSS) media" . SPARSER::PROTEIN)
    ("ESR1 mutants and the ESR1/YAP1 fusion" . SPARSER::COLLECTION)
    ("Fulvestrant" . SPARSER::DRUG) ("ESR" . SPARSER::PROTEIN)
    ("an N-terminal ESR1 antibody and a YAP1 antibody" . SPARSER::COLLECTION)
    ("fulvestrant" . SPARSER::DRUG) ("Four lumenal PDX" . SPARSER::PROTEIN)
    ("Estradiol" . SPARSER::PROTEIN)
    ("KRAS , SLC23A , LRRC58 , MAPK9 , KIF21B , and PIK3R4"
     . SPARSER::COLLECTION)
    ("Hist1H1E" . SPARSER::PROTEIN) ("cancer-associated genes" . SPARSER::GENE)
    ("genomes" . SPARSER::PROTEIN) ("CBLB" . SPARSER::PROTEIN)
    ("at least one SMG" . SPARSER::PROTEIN) ("SMG" . SPARSER::PROTEIN)
    ("SMGs" . SPARSER::PROTEIN) ("nonsilent protein" . SPARSER::PROTEIN)
    ("germ-line" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase/AKT" . SPARSER::COLLECTION)
    ("protein and
phosphoprotein"
     . SPARSER::COLLECTION)
    ("intra-PDX" . SPARSER::PROTEIN-PAIR)
    ("WHIM2 and WHIM5, and WHIM20 and WHIM23" . SPARSER::COLLECTION)
    ("Genome" . SPARSER::PROTEIN) ("claudin" . SPARSER::PROTEIN)
    ("UNC Agilent chip" . SPARSER::PROTEIN) ("chip" . SPARSER::PROTEIN)
    ("UNC" . SPARSER::PROTEIN) ("keratins" . SPARSER::PROTEIN)
    ("the counterpart lumenal PDX" . SPARSER::PROTEIN)
    ("CK5 , and CK17" . SPARSER::COLLECTION)
    ("CKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PAM" . SPARSER::PROTEIN)
    ("Claudin" . SPARSER::PROTEIN) ("pink" . SPARSER::PROTEIN)
    ("FDR" . SPARSER::PROTEIN) ("ER and HER2" . SPARSER::COLLECTION)
    ("yielded 22 serially transplantable PDXs" . SPARSER::PROTEIN)
    ("protein and phosphoprotein" . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN) ("RPPA" . SPARSER::PROTEIN)
    ("trio" . SPARSER::PROTEIN) ("partial-genome" . SPARSER::COLLECTION)
    ("SVs" . SPARSER::MOLECULE) ("gold" . SPARSER::MOLECULE)
    ("very few breast cancer PDXs" . SPARSER::PROTEIN)
    ("partial and whole-genome" . SPARSER::COLLECTION)
    ("ESR1/YAP1" . SPARSER::COLLECTION) ("Variant" . SPARSER::VARIANT)
    ("PDX" . SPARSER::PROTEIN) ("PDXs" . SPARSER::PROTEIN)
    ("ASXL2" . SPARSER::PROTEIN) ("s 4" . SPARSER::PROTEIN-FAMILY)
    ("xeroderma pigmentosum" . SPARSER::PROTEIN) ("AKAP12" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("trefoil factor 1" . SPARSER::PROTEIN)
    ("MAP3K1" . SPARSER::PROTEIN) ("KIF21B" . SPARSER::PROTEIN)
    ("MAPK9" . SPARSER::PROTEIN) ("LRRC58" . SPARSER::PROTEIN)
    ("ZNF687" . SPARSER::PROTEIN) ("WDR81" . SPARSER::PROTEIN)
    ("H1E" . SPARSER::PROTEIN) ("Hist1" . SPARSER::PROTEIN)
    ("WHIM 2" . SPARSER::PROTEIN-FAMILY) ("MAP4K2" . SPARSER::PROTEIN)
    ("PIK3R4" . SPARSER::PROTEIN) ("WNK2" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WHIM2" . SPARSER::PROTEIN-FAMILY) ("CK17" . SPARSER::PROTEIN)
    ("CK5" . SPARSER::PROTEIN) ("CK14" . SPARSER::PROTEIN)
    ("cytokeratin 14" . SPARSER::PROTEIN)
    ("estrogen-receptor" . SPARSER::PROTEIN) ("YAP1" . SPARSER::PROTEIN)
    ("Estrogen-receptor" . SPARSER::PROTEIN) ("Age" . SPARSER::PROTEIN)
    ("Alcohol" . SPARSER::DRUG) ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("Forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cohort" . SPARSER::MOLECULE)
    ("its allelic variants" . SPARSER::VARIANT)
    ("allele (TT)" . SPARSER::ALLELE) ("allele (CC)" . SPARSER::ALLELE)
    ("other reproductive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Allele" . SPARSER::ALLELE)
    ("factors and FGFR2" . SPARSER::COLLECTION)
    ("gene and breast" . SPARSER::COLLECTION)
    ("the allelic variants" . SPARSER::VARIANT) ("Aims" . SPARSER::PROTEIN)
    ("BPC3" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("MgCl2" . SPARSER::MOLECULE) ("− 3" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor Receptor 2" . SPARSER::PROTEIN)
    ("normal HSCs" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("calpain" . SPARSER::PROTEIN) ("bortezomib" . SPARSER::DRUG)
    ("CHS" . SPARSER::PROTEIN) ("NF-κB and coactivates" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN) ("chromatin or DNA" . SPARSER::COLLECTION)
    ("RELA or p50" . SPARSER::COLLECTION)
    ("aberrant elongation" . SPARSER::PROTEIN) ("pol" . SPARSER::PROTEIN)
    ("HOX" . SPARSER::PROTEIN)
    ("MLL-rearranged acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("AML1-ETO" . SPARSER::COLLECTION) ("ETO" . SPARSER::PROTEIN)
    ("KIT" . SPARSER::PROTEIN) ("PPP4C and IRAK3" . SPARSER::COLLECTION)
    ("IKKα, IKKβ, IKKγ, PPP4C, IRAK3, and PLK1" . SPARSER::COLLECTION)
    ("essential target genes" . SPARSER::GENE)
    ("a model whereby NF-κB and MLL oncoproteins" . SPARSER::PROTEIN)
    ("NF-κB and MLL" . SPARSER::COLLECTION)
    ("Meis1 and Hoxa9" . SPARSER::COLLECTION)
    ("promoter-associated MLL-AF10" . SPARSER::COLLECTION)
    ("HOXA9/MEIS1" . SPARSER::COLLECTION)
    ("Hoxa9 and Meis1" . SPARSER::COLLECTION) ("Nras" . SPARSER::PROTEIN)
    ("Genes" . SPARSER::GENE) ("MEIS1 and HOXA9" . SPARSER::COLLECTION)
    ("IKK inhibition negatively impacts LSCs" . SPARSER::PROTEIN)
    ("pediatric AML" . SPARSER::PROTEIN)
    ("MYC, MAX, MYCN, DMAP1, E2F1, E2F4, and ZFX" . SPARSER::COLLECTION)
    ("ZFX" . SPARSER::PROTEIN) ("MYCN" . SPARSER::PROTEIN)
    ("MAX" . SPARSER::PROTEIN) ("ESC" . SPARSER::PROTEIN)
    ("IKK inhibitor-treated mouse and human leukemia cells genes"
     . SPARSER::GENE)
    ("LSCs" . SPARSER::PROTEIN) ("GMPs" . SPARSER::GMP)
    ("LSC" . SPARSER::PROTEIN) ("VII" . SPARSER::PROTEIN)
    ("MLL oncogenes ( MLL-AF9 or MLL-ENL ) or oncogenes" . SPARSER::COLLECTION)
    ("acute leukemia" . SPARSER::PROTEIN) ("E2A-HLF" . SPARSER::COLLECTION)
    ("NUP98-HOXA9" . SPARSER::COLLECTION) ("MLL-ENL" . SPARSER::COLLECTION)
    ("methylcellulose" . SPARSER::DRUG) ("E2A" . SPARSER::PROTEIN)
    ("Ikkα and Ikkγ" . SPARSER::COLLECTION)
    ("Ikkα, Ikkβ, or Ikkγ" . SPARSER::COLLECTION)
    ("E2A-PBX1" . SPARSER::COLLECTION) ("MLL-AF6" . SPARSER::COLLECTION)
    ("HLF" . SPARSER::PROTEIN) ("AF6" . SPARSER::PROTEIN)
    ("MV" . SPARSER::PROTEIN) ("Pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("MLL-associated leukemia" . SPARSER::PROTEIN)
    ("MLL-associated AML" . SPARSER::PROTEIN)
    ("HOXA9 and NF-κB" . SPARSER::COLLECTION) ("MLL-AF9" . SPARSER::COLLECTION)
    ("MLL-AF10" . SPARSER::COLLECTION) ("HSA" . SPARSER::PROTEIN)
    ("IL-1R-associated kinase" . SPARSER::KINASE)
    ("IKKα, IKKβ, and IKKγ" . SPARSER::COLLECTION)
    ("kinases or phosphatases" . SPARSER::COLLECTION)
    ("shRNAs" . SPARSER::PROTEIN)
    ("stalled RNA polymerase II as well as factors (NELF, DSIF)"
     . SPARSER::COLLECTION)
    ("DSIF" . SPARSER::PROTEIN) ("NELF" . SPARSER::PROTEIN)
    ("AF10, AF9, and ENL" . SPARSER::COLLECTION) ("ENL" . SPARSER::PROTEIN)
    ("these accessory factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HOXA9 and MEIS1" . SPARSER::COLLECTION) ("Chemical" . SPARSER::MOLECULE)
    ("epithelium-derived growth factor (LEDGF)" . SPARSER::PROTEIN-PAIR)
    ("epithelium-derived growth factor" . SPARSER::PROTEIN-PAIR)
    ("bromodomain" . SPARSER::PROTEIN) ("demethylase" . SPARSER::PROTEIN)
    ("methyltransferase" . SPARSER::PROTEIN) ("LEDGF" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("multi-protein" . SPARSER::COLLECTION)
    ("classical activators" . SPARSER::ACTIVATOR)
    ("its inherent histone methyltransferase activity" . SPARSER::PROTEIN)
    ("IKK/NF-κB" . SPARSER::COLLECTION) ("IKK" . SPARSER::PROTEIN)
    ("RELA" . SPARSER::PROTEIN) ("epigenetic cofactors" . SPARSER::PROTEIN)
    ("robust anti-leukemia" . SPARSER::ANTIBODY)
    ("cofactors" . SPARSER::PROTEIN)
    ("aberrant transcriptional elongation" . SPARSER::PROTEIN)
    ("oncoproteins" . SPARSER::PROTEIN) ("elongation" . SPARSER::PROTEIN)
    ("MLL" . SPARSER::PROTEIN) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ikk β" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("GSK3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("AML1" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("Meis1" . SPARSER::PROTEIN)
    ("Hoxa9" . SPARSER::PROTEIN) ("E2F4" . SPARSER::PROTEIN)
    ("DMAP1" . SPARSER::PROTEIN) ("NUP98" . SPARSER::PROTEIN)
    ("Ikkγ" . SPARSER::PROTEIN) ("Ikkβ" . SPARSER::PROTEIN)
    ("Ikkα" . SPARSER::PROTEIN) ("PBX1" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN) ("AF1" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("IRAK3" . SPARSER::PROTEIN)
    ("IL-1R" . SPARSER::PROTEIN) ("PPP4C" . SPARSER::PROTEIN)
    ("protein phosphatase 4 catalytic subunit" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN) ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("elongation factor" . SPARSER::PROTEIN) ("AF9" . SPARSER::PROTEIN)
    ("AF10" . SPARSER::PROTEIN) ("MEIS1" . SPARSER::PROTEIN)
    ("HOXA9" . SPARSER::PROTEIN) ("BRD4" . SPARSER::PROTEIN)
    ("KDM1A" . SPARSER::PROTEIN) ("CBX8" . SPARSER::PROTEIN)
    ("chromobox homolog 8" . SPARSER::PROTEIN) ("DOT1L" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("this cytogenetic biomarker" . SPARSER::MOLECULE)
    ("XRCC3 (Thr241Met) and XRCC4 (Ile401Thr)" . SPARSER::COLLECTION)
    ("XRCC1 (Arg399Gln), OGG1 (Ser326Cys), XRCC3 (Thr241Met) and XRCC4 (Ile401Thr)"
     . SPARSER::COLLECTION)
    ("histone" . SPARSER::PROTEIN) ("potential biomarkers" . SPARSER::MOLECULE)
    ("KR" . SPARSER::PROTEIN) ("XRCC1 and XRCC4" . SPARSER::COLLECTION)
    ("DNA Ligase III and DNA Ligase IV" . SPARSER::COLLECTION)
    ("XRCC2 and XRCC3" . SPARSER::COLLECTION) ("Rad51-" . SPARSER::PROTEIN)
    ("polymorphic variants" . SPARSER::VARIANT)
    ("Arg/Arg" . SPARSER::COLLECTION)
    ("XRCC1 (Arg399Gln) and OGG1 (Ser326Cys)" . SPARSER::COLLECTION)
    ("genetic polymorphisms XRCC1 (Arg399Gln) and XRCC3 (Thr241Met)"
     . SPARSER::COLLECTION)
    ("FEV" . SPARSER::PROTEIN)
    ("The XRCC4 (Ile401Thr) and OGG1 (ser326Cys) risk alleles"
     . SPARSER::COLLECTION)
    ("ser" . SPARSER::AMINO-ACID)
    ("XRCC1 (Arg399Gln) and XRCC3 (Thr241Met)" . SPARSER::COLLECTION)
    ("COPD and control group" . SPARSER::COLLECTION)
    ("cigarettes" . SPARSER::DRUG) ("barrier" . SPARSER::PROTEIN)
    ("COPD, and XRCC1" . SPARSER::COLLECTION)
    ("a key biomarker" . SPARSER::MOLECULE)
    ("OGG1 and XRCC1" . SPARSER::COLLECTION)
    ("the risk allele XRCC1 (Arg399Gln) and XRCC3 (Thr241Met)"
     . SPARSER::COLLECTION)
    ("alkaline" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("DNA Ligase IV" . SPARSER::PROTEIN) ("DNA Ligase III" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("APEX1" . SPARSER::PROTEIN)
    ("APE1" . SPARSER::PROTEIN)
    ("8-oxoguanine DNA glycosylase" . SPARSER::PROTEIN)
    ("XRCC4" . SPARSER::PROTEIN) ("IPT" . SPARSER::PROTEIN)
    ("HK" . SPARSER::PROTEIN) ("ET" . SPARSER::PROTEIN)
    ("TLR-3 or even other receptors [ xref ]" . SPARSER::COLLECTION)
    ("even other receptors" . SPARSER::RECEPTOR) ("PRRs" . SPARSER::PROTEIN)
    ("monocyte-derived human DCs" . SPARSER::PROTEIN)
    ("both proTα and its shorter immunoactive decapeptide"
     . SPARSER::COLLECTION)
    ("HSP22, HSP60, HSP70 and HSP90" . SPARSER::COLLECTION)
    ("TNF-α and type I" . SPARSER::COLLECTION)
    ("human mature DCs" . SPARSER::PROTEIN)
    ("either HMGB1 (Hp91; [ xref ]) or HSP70 (HSP70 359-610 ; [ xref ])"
     . SPARSER::COLLECTION)
    ("family and granulysin" . SPARSER::COLLECTION)
    ("granulysin" . SPARSER::PROTEIN)
    ("tumor antigenic peptides" . SPARSER::PEPTIDE)
    ("IFN-γ and IL-2" . SPARSER::COLLECTION) ("class I-" . SPARSER::PROTEIN)
    ("tumor-associated immunogenic peptides" . SPARSER::PEPTIDE)
    ("CD80/CD86" . SPARSER::COLLECTION)
    ("proTα or its immunoreactive decapeptide" . SPARSER::COLLECTION)
    ("TRIF, TIRAP and MyD88" . SPARSER::COLLECTION)
    ("proTα (2.537 for TRIF, 2.28 for TIRAP and 1.577 for MyD88) or proTα(100–109)"
     . SPARSER::COLLECTION)
    ("the latter case" . SPARSER::PROTEIN)
    ("LPS, proTα or proTα" . SPARSER::COLLECTION)
    ("TLRs" . SPARSER::PROTEIN-FAMILY) ("TLR-2" . SPARSER::PROTEIN)
    ("post-LPS" . SPARSER::COLLECTION)
    ("Immature DCs (iDCs) and DCs" . SPARSER::COLLECTION)
    ("Immature DCs" . SPARSER::PROTEIN) ("TRIF-" . SPARSER::PROTEIN)
    ("IFN-γ, TNF-α and IL-2" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("TNF-α-, proTα- or proTα" . SPARSER::COLLECTION)
    ("tyr" . SPARSER::PROTEIN) ("tyrosinase" . SPARSER::PROTEIN)
    ("Cytotoxic" . SPARSER::PROTEIN)
    ("proTα- and proTα(100–109)-matured HER-2(9 369 )-pulsed DCs"
     . SPARSER::PROTEIN)
    ("IL-2-" . SPARSER::PROTEIN)
    ("anti-inflammatory cytokines (IL-4, IL-10) and IL-17"
     . SPARSER::COLLECTION)
    ("minor" . SPARSER::PROTEIN) ("IL-4 and IL-10" . SPARSER::COLLECTION)
    ("IFN" . SPARSER::PROTEIN)
    ("similarly matured autologous DCs" . SPARSER::PROTEIN)
    ("proTα(100–109) or TNF-α (used as a conventional DC maturation agent)"
     . SPARSER::COLLECTION)
    ("proTα- and proTα" . SPARSER::COLLECTION)
    ("ProTα and proTα" . SPARSER::COLLECTION)
    ("LPS- and proTα-matured DCs" . SPARSER::COLLECTION)
    ("LPS-, proTα- and proTα" . SPARSER::COLLECTION)
    ("LPS-, TNF-α-, proTα- and proTα" . SPARSER::COLLECTION)
    ("TNF-α-" . SPARSER::PROTEIN) ("LPS or TNF-α" . SPARSER::COLLECTION)
    ("TNF-α and IL-12" . SPARSER::COLLECTION) ("mature DCs" . SPARSER::PROTEIN)
    ("IL-12:IL-10" . SPARSER::BIO-COMPLEX) ("IL" . SPARSER::PROTEIN)
    ("functionally competent mature DCs" . SPARSER::PROTEIN)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::PROTEIN)
    ("either proTα or its decapeptide" . SPARSER::COLLECTION)
    ("LPS- or TNF-α-matured DCs" . SPARSER::COLLECTION)
    ("HLA-DR, CD11b, CD80, CD83, CD86 and CD40" . SPARSER::COLLECTION)
    ("proTα and proTα(100–109) efficiently mature human DCs"
     . SPARSER::PROTEIN)
    ("both proTα and its decapeptide proTα(100–109)" . SPARSER::COLLECTION)
    ("CD80, CD83 and CD86" . SPARSER::COLLECTION) ("multi" . SPARSER::PROTEIN)
    ("protein and heat shock protein (HSP)" . SPARSER::COLLECTION)
    ("protein and heat shock protein" . SPARSER::COLLECTION)
    ("DAMPs" . SPARSER::DAMP)
    ("a TLR-7 agonist [ xref ] and monophosphoryl lipid A"
     . SPARSER::COLLECTION)
    ("imiquimod" . SPARSER::DRUG) ("PAMPs" . SPARSER::PROTEIN)
    ("Adjuvants" . SPARSER::DRUG) ("immunocompetent DCs" . SPARSER::PROTEIN)
    ("tumor-associated suppressive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("co-administering immunogenic peptides" . SPARSER::PEPTIDE)
    ("proTα and the proTα-derived immunoactive decapeptide"
     . SPARSER::COLLECTION)
    ("proTα and proTα" . SPARSER::COLLECTION)
    ("TIRAP, MyD88 and TRIF" . SPARSER::COLLECTION)
    ("TIRAP" . SPARSER::PROTEIN) ("ProTα- and proTα" . SPARSER::COLLECTION)
    ("ProTα-" . SPARSER::PROTEIN) ("Monocyte-derived DCs" . SPARSER::PROTEIN)
    ("proTα or proTα" . SPARSER::COLLECTION)
    ("proTα- or proTα" . SPARSER::COLLECTION) ("proTα-" . SPARSER::PROTEIN)
    ("prothymosin alpha (proTα) and its immunoreactive decapeptide proTα(100–109)"
     . SPARSER::COLLECTION)
    ("its immunoreactive decapeptide proTα" . SPARSER::PROTEIN)
    ("receptor (TLR)" . SPARSER::RECEPTOR) ("agonists" . SPARSER::AGONIST)
    ("TLR" . SPARSER::PROTEIN) ("adjuvants" . SPARSER::DRUG)
    ("Active" . SPARSER::ACTIVE) ("Prothymosin alpha" . SPARSER::PROTEIN)
    ("Heat shock protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD-" . SPARSER::PROTEIN) ("CD11c " . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("IgG2" . SPARSER::BIO-COMPLEX)
    ("C11" . SPARSER::PROTEIN) ("HSP60" . SPARSER::PROTEIN)
    ("HSP22" . SPARSER::PROTEIN) ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP70" . SPARSER::PROTEIN) ("CD107a" . SPARSER::PROTEIN)
    ("DR4" . SPARSER::PROTEIN) ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor antigen" . SPARSER::DRUG) ("IL-12" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("CD83" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("IRAK-4" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("High mobility group box 1" . SPARSER::PROTEIN)
    ("TLR-7" . SPARSER::PROTEIN) ("TLR-3" . SPARSER::PROTEIN)
    ("TLR-9" . SPARSER::PROTEIN) ("MyD88" . SPARSER::PROTEIN)
    ("TLR-4" . SPARSER::PROTEIN) ("ProTα" . SPARSER::PROTEIN)
    ("proTα" . SPARSER::PROTEIN) ("prothymosin alpha" . SPARSER::PROTEIN)
    ("SC" . SPARSER::PROTEIN) ("ARB, and CXW" . SPARSER::COLLECTION)
    ("ARB" . SPARSER::PROTEIN) ("-Hexachlorobiphenyl" . SPARSER::MOLECULE)
    ("Dihydrotestosterone" . SPARSER::DRUG)
    ("Hexachlorobiphenyl" . SPARSER::MOLECULE) ("Endocrine" . SPARSER::PROTEIN)
    ("a novel potential binding site PBS1" . SPARSER::PROTEIN)
    ("two most widespread POPs" . SPARSER::MOLECULE)
    ("DHT and POPs" . SPARSER::COLLECTION)
    ("POPs and DHT" . SPARSER::COLLECTION)
    ("H11, H12, and β1" . SPARSER::COLLECTION) ("Ala" . SPARSER::AMINO-ACID)
    ("cation" . SPARSER::MOLECULE)
    ("PBS1, PBS2, and PBS4" . SPARSER::COLLECTION)
    ("DHT and AR/LBD" . SPARSER::COLLECTION)
    ("The detailed energetic components" . SPARSER::COMPONENT)
    ("-DDE (−177.0 kJ/mol) and CB-153 (−192.9 kJ/mol)" . SPARSER::COLLECTION)
    ("AR/LBD" . SPARSER::PROTEIN) ("AR/LBD-DHT" . SPARSER::COLLECTION)
    ("the configurational entropic component" . SPARSER::COMPONENT)
    ("PBS1 or PBS2" . SPARSER::COLLECTION) ("PB" . SPARSER::PROTEIN)
    ("monomers or complex" . SPARSER::COLLECTION) ("int" . SPARSER::PROTEIN)
    ("monomers" . SPARSER::MONOMER) ("gas" . SPARSER::PROTEIN)
    ("PBS1 and PBS2" . SPARSER::COLLECTION) ("rest" . SPARSER::PROTEIN)
    ("PBS1, PBS2, PBS4, and PBS5" . SPARSER::COLLECTION)
    ("MM/PBSA" . SPARSER::COLLECTION) ("PBSA" . SPARSER::PROTEIN)
    ("PBS1" . SPARSER::PROTEIN) ("PBSs" . SPARSER::PROTEIN)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("ray" . SPARSER::PROTEIN)
    ("BF" . SPARSER::PROTEIN)
    ("estrogen receptors (ER) and progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("receptors (ER)" . SPARSER::RECEPTOR) ("NR" . SPARSER::PROTEIN)
    ("coactivators" . SPARSER::PROTEIN) ("SRC" . SPARSER::PROTEIN)
    ("agonist" . SPARSER::AGONIST)
    ("testosterone or 5α-dihydrotestosterone (DHT)" . SPARSER::COLLECTION)
    ("testosterone or 5α-dihydrotestosterone" . SPARSER::COLLECTION)
    ("testosterone" . SPARSER::MOLECULE)
    ("a soluble protein" . SPARSER::PROTEIN) ("NRs" . SPARSER::PROTEIN)
    ("-hexachlorobiphenyl" . SPARSER::MOLECULE)
    ("hexachlorobiphenyl" . SPARSER::MOLECULE)
    ("dichlorodiphenyltrichloroethane (DDT)" . SPARSER::MOLECULE)
    ("the major metabolite" . SPARSER::MOLECULE) ("DDT" . SPARSER::PROTEIN)
    ("dichlorodiphenyltrichloroethane" . SPARSER::MOLECULE)
    ("metabolite" . SPARSER::MOLECULE)
    ("potential endocrine" . SPARSER::PROTEIN) ("EDCs" . SPARSER::MOLECULE)
    ("DHT" . SPARSER::PROTEIN) ("dihydrotestosterone" . SPARSER::DRUG)
    ("-DDE and CB-153" . SPARSER::COLLECTION) ("CB" . SPARSER::PROTEIN)
    ("-DDE" . SPARSER::MOLECULE) ("PCBs" . SPARSER::PROTEIN)
    ("biphenyls" . SPARSER::DRUG) ("DDE" . SPARSER::MOLECULE)
    ("pesticides" . SPARSER::MOLECULE) ("POPs" . SPARSER::MOLECULE)
    ("Nuclear receptor" . SPARSER::PROTEIN) ("H12" . SPARSER::PROTEIN)
    ("H11" . SPARSER::PROTEIN) ("benzyl group" . SPARSER::MOLECULE)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PBS2" . SPARSER::PROTEIN)
    ("nuclear receptor" . SPARSER::PROTEIN)
    ("Androgen receptor" . SPARSER::PROTEIN) ("AF2" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN) ("PPA" . SPARSER::PROTEIN)
    ("RM" . SPARSER::PROTEIN) ("MFL" . SPARSER::PROTEIN)
    ("SD" . SPARSER::PROTEIN) ("MACS" . SPARSER::PROTEIN)
    ("ASK" . SPARSER::PROTEIN) ("MMP-2 and/or MMP-9" . SPARSER::COLLECTION)
    ("FISH" . SPARSER::PROTEIN) ("FBXW7 and p53" . SPARSER::COLLECTION)
    ("a haploinsufficient tumor suppressor gene" . SPARSER::PROTEIN)
    ("an abnormal MYC protein" . SPARSER::PROTEIN)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ig" . SPARSER::MOLECULE)
    ("a strong factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Western blot" . SPARSER::PROTEIN) ("Western blot" . SPARSER::PROTEIN)
    ("MYC and p53" . SPARSER::COLLECTION) ("Nuclear" . SPARSER::PROTEIN)
    ("RQ" . SPARSER::MOLECULE)
    ("FBXW7 mRNA (0.53 ± 0.40 fold change) and TP53 mRNA (0.84 ± 0.55 fold change)"
     . SPARSER::COLLECTION)
    ("JUN" . SPARSER::PROTEIN) ("SCF" . SPARSER::PROTEIN)
    ("FBXW7 and MYC" . SPARSER::COLLECTION) ("ACP" . SPARSER::PROTEIN)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("MYC and FBXW7" . SPARSER::COLLECTION)
    ("FBXW7 and TP53" . SPARSER::COLLECTION)
    ("MYC , FBXW7 , and TP53" . SPARSER::COLLECTION)
    ("MYC protein" . SPARSER::PROTEIN) ("30 K" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("cyclin E" . SPARSER::PROTEIN) ("Cul1" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("a selective antifungal antifolate" . SPARSER::MOLECULE)
    ("conformation and form" . SPARSER::COLLECTION) ("TS" . SPARSER::PROTEIN)
    ("a novel antimalarial antifolate" . SPARSER::MOLECULE)
    ("selective antimicrobial antifolates" . SPARSER::MOLECULE)
    ("NADPH and the PLAs" . SPARSER::COLLECTION)
    ("ID:1KMV" . SPARSER::PROTEIN-PAIR)
    ("the latter complex" . SPARSER::BIO-COMPLEX) ("SRI" . SPARSER::PROTEIN)
    ("the propargylic methyl group" . SPARSER::MOLECULE)
    ("NADPH and UCP1006" . SPARSER::COLLECTION)
    ("MIC" . SPARSER::PROTEIN-FAMILY)
    ("the coplanar conformation" . SPARSER::BIO-CONFORMATION)
    ("Inhibitor" . SPARSER::INHIBITOR) ("Ligands" . SPARSER::LIGAND)
    ("the basic nitrogen and bulk solvent" . SPARSER::COLLECTION)
    ("the basic nitrogen" . SPARSER::MOLECULE) ("weaker" . SPARSER::PROTEIN)
    ("Leu" . SPARSER::AMINO-ACID) ("van" . SPARSER::PROTEIN)
    ("similar conformations and the same configuration" . SPARSER::COLLECTION)
    ("conformations" . SPARSER::BIO-CONFORMATION) ("Glu" . SPARSER::AMINO-ACID)
    ("anchor" . SPARSER::ANCHOR)
    ("UCP1006, UCP1025, UCP1017 and UCP1019" . SPARSER::COLLECTION)
    ("ID" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("cofactor, NADPH and ligand" . SPARSER::COLLECTION)
    ("NADPH" . SPARSER::PROTEIN) ("flash" . SPARSER::PROTEIN)
    ("isoquinoline" . SPARSER::DRUG) ("biaryl" . SPARSER::MOLECULE)
    ("pyrimidine" . SPARSER::DRUG)
    ("UCP1006, UCP1015, UCP1017, UCP1019 and UCP1025" . SPARSER::COLLECTION)
    ("Antifolates" . SPARSER::MOLECULE) ("aid" . SPARSER::PROTEIN)
    ("UCP" . SPARSER::PROTEIN) ("the pathogenic enzyme" . SPARSER::ENZYME)
    ("antimicrobial antifolates" . SPARSER::MOLECULE)
    ("pathogenic enzymes" . SPARSER::ENZYME)
    ("antimicrobial DHFR inhibitors" . SPARSER::INHIBITOR)
    ("pyrimethamine" . SPARSER::DRUG) ("trimethoprim" . SPARSER::DRUG)
    ("methotrexate" . SPARSER::DRUG)
    ("purines and several amino acids" . SPARSER::COLLECTION)
    ("an essential metabolic enzyme" . SPARSER::ENZYME)
    ("purines" . SPARSER::DRUG) ("dTMP" . SPARSER::MOLECULE)
    ("deoxythymidine" . SPARSER::MOLECULE) ("Ile" . SPARSER::AMINO-ACID)
    ("Val" . SPARSER::AMINO-ACID) ("PLA" . SPARSER::PROTEIN)
    ("Phe" . SPARSER::AMINO-ACID) ("Asn" . SPARSER::AMINO-ACID)
    ("PLAs" . SPARSER::PROTEIN) ("antifolates" . SPARSER::MOLECULE)
    ("dihydrofolate reductase (DHFR)" . SPARSER::PROTEIN)
    ("antimicrobial drugs" . SPARSER::DRUG) ("DHFR" . SPARSER::PROTEIN)
    ("PY957" . SPARSER::DRUG) ("pyridine ring" . SPARSER::MOLECULE)
    ("group C" . SPARSER::PROTEIN) ("ID 2" . SPARSER::PROTEIN)
    ("CCP4" . SPARSER::PROTEIN) ("potassium chloride" . SPARSER::MOLECULE)
    ("Dihydrofolate reductase" . SPARSER::PROTEIN)
    ("noninflammatory molecule" . SPARSER::MOLECULE)
    ("this cytokine and the masking" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the HGF/c-Met pathway sheds some mechanistic light" . SPARSER::PROTEIN)
    ("tumor-associated mitogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("inducers" . SPARSER::MOLECULE) ("exogenous HGF" . SPARSER::PROTEIN)
    ("cpd" . SPARSER::PROTEIN) ("leukocytes and MDSCs" . SPARSER::COLLECTION)
    ("HGF/c-Met" . SPARSER::COLLECTION) ("mitogen" . SPARSER::MITOGEN)
    ("iNOS and ARG1" . SPARSER::COLLECTION)
    ("stromal-related factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HGF, and IL-6" . SPARSER::COLLECTION)
    ("RANTES/CCL5" . SPARSER::COLLECTION)
    ("relevant secreted molecules" . SPARSER::MOLECULE)
    ("IL-10 and TGFβ" . SPARSER::COLLECTION)
    ("MSCs, and CD14" . SPARSER::COLLECTION)
    ("multipotent MSCs" . SPARSER::PROTEIN)
    ("the costimulatory molecules CD80" . SPARSER::PROTEIN)
    ("placental MSCs" . SPARSER::PROTEIN)
    ("CD73, CD105, and CD90" . SPARSER::COLLECTION)
    ("Functional CD14" . SPARSER::PROTEIN) ("Leukocytes" . SPARSER::PROTEIN)
    ("a potent mitogenic growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("IL-1β, IL-6, and prostaglandin E 2" . SPARSER::COLLECTION)
    ("the enzymes arginase 1 (ARG1) and inducible nitric oxide synthase (iNOS)"
     . SPARSER::COLLECTION)
    ("ARG" . SPARSER::PROTEIN) ("tolerogenic DCs" . SPARSER::PROTEIN)
    ("TGF-β, IDO, and interleukin-10" . SPARSER::COLLECTION)
    ("immature myeloid DCs" . SPARSER::PROTEIN) ("DCs" . SPARSER::PROTEIN)
    ("killer" . SPARSER::PROTEIN)
    ("indoleamine-2,3-dioxygenase (IDO)" . SPARSER::PROTEIN)
    ("CD4 and CD8" . SPARSER::COLLECTION) ("IDO" . SPARSER::PROTEIN)
    ("adipocytes, osteoblasts, and chondrocytes" . SPARSER::COLLECTION)
    ("adipocytes" . SPARSER::PROTEIN) ("HGF" . SPARSER::PROTEIN)
    ("arginase" . SPARSER::PROTEIN) ("MSC" . SPARSER::PROTEIN)
    ("immunomodulatory leukocytes" . SPARSER::PROTEIN)
    ("MSCs" . SPARSER::PROTEIN) ("CD28" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("for 3 " . SPARSER::PROTEIN)
    ("HGF Receptor" . SPARSER::PROTEIN) ("PHA-665752" . SPARSER::DRUG)
    ("CD127" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN) ("CD90" . SPARSER::PROTEIN)
    ("CD105" . SPARSER::PROTEIN) ("CD73" . SPARSER::PROTEIN)
    ("PGE 2" . SPARSER::DRUG) ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("IL-1β" . SPARSER::PROTEIN) ("L-arginine" . SPARSER::MOLECULE)
    ("CD3-ζ" . SPARSER::PROTEIN) ("arginase 1" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("interleukin-10" . SPARSER::PROTEIN)
    ("indoleamine-2,3-dioxygenase" . SPARSER::PROTEIN)
    ("CD8" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN) ("CD33" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("doxorubicin and radioiodine" . SPARSER::COLLECTION)
    ("iodine" . SPARSER::MOLECULE)
    ("doxorubicin, p73 and p53" . SPARSER::COLLECTION)
    ("normal and transformed hepatocytes" . SPARSER::PROTEIN)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("homeobox" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase 7 and caspase 3" . SPARSER::COLLECTION)
    ("the NIS proximal promoter" . SPARSER::PROMOTER)
    ("etoposide and cisplatin" . SPARSER::COLLECTION)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("sharp" . SPARSER::PROTEIN)
    ("p73 and p63" . SPARSER::COLLECTION) ("paralogs" . SPARSER::PROTEIN)
    ("Exogenous p53" . SPARSER::PROTEIN) ("Luc" . SPARSER::PROTEIN)
    ("NIS-Luc" . SPARSER::COLLECTION)
    ("p53, p63 and p73" . SPARSER::COLLECTION)
    ("anti-p53, anti-p63 or anti-p73" . SPARSER::COLLECTION)
    ("p63 and p73" . SPARSER::COLLECTION)
    ("the human NIS proximal promoter" . SPARSER::PROMOTER)
    ("nitrosamine" . SPARSER::MOLECULE) ("DEN" . SPARSER::PROTEIN)
    ("p53 and p53-related proteins" . SPARSER::COLLECTION)
    ("NIS proximal promoter" . SPARSER::PROMOTER)
    ("Pax-8 and Nkx2.1" . SPARSER::COLLECTION) ("PTTG" . SPARSER::PROTEIN)
    ("PBF" . SPARSER::PROTEIN) ("cAMP" . SPARSER::PROTEIN)
    ("TSH" . SPARSER::PROTEIN) ("diagnostic nuclear" . SPARSER::PROTEIN)
    ("symporter (NIS)" . SPARSER::PROTEIN)
    ("The solute carrier family 5 member A5 SLC5A5" . SPARSER::PROTEIN)
    ("lactating" . SPARSER::MOLECULE) ("p53 and p73" . SPARSER::COLLECTION)
    ("HCC and CCA" . SPARSER::COLLECTION) ("PHH" . SPARSER::PROTEIN)
    ("p53–REs" . SPARSER::COLLECTION) ("REs" . SPARSER::PROTEIN)
    ("hepatocytes (PHH)" . SPARSER::PROTEIN) ("CCA" . SPARSER::PROTEIN)
    ("SLC" . SPARSER::PROTEIN) ("NIS" . SPARSER::PROTEIN)
    ("symporter" . SPARSER::PROTEIN) ("of 45 " . SPARSER::PROTEIN)
    ("TAp63" . SPARSER::PROTEIN) ("P73" . SPARSER::PROTEIN)
    ("P63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LT1" . SPARSER::PROTEIN)
    ("TP73" . SPARSER::PROTEIN) ("TP63" . SPARSER::PROTEIN)
    ("caspase 7" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("p63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CCLP1" . SPARSER::PROTEIN)
    ("Nkx2.5" . SPARSER::PROTEIN) ("RAR α" . SPARSER::PROTEIN)
    ("Nkx2.1" . SPARSER::PROTEIN) ("Pax-8" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("p38b" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("retinoic acid" . SPARSER::MOLECULE) ("member A" . SPARSER::PROTEIN)
    ("solute carrier family" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p73" . SPARSER::PROTEIN)
    ("signed-rank" . SPARSER::PROTEIN)
    ("Mouse monoclonal antibodies EH1 or AE6" . SPARSER::COLLECTION)
    ("EH1 or AE6" . SPARSER::COLLECTION)
    ("antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rabbit anti-Hck" . SPARSER::ANTIBODY)
    ("the relevant Src kinase" . SPARSER::PROTEIN)
    ("nitrocellulose" . SPARSER::MOLECULE) ("Sepharose" . SPARSER::MOLECULE)
    ("MDMs and PBL" . SPARSER::COLLECTION) ("FS" . SPARSER::PROTEIN)
    ("Monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("g/mL" . SPARSER::COLLECTION)
    ("Bank, Sydney, Australia or MP" . SPARSER::COLLECTION)
    ("gentamicin" . SPARSER::DRUG) ("MP" . SPARSER::PROTEIN)
    ("Monocytes" . SPARSER::PROTEIN) ("streptomycin" . SPARSER::DRUG)
    ("RPMI" . SPARSER::PROTEIN) ("Adherent monocytes" . SPARSER::PROTEIN)
    ("Bank" . SPARSER::PROTEIN) ("Red" . SPARSER::PROTEIN)
    ("mL" . SPARSER::PROTEIN) ("calcium" . SPARSER::CALCIUM) ("Type" . TYPE)
    ("monoclonal anti-Hck (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) and horseradish-conjugated mouse anti-rabbit IgG (Amersham, Little Chalfont, UK)"
     . SPARSER::COLLECTION)
    ("monoclonal anti-Hck" . SPARSER::ANTIBODY)
    ("Strepdavidin-HRP" . SPARSER::COLLECTION) ("UK" . SPARSER::PROTEIN)
    ("HRP" . SPARSER::PROTEIN)
    ("The AG11, EH1 and AE6 mouse monoclonal antibodies" . SPARSER::ANTIBODY)
    ("AG11, EH1 and AE6" . SPARSER::COLLECTION) ("Reagent" . SPARSER::MOLECULE)
    ("XhoI" . SPARSER::PROTEIN-FAMILY) ("env" . SPARSER::PROTEIN)
    ("pNL" . SPARSER::PROTEIN) ("TCC" . SPARSER::PROTEIN)
    ("TAC" . SPARSER::PROTEIN) ("TAG" . SPARSER::PROTEIN)
    ("TTG" . SPARSER::PROTEIN) ("GAT" . SPARSER::PROTEIN)
    ("CTA" . SPARSER::PROTEIN) ("CGT" . SPARSER::PROTEIN)
    ("AAA" . SPARSER::PROTEIN) ("CAC" . SPARSER::PROTEIN)
    ("GGC" . SPARSER::PROTEIN) ("TAA" . SPARSER::PROTEIN)
    ("ATA" . SPARSER::PROTEIN) ("P72, P75 and P78" . SPARSER::COLLECTION)
    ("Paris" . SPARSER::PROTEIN) ("AAT" . SPARSER::PROTEIN)
    ("AAG" . SPARSER::PROTEIN) ("AGT" . SPARSER::PROTEIN)
    ("GCC" . SPARSER::PROTEIN) ("GGG" . SPARSER::MOLECULE)
    ("GGT" . SPARSER::PROTEIN) ("Proline" . SPARSER::AMINO-ACID)
    ("nef" . SPARSER::PROTEIN)
    ("Several viral components" . SPARSER::COMPONENT)
    ("Hck and Lck" . SPARSER::COLLECTION) ("PHA-" . SPARSER::PROTEIN)
    ("PHA and IL-2" . SPARSER::COLLECTION) ("PHA" . SPARSER::PROTEIN)
    ("PBL" . SPARSER::PROTEIN) ("viral protein Vif" . SPARSER::PROTEIN)
    ("Vif" . SPARSER::PROTEIN) ("viral proteins" . SPARSER::PROTEIN)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("mock-infected MDM" . SPARSER::PROTEIN) ("MDM" . SPARSER::PROTEIN)
    ("only one form" . SPARSER::FORM)
    ("approximately 61 kDa" . SPARSER::PROTEIN)
    ("approximately 56 kDa" . SPARSER::PROTEIN)
    ("approximately 20 kDa and 27 kDa" . SPARSER::COLLECTION)
    ("approximately 20 kDa" . SPARSER::PROTEIN)
    ("only two major reactive proteins" . SPARSER::PROTEIN)
    ("subtilisin" . SPARSER::PROTEIN) ("sucrose" . SPARSER::MOLECULE)
    ("Lck and MAPK" . SPARSER::COLLECTION)
    ("infected primary macrophages" . SPARSER::PROTEIN)
    ("primary MDMs" . SPARSER::PROTEIN) ("mRNA and Tat" . SPARSER::COLLECTION)
    ("soluble CD4" . SPARSER::PROTEIN) ("RT" . SPARSER::PROTEIN)
    ("a potential drug target" . SPARSER::TARGET-PROTEIN)
    ("Monocyte-Derived Macrophages" . SPARSER::PROTEIN)
    ("MDMs" . SPARSER::PROTEIN) ("lysosomal" . SPARSER::PROTEIN)
    ("face" . SPARSER::PROTEIN)
    ("differentially phosphorylated forms" . SPARSER::FORM)
    ("at least three forms" . SPARSER::FORM) ("HIV-1 AD8" . SPARSER::PROTEIN)
    ("primary macrophages" . SPARSER::PROTEIN) ("AD" . SPARSER::PROTEIN)
    ("primary monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("virion-associated Hck" . SPARSER::PROTEIN)
    ("the subsequent impact" . SPARSER::PROTEIN) ("Src" . SPARSER::PROTEIN)
    ("DFPs" . SPARSER::PROTEIN-FAMILY) ("classes" . CLASS)
    ("potential drug" . SPARSER::DRUG) ("Macrophages" . SPARSER::PROTEIN)
    ("SH3" . SPARSER::PROTEIN) ("MAPK and Lck" . SPARSER::COLLECTION)
    ("Lck" . SPARSER::PROTEIN)
    ("The human immunodeficiency virus type 1 (HIV-1) accessory protein Nef"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hck" . SPARSER::PROTEIN) ("proline" . SPARSER::AMINO-ACID)
    ("p24" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin 2" . SPARSER::PROTEIN) ("EH1" . SPARSER::PROTEIN)
    ("Nef3" . SPARSER::PROTEIN) ("Nef5" . SPARSER::PROTEIN)
    ("P78" . SPARSER::PROTEIN) ("P75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P72" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IL-2" . SPARSER::PROTEIN)
    ("APOBEC3G" . SPARSER::PROTEIN) ("envelope protein" . SPARSER::PROTEIN)
    ("p61" . SPARSER::PROTEIN) ("p56" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD4" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p59 Hck" . SPARSER::PROTEIN) ("p61 Hck" . SPARSER::PROTEIN)
    ("p59" . SPARSER::PROTEIN) ("protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("target cell" . SPARSER::PROTEIN) ("Src kinase" . SPARSER::PROTEIN)
    ("functional PER2" . SPARSER::PROTEIN)
    ("PML and p53" . SPARSER::COLLECTION) ("p53 and PML" . SPARSER::COLLECTION)
    ("p53, PML and Per 2" . SPARSER::COLLECTION) ("PERIOD" . SPARSER::PROTEIN)
    ("Per1 and Cry1" . SPARSER::COLLECTION) ("Period" . SPARSER::PROTEIN)
    ("the circadian clock regulators" . SPARSER::REGULATOR)
    ("cue" . SPARSER::PROTEIN) ("Per2 and p53" . SPARSER::COLLECTION)
    ("Nutlin-3 or vehicle (DMSO)" . SPARSER::COLLECTION)
    ("anti-BMAL1 or anti-FLAG" . SPARSER::COLLECTION)
    ("Flag-Clock" . SPARSER::COLLECTION) ("FLAG-CLOCK" . SPARSER::COLLECTION)
    ("Chromatin" . SPARSER::PROTEIN)
    ("two commercial p53 antibodies" . SPARSER::ANTIBODY)
    ("-XRXCXXGXYY-3" . SPARSER::COLLECTION)
    ("p53 and PER2" . SPARSER::COLLECTION) ("inp53" . SPARSER::PROTEIN)
    ("anti-p53 and anti-PER2" . SPARSER::COLLECTION) ("ROR" . SPARSER::PROTEIN)
    ("Bmal1 or Per2" . SPARSER::COLLECTION)
    ("p53, WRN, RB, and RARα" . SPARSER::COLLECTION) ("RB" . SPARSER::PROTEIN)
    ("WRN" . SPARSER::PROTEIN) ("PML-associated proteins" . SPARSER::PROTEIN)
    ("CBP and SIRT1" . SPARSER::COLLECTION)
    ("PER2, BMAL1, SIRT1, CBP, WDR5 and SIN3A" . SPARSER::COLLECTION)
    ("CBP" . SPARSER::PROTEIN) ("NB" . SPARSER::PROTEIN)
    ("the circadian clock" . SPARSER::PROTEIN) ("PML" . SPARSER::PROTEIN)
    ("Per1, Per2, Cry1 and Cry2" . SPARSER::COLLECTION)
    ("CLOCK/BMAL1" . SPARSER::COLLECTION)
    ("Clock, Npas2, Bmal1, Per1, Per2, Cry1, Cry2, CK1ε, CK1δ, Rev-Erbα, and RORα"
     . SPARSER::COLLECTION)
    ("Bmal1" . SPARSER::PROTEIN) ("Npas2" . SPARSER::PROTEIN)
    ("Erb" . SPARSER::PROTEIN) ("Rev" . SPARSER::PROTEIN)
    ("Clock" . SPARSER::PROTEIN) ("clock" . SPARSER::PROTEIN)
    ("stress-induced p53" . SPARSER::PROTEIN) ("SCN" . SPARSER::MOLECULE)
    ("BMAL1/CLOCK" . SPARSER::COLLECTION) ("CLOCK" . SPARSER::PROTEIN)
    ("a circadian regulator" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("mPER2" . SPARSER::PROTEIN) ("NaHCO 3" . SPARSER::DRUG)
    ("NP40" . SPARSER::MOLECULE) ("SO 4" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("Rorα" . SPARSER::PROTEIN)
    ("PA1" . SPARSER::PROTEIN) ("mPer2" . SPARSER::PROTEIN)
    ("α-tubulin" . SPARSER::PROTEIN) ("casein kinase 1" . SPARSER::PROTEIN)
    ("Per 2" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("RARα" . SPARSER::PROTEIN) ("SIN3A" . SPARSER::PROTEIN)
    ("WDR5" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("PER2" . SPARSER::PROTEIN) ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("RORα" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("Cry2" . SPARSER::PROTEIN) ("Cry1" . SPARSER::PROTEIN)
    ("Per1" . SPARSER::PROTEIN) ("Nutlin-3" . SPARSER::DRUG)
    ("BMAL1" . SPARSER::PROTEIN) ("Per2" . SPARSER::PROTEIN)
    ("Period 2" . SPARSER::PROTEIN) ("MDM2–p53" . SPARSER::COLLECTION)
    ("Nutlins" . SPARSER::DRUG) ("intrinsic PHB2" . SPARSER::PROTEIN)
    ("ERα–PI3K" . SPARSER::COLLECTION) ("ERα–IGF-1Rβ" . SPARSER::PROTEIN-PAIR)
    ("ERα and non-canonical" . SPARSER::COLLECTION)
    ("tamoxifen or aromatase" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN) ("mark" . SPARSER::PROTEIN)
    ("a potential solution" . SPARSER::MOLECULE)
    ("solution" . SPARSER::MOLECULE)
    ("a dominant-negative peptide" . SPARSER::PEPTIDE)
    ("ERα and the co-activator SRC-1" . SPARSER::COLLECTION)
    ("a potential target gene" . SPARSER::PROTEIN)
    ("TFF1 , CCND1 and c- Myc" . SPARSER::COLLECTION)
    ("E2 and IGF-2" . SPARSER::COLLECTION)
    ("tamoxifen and E2" . SPARSER::COLLECTION)
    ("ERα target genes ( xref ) and the development" . SPARSER::COLLECTION)
    ("MAPK and ERα" . SPARSER::COLLECTION)
    ("TFF1 , CCND1 , and c-Myc" . SPARSER::COLLECTION)
    ("tamoxifen or E2" . SPARSER::COLLECTION) ("MCF-10 A" . SPARSER::PROTEIN)
    ("ERα, BIG3 and PHB2" . SPARSER::COLLECTION)
    ("Akt or p42/44" . SPARSER::COLLECTION)
    ("Akt and p42/44" . SPARSER::COLLECTION)
    ("ERα and PI3K" . SPARSER::COLLECTION)
    ("a new ternary complex" . SPARSER::BIO-COMPLEX) ("KLP" . SPARSER::PROTEIN)
    ("membrane-bound and cytoplasmic ERα" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("TFF1 , CCND1 , c-Myc , E2F1 and PgR" . SPARSER::COLLECTION)
    ("PgR" . SPARSER::PROTEIN) ("mRNA or protein" . SPARSER::COLLECTION)
    ("NcoR, HDAC1 and PHB2" . SPARSER::COLLECTION)
    ("HDAC1 and NcoR" . SPARSER::COLLECTION) ("NcoR" . SPARSER::PROTEIN)
    ("TFF1 and CCND1" . SPARSER::COLLECTION) ("ERα–PHB2" . SPARSER::COLLECTION)
    ("AP-1" . SPARSER::PROTEIN) ("ERα or BIG3" . SPARSER::COLLECTION)
    ("ERAP" . SPARSER::PEPTIDE) ("peptide (ERAP)" . SPARSER::PEPTIDE)
    ("activity-regulator" . SPARSER::PROTEIN)
    ("polyarginine" . SPARSER::MOLECULE) ("MLS" . SPARSER::PROTEIN)
    ("a dominant-negative inhibitor" . SPARSER::INHIBITOR)
    ("HA-PHB2" . SPARSER::COLLECTION)
    ("dominant-negative peptide" . SPARSER::PEPTIDE)
    ("PHB2 and ERα" . SPARSER::COLLECTION)
    ("The novel E2/ERα signalling regulator brefeldin A-inhibited guanine nucleotide-exchange protein 3"
     . SPARSER::PROTEIN)
    ("guanine" . SPARSER::PROTEIN)
    ("growth factors and kinase" . SPARSER::COLLECTION)
    ("E2 and ERα" . SPARSER::COLLECTION)
    ("the latter type E2-bound ERα" . SPARSER::PROTEIN)
    ("the former type nuclear ERα" . SPARSER::PROTEIN)
    ("Akt and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("Shc" . SPARSER::PROTEIN) ("IGF" . SPARSER::PROTEIN)
    ("membrane-associated ERα" . SPARSER::PROTEIN)
    ("Intrinsic PHB2" . SPARSER::PROTEIN)
    ("a cell-permeable peptide inhibitor" . SPARSER::INHIBITOR)
    ("BIG3 and PHB2" . SPARSER::COLLECTION) ("BIG3–PHB2" . SPARSER::COLLECTION)
    ("endocrine" . SPARSER::PROTEIN) ("β-Tubulin" . SPARSER::PROTEIN)
    ("TIP120" . SPARSER::PROTEIN) ("for 3 " . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("U13" . SPARSER::PROTEIN)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("F11" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("c- Myc" . SPARSER::PROTEIN) ("IGF-2" . SPARSER::PROTEIN)
    ("p42/44" . SPARSER::PROTEIN) ("cell membrane" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN) ("SRC-1" . SPARSER::PROTEIN)
    ("TFF1" . SPARSER::PROTEIN) ("prohibitin 2" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("brefeldin A" . SPARSER::MOLECULE)
    ("IGF-1R" . SPARSER::PROTEIN) ("PHB2" . SPARSER::PROTEIN)
    ("BIG3" . SPARSER::PROTEIN)
    ("these proteins and their antagonists" . SPARSER::COLLECTION)
    ("proteins, Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("p21 and senescence-associated β-gal" . SPARSER::COLLECTION)
    ("senescence-associated β-gal" . SPARSER::PROTEIN)
    ("pancytoplasmic type" . TYPE) ("Bcl-2/Bcl-xL" . SPARSER::COLLECTION)
    ("p53 and mortalin" . SPARSER::COLLECTION)
    ("mortalin and BCL-2" . SPARSER::COLLECTION) ("Post" . SPARSER::PROTEIN)
    ("mortalin and Bcl-2" . SPARSER::COLLECTION)
    ("their respective proteins" . SPARSER::PROTEIN)
    ("solvent" . SPARSER::MOLECULE)
    ("V5-tagged mortalin mutants" . SPARSER::MUTANT)
    ("these proteins make physical complexes" . SPARSER::BIO-COMPLEX)
    ("Bcl-xL and Bcl-2" . SPARSER::COLLECTION)
    ("the Hsp70 (mortalin) and the two target proteins" . SPARSER::COLLECTION)
    ("CAA" . SPARSER::PROTEIN) ("Dr" . SPARSER::MOLECULE)
    ("cut" . SPARSER::PROTEIN) ("atm" . SPARSER::PROTEIN)
    ("water" . SPARSER::MOLECULE) ("TIP" . SPARSER::PROTEIN)
    ("Protein–protein" . SPARSER::COLLECTION)
    ("mortalin-Bcl-xL" . SPARSER::COLLECTION)
    ("mortalin-Bcl-2" . SPARSER::COLLECTION)
    ("comparative homology" . SPARSER::PROTEIN) ("pdb" . SPARSER::MOLECULE)
    ("mortalin, Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("CCD" . SPARSER::PROTEIN)
    ("donkey anti-goat IgG (Alexa Fluor® 488-conjugated) or donkey anti-rabbit IgG (Alexa Fluor® 594-conjugated; both from Molecular Probes)"
     . SPARSER::COLLECTION)
    ("secondary antibodies, donkey anti-goat IgG (Alexa Fluor® 488-conjugated) or donkey anti-rabbit IgG (Alexa Fluor® 594-conjugated; both from Molecular Probes)"
     . SPARSER::COLLECTION)
    ("secondary antibodies" . SPARSER::ANTIBODY) ("Fluor" . SPARSER::MOLECULE)
    ("goat" . SPARSER::PROTEIN)
    ("Bcl-xL, mortalin and p53" . SPARSER::COLLECTION)
    ("BSA" . SPARSER::PROTEIN) ("ice" . SPARSER::PROTEIN)
    ("mixture" . SPARSER::MOLECULE) ("acetone" . SPARSER::MOLECULE)
    ("methanol" . SPARSER::MOLECULE) ("PVDF" . SPARSER::DRUG)
    ("SDS" . SPARSER::PROTEIN) ("Agarose" . SPARSER::MOLECULE)
    ("IC" . SPARSER::PROTEIN)
    ("anti-p53 CM1 (Novocastra) and monoclonal anti-actin (Chemicon)"
     . SPARSER::COLLECTION)
    ("monoclonal anti-actin" . SPARSER::ANTIBODY)
    ("monoclonal anti-Bcl-xL" . SPARSER::ANTIBODY) ("anti" . SPARSER::PROTEIN)
    ("Santa" . SPARSER::PROTEIN) ("Gly" . SPARSER::AMINO-ACID)
    ("EDTA" . SPARSER::MOLECULE) ("NaCl" . SPARSER::PROTEIN)
    ("pH " . SPARSER::PROTEIN) ("Tris" . SPARSER::MOLECULE)
    ("Protein" . SPARSER::PROTEIN) ("GAG" . SPARSER::PROTEIN)
    ("GAA" . SPARSER::PROTEIN) ("ACT" . SPARSER::PROTEIN)
    ("CCG" . SPARSER::PROTEIN) ("AAC" . SPARSER::PROTEIN)
    ("AGC" . SPARSER::PROTEIN)
    ("the pro-apoptotic Bad protein" . SPARSER::PROTEIN)
    ("p53 and Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION) ("p53-Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and mortalin" . SPARSER::COLLECTION)
    ("promyelocytic" . SPARSER::PROTEIN)
    ("Mortalin/mtHsp70/PBP74/Grp75" . SPARSER::COLLECTION)
    ("Mortalin" . SPARSER::PROTEIN) ("Pro" . SPARSER::AMINO-ACID)
    ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bad, Bak, Bax, Bid, Bim and Bcl-xS" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bcl-2 family proteins" . SPARSER::PROTEIN)
    ("Bak, Bax and Bim" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Bax and Bak" . SPARSER::COLLECTION) ("pH" . SPARSER::PROTEIN)
    ("Bax, Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("mitochondrial apoptogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TM" . SPARSER::PROTEIN) ("BH" . SPARSER::PROTEIN)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bcl-xS, Bax, Bak, Bid and Bad" . SPARSER::COLLECTION)
    ("Bak" . SPARSER::PROTEIN) ("Bax" . SPARSER::PROTEIN)
    ("mortalin-p53" . SPARSER::COLLECTION) ("mortalin" . SPARSER::PROTEIN)
    ("Bcl-2 " . SPARSER::PROTEIN) ("β-gal" . SPARSER::PROTEIN)
    ("p53 " . SPARSER::PROTEIN) ("U20" . SPARSER::PROTEIN)
    ("P10415" . SPARSER::PROTEIN) ("Hsp70" . SPARSER::PROTEIN)
    ("protein–1" . SPARSER::PROTEIN) ("Bcl-W" . SPARSER::PROTEIN)
    ("Triton X-100 " . SPARSER::MOLECULE) ("CM1" . SPARSER::PROTEIN)
    ("TGA 3" . SPARSER::PROTEIN) ("Hsp 70" . SPARSER::PROTEIN)
    ("mot-2" . SPARSER::PROTEIN) ("Grp75" . SPARSER::PROTEIN)
    ("PBP74" . SPARSER::PROTEIN) ("mtHsp70" . SPARSER::PROTEIN)
    ("Bcl-X" . SPARSER::PROTEIN) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("BH4" . SPARSER::PROTEIN-FAMILY) ("Bcl-xS" . SPARSER::PROTEIN)
    ("Mcl-1" . SPARSER::PROTEIN) ("Bcl-w" . SPARSER::PROTEIN)
    ("CHT" . SPARSER::PROTEIN) ("reagents" . SPARSER::MOLECULE)
    ("HTH" . SPARSER::PROTEIN) ("CYC" . SPARSER::PROTEIN)
    ("adiponectin" . SPARSER::PROTEIN)
    ("a heterotrimeric serine/threonine kinase" . SPARSER::KINASE)
    ("CCL" . SPARSER::DRUG) ("CCL3-CCR5" . SPARSER::COLLECTION)
    ("exogenous CCL3" . SPARSER::PROTEIN)
    ("receptor, AMPK, and p38" . SPARSER::COLLECTION)
    ("p38, IKKα, or IKKβ" . SPARSER::COLLECTION)
    ("compound C, or SB203580" . SPARSER::COLLECTION)
    ("NF-κB-luciferase" . SPARSER::COLLECTION)
    ("SB203580, or PDTC" . SPARSER::COLLECTION)
    ("CCR5, AMPK, and p38" . SPARSER::COLLECTION)
    ("mAb, compound C, or SB203580" . SPARSER::COLLECTION)
    ("IKKα or IKKβ" . SPARSER::COLLECTION)
    ("PDTC or TPCK" . SPARSER::COLLECTION) ("TPCK" . SPARSER::MOLECULE)
    ("PDTC" . SPARSER::DRUG) ("AMPKα1 and AMPKα2" . SPARSER::COLLECTION)
    ("AMPKα1 or AMPKα2" . SPARSER::COLLECTION) ("RANTES" . SPARSER::PROTEIN)
    ("mAb" . SPARSER::DRUG) ("transfectants" . SPARSER::PROTEIN)
    ("inhibitor and siRNA" . SPARSER::COLLECTION)
    ("primary chondrocytes" . SPARSER::PROTEIN)
    ("CCR5 and MMP-2" . SPARSER::COLLECTION)
    ("CCL3 and MMP-2" . SPARSER::COLLECTION)
    ("chondrocytes" . SPARSER::PROTEIN)
    ("CCL3, CCR5 and MMP-2" . SPARSER::COLLECTION)
    ("receptor, AMPK, p38, and NF-κB" . SPARSER::COLLECTION)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN) ("chemokine" . SPARSER::PROTEIN)
    ("low-molecular weight secretory proteins" . SPARSER::PROTEIN)
    ("Chemokines" . SPARSER::PROTEIN) ("collagenase" . SPARSER::PROTEIN)
    ("MMP-1, MMP-2, MMP-3, MMP-9, and MMP-13" . SPARSER::COLLECTION)
    ("MMPs, cytokines, growth factors, and chemokines" . SPARSER::COLLECTION)
    ("MMPs" . SPARSER::PROTEIN) ("anoikis" . SPARSER::PROTEIN)
    ("CCR5, AMPK, p38, and NF-κB" . SPARSER::COLLECTION)
    ("CCL3, CCR5, and MMP-2" . SPARSER::COLLECTION)
    ("AMPK, p38, and NF-κB" . SPARSER::COLLECTION)
    ("p38-MAPK" . SPARSER::COLLECTION)
    ("CCR5 and AMP-activated" . SPARSER::COLLECTION)
    ("inhibitor or siRNA" . SPARSER::COLLECTION) ("AMPK" . SPARSER::PROTEIN)
    ("Pre" . SPARSER::PROTEIN)
    ("polymorphonuclear leukocytes" . SPARSER::PROTEIN)
    ("Chemokine" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("S2" . SPARSER::MOLECULE) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("AMPKα1" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("compound C" . SPARSER::MOLECULE) ("IKKα" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("MIP-1α" . SPARSER::PROTEIN)
    ("macrophage inflammatory protein" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("MMP-1" . SPARSER::PROTEIN)
    ("p38 mitogen activated protein kinase" . SPARSER::PROTEIN)
    ("AMP-activated" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("macrophage inflammatory protein-1α" . SPARSER::PROTEIN)
    ("CCL3" . SPARSER::PROTEIN) ("C-C motif" . SPARSER::PROTEIN)
    ("a global transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("tempol and PMA" . SPARSER::COLLECTION)
    ("SESN2-peroxiredoxin" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("peroxiredoxin" . SPARSER::PROTEIN)
    ("a master regulator of lung remodelling and injury repair ()"
     . SPARSER::COLLECTION)
    ("KGF and elastin" . SPARSER::COLLECTION)
    ("the pulmonary vasculature" . SPARSER::PROTEIN)
    ("oxide" . SPARSER::MOLECULE) ("nitric" . SPARSER::PROTEIN)
    ("peroxynitrite" . SPARSER::MOLECULE) ("PMA" . SPARSER::PROTEIN)
    ("phorbol" . SPARSER::DRUG) ("EPR" . SPARSER::PROTEIN)
    ("electron" . SPARSER::MOLECULE)
    ("the superoxide dismutase mimetic tempol" . SPARSER::DRUG)
    ("tempol" . SPARSER::DRUG) ("superoxide" . SPARSER::MOLECULE)
    ("PEG-catalase" . SPARSER::COLLECTION) ("catalase" . SPARSER::PROTEIN)
    ("PEG" . SPARSER::PROTEIN)
    ("ROS ( xref ; xref ) and ROS" . SPARSER::COLLECTION)
    ("post-elastase" . SPARSER::COLLECTION) ("imatinib" . SPARSER::DRUG)
    ("elastase" . SPARSER::PROTEIN)
    ("phosphorylated AKT (p-AKT) and P70S6K (p-P70S6K)" . SPARSER::COLLECTION)
    ("PDGFR and mTOR" . SPARSER::COLLECTION) ("p-P70S6K" . SPARSER::COLLECTION)
    ("PDGFRβ, KGF and elastin" . SPARSER::COLLECTION)
    ("pan-TGFβ" . SPARSER::COLLECTION) ("WT-and KO-MLF CM" . SPARSER::PROTEIN)
    ("KO-MLF" . SPARSER::COLLECTION) ("MLF" . SPARSER::PROTEIN)
    ("CM" . SPARSER::PROTEIN)
    ("a well-known lung protective cytokine" . SPARSER::PROTEIN)
    ("KGF" . SPARSER::PROTEIN)
    ("re-expressed exogenous SESN2" . SPARSER::PROTEIN)
    ("PDGF" . SPARSER::PROTEIN) ("KO-MLFs" . SPARSER::COLLECTION)
    ("MLFs" . SPARSER::PROTEIN-FAMILY)
    ("the ATII-cell-specific surfactant protein C" . SPARSER::PROTEIN)
    ("inhalable small-molecule antagonists" . SPARSER::MOLECULE)
    ("antagonists" . SPARSER::MOLECULE) ("tobacco" . SPARSER::DRUG)
    ("environmentally driven form" . SPARSER::FORM)
    ("genetically determined pulmonary emphysema" . SPARSER::PROTEIN)
    ("Pulmonary emphysema" . SPARSER::PROTEIN)
    ("developing cigarette smoke-induced pulmonary emphysema"
     . SPARSER::PROTEIN)
    ("Ltbp4S/Sesn2" . SPARSER::COLLECTION)
    ("the centrilobular emphysema" . SPARSER::PROTEIN)
    ("KO" . SPARSER::PROTEIN) ("Ltbp" . SPARSER::PROTEIN-FAMILY)
    ("rapamycin" . SPARSER::DRUG)
    ("a prometabolic serine/threonine kinase" . SPARSER::KINASE)
    ("peroxidase" . SPARSER::PROTEIN)
    ("pulmonary emphysema" . SPARSER::PROTEIN) ("Cigarette" . SPARSER::DRUG)
    ("INTRODUCTION TRANSLATIONAL IMPACT" . SPARSER::PROTEIN)
    ("IMPACT" . SPARSER::PROTEIN) ("SESN2-PDGFRβ" . SPARSER::COLLECTION)
    ("cigarette-smoke-induced pulmonary emphysema" . SPARSER::PROTEIN)
    ("Sesn2" . SPARSER::PROTEIN) ("emphysema" . SPARSER::PROTEIN)
    ("PEG-SOD" . SPARSER::DRUG) ("S6K" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("α-SMA" . SPARSER::PROTEIN) ("NADPH oxidase" . SPARSER::PROTEIN)
    ("P70S6K" . SPARSER::PROTEIN) ("TGFβ1" . SPARSER::PROTEIN)
    ("FGF7" . SPARSER::PROTEIN)
    ("fibroblast growth factor 7" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("Pdgfrβ" . SPARSER::PROTEIN)
    ("platelet derived growth factor receptor beta" . SPARSER::PROTEIN)
    ("SP-C" . SPARSER::PROTEIN) ("surfactant protein C" . SPARSER::PROTEIN)
    ("TTF1" . SPARSER::PROTEIN)
    ("thyroid transcription factor 1" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("transforming growth factor beta" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("superoxide anions" . SPARSER::MOLECULE) ("PDGFRβ" . SPARSER::PROTEIN)
    ("SESN2" . SPARSER::PROTEIN) ("sestrin-2" . SPARSER::PROTEIN)
    ("PICT1 and RPL11" . SPARSER::COLLECTION)
    ("a novel prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("camptothecin and cisplatin" . SPARSER::COLLECTION)
    ("fluorouracil, and camptothecin" . SPARSER::COLLECTION)
    ("fluorouracil" . SPARSER::DRUG) ("this TP53" . SPARSER::PROTEIN)
    ("-mutant" . SPARSER::MUTANT) ("PICT1 and CDKN1A" . SPARSER::COLLECTION)
    ("the MDM2 high-expression group and the low-expression group"
     . SPARSER::COLLECTION)
    ("TP53 or mutant" . SPARSER::COLLECTION)
    ("PICT1/GAPDH" . SPARSER::COLLECTION) ("GAPDH" . SPARSER::PROTEIN)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("PICT1 and TP53" . SPARSER::COLLECTION)
    ("lentiviral PICT1 -shRNA" . SPARSER::COLLECTION)
    ("-DsRed" . SPARSER::COLLECTION) ("-shRNA" . SPARSER::COLLECTION)
    ("DsRed" . SPARSER::PROTEIN) ("antigastric cancer drugs" . SPARSER::DRUG)
    ("cisplatin and camptothecin" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG) ("cisplatin" . SPARSER::DRUG)
    ("Ub-TP53" . SPARSER::PROTEIN-PAIR) ("HA-Ub" . SPARSER::PROTEIN-PAIR)
    ("HA" . SPARSER::PROTEIN) ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDKN1A and BAX" . SPARSER::COLLECTION)
    ("PICT1-shRNA" . SPARSER::COLLECTION)
    ("the gastric cancer cell line AGS" . SPARSER::PROTEIN)
    ("AGS" . SPARSER::PROTEIN) ("CRC" . SPARSER::PROTEIN)
    ("Rpl11" . SPARSER::PROTEIN)
    ("certain ribosomal proteins" . SPARSER::PROTEIN)
    ("RPL5, RPL11, RPL23, and RPS7" . SPARSER::COLLECTION)
    ("MDM2-TP53" . SPARSER::COLLECTION) ("actinomycin D" . SPARSER::MOLECULE)
    ("Annexin-V" . SPARSER::PROTEIN) ("LSM5" . SPARSER::PROTEIN)
    ("and 1 " . SPARSER::PROTEIN) ("ligase activity" . SPARSER::PROTEIN)
    ("Ubiquitin ligase" . SPARSER::PROTEIN) ("β -actin" . SPARSER::PROTEIN)
    ("CDKN1A" . SPARSER::PROTEIN) ("Pict1" . SPARSER::PROTEIN)
    ("RPS7" . SPARSER::PROTEIN) ("RPL23" . SPARSER::PROTEIN)
    ("RPL5" . SPARSER::PROTEIN) ("RPL11" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("GLTSCR2" . SPARSER::PROTEIN)
    ("PICT1" . SPARSER::PROTEIN) ("TP53" . SPARSER::PROTEIN)
    ("anti-RET and anti-ER" . SPARSER::COLLECTION)
    ("dual-receptor" . SPARSER::PROTEIN) ("PDGFR" . SPARSER::PROTEIN)
    ("VEGFR" . SPARSER::PROTEIN) ("FGFR2 and FGFR4" . SPARSER::COLLECTION)
    ("multi-TKI" . SPARSER::PROTEIN-PAIR)
    ("media or tamoxifen" . SPARSER::COLLECTION)
    ("ER or TFAP2C" . SPARSER::COLLECTION) ("FACS" . SPARSER::PROTEIN)
    ("Hormone" . SPARSER::PROTEIN) ("Tamoxifen" . SPARSER::MOLECULE)
    ("RTKs" . SPARSER::PROTEIN)
    ("sunitinib and vandetanib" . SPARSER::COLLECTION)
    ("NT" . SPARSER::PROTEIN) ("Sunitinib" . SPARSER::DRUG)
    ("sunitinib and tamoxifen" . SPARSER::COLLECTION)
    ("sunitinib or tamoxifen" . SPARSER::COLLECTION)
    ("RET, ER, or TFAP2C" . SPARSER::COLLECTION)
    ("RET and ER" . SPARSER::COLLECTION)
    ("TFAP2C-RET-ERK/AKT" . SPARSER::COLLECTION)
    ("ERK1/2 or AKT" . SPARSER::COLLECTION)
    ("RET and TFAP2C" . SPARSER::COLLECTION)
    ("ERK1/2 and a 2-fold" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION) ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::PROTEIN) ("RET-ER" . SPARSER::COLLECTION)
    ("States" . SPARSER::BIO-STATE)
    ("antiestrogen and anti-RET" . SPARSER::COLLECTION)
    ("antiestrogen" . SPARSER::DRUG) ("nick" . SPARSER::PROTEIN)
    ("dUTP" . SPARSER::MOLECULE)
    ("tamoxifen and sunitinib" . SPARSER::COLLECTION)
    ("ER and RET" . SPARSER::COLLECTION) ("tamoxifen" . SPARSER::MOLECULE)
    ("which controls both ER (estrogen receptor) and RET"
     . SPARSER::COLLECTION)
    ("TFAP2C, which controls both ER (estrogen receptor) and RET"
     . SPARSER::COLLECTION)
    ("which controls both ER" . SPARSER::PROTEIN)
    ("RET or ER" . SPARSER::COLLECTION)
    ("sunitinib or vandetanib" . SPARSER::COLLECTION)
    ("vandetanib" . SPARSER::DRUG) ("sunitinib" . SPARSER::DRUG)
    ("TFAP2C or RET" . SPARSER::COLLECTION) ("glial" . SPARSER::PROTEIN)
    ("GDNF" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases (ERK) and AKT"
     . SPARSER::COLLECTION)
    ("using phosphorylation-specific Western blot" . SPARSER::PROTEIN)
    ("ESR1 and RET" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR4" . SPARSER::PROTEIN) ("Casp 3" . SPARSER::PROTEIN)
    ("4-Hydroxytamoxifen" . SPARSER::DRUG)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AP2" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("neurotrophic factor" . SPARSER::PROTEIN) ("TFAP2C" . SPARSER::PROTEIN)
    ("other EC antigens or immune complexes" . SPARSER::COLLECTION)
    ("form or deposit" . SPARSER::COLLECTION)
    ("autoantibodies" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("lymphoid" . SPARSER::PROTEIN) ("cIAP-2, and TRAF3" . SPARSER::COLLECTION)
    ("c-IAP1" . SPARSER::COLLECTION)
    ("LIGHT, or toll-like" . SPARSER::COLLECTION) ("TRIF" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("leukocytes" . SPARSER::PROTEIN)
    ("PRA sera or IgG-depleted PRA sera" . SPARSER::COLLECTION)
    ("PRA serum-treated EC" . SPARSER::PROTEIN)
    ("IgG and polyC9" . SPARSER::COLLECTION)
    ("IgG, C4d, polyC9, or NIK" . SPARSER::COLLECTION)
    ("PRA or IgG" . SPARSER::COLLECTION) ("IgG and C4d" . SPARSER::COLLECTION)
    ("E-selectin and VCAM-1" . SPARSER::COLLECTION)
    ("agglutinin" . SPARSER::PROTEIN) ("sera or PRA" . SPARSER::COLLECTION)
    ("human arterial EC" . SPARSER::PROTEIN)
    ("peritubular capillary EC" . SPARSER::PROTEIN)
    ("DSA and C4d" . SPARSER::COLLECTION)
    ("essential components" . SPARSER::COMPONENT)
    ("NIK or p100" . SPARSER::COLLECTION)
    ("CCL5, CCL20, IL-6, E-selectin and VCAM-1" . SPARSER::COLLECTION)
    ("melittin and ionomycin" . SPARSER::COLLECTION)
    ("ionomycin" . SPARSER::DRUG) ("melittin" . SPARSER::PROTEIN)
    ("p52 and relB" . SPARSER::COLLECTION) ("relB" . SPARSER::PROTEIN)
    ("IκBα, p52, or NIK" . SPARSER::COLLECTION)
    ("kinase (NIK)" . SPARSER::KINASE) ("NIK" . SPARSER::PROTEIN)
    ("TNF-α or LIGHT" . SPARSER::COLLECTION) ("LIGHT" . SPARSER::PROTEIN)
    ("intact PRA" . SPARSER::PROTEIN) ("fractions" . SPARSER::COMPONENT)
    ("the latter two molecules" . SPARSER::MOLECULE)
    ("SELE" . SPARSER::PROTEIN) ("NPRA" . SPARSER::PROTEIN)
    ("IL-4 and IL-17" . SPARSER::COLLECTION) ("CFSE" . SPARSER::DRUG)
    ("PRA, CIPRA, or vehicle" . SPARSER::COLLECTION)
    ("IFN-γ-pre-treated EC" . SPARSER::PROTEIN)
    ("PRA, CIPRA, or vehicle, and human" . SPARSER::COLLECTION)
    ("PRA and MAC" . SPARSER::COLLECTION) ("PRA-treated EC" . SPARSER::PROTEIN)
    ("antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IgG 1 and IgG 3" . SPARSER::COLLECTION) ("subtypes" . SPARSER::PROTEIN)
    ("sera" . SPARSER::PROTEIN) ("complex (MAC)" . SPARSER::BIO-COMPLEX)
    ("the relevant HLA allele" . SPARSER::ALLELE)
    ("microvascular EC" . SPARSER::PROTEIN) ("CAMR" . SPARSER::PROTEIN)
    ("DSA" . SPARSER::ANTIBODY) ("HLA" . SPARSER::PROTEIN)
    ("SMC" . SPARSER::PROTEIN) ("class I" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN) ("MAC" . SPARSER::BIO-COMPLEX)
    ("complexes (MAC)" . SPARSER::BIO-COMPLEX)
    ("antibody (PRA)" . SPARSER::ANTIBODY) ("PRA" . SPARSER::PROTEIN)
    ("antibody (DSA)" . SPARSER::ANTIBODY)
    ("a vasculopathic cytokine" . SPARSER::PROTEIN) ("CAV" . SPARSER::PROTEIN)
    ("TRAF3" . SPARSER::PROTEIN) ("cIAP-2" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gr-1" . SPARSER::PROTEIN) ("VCAM-1" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("p100" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("C5a" . SPARSER::PROTEIN) ("E-selectin" . SPARSER::PROTEIN)
    ("CCL20" . SPARSER::PROTEIN) ("CCL5" . SPARSER::PROTEIN)
    ("IL-4" . SPARSER::PROTEIN) ("IgG 3" . SPARSER::BIO-COMPLEX)
    ("IgG 1" . SPARSER::BIO-COMPLEX) ("De-" . SPARSER::MOLECULE)
    ("MM" . SPARSER::PROTEIN) ("PSH" . SPARSER::PROTEIN)
    ("multidrug-" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN)
    ("/CD24" . SPARSER::COLLECTION) ("CAR" . SPARSER::PROTEIN)
    ("protein (PDCD)" . SPARSER::PROTEIN) ("EMT" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK and AKT" . SPARSER::COLLECTION) ("ALDH" . SPARSER::PROTEIN)
    ("SV" . SPARSER::MOLECULE) ("CPE" . SPARSER::PROTEIN)
    ("dl" . SPARSER::MOLECULE) ("adenoviral DNA" . SPARSER::DNA)
    ("RCA" . SPARSER::PROTEIN)
    ("the adenoviral E1A protein" . SPARSER::PROTEIN)
    ("both total and phosphorylated YB-1" . SPARSER::PROTEIN)
    ("MAPK/RSK" . SPARSER::COLLECTION) ("EC" . SPARSER::PROTEIN)
    ("MGMT" . SPARSER::PROTEIN) ("Methyltransferase" . SPARSER::PROTEIN)
    ("phospho-AKT and phospho-ERK" . SPARSER::COLLECTION)
    ("phospho-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribosomal S6 kinase (RSK)" . SPARSER::PROTEIN-FAMILY)
    ("RSK" . SPARSER::PROTEIN)
    ("activated AKT and MAPK/ERK" . SPARSER::COLLECTION)
    ("AKT and MAPK/ERK" . SPARSER::COLLECTION)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("PKB/AKT" . SPARSER::COLLECTION)
    ("PKB" . SPARSER::PROTEIN) ("Twist" . SPARSER::PROTEIN)
    ("CD44 and CD49f" . SPARSER::COLLECTION)
    ("a relevant biomarker" . SPARSER::MOLECULE)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("PI3-K/AKT" . SPARSER::COLLECTION) ("TIC" . SPARSER::PROTEIN)
    ("PBS" . SPARSER::PROTEIN) ("TMZ" . SPARSER::DRUG)
    ("temozolomide" . SPARSER::DRUG) ("astrocytes" . SPARSER::PROTEIN)
    ("CSC" . SPARSER::PROTEIN) ("alkylating agent" . SPARSER::MOLECULE)
    ("CD133" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("1A1" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("b19" . SPARSER::PROTEIN) ("E1" . SPARSER::MOLECULE)
    ("green fluorescent" . SPARSER::PROTEIN)
    ("Ribosomal Protein" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("p90" . SPARSER::PROTEIN)
    ("YB1" . SPARSER::PROTEIN) ("RGD motif" . SPARSER::PROTEIN)
    ("E1B19K" . SPARSER::PROTEIN) ("B27" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("E1B" . SPARSER::PROTEIN) ("S protein" . SPARSER::PROTEIN)
    ("CR3" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("CD49f" . SPARSER::PROTEIN)
    ("highly expressed in cancer" . SPARSER::PROTEIN)
    ("YB-1" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-K" . SPARSER::PROTEIN) ("EP, JW, and RG" . SPARSER::COLLECTION)
    ("RG" . SPARSER::PROTEIN) ("EP" . SPARSER::PROTEIN)
    ("KL and QC" . SPARSER::COLLECTION) ("KL" . SPARSER::PROTEIN)
    ("WX, SZ, LL, and XY" . SPARSER::COLLECTION)
    ("WX, SZ, LL, and WG" . SPARSER::COLLECTION) ("LL" . SPARSER::PROTEIN)
    ("WX" . SPARSER::PROTEIN)
    ("Adjuvant lapatinib and/or trastuzumab treatment optimization"
     . SPARSER::COLLECTION)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("eIF4E-binding protein 1" . SPARSER::PROTEIN)
    ("glucocorticoid" . SPARSER::PROTEIN)
    ("Phosphoinositide" . SPARSER::PROTEIN) ("Heregulin" . SPARSER::PROTEIN)
    ("Adjuvant" . SPARSER::DRUG) ("Metallopeptidase" . SPARSER::PROTEIN)
    ("ADAM" . SPARSER::PROTEIN) ("eIF" . SPARSER::PROTEIN)
    ("promiscuous kinase inhibitors" . SPARSER::INHIBITOR)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("a supposed equipotent HER2 and EGFR kinase inhibitor"
     . SPARSER::INHIBITOR)
    ("the FDA-approved dual HER2/EGFR TKI lapatinib" . SPARSER::DRUG)
    ("Past" . SPARSER::PROTEIN)
    ("kinases and receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("PI3K or mTOR" . SPARSER::COLLECTION)
    ("lapatinib, erlotinib, and gefitinib" . SPARSER::COLLECTION)
    ("HRG-HER3-EGFR-PI3K-PDK1" . SPARSER::COLLECTION)
    ("San" . SPARSER::PROTEIN) ("HER3 or phospho-Akt" . SPARSER::COLLECTION)
    ("phosphatase (PHLPPL)" . SPARSER::PROTEIN)
    ("the distinct biologic" . SPARSER::DRUG)
    ("lapatinib and trastuzumab" . SPARSER::COLLECTION)
    ("homodimers" . SPARSER::HOMODIMER) ("betacellulin" . SPARSER::PROTEIN)
    ("autocrine HRG" . SPARSER::PROTEIN)
    ("EGFR-HER3-PI3K-PDK1" . SPARSER::COLLECTION)
    ("HER2, ER, and PR" . SPARSER::COLLECTION)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RFS" . SPARSER::PROTEIN)
    ("the lower-molecular-weight (40 kDa) soluble form" . SPARSER::FORM)
    ("trastuzumab" . SPARSER::DRUG)
    ("smaller-molecular-weight soluble forms" . SPARSER::FORM)
    ("metallopeptidase" . SPARSER::PROTEIN)
    ("the 40-kDa soluble form" . SPARSER::FORM)
    ("the predominant form" . SPARSER::FORM)
    ("HER3-EGFR" . SPARSER::COLLECTION) ("ligand (EGF)" . SPARSER::MOLECULE)
    ("a soluble ligand" . SPARSER::LIGAND)
    ("HER3 and HER4" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("HER3-EGFR-PI3K" . SPARSER::COLLECTION)
    ("EGFR, HER3, and Akt" . SPARSER::COLLECTION)
    ("lapatinib, gefitinib, and erlotinib" . SPARSER::COLLECTION)
    ("EGFR and HER2" . SPARSER::COLLECTION) ("Neratinib" . SPARSER::DRUG)
    ("Gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("Gefitinib" . SPARSER::DRUG)
    ("PHLPPL" . SPARSER::PROTEIN) ("EGFR-HER3-PI3K" . SPARSER::COLLECTION)
    ("tyrosines" . SPARSER::AMINO-ACID) ("heterodimer" . SPARSER::HETERODIMER)
    ("c-src" . SPARSER::COLLECTION) ("src" . SPARSER::PROTEIN)
    ("EGFR-HER3" . SPARSER::COLLECTION) ("Akt or PDK1" . SPARSER::COLLECTION)
    ("PKCβ or SGK" . SPARSER::COLLECTION)
    ("Akt, PDK1, SGK, and PKCβ" . SPARSER::COLLECTION)
    ("SGK" . SPARSER::PROTEIN) ("PI3K-PDK1-Akt" . SPARSER::COLLECTION)
    ("p70S6K" . SPARSER::PROTEIN) ("PI3K-p85" . SPARSER::COLLECTION)
    ("Bad" . SPARSER::PROTEIN) ("RPMA" . SPARSER::PROTEIN)
    ("protein/phosphoproteins" . SPARSER::COLLECTION)
    ("phosphoproteins" . SPARSER::PROTEIN) ("HER2/EGFR" . SPARSER::COLLECTION)
    ("HER2-" . SPARSER::PROTEIN) ("HRG-HER3-EGFR-PI3K" . SPARSER::COLLECTION)
    ("TKIs and kinase" . SPARSER::COLLECTION) ("arm" . SPARSER::PROTEIN)
    ("an equipotent inhibitor" . SPARSER::INHIBITOR)
    ("HER2 and EGFR" . SPARSER::COLLECTION) ("Lapatinib" . SPARSER::DRUG)
    ("HER2-HER3" . SPARSER::COLLECTION) ("activators" . SPARSER::ACTIVATOR)
    ("dimers" . SPARSER::DIMER) ("subunit" . SPARSER::FRAGMENT)
    ("dimer" . SPARSER::DIMER) ("heterodimers" . SPARSER::HETERODIMER)
    ("Ligand" . SPARSER::LIGAND)
    ("transmembrane receptor tyrosine kinases (HER1/EGFR; HER2; HER3; HER4) and their respective ligands"
     . SPARSER::COLLECTION)
    ("their respective ligands" . SPARSER::LIGAND)
    ("transmembrane receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER1/EGFR" . SPARSER::COLLECTION) ("biologic" . SPARSER::DRUG)
    ("HER3 and EGFR" . SPARSER::COLLECTION) ("pan-HER" . SPARSER::COLLECTION)
    ("neratinib" . SPARSER::DRUG) ("heregulin (HRG)" . SPARSER::PROTEIN)
    ("HER3-EGFR-PI3K-PDK1" . SPARSER::COLLECTION)
    ("HER2-HER3-PI3K" . SPARSER::COLLECTION) ("HRG" . SPARSER::PROTEIN)
    ("heregulin" . SPARSER::PROTEIN) ("TKIs" . SPARSER::PROTEIN)
    ("HER" . SPARSER::PROTEIN) ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("HER2 and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("TKI" . SPARSER::PROTEIN) ("lapatinib" . SPARSER::DRUG)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("RTK" . SPARSER::PROTEIN) ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("regulated kinase" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("Catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("Phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("Adenosine triphosphate" . SPARSER::MOLECULE)
    ("Protein kinase B" . SPARSER::PROTEIN)
    ("4E-binding protein 1" . SPARSER::PROTEIN) ("HKI-272" . SPARSER::DRUG)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("HRG1" . SPARSER::PROTEIN)
    ("PI3K-mTOR" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("c-met" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN) ("catalytic subunit" . SPARSER::PROTEIN)
    ("p110" . SPARSER::PROTEIN) ("4EBP1" . SPARSER::PROTEIN)
    ("p70S6" . SPARSER::PROTEIN) ("NRG1" . SPARSER::PROTEIN)
    ("NVP-BEZ 235" . SPARSER::DRUG) ("AZD0530" . SPARSER::DRUG)
    ("SU11274" . SPARSER::DRUG) ("ADAM17" . SPARSER::PROTEIN)
    ("PHLPP2" . SPARSER::PROTEIN) ("Akt1" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN) ("PI3" . SPARSER::PROTEIN)
    ("p85" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HER4" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("HER2" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("an estimated population attributable fraction" . SPARSER::COMPONENT)
    ("around PTTG1" . SPARSER::PROTEIN) ("hormone" . SPARSER::PROTEIN)
    ("FOXA1 and GATA3" . SPARSER::COLLECTION)
    ("MRs and regulons" . SPARSER::COLLECTION) ("securin" . SPARSER::PROTEIN)
    ("MRs, ESR1, GATA3 and FOXA1" . SPARSER::COLLECTION)
    ("E2F2 and FOXM1" . SPARSER::COLLECTION)
    ("both E2 and FGFR2 unique genes" . SPARSER::GENE)
    ("E2 and FGFR2" . SPARSER::COLLECTION)
    ("ESR1, GATA3 and FOXA1" . SPARSER::COLLECTION)
    ("MYC and GREB" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("MRs and FGFR2" . SPARSER::COLLECTION)
    ("the MRs and all five MR regulons" . SPARSER::COLLECTION)
    ("SPDEF and PTTG1" . SPARSER::COLLECTION)
    ("ERα, GATA3 and FOXA1" . SPARSER::COLLECTION)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("PWMs" . SPARSER::DRUG)
    ("GATA3, ESR1 and FOXA1" . SPARSER::COLLECTION)
    ("ERα and SPDEF" . SPARSER::COLLECTION)
    ("ESR1, FOXA1 and GATA3" . SPARSER::COLLECTION) ("PWM" . SPARSER::DRUG)
    ("ESR1, FOXA1, GATA3 and SPDEF" . SPARSER::COLLECTION)
    ("a particular MR" . SPARSER::PROTEIN) ("TSS" . SPARSER::PROTEIN)
    ("meta-PCNA" . SPARSER::COLLECTION) ("PCNA" . SPARSER::PROTEIN)
    ("Exp2 and Exp3" . SPARSER::COLLECTION)
    ("GATA3 and FOXA1" . SPARSER::COLLECTION)
    ("ESR1 and PTTG1" . SPARSER::COLLECTION) ("ER−" . SPARSER::PROTEIN)
    ("SPDEF, GATA3 and FOXA1" . SPARSER::COLLECTION)
    ("SPDEF, ERα, FOXA1 and GATA3" . SPARSER::COLLECTION)
    ("ESR1 and its co-factors FOXA1 and GATA3, and PTTG1 ( xref )"
     . SPARSER::COLLECTION)
    ("SPDEF, ESR1 and its co-factors FOXA1 and GATA3, and PTTG1 ( xref )"
     . SPARSER::COLLECTION)
    ("FOXA1 and GATA3, and PTTG1" . SPARSER::COLLECTION)
    ("GATA3, and PTTG1" . SPARSER::COLLECTION) ("cohorts" . SPARSER::MOLECULE)
    ("DPI" . SPARSER::PROTEIN) ("–TF 2" . SPARSER::COLLECTION)
    ("TF 1" . SPARSER::PROTEIN) ("FGFR2 and E2" . SPARSER::COLLECTION)
    ("Tet" . SPARSER::PROTEIN)
    ("400 kb windows around each SNP" . SPARSER::PROTEIN)
    ("potential target genes" . SPARSER::GENE) ("eQTL" . SPARSER::PROTEIN)
    ("FOXA1-" . SPARSER::PROTEIN) ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Exp1–3" . SPARSER::COLLECTION) ("cis-eQTL" . SPARSER::COLLECTION)
    ("cis" . SPARSER::PROTEIN) ("DEG" . SPARSER::PROTEIN)
    ("DEGs" . SPARSER::PROTEIN) ("call" . SPARSER::PROTEIN)
    ("FGFR" . SPARSER::PROTEIN) ("tetracycline" . SPARSER::DRUG)
    ("FGFRs" . SPARSER::PROTEIN) ("TN" . SPARSER::PROTEIN)
    ("genes and genes" . SPARSER::COLLECTION) ("MR" . SPARSER::PROTEIN)
    ("MRA" . SPARSER::PROTEIN) ("TF" . SPARSER::PROTEIN)
    ("MRs" . SPARSER::PROTEIN)
    ("other nearby potential target genes" . SPARSER::GENE)
    ("refs" . SPARSER::PROTEIN)
    ("Asians and African-Americans" . SPARSER::COLLECTION)
    ("ERα, FOXA1 and GATA3" . SPARSER::COLLECTION)
    ("SPDEF, ERα, FOXA1, GATA3 and PTTG1" . SPARSER::COLLECTION)
    ("SPDEF" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("2b" . SPARSER::HUMAN-PROTEIN-FAMILY) ("phenol red" . SPARSER::DRUG)
    ("ml −1" . SPARSER::PROTEIN) ("anti-estrogens" . SPARSER::DRUG)
    ("co-factor" . SPARSER::MOLECULE) ("CCND1" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("TOX3" . SPARSER::PROTEIN) ("EGR2" . SPARSER::PROTEIN)
    ("co-factors" . SPARSER::MOLECULE) ("TF 2" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("ESR1" . SPARSER::PROTEIN)
    ("PD173074" . SPARSER::DRUG) ("IL8" . SPARSER::PROTEIN)
    ("Exp3" . SPARSER::PROTEIN) ("Exp2" . SPARSER::PROTEIN)
    ("AP20187" . SPARSER::DRUG) ("iF2" . SPARSER::PROTEIN)
    ("Exp1" . SPARSER::PROTEIN) ("FGF10" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN) ("anti-oestrogen" . SPARSER::DRUG)
    ("PTTG1" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("ERα" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 2" . SPARSER::PROTEIN)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("cerebral ischemia" . SPARSER::PROTEIN) ("ischemia" . SPARSER::PROTEIN)
    ("MS" . SPARSER::PROTEIN) ("an essential molecule" . SPARSER::MOLECULE)
    ("Mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondrial enzyme" . SPARSER::ENZYME) ("AceCS" . SPARSER::PROTEIN)
    ("HDAC" . SPARSER::PROTEIN) ("NAD (NADP)" . SPARSER::MOLECULE)
    ("an essential step" . SPARSER::PROTEIN) ("NADP" . SPARSER::MOLECULE)
    ("NMNAT" . SPARSER::PROTEIN) ("adenylyltransferase" . SPARSER::PROTEIN)
    ("both full-length and the carboxy-terminal SIRT3 C1 fragments (residues 29–307)"
     . SPARSER::COLLECTION)
    ("thymidine" . SPARSER::MOLECULE) ("BrdU" . SPARSER::DRUG)
    ("NMNAT2 or NMNAT2+SIRT3" . SPARSER::COLLECTION)
    ("Seahorse" . SPARSER::PROTEIN) ("OCR" . SPARSER::PROTEIN)
    ("mononucleotide (NMN)" . SPARSER::MOLECULE) ("NMN" . SPARSER::PROTEIN)
    ("mononucleotide" . SPARSER::MOLECULE) ("nicotinamide" . SPARSER::PROTEIN)
    ("TSA and NAM" . SPARSER::COLLECTION)
    ("NAM (10 mM for 24 h) and/or TSA (5 μ M for 6 h)" . SPARSER::COLLECTION)
    ("TSA" . SPARSER::PROTEIN) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("NAD" . SPARSER::MOLECULE) ("Flag-NMNAT2" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN) ("NMNAT2-SIRT3" . SPARSER::COLLECTION)
    ("SIRT3-NMNAT2" . SPARSER::COLLECTION) ("FLAG-SIRT3" . SPARSER::COLLECTION)
    ("both full-length and the carboxy-terminal fragments"
     . SPARSER::COLLECTION)
    ("fragment" . SPARSER::FRAGMENT) ("fragments" . SPARSER::FRAGMENT)
    ("carboxy" . SPARSER::MOLECULE) ("NMNAT2 and SIRT3" . SPARSER::COLLECTION)
    ("NMNAT2 (red, xref ) and SIRT3 (green, xref ) protein"
     . SPARSER::COLLECTION)
    ("green" . SPARSER::PROTEIN) ("PFA and DAPI" . SPARSER::COLLECTION)
    ("META" . SPARSER::PROTEIN) ("DAPI" . SPARSER::DRUG)
    ("PFA" . SPARSER::MOLECULE) ("pDS-RED1-N1-NMNAT2" . SPARSER::COLLECTION)
    ("pDS" . SPARSER::PROTEIN) ("GST-NMNAT2" . SPARSER::COLLECTION)
    ("anti-SIRT3 and anti-NMNAT2" . SPARSER::COLLECTION)
    ("Glo" . SPARSER::PROTEIN) ("Luciferase" . SPARSER::PROTEIN)
    ("pACT-MyoD" . SPARSER::COLLECTION) ("MyoD" . SPARSER::PROTEIN)
    ("pBIND-NMNAT2" . SPARSER::PROTEIN-PAIR)
    ("pACT-SIRT3" . SPARSER::COLLECTION) ("pACT" . SPARSER::PROTEIN)
    ("Myc-NMNAT2" . SPARSER::COLLECTION) ("Flag-SIRT3" . SPARSER::COLLECTION)
    ("IB" . SPARSER::PROTEIN) ("IP" . SPARSER::PROTEIN)
    ("NMNAT2, or Myc" . SPARSER::COLLECTION)
    ("a human lung cDNA library using full-length SIRT3" . SPARSER::PROTEIN)
    ("substrates" . SPARSER::SUBSTRATE) ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("ATP" . SPARSER::ATP) ("nutrient" . SPARSER::MOLECULE)
    ("deacetylases" . SPARSER::PROTEIN) ("RRs" . SPARSER::MOLECULE)
    ("NMNAT2 and NAD +" . SPARSER::COLLECTION)
    ("SIRT3 and NMNAT2" . SPARSER::COLLECTION)
    ("deacetylase" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("SIRT1" . SPARSER::PROTEIN)
    ("NAD (+)" . SPARSER::MOLECULE) ("monoclonal antibody" . SPARSER::DRUG)
    ("Myc -tagged" . SPARSER::PROTEIN)
    ("alcohol dehydrogenase" . SPARSER::PROTEIN) ("MgCl 2" . SPARSER::MOLECULE)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("RED1" . SPARSER::PROTEIN) ("Protein A" . SPARSER::PROTEIN)
    ("mM 3" . SPARSER::PROTEIN) ("hSIRT3" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("NAD +" . SPARSER::MOLECULE) ("NMNAT2" . SPARSER::PROTEIN)
    ("nicotinamide mononucleotide adenylyltransferase 2" . SPARSER::PROTEIN)
    ("SIRT3" . SPARSER::PROTEIN) ("ZW" . SPARSER::PROTEIN)
    ("MMB and JA" . SPARSER::COLLECTION) ("MMB" . SPARSER::PROTEIN)
    ("JA and ZPZ" . SPARSER::COLLECTION) ("JA" . SPARSER::PROTEIN)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("FDA" . SPARSER::PROTEIN) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE) ("essential genes" . SPARSER::GENE)
    ("a posttranscriptional gene" . SPARSER::GENE)
    ("a respective mRNA molecule" . SPARSER::MOLECULE)
    ("an attractive molecular target" . SPARSER::TARGET-PROTEIN)
    ("clinicopathologic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prostatic" . SPARSER::PROTEIN) ("metablastin" . SPARSER::PROTEIN)
    ("FBS" . SPARSER::PROTEIN) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("sh" . SPARSER::PROTEIN-FAMILY) ("lenti-shRNA" . SPARSER::COLLECTION)
    ("stathmin1 in MKN-45 cell’s" . SPARSER::PROTEIN)
    ("ICC" . SPARSER::PROTEIN) ("IF" . SPARSER::PROTEIN)
    ("dsRNA" . SPARSER::RNA) ("an attractive target" . SPARSER::TARGET-PROTEIN)
    ("Stathmin" . SPARSER::PROTEIN)
    ("Stathmin1/oncoprotein 18" . SPARSER::COLLECTION)
    ("shRNA" . SPARSER::PROTEIN) ("stathmin-shRNA" . SPARSER::PROTEIN-PAIR)
    ("chemotaxis" . SPARSER::PROTEIN) ("G1-S" . SPARSER::PROTEIN)
    ("LAP 18" . SPARSER::PROTEIN) ("p19" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p18" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p17" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Op18" . SPARSER::PROTEIN)
    ("Stathmin 1" . SPARSER::PROTEIN) ("Na3VO4" . SPARSER::MOLECULE)
    ("Beta-Actin" . SPARSER::PROTEIN) ("and 1 " . SPARSER::PROTEIN)
    ("Stmn1" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("–3 " . SPARSER::PROTEIN) ("op18" . SPARSER::PROTEIN)
    ("STMN-1" . SPARSER::PROTEIN) ("oncoprotein 18" . SPARSER::PROTEIN)
    ("Stathmin1" . SPARSER::PROTEIN) ("stathmin1" . SPARSER::PROTEIN)
    ("acetaldehyde" . SPARSER::MOLECULE)
    ("single-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("meta" . SPARSER::PROTEIN) ("mix" . SPARSER::PROTEIN)
    ("RAD51 and BRCA1/2" . SPARSER::COLLECTION) ("RecA" . SPARSER::PROTEIN)
    ("OGG1 (Ser326Cys) and XPD (Lys751Gln)" . SPARSER::COLLECTION)
    ("XPC" . SPARSER::PROTEIN) ("Lys" . SPARSER::AMINO-ACID)
    ("XPD" . SPARSER::PROTEIN) ("Met" . SPARSER::AMINO-ACID)
    ("Thr" . SPARSER::AMINO-ACID) ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type and ethnicity" . SPARSER::COLLECTION)
    ("estrogen" . SPARSER::MOLECULE) ("Sun" . SPARSER::PROTEIN)
    ("Gao" . SPARSER::PROTEIN) ("BRCA1/BRCA2" . SPARSER::COLLECTION)
    ("tran" . SPARSER::PROTEIN) ("fix" . SPARSER::PROTEIN)
    ("recA" . SPARSER::PROTEIN) ("defective DNA-repair" . SPARSER::DNA)
    ("DNA-repair" . SPARSER::DNA) ("genome" . SPARSER::PROTEIN)
    ("mutagens" . SPARSER::MOLECULE) ("homolog of" . SPARSER::PROTEIN)
    ("XRCC2" . SPARSER::PROTEIN) ("OGG1" . SPARSER::PROTEIN)
    ("XRCC3" . SPARSER::PROTEIN) ("BRCA2 protein" . SPARSER::PROTEIN)
    ("ataxia telangiectasia" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("TGF-β1 and VEGF" . SPARSER::COLLECTION)
    ("a ubiquitous ECM glycoprotein" . SPARSER::PROTEIN)
    ("FN 1, and miR-206" . SPARSER::COLLECTION) ("BDNF" . SPARSER::PROTEIN)
    ("Shh" . SPARSER::PROTEIN) ("COPD" . SPARSER::PROTEIN)
    ("zebra" . SPARSER::PROTEIN) ("VegfA" . SPARSER::PROTEIN)
    ("adr" . SPARSER::PROTEIN) ("adr 1-3" . SPARSER::COLLECTION)
    ("TIMP-1, IL-1 and TNF-α" . SPARSER::COLLECTION)
    ("pMIR-FN 1" . SPARSER::COLLECTION)
    ("the approximately 800 candidate genes" . SPARSER::GENE)
    ("AS" . SPARSER::PROTEIN) ("miR-206-mediated ECM" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN) ("elastin" . SPARSER::PROTEIN)
    ("tissue inhibitor of metalloproteinases 1" . SPARSER::PROTEIN)
    ("transforming growth factor-β1" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("IL-1" . SPARSER::PROTEIN)
    ("TIMP-1" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("de-" . SPARSER::MOLECULE) ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("adr 1" . SPARSER::PROTEIN) ("FN 1" . SPARSER::PROTEIN)
    ("fibronectin 1" . SPARSER::PROTEIN) ("fn 1" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("Fibronectin 1" . SPARSER::PROTEIN)
    ("detrimental long-term side" . SPARSER::PROTEIN)
    ("at least several enzymes" . SPARSER::ENZYME)
    ("matrigel" . SPARSER::PROTEIN) ("neo" . SPARSER::PROTEIN)
    ("Mdm2 and VEGF" . SPARSER::COLLECTION)
    ("Mdm2-HIF1α-VEGF" . SPARSER::COLLECTION)
    ("HIF1α and VEGF" . SPARSER::COLLECTION) ("vasculature" . SPARSER::PROTEIN)
    ("a strong activator" . SPARSER::ACTIVATOR)
    ("the most aggressive forms" . SPARSER::FORM)
    ("Serdemetan and hypoxia" . SPARSER::COLLECTION)
    ("Enolase, Glut1, MMP2 and PGK1/2" . SPARSER::COLLECTION)
    ("Enolase" . SPARSER::PROTEIN)
    ("vegf and several genes" . SPARSER::COLLECTION)
    ("vegf" . SPARSER::PROTEIN) ("MG132, and Serdemetan" . SPARSER::COLLECTION)
    ("-HIF1α" . SPARSER::COLLECTION) ("VEGF and EPO" . SPARSER::COLLECTION)
    ("EPO" . SPARSER::PROTEIN) ("Mdm2–p53" . SPARSER::COLLECTION)
    ("p53-Mdm2" . SPARSER::COLLECTION)
    ("VEGF and other HIF1α" . SPARSER::COLLECTION)
    ("hypoxia and Serdemetan" . SPARSER::COLLECTION)
    ("derivative" . SPARSER::DERIVATIVE) ("tryptamine" . SPARSER::DRUG)
    ("Complex" . SPARSER::BIO-COMPLEX)
    ("Mdm2 and Hypoxia inducible factor 1α" . SPARSER::COLLECTION)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("VEGF and the glycolytic enzymes (enolase, phosphoglycerate kinase1/2, and glucose transporter 1)"
     . SPARSER::COLLECTION)
    ("HIF1α downstream targets, VEGF and the glycolytic enzymes (enolase, phosphoglycerate kinase1/2, and glucose transporter 1)"
     . SPARSER::COLLECTION)
    ("enolase, phosphoglycerate kinase1/2, and glucose" . SPARSER::COLLECTION)
    ("transporter" . SPARSER::PROTEIN) ("glucose" . SPARSER::PROTEIN)
    ("enolase" . SPARSER::PROTEIN) ("Mdm2-HIF1α" . SPARSER::COLLECTION)
    ("antagonist" . SPARSER::MOLECULE) ("Serdemetan" . SPARSER::DRUG)
    ("MMP2" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("nutlin3" . SPARSER::DRUG) ("Nutlin3" . SPARSER::DRUG)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("U87MG" . SPARSER::PROTEIN)
    ("PGK1" . SPARSER::PROTEIN) ("Glut1" . SPARSER::PROTEIN)
    ("U87" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("phosphoglycerate kinase1" . SPARSER::PROTEIN)
    ("HIF1α" . SPARSER::PROTEIN) ("integrins and FAK" . SPARSER::COLLECTION)
    ("punctate" . SPARSER::PROTEIN) ("Acceptor" . SPARSER::MOLECULE)
    ("GEF" . SPARSER::PROTEIN) ("Kinase (FAK)" . SPARSER::KINASE)
    ("Kinase" . SPARSER::KINASE)
    ("the potential molecular mediators" . SPARSER::PROTEIN)
    ("mediators" . SPARSER::PROTEIN) ("mDia" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR) ("Rho kinase (ROCK)" . SPARSER::PROTEIN)
    ("p190RhoGEF" . SPARSER::PROTEIN) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("RhoGEF" . SPARSER::PROTEIN) ("CDM or 3D" . SPARSER::COLLECTION)
    ("MLC" . SPARSER::PROTEIN) ("antibodies" . SPARSER::ANTIBODY)
    ("acceptor" . SPARSER::MOLECULE) ("CFP/YFP" . SPARSER::COLLECTION)
    ("lab" . SPARSER::PROTEIN) ("YFP" . SPARSER::PROTEIN)
    ("CFP" . SPARSER::PROTEIN) ("an essential regulator" . SPARSER::PROTEIN)
    ("scaffolds" . SPARSER::SCAFFOLD) ("lifeact-GFP" . SPARSER::COLLECTION)
    ("MMP9 or MT1MMP" . SPARSER::COLLECTION)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MB" . SPARSER::PROTEIN)
    ("‘organotypic’ 3D ECM" . SPARSER::PROTEIN)
    ("soluble factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the ECM as well as enzymes" . SPARSER::COLLECTION)
    ("angiogenic and immunological chemokines" . SPARSER::PROTEIN)
    ("chemical" . SPARSER::MOLECULE)
    ("complex fibrillar ECM" . SPARSER::PROTEIN)
    ("FN and CDM" . SPARSER::COLLECTION) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("fibrillar fibronectin and collagen" . SPARSER::COLLECTION)
    ("matrices (CDM)" . SPARSER::PROTEIN-FAMILY)
    ("fibronectin and collagen" . SPARSER::COLLECTION)
    ("CDM" . SPARSER::PROTEIN) ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("collagen and vitronectin" . SPARSER::COLLECTION)
    ("subunits" . SPARSER::FRAGMENT) ("Integrin" . SPARSER::PROTEIN)
    ("specifically knockdown (kd) each integrin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ligand" . SPARSER::LIGAND)
    ("F-actin and phosphotyrosine" . SPARSER::COLLECTION)
    ("PY" . SPARSER::MOLECULE)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("vitronectin (VN; to engage β3) or fibronectin (FN, to engage β1 and β3)"
     . SPARSER::COLLECTION)
    ("collagen (COLI; to engage β1), vitronectin (VN; to engage β3) or fibronectin (FN, to engage β1 and β3)"
     . SPARSER::COLLECTION)
    ("FN" . SPARSER::PROTEIN) ("VN" . SPARSER::PROTEIN)
    ("vitronectin" . SPARSER::PROTEIN)
    ("collagen" . SPARSER::HUMAN-PROTEIN-FAMILY) ("glass" . SPARSER::MOLECULE)
    ("MDA" . SPARSER::DRUG) ("FAK and RhoA" . SPARSER::COLLECTION)
    ("growth factor, ECM and protease" . SPARSER::COLLECTION)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nodal" . SPARSER::PROTEIN)
    ("biochemical complexes" . SPARSER::BIO-COMPLEX)
    ("families" . SPARSER::PROTEIN-FAMILY) ("complexes" . SPARSER::BIO-COMPLEX)
    ("MMP" . SPARSER::PROTEIN) ("growth factors and ECM" . SPARSER::COLLECTION)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("common ligands (such a fibronectin) and intracellular binding partners (such as talin)"
     . SPARSER::COLLECTION)
    ("talin" . SPARSER::PROTEIN) ("ligands" . SPARSER::LIGAND)
    ("GTPases" . SPARSER::GTPASE)
    ("vinculin and focal adhesion kinase (FAK)" . SPARSER::COLLECTION)
    ("classical FA proteins" . SPARSER::PROTEIN)
    ("vinculin" . SPARSER::PROTEIN) ("paxillin" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN)
    ("24 ubiquitous heterodimeric transmembrane receptors proteins"
     . SPARSER::PROTEIN)
    ("Integrins" . SPARSER::PROTEIN) ("actin" . SPARSER::PROTEIN)
    ("FAK-RhoA" . SPARSER::COLLECTION)
    ("focal adhesion kinase (FAK) and the small GTPase RhoA"
     . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE) ("RhoA" . SPARSER::PROTEIN)
    ("GTPase" . SPARSER::GTPASE) ("FAK" . SPARSER::PROTEIN)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("fibronectin" . SPARSER::PROTEIN)
    ("these ubiquitous receptors" . SPARSER::PROTEIN)
    ("integrins" . SPARSER::PROTEIN) ("integrin" . SPARSER::PROTEIN)
    ("ECM" . SPARSER::PROTEIN) ("TX-100" . SPARSER::DRUG)
    ("sodium bicarbonate" . SPARSER::DRUG)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("R-250" . SPARSER::PROTEIN)
    ("pSM2" . SPARSER::PROTEIN) ("and 1 µ" . SPARSER::PROTEIN)
    ("G418" . SPARSER::MOLECULE) ("N1" . SPARSER::PROTEIN)
    ("anti- β" . SPARSER::PROTEIN) ("LEM2" . SPARSER::PROTEIN)
    ("Anti- β" . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("PF-228" . SPARSER::DRUG) ("P190" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN) ("p190" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MT1MMP" . SPARSER::PROTEIN) ("MMP9" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("Rho family" . SPARSER::PROTEIN)
    ("Pim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Pim-1 inhibitors and FLT3 inhibitors" . SPARSER::COLLECTION)
    ("Clinically applicable Pim-1 inhibitors" . SPARSER::INHIBITOR)
    ("Serines" . SPARSER::AMINO-ACID) ("alanine" . SPARSER::AMINO-ACID)
    ("a transmembrane chaperone" . SPARSER::PROTEIN) ("forms" . SPARSER::FORM)
    ("calreticulin and HSP90" . SPARSER::COLLECTION)
    ("calreticulin" . SPARSER::PROTEIN)
    ("wild-type FLT3 as well as FLT3-ITD" . SPARSER::COLLECTION)
    ("Pim-1 and Pim-2" . SPARSER::COLLECTION)
    ("FLT3 and Pim-1" . SPARSER::COLLECTION)
    ("PKC412 and quercetagetin" . SPARSER::COLLECTION)
    ("sorafenib and quercetagetin" . SPARSER::COLLECTION)
    ("PKC412 and sorafenib" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("protein-protein" . SPARSER::COLLECTION)
    ("the S935A mutant and the phosphomimetic S935D and S935E mutants"
     . SPARSER::COLLECTION)
    ("the phosphomimetic S935D and S935E mutants" . SPARSER::MUTANT)
    ("DG" . SPARSER::PROTEIN) ("Pim-1 and serine" . SPARSER::COLLECTION)
    ("quercetagetin or AR339" . SPARSER::COLLECTION)
    ("DMSO" . SPARSER::MOLECULE) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Quercetagetin" . SPARSER::MOLECULE)
    ("FLT3-ITD-expressing Ba/F3-ITD" . SPARSER::PROTEIN)
    ("the PI3 kinase target Akt or the JNK target c-jun ( xref )"
     . SPARSER::COLLECTION)
    ("PI3 kinase and c-Jun" . SPARSER::COLLECTION)
    ("quercetagetin" . SPARSER::MOLECULE) ("peptide" . SPARSER::PEPTIDE)
    ("GST-Pim-1" . SPARSER::COLLECTION)
    ("immobilized GST-tagged Pim-1 fusion protein or control GST"
     . SPARSER::COLLECTION)
    ("Pim-1 and FLT3" . SPARSER::COLLECTION) ("GST" . SPARSER::PROTEIN)
    ("ABCB1 and ABCG2" . SPARSER::COLLECTION)
    ("ABCB1 or P-glycoprotein" . SPARSER::COLLECTION)
    ("ABCG2 or breast cancer resistance protein" . SPARSER::COLLECTION)
    ("BCRP" . SPARSER::PROTEIN) ("Pgp" . SPARSER::PROTEIN)
    ("Pim-2 and Pim-3" . SPARSER::COLLECTION)
    ("pim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("33 kDa and 44 kDa" . SPARSER::COLLECTION)
    ("chaperone" . SPARSER::PROTEIN) ("mannose" . SPARSER::MOLECULE)
    ("sorafenib" . SPARSER::DRUG) ("midostaurin" . SPARSER::DRUG)
    ("lestaurtinib" . SPARSER::DRUG) ("tyrosine" . SPARSER::AMINO-ACID)
    ("ITD" . SPARSER::PROTEIN) ("calnexin and HSP90" . SPARSER::COLLECTION)
    ("calnexin and heat shock protein (HSP)" . SPARSER::COLLECTION)
    ("calnexin and heat shock protein" . SPARSER::COLLECTION)
    ("FLT3-ITD" . SPARSER::PROTEIN-PAIR) ("HSP" . SPARSER::PROTEIN)
    ("calnexin" . SPARSER::PROTEIN) ("kDa" . SPARSER::PROTEIN)
    ("AML" . SPARSER::PROTEIN) ("SGI-1776" . SPARSER::DRUG)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("c-Cbl" . SPARSER::PROTEIN)
    ("PKC412" . SPARSER::DRUG) ("PI3 kinase" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("MG-132" . SPARSER::DRUG)
    ("D-glucose" . SPARSER::MOLECULE) ("MG132" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE)
    ("Glutathione S-transferase" . SPARSER::PROTEIN) ("G10" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN) ("protein A" . SPARSER::PROTEIN)
    ("breast cancer resistance protein" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN) ("ABCB1" . SPARSER::PROTEIN)
    ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("multidrug resistance" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN) ("c-myc" . SPARSER::PROTEIN)
    ("RUNX3" . SPARSER::PROTEIN) ("SOCS-1" . SPARSER::PROTEIN)
    ("Cdc25C" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN) ("Pim-3" . SPARSER::PROTEIN)
    ("Pim-2" . SPARSER::PROTEIN) ("proto-oncogene" . SPARSER::PROTO-ONCOGENE)
    ("AC220" . SPARSER::DRUG) ("Pim-1" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN)
    ("heat shock protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLT3" . SPARSER::PROTEIN)
    ("fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hope" . SPARSER::PROTEIN)
    ("BclXL" . SPARSER::PROTEIN) ("pre" . SPARSER::PROTEIN)
    ("phosphatidylserine" . SPARSER::PROTEIN)
    ("post-MOMP" . SPARSER::COLLECTION) ("pre-MOMP" . SPARSER::COLLECTION)
    ("LNCaP and Du145" . SPARSER::COLLECTION)
    ("a potential biomarker" . SPARSER::MOLECULE)
    ("attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("BAK and BH3-only" . SPARSER::COLLECTION) ("ligase" . SPARSER::LIGASE)
    ("MULE" . SPARSER::PROTEIN) ("ubiquitin" . SPARSER::PROTEIN)
    ("MAP/ERK" . SPARSER::COLLECTION) ("MAP" . SPARSER::PROTEIN)
    ("PI3K inhibitors and translation inhibitors" . SPARSER::COLLECTION)
    ("a critical apoptosis-regulatory molecule" . SPARSER::MOLECULE)
    ("receptor tyrosine kinases and G-protein coupled" . SPARSER::COLLECTION)
    ("apoptosis-regulatory molecules" . SPARSER::MOLECULE)
    ("the pan-PI3K inhibitors ZSTK474 (Zenyaku Kogyo Co) and BKM120 (Novartis)"
     . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor BEZ235" . SPARSER::DRUG)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("pan-PI3K" . SPARSER::COLLECTION)
    ("mTOR" . SPARSER::PROTEIN) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("GFP-BAX" . SPARSER::COLLECTION) ("GFP" . SPARSER::PROTEIN)
    ("PC3 and DU145" . SPARSER::COLLECTION)
    ("BAD2SA and MCL-1 shRNA" . SPARSER::COLLECTION)
    ("BAD2SA and MCL-1shRNA" . SPARSER::COLLECTION)
    ("alanines" . SPARSER::AMINO-ACID)
    ("cycloheximide and ZSTK474" . SPARSER::COLLECTION)
    ("FLAG-MCL-1" . SPARSER::COLLECTION) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("BIM and NOXA" . SPARSER::COLLECTION) ("BIM" . SPARSER::PROTEIN)
    ("Flag-MCL-1" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("doxycycline" . SPARSER::DRUG) ("Mcl1" . SPARSER::PROTEIN)
    ("Mcl" . SPARSER::PROTEIN)
    ("BCL-XL, BCL-2, and MCL-1" . SPARSER::COLLECTION)
    ("BCL-XL, BCL-2, and BCL-W" . SPARSER::COLLECTION)
    ("ZSTK474 and cycloheximide" . SPARSER::COLLECTION)
    ("caspase 3, and TUNEL" . SPARSER::COLLECTION)
    ("ZSTK474 or cycloheximide" . SPARSER::COLLECTION)
    ("androgen or other external survival factors" . SPARSER::COLLECTION)
    ("BAD and MCL-1" . SPARSER::COLLECTION)
    ("cycloheximide or shRNA" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-XL" . SPARSER::COLLECTION)
    ("BCL-XL or BCL-2" . SPARSER::COLLECTION) ("chaperones" . SPARSER::PROTEIN)
    ("serines" . SPARSER::AMINO-ACID) ("NOXA and PUMA" . SPARSER::COLLECTION)
    ("BCL-2, BCL-XL, and BCL-W" . SPARSER::COLLECTION)
    ("sentinels" . SPARSER::DRUG) ("BAD, NOXA, and PUMA" . SPARSER::COLLECTION)
    ("Bid and Bim" . SPARSER::COLLECTION) ("BAX and BAK" . SPARSER::COLLECTION)
    ("BAX/BAK" . SPARSER::COLLECTION) ("Bim" . SPARSER::PROTEIN)
    ("Bid" . SPARSER::PROTEIN) ("PUMA" . SPARSER::PROTEIN)
    ("NOXA" . SPARSER::PROTEIN) ("subsequent MOMP" . SPARSER::PROTEIN)
    ("BCL-2, BCL-XL, and MCL-1" . SPARSER::COLLECTION)
    ("BAK and BAX" . SPARSER::COLLECTION) ("BAX" . SPARSER::PROTEIN)
    ("BAK" . SPARSER::PROTEIN)
    ("multidomain pro-apoptotic proteins, and BH3-only proteins"
     . SPARSER::PROTEIN)
    ("proteins, and BH3-only" . SPARSER::COLLECTION)
    ("homology" . SPARSER::PROTEIN)
    ("cytochrome c, SMAC, and apoptosis-inducing" . SPARSER::COLLECTION)
    ("SMAC" . SPARSER::PROTEIN) ("MOMP" . SPARSER::PROTEIN)
    ("Proteins" . SPARSER::PROTEIN) ("androgens" . SPARSER::DRUG)
    ("Androgen" . SPARSER::PROTEIN)
    ("a negative regulator of Akt and the PI3K pathway" . SPARSER::COLLECTION)
    ("The lipid phosphatase and tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10)"
     . SPARSER::COLLECTION)
    ("lipid" . SPARSER::LIPID) ("phosphoinositide" . SPARSER::PROTEIN)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BAD2SA" . SPARSER::PROTEIN)
    ("a main apoptosis-regulatory molecule" . SPARSER::MOLECULE)
    ("ell" . SPARSER::PROTEIN) ("BAD" . SPARSER::PROTEIN)
    ("cycloheximide" . SPARSER::PROTEIN) ("media" . SPARSER::PROTEIN)
    ("androgen" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("NP-40" . SPARSER::DRUG) ("caspase3" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG) ("g protein" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("α -tocopherol" . SPARSER::MOLECULE)
    ("BCL2" . SPARSER::PROTEIN) ("sensitive to apoptosis" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN) ("GSK3β" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("E3" . SPARSER::MOLECULE) ("mir29 b" . SPARSER::RNA)
    ("G-protein coupled" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BEZ235" . SPARSER::DRUG) ("BKM120" . SPARSER::DRUG)
    ("DU145" . SPARSER::PROTEIN) ("ABT-737" . SPARSER::DRUG)
    ("MCL1" . SPARSER::PROTEIN) ("Bcl2" . SPARSER::PROTEIN)
    ("14-3-3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BCL-W" . SPARSER::PROTEIN)
    ("BCL-XL" . SPARSER::PROTEIN) ("BH1" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("PDK1" . SPARSER::PROTEIN) ("PIP2" . SPARSER::PROTEIN)
    ("PIP3" . SPARSER::PIP3) ("2SA" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("cl2" . SPARSER::PROTEIN)
    ("ZSTK474" . SPARSER::DRUG) ("RP" . SPARSER::PROTEIN)
    ("Asian" . SPARSER::PROTEIN) ("cohort" . SPARSER::MOLECULE)
    ("PFS" . SPARSER::PROTEIN) ("RR" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("at least three target enzymes" . SPARSER::ENZYME)
    ("thymidylate synthase, dihydrofolate reductase, and glycinamide"
     . SPARSER::COLLECTION)
    ("second-line" . SPARSER::PROTEIN) ("ribonucleotide" . SPARSER::MOLECULE)
    ("folate" . SPARSER::MOLECULE) ("antifolate" . SPARSER::MOLECULE)
    ("Pemetrexed" . SPARSER::DRUG) ("first-line" . SPARSER::PROTEIN)
    ("docetaxel" . SPARSER::DRUG) ("paclitaxel" . SPARSER::DRUG)
    ("platinum" . SPARSER::MOLECULE) ("Platinum" . SPARSER::MOLECULE)
    ("HR" . SPARSER::PROTEIN) ("pemetrexed" . SPARSER::DRUG)
    ("TYMS" . SPARSER::PROTEIN) ("Chi 2" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN)
    ("a complex and multifactorial disease" . SPARSER::COLLECTION)
    ("potential confounding factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CART" . SPARSER::PROTEIN) ("strong LD" . SPARSER::PROTEIN)
    ("proto-oncogenes or tumor suppressor genes xref" . SPARSER::COLLECTION)
    ("Tyr" . SPARSER::AMINO-ACID) ("Cys" . SPARSER::AMINO-ACID)
    ("cytochrome c and apoptosis-inducing" . SPARSER::COLLECTION)
    ("mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("post-genome" . SPARSER::PROTEIN-PAIR)
    ("gene and risk" . SPARSER::COLLECTION) ("FPRP" . SPARSER::PROTEIN)
    ("alcohol" . SPARSER::DRUG) ("PROC" . SPARSER::PROTEIN)
    ("SAS" . SPARSER::PROTEIN) ("LD" . SPARSER::PROTEIN)
    ("GCA" . SPARSER::PROTEIN)
    ("1,117 gastric cancer patients and 1" . SPARSER::PROTEIN)
    ("class" . CLASS) ("insulin" . SPARSER::PROTEIN)
    ("cysteine-aspartic acid" . SPARSER::COLLECTION)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cysteine" . SPARSER::AMINO-ACID) ("Caspases" . SPARSER::PROTEIN)
    ("salt" . SPARSER::MOLECULE)
    ("Strong environmental component" . SPARSER::COMPONENT)
    ("Group" . SPARSER::MOLECULE) ("MDR" . SPARSER::PROTEIN)
    ("regulator and executioner" . SPARSER::COLLECTION)
    ("caspase-7" . SPARSER::PROTEIN) ("Caspase-7" . SPARSER::PROTEIN)
    ("beta 8" . SPARSER::PROTEIN) ("aspartic acid" . SPARSER::AMINO-ACID)
    ("CASP7" . SPARSER::PROTEIN) ("Caspase 7" . SPARSER::PROTEIN)
    ("mammary fat" . SPARSER::PROTEIN)
    ("BRIP1 and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 and SATB1" . SPARSER::COLLECTION)
    ("growth arrest–specific gene GAS1" . SPARSER::PROTEIN)
    ("WASP and WAVE" . SPARSER::COLLECTION) ("WAVE" . SPARSER::PROTEIN)
    ("WASP" . SPARSER::PROTEIN) ("COL8A1 and MCAM" . SPARSER::COLLECTION)
    ("the epithelial-specific Ets transcription factor ELF3"
     . SPARSER::PROTEIN)
    ("ESX" . SPARSER::PROTEIN) ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RICH2 and PCSK5" . SPARSER::COLLECTION)
    ("Rho-type GTPase-activating protein RICH2 and pro-protein convertase PCSK5"
     . SPARSER::COLLECTION)
    ("transcriptional regulator SATB1 , Rho-type GTPase-activating protein RICH2 and pro-protein convertase PCSK5"
     . SPARSER::COLLECTION)
    ("pro-protein" . SPARSER::COLLECTION)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN or PI3K" . SPARSER::COLLECTION) ("ATM-p53" . SPARSER::COLLECTION)
    ("DNA-damage" . SPARSER::DNA)
    ("ATM, p53, and phosphatidylinositol" . SPARSER::COLLECTION)
    ("MAPK and Wnt" . SPARSER::COLLECTION)
    ("MAPK and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("/AKT" . SPARSER::COLLECTION)
    ("mammary epithelial acini" . SPARSER::PROTEIN) ("luminal" . SPARSER::DRUG)
    ("the mammary fat" . SPARSER::PROTEIN) ("side" . SPARSER::PROTEIN)
    ("fat" . SPARSER::PROTEIN) ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN) ("tensin" . SPARSER::PROTEIN)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("ATM, p53 and phosphatidylinositol" . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::MOLECULE) ("ATM" . SPARSER::PROTEIN)
    ("telomerase" . SPARSER::PROTEIN)
    ("several other tumor-associated genes" . SPARSER::GENE)
    ("RICH2 , PCSK5 , ELF3 , WIPF1 , MCAM , COL8A1 , and GAS1"
     . SPARSER::COLLECTION)
    ("GO" . SPARSER::PROTEIN) ("polarized spherical acini" . SPARSER::PROTEIN)
    ("LPA, Myc, Wnt, PI3K, and PTEN" . SPARSER::COLLECTION)
    ("LPA" . SPARSER::PROTEIN)
    ("frequent loss of heterozygosity" . SPARSER::PROTEIN)
    ("BACH1 and FANCJ" . SPARSER::COLLECTION) ("FANCJ" . SPARSER::PROTEIN)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("an appreciable fraction" . SPARSER::COMPONENT)
    ("fraction" . SPARSER::COMPONENT)
    ("MCAM , COL8A1 , WIPF1 , RICH2 , PCSK5 , GAS1 , SATB1, and ELF3"
     . SPARSER::COLLECTION)
    ("MCAM" . SPARSER::PROTEIN) ("Differentially" . SPARSER::PROTEIN)
    ("acini" . SPARSER::PROTEIN) ("GSEA" . SPARSER::PROTEIN)
    ("MCF-10A" . SPARSER::PROTEIN) ("helicase" . SPARSER::PROTEIN)
    ("SATB 1" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lysophosphatidic acid" . SPARSER::LPA)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("3D" . SPARSER::PROTEIN-FAMILY) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("BACH1" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BRCA2" . SPARSER::PROTEIN)
    ("LPA receptor" . SPARSER::PROTEIN) ("ELF3" . SPARSER::PROTEIN)
    ("SATB1" . SPARSER::PROTEIN) ("GAS1" . SPARSER::PROTEIN)
    ("PCSK5" . SPARSER::PROTEIN) ("RICH2" . SPARSER::PROTEIN)
    ("WIPF1" . SPARSER::PROTEIN) ("COL8A1" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("BRIP1" . SPARSER::PROTEIN)
    ("AKT-ERK" . SPARSER::COLLECTION) ("MARCKS" . SPARSER::PROTEIN)
    ("step" . SPARSER::PROTEIN) ("survivin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCα, and miR-203" . SPARSER::COLLECTION) ("LNCaP" . SPARSER::PROTEIN)
    ("a tumor-suppressive microRNA" . SPARSER::MICRO-RNA)
    ("HCC" . SPARSER::PROTEIN) ("min" . SPARSER::PROTEIN)
    ("miR-203-resistant PKCα" . SPARSER::PROTEIN) ("ORF" . SPARSER::PROTEIN)
    ("si-PKCα" . SPARSER::COLLECTION) ("post" . SPARSER::PROTEIN)
    ("β-galactosidase and pre-miR-203" . SPARSER::COLLECTION)
    ("fused" . SPARSER::PROTEIN) ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("ncRNA or pre-miR-203" . SPARSER::COLLECTION) ("ncRNA" . SPARSER::RNA)
    ("perfect base" . SPARSER::PROTEIN) ("Mature miRNAs" . SPARSER::MICRO-RNA)
    ("mRNAs" . SPARSER::PROTEIN) ("regulators" . SPARSER::REGULATOR)
    ("uPA" . SPARSER::PROTEIN) ("urokinase" . SPARSER::PROTEIN)
    ("Staurosporine" . SPARSER::MOLECULE) ("discs" . SPARSER::BIO-COMPLEX)
    ("part" . SPARSER::COMPONENT) ("substrate" . SPARSER::SUBSTRATE)
    ("cofactor" . SPARSER::MOLECULE) ("serine/threonine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID) ("PKC" . SPARSER::PROTEIN)
    ("PKCα and miRNAs" . SPARSER::COLLECTION) ("PRKCA" . SPARSER::PROTEIN)
    ("Du145" . SPARSER::PROTEIN) ("Go6976" . SPARSER::DRUG)
    ("full-length" . SPARSER::PROTEIN) ("β- galactosidase" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hydrogen peroxide" . SPARSER::MOLECULE) ("CCK-8" . SPARSER::MOLECULE)
    ("a 20" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("plasminogen activator" . SPARSER::PROTEIN)
    ("IL1-beta" . SPARSER::PROTEIN) ("CL3" . SPARSER::PROTEIN)
    ("DLG1" . SPARSER::PROTEIN) ("large homolog 1" . SPARSER::PROTEIN)
    ("scaffold protein" . SPARSER::PROTEIN) ("ι/λ" . SPARSER::PROTEIN)
    ("Protein kinase" . SPARSER::PROTEIN) ("protein kinase" . SPARSER::PROTEIN)
    ("PKCα" . SPARSER::PROTEIN) ("SALL2 in Wilm’s" . SPARSER::PROTEIN)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("Runx3" . SPARSER::PROTEIN) ("Myc" . SPARSER::PROTEIN)
    ("examples" . SPARSER::EXAMPLE) ("SALL2 and p53" . SPARSER::COLLECTION)
    ("PTEN, ARF, and HIPK2" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("p53 and SALL2" . SPARSER::COLLECTION) ("/p53" . SPARSER::COLLECTION)
    ("hypoxia" . SPARSER::PROTEIN) ("GSE" . SPARSER::PROTEIN)
    ("MCF7" . SPARSER::PROTEIN) ("hepatocytes" . SPARSER::PROTEIN)
    ("gamma" . SPARSER::PROTEIN) ("AP4 or SP1" . SPARSER::COLLECTION)
    ("SP1" . SPARSER::PROTEIN)
    ("the humans polycystic kidney disease-1, and AP-endonuclease promoters"
     . SPARSER::PROMOTER)
    ("myc, or nanog" . SPARSER::COLLECTION)
    ("HSP90-beta" . SPARSER::COLLECTION) ("nanog" . SPARSER::PROTEIN)
    ("myc" . SPARSER::PROTEIN) ("beta" . SPARSER::PROTEIN)
    ("stathmin" . SPARSER::PROTEIN) ("map" . SPARSER::PROTEIN)
    ("corepressors" . SPARSER::PROTEIN) ("Chip" . SPARSER::PROTEIN)
    ("functional p53" . SPARSER::PROTEIN) ("receptor" . SPARSER::PROTEIN)
    ("example" . SPARSER::EXAMPLE) ("hot" . SPARSER::PROTEIN)
    ("pGL3-luciferase" . SPARSER::COLLECTION)
    ("repressor" . SPARSER::REPRESSOR) ("GT, TC or GA" . SPARSER::COLLECTION)
    ("TC" . SPARSER::PROTEIN) ("AG" . SPARSER::PROTEIN)
    ("AC" . SPARSER::PROTEIN)
    ("response element (RE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AA or TT" . SPARSER::COLLECTION) ("TG" . SPARSER::PROTEIN)
    ("GC" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("AT" . SPARSER::PROTEIN) ("systemic 4-hydroxytamoxifen" . SPARSER::DRUG)
    ("doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN) ("MEF" . SPARSER::PROTEIN)
    ("4-OHT-" . SPARSER::DRUG)
    ("p53 and a modified form" . SPARSER::COLLECTION)
    ("a nonspecific IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DO" . SPARSER::PROTEIN)
    ("formaldehyde" . SPARSER::MOLECULE) ("ChIP" . SPARSER::PROTEIN)
    ("PAb" . SPARSER::PROTEIN) ("antibody" . SPARSER::ANTIBODY)
    ("t" . SPARSER::PROTEIN) ("derivatives" . SPARSER::DERIVATIVE)
    ("Doxorubicin" . SPARSER::PROTEIN) ("Ser" . SPARSER::AMINO-ACID)
    ("serine" . SPARSER::AMINO-ACID) ("inactive" . SPARSER::INACTIVE)
    ("dinucleotide" . SPARSER::MOLECULE) ("Promoter" . SPARSER::PROMOTER)
    ("the human SALL2 and murine Sall2 promoter" . SPARSER::COLLECTION)
    ("ATG" . SPARSER::DRUG)
    ("TRED, TESS, TRANSFAC and MAPPER" . SPARSER::COLLECTION)
    ("NM" . SPARSER::PROTEIN) ("TESS" . SPARSER::PROTEIN)
    ("TRED" . SPARSER::PROTEIN) ("states" . SPARSER::BIO-STATE)
    ("CpG" . SPARSER::PROTEIN) ("SALL2 and AP4" . SPARSER::COLLECTION)
    ("promoters" . SPARSER::PROMOTER)
    ("Growth Factor (NGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rat" . SPARSER::PROTEIN) ("NGF" . SPARSER::PROTEIN)
    ("hedgehog" . SPARSER::PROTEIN) ("fish" . SPARSER::PROTEIN)
    ("Dpp" . SPARSER::MOLECULE) ("TGC" . SPARSER::PROTEIN)
    ("WAF" . SPARSER::PROTEIN) ("NTD" . SPARSER::PROTEIN)
    ("tube" . SPARSER::PROTEIN)
    ("SALL1, SALL3 and SALL4" . SPARSER::COLLECTION)
    ("limb" . SPARSER::PROTEIN) ("SALL" . SPARSER::PROTEIN)
    ("Sal" . SPARSER::PROTEIN) ("RNA and protein" . SPARSER::COLLECTION)
    ("MEFs" . SPARSER::PROTEIN) ("RNA" . SPARSER::RNA)
    ("TAM" . SPARSER::PROTEIN) ("ER" . SPARSER::PROTEIN)
    ("chromatin" . SPARSER::PROTEIN) ("mutants" . SPARSER::MUTANT)
    ("the genotoxic agent doxorubicin" . SPARSER::PROTEIN)
    ("doxorubicin" . SPARSER::PROTEIN) ("WT1 and AP4" . SPARSER::COLLECTION)
    ("neurotrophin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SALL2-" . SPARSER::PROTEIN) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIPK2" . SPARSER::PROTEIN) ("Zbtb4" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC1" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("4-OHT" . SPARSER::DRUG)
    ("estrogen receptor" . SPARSER::PROTEIN) ("4- OHT" . SPARSER::DRUG)
    ("as 2" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("1A" . SPARSER::PROTEIN) ("P40" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("β-galactosidase" . SPARSER::PROTEIN)
    ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β-Gal" . SPARSER::PROTEIN)
    ("β-Galactosidase" . SPARSER::PROTEIN) ("P21" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("GL2" . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN) ("4-Hydroxy-Tamoxifen" . SPARSER::DRUG)
    ("P53" . SPARSER::PROTEIN) ("Activator Protein" . SPARSER::PROTEIN)
    ("WT-1" . SPARSER::PROTEIN) ("Wilms tumor" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p21 protein" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("valproic acid" . SPARSER::MOLECULE)
    ("SALL4" . SPARSER::PROTEIN) ("SALL3" . SPARSER::PROTEIN)
    ("SALL1" . SPARSER::PROTEIN) ("4-hydroxy-tamoxifen" . SPARSER::DRUG)
    ("Sall2" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN) ("AP4" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("SALL2" . SPARSER::PROTEIN)
    ("a potential prognostic biomarker" . SPARSER::MOLECULE)
    ("PC and NP" . SPARSER::COLLECTION) ("family" . SPARSER::PROTEIN-FAMILY)
    ("bad" . SPARSER::PROTEIN) ("-UTR" . SPARSER::COLLECTION)
    ("multidrug" . SPARSER::PROTEIN)
    ("prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MiRNAs" . SPARSER::MICRO-RNA)
    ("STAT3 and miR-130b" . SPARSER::COLLECTION)
    ("western blot" . SPARSER::PROTEIN) ("MUT" . SPARSER::PROTEIN)
    ("the potential targets" . SPARSER::TARGET-PROTEIN)
    ("the potential target" . SPARSER::TARGET-PROTEIN)
    ("Target" . SPARSER::TARGET-PROTEIN) ("HP" . SPARSER::PROTEIN)
    ("Matrigel" . SPARSER::PROTEIN) ("NC" . SPARSER::PROTEIN)
    ("LV" . SPARSER::MOLECULE) ("MiR" . SPARSER::MICRO-RNA)
    ("independent prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cox" . SPARSER::PROTEIN) ("NP" . SPARSER::PROTEIN)
    ("VEGF and MMP-2" . SPARSER::COLLECTION) ("VEGF" . SPARSER::PROTEIN)
    ("a key cytoplasmic transcription factor that is activated by tyrosine kinase growth and cytokine receptors"
     . SPARSER::COLLECTION)
    ("receptors" . SPARSER::PROTEIN) ("microRNA" . SPARSER::MICRO-RNA)
    ("the potential direct target" . SPARSER::TARGET-PROTEIN)
    ("modulators" . SPARSER::PROTEIN) ("miRNA" . SPARSER::MICRO-RNA)
    ("UTR" . SPARSER::PROTEIN) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("RNAs" . SPARSER::RNA) ("MicroRNAs" . SPARSER::MICRO-RNA)
    ("luciferase" . SPARSER::PROTEIN) ("miR" . SPARSER::MICRO-RNA)
    ("miRNAs" . SPARSER::MICRO-RNA) ("microRNAs" . SPARSER::MICRO-RNA)
    ("CSF-1" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("triton X-100" . SPARSER::MOLECULE)
    ("Annexin V" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN) ("miR-34a" . SPARSER::MOLECULE)
    ("simple" . SPARSER::PROTEIN) ("cip" . SPARSER::PROTEIN)
    ("the homozygous SNP alleles" . SPARSER::ALLELE)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NRF2 and KEAP1" . SPARSER::COLLECTION)
    ("the KEAP1 and/or NRF2 genes" . SPARSER::COLLECTION)
    ("the MDM2 gene and the –617A allele" . SPARSER::COLLECTION)
    ("stimulatory protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oncoprotein" . SPARSER::PROTEIN) ("log-rank" . SPARSER::COLLECTION)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION) ("Iressa" . SPARSER::DRUG)
    ("enzymes, and ABC" . SPARSER::COLLECTION) ("ABC" . SPARSER::PROTEIN)
    ("Biomarker" . SPARSER::MOLECULE) ("Asians" . SPARSER::PROTEIN)
    ("Pan-Asian" . SPARSER::PROTEIN-PAIR) ("IRESSA" . SPARSER::DRUG)
    ("ALK" . SPARSER::PROTEIN) ("KRAS" . SPARSER::PROTEIN)
    ("the MDM2 gene as well as the SNP (–617C>A)" . SPARSER::COLLECTION)
    ("MDM2 and NRF2" . SPARSER::COLLECTION)
    ("NRF2 and MDM2" . SPARSER::COLLECTION)
    ("homozygous alleles" . SPARSER::ALLELE) ("adjuvant" . SPARSER::DRUG)
    ("n " . SPARSER::PROTEIN) ("the homozygous SNP" . SPARSER::PROTEIN)
    ("homozygous WT alleles" . SPARSER::ALLELE)
    ("heterozygous alleles" . SPARSER::ALLELE) ("gefitinib" . SPARSER::DRUG)
    ("either exon 19 or exon" . SPARSER::COLLECTION)
    ("seven" . SPARSER::PROTEIN) ("n" . SPARSER::PROTEIN)
    ("GT" . SPARSER::PROTEIN) ("thymine" . SPARSER::NUCLEOBASE)
    ("dye" . SPARSER::MOLECULE) ("TP, OP, FP, and BP" . SPARSER::COLLECTION)
    ("BP" . SPARSER::PROTEIN) ("FP" . SPARSER::PROTEIN)
    ("OP" . SPARSER::PROTEIN) ("TP" . SPARSER::PROTEIN)
    ("PRISM" . SPARSER::PROTEIN) ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("pGEM" . SPARSER::MOLECULE) ("TA" . SPARSER::PROTEIN)
    ("Gene" . SPARSER::GENE) ("IV" . SPARSER::PROTEIN)
    ("TNM" . SPARSER::MOLECULE) ("The histological type" . TYPE)
    ("age" . SPARSER::PROTEIN) ("the SNP homozygous allele" . SPARSER::ALLELE)
    ("homozygous SNP" . SPARSER::PROTEIN)
    ("the NRF2 gene and the 309T (WT) allele" . SPARSER::COLLECTION)
    ("homozygous SNP alleles" . SPARSER::ALLELE)
    ("the SNP homozygous SNP allele" . SPARSER::ALLELE)
    ("numerous phase II drug-metabolizing enzymes and phase III drug-transporters ( e.g. , ABCC1, ABCC2, ABCC4, and ABCG2)"
     . SPARSER::COLLECTION)
    ("ABCC1, ABCC2, ABCC4, and ABCG2" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN) ("III" . SPARSER::PROTEIN)
    ("II" . SPARSER::PROTEIN) ("oxidant" . SPARSER::PROTEIN)
    ("MAF" . SPARSER::PROTEIN)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("basic region-leucine zipper (CNC-bZip) transcription factor"
     . SPARSER::PROTEIN)
    ("CNC-bZip" . SPARSER::COLLECTION) ("bZip" . SPARSER::PROTEIN-FAMILY)
    ("CNC" . SPARSER::PROTEIN) ("leucine" . SPARSER::AMINO-ACID)
    ("the NRF2 gene and its genetic polymorphisms" . SPARSER::COLLECTION)
    ("impact" . SPARSER::PROTEIN) ("electrophiles" . SPARSER::MOLECULE)
    ("smoke" . SPARSER::MOLECULE)
    ("NRF2 SNP homozygous alleles" . SPARSER::ALLELE)
    ("rank" . SPARSER::PROTEIN) ("log" . SPARSER::PROTEIN)
    ("alleles" . SPARSER::ALLELE)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT) ("SNP" . SPARSER::PROTEIN)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("for 3" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("Mdm2" . SPARSER::PROTEIN) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("p21" . SPARSER::PROTEIN) ("p15" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("CYP2A6" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ABCG2" . SPARSER::PROTEIN) ("ABCC4" . SPARSER::PROTEIN)
    ("ABCC2" . SPARSER::PROTEIN) ("ABCC1" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("KEAP1" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("cap‘n’collar" . SPARSER::PROTEIN)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN) ("MDM2" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN) ("transcription factor" . SPARSER::PROTEIN)
    ("regulator" . SPARSER::REGULATOR) ("LPS-" . SPARSER::PROTEIN)
    ("LPS" . SPARSER::PROTEIN) ("inducer" . SPARSER::MOLECULE)
    ("JNK and ERK1/2 and GSH" . SPARSER::COLLECTION)
    ("ERK1/2 and GSH" . SPARSER::COLLECTION)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("nitrogen" . SPARSER::MOLECULE)
    ("ERK1/2 and not the vice versa" . SPARSER::COLLECTION)
    ("versa" . SPARSER::PROTEIN) ("JNK and ERK1/2" . SPARSER::COLLECTION)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("pharmacologic drugs" . SPARSER::DRUG)
    ("an essential component" . SPARSER::COMPONENT)
    ("component" . SPARSER::COMPONENT) ("state" . SPARSER::BIO-STATE)
    ("JNK-" . SPARSER::PROTEIN) ("antioxidants" . SPARSER::DRUG)
    ("the respective isoforms" . SPARSER::ISOFORM)
    ("BSO or combination" . SPARSER::COLLECTION)
    ("eNOS or nNOS" . SPARSER::COLLECTION) ("nNOS" . SPARSER::PROTEIN)
    ("eNOS" . SPARSER::PROTEIN) ("isoforms" . SPARSER::ISOFORM)
    ("NOS" . SPARSER::PROTEIN) ("isoform" . SPARSER::ISOFORM)
    ("ERK2 or JNK1" . SPARSER::COLLECTION)
    ("JNK1 or ERK2" . SPARSER::COLLECTION) ("JNK or ERK" . SPARSER::COLLECTION)
    ("Neither HCH nor BSO" . SPARSER::COLLECTION)
    ("JNK, ERK or p38" . SPARSER::COLLECTION)
    ("HCH, BSO and HCH" . SPARSER::COLLECTION)
    ("JNK and ERK" . SPARSER::COLLECTION) ("cPTIO" . SPARSER::DRUG)
    ("ester (GME)" . SPARSER::MOLECULE) ("GME" . SPARSER::PROTEIN)
    ("ester" . SPARSER::MOLECULE) ("pan-caspase" . SPARSER::COLLECTION)
    ("pan" . SPARSER::PROTEIN) ("partial" . SPARSER::PROTEIN)
    ("caspase-8 or caspase-9" . SPARSER::COLLECTION) ("Pan" . SPARSER::PROTEIN)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("Neither caspase-8 nor caspase-9" . SPARSER::COLLECTION)
    ("caspases" . SPARSER::PROTEIN) ("Caspase" . SPARSER::PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN) ("HCH-" . SPARSER::MOLECULE)
    ("annexin V and PI" . SPARSER::COLLECTION)
    ("Synergizes" . SPARSER::PROTEIN) ("HCH or BSO" . SPARSER::COLLECTION)
    ("cytotoxic" . SPARSER::PROTEIN) ("HCH and BSO" . SPARSER::COLLECTION)
    ("complex" . SPARSER::BIO-COMPLEX)
    ("the stress-activated protein kinase c-Jun NH2-terminal kinase (JNK) and the p38 kinase"
     . SPARSER::COLLECTION)
    ("kinases (ERK)" . SPARSER::KINASE) ("kinase (JNK)" . SPARSER::KINASE)
    ("extracellular" . SPARSER::PROTEIN) ("kinase" . SPARSER::KINASE)
    ("MAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("estradiol" . SPARSER::PROTEIN) ("enzyme" . SPARSER::PROTEIN)
    ("synthetase" . SPARSER::PROTEIN)
    ("isothiocyanate (PEITC)" . SPARSER::MOLECULE)
    ("sulforaphane" . SPARSER::PROTEIN) ("PEITC" . SPARSER::DRUG)
    ("isothiocyanate" . SPARSER::MOLECULE) ("drug" . SPARSER::DRUG)
    ("peroxiredoxins" . SPARSER::PROTEIN) ("thiol" . SPARSER::MOLECULE)
    ("redox" . SPARSER::PROTEIN) ("antioxidant" . SPARSER::PROTEIN)
    ("Glutathione" . SPARSER::DRUG) ("synergizes" . SPARSER::PROTEIN)
    ("iNOS-" . SPARSER::PROTEIN) ("effector" . SPARSER::EFFECTOR)
    ("ROS-" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("JNK" . SPARSER::PROTEIN) ("caspase" . SPARSER::PROTEIN)
    ("ROS and nitric oxide" . SPARSER::COLLECTION)
    ("DAF-FM" . SPARSER::COLLECTION) ("FM" . SPARSER::PROTEIN)
    ("DAF" . SPARSER::PROTEIN) ("diacetate" . SPARSER::MOLECULE)
    ("GSH" . SPARSER::DRUG)
    ("caspase- 3 and poly (ADP)-ribose polymerase proteins"
     . SPARSER::COLLECTION)
    ("iodide (PI)" . SPARSER::PROTEIN) ("cytometry (FCM)" . SPARSER::PROTEIN)
    ("AIF" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("ADP" . SPARSER::PROTEIN) ("PI" . SPARSER::PROTEIN)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("FITC" . SPARSER::MOLECULE) ("annexinV" . SPARSER::PROTEIN)
    ("FCM" . SPARSER::MOLECULE) ("cytometry" . SPARSER::PROTEIN)
    ("BSO and HCH" . SPARSER::COLLECTION) ("PC-3" . SPARSER::COLLECTION)
    ("PC" . SPARSER::PROTEIN) ("MIA" . SPARSER::PROTEIN)
    ("BSO" . SPARSER::DRUG) ("glutathione" . SPARSER::DRUG)
    ("CML" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("aim" . SPARSER::PROTEIN) ("ROS" . SPARSER::PROTEIN)
    ("HCH" . SPARSER::MOLECULE)
    ("gamma-glutamylcysteine synthetase" . SPARSER::PROTEIN)
    ("pro-oxidants" . SPARSER::MOLECULE)
    ("Nitric Oxide Synthase" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("JNK1" . SPARSER::PROTEIN) ("Nitric oxide" . SPARSER::MOLECULE)
    ("Apoptosis-inducing" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("PC3" . SPARSER::PROTEIN) ("serum albumin" . SPARSER::PROTEIN)
    ("Triton X-100" . SPARSER::MOLECULE) ("18 h" . SPARSER::PROTEIN)
    ("Nitric Oxide" . SPARSER::MOLECULE) ("H 2 O 2" . SPARSER::DRUG)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("annexin V" . SPARSER::PROTEIN) ("Cytochrome c" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("caspase 9" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("Z-IETD-FMK" . SPARSER::DRUG)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("SP600125" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE)
    ("extracellular signal regulated kinase 1/2" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NH2" . SPARSER::MOLECULE) ("c-Jun" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("DCF-DA" . SPARSER::DRUG)
    ("caspase- 3" . SPARSER::PROTEIN) ("JC-1" . SPARSER::MOLECULE)
    ("Anti-" . SPARSER::ANTIBODY) ("buthionine sulfoximine" . SPARSER::DRUG)
    ("synergistic biomarkers" . SPARSER::MOLECULE)
    ("biomarkers" . SPARSER::MOLECULE) ("oligonucleotide" . SPARSER::MOLECULE)
    ("both farnesyl transferase inhibitors and antisense oligonucleotides"
     . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE)
    ("BRAF or EGFR" . SPARSER::COLLECTION) ("target" . SPARSER::TARGET-PROTEIN)
    ("PARP" . SPARSER::PROTEIN) ("EGFR" . SPARSER::PROTEIN)
    ("BRAF" . SPARSER::PROTEIN) ("RAF/MAPK" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-ras and other Inhibitors" . SPARSER::COLLECTION)
    ("Inhibitors" . SPARSER::INHIBITOR) ("kB" . SPARSER::PROTEIN)
    ("components" . SPARSER::COMPONENT)
    ("oncogenes and tumor suppressor genes (APC, p53, K-ras)"
     . SPARSER::COLLECTION)
    ("variety" . SPARSER::VARIETY) ("APC" . SPARSER::PROTEIN)
    ("suppressor" . SPARSER::SUPPRESSOR) ("MMR" . SPARSER::PROTEIN)
    ("mismatch" . SPARSER::PROTEIN) ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IFN- α and antisense" . SPARSER::COLLECTION)
    ("antisense" . SPARSER::PROTEIN)
    ("melanoma and Kaposi" . SPARSER::COLLECTION)
    ("melanoma" . SPARSER::PROTEIN) ("HER-2/neu" . SPARSER::COLLECTION)
    ("neu" . SPARSER::PROTEIN) ("pro" . SPARSER::PROTEIN)
    ("interferon" . SPARSER::PROTEIN)
    ("IFN-α and IFN-β1a" . SPARSER::COLLECTION) ("peptides" . SPARSER::PEPTIDE)
    ("aberrant GM-CSF chronic myelomonocytic leukemia" . SPARSER::PROTEIN)
    ("leukemia" . SPARSER::PROTEIN) ("RAS/MAPK" . SPARSER::COLLECTION)
    ("RAS/ERK" . SPARSER::COLLECTION) ("JAK/STAT" . SPARSER::COLLECTION)
    ("JAK" . SPARSER::PROTEIN)
    ("a well-known hematopoietic and inflammatory cytokine" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN) ("cytokine" . SPARSER::PROTEIN)
    ("FTase" . SPARSER::PROTEIN)
    ("an autocrine growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-17 and IL-23" . SPARSER::COLLECTION)
    ("interleukins and K-ras" . SPARSER::COLLECTION)
    ("RAS-ERK-MAPK" . SPARSER::COLLECTION) ("trigger" . SPARSER::PROTEIN)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("line" . SPARSER::PROTEIN)
    ("red" . SPARSER::PROTEIN) ("inhibitors" . SPARSER::INHIBITOR)
    ("MTT" . SPARSER::MOLECULE) ("mRNA and protein" . SPARSER::COLLECTION)
    ("K-ras and IL-23" . SPARSER::COLLECTION)
    ("healthy control group" . SPARSER::MOLECULE)
    ("protein and mRNA" . SPARSER::COLLECTION) ("mRNA" . SPARSER::RNA)
    ("pg" . SPARSER::MOLECULE) ("Western Blot" . SPARSER::PROTEIN)
    ("IL-17, IL-22 and IL-23" . SPARSER::COLLECTION)
    ("Blot" . SPARSER::PROTEIN) ("Interleukin and K-ras" . SPARSER::COLLECTION)
    ("Interleukin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The collective observations shed light" . SPARSER::PROTEIN)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("light" . SPARSER::PROTEIN)
    ("targets" . SPARSER::TARGET-PROTEIN)
    ("STAT3 and its downstream anti-apoptotic proteins Bcl-2 and Bcl-xL"
     . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION) ("molecule" . SPARSER::MOLECULE)
    ("JAK1, Tyk2, and MAP kinases" . SPARSER::COLLECTION)
    ("kinases" . SPARSER::KINASE)
    ("CXCL8, CXCL6 and CXCL1" . SPARSER::COLLECTION)
    ("factor-kappa" . SPARSER::COLLECTION) ("neutrophil" . SPARSER::PROTEIN)
    ("macrophage" . SPARSER::PROTEIN) ("chemokines" . SPARSER::PROTEIN)
    ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("factor" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nuclear" . SPARSER::PROTEIN)
    ("active" . SPARSER::ACTIVE) ("past" . SPARSER::PROTEIN)
    ("MAPK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("STAT" . SPARSER::PROTEIN)
    ("activator" . SPARSER::ACTIVATOR)
    ("One such representative biomarker" . SPARSER::MOLECULE)
    ("GTP" . SPARSER::NUCLEOTIDE) ("oncogene" . SPARSER::ONCOGENE)
    ("biomarker" . SPARSER::MOLECULE)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("PTEN" . SPARSER::PROTEIN) ("PI3K/AKT" . SPARSER::COLLECTION)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("suppressors" . SPARSER::SUPPRESSOR) ("oncogenes" . SPARSER::ONCOGENE)
    ("genes" . SPARSER::GENE) ("form" . SPARSER::FORM)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("inhibitor" . SPARSER::INHIBITOR)
    ("K-ras and cytokines" . SPARSER::COLLECTION)
    ("GM-CSF and IFN-γ" . SPARSER::COLLECTION) ("cytokines" . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT)
    ("interleukin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("differentially" . SPARSER::PROTEIN) ("interleukins" . SPARSER::PROTEIN)
    ("IL-17, IL-22, and IL-23" . SPARSER::COLLECTION)
    ("molecules" . SPARSER::MOLECULE) ("types" . TYPE)
    ("Interleukins" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("TNF-a" . SPARSER::PROTEIN) ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("IFN- α" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("IFN-β" . SPARSER::PROTEIN) ("IFN-α" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("NF-kB" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-1b" . SPARSER::PROTEIN) ("IL-8" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN) ("1–C" . SPARSER::PROTEIN)
    ("farnesyl transferase inhibitor" . SPARSER::DRUG)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("L-glutamine" . SPARSER::MOLECULE) ("CO 2" . SPARSER::PROTEIN)
    ("Tween 20" . SPARSER::MOLECULE) ("per 1" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("-3" . SPARSER::PROTEIN)
    ("1L" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("mM 1" . SPARSER::PROTEIN)
    ("sodium chloride" . SPARSER::DRUG)
    ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("interferon gamma" . SPARSER::PROTEIN) (NIL . SPARSER::PROTEIN)
    ("TNF-alpha" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-xL" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("anti-" . SPARSER::ANTIBODY) ("STAT3" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Tyk2" . SPARSER::PROTEIN)
    ("JAK1" . SPARSER::PROTEIN) ("ICAM-1" . SPARSER::PROTEIN)
    ("IL-6" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN) ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("CXCL1" . SPARSER::PROTEIN) ("CXCL6" . SPARSER::PROTEIN)
    ("CXCL8" . SPARSER::PROTEIN) ("NF-κB" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("PI3K" . SPARSER::PROTEIN)
    ("PIK3CA" . SPARSER::PROTEIN) ("Manumycin A" . SPARSER::MOLECULE)
    ("IFN-γ" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("IL-22" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("carcinogenic chemicals" . SPARSER::MOLECULE) ("type" . TYPE)
    ("Meta" . SPARSER::PROTEIN) ("oxygen" . SPARSER::MOLECULE)
    ("nitrosamines" . SPARSER::MOLECULE) ("arylamines" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("Wang" . SPARSER::PROTEIN) ("Lao" . SPARSER::PROTEIN)
    ("modifiers" . SPARSER::MOLECULE) ("QC" . SPARSER::PROTEIN)
    ("pathological or histological conformation" . SPARSER::BIO-CONFORMATION)
    ("conformation" . SPARSER::BIO-CONFORMATION) ("allele" . SPARSER::ALLELE)
    ("variant" . SPARSER::VARIANT)
    ("XRCC1 and other BER proteins" . SPARSER::COLLECTION)
    ("protein–protein" . SPARSER::COLLECTION) ("His" . SPARSER::AMINO-ACID)
    ("Trp" . SPARSER::AMINO-ACID) ("Gln" . SPARSER::AMINO-ACID)
    ("Arg" . SPARSER::AMINO-ACID) ("exon" . SPARSER::PROTEIN)
    ("approximately 35 variants" . SPARSER::VARIANT)
    ("promoter" . SPARSER::PROMOTER) ("variants" . SPARSER::VARIANT)
    ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("a central scaffolding protein" . SPARSER::PROTEIN)
    ("polymerase" . SPARSER::PROTEIN) ("endonuclease" . SPARSER::PROTEIN)
    ("COOH" . SPARSER::PROTEIN)
    ("an essential DNA repair protein" . SPARSER::PROTEIN)
    ("Base" . SPARSER::PROTEIN) ("DNA" . SPARSER::DNA)
    ("cyclophosphamide" . SPARSER::DRUG) ("drugs" . SPARSER::DRUG)
    ("cigarette" . SPARSER::DRUG) ("factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TT" . SPARSER::PROTEIN) ("GA" . SPARSER::PROTEIN)
    ("CI" . SPARSER::PROTEIN) ("AA" . SPARSER::MOLECULE)
    ("met" . SPARSER::PROTEIN) ("case" . SPARSER::PROTEIN)
    ("CIs" . SPARSER::PROTEIN) ("period" . SPARSER::PROTEIN)
    ("proteins" . SPARSER::PROTEIN) ("gene" . SPARSER::PROTEIN)
    ("Variants" . SPARSER::VARIANT) ("enzymes" . SPARSER::ENZYME)
    ("scaffold" . SPARSER::SCAFFOLD) ("base" . SPARSER::PROTEIN)
    ("protein" . SPARSER::PROTEIN) ("group" . SPARSER::MOLECULE)
    ("and 1" . SPARSER::PROTEIN) ("amino acids" . SPARSER::AMINO-ACID)
    ("amino acid" . SPARSER::AMINO-ACID) ("ADP-ribose" . SPARSER::MOLECULE)
    ("polynucleotide kinase" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("DNA polymerase" . SPARSER::PROTEIN) ("DNA ligase III" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN)
    ("DNA repair protein" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("CI 1" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN)))